data_1hdn_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1hdn _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 ttp . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -120.7 134.07 55.31 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 125.639 1.837 . . . . 0.0 108.797 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -128.64 153.61 47.1 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.634 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -142.55 121.98 13.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.113 168.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -87.72 97.37 10.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 123.199 1.476 . . . . 0.0 111.275 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.57 155.48 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 112.118 -2.31 . . . . 0.0 108.113 -171.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 p -120.09 154.76 34.21 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.303 0.573 . . . . 0.0 112.215 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.5 115.16 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.154 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 p -99.24 -0.47 41.31 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.87 139.83 22.29 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 110.638 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -55.5 -68.79 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.655 2.903 . . . . 0.0 114.229 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.72 -35.77 80.84 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.245 1.018 . . . . 0.0 113.23 167.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.44 -135.62 19.87 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 124.957 1.411 . . . . 0.0 111.299 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tp -92.88 57.45 2.81 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 113.013 -1.594 . . . . 0.0 109.417 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -67.73 167.51 13.13 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.817 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.4 p 1.26 -68.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 118.687 2.847 . . . . 0.0 118.687 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.416 7.7 ptt-85 -85.18 -38.82 0.62 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -54.91 -41.46 78.36 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.214 2.61 . . . . 0.0 113.436 159.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.22 -47.27 81.73 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 171.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.26 -44.38 79.64 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -63.32 -42.05 98.97 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.69 1.196 . . . . 0.0 113.728 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -62.62 -43.42 98.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.297 0.639 . . . . 0.0 112.119 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.66 -48.16 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.56 0.744 . . . . 0.0 111.936 173.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tttm -43.74 -55.02 4.69 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.29 0.994 . . . . 0.0 111.781 172.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -66.03 -46.85 76.38 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 124.227 0.955 . . . . 0.0 112.674 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.75 70.3 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.814 1.245 . . . . 0.0 114.063 175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -61.17 -29.78 70.0 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.33 19.29 23.95 Favored Glycine 0 N--CA 1.481 1.663 0 O-C-N 124.225 0.953 . . . . 0.0 114.787 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -129.92 143.29 50.73 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.323 1.049 . . . . 0.0 110.669 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.413 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 59.2 p -67.21 -41.46 85.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.987 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.8 m -52.32 144.63 12.52 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.591 1.556 . . . . 0.0 113.111 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -86.82 92.38 8.96 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.137 0.97 . . . . 0.0 109.654 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 mp -76.96 107.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 112.66 -2.063 . . . . 0.0 109.478 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.7 m -106.86 137.67 44.47 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.09 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.58 115.07 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 112.48 -2.146 . . . . 0.0 107.398 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.9 m -111.58 97.7 6.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.451 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.6 m -92.94 93.83 8.59 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.169 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m120 48.52 76.97 0.11 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.443 -174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.09 -46.34 2.42 Favored Glycine 0 N--CA 1.488 2.146 0 CA-C-N 113.704 -1.589 . . . . 0.0 114.83 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -76.3 126.94 31.91 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.395 1.078 . . . . 0.0 113.156 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.0 p -108.75 141.2 41.1 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.51 135.97 24.14 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.399 167.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.5 t -67.52 127.85 34.25 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.286 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.39 -9.47 48.49 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 112.99 -1.914 . . . . 0.0 111.717 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -95.24 35.61 1.29 Allowed 'General case' 0 CA--C 1.552 1.055 0 O-C-N 121.181 -0.949 . . . . 0.0 111.744 173.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.5 t -154.29 117.23 4.45 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.334 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.9 mt -52.51 -61.58 2.19 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.041 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -52.45 -45.97 66.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.844 1.258 . . . . 0.0 113.751 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.39 -43.83 84.73 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 tp -72.45 -23.95 61.14 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -78.73 -27.19 44.82 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.6 p -86.2 -33.27 20.82 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -64.86 131.51 46.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.304 0.642 . . . . 0.0 111.732 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.83 90.39 0.21 Allowed Glycine 0 N--CA 1.476 1.319 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.91 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mt -107.93 76.78 1.07 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.057 0.943 . . . . 0.0 111.985 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 t -137.73 172.87 12.31 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.444 -1.707 . . . . 0.0 112.331 -168.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -35.9 125.56 0.72 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.763 2.025 . . . . 0.0 115.435 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.02 -92.14 1.16 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.372 1.463 . . . . 0.0 110.088 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 m 24.55 123.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 128.216 2.606 . . . . 0.0 117.895 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.8 102.3 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 112.358 -2.201 . . . . 0.0 106.226 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.85 106.77 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 113.294 -1.775 . . . . 0.0 112.173 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.0 m -83.47 115.23 21.98 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.945 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.4 mt -93.31 102.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.6 t -116.62 117.72 30.61 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.091 -171.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.19 126.29 50.3 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.927 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -127.93 122.75 33.21 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 125.003 1.44 . . . . 0.0 114.18 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.0 -168.01 31.79 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 113.033 -1.894 . . . . 0.0 110.575 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -52.82 -40.65 63.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.413 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 10.9 p30 -111.09 37.66 2.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -175.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -45.94 -58.5 3.5 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -59.62 -51.22 70.75 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.192 1.397 . . . . 0.0 113.859 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -56.72 -41.12 76.91 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.3 1.84 . . . . 0.0 112.387 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.92 -59.84 4.74 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.46 -44.94 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.067 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -49.2 -62.54 1.48 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.086 0.954 . . . . 0.0 112.127 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -66.0 -35.48 80.68 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.063 1.345 . . . . 0.0 113.766 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.3 mt -69.94 -30.69 68.14 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.9 t -62.63 -39.9 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.478 0.311 . . . . 0.0 110.322 171.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -57.4 -51.32 69.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.236 0.614 . . . . 0.0 112.261 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.5 -45.22 73.22 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.8 tpp -59.3 -48.74 80.49 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 172.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.21 -31.9 73.0 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -97.79 -27.64 14.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.1 mt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 -176.398 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.94 109.46 3.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 113.756 -1.565 . . . . 0.0 109.86 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.03 125.25 48.91 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 124.338 1.024 . . . . 0.0 109.403 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -129.9 130.86 45.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.298 -1.319 . . . . 0.0 114.357 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -98.16 90.45 4.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.173 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.1 t -96.2 126.48 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.158 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.7 m -102.32 120.31 40.27 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.6 125.14 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 124.974 1.421 . . . . 0.0 108.051 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 t -119.25 -22.1 7.26 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -171.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.22 142.85 98.07 Favored Pre-proline 0 N--CA 1.48 1.036 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.81 -30.95 78.24 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.436 2.757 . . . . 0.0 113.963 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -72.97 -49.51 28.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.831 0.852 . . . . 0.0 111.489 166.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.57 171.75 45.19 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.376 1.465 . . . . 0.0 112.129 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.1 mt -73.53 58.73 0.59 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.432 1.587 . . . . 0.0 110.49 164.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -70.19 -147.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 112.7 -2.045 . . . . 0.0 116.298 -166.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -60.49 -54.28 47.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.069 1.347 . . . . 0.0 113.566 -168.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -72.9 -36.77 3.6 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 116.57 -1.681 . . . . 0.0 113.517 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.78 -50.33 10.72 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.822 2.348 . . . . 0.0 112.017 165.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.11 -44.18 71.08 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.7 -47.01 77.53 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.058 0.943 . . . . 0.0 113.369 174.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -59.43 -46.09 89.71 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -63.78 -46.49 84.96 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.234 1.414 . . . . 0.0 113.293 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.6 t -56.64 -51.18 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 124.331 1.052 . . . . 0.0 110.461 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -52.5 -53.97 38.83 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.355 1.462 . . . . 0.0 110.9 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.17 -46.64 88.06 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.696 1.247 . . . . 0.0 114.024 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.78 70.71 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.984 0.914 . . . . 0.0 113.318 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -66.5 -12.18 56.18 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.97 21.21 44.51 Favored Glycine 0 CA--C 1.544 1.888 0 C-N-CA 124.309 0.957 . . . . 0.0 113.455 172.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -122.59 125.15 45.08 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.04 0.936 . . . . 0.0 108.49 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.2 p -57.95 -36.97 73.29 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.825 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 p -59.23 157.97 9.8 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.147 1.779 . . . . 0.0 112.624 168.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -111.76 136.13 51.44 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.386 1.089 . . . . 0.0 112.841 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.4 111.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 111.893 -2.412 . . . . 0.0 112.205 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.2 m -93.21 98.82 11.52 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 112.551 -2.113 . . . . 0.0 107.122 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.9 t -109.48 90.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.737 -172.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.1 p -104.74 101.8 11.4 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 112.376 -2.193 . . . . 0.0 113.684 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.0 t -60.27 103.86 0.27 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.521 166.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -19.32 90.12 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.881 2.472 . . . . 0.0 116.885 -172.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.08 -72.38 0.26 Allowed Glycine 0 CA--C 1.538 1.53 0 CA-C-N 112.793 -2.003 . . . . 0.0 114.35 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -114.25 144.12 43.74 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -170.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.4 m -76.01 130.6 38.66 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.52 131.29 7.13 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.945 -1.48 . . . . 0.0 112.909 -174.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.2 t -89.06 140.85 29.03 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.106 165.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.42 -23.2 66.89 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.744 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -82.14 31.17 0.38 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.6 t -160.23 113.32 2.1 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.959 -1.928 . . . . 0.0 109.182 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp -52.98 -62.24 1.78 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.596 -1.638 . . . . 0.0 112.871 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -63.77 -32.72 74.32 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -68.64 -39.64 80.63 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 123.731 0.644 . . . . 0.0 112.015 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -70.85 -53.27 15.87 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 123.522 0.514 . . . . 0.0 111.464 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -63.9 -28.15 69.64 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -173.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.5 t -71.45 -16.82 62.39 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.18 154.44 21.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.621 0.768 . . . . 0.0 111.575 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.33 94.11 0.04 OUTLIER Glycine 0 N--CA 1.479 1.523 0 C-N-CA 124.695 1.141 . . . . 0.0 112.84 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.4 mt -100.38 48.45 0.92 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.887 1.327 . . . . 0.0 110.565 170.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 t -132.03 168.94 17.07 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.573 -168.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -55.0 121.73 9.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.351 1.06 . . . . 0.0 111.902 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.51 -29.06 12.08 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 114.481 -1.236 . . . . 0.0 115.275 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.2 p -73.67 136.93 43.84 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.3 t -96.72 111.89 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.475 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 m -92.95 101.59 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.235 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.8 p -84.77 94.37 8.68 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.292 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.78 98.55 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 112.899 -1.955 . . . . 0.0 109.013 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -104.52 134.43 47.72 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.895 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.47 132.62 54.43 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -173.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.44 136.55 39.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.295 1.038 . . . . 0.0 113.162 174.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.8 -177.23 17.15 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 115.691 1.036 . . . . 0.0 115.691 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -54.84 -33.0 61.19 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -110.32 28.27 8.81 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -53.63 -57.62 10.12 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -172.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -47.35 72.51 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -57.73 -41.76 82.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.222 1.409 . . . . 0.0 112.613 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.21 -57.51 12.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.2 1.0 . . . . 0.0 112.599 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -67.96 -36.7 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.166 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -52.85 -57.18 11.08 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.036 0.835 . . . . 0.0 111.173 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -65.66 -40.62 92.65 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.6 -43.16 97.74 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -60.22 -43.67 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 122.893 0.477 . . . . 0.0 111.496 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -55.71 -43.66 76.71 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.853 0.861 . . . . 0.0 111.517 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.08 -56.89 15.66 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.772 0.829 . . . . 0.0 112.888 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 20.3 mtp -47.75 -45.08 28.66 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.613 1.165 . . . . 0.0 113.549 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.83 -43.72 63.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.769 1.627 . . . . 0.0 115.307 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -111.74 15.53 20.91 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 172.085 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttp . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -141.02 131.61 25.5 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.76 1.288 . . . . 0.0 109.095 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.7 127.35 49.15 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.799 -171.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -126.56 122.5 35.28 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.614 0.721 . . . . 0.0 112.664 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -79.5 103.24 9.28 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.272 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.25 135.58 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.653 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.22 128.89 50.07 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.154 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 mt -97.95 92.4 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 167.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -86.02 -24.72 26.3 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.7 133.98 46.13 Favored Pre-proline 0 N--CA 1.482 1.145 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -58.53 -47.35 19.44 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 123.83 3.02 . . . . 0.0 113.2 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -54.17 -36.37 63.31 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 166.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.92 -163.49 24.64 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 125.118 1.511 . . . . 0.0 113.791 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.4 mt -115.61 69.35 0.73 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.481 -1.86 . . . . 0.0 110.271 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -73.71 -175.04 1.93 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 111.864 -2.426 . . . . 0.0 114.976 -166.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.4 p -40.3 -40.52 1.17 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.254 9.6 mmm180 -75.34 -48.43 4.16 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 116.139 -1.886 . . . . 0.0 113.48 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -54.64 -47.86 24.46 Favored 'Trans proline' 0 N--CA 1.482 0.826 0 C-N-CA 122.214 1.943 . . . . 0.0 113.877 162.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.29 -41.57 72.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.07 -31.59 72.76 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -80.75 -37.53 30.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.581 0.752 . . . . 0.0 112.282 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -57.19 -46.34 82.94 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.255 1.022 . . . . 0.0 111.566 173.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.5 t -42.31 -61.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 125.227 1.411 . . . . 0.0 113.14 170.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -42.71 -50.03 5.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.986 1.315 . . . . 0.0 113.575 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -66.16 -47.88 72.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.907 0.883 . . . . 0.0 112.992 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.62 71.77 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -50.62 -52.8 36.17 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.09 -27.22 68.55 Favored Glycine 0 CA--C 1.541 1.661 0 O-C-N 125.843 1.964 . . . . 0.0 115.13 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -70.15 110.61 5.26 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -38.45 22.06 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.674 1.59 . . . . 0.0 111.617 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.02 140.31 57.86 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 169.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -92.1 101.52 14.05 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.938 1.827 . . . . 0.0 111.55 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.9 mm -71.68 82.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 110.22 -3.173 . . . . 0.0 110.108 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 m -73.69 104.59 4.67 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.795 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.4 t -98.1 85.58 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 112.611 -2.086 . . . . 0.0 106.962 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -86.79 97.69 10.77 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.422 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 t -70.44 92.15 0.8 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.379 172.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.289 37.7 p30 2.67 101.34 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 110.189 -3.187 . . . . 0.0 117.461 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.37 -87.05 0.42 Allowed Glycine 0 CA--C 1.541 1.685 0 CA-C-N 112.721 -2.036 . . . . 0.0 110.122 -168.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -94.96 140.07 30.46 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.202 0.525 . . . . 0.0 112.363 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.1 m -78.61 128.56 33.67 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.65 169.54 9.48 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.05 166.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -132.71 126.17 31.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.596 0.358 . . . . 0.0 110.781 -176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.05 -30.97 69.55 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.564 1.165 . . . . 0.0 112.925 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -72.73 -36.13 67.7 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.916 1.287 . . . . 0.0 113.403 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -96.73 102.84 14.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 122.321 1.058 . . . . 0.0 110.794 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.8 tp -44.3 -68.73 0.17 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 111.959 -2.382 . . . . 0.0 114.503 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -63.17 -41.66 99.27 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -55.91 -40.74 73.5 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.03 -47.54 68.15 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 118.927 -0.559 . . . . 0.0 111.677 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -63.66 -23.93 67.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -79.44 -27.98 41.67 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.33 168.82 15.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.044 0.938 . . . . 0.0 112.343 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.1 117.19 4.77 Favored Glycine 0 CA--C 1.546 2.002 0 C-N-CA 125.256 1.408 . . . . 0.0 113.428 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.6 mt -123.7 60.53 1.09 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.405 1.098 . . . . 0.0 109.2 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 t -153.08 -169.59 3.37 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.259 -160.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -49.01 104.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.163 2.185 . . . . 0.0 113.128 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.23 -18.65 56.27 Favored Glycine 0 CA--C 1.547 2.093 0 CA-C-N 112.919 -1.946 . . . . 0.0 114.556 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.4 p -69.61 125.16 25.88 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.266 0.627 . . . . 0.0 111.838 -166.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.9 t -97.83 122.56 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.802 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.5 m -105.04 103.45 15.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.067 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.0 p -83.22 88.15 6.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.965 -1.925 . . . . 0.0 109.502 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.8 mt -72.14 94.19 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 111.622 -2.536 . . . . 0.0 108.625 -172.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 t -101.41 84.22 2.58 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.377 -1.738 . . . . 0.0 109.726 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 100.41 5.7 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.624 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.42 136.34 34.83 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.285 -1.325 . . . . 0.0 113.784 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.49 -147.9 16.32 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 112.735 -2.029 . . . . 0.0 114.172 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -67.32 -25.29 65.94 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 -163.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -106.74 -1.69 22.37 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -8.0 -70.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 120.323 3.453 . . . . 0.0 120.323 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.24 -48.08 37.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -175.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -55.66 -32.91 63.62 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.393 1.477 . . . . 0.0 112.233 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.16 -63.7 1.01 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.724 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 t -55.03 -41.29 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.709 0.804 . . . . 0.0 111.916 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -45.43 -60.8 1.96 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.054 1.342 . . . . 0.0 112.203 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -69.28 -45.84 68.65 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 114.797 -1.092 . . . . 0.0 113.055 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.35 -35.46 77.5 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.04 -43.54 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.429 0.692 . . . . 0.0 110.655 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -48.92 -48.28 42.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.378 1.071 . . . . 0.0 111.988 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.4 mt -59.73 -59.1 5.98 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 123.914 0.759 . . . . 0.0 113.011 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 mtt -48.61 -27.2 2.65 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.88 67.49 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -123.34 44.99 2.54 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.905 0.859 . . . . 0.0 112.626 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 119.626 3.195 . . . . 0.0 119.626 -171.288 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.475 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 18.6 ttp . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -108.0 126.25 52.5 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 124.955 1.409 . . . . 0.0 109.523 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.61 116.02 26.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.815 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -119.2 121.79 40.51 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.694 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -81.54 113.02 19.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 112.743 -2.026 . . . . 0.0 108.72 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.6 t -124.84 141.05 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 113.427 -1.715 . . . . 0.0 108.88 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.4 p -113.9 121.01 42.67 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.979 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.09 126.34 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 5.1 t -126.14 55.52 1.48 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.74 114.87 65.5 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-N 112.205 -2.271 . . . . 0.0 113.602 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.72 -35.43 57.73 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.595 2.197 . . . . 0.0 112.126 171.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -52.1 66.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.286 1.834 . . . . 0.0 113.128 168.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.97 146.05 1.25 Allowed Glycine 0 N--CA 1.483 1.806 0 O-C-N 124.706 1.254 . . . . 0.0 115.462 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.25 79.06 9.66 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.169 1.461 . . . . 0.0 111.008 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -67.41 -167.03 0.06 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 112.501 -2.136 . . . . 0.0 114.795 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.7 p -51.86 -45.04 63.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.191 1.796 . . . . 0.0 115.347 -175.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.251 13.9 mmm180 -73.04 -45.5 8.31 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 116.44 -1.743 . . . . 0.0 114.337 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.31 -45.8 35.14 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.269 1.979 . . . . 0.0 112.647 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -44.24 79.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.32 99.18 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -64.94 -43.07 93.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.078 0.951 . . . . 0.0 111.14 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -62.02 -41.4 98.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.06 1.344 . . . . 0.0 111.994 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.6 t -53.36 -47.49 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.063 0.545 . . . . 0.0 111.545 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -60.39 -47.22 87.04 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 119.08 -0.486 . . . . 0.0 112.135 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.08 -42.07 99.56 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.04 89.64 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.421 1.088 . . . . 0.0 113.715 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -60.95 -28.4 68.94 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.73 -43.77 98.47 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.095 1.331 . . . . 0.0 113.3 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -78.38 147.0 34.28 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.513 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 81.0 p -70.64 -38.53 73.87 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.486 -172.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.0 p -64.36 152.5 41.14 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -92.35 107.42 19.2 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.891 1.329 . . . . 0.0 111.288 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.2 mm -75.28 104.94 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 111.043 -2.798 . . . . 0.0 109.825 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -110.29 114.24 27.54 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.134 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.55 100.97 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.618 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.5 m -86.34 97.05 10.2 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.653 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -76.74 100.59 5.49 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.888 171.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.313 12.6 p-10 -0.55 87.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 -168.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.61 -60.73 0.55 Allowed Glycine 0 N--CA 1.483 1.815 0 CA-C-N 111.397 -2.638 . . . . 0.0 111.916 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.61 116.07 31.85 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 m -74.78 111.84 10.38 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 113.472 -1.694 . . . . 0.0 114.912 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.12 112.54 21.87 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.45 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -68.44 115.13 7.5 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.752 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.23 -14.67 62.3 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.333 -1.758 . . . . 0.0 112.269 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -81.77 10.44 6.22 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 167.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.9 t -133.91 127.41 32.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.369 0.668 . . . . 0.0 111.933 169.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.1 tp -47.74 -69.14 0.13 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.389 1.876 . . . . 0.0 110.972 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -51.67 -45.16 63.31 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.221 1.408 . . . . 0.0 113.418 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -64.94 -52.63 55.28 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 tp -63.0 -46.33 88.17 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.78 -0.629 . . . . 0.0 112.319 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -56.72 -32.88 65.96 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -78.87 -2.22 38.75 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.22 140.45 49.78 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.27 118.27 6.21 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 113.52 -1.673 . . . . 0.0 113.307 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.35 87.35 2.67 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 168.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -135.3 -132.37 0.15 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.993 -162.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -86.57 134.75 33.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.696 0.798 . . . . 0.0 111.636 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.28 -61.22 4.43 Favored Glycine 0 N--CA 1.484 1.876 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.763 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 p -3.09 114.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.26 108.03 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 112.45 -2.159 . . . . 0.0 107.325 -174.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.74 119.78 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.885 -172.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -103.97 104.27 14.22 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.945 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -87.0 103.01 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.677 -2.056 . . . . 0.0 107.466 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 t -101.24 108.86 20.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.663 173.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.66 97.73 9.95 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.825 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.18 100.96 12.68 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.77 -173.5 33.15 Favored Glycine 0 N--CA 1.48 1.592 0 CA-C-N 111.543 -2.572 . . . . 0.0 111.172 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.98 -55.88 28.59 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.513 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 24.8 p30 -81.3 33.73 0.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.475 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 11.5 pt-20 -41.95 -50.1 4.55 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.053 2.141 . . . . 0.0 115.878 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.468 ' NE2' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -69.54 -55.45 10.15 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.378 1.471 . . . . 0.0 114.478 -178.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -67.44 -33.77 75.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.82 -55.88 25.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.063 -0.972 . . . . 0.0 112.012 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.0 t -64.1 -45.25 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.98 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -52.34 -54.3 33.43 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.697 1.199 . . . . 0.0 113.847 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -63.01 -40.32 97.41 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.2 mt -67.34 -37.59 83.52 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.47 -46.05 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.304 1.042 . . . . 0.0 111.094 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -48.38 -53.44 17.62 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 124.441 1.088 . . . . 0.0 111.382 170.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.91 -45.92 91.62 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 45.8 mtm -52.13 -50.94 60.72 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.092 0.87 . . . . 0.0 112.354 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.59 79.88 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.275 12.9 pt-20 -82.5 -18.45 41.53 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.4 mt . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 176.438 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.43 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 1.3 mmm . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -139.3 142.11 37.71 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.94 1.4 . . . . 0.0 110.976 -172.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -128.66 130.93 47.91 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 124.809 1.318 . . . . 0.0 110.315 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -112.66 113.06 25.0 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.271 -1.332 . . . . 0.0 111.212 163.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -77.73 92.83 4.2 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.008 -1.905 . . . . 0.0 109.717 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.81 147.05 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 112.249 -2.25 . . . . 0.0 108.762 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -114.22 153.68 29.22 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.031 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mt -115.24 104.81 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 167.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -118.48 53.79 0.96 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.116 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.72 121.64 29.71 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 111.765 -2.471 . . . . 0.0 110.86 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -55.55 -44.4 48.64 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.212 3.274 . . . . 0.0 111.473 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -60.19 -59.57 5.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.394 1.878 . . . . 0.0 112.768 168.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.22 -168.22 54.82 Favored Glycine 0 N--CA 1.478 1.485 0 C-N-CA 124.71 1.148 . . . . 0.0 113.955 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 tp -99.64 58.18 1.04 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 124.161 1.934 . . . . 0.0 108.837 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -62.86 -169.6 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 113.099 -1.864 . . . . 0.0 115.61 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.36 -60.25 2.45 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -166.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.301 9.4 mmm180 -73.68 -37.84 3.69 Favored Pre-proline 0 N--CA 1.485 1.28 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -54.57 -50.9 11.83 Favored 'Trans proline' 0 N--CA 1.478 0.61 0 C-N-CA 122.854 2.369 . . . . 0.0 113.082 167.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.73 -42.98 84.96 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 172.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.5 88.72 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -66.7 -43.09 85.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.769 0.827 . . . . 0.0 111.79 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -59.66 -39.49 84.58 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.064 1.745 . . . . 0.0 112.301 172.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.51 -51.43 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.107 0.963 . . . . 0.0 111.585 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -49.08 -49.74 40.19 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.791 0.682 . . . . 0.0 111.71 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.59 -49.79 71.97 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.314 1.008 . . . . 0.0 113.624 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.96 70.79 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -65.33 -26.12 67.9 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.45 -35.82 90.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 124.157 0.911 . . . . 0.0 113.71 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -71.44 154.99 41.12 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.492 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 76.0 p -73.88 -45.33 51.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.404 177.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.3 p -70.03 150.24 46.85 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.175 0.99 . . . . 0.0 112.885 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -94.22 101.37 13.35 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.842 1.306 . . . . 0.0 110.541 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.42 111.57 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 110.883 -2.871 . . . . 0.0 110.021 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.02 120.26 41.26 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.176 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.9 t -108.78 84.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.282 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.0 m -81.86 110.95 17.63 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.925 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.0 t -85.48 99.82 11.47 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.104 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 2.56 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 128.01 2.524 . . . . 0.0 117.462 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.17 -45.04 1.33 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 112.836 -1.983 . . . . 0.0 113.005 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.87 134.95 53.46 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 m -72.06 137.8 47.4 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 113.954 -1.475 . . . . 0.0 112.943 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.07 137.16 37.5 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.024 171.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -107.54 118.83 37.77 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.51 0.671 . . . . 0.0 109.808 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.61 -30.98 71.04 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 113.725 -1.58 . . . . 0.0 112.143 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -77.28 16.01 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.827 0.851 . . . . 0.0 113.196 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -154.17 118.87 4.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.56 1.544 . . . . 0.0 112.454 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.6 tp -53.37 -71.0 0.08 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.503 -1.681 . . . . 0.0 114.611 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -63.13 -31.41 72.55 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.28 -37.7 86.07 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.113 0.565 . . . . 0.0 111.718 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.6 tp -72.88 -54.56 8.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.023 0.529 . . . . 0.0 112.366 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -55.33 -38.29 68.54 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 t -61.19 -18.58 58.93 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.64 157.72 16.47 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.85 93.81 0.19 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 113.457 -1.701 . . . . 0.0 113.362 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.3 mt -103.82 56.75 0.73 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.647 -1.276 . . . . 0.0 111.134 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.5 t -143.03 178.63 7.56 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.52 -168.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -52.45 123.22 10.42 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.835 1.254 . . . . 0.0 113.586 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.99 34.18 10.16 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 112.784 -2.007 . . . . 0.0 113.347 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 p -119.3 140.2 50.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.658 0.383 . . . . 0.0 111.934 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.7 t -108.49 105.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.5 m -107.34 92.13 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.394 -171.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.6 p -78.52 102.44 7.89 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.579 -1.646 . . . . 0.0 110.2 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 58.6 mt -87.14 95.93 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.374 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.5 t -104.21 122.22 44.92 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.827 -1.988 . . . . 0.0 110.913 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -109.42 115.16 29.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.602 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.87 102.86 12.27 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 112.858 -1.973 . . . . 0.0 112.434 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.82 -162.79 28.98 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 112.766 -2.015 . . . . 0.0 113.266 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -63.06 -61.04 2.65 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 -169.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.492 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 9.3 p30 -82.12 47.05 1.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.43 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 9.5 pt-20 -48.62 -39.38 23.83 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 112.322 -2.217 . . . . 0.0 116.482 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.4 -53.16 4.97 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -66.09 -44.66 83.76 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.302 1.441 . . . . 0.0 113.971 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.18 83.53 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.878 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.36 -47.4 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.438 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -47.52 -57.06 5.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.253 1.421 . . . . 0.0 112.929 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -59.48 -46.25 89.32 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.01 -39.31 87.04 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.76 -46.58 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.588 0.755 . . . . 0.0 110.338 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -50.83 -49.91 57.72 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.663 1.227 . . . . 0.0 111.993 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.9 -54.15 49.84 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.185 0.594 . . . . 0.0 112.514 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 49.6 ttm -54.28 -42.07 69.6 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.227 1.011 . . . . 0.0 112.739 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.44 92.6 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.85 22.97 6.72 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 125.195 1.398 . . . . 0.0 113.073 171.441 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -119.69 143.17 47.89 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.857 1.348 . . . . 0.0 111.111 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -127.06 136.06 51.64 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.48 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -133.97 106.85 7.47 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.188 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -78.03 92.76 4.39 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.231 1.491 . . . . 0.0 115.002 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.4 t -109.35 137.89 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.258 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 p -93.58 147.18 23.23 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -112.85 122.62 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.779 168.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 t -115.75 -27.0 7.2 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.609 -1.632 . . . . 0.0 114.84 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.54 137.27 17.21 Favored Pre-proline 0 N--CA 1.493 1.701 0 C-N-CA 124.72 1.208 . . . . 0.0 112.996 172.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -54.88 -54.07 5.04 Favored 'Trans proline' 0 CA--C 1.552 1.382 0 C-N-CA 124.468 3.446 . . . . 0.0 114.546 -171.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -63.95 -33.18 75.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.19 -170.2 38.3 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 124.993 1.282 . . . . 0.0 112.674 -163.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.03 81.89 7.82 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 113.509 -1.345 . . . . 0.0 108.941 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -62.75 175.59 0.8 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.577 -2.101 . . . . 0.0 115.351 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.1 p -58.18 -37.98 75.79 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -167.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -70.52 -46.74 18.64 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 116.608 -1.663 . . . . 0.0 113.414 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.78 -45.86 30.29 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.245 2.63 . . . . 0.0 113.457 164.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -39.59 72.89 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.14 86.94 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -58.63 -41.96 87.17 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.784 0.833 . . . . 0.0 111.468 172.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -58.78 -50.93 72.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.987 1.315 . . . . 0.0 111.692 172.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -54.77 -42.65 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.351 0.66 . . . . 0.0 112.575 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -52.53 -55.0 25.17 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.779 0.432 . . . . 0.0 111.127 175.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -62.57 -43.76 98.01 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.202 0.601 . . . . 0.0 111.546 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.31 78.87 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -51.18 -36.17 39.84 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.75 27.96 12.78 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.724 1.154 . . . . 0.0 115.489 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -117.86 149.93 40.04 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.142 0.577 . . . . 0.0 110.768 165.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.507 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 82.3 p -69.23 -45.43 69.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.052 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.5 p -55.23 136.06 49.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.64 1.176 . . . . 0.0 113.498 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -91.51 83.76 5.44 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.616 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . 0.428 ' CD1' ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -64.57 92.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 110.509 -3.041 . . . . 0.0 113.42 176.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.51 113.37 21.71 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.626 172.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -98.19 94.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 122.559 1.171 . . . . 0.0 107.97 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.3 m -88.81 118.42 28.5 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.453 -1.703 . . . . 0.0 110.877 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.3 t -90.15 90.95 8.33 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 112.852 -1.976 . . . . 0.0 111.066 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.26 26.4 p30 32.81 67.47 0.17 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.958 1.703 . . . . 0.0 114.859 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.13 -49.04 1.09 Allowed Glycine 0 N--CA 1.48 1.577 0 CA-C-N 113.043 -1.889 . . . . 0.0 112.93 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -68.15 93.69 0.46 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 m -58.44 106.41 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.489 -1.687 . . . . 0.0 115.431 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.79 97.24 5.35 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.1 -1.409 . . . . 0.0 113.083 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -47.65 106.09 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.717 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 -4.64 37.67 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.459 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -78.54 -15.98 57.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.44 0.696 . . . . 0.0 112.592 163.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.8 t -103.49 106.23 16.69 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.226 1.012 . . . . 0.0 110.656 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 tt -46.06 -40.23 10.42 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 112.336 -2.211 . . . . 0.0 112.931 169.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -59.35 -62.97 1.48 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.58 1.152 . . . . 0.0 109.846 174.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -57.39 -41.14 79.7 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 tp -76.15 -37.59 57.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -80.43 -15.91 55.66 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.4 t -87.13 -25.79 23.94 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 168.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.5 127.27 36.18 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 122.278 1.037 . . . . 0.0 111.834 171.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.71 103.38 2.2 Favored Glycine 0 N--CA 1.479 1.561 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.586 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mp -80.8 67.07 6.56 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.24 1.019 . . . . 0.0 109.389 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.5 t -126.62 156.94 40.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.444 -1.253 . . . . 0.0 113.349 -164.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -18.12 109.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.354 2.262 . . . . 0.0 115.83 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.19 14.1 40.11 Favored Glycine 0 CA--C 1.539 1.536 0 CA-C-N 113.169 -1.832 . . . . 0.0 114.766 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.7 p -103.4 124.87 49.52 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.485 1.136 . . . . 0.0 113.609 173.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.7 110.77 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 112.52 -2.127 . . . . 0.0 106.06 165.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 m -102.01 100.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.125 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.6 p -77.01 104.73 7.67 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 113.083 -1.871 . . . . 0.0 110.856 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mt -85.17 94.21 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.439 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.3 t -94.27 102.22 14.22 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 112.816 -1.993 . . . . 0.0 110.716 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.26 100.0 11.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.515 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -97.05 101.33 12.88 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.323 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.67 -164.76 34.27 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 112.195 -2.275 . . . . 0.0 110.501 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -82.1 -47.91 12.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 117.152 2.278 . . . . 0.0 117.152 -174.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.507 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 9.6 p30 -80.71 40.52 0.52 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 173.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -47.78 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.99 2.116 . . . . 0.0 116.243 -173.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -36.09 69.16 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -72.01 -46.25 57.89 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.098 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.64 -47.03 87.19 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.117 0.886 . . . . 0.0 111.462 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.2 t -58.66 -54.37 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.059 0.944 . . . . 0.0 111.114 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -52.83 -51.39 61.07 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.341 1.056 . . . . 0.0 112.978 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -63.61 -41.15 98.33 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.2 mt -69.68 -31.56 69.68 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.08 -45.2 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.921 0.889 . . . . 0.0 110.521 171.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -50.45 -46.15 56.48 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.376 1.071 . . . . 0.0 111.59 167.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.66 -50.35 73.84 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 173.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 92.3 mtp -44.72 -48.7 10.75 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.379 1.072 . . . . 0.0 113.381 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.04 -32.64 74.27 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.27 13.7 pt-20 -100.47 25.57 7.56 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.322 1.058 . . . . 0.0 113.779 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.5 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 127.724 2.41 . . . . 0.0 111.287 173.935 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.464 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 9.0 tmm? . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -125.54 134.3 52.04 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 125.336 1.647 . . . . 0.0 108.231 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.59 145.42 45.41 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 124.785 1.303 . . . . 0.0 113.764 -173.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -157.14 117.73 3.57 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 125.481 1.738 . . . . 0.0 112.19 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.27 132.98 40.18 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.562 169.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.17 129.84 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.424 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 p -81.67 143.41 31.91 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.453 -1.248 . . . . 0.0 112.395 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mt -120.44 113.53 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.57 167.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 t -100.75 -17.86 16.74 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.25 -1.796 . . . . 0.0 114.371 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.04 143.7 94.67 Favored Pre-proline 0 N--CA 1.477 0.895 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 169.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -42.08 -76.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 1 C-N-CA 125.547 4.165 . . . . 0.0 116.095 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -90.56 -22.5 21.25 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.85 -103.09 0.47 Allowed Glycine 0 N--CA 1.479 1.532 0 C-N-CA 125.533 1.54 . . . . 0.0 113.771 169.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.8 mt -97.35 66.21 2.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 112.396 -1.902 . . . . 0.0 108.501 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -66.49 -155.52 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 113.709 -1.587 . . . . 0.0 113.629 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -61.03 -49.73 76.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.259 1.424 . . . . 0.0 113.61 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.51 -43.74 53.14 Favored Pre-proline 0 N--CA 1.484 1.271 0 CA-C-O 116.041 -1.933 . . . . 0.0 115.126 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -60.59 -40.99 51.37 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.585 2.19 . . . . 0.0 111.977 168.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.07 94.24 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.61 -49.78 71.88 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -56.37 -47.98 77.76 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -50.65 -43.66 57.32 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.984 1.428 . . . . 0.0 113.471 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 t -59.93 -54.54 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 123.802 0.689 . . . . 0.0 111.175 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -54.24 -47.24 72.46 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.492 1.12 . . . . 0.0 112.456 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -66.64 -53.76 30.6 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.776 1.298 . . . . 0.0 113.134 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.02 -37.88 67.2 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.261 1.025 . . . . 0.0 113.42 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.9 mmtt -47.11 -34.0 5.58 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.87 28.93 13.28 Favored Glycine 0 CA--C 1.539 1.534 0 O-C-N 124.866 1.354 . . . . 0.0 114.263 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.82 145.54 41.28 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.708 0.803 . . . . 0.0 110.971 168.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.45 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 75.8 p -78.77 -28.85 44.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 124.412 1.07 . . . . 0.0 112.552 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.2 p -77.55 139.28 39.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.044 164.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.37 99.34 8.63 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.882 0.849 . . . . 0.0 110.727 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.72 101.7 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 112.035 -2.348 . . . . 0.0 111.022 173.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -100.49 131.84 46.19 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.025 171.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.4 t -118.17 91.22 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 m -83.63 137.99 33.55 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.901 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.8 t -127.41 92.43 3.5 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 170.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.265 20.6 p30 47.47 88.47 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 112.786 -2.006 . . . . 0.0 115.726 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.54 -49.26 2.69 Favored Glycine 0 N--CA 1.483 1.774 0 CA-C-N 113.383 -1.735 . . . . 0.0 114.025 -174.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -64.37 103.92 0.71 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 m -88.82 109.74 20.45 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.109 -1.405 . . . . 0.0 114.531 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.74 96.06 5.66 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.703 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.6 t -59.22 116.01 3.6 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.373 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.6 -22.74 65.48 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.445 -1.252 . . . . 0.0 114.102 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -71.03 0.76 6.8 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.6 t -131.73 118.77 20.4 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.879 0.871 . . . . 0.0 110.538 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -55.55 -42.82 75.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.655 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.08 -60.7 2.98 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.366 171.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -61.26 -30.97 70.79 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.3 tp -86.3 -53.92 4.74 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -67.93 -14.16 62.75 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -173.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -68.25 -32.78 73.2 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 165.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.71 143.44 39.99 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.099 0.952 . . . . 0.0 111.578 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.82 108.02 3.57 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 113.162 -1.836 . . . . 0.0 110.355 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.71 90.48 3.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 125.61 1.418 . . . . 0.0 107.301 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -149.57 -172.46 4.15 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.553 -160.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -57.13 113.34 1.67 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.064 0.946 . . . . 0.0 111.908 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.5 -35.68 4.9 Favored Glycine 0 N--CA 1.484 1.885 0 CA-C-N 112.301 -2.227 . . . . 0.0 113.595 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.7 p -64.37 101.87 0.48 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.779 0.832 . . . . 0.0 112.217 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.8 t -76.72 101.72 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 113.415 -1.72 . . . . 0.0 106.786 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 m -94.77 128.2 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 112.951 -1.931 . . . . 0.0 112.701 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -98.35 109.26 22.05 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.366 -171.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 mt -82.41 112.32 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 173.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 t -120.46 110.56 16.64 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 111.718 -2.492 . . . . 0.0 108.842 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.47 97.16 7.43 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.04 93.02 9.36 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.17 -163.03 29.4 Favored Glycine 0 CA--C 1.541 1.686 0 CA-C-N 112.645 -2.071 . . . . 0.0 113.83 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -54.76 -60.61 3.13 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 118.926 2.936 . . . . 0.0 118.926 -169.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.45 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 14.9 p30 -83.28 36.52 0.52 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.464 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 8.3 pt-20 -40.82 -69.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -42.68 99.01 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -67.39 -44.44 78.87 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.91 86.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.533 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.64 -47.66 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.334 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -49.39 -49.94 42.53 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.695 1.198 . . . . 0.0 110.95 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -57.83 -57.13 14.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.28 1.832 . . . . 0.0 112.072 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 -26.31 67.07 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 t -66.74 -47.63 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 167.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -54.37 -52.29 62.1 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.598 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -52.52 -57.41 10.04 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.7 mtt -52.43 -39.79 61.43 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.04 -44.07 73.4 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.543 1.152 . . . . 0.0 113.929 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.314 10.3 pt-20 -72.4 -27.08 62.14 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.4 mt . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -178.479 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tmm? . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -88.23 130.77 34.99 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.755 0.788 . . . . 0.0 110.023 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -134.05 142.32 47.53 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.073 -1.876 . . . . 0.0 111.72 -173.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -147.71 139.72 24.19 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 124.94 1.4 . . . . 0.0 110.602 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -93.34 131.4 38.53 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.915 0.759 . . . . 0.0 112.535 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.84 136.14 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.611 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.0 p -102.43 108.91 20.4 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 112.588 -2.096 . . . . 0.0 110.631 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 mt -71.19 96.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 113.12 -1.854 . . . . 0.0 107.503 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 t -86.26 -26.91 24.73 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 113.24 -1.8 . . . . 0.0 113.501 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.1 135.36 80.57 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 124.18 0.992 . . . . 0.0 111.219 171.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -46.34 -37.65 19.36 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 124.638 3.559 . . . . 0.0 116.435 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.29 -37.06 2.07 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.97 -93.5 0.41 Allowed Glycine 0 N--CA 1.476 1.309 0 O-C-N 124.031 0.832 . . . . 0.0 112.903 163.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -94.4 63.43 3.01 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 122.615 1.198 . . . . 0.0 112.574 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -72.34 -169.51 0.53 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.291 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.6 p -47.47 -47.72 27.11 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.293 12.6 mmt180 -70.16 -51.7 13.57 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-O 115.398 -2.239 . . . . 0.0 114.932 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -60.8 -39.24 64.2 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.203 1.936 . . . . 0.0 113.816 172.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.54 -47.57 85.61 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.25 0.62 . . . . 0.0 112.639 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.52 85.32 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -66.4 -44.78 82.07 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.3 -51.63 64.04 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.261 1.024 . . . . 0.0 111.162 171.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.6 t -51.62 -51.52 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.465 1.106 . . . . 0.0 111.835 173.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -56.04 -53.97 50.6 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.717 1.207 . . . . 0.0 111.214 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.42 -43.94 88.94 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.361 1.038 . . . . 0.0 113.089 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -40.07 72.65 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -58.53 -14.33 7.76 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 174.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.68 -35.49 22.22 Favored Glycine 0 N--CA 1.48 1.63 0 C-N-CA 124.41 1.005 . . . . 0.0 114.74 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -80.8 154.33 27.23 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.849 0.86 . . . . 0.0 113.032 -174.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.411 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 71.2 p -69.77 -43.09 72.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 123.984 0.803 . . . . 0.0 111.787 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.6 p -61.23 145.54 50.88 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -83.26 134.05 34.96 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.985 0.898 . . . . 0.0 111.189 167.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.6 mm -112.12 106.98 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.074 -166.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.66 119.35 33.45 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.248 -1.797 . . . . 0.0 109.438 -174.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.1 t -110.21 87.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -77.88 100.65 6.45 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.845 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.2 t -76.7 97.31 4.42 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.099 -1.409 . . . . 0.0 111.716 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 p30 35.12 61.97 0.59 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.86 -76.26 0.3 Allowed Glycine 0 N--CA 1.485 1.919 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.844 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.63 138.84 41.66 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.468 0.652 . . . . 0.0 112.513 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.5 m -99.35 140.13 33.98 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.76 134.94 52.62 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 113.571 -1.649 . . . . 0.0 109.232 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 t -117.26 126.56 52.94 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.95 -15.46 43.61 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 125.488 1.743 . . . . 0.0 113.637 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -71.87 -6.63 43.14 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 171.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -131.26 134.49 46.45 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.63 1.572 . . . . 0.0 109.598 168.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.67 -52.38 65.75 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.498 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -62.92 -49.35 75.13 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 112.912 -1.949 . . . . 0.0 113.644 -175.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -65.22 -32.19 73.74 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.846 0.716 . . . . 0.0 112.909 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.53 -44.93 32.87 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 119.015 -0.517 . . . . 0.0 112.233 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -59.45 -39.54 83.93 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.5 t -58.83 -39.46 81.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.81 140.79 39.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.329 1.062 . . . . 0.0 113.159 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.27 81.37 0.2 Allowed Glycine 0 CA--C 1.535 1.319 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.274 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.8 mt -82.27 60.8 5.17 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 123.626 1.679 . . . . 0.0 110.172 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 t -123.32 -178.68 4.06 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 112.495 -2.139 . . . . 0.0 112.477 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -51.68 127.64 21.14 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.774 1.229 . . . . 0.0 112.545 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.71 -32.61 6.61 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 112.962 -1.926 . . . . 0.0 113.468 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.0 p -62.45 116.82 5.42 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 122.474 1.131 . . . . 0.0 113.858 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -86.75 95.13 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 112.239 -2.255 . . . . 0.0 106.075 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 m -95.65 113.45 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 112.608 -2.087 . . . . 0.0 110.365 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.43 108.74 20.1 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.247 -173.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.6 mt -91.17 107.08 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.724 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.5 t -103.12 126.93 50.52 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 112.614 -2.085 . . . . 0.0 111.075 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.09 111.34 21.97 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 124.679 1.237 . . . . 0.0 110.533 168.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -103.05 99.17 9.03 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.04 -159.74 28.68 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.576 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -54.48 39.0 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -173.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.411 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 5.3 p30 -83.05 33.49 0.44 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -45.04 -59.35 2.64 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -40.08 91.29 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -70.31 -43.14 70.94 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.228 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.35 -52.82 64.01 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.461 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.08 -47.05 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.662 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -52.78 -57.55 9.79 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.16 0.984 . . . . 0.0 112.775 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.79 -45.54 93.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.215 1.006 . . . . 0.0 112.816 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.46 -33.44 72.92 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -69.01 -48.4 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.787 0.835 . . . . 0.0 111.456 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -52.0 -45.49 64.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 123.829 0.705 . . . . 0.0 112.046 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.9 tp -52.85 -59.25 4.74 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.687 1.195 . . . . 0.0 112.475 174.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 38.7 mtt -47.95 -43.13 29.03 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.89 -45.66 88.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 118.152 -0.928 . . . . 0.0 113.337 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -86.24 -3.18 58.92 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.484 1.231 0 C-N-CA 123.912 0.885 . . . . 0.0 111.141 170.747 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.472 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -133.13 127.51 34.07 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 124.385 1.053 . . . . 0.0 111.321 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -110.28 146.03 36.37 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.814 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -155.07 125.82 7.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.756 1.222 . . . . 0.0 108.072 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -105.86 96.16 6.3 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 125.04 2.353 . . . . 0.0 113.622 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.7 t -95.73 119.22 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 111.222 -2.717 . . . . 0.0 110.841 -166.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 m -74.85 115.67 14.71 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.571 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.25 135.93 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.34 -23.25 4.89 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.37 -1.741 . . . . 0.0 113.856 -173.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 138.72 30.5 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.604 1.162 . . . . 0.0 111.386 169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -39.98 -50.71 3.3 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 C-N-CA 124.66 3.573 . . . . 0.0 117.345 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -116.88 21.95 12.96 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.01 -98.48 0.01 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.352 1.453 . . . . 0.0 113.822 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.4 mt -119.1 110.93 17.65 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 113.766 -1.217 . . . . 0.0 111.604 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -91.15 -165.8 1.44 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.211 164.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -51.47 -43.93 62.28 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.253 11.4 ttm105 -68.98 -45.17 30.56 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.281 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -61.26 -30.21 87.68 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.671 2.248 . . . . 0.0 115.169 167.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -46.15 84.25 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.759 0.709 . . . . 0.0 112.207 168.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.68 -44.93 80.46 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.225 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -51.94 -53.25 43.39 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.094 0.958 . . . . 0.0 112.971 172.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -51.87 -60.52 3.08 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -46.47 -55.88 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.908 1.283 . . . . 0.0 112.707 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -51.97 -47.42 64.84 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 124.563 1.164 . . . . 0.0 112.279 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.01 -56.06 8.92 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.713 1.258 . . . . 0.0 112.688 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.22 -44.46 75.44 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.248 1.819 . . . . 0.0 115.049 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -51.56 -31.98 26.59 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.14 -49.42 78.8 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 125.449 1.718 . . . . 0.0 114.394 173.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -60.45 154.74 19.88 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.413 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 67.3 p -86.72 -15.88 38.13 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.838 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.4 p -82.94 153.02 25.25 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.718 164.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.3 131.89 39.45 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.388 0.675 . . . . 0.0 109.191 173.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 mm -112.97 100.47 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.998 -159.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.9 m -104.28 126.34 51.3 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.18 85.82 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.599 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 50.3 m -64.45 120.68 12.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.348 170.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.8 t -94.0 95.43 9.04 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 24.98 63.98 0.05 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.63 -24.6 8.43 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 117.3 1.68 . . . . 0.0 117.3 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -130.51 140.93 50.5 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 118.656 1.228 . . . . 0.0 109.641 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.6 p -101.28 129.44 47.25 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -162.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.99 104.05 11.52 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.103 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -59.34 113.84 2.37 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 169.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.48 0.15 43.72 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.59 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -89.99 -44.43 9.87 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.533 164.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -70.62 116.96 11.54 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.362 0.601 . . . . 0.0 112.016 169.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 tp -64.37 -44.76 90.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.241 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -66.25 -34.79 78.81 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.416 1.086 . . . . 0.0 111.693 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -76.96 -47.73 20.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.9 tp -51.81 -49.37 62.89 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -63.85 -27.37 69.12 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.266 3.6 t -74.09 -20.61 60.21 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.14 135.8 33.16 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.419 1.104 . . . . 0.0 113.001 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.02 90.75 1.1 Allowed Glycine 0 CA--C 1.537 1.466 0 CA-C-N 113.182 -1.826 . . . . 0.0 109.561 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.65 64.64 3.57 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.558 1.17 . . . . 0.0 110.288 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.7 t -108.13 174.73 5.75 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.045 -170.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -50.63 137.45 19.71 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.305 1.042 . . . . 0.0 110.667 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.24 -47.19 1.79 Allowed Glycine 0 N--CA 1.481 1.699 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.597 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.8 p -56.92 120.75 8.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.875 0.397 . . . . 0.0 111.275 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 t -86.65 109.63 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 111.837 -2.438 . . . . 0.0 107.917 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.95 116.41 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -170.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 m -82.8 97.47 8.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.149 0.98 . . . . 0.0 109.006 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mt -74.05 92.16 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 166.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -100.13 108.75 20.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 110.129 -3.214 . . . . 0.0 109.578 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.42 100.49 9.77 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.747 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -96.72 89.82 5.07 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.05 -162.7 29.27 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.637 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -56.39 -59.35 5.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 118.721 2.86 . . . . 0.0 118.721 -162.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.413 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 14.0 p30 -85.41 50.16 1.9 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.472 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 12.3 pt-20 -51.72 -53.15 42.58 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.193 -2.276 . . . . 0.0 116.079 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -43.17 57.16 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.69 -49.78 76.14 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.6 -52.07 42.69 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.918 1.387 . . . . 0.0 112.614 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.5 t -53.68 -56.08 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 123.975 0.797 . . . . 0.0 111.795 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.13 -53.09 62.25 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -52.91 -47.6 67.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.952 1.301 . . . . 0.0 113.969 175.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -66.22 -36.71 83.74 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.0 t -64.94 -47.21 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 O-C-N 122.336 -0.227 . . . . 0.0 110.698 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -54.05 -37.74 64.48 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.9 tt -60.99 -51.84 67.53 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.043 0.937 . . . . 0.0 110.014 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.6 ttm -60.57 -46.98 88.2 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.393 1.077 . . . . 0.0 113.005 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.12 -14.79 0.69 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -125.49 45.19 2.64 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 170.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.8 mt . . . . . 0 N--CA 1.476 0.85 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.258 169.705 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.5 ttm . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -120.8 140.62 51.47 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.964 1.415 . . . . 0.0 109.576 173.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -128.65 142.67 50.96 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.518 1.136 . . . . 0.0 112.032 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -150.49 119.62 6.75 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.025 1.453 . . . . 0.0 110.799 169.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.88 126.65 30.44 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.888 -1.506 . . . . 0.0 113.223 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.12 131.75 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.098 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.9 m -111.34 110.48 20.97 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.73 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.1 mt -72.62 113.9 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.445 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -85.74 -19.08 31.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.388 -1.733 . . . . 0.0 114.844 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.87 127.64 62.03 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.554 1.142 . . . . 0.0 113.009 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.11 -62.3 0.32 Allowed 'Trans proline' 0 N--CA 1.485 0.999 0 C-N-CA 124.602 3.535 . . . . 0.0 113.314 -169.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.29 29.62 2.16 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 174.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 33.74 -134.06 0.31 Allowed Glycine 0 N--CA 1.479 1.546 0 C-N-CA 127.345 2.402 . . . . 0.0 116.345 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.8 122.43 44.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.117 -2.042 . . . . 0.0 109.966 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -109.2 -154.93 0.54 Allowed 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.195 -1.82 . . . . 0.0 113.579 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 m -61.01 -48.36 82.15 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -166.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -63.27 -47.61 84.4 Favored Pre-proline 0 N--CA 1.489 1.502 0 CA-C-O 116.599 -1.667 . . . . 0.0 112.233 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.79 -47.14 28.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.823 2.349 . . . . 0.0 113.48 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.92 -48.26 73.32 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.9 -46.91 84.21 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.118 0.967 . . . . 0.0 113.381 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -57.89 -42.78 85.37 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -66.28 -49.24 67.78 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.07 -35.84 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.448 0.699 . . . . 0.0 112.521 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -62.81 -65.07 0.74 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.029 0.932 . . . . 0.0 111.014 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.52 -52.76 62.18 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -27.27 68.74 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -58.5 -35.52 72.38 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 169.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.66 -31.83 79.31 Favored Glycine 0 N--CA 1.482 1.731 0 O-C-N 125.78 1.925 . . . . 0.0 113.579 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -79.01 142.17 36.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.294 0.638 . . . . 0.0 110.695 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.487 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 70.1 p -64.5 -43.75 93.12 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.64 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.2 p -59.68 143.8 49.68 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 114.419 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -90.78 126.3 35.97 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.744 1.259 . . . . 0.0 109.999 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.4 mm -98.4 98.56 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 112.765 -2.016 . . . . 0.0 109.71 -169.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.86 101.28 11.54 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.705 -1.588 . . . . 0.0 107.554 175.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.5 t -87.43 77.6 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.9 m -75.45 88.28 2.63 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.339 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.7 t -79.8 86.68 5.34 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.819 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 21.12 81.4 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 111.295 -2.684 . . . . 0.0 115.484 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.37 -63.37 0.28 Allowed Glycine 0 CA--C 1.543 1.81 0 CA-C-N 112.173 -2.285 . . . . 0.0 112.79 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -104.9 133.02 50.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -169.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 p -88.71 116.23 26.82 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 113.557 -1.656 . . . . 0.0 115.444 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.29 164.96 11.39 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.546 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -125.69 119.38 27.85 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.305 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.57 5.97 2.72 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 124.42 1.075 . . . . 0.0 113.059 170.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -113.89 -15.21 12.4 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 172.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.0 t -119.02 120.9 38.58 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.824 0.849 . . . . 0.0 111.685 172.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.0 tp -57.44 -61.83 2.21 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.018 -1.447 . . . . 0.0 113.386 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -45.37 -50.78 11.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.29 1.436 . . . . 0.0 113.238 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -67.67 -30.93 70.59 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.6 tp -72.98 -47.06 48.59 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.513 0.508 . . . . 0.0 111.752 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -65.99 -31.53 72.48 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.5 t -85.03 33.71 0.54 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.856 1.313 . . . . 0.0 114.351 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.05 140.72 44.03 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.907 171.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.7 93.23 0.17 Allowed Glycine 0 N--CA 1.479 1.525 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.256 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.0 mt -94.96 57.86 2.14 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.293 1.044 . . . . 0.0 110.721 173.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -109.39 176.88 4.92 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.866 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -58.58 126.15 26.38 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.758 0.79 . . . . 0.0 111.888 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.66 16.23 64.23 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 113.385 -1.734 . . . . 0.0 114.925 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.0 p -88.23 120.44 29.59 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.543 0.687 . . . . 0.0 111.313 175.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 t -93.54 85.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 112.4 -2.182 . . . . 0.0 107.642 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -80.5 94.46 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 112.129 -2.305 . . . . 0.0 112.382 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -76.12 100.66 5.06 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.761 172.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.3 mt -79.23 102.12 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.975 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -106.56 104.86 14.65 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 111.82 -2.445 . . . . 0.0 110.408 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.59 101.49 13.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.763 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.89 99.56 12.39 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.982 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.09 -169.15 31.99 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-N 112.39 -2.187 . . . . 0.0 111.38 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.42 -48.9 75.91 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 -169.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.487 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 3.6 p30 -85.62 42.71 0.98 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 177.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -51.77 -48.65 63.65 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.44 -42.88 28.72 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -59.11 -44.19 91.95 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.545 1.138 . . . . 0.0 112.719 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.34 -49.68 70.72 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.192 0.997 . . . . 0.0 113.308 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.3 t -59.84 -55.11 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.47 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -47.97 -45.04 30.94 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -70.13 -51.22 33.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mt -60.56 -33.86 73.31 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.65 -54.69 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 124.039 0.837 . . . . 0.0 109.966 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -50.99 -49.98 59.33 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 124.17 0.919 . . . . 0.0 112.988 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.48 -46.25 90.84 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 44.5 mtt -66.41 -21.67 66.22 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.3 -32.46 16.51 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -74.25 -39.72 62.85 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 178.545 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.427 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 36.8 ttp . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -124.88 135.64 53.06 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 125.277 1.611 . . . . 0.0 108.246 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -133.97 135.19 43.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.059 -172.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -142.76 144.49 32.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.047 1.339 . . . . 0.0 112.185 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.16 141.91 28.31 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.507 169.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.73 135.18 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 113.577 -1.647 . . . . 0.0 106.722 160.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.9 m -102.75 113.7 27.32 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.4 mt -72.63 124.69 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 122.317 1.056 . . . . 0.0 108.735 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -127.11 -30.12 2.71 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.868 -171.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.62 121.86 5.48 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 124.258 1.023 . . . . 0.0 111.367 161.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -53.67 -69.35 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.454 2.769 . . . . 0.0 114.048 -169.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -24.0 58.87 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.25 -125.2 17.83 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.999 1.285 . . . . 0.0 113.599 167.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.45 110.43 22.8 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.896 1.331 . . . . 0.0 112.984 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -109.6 -169.81 1.54 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 111.95 -2.386 . . . . 0.0 111.203 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 m -27.53 -76.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.394 2.278 . . . . 0.0 115.933 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -62.63 -49.35 83.33 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-O 116.237 -1.84 . . . . 0.0 113.696 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -51.51 -45.95 34.6 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.448 2.765 . . . . 0.0 114.044 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.7 -51.14 68.35 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.289 0.636 . . . . 0.0 112.403 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.28 81.31 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.62 -58.08 8.91 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.44 1.096 . . . . 0.0 111.986 171.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.79 -41.69 82.62 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.206 1.003 . . . . 0.0 112.719 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.58 -51.06 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.122 0.569 . . . . 0.0 111.642 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -53.15 -47.94 68.35 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.354 0.662 . . . . 0.0 109.827 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.06 -49.72 66.64 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.01 -45.85 75.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.525 0.73 . . . . 0.0 112.081 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -59.59 -36.08 75.55 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 173.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.22 -43.07 93.79 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 124.875 1.359 . . . . 0.0 112.199 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -62.02 145.99 51.48 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.99 0.916 . . . . 0.0 112.554 172.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.7 p -79.44 -31.36 42.53 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.232 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.7 p -71.95 141.82 49.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.76 0.824 . . . . 0.0 112.398 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -72.35 130.62 41.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.479 0.656 . . . . 0.0 110.462 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 mm -113.43 86.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.369 -1.742 . . . . 0.0 109.303 -164.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.1 m -92.54 111.9 23.65 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 112.26 -2.245 . . . . 0.0 108.707 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.51 103.46 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 113.45 -1.705 . . . . 0.0 108.873 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.0 m -81.57 98.35 8.28 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.219 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.6 t -95.39 94.16 7.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.16 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.288 30.7 p-10 43.51 77.32 0.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 111.053 -2.794 . . . . 0.0 115.628 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.06 -52.59 3.21 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 112.276 -2.238 . . . . 0.0 113.742 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -93.46 134.48 35.67 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.5 p -89.8 148.9 22.94 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 122.526 1.155 . . . . 0.0 113.561 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.66 122.59 12.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.586 171.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.5 t -57.73 107.45 0.45 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.315 0.578 . . . . 0.0 110.059 166.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.78 -23.4 60.15 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.378 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -65.11 3.46 0.6 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.789 -1.551 . . . . 0.0 114.994 168.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -125.94 118.04 24.57 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.885 0.874 . . . . 0.0 110.427 175.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.1 tp -53.41 -47.75 69.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.793 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -58.22 -51.05 71.35 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.544 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -68.19 -43.69 77.56 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.41 -45.53 92.72 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.057 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -64.49 -36.45 84.22 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -74.62 -30.44 61.66 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.07 155.6 23.78 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 122.067 0.937 . . . . 0.0 113.475 173.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -56.63 121.05 23.17 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 113.776 -1.556 . . . . 0.0 113.433 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 76.1 mt -124.31 36.66 4.57 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.061 1.344 . . . . 0.0 113.355 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -139.36 160.32 40.1 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -163.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -34.52 109.51 0.08 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.618 1.567 . . . . 0.0 113.429 173.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.75 -40.8 1.93 Allowed Glycine 0 CA--C 1.534 1.276 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.817 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.7 p -74.89 133.35 41.83 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.57 110.06 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 113.279 -1.782 . . . . 0.0 106.785 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 m -98.7 89.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 125.065 1.478 . . . . 0.0 111.968 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.15 90.16 2.52 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.717 -2.038 . . . . 0.0 110.096 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.3 mt -76.65 111.87 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.275 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.2 t -117.2 124.75 49.87 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.821 -1.536 . . . . 0.0 109.631 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.28 110.66 21.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.365 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -108.95 110.34 21.62 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.651 -1.158 . . . . 0.0 113.674 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.82 -158.57 27.77 Favored Glycine 0 N--CA 1.483 1.831 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.002 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.88 -65.76 0.63 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -81.34 45.38 0.85 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.427 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 10.1 pt-20 -51.33 -62.27 1.72 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.683 1.593 . . . . 0.0 114.533 -177.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.28 -41.98 93.62 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -56.96 -49.01 77.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.457 1.103 . . . . 0.0 113.52 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.9 -51.64 68.8 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.451 0.701 . . . . 0.0 111.838 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.68 -46.32 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.449 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -49.21 -54.73 15.22 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.21 1.404 . . . . 0.0 112.096 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -69.09 -34.75 75.6 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.5 mt -73.24 -39.9 65.1 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.8 t -58.91 -43.6 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.289 0.636 . . . . 0.0 110.217 170.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -56.63 -53.66 55.12 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 171.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.3 mt -49.76 -48.77 50.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.06 0.944 . . . . 0.0 113.464 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.9 mmt -59.16 -43.73 92.1 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.36 -40.66 89.91 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -74.18 -19.09 60.66 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 117.203 2.298 . . . . 0.0 117.203 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 CA--C 1.554 1.117 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -172.53 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.487 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 1.2 tmt? . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -141.29 134.07 28.8 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.969 1.418 . . . . 0.0 111.318 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -122.98 139.94 53.55 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.156 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.73 140.31 38.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.171 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -100.63 116.14 31.85 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 122.74 1.257 . . . . 0.0 111.443 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.5 p -122.62 135.72 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 112.88 -1.963 . . . . 0.0 111.286 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -87.91 162.54 16.85 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.494 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.6 mm -115.85 132.38 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 125.234 1.584 . . . . 0.0 106.885 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.77 -29.92 11.19 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.54 132.83 1.69 Allowed Pre-proline 0 N--CA 1.474 0.747 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -54.69 -45.94 37.15 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.915 3.077 . . . . 0.0 112.411 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 13' ' ' GLY . 6.2 p-10 -73.03 -64.37 0.98 Allowed 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.531 1.144 . . . . 0.0 112.967 171.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . 0.424 ' H ' ' ND2' ' A' ' 12' ' ' ASN . . . 105.61 100.31 2.64 Favored Glycine 0 N--CA 1.475 1.286 0 N-CA-C 110.386 -1.085 . . . . 0.0 110.386 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 32.21 84.57 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.134 2.173 . . . . 0.0 114.722 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -64.23 169.81 4.25 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.111 1.434 . . . . 0.0 114.213 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 p -59.71 -17.28 33.36 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.261 96.8 mtt180 -80.32 -47.38 1.32 Allowed Pre-proline 0 N--CA 1.478 0.929 0 CA-C-O 116.75 -1.595 . . . . 0.0 114.473 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.66 -37.22 89.16 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 122.097 1.865 . . . . 0.0 113.976 162.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.38 -44.99 89.16 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.08 92.89 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 172.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -63.54 -48.1 78.88 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.864 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -45.92 -56.27 5.68 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.54 1.536 . . . . 0.0 113.519 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.01 -43.66 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.185 0.994 . . . . 0.0 112.496 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.35 -50.13 68.96 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -59.58 -48.92 79.78 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.778 1.299 . . . . 0.0 111.257 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.67 -39.36 80.44 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -65.65 -38.02 88.19 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.18 -53.6 35.55 Favored Glycine 0 N--CA 1.482 1.726 0 O-C-N 125.614 1.821 . . . . 0.0 111.794 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -52.34 137.03 30.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 125.322 1.248 . . . . 0.0 110.378 171.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.493 ' HG1' ' CD ' ' A' ' 68' ' ' GLU . 2.9 p -74.11 -36.36 64.21 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.4 m -46.28 146.85 1.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.135 1.774 . . . . 0.0 114.877 170.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -86.05 133.72 33.88 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.792 0.806 . . . . 0.0 109.878 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.0 mm -117.04 97.44 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.165 -164.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.0 m -94.77 117.91 30.9 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.4 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.0 t -116.88 100.92 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 112.796 -2.002 . . . . 0.0 107.17 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -111.26 102.46 10.87 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.673 -167.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.5 m -76.52 91.8 3.39 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.751 170.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.263 6.8 p-10 32.24 105.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 118.706 2.854 . . . . 0.0 118.706 -172.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.38 -37.37 0.82 Allowed Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -94.58 120.05 34.2 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.938 0.895 . . . . 0.0 110.161 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.0 m -98.31 124.21 42.83 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -169.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.28 166.6 12.09 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.74 -2.027 . . . . 0.0 109.723 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 t -126.01 132.34 52.03 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.91 -20.43 64.23 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.327 -1.761 . . . . 0.0 113.907 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -66.29 -12.3 55.64 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 84.4 p -136.44 137.26 40.25 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 160.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.6 tp -55.11 -39.23 69.13 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 124.121 0.888 . . . . 0.0 111.908 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -46.4 -56.35 6.02 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.04 1.736 . . . . 0.0 113.272 168.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -76.49 -30.47 57.25 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.9 -65.56 0.66 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -59.99 -23.62 63.78 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -60.88 -26.5 67.46 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 174.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.4 mt -123.27 85.15 2.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.542 1.137 . . . . 0.0 109.459 169.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.88 135.86 17.72 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 112.949 -1.932 . . . . 0.0 113.135 -173.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.22 101.32 7.93 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 113.47 -1.365 . . . . 0.0 109.715 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -129.71 162.23 28.86 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.804 -1.543 . . . . 0.0 111.979 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -58.02 145.74 35.19 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.44 -51.16 4.52 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.95 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -71.38 113.33 8.31 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.907 0.86 . . . . 0.0 111.245 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.0 p -71.43 132.37 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.709 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -116.59 123.92 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.08 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 m -79.95 120.53 24.28 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.968 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.01 100.33 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.6 t -110.18 125.39 52.99 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 112.909 -1.95 . . . . 0.0 112.104 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.15 111.89 18.83 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.547 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.53 103.8 12.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 113.778 -1.555 . . . . 0.0 112.91 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.57 -156.4 26.66 Favored Glycine 0 N--CA 1.479 1.533 0 CA-C-N 111.798 -2.455 . . . . 0.0 109.8 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.493 ' CD ' ' HG1' ' A' ' 30' ' ' THR . 3.2 mp0 -67.3 -49.53 63.84 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.93 20.44 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.487 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 12.0 pt-20 -41.43 -55.71 2.72 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -171.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -75.75 -52.26 10.84 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.939 0.896 . . . . 0.0 112.157 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -48.33 -54.31 14.28 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.421 1.888 . . . . 0.0 113.069 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.92 -51.99 66.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.452 1.101 . . . . 0.0 112.732 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.8 -49.24 80.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.734 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -53.79 -51.79 62.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.31 1.006 . . . . 0.0 111.025 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -65.17 -43.65 91.04 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.7 mt -64.51 -35.61 81.53 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.4 t -74.08 -35.18 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 123.126 0.57 . . . . 0.0 111.451 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -66.66 -36.01 81.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 171.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -55.32 -50.27 70.04 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.515 1.135 . . . . 0.0 109.335 168.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 66.0 mtt -58.12 -44.14 87.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.16 -20.62 27.41 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -110.81 -31.73 7.08 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 N--CA 1.481 1.113 0 C-N-CA 124.858 1.263 . . . . 0.0 114.079 -173.777 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 tmm? . . . . . 0 C--O 1.239 0.531 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -124.7 128.3 48.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.669 1.23 . . . . 0.0 109.397 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -124.74 138.84 54.26 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.512 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -129.68 140.79 51.04 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.203 172.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -98.78 120.77 39.78 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.683 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -123.22 144.83 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 113.875 -1.512 . . . . 0.0 113.131 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -105.26 143.81 32.92 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.618 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -114.49 133.16 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.67 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 p -116.95 -41.05 3.06 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.6 132.49 3.79 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 170.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.23 -42.67 54.25 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.979 2.453 . . . . 0.0 113.752 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -69.22 -35.18 75.91 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.692 1.245 . . . . 0.0 114.051 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.51 80.66 0.12 Allowed Glycine 0 N--CA 1.473 1.158 0 O-C-N 125.154 1.533 . . . . 0.0 112.431 -176.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.1 mt 61.16 92.34 0.05 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.211 1.804 . . . . 0.0 112.849 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -71.71 -165.66 0.17 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -173.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.46 -46.17 9.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.477 2.711 . . . . 0.0 113.692 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.267 68.1 mtt180 -80.52 -42.64 1.31 Allowed Pre-proline 0 N--CA 1.486 1.349 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -53.02 -48.39 22.4 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.903 2.402 . . . . 0.0 113.295 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.81 -47.39 77.24 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.54 -39.34 76.42 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.01 -50.7 71.01 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.856 0.863 . . . . 0.0 112.931 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -53.66 -41.03 66.4 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.936 0.894 . . . . 0.0 111.759 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.3 t -60.3 -59.9 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.605 1.162 . . . . 0.0 111.804 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -53.31 -48.08 68.72 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.666 0.604 . . . . 0.0 111.699 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -45.89 78.59 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.95 74.61 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 173.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -66.16 -45.55 80.55 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.31 -45.65 96.02 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.693 1.616 . . . . 0.0 113.319 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -65.65 147.58 53.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.83 0.852 . . . . 0.0 111.122 167.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.495 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 40.5 p -66.79 -56.6 9.72 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.777 1.231 . . . . 0.0 113.664 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -46.6 144.96 2.02 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -82.35 117.24 22.27 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.582 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.0 mm -94.5 114.61 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.22 -174.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.08 120.9 26.71 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 125.419 1.699 . . . . 0.0 110.596 173.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.8 t -108.8 86.55 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.9 m -94.0 90.61 6.51 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.225 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 p -76.2 98.59 4.46 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.253 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.255 52.0 p-10 24.09 60.12 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.051 2.14 . . . . 0.0 116.533 -167.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.69 -34.93 4.76 Favored Glycine 0 CA--C 1.542 1.747 0 CA-C-N 113.72 -1.582 . . . . 0.0 115.449 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -81.26 96.92 7.42 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -73.3 89.62 1.59 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.15 158.43 19.77 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.792 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -110.62 120.84 43.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.432 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.93 -32.21 73.66 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.302 1.626 . . . . 0.0 112.637 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -67.89 -9.95 49.12 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.552 1.541 . . . . 0.0 114.201 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 t -121.85 118.22 28.43 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.743 1.217 . . . . 0.0 111.326 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.7 tp -55.38 -47.21 76.17 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 113.55 -1.659 . . . . 0.0 112.621 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -60.57 -57.77 11.33 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.973 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -61.47 -43.97 97.93 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.5 tp -57.88 -57.32 13.31 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.514 1.134 . . . . 0.0 112.612 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -71.38 -27.67 63.49 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.5 t -72.77 -24.8 60.99 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 171.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.76 74.46 1.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.968 1.366 . . . . 0.0 110.505 172.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.49 152.54 49.83 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 112.428 -2.169 . . . . 0.0 114.611 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -100.39 158.71 15.7 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 112.588 -1.806 . . . . 0.0 109.787 173.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.8 t -161.54 165.87 27.88 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.081 1.352 . . . . 0.0 110.588 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -63.65 125.65 24.98 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.08 -19.29 54.03 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.527 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.6 m -75.98 104.12 6.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.234 0.613 . . . . 0.0 109.393 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.51 137.37 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.724 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.36 123.69 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 122.245 1.022 . . . . 0.0 113.557 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 116.86 28.25 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.111 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.7 mm -92.66 103.93 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.4 t -115.92 129.52 56.43 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.721 -1.581 . . . . 0.0 111.068 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.88 122.84 40.35 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.547 1.165 . . . . 0.0 111.665 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -96.88 116.67 29.57 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.382 -2.19 . . . . 0.0 114.059 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.38 177.6 10.36 Favored Glycine 0 CA--C 1.541 1.697 0 CA-C-N 111.824 -2.444 . . . . 0.0 113.237 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.257 50.3 mt-10 41.6 -93.24 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 172.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.495 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 84.9 m-20 -77.15 -0.64 25.72 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -18.51 -62.91 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -64.93 -57.59 8.37 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.882 0.873 . . . . 0.0 112.882 -175.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -62.6 -38.15 89.06 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.583 0.753 . . . . 0.0 112.214 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.87 -57.42 12.12 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.832 . . . . 0.0 112.269 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.89 -49.15 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 118.51 -0.757 . . . . 0.0 111.771 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -49.7 -55.82 12.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.86 0.864 . . . . 0.0 113.255 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -63.67 -48.68 76.18 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.816 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -61.56 -38.3 86.97 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.14 -42.1 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.537 0.735 . . . . 0.0 111.167 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -60.78 -45.69 93.36 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 118.283 -0.865 . . . . 0.0 112.968 173.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.2 mt -52.34 -52.59 52.41 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.574 0.75 . . . . 0.0 112.79 170.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.0 mtt -60.09 -33.6 72.32 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.42 -36.1 60.87 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.59 -21.08 28.66 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.3 mt . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -174.931 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 tmm? . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -125.12 131.18 53.31 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 125.093 1.495 . . . . 0.0 110.345 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -135.11 128.27 31.85 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.61 1.194 . . . . 0.0 113.527 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -125.71 127.77 46.74 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 124.823 1.327 . . . . 0.0 112.126 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -84.57 135.89 34.02 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.563 -1.653 . . . . 0.0 112.385 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.93 142.42 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.173 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.01 136.7 45.22 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.235 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.0 mm -105.93 139.09 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.059 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -103.27 -37.51 7.64 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.777 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.88 124.49 12.78 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.206 1.002 . . . . 0.0 112.629 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.27 -52.03 8.08 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.942 3.095 . . . . 0.0 112.936 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -63.53 -42.61 98.43 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.846 1.258 . . . . 0.0 113.241 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.98 -158.57 51.27 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.013 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.09 80.36 9.2 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 113.404 -1.398 . . . . 0.0 111.465 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -75.92 -169.05 1.0 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.721 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -37.44 -52.42 1.14 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.472 2.309 . . . . 0.0 113.24 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.252 44.5 ttt180 -69.95 -50.84 15.96 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-O 115.881 -2.009 . . . . 0.0 114.537 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -63.88 -42.72 18.49 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.64 2.227 . . . . 0.0 113.188 170.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.31 -45.29 80.34 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.96 -41.65 68.05 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -70.73 -47.98 56.89 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.246 0.618 . . . . 0.0 111.12 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -57.52 -40.09 77.99 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.131 0.972 . . . . 0.0 113.342 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.1 t -56.56 -53.86 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 124.059 0.944 . . . . 0.0 110.71 171.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -56.73 -46.35 81.37 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.23 -48.95 79.14 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.18 0.925 . . . . 0.0 112.345 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.28 -40.52 74.4 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.183 0.993 . . . . 0.0 113.477 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -58.23 -36.34 73.02 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 173.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.92 -41.05 56.3 Favored Glycine 0 N--CA 1.483 1.773 0 O-C-N 124.87 1.356 . . . . 0.0 112.522 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -69.94 117.56 11.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.609 1.195 . . . . 0.0 112.41 175.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.5 p -49.11 -49.52 41.53 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.306 -1.77 . . . . 0.0 113.093 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 p -62.8 140.66 58.78 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.704 1.202 . . . . 0.0 113.817 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -77.09 93.17 3.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.619 -175.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.5 mm -68.73 84.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 112.788 -2.005 . . . . 0.0 111.276 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -82.9 115.93 21.98 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.004 -1.907 . . . . 0.0 107.797 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.22 99.84 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.1 m -88.33 99.04 11.95 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.696 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 t -101.45 109.91 21.82 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.605 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.296 37.6 p30 25.26 75.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.687 1.995 . . . . 0.0 115.953 -164.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.58 -26.5 4.06 Favored Glycine 0 CA--C 1.544 1.869 0 CA-C-N 112.055 -2.339 . . . . 0.0 115.182 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -84.69 87.98 7.33 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.713 1.244 . . . . 0.0 112.87 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -71.0 104.64 3.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.742 -2.026 . . . . 0.0 113.573 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.41 120.51 23.15 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 t -56.76 123.8 16.22 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.588 170.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.93 -30.56 70.29 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.805 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -62.82 -22.21 66.47 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.6 t -94.35 112.94 24.75 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.878 0.847 . . . . 0.0 108.93 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -46.22 -52.05 13.2 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.254 -1.794 . . . . 0.0 112.981 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -54.34 -46.2 72.85 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.018 -1.447 . . . . 0.0 113.637 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -63.41 -53.42 52.56 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.241 0.963 . . . . 0.0 113.209 -176.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.2 tp -64.71 -33.42 75.92 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.135 0.897 . . . . 0.0 113.187 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -63.99 -47.37 80.61 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.4 t -74.35 -19.13 60.56 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.1 tp -73.95 130.64 40.27 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.086 1.355 . . . . 0.0 111.346 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.39 102.06 1.33 Allowed Glycine 0 N--CA 1.482 1.762 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.823 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.0 mt -113.06 69.3 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.628 0.728 . . . . 0.0 112.818 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 t -145.79 179.88 7.15 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -61.08 138.7 58.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.343 1.057 . . . . 0.0 112.665 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.08 -52.7 3.55 Favored Glycine 0 N--CA 1.481 1.674 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.123 -172.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -72.53 97.38 2.1 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.08 1.352 . . . . 0.0 110.522 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.5 p -75.24 142.16 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.151 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.29 125.39 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -170.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.64 118.17 35.91 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.602 177.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mm -87.25 96.4 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -108.81 128.58 55.02 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 124.721 1.263 . . . . 0.0 111.65 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.25 127.35 35.52 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.44 130.9 56.23 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 168.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.88 -155.08 22.15 Favored Glycine 0 N--CA 1.483 1.782 0 O-C-N 124.29 0.994 . . . . 0.0 111.472 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.73 -65.9 0.61 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -66.16 14.91 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -42.34 -58.83 2.04 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -168.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -71.25 -47.22 58.4 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.712 -1.131 . . . . 0.0 114.044 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -63.79 -45.54 89.24 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.469 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.99 95.68 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.946 0.899 . . . . 0.0 112.086 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.8 t -58.34 -57.14 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 116.951 -1.5 . . . . 0.0 110.129 171.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -50.71 -49.6 57.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.479 0.712 . . . . 0.0 112.91 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -61.54 -52.21 65.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.364 1.066 . . . . 0.0 112.693 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.03 -27.29 60.87 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -54.94 -44.48 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.07 0.948 . . . . 0.0 110.388 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.81 -61.27 2.52 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.693 1.246 . . . . 0.0 111.12 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -51.13 -37.16 44.43 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.0 tpt -53.68 -38.58 64.33 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.054 0.942 . . . . 0.0 113.429 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.55 -16.53 28.64 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.73 -25.4 16.71 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.2 mt . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 179.909 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tmm? . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -127.06 130.3 49.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.15 1.531 . . . . 0.0 108.145 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -134.74 153.54 51.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.227 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -141.76 144.16 33.85 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 126.353 2.283 . . . . 0.0 110.318 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -113.12 134.39 54.57 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.915 1.385 . . . . 0.0 111.316 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.17 124.8 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 111.724 -2.489 . . . . 0.0 113.237 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -94.21 123.71 37.77 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 112.65 -2.068 . . . . 0.0 107.732 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.1 mm -95.64 106.22 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.17 -173.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.9 p -92.34 -20.87 20.64 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 113.101 -1.863 . . . . 0.0 113.218 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.65 130.82 93.93 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.995 1.318 . . . . 0.0 111.51 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -56.57 -34.12 94.54 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.945 3.097 . . . . 0.0 114.733 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -113.82 4.46 15.91 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 38.65 -117.06 0.6 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.874 2.178 . . . . 0.0 115.2 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.53 74.01 0.87 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 123.643 1.687 . . . . 0.0 111.507 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -75.37 -162.06 0.18 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 111.885 -2.416 . . . . 0.0 112.718 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.2 p -55.9 -44.49 78.28 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -66.93 -47.81 52.48 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-O 116.702 -1.618 . . . . 0.0 114.377 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -68.16 -40.47 8.7 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.104 2.536 . . . . 0.0 113.571 173.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -44.7 72.13 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.11 -41.04 62.15 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 170.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.3 -45.89 68.49 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.258 0.623 . . . . 0.0 111.647 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -60.95 -49.87 75.7 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.07 1.348 . . . . 0.0 113.381 -171.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.76 -42.57 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.32 1.048 . . . . 0.0 113.492 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -62.72 -51.77 65.85 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.997 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -57.69 -49.68 75.72 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.412 1.07 . . . . 0.0 111.915 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.3 -40.17 70.77 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -55.46 -38.56 69.22 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.27 -28.83 73.77 Favored Glycine 0 N--CA 1.483 1.816 0 O-C-N 125.812 1.945 . . . . 0.0 114.786 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.45 134.63 34.77 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.3 p -71.28 -42.97 68.07 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.503 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.6 m -44.15 136.4 3.9 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.243 1.817 . . . . 0.0 114.728 168.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.81 134.03 35.12 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.213 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.6 mm -111.18 101.14 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.076 -171.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.7 p -94.72 120.92 35.73 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.654 1.216 . . . . 0.0 111.927 170.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.6 t -97.83 91.7 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 110.901 -2.863 . . . . 0.0 105.846 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -83.59 84.07 7.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 111.987 -2.37 . . . . 0.0 111.057 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.1 t -74.83 90.95 2.39 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.418 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.322 6.7 p30 37.08 69.38 0.22 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 113.157 -1.838 . . . . 0.0 114.767 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 -46.55 2.31 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 112.175 -2.284 . . . . 0.0 114.147 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -76.43 96.75 4.11 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 p -83.8 119.31 24.68 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 112.659 -2.064 . . . . 0.0 115.44 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.42 146.36 44.3 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.065 -1.425 . . . . 0.0 112.256 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.1 t -62.3 134.57 56.68 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.9 -41.31 71.45 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 125.686 1.866 . . . . 0.0 113.114 170.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -60.18 -38.35 82.96 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.097 1.359 . . . . 0.0 111.624 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.3 t -76.23 94.5 3.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.896 170.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.9 tp -51.93 -32.14 31.76 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.726 170.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -52.66 -64.23 0.89 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.755 1.222 . . . . 0.0 110.653 170.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -63.8 -47.36 81.17 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 tp -51.15 -46.34 61.98 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -74.27 -41.15 61.73 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -84.63 53.16 2.59 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 122.237 1.017 . . . . 0.0 112.102 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 tp -154.67 136.13 14.19 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.409 -172.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.59 108.37 2.46 Favored Glycine 0 N--CA 1.48 1.623 0 C-N-CA 125.275 1.417 . . . . 0.0 113.076 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.7 mt -127.68 35.09 4.55 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 t -119.31 178.37 4.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -57.13 139.56 52.1 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.42 -9.91 73.69 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 113.886 -1.506 . . . . 0.0 114.254 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.6 m -102.65 127.5 49.73 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.92 132.74 35.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.279 167.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -125.2 137.92 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.523 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.57 126.5 54.5 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.291 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.08 108.01 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.4 t -113.45 135.21 54.13 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 124.56 1.162 . . . . 0.0 112.137 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.11 146.72 41.02 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.751 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.1 138.62 49.62 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.818 -173.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.11 -146.82 18.36 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 114.577 0.591 . . . . 0.0 114.577 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.14 -48.7 53.53 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -169.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -107.43 31.63 5.27 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.214 -174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -60.32 -48.23 82.64 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -171.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -70.2 -61.46 1.76 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.023 0.827 . . . . 0.0 112.232 176.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -49.07 -50.62 35.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.641 1.576 . . . . 0.0 114.256 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.5 -55.09 38.11 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.9 -47.98 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.942 -174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -45.08 -49.15 11.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.175 1.39 . . . . 0.0 112.747 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -66.91 -55.8 13.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.973 0.909 . . . . 0.0 113.168 173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.7 mt -59.72 -28.91 67.74 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.5 t -74.09 -45.74 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.288 0.635 . . . . 0.0 112.346 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -52.61 -37.67 58.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 170.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.3 mt -56.83 -33.44 66.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -62.7 -24.48 67.68 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.32 -31.59 24.76 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.192 0.997 . . . . 0.0 113.115 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -91.42 -33.3 15.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 118.37 2.729 . . . . 0.0 118.37 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 178.418 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 tmm? . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -122.47 135.82 54.75 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.287 0.992 . . . . 0.0 112.749 -167.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -121.34 137.19 54.81 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.859 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -128.13 123.59 34.81 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -96.3 99.0 10.73 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.991 1.432 . . . . 0.0 112.144 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.7 126.17 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 113.539 -1.664 . . . . 0.0 110.408 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 m -83.92 116.83 22.98 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.053 165.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.81 125.79 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 p -117.1 -36.48 3.78 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.56 113.05 0.94 Allowed Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 125.947 1.699 . . . . 0.0 115.072 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -53.59 -33.03 66.9 Favored 'Trans proline' 0 N--CA 1.483 0.894 0 C-N-CA 124.481 3.454 . . . . 0.0 114.35 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -62.86 -27.24 69.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.82 161.96 11.31 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 123.988 0.804 . . . . 0.0 113.244 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.89 78.04 6.52 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 122.871 1.319 . . . . 0.0 109.245 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -72.94 -153.65 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.218 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 p -51.75 -59.54 4.19 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.205 1.002 . . . . 0.0 113.685 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -55.39 -49.16 94.1 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 115.978 -1.963 . . . . 0.0 114.84 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.25 -52.05 6.42 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 122.33 2.02 . . . . 0.0 112.473 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.22 89.58 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.74 -47.73 84.96 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.059 0.944 . . . . 0.0 113.494 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -68.54 -36.82 79.35 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.777 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -64.42 -48.67 74.47 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.549 1.14 . . . . 0.0 112.568 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.72 -48.0 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -51.85 -45.0 63.87 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.81 1.244 . . . . 0.0 112.635 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -75.61 -46.59 30.79 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.658 0.599 . . . . 0.0 112.172 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.05 -39.87 63.56 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.777 1.231 . . . . 0.0 114.262 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -63.18 -37.27 86.56 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.24 -33.08 73.64 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.053 1.311 . . . . 0.0 114.629 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -86.65 121.75 29.6 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.788 0.804 . . . . 0.0 110.809 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 p -58.18 -39.78 79.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.897 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -47.44 144.25 3.11 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 126.86 2.064 . . . . 0.0 113.496 166.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -94.68 122.06 36.9 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.529 1.157 . . . . 0.0 111.529 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 mm -108.63 106.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 112.324 -2.216 . . . . 0.0 106.949 -173.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.1 m -103.2 122.72 45.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.113 -176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -101.67 103.84 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 113.534 -1.666 . . . . 0.0 107.01 -174.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -104.34 97.79 7.68 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.035 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.8 t -88.36 92.39 9.15 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.548 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.08 61.03 2.49 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 113.753 -1.567 . . . . 0.0 114.184 174.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.28 -63.37 0.41 Allowed Glycine 0 CA--C 1.543 1.801 0 CA-C-N 113.65 -1.614 . . . . 0.0 113.222 -168.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -68.62 111.02 4.53 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.394 1.093 . . . . 0.0 112.847 -170.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.1 p -106.62 117.82 35.06 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.413 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.74 143.58 46.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 112.197 -2.274 . . . . 0.0 110.275 173.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.8 t -73.96 134.21 43.11 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.12 0.486 . . . . 0.0 109.816 173.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.02 68.14 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.06 -0.53 4.59 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.2 t -127.17 111.58 14.15 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.92 1.288 . . . . 0.0 111.067 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.9 tp -59.07 -39.99 83.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.233 1.013 . . . . 0.0 111.552 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -55.53 -50.15 70.76 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.623 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -65.19 -45.29 85.43 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.649 0.779 . . . . 0.0 112.943 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 tp -63.82 -47.25 81.58 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 124.568 1.168 . . . . 0.0 113.486 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -70.56 -37.24 73.97 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -74.62 -11.62 60.24 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.1 tp -88.43 143.81 26.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.353 1.061 . . . . 0.0 109.335 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.37 88.78 0.13 Allowed Glycine 0 N--CA 1.484 1.859 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.092 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -122.35 74.33 1.17 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 123.813 1.768 . . . . 0.0 110.353 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 t -137.25 175.0 10.0 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.371 -1.741 . . . . 0.0 109.716 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -45.58 150.06 0.53 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.76 34.33 56.55 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 125.155 1.36 . . . . 0.0 115.261 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.3 m -120.99 141.3 50.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.276 11.8 p -111.22 116.4 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.731 0.776 . . . . 0.0 112.524 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.54 129.55 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 112.286 -2.233 . . . . 0.0 112.989 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -103.12 123.12 46.08 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.537 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.0 mm -97.17 94.05 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 113.402 -1.727 . . . . 0.0 108.037 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.5 t -88.62 132.52 34.52 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.097 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.71 138.58 24.62 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -134.0 149.54 51.21 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.612 162.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.38 -165.09 24.81 Favored Glycine 0 CA--C 1.54 1.614 0 O-C-N 124.753 1.283 . . . . 0.0 111.429 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -50.81 -75.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.22 1.408 . . . . 0.0 113.184 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.69 74.78 1.54 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.052 0.941 . . . . 0.0 108.621 168.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.22 -64.73 0.82 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.82 -55.41 4.83 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -171.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -42.33 -53.19 4.27 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.371 -1.741 . . . . 0.0 113.717 172.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -37.94 78.85 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 t -65.78 -60.42 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -46.28 -47.55 18.23 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.513 1.525 . . . . 0.0 114.62 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -61.18 -51.15 70.22 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.322 1.049 . . . . 0.0 113.155 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 mt -69.15 -27.87 65.93 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 174.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.9 t -63.86 -34.63 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-O 118.957 -0.544 . . . . 0.0 110.738 170.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -62.18 -42.2 99.05 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 mp -57.55 -44.07 84.91 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.4 mtt -62.42 -18.9 62.79 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.6 -43.25 7.3 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -74.03 -39.36 63.6 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.3 mt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -171.379 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 C--O 1.223 -0.342 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -107.6 109.18 20.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 125.395 1.685 . . . . 0.0 108.254 171.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -117.8 125.18 50.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.576 -170.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -138.73 129.93 26.97 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.189 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -89.42 116.88 27.93 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.061 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.07 119.86 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.749 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 m -86.17 112.45 21.34 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.732 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.05 122.05 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 114.684 -1.143 . . . . 0.0 110.083 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.4 p -107.23 -0.4 22.66 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.22 117.76 43.08 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.133 0.973 . . . . 0.0 111.723 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.67 -41.94 44.36 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 124.75 3.634 . . . . 0.0 114.49 -174.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -57.77 -40.82 80.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.17 50.83 6.05 Favored Glycine 0 CA--C 1.55 2.252 0 O-C-N 123.757 0.661 . . . . 0.0 113.788 -169.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.8 mt 58.81 59.76 2.74 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 126.241 1.816 . . . . 0.0 115.03 175.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.254 28.1 p80 -41.27 -97.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 119.091 2.997 . . . . 0.0 119.091 -163.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.5 p -108.49 -64.9 1.18 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.842 0.857 . . . . 0.0 111.214 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -51.71 -51.97 65.09 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 125.988 1.715 . . . . 0.0 113.67 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -64.96 -44.32 10.15 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.431 2.087 . . . . 0.0 113.407 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.65 -52.03 51.19 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 174.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.73 -45.96 92.25 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -61.59 -41.73 97.85 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.4 -53.23 60.6 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.09 0.869 . . . . 0.0 111.226 174.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.22 -43.42 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 123.663 0.785 . . . . 0.0 111.782 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -48.39 -56.24 8.68 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.57 0.748 . . . . 0.0 111.723 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.73 -40.83 72.54 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.88 -41.61 67.73 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.828 0.851 . . . . 0.0 113.281 172.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -70.04 -30.61 67.92 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.3 -29.44 74.9 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.911 1.243 . . . . 0.0 113.069 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -86.01 124.33 32.33 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.189 0.995 . . . . 0.0 112.557 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.45 ' HG1' ' CD ' ' A' ' 68' ' ' GLU . 17.0 p -65.65 -42.88 90.88 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.086 170.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.1 t -44.1 143.15 1.23 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.168 1.787 . . . . 0.0 112.228 162.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -95.27 136.26 35.83 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.056 0.932 . . . . 0.0 112.757 -173.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mm -115.28 101.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.213 -169.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.0 m -99.82 130.1 45.99 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.887 173.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 t -110.06 107.72 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 m -105.62 122.68 46.54 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.079 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 t -125.3 98.75 5.76 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.437 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 p30 32.47 85.97 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 112.007 -2.36 . . . . 0.0 116.251 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.56 -41.99 3.11 Favored Glycine 0 N--CA 1.478 1.484 0 CA-C-N 112.77 -2.013 . . . . 0.0 114.355 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -92.46 138.59 31.39 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.532 0.682 . . . . 0.0 112.248 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.0 p -116.9 135.62 53.58 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.549 1.14 . . . . 0.0 113.513 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.24 131.04 43.63 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.237 173.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 t -81.0 111.24 17.29 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.022 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.28 -26.21 64.75 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.324 -1.762 . . . . 0.0 114.631 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -61.69 -21.01 64.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 t -105.52 116.23 31.6 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.543 0.687 . . . . 0.0 110.809 167.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.8 tp -52.23 -46.31 65.65 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.386 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -50.95 -51.3 53.78 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.185 0.994 . . . . 0.0 112.359 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -63.31 -49.0 75.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 tp -54.08 -43.76 70.6 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.606 1.191 . . . . 0.0 112.468 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -65.16 -31.56 72.8 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 t -93.12 55.78 2.4 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 123.999 1.857 . . . . 0.0 112.142 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 tp -152.27 150.63 29.99 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.722 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.14 76.62 2.13 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 124.231 0.92 . . . . 0.0 113.467 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.65 42.23 1.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.5 t -102.53 170.75 7.85 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.704 -1.589 . . . . 0.0 115.22 -158.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -52.17 114.99 1.5 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.342 1.457 . . . . 0.0 113.831 176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.93 -21.39 38.3 Favored Glycine 0 CA--C 1.543 1.802 0 CA-C-N 113.043 -1.89 . . . . 0.0 113.535 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.7 m -72.67 132.16 43.34 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.304 1.05 . . . . 0.0 112.86 -171.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.7 p -86.0 110.81 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 113.156 -1.838 . . . . 0.0 108.326 164.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.07 129.04 59.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.709 -1.587 . . . . 0.0 110.896 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -91.56 107.66 19.36 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.24 -174.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.18 100.7 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -99.55 100.56 11.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 112.163 -2.289 . . . . 0.0 109.323 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.06 126.69 52.68 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.332 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -127.22 138.91 53.21 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.125 176.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.02 -141.58 16.97 Favored Glycine 0 N--CA 1.48 1.608 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.659 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . 0.45 ' CD ' ' HG1' ' A' ' 30' ' ' THR . 51.0 mt-10 -46.13 -86.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -174.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.25 48.46 1.27 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.275 10.8 pt-20 -58.34 -37.27 74.82 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -177.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -69.66 -59.59 2.86 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.645 0.778 . . . . 0.0 112.813 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -56.66 -47.9 78.75 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.915 1.686 . . . . 0.0 114.168 -176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.99 -41.76 62.41 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.9 t -66.28 -55.52 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 123.753 0.658 . . . . 0.0 110.893 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -46.5 -49.63 18.18 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.319 1.448 . . . . 0.0 112.794 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -63.0 -50.63 69.97 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.619 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.6 mt -59.39 -37.96 79.3 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.09 -53.64 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.819 0.847 . . . . 0.0 111.173 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -61.13 -46.15 91.75 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.311 1.007 . . . . 0.0 111.733 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -53.66 -50.24 66.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.011 0.924 . . . . 0.0 111.73 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 32.5 mtp -58.17 -46.39 85.81 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.806 1.242 . . . . 0.0 112.903 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.28 -21.76 66.28 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.42 1.79 27.68 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -169.459 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.8 mtm . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -127.14 114.54 17.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.252 0.97 . . . . 0.0 111.76 -173.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -123.53 121.57 35.99 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.59 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.01 158.8 31.26 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 113.787 -1.551 . . . . 0.0 112.053 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -104.25 122.22 44.94 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.563 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.43 129.44 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.749 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m -96.38 126.61 41.7 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.105 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.3 mm -76.26 108.46 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -99.94 -16.61 17.91 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.06 120.0 30.96 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.457 1.103 . . . . 0.0 112.891 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -63.5 -45.63 11.15 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.696 2.931 . . . . 0.0 113.914 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -71.53 -36.0 70.88 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.379 0.424 . . . . 0.0 112.14 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.05 179.98 18.02 Favored Glycine 0 N--CA 1.477 1.428 0 O-C-N 124.506 1.129 . . . . 0.0 110.706 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.5 mt -99.84 85.11 3.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.593 1.187 . . . . 0.0 110.88 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.74 -148.41 0.23 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 113.352 -1.749 . . . . 0.0 114.693 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 p -57.57 -55.92 28.64 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -168.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -57.14 -49.13 95.72 Favored Pre-proline 0 CA--C 1.557 1.235 0 CA-C-O 116.927 -1.511 . . . . 0.0 112.568 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -57.92 -50.3 10.64 Favored 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 122.909 2.406 . . . . 0.0 113.903 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.61 -49.33 75.27 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 118.046 -0.978 . . . . 0.0 112.616 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.78 76.94 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.117 0.967 . . . . 0.0 113.274 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -61.71 -51.31 68.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.972 0.909 . . . . 0.0 113.305 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -50.89 71.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.362 1.465 . . . . 0.0 111.832 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.71 -45.81 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.449 1.099 . . . . 0.0 111.616 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -55.73 -47.29 77.16 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.881 0.738 . . . . 0.0 111.408 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.25 -44.57 71.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.44 -39.79 73.71 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -71.23 -38.79 71.96 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 -42.95 97.15 Favored Glycine 0 N--CA 1.479 1.512 0 O-C-N 125.294 1.621 . . . . 0.0 112.823 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -73.02 135.54 44.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.864 0.866 . . . . 0.0 110.124 168.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.8 p -67.61 -41.55 83.83 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.87 123.36 2.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.074 1.749 . . . . 0.0 115.099 172.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -81.74 132.0 35.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.908 0.861 . . . . 0.0 111.316 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 mm -121.51 110.31 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 113.917 -1.492 . . . . 0.0 111.529 -168.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.2 m -102.07 117.6 35.14 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.156 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.5 t -108.72 96.17 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 113.372 -1.74 . . . . 0.0 106.395 -174.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -106.99 109.27 21.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.054 -168.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 t -106.5 109.2 21.06 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.766 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 p30 45.88 60.67 3.03 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.376 -1.738 . . . . 0.0 114.688 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.99 -28.87 2.16 Favored Glycine 0 N--CA 1.485 1.919 0 CA-C-N 114.29 -1.323 . . . . 0.0 114.877 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -75.21 105.55 6.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 122.101 0.953 . . . . 0.0 111.1 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.6 p -93.31 114.14 26.51 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.84 148.41 26.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 112.625 -2.079 . . . . 0.0 109.879 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.5 t -103.36 118.46 36.82 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.02 -29.14 56.75 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 125.241 1.588 . . . . 0.0 113.222 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -63.03 -24.34 67.87 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.145 1.378 . . . . 0.0 114.251 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 t -115.49 117.05 29.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.815 0.446 . . . . 0.0 110.866 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 tp -49.98 -52.7 31.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.116 1.367 . . . . 0.0 112.719 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.08 -36.48 77.46 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.402 1.081 . . . . 0.0 112.745 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -77.59 -44.12 29.44 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.549 0.531 . . . . 0.0 112.047 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.2 tp -62.33 -39.61 93.65 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.636 0.774 . . . . 0.0 112.594 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -60.21 -37.0 78.95 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 t -90.38 59.68 4.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 123.538 1.637 . . . . 0.0 112.025 175.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -144.14 153.01 41.69 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.757 -2.02 . . . . 0.0 109.579 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.12 79.68 0.05 OUTLIER Glycine 0 N--CA 1.485 1.916 0 C-N-CA 124.604 1.097 . . . . 0.0 112.844 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.5 mt -100.13 42.56 1.1 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.222 1.01 . . . . 0.0 111.98 173.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -113.26 156.89 22.52 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 113.352 -1.749 . . . . 0.0 112.179 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -48.98 108.09 0.17 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.558 1.543 . . . . 0.0 114.2 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.02 -23.19 11.71 Favored Glycine 0 CA--C 1.548 2.125 0 CA-C-N 113.277 -1.783 . . . . 0.0 115.495 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -73.42 127.03 31.56 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 117.638 0.719 . . . . 0.0 112.358 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.65 140.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 121.837 0.827 . . . . 0.0 111.803 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.74 131.38 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.985 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.71 109.18 15.88 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.489 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.7 mm -91.43 96.69 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -104.58 113.73 27.5 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.74 1.275 . . . . 0.0 112.054 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.12 131.29 55.89 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.372 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.15 152.59 39.76 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.5 173.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.33 -152.35 19.21 Favored Glycine 0 N--CA 1.48 1.605 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.532 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -42.75 -61.88 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 -173.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -104.79 40.56 1.47 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.353 0.661 . . . . 0.0 112.315 -174.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -47.77 -48.48 30.08 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -75.05 -48.73 22.52 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.81 -39.35 77.4 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.117 1.367 . . . . 0.0 112.85 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.95 -61.22 2.43 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.918 173.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.2 t -64.53 -41.69 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 118.384 -0.817 . . . . 0.0 111.216 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -51.2 -61.15 2.41 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.133 0.973 . . . . 0.0 112.375 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -69.44 -30.52 68.46 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.2 -34.95 79.19 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.06 1.134 . . . . 0.0 114.06 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.82 -46.66 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 119.002 -0.523 . . . . 0.0 109.717 169.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -51.34 -49.59 61.1 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.042 0.937 . . . . 0.0 111.574 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mt -50.42 -62.11 1.78 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.631 1.173 . . . . 0.0 113.533 171.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 69.0 mtm -57.03 -36.04 70.01 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.97 -32.38 67.2 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -79.59 -17.96 52.7 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 123.713 0.805 . . . . 0.0 111.175 174.756 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -130.39 116.76 18.72 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.849 1.343 . . . . 0.0 111.391 -176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -123.72 140.93 52.5 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -135.71 139.84 43.97 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 125.089 1.493 . . . . 0.0 113.303 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -84.98 120.01 26.03 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.633 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.2 t -126.21 121.5 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.43 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -83.51 129.71 34.98 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.108 0.956 . . . . 0.0 110.619 170.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.8 mm -107.79 117.89 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.9 p -111.45 -2.14 15.65 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.08 121.1 69.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 124.071 0.948 . . . . 0.0 111.947 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -57.78 -44.56 39.78 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 C-N-CA 123.403 2.735 . . . . 0.0 114.018 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -68.88 -34.73 75.91 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.87 -170.18 54.87 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.535 1.54 . . . . 0.0 114.56 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -79.58 74.35 6.24 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 123.24 1.495 . . . . 0.0 113.474 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -102.08 169.98 8.4 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.329 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.9 p 38.9 -104.48 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.507 1.923 . . . . 0.0 115.658 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -78.0 -44.26 2.29 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 115.553 -2.165 . . . . 0.0 112.948 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -48.95 -46.88 23.44 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.621 2.214 . . . . 0.0 113.908 168.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.83 -54.8 40.71 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.251 0.621 . . . . 0.0 112.531 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.78 -40.85 69.86 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -57.07 -53.63 55.94 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.861 0.865 . . . . 0.0 113.126 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -61.18 -47.76 84.68 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.733 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.0 t -57.49 -52.04 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.504 1.122 . . . . 0.0 112.048 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -60.44 -47.57 85.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.222 0.609 . . . . 0.0 111.742 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.62 -43.02 99.86 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 124.097 0.873 . . . . 0.0 112.55 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.01 98.6 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 171.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -61.16 -23.67 65.73 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.38 -30.66 49.02 Favored Glycine 0 CA--C 1.548 2.107 0 C-N-CA 124.535 1.064 . . . . 0.0 114.041 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -87.79 124.7 33.88 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 122.109 0.957 . . . . 0.0 112.578 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.6 p -71.36 -4.31 25.46 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 m -93.19 145.39 24.46 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.603 1.161 . . . . 0.0 108.6 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.55 131.16 34.24 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.5 0.667 . . . . 0.0 112.492 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.5 mm -120.89 118.48 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 112.976 -1.92 . . . . 0.0 108.834 -168.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.2 m -113.53 123.25 49.56 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 112.148 -2.297 . . . . 0.0 110.689 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.9 t -99.0 90.45 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 113.52 -1.673 . . . . 0.0 106.49 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.8 m -97.52 112.89 24.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.066 -1.424 . . . . 0.0 112.516 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.3 t -111.49 98.0 7.14 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.184 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 p30 39.35 64.84 0.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 114.043 -1.435 . . . . 0.0 114.822 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.51 -49.9 2.93 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.432 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.02 112.89 2.79 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.295 1.038 . . . . 0.0 111.711 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.2 p -106.99 104.76 14.51 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.903 -1.499 . . . . 0.0 114.214 -171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.2 144.02 25.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.414 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.9 t -80.04 124.93 29.16 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.647 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.5 -26.42 63.44 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 125.009 1.443 . . . . 0.0 114.515 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -83.04 27.47 0.55 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.5 t -145.2 118.27 8.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.777 1.231 . . . . 0.0 113.004 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.7 tp -56.74 -47.01 81.0 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.736 -1.574 . . . . 0.0 112.062 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -54.56 -51.54 64.93 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 117.961 -1.019 . . . . 0.0 112.07 171.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -58.34 -43.05 88.13 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.7 mp -63.89 -52.5 59.61 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -66.46 -27.81 68.1 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 t -79.26 -15.02 58.64 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -107.12 137.38 45.29 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.844 0.831 . . . . 0.0 109.415 -177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.43 71.11 0.65 Allowed Glycine 0 CA--C 1.541 1.681 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.659 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.05 71.91 10.87 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.751 0.786 . . . . 0.0 110.181 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -128.93 -157.56 0.83 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -162.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -66.5 102.43 0.89 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.74 1.616 . . . . 0.0 114.806 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.64 39.85 7.49 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 112.84 -1.982 . . . . 0.0 112.328 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 m -105.72 114.73 29.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -95.19 112.03 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.397 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.6 112.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.212 -2.267 . . . . 0.0 111.838 -172.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -78.29 98.85 6.07 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.812 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.0 mm -76.35 107.89 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 113.747 -1.57 . . . . 0.0 108.126 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -101.35 138.47 38.33 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.851 -1.977 . . . . 0.0 111.671 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.35 144.48 51.27 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.518 1.127 . . . . 0.0 112.832 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -143.38 140.18 30.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.148 167.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.98 -145.16 15.99 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 115.138 0.815 . . . . 0.0 115.138 173.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -55.44 -66.22 0.45 Allowed 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -169.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.25 23.07 10.57 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.777 1.231 . . . . 0.0 112.756 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -32.35 -59.46 0.3 Allowed 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 119.027 2.973 . . . . 0.0 119.027 -168.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -60.12 -54.67 43.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -58.77 -43.06 90.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.356 1.463 . . . . 0.0 111.953 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.01 -52.42 50.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.944 0.898 . . . . 0.0 112.658 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.263 17.5 t -71.61 -39.09 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.588 176.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -50.31 -50.96 49.13 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.396 1.078 . . . . 0.0 111.923 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -59.18 -53.38 58.92 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.751 1.221 . . . . 0.0 111.63 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.3 mt -57.69 -35.43 70.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.03 -46.35 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.987 0.915 . . . . 0.0 110.831 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -58.53 -48.41 80.95 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.463 0.477 . . . . 0.0 111.006 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tp -51.94 -51.08 59.49 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.979 1.312 . . . . 0.0 112.387 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.0 mtt -53.12 -27.57 21.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.77 -28.24 16.71 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.57 -23.17 63.51 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.6 mt . . . . . 0 N--CA 1.492 1.628 0 C-N-CA 124.163 0.985 . . . . 0.0 113.649 -177.055 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -123.73 137.17 54.74 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.895 1.372 . . . . 0.0 111.352 -171.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -128.45 141.52 51.37 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 125.376 1.673 . . . . 0.0 112.115 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -132.26 123.32 26.7 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.821 167.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -96.64 118.13 32.46 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.073 0.858 . . . . 0.0 110.817 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.5 m -118.13 134.0 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 112.81 -1.995 . . . . 0.0 113.246 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 m -89.64 86.75 6.79 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.404 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.6 mm -77.16 112.32 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.19 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 p -114.5 39.62 2.76 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 112.686 -2.052 . . . . 0.0 113.019 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.54 123.0 87.63 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.188 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -47.54 -47.14 18.71 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.89 3.727 . . . . 0.0 115.55 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -102.56 -50.56 3.54 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 169.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.55 -157.1 15.28 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 124.575 1.172 . . . . 0.0 112.568 171.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp -93.13 75.72 4.66 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.83 1.3 . . . . 0.0 112.424 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -97.21 -152.23 0.38 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.232 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.6 p -42.96 -71.58 0.08 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -163.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -74.16 -44.04 6.11 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-O 116.152 -1.88 . . . . 0.0 114.766 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.51 -43.58 53.98 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.579 2.186 . . . . 0.0 113.911 173.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.94 88.7 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.982 0.513 . . . . 0.0 112.308 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 -41.97 79.21 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -58.91 -45.88 89.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.188 0.995 . . . . 0.0 113.071 173.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -62.35 -48.67 78.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.39 1.076 . . . . 0.0 112.121 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.2 t -57.63 -44.73 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.137 0.975 . . . . 0.0 111.962 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -54.17 -51.81 63.16 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.797 0.839 . . . . 0.0 111.125 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -69.67 -39.26 77.1 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -44.98 78.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.371 0.668 . . . . 0.0 112.117 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -61.46 -29.39 69.93 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.995 1.479 . . . . 0.0 114.995 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.6 -33.65 87.81 Favored Glycine 0 CA--C 1.544 1.882 0 C-N-CA 124.879 1.228 . . . . 0.0 113.126 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -85.67 139.39 31.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.027 0.931 . . . . 0.0 111.958 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 p -74.4 -45.99 43.21 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.052 172.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.3 m -53.43 144.14 17.54 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.127 1.371 . . . . 0.0 113.143 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -92.77 127.09 38.15 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.119 0.961 . . . . 0.0 112.999 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.2 mm -101.27 117.42 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.705 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -102.22 119.21 38.44 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 112.049 -2.342 . . . . 0.0 108.632 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.16 99.47 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 113.792 -1.549 . . . . 0.0 107.036 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -113.85 113.76 25.34 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.606 -171.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.2 t -119.87 115.06 23.07 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.697 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.282 24.1 p30 35.57 69.92 0.16 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 112.697 -2.047 . . . . 0.0 115.935 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.77 -36.62 3.24 Favored Glycine 0 CA--C 1.545 1.959 0 CA-C-N 112.594 -2.094 . . . . 0.0 114.784 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -78.89 102.3 8.16 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.9 p -84.85 115.29 22.67 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.39 -1.732 . . . . 0.0 114.16 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.83 138.61 45.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.171 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.1 t -90.22 102.14 14.86 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.788 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.13 -40.2 57.96 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -63.54 -12.27 31.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -109.13 121.19 44.61 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 173.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -53.47 -46.0 69.77 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.042 1.463 . . . . 0.0 112.285 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -57.63 -53.55 56.92 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.809 172.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -67.28 -31.37 71.64 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -176.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 tp -67.55 -55.38 13.66 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.126 0.57 . . . . 0.0 111.732 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.15 -30.32 71.49 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -63.52 -16.58 61.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -96.52 129.21 43.93 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.51 88.1 0.43 Allowed Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.297 -176.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.24 90.73 4.94 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.188 0.518 . . . . 0.0 111.196 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -136.1 -145.99 0.23 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.772 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -88.35 115.12 25.63 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.18 40.67 2.39 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 112.614 -2.085 . . . . 0.0 113.617 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.6 m -115.58 104.95 12.23 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 p -85.46 105.12 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.46 123.89 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 111.582 -2.553 . . . . 0.0 113.077 -171.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 115.28 23.25 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 113.396 -1.729 . . . . 0.0 110.009 176.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.6 mm -98.39 103.93 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.3 t -116.31 130.56 56.84 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.097 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.24 141.15 49.18 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.87 130.01 46.31 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.181 -1.827 . . . . 0.0 113.218 169.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.27 -154.09 19.78 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 113.105 -1.861 . . . . 0.0 112.235 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -45.13 -71.25 0.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.253 1.821 . . . . 0.0 115.348 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -93.68 46.95 1.21 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.82 0.848 . . . . 0.0 112.414 -173.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -48.98 -60.6 2.63 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -62.55 -43.82 97.87 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -63.61 -52.46 60.78 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.126 0.97 . . . . 0.0 112.868 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.43 -40.5 68.39 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.43 -62.23 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.067 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -47.99 -53.07 17.34 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.106 1.763 . . . . 0.0 113.297 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -66.68 -41.16 88.56 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.1 mt -68.28 -36.17 78.98 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 172.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.39 -45.23 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.911 0.884 . . . . 0.0 110.204 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -52.34 -53.62 42.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.553 1.541 . . . . 0.0 111.018 173.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.5 tt -53.33 -55.84 21.52 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.204 1.002 . . . . 0.0 111.866 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.3 ttt -56.3 -48.64 76.25 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.013 1.325 . . . . 0.0 113.767 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.53 -29.12 68.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -99.18 14.65 28.68 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.7 mt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -178.212 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -124.48 142.5 51.28 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.623 1.202 . . . . 0.0 111.236 -179.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -139.46 142.92 37.35 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.666 -1.606 . . . . 0.0 114.527 -174.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -131.23 124.16 29.99 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 125.621 1.826 . . . . 0.0 110.888 168.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -98.05 128.21 44.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.155 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 m -128.29 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.128 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -88.29 103.2 15.58 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.523 174.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.73 102.73 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.03 176.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -116.02 13.64 15.92 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 112.259 -2.246 . . . . 0.0 116.063 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.74 134.12 81.84 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 168.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.57 -53.54 3.73 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 125.135 3.89 . . . . 0.0 115.293 -169.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.27 -39.36 10.1 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 172.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.02 -88.17 0.98 Allowed Glycine 0 N--CA 1.483 1.781 0 O-C-N 124.495 1.122 . . . . 0.0 112.385 171.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.43 73.46 0.82 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.867 1.318 . . . . 0.0 113.343 177.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -81.38 -165.04 0.86 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.928 169.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.8 p -53.31 -46.09 69.26 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -171.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.25 32.8 ttt180 -70.25 -54.8 8.74 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-O 116.689 -1.624 . . . . 0.0 114.274 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -56.58 -38.22 95.94 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 122.343 2.029 . . . . 0.0 112.881 173.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.66 -56.05 25.89 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.65 -40.8 66.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 175.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.55 -58.47 7.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.516 1.127 . . . . 0.0 112.477 170.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -54.39 -49.4 69.98 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.73 1.269 . . . . 0.0 111.853 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.7 t -57.8 -53.39 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.084 1.353 . . . . 0.0 111.789 177.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -58.92 -48.84 80.05 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.033 0.833 . . . . 0.0 112.131 -177.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.61 -40.97 80.18 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.677 1.236 . . . . 0.0 112.696 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.61 79.93 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -64.87 -32.01 73.51 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 175.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.46 -41.04 99.8 Favored Glycine 0 N--CA 1.487 2.092 0 O-C-N 124.587 1.179 . . . . 0.0 112.034 169.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -70.7 120.63 16.59 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.705 0.764 . . . . 0.0 112.799 174.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.8 p -62.26 -38.05 87.79 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.359 -1.292 . . . . 0.0 112.216 174.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.1 m -61.35 153.58 26.37 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 126.634 1.973 . . . . 0.0 111.352 175.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -96.52 137.08 36.13 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 122.086 0.946 . . . . 0.0 111.885 -175.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.7 mm -118.29 106.32 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.179 -166.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.2 m -99.25 134.48 42.05 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.436 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.66 110.57 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 113.582 -1.644 . . . . 0.0 107.338 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.7 m -115.53 119.87 37.61 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t -111.92 99.8 8.39 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.428 171.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 p30 36.38 85.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.94 -41.41 2.19 Favored Glycine 0 N--CA 1.484 1.887 0 CA-C-N 114.265 -1.334 . . . . 0.0 115.097 177.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.09 123.08 36.1 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.758 0.79 . . . . 0.0 111.619 177.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.0 p -113.08 153.44 28.16 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -173.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.99 152.93 31.56 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 111.987 -2.37 . . . . 0.0 112.55 -176.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 t -105.86 105.85 16.08 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.054 175.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.58 -32.87 72.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 125.245 1.59 . . . . 0.0 115.139 -170.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -71.32 19.09 0.06 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 176.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 t -145.16 126.15 14.53 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.958 0.903 . . . . 0.0 111.077 176.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.99 -53.18 56.53 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.238 0.961 . . . . 0.0 113.041 173.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -54.42 -60.27 3.56 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.625 0.77 . . . . 0.0 112.061 172.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -68.34 -17.88 64.36 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -173.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.8 tp -81.3 -65.8 0.97 Allowed 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.396 1.06 . . . . 0.0 111.667 164.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -63.45 -19.45 64.73 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -171.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -51.25 -29.27 13.96 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 168.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.4 mp -84.71 139.34 32.07 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.784 1.234 . . . . 0.0 110.499 171.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.48 75.23 1.99 Allowed Glycine 0 CA--C 1.541 1.667 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.419 177.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 mt -81.05 79.13 7.78 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.475 1.131 . . . . 0.0 109.459 176.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -129.83 -155.37 0.69 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.272 -1.785 . . . . 0.0 110.942 -165.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -77.87 120.5 22.84 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.672 -0.643 . . . . 0.0 111.705 172.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.72 35.52 8.39 Favored Glycine 0 N--CA 1.487 2.073 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.419 -178.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.9 m -109.53 91.89 3.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -74.43 103.49 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.223 167.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.67 137.43 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-N 111.502 -2.59 . . . . 0.0 112.168 -173.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.57 128.68 45.68 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.073 -1.422 . . . . 0.0 110.262 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mm -101.6 108.36 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 m -113.54 128.39 56.42 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 125.845 1.966 . . . . 0.0 111.809 -176.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.06 122.68 44.84 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.641 177.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -114.85 136.82 52.67 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.24 175.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.05 -131.03 8.26 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.546 175.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.4 -66.77 0.58 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.064 1.346 . . . . 0.0 113.574 -172.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -92.88 49.69 1.47 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.975 0.91 . . . . 0.0 111.763 -172.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -54.0 -45.24 71.42 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -68.78 -62.03 1.56 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.698 0.799 . . . . 0.0 111.359 173.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -48.15 -51.69 23.84 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.804 2.042 . . . . 0.0 113.656 -176.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.23 82.4 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.94 -53.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.17 178.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -48.48 -50.36 31.94 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.985 1.314 . . . . 0.0 112.508 176.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -65.15 -41.43 94.75 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.189 1.395 . . . . 0.0 113.279 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 mt -80.28 -24.47 40.01 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 177.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.91 -41.72 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 168.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -52.57 -50.64 62.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.64 1.176 . . . . 0.0 110.889 169.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.6 -49.97 66.64 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.412 1.085 . . . . 0.0 113.01 171.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.4 mtt -64.05 -29.55 70.68 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 176.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.57 -51.3 24.13 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 174.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.1 60.37 4.86 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.462 1.105 . . . . 0.0 112.371 -174.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.479 1.005 0 C-N-CA 124.272 1.029 . . . . 0.0 113.75 -179.481 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.416 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 18.5 ttt . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.18 142.13 50.16 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 125.829 1.956 . . . . 0.0 111.678 -177.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.97 151.53 49.11 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.77 1.293 . . . . 0.0 113.371 176.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -142.61 128.28 19.22 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.135 167.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -91.06 109.95 21.21 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.006 174.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 p -118.74 115.75 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.719 -174.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -68.53 114.66 7.13 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.481 177.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.73 100.05 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 122.285 1.041 . . . . 0.0 110.289 174.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -76.84 -22.44 53.54 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 112.144 -2.298 . . . . 0.0 115.191 172.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.84 118.25 24.93 Favored Pre-proline 0 C--O 1.245 0.839 0 C-N-CA 124.518 1.127 . . . . 0.0 110.924 177.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -55.59 -53.31 5.86 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 124.194 3.263 . . . . 0.0 111.872 -172.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -62.8 -52.52 62.85 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.764 1.626 . . . . 0.0 112.531 170.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.91 -156.18 16.97 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 124.57 1.081 . . . . 0.0 111.558 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.89 84.95 2.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.962 1.363 . . . . 0.0 110.086 -173.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -81.94 -165.8 1.08 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.996 -1.457 . . . . 0.0 113.991 178.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.0 p -53.38 -49.28 67.54 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -166.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.439 15.8 ptt-85 -65.36 -47.3 70.26 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-O 115.795 -2.05 . . . . 0.0 116.471 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -65.84 -39.36 20.14 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.832 1.688 . . . . 0.0 113.209 169.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.22 79.76 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.39 86.01 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 172.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -56.68 -45.14 81.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.153 0.981 . . . . 0.0 112.558 174.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -56.99 -47.61 80.41 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.744 1.618 . . . . 0.0 111.897 175.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.33 -43.2 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 123.786 0.835 . . . . 0.0 112.522 175.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -58.37 -41.95 85.93 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.197 0.599 . . . . 0.0 111.34 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.55 -52.96 48.55 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 125.054 1.471 . . . . 0.0 111.868 169.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.81 -38.49 64.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -178.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -75.76 10.95 1.52 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 174.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.04 -17.57 40.09 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 124.572 1.17 . . . . 0.0 112.389 163.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -96.24 125.56 40.84 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.152 0.977 . . . . 0.0 108.973 179.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.4 p -62.4 -35.73 80.11 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.987 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.8 m -53.84 150.73 7.19 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.597 1.959 . . . . 0.0 114.973 176.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -80.83 89.77 5.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.719 173.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -73.94 98.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 109.822 -3.354 . . . . 0.0 114.288 175.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.8 m -104.01 128.58 51.59 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 112.261 -2.245 . . . . 0.0 109.512 -178.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.5 t -114.52 107.54 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 114.035 -1.439 . . . . 0.0 108.455 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.4 m -108.69 104.29 13.55 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.88 -176.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.6 p -90.37 54.64 2.81 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 113.797 -1.547 . . . . 0.0 113.548 -177.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.6 m120 48.89 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 123.672 1.701 . . . . 0.0 114.758 -174.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.91 -32.62 6.43 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 112.481 -2.145 . . . . 0.0 114.055 -178.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -111.58 132.93 54.2 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.373 0.669 . . . . 0.0 109.287 -177.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -123.13 134.84 54.18 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 122.183 0.992 . . . . 0.0 111.808 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.74 125.69 27.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 113.692 -1.595 . . . . 0.0 111.992 174.149 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.0 t -68.58 122.26 18.11 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.725 171.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.76 13.2 0.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.344 -1.298 . . . . 0.0 114.126 176.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -77.57 -7.72 56.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 169.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.4 t -133.46 133.66 42.57 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.377 1.071 . . . . 0.0 112.381 174.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -57.44 -53.25 60.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.116 1.366 . . . . 0.0 111.131 177.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -56.55 -34.41 67.04 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.107 -1.406 . . . . 0.0 114.559 176.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -58.57 -53.32 59.71 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 175.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.04 -32.88 61.66 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 176.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.94 -14.88 63.3 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 p -106.13 18.59 21.81 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 167.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 tp -114.81 120.89 41.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.53 70.51 1.93 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.393 -175.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 mt -75.9 94.55 3.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.898 176.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -142.33 -174.65 4.18 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -43.05 136.07 2.93 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.884 2.474 . . . . 0.0 113.83 -176.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.05 -32.16 3.57 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 113.481 -1.69 . . . . 0.0 115.71 175.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.2 p -59.37 120.2 8.86 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.9 t -90.34 77.4 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.87 113.37 14.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 112.518 -2.128 . . . . 0.0 112.692 -169.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.51 94.77 1.31 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.716 176.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.48 103.97 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 167.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -115.67 133.7 55.77 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 112.342 -2.208 . . . . 0.0 110.922 -176.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.65 120.06 25.85 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.27 0.981 . . . . 0.0 112.721 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -115.25 118.05 32.2 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.336 -1.756 . . . . 0.0 111.697 -178.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.25 -151.63 21.94 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.314 -178.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.52 -67.91 0.43 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -176.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -80.95 40.51 0.54 Allowed 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -178.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 7.5 pt-20 -46.7 -62.82 1.21 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.462 1.905 . . . . 0.0 115.569 -176.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -64.83 -40.63 95.49 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.676 1.19 . . . . 0.0 113.309 -178.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -59.71 -48.5 81.41 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.177 0.991 . . . . 0.0 111.158 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.68 67.84 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.212 0.945 . . . . 0.0 112.918 175.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.9 -53.86 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.289 0.636 . . . . 0.0 111.302 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -50.92 -50.8 56.81 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.01 1.324 . . . . 0.0 111.507 -178.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.95 -61.05 2.86 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.972 1.309 . . . . 0.0 111.61 177.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.63 -36.66 81.38 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -175.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.06 -47.72 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.342 0.657 . . . . 0.0 111.67 176.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -59.2 -50.08 75.41 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 123.709 0.631 . . . . 0.0 111.655 175.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.0 tp -52.27 -51.61 57.47 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.428 1.491 . . . . 0.0 112.426 175.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.4 tpp -52.2 -52.41 52.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.634 1.574 . . . . 0.0 113.002 173.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.16 -28.33 66.33 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.96 -20.13 24.86 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 178.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.6 mt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.512 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tmm? . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -141.07 140.05 34.15 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.539 1.149 . . . . 0.0 111.652 173.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -132.27 155.82 47.64 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.722 1.264 . . . . 0.0 113.775 176.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -141.65 125.46 17.02 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 124.563 1.165 . . . . 0.0 113.811 165.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -81.43 106.19 13.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.871 174.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.7 p -124.33 140.12 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.913 -177.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 p -99.94 129.01 45.97 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.129 178.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.86 122.38 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.429 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -77.96 -35.17 50.57 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 125.655 1.847 . . . . 0.0 114.472 176.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.79 123.4 81.47 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 124.472 1.109 . . . . 0.0 113.208 -174.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.86 -50.47 13.97 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.86 3.04 . . . . 0.0 112.022 174.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -62.29 -39.23 92.29 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 169.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.97 -136.04 12.64 Favored Glycine 0 N--CA 1.481 1.672 0 C-N-CA 124.342 0.973 . . . . 0.0 111.9 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mp -115.53 75.14 0.92 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.16 0.981 . . . . 0.0 112.521 174.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -75.55 -153.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 113.388 -1.733 . . . . 0.0 111.773 174.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.1 p -57.75 -61.1 2.76 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -167.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.357 20.7 ptt-85 -68.9 -38.38 11.3 Favored Pre-proline 0 N--CA 1.48 1.062 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.75 -37.08 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 CA-C-N 122.816 2.041 . . . . 0.0 113.747 173.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.41 98.87 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 169.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.81 -44.04 73.48 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 172.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -63.18 -47.14 83.86 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.569 0.543 . . . . 0.0 112.442 174.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -60.74 -47.74 84.93 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -51.83 -48.95 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.405 1.082 . . . . 0.0 111.765 175.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -54.48 -49.16 70.78 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.831 0.707 . . . . 0.0 111.414 179.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.07 -49.59 67.08 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.591 1.182 . . . . 0.0 110.959 -178.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.35 -42.05 77.13 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 175.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -58.44 -31.7 68.0 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.822 0.849 . . . . 0.0 112.615 176.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.74 5.55 74.27 Favored Glycine 0 CA--C 1.544 1.901 0 O-C-N 124.919 1.387 . . . . 0.0 115.369 -176.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -104.83 141.78 35.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.517 0.658 . . . . 0.0 110.212 169.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.525 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -56.57 -45.19 81.43 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 119.002 -0.523 . . . . 0.0 111.588 176.596 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.5 m -52.88 136.61 34.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.129 1.772 . . . . 0.0 113.512 179.205 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.78 112.77 10.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 167.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.9 mt -104.02 120.37 54.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 112.838 -1.983 . . . . 0.0 108.88 -174.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.7 m -123.32 133.37 54.15 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 112.235 -2.257 . . . . 0.0 110.713 -176.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.11 108.15 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 110.929 -2.85 . . . . 0.0 107.15 -169.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.7 m -112.54 103.23 11.29 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 112.876 -1.966 . . . . 0.0 113.035 -175.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.2 p -90.6 89.47 7.55 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 112.991 -1.913 . . . . 0.0 111.53 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.6 m120 50.93 63.26 2.31 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 123.406 1.574 . . . . 0.0 114.047 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.69 -25.66 6.43 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-N 113.724 -1.58 . . . . 0.0 115.698 -176.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -84.5 121.02 27.0 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 177.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -111.19 139.32 46.67 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -172.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.99 145.31 29.69 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.634 166.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.0 t -71.26 119.43 15.39 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.999 171.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.78 -30.69 67.76 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.083 -1.872 . . . . 0.0 112.908 174.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -74.44 15.06 0.38 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 176.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.4 t -133.36 138.94 46.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.166 0.986 . . . . 0.0 111.572 170.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.8 tp -66.72 -62.36 1.49 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 111.713 -2.494 . . . . 0.0 110.188 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -50.27 -55.62 14.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.524 1.529 . . . . 0.0 111.224 176.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -58.56 -53.86 53.59 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.79 -46.97 79.81 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -57.07 -37.79 72.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 174.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.7 p -86.19 -10.1 55.33 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.47 120.81 22.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.911 0.863 . . . . 0.0 108.869 164.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.94 89.3 0.24 Allowed Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.054 1.311 . . . . 0.0 113.558 -176.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.2 mt -106.0 103.88 13.47 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.571 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -130.75 177.22 7.57 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.67 -1.15 . . . . 0.0 113.046 -177.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -43.18 120.9 1.98 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.483 1.913 . . . . 0.0 114.03 177.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.64 -14.1 14.47 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 117.796 1.878 . . . . 0.0 117.796 177.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.6 m -58.9 129.17 40.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.107 1.454 . . . . 0.0 111.278 -179.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.22 93.56 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 113.221 -1.809 . . . . 0.0 107.843 -174.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -100.1 111.85 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 113.028 -1.896 . . . . 0.0 112.794 -176.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 m -81.68 102.27 10.6 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.737 175.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.2 mt -87.36 103.3 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 172.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.2 t -115.58 146.24 41.94 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.813 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.43 132.79 44.6 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.685 1.24 . . . . 0.0 113.734 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.3 110.44 16.13 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 112.871 -1.968 . . . . 0.0 112.54 177.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.58 -124.84 1.28 Allowed Glycine 0 CA--C 1.536 1.403 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.85 171.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -103.17 -53.38 2.83 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.599 -1.3 . . . . 0.0 113.631 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.525 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 46.3 p30 -88.92 46.74 1.42 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 175.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -55.38 -63.64 1.1 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.352 -1.749 . . . . 0.0 115.485 -178.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -67.78 -43.32 80.03 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -52.43 -47.7 66.22 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.781 1.301 . . . . 0.0 112.157 173.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.97 -50.63 67.82 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.65 0.78 . . . . 0.0 112.931 177.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.46 -52.57 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.985 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -48.97 -54.52 15.24 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.329 1.452 . . . . 0.0 111.518 177.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -56.66 -46.39 81.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.347 1.459 . . . . 0.0 113.121 -178.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.53 -36.03 26.72 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -176.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.3 t -61.39 -41.33 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.438 0.695 . . . . 0.0 110.745 172.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -63.27 -50.04 71.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 172.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.6 tp -54.43 -51.9 63.47 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.738 0.649 . . . . 0.0 112.667 175.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -36.69 77.31 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 176.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.43 89.93 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 174.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.04 -30.74 44.29 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.7 mt . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 123.504 0.722 . . . . 0.0 112.396 178.533 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.439 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 15.1 tmm? . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -121.08 133.69 55.24 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.335 1.647 . . . . 0.0 107.677 175.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -134.9 136.96 42.75 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.803 -1.544 . . . . 0.0 112.667 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -125.85 116.11 21.04 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.844 175.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -81.14 100.39 9.04 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.122 -2.308 . . . . 0.0 108.499 175.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.6 140.18 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.486 -172.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -73.34 152.08 41.02 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 123.039 1.4 . . . . 0.0 113.242 173.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 mt -85.58 110.39 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 164.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -88.09 -21.61 24.61 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 112.823 -1.99 . . . . 0.0 115.376 -175.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 121.14 56.92 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.091 1.356 . . . . 0.0 112.598 174.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -60.34 -52.45 4.01 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.277 2.651 . . . . 0.0 115.509 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -67.61 -31.8 72.09 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.95 158.35 32.98 Favored Glycine 0 N--CA 1.481 1.674 0 O-C-N 124.525 1.141 . . . . 0.0 112.564 168.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.9 mp -78.73 72.44 5.25 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 122.622 1.201 . . . . 0.0 112.92 -175.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -67.19 -167.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.97 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 p -46.24 -48.86 17.78 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 -174.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.475 35.9 ptt180 -78.22 -39.44 1.74 Allowed Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 177.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -59.51 -39.2 77.66 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 121.836 1.69 . . . . 0.0 112.055 169.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.02 98.13 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 173.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.19 -44.15 97.24 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -53.98 -49.76 68.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.057 1.343 . . . . 0.0 111.424 172.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -59.85 -36.14 76.23 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.126 -1.397 . . . . 0.0 114.054 175.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.25 -46.73 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.114 0.566 . . . . 0.0 111.902 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.52 -49.86 63.97 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.668 0.787 . . . . 0.0 109.78 177.003 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -60.35 -47.29 86.69 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.54 1.536 . . . . 0.0 113.611 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.44 94.03 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 176.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -63.5 -30.84 71.9 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.003 0.921 . . . . 0.0 112.587 174.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.0 -21.79 61.78 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.916 1.722 . . . . 0.0 115.081 175.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -95.2 155.18 16.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.944 0.898 . . . . 0.0 112.734 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.6 p -78.8 -46.32 19.01 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 117.642 -1.17 . . . . 0.0 112.128 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -54.83 139.13 40.93 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.835 1.254 . . . . 0.0 110.449 175.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -78.94 110.11 13.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.963 175.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.61 121.92 37.38 Favored 'Isoleucine or valine' 0 C--O 1.248 0.996 0 CA-C-N 110.751 -2.932 . . . . 0.0 112.149 175.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.3 m -116.54 132.67 56.62 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-N 111.43 -2.623 . . . . 0.0 109.017 174.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.0 t -113.41 93.32 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.821 -1.99 . . . . 0.0 107.727 -176.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -87.81 94.79 9.86 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.596 -178.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 t -92.98 95.65 9.61 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.956 -176.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.7 m120 32.53 81.0 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.759 1.623 . . . . 0.0 114.811 -168.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.11 -49.29 4.2 Favored Glycine 0 N--CA 1.481 1.697 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.235 -174.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -67.27 102.12 1.02 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -177.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.0 m -91.61 100.36 13.1 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.377 -177.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.37 143.02 45.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.98 1.371 . . . . 0.0 111.81 174.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.4 t -61.58 121.23 12.24 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 112.802 -1.999 . . . . 0.0 111.374 175.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.83 -23.68 64.28 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.929 166.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -79.75 -17.68 52.91 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 176.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 t -107.95 120.54 42.58 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 177.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.2 mt -50.6 -62.84 1.36 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 112.872 -1.967 . . . . 0.0 113.875 -178.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -66.37 -13.0 59.97 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -177.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -97.31 -37.25 10.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.367 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 tp -75.37 -43.64 49.24 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 170.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -58.02 -23.75 55.46 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 176.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.8 p -95.06 -14.1 24.58 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 177.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.2 tp -77.51 134.65 38.26 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.189 0.995 . . . . 0.0 111.833 -176.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.39 82.26 0.02 OUTLIER Glycine 0 N--CA 1.481 1.652 0 CA-C-N 113.824 -1.534 . . . . 0.0 112.731 169.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.5 mt -102.1 78.71 1.8 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.686 -1.257 . . . . 0.0 109.811 171.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 t -125.74 169.53 12.47 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -174.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -47.26 118.03 1.99 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.56 1.544 . . . . 0.0 112.671 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.59 -29.87 11.45 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 112.625 -2.079 . . . . 0.0 113.923 175.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 m -66.4 118.49 10.12 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.981 0.896 . . . . 0.0 111.208 -173.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.06 107.51 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 112.419 -2.173 . . . . 0.0 109.261 -178.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.86 118.86 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 113.353 -1.748 . . . . 0.0 111.409 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 m -84.3 100.67 11.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.918 174.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mt -78.16 110.8 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.23 172.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 t -119.71 139.49 52.17 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.378 1.049 . . . . 0.0 112.089 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.21 112.71 17.38 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 125.131 1.519 . . . . 0.0 110.93 175.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -109.01 101.24 10.34 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 112.574 -2.103 . . . . 0.0 110.26 -176.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.36 -159.03 24.67 Favored Glycine 0 N--CA 1.48 1.567 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.727 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -39.21 -84.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 -174.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -72.75 45.03 0.14 Allowed 'General case' 0 C--O 1.256 1.417 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.439 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 8.7 pt-20 -49.6 -61.17 2.26 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -177.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -65.78 -45.15 83.56 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -62.43 -40.49 96.72 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 113.897 -1.501 . . . . 0.0 113.166 178.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.23 -52.91 61.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.696 0.398 . . . . 0.0 111.964 -177.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.3 t -56.43 -61.46 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.419 175.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -42.6 -56.88 2.92 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.895 1.278 . . . . 0.0 113.077 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -53.91 -47.34 71.27 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.44 1.496 . . . . 0.0 113.675 177.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.1 mt -73.45 -30.65 63.33 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.3 t -64.2 -44.31 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -61.22 -42.9 99.4 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 176.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.28 -62.09 2.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.569 172.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 60.0 ttm -49.58 -46.9 49.58 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.96 1.304 . . . . 0.0 113.277 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.19 92.68 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -178.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.34 6.28 49.12 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 125.114 1.509 . . . . 0.0 114.711 -175.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 172.301 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 1' ' ' MET . . . . . 0.451 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 10.0 tmm? . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -122.61 139.65 53.69 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.017 0.823 . . . . 0.0 111.491 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -123.95 147.22 47.91 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 113.942 -1.481 . . . . 0.0 111.377 178.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -137.55 134.22 35.39 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.539 1.15 . . . . 0.0 110.557 162.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -97.84 112.17 24.18 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.717 1.26 . . . . 0.0 108.813 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.36 151.83 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.169 -174.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.8 p -106.41 151.68 24.6 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 176.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 mp -81.09 119.91 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -99.21 -38.65 8.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 112.593 -2.094 . . . . 0.0 114.629 -174.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.16 126.13 14.9 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.916 1.286 . . . . 0.0 113.062 176.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.69 -33.85 33.19 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 125.165 3.91 . . . . 0.0 115.035 -177.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.431 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 2.5 p30 -96.89 -70.63 0.71 Allowed 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.288 0.992 . . . . 0.0 111.539 171.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.42 -174.52 20.33 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 123.688 0.661 . . . . 0.0 113.397 173.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.68 73.53 1.51 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 122.79 1.281 . . . . 0.0 113.471 -179.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -73.99 -174.15 1.79 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.705 -1.588 . . . . 0.0 113.268 177.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -40.65 -48.37 2.91 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -171.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.265 48.0 mtm105 -82.97 -47.45 0.83 Allowed Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -175.346 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.23 -36.38 68.95 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 122.592 2.195 . . . . 0.0 113.795 168.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.61 91.85 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 171.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.5 -42.57 82.99 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 173.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -60.26 -49.72 76.5 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 172.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -57.01 -44.95 83.31 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.945 0.898 . . . . 0.0 112.068 177.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.41 -49.52 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.488 0.715 . . . . 0.0 111.67 174.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -51.16 -48.58 61.84 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.209 0.943 . . . . 0.0 112.493 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . 0.462 ' CD ' ' HE2' ' A' ' 76' ' ' HIS . 16.3 tp10 -64.58 -56.48 13.67 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.285 0.991 . . . . 0.0 112.078 175.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.74 -34.19 51.58 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -179.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -55.18 -28.02 49.98 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 173.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.01 16.53 60.26 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 124.202 0.938 . . . . 0.0 115.405 -175.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -111.23 145.14 39.25 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.813 0.845 . . . . 0.0 109.318 169.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.4 p -63.81 -43.68 95.52 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.4 m -57.23 148.51 22.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.159 1.784 . . . . 0.0 112.588 176.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.73 104.35 14.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.837 1.304 . . . . 0.0 109.132 174.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 mp -78.58 110.12 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 111.363 -2.653 . . . . 0.0 111.186 -175.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.4 m -90.18 95.45 10.21 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 112.879 -1.964 . . . . 0.0 108.137 176.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.6 t -84.4 99.35 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 112.418 -2.174 . . . . 0.0 107.348 178.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -96.35 104.4 16.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.346 -176.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -105.79 100.88 10.42 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.302 -175.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.5 m120 37.61 81.01 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.532 1.933 . . . . 0.0 115.404 -169.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.35 -39.13 1.43 Allowed Glycine 0 CA--C 1.544 1.887 0 CA-C-N 113.212 -1.813 . . . . 0.0 114.953 -178.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -89.15 125.59 35.11 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.649 0.78 . . . . 0.0 111.674 -174.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -111.92 142.5 44.23 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.56 142.61 35.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.207 -1.36 . . . . 0.0 114.247 173.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -61.85 117.77 6.33 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.573 171.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.04 -16.44 43.56 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.621 174.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -91.77 5.17 50.86 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -176.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 t -127.72 128.39 45.31 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.95 0.9 . . . . 0.0 112.022 -178.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 67.7 mt -55.44 -59.85 4.24 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.276 -1.784 . . . . 0.0 111.989 175.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -53.16 -45.33 68.41 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.666 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -62.9 -56.2 19.38 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.96 0.787 . . . . 0.0 112.989 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.65 -38.32 73.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -178.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -65.22 -11.73 43.89 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.4 p -119.44 9.78 11.68 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 173.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.83 149.5 25.66 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.749 0.82 . . . . 0.0 109.145 176.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.78 68.23 0.3 Allowed Glycine 0 CA--C 1.543 1.792 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.556 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.6 mt -102.75 82.96 2.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.123 0.969 . . . . 0.0 111.43 178.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.5 t -132.33 164.29 26.77 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.152 -1.84 . . . . 0.0 110.126 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -48.97 136.41 14.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.326 1.05 . . . . 0.0 113.004 177.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.24 -28.13 5.83 Favored Glycine 0 N--CA 1.483 1.823 0 CA-C-N 113.93 -1.487 . . . . 0.0 115.203 175.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 m -55.53 142.75 32.07 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.151 0.98 . . . . 0.0 112.298 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.22 127.01 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.592 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -121.25 116.08 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-O 122.828 1.299 . . . . 0.0 114.034 -178.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.78 104.38 16.1 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.431 170.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.3 mt -87.11 95.23 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.9 t -107.11 122.16 45.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.018 -177.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.89 110.21 19.31 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 178.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.37 122.02 33.61 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 113.038 -1.892 . . . . 0.0 110.573 169.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.42 -152.33 24.48 Favored Glycine 0 N--CA 1.475 1.269 0 O-C-N 124.737 1.273 . . . . 0.0 111.692 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -89.97 -60.78 1.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.186 1.394 . . . . 0.0 113.316 -174.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -77.58 38.06 0.24 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 6.8 pt-20 -48.06 -66.23 0.44 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.559 2.343 . . . . 0.0 114.918 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -56.25 -46.04 79.79 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.859 1.663 . . . . 0.0 113.374 177.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -61.74 -47.54 84.78 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.785 1.234 . . . . 0.0 111.776 -178.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.59 -50.82 71.88 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 124.23 0.956 . . . . 0.0 112.39 174.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.24 -51.02 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.632 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -48.25 -54.49 13.44 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.453 1.501 . . . . 0.0 112.466 178.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . 0.462 ' HE2' ' CD ' ' A' ' 25' ' ' GLU . 82.5 t60 -65.28 -51.67 59.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.191 177.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.35 -26.4 68.01 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -176.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.0 t -57.02 -45.5 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.724 0.81 . . . . 0.0 111.569 169.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -59.09 -52.77 64.32 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.353 1.033 . . . . 0.0 110.978 176.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.03 -47.75 74.33 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.698 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 60.9 tpp -52.84 -36.81 59.34 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 174.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.11 -28.64 25.44 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -107.84 22.91 15.27 Favored 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -171.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 mt . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 179.69 . . . . . . . . 0 0 . 1 . 026 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -136.74 141.9 43.03 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.882 1.364 . . . . 0.0 110.76 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -132.12 141.06 49.01 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.249 -179.271 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -133.89 125.0 27.39 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.159 0.912 . . . . 0.0 110.995 176.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -74.09 111.6 9.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.654 172.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.9 t -128.98 140.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.818 -177.002 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 p -113.22 149.41 33.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.809 0.814 . . . . 0.0 111.313 171.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 mt -77.43 123.42 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.066 175.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -93.12 -36.0 12.89 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 177.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.12 133.94 68.26 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 176.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -58.72 -49.54 11.44 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.859 3.04 . . . . 0.0 112.381 178.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -68.82 -44.73 72.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.123 1.769 . . . . 0.0 112.961 171.236 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.42 -141.51 39.09 Favored Glycine 0 N--CA 1.475 1.283 0 O-C-N 124.54 1.15 . . . . 0.0 113.153 172.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -92.66 57.92 2.99 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.806 1.288 . . . . 0.0 110.145 -175.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -70.99 -162.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.088 176.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -47.34 -61.02 2.1 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -167.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.407 10.5 ptt180 -64.8 -49.37 69.46 Favored Pre-proline 0 N--CA 1.481 1.115 0 CA-C-O 115.375 -2.25 . . . . 0.0 116.297 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -59.33 -42.72 46.69 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.063 2.509 . . . . 0.0 113.03 172.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.42 74.14 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.96 87.61 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -60.88 -45.86 92.9 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.759 1.224 . . . . 0.0 112.005 175.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -57.99 -45.28 87.06 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.233 1.413 . . . . 0.0 112.777 176.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.0 t -55.43 -47.8 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.355 0.662 . . . . 0.0 111.752 176.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -56.99 -46.44 82.27 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.948 0.78 . . . . 0.0 111.933 177.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -63.71 -47.26 81.84 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 123.796 0.685 . . . . 0.0 112.332 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.43 74.68 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.338 1.055 . . . . 0.0 113.791 172.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -54.35 -33.74 59.68 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 172.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.23 25.09 7.29 Favored Glycine 0 N--CA 1.479 1.511 0 C-N-CA 124.518 1.056 . . . . 0.0 114.264 -177.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -125.08 145.43 49.93 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.823 1.249 . . . . 0.0 110.469 169.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.459 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 56.7 p -66.06 -43.59 86.98 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.76 178.474 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.6 m -54.99 151.16 9.2 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.82 1.648 . . . . 0.0 113.462 174.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.29 124.76 43.09 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.663 1.221 . . . . 0.0 109.302 164.151 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.11 99.11 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 111.206 -2.725 . . . . 0.0 109.204 -176.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.0 m -83.59 115.46 22.14 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 112.422 -2.172 . . . . 0.0 108.678 175.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.37 103.83 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 114.031 -1.44 . . . . 0.0 108.746 -177.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 m -103.67 103.89 13.86 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.477 -175.018 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.1 t -96.96 97.46 9.28 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.708 176.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m120 38.06 79.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.059 -1.882 . . . . 0.0 115.444 -171.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.37 -48.69 4.09 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 113.605 -1.634 . . . . 0.0 114.247 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -77.47 119.43 21.05 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.785 0.834 . . . . 0.0 111.198 -176.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.7 p -110.1 139.57 45.09 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -173.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.35 138.93 46.55 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.348 176.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.5 t -69.42 118.16 11.95 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.249 170.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -23.79 66.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.129 174.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -77.86 6.15 8.19 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 175.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.8 t -130.36 125.26 34.17 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.782 1.233 . . . . 0.0 112.361 178.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.3 mt -53.59 -56.96 12.68 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.992 -1.458 . . . . 0.0 112.221 176.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.48 -34.73 77.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.89 -177.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -67.72 -56.61 8.6 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 118.972 -0.537 . . . . 0.0 112.181 175.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.78 -47.18 84.61 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.99 -23.34 66.56 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -178.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 p -87.89 -25.1 23.43 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 175.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.5 tp -74.89 130.63 39.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.075 0.94 . . . . 0.0 111.818 178.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.06 95.84 0.18 Allowed Glycine 0 CA--C 1.537 1.451 0 CA-C-N 114.113 -1.403 . . . . 0.0 113.35 177.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 mt -105.77 74.7 1.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.322 1.058 . . . . 0.0 111.881 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 t -136.1 142.22 44.28 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.697 -2.047 . . . . 0.0 112.029 -171.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 2.32 128.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 119.24 3.052 . . . . 0.0 119.24 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.91 -29.67 0.92 Allowed Glycine 0 N--CA 1.481 1.669 0 CA-C-N 114.003 -1.453 . . . . 0.0 115.981 168.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.7 m -61.4 136.53 58.07 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.73 1.212 . . . . 0.0 111.026 -178.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.56 110.0 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.521 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.9 p -108.16 92.32 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 112.488 -2.142 . . . . 0.0 109.395 178.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.1 p -82.69 99.48 9.64 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.302 -177.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.8 mp -73.73 109.64 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 112.034 -2.348 . . . . 0.0 109.415 174.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -113.73 109.48 18.64 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.735 -2.03 . . . . 0.0 111.125 -177.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.64 123.24 47.82 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 122.408 1.099 . . . . 0.0 112.551 -178.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -119.6 91.2 3.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.294 -177.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.08 -161.92 30.62 Favored Glycine 0 CA--C 1.548 2.116 0 CA-C-N 112.669 -2.059 . . . . 0.0 110.849 169.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.87 -51.18 58.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.459 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 11.8 p30 -79.63 36.81 0.33 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 176.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -39.95 -68.47 0.17 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 128.988 2.915 . . . . 0.0 115.475 -177.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.02 -41.43 92.15 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -71.34 -38.69 71.64 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.012 -176.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.57 74.9 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.105 0.878 . . . . 0.0 112.741 170.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -74.0 -66.03 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.318 176.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -42.37 -53.08 4.36 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 126.13 1.772 . . . . 0.0 112.633 -174.028 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -65.25 -45.88 82.82 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.473 -178.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.3 -30.45 67.45 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.7 t -59.51 -41.62 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.32 0.648 . . . . 0.0 111.09 171.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.89 -53.31 59.42 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.788 0.68 . . . . 0.0 112.24 172.271 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mp -53.87 -44.61 70.56 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 52.0 tpp -55.9 -43.16 76.99 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.97 1.308 . . . . 0.0 113.669 173.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.41 -37.32 37.44 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 179.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -98.57 -27.08 14.18 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 119.084 2.994 . . . . 0.0 119.084 -169.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.1 mt . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.178 . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 ttp . . . . . 0 C--O 1.237 0.444 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 . . . . . . . . . 0 0 . 1 . 027 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -109.04 120.93 44.0 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.848 1.343 . . . . 0.0 109.074 177.016 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -111.84 120.65 42.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.842 -176.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -121.96 122.96 40.56 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.735 177.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.45 123.98 32.27 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.608 1.192 . . . . 0.0 112.55 177.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.6 t -129.16 133.26 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.0 178.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.41 118.27 25.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.675 175.423 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.05 116.15 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 170.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p -124.24 16.67 9.1 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -178.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.68 134.34 39.98 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.255 175.4 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -49.27 -35.06 33.49 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.934 3.089 . . . . 0.0 115.996 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -92.63 -41.82 9.99 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 165.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.18 -133.83 48.66 Favored Glycine 0 N--CA 1.474 1.211 0 O-C-N 124.207 0.942 . . . . 0.0 111.564 -176.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.6 93.7 9.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.834 0.826 . . . . 0.0 111.132 -176.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -105.14 -147.79 0.4 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 113.693 -1.594 . . . . 0.0 113.059 174.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.2 p -57.24 -72.34 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.779 1.631 . . . . 0.0 114.785 -166.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.34 20.8 ptt180 -62.19 -33.83 13.47 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 176.397 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.16 -47.35 23.02 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 122.356 2.037 . . . . 0.0 112.872 166.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.67 94.06 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 174.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.34 -46.99 69.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 173.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -62.7 -49.82 73.56 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.137 0.975 . . . . 0.0 112.174 174.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -54.57 -48.32 72.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.278 1.431 . . . . 0.0 111.987 178.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.5 t -59.39 -49.88 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 124.145 0.978 . . . . 0.0 112.249 176.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -53.23 -52.79 57.8 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 123.868 0.73 . . . . 0.0 110.829 178.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -72.33 -38.26 68.69 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 -178.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.85 82.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 173.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -61.35 -21.17 63.77 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 173.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.63 4.16 81.92 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.665 1.126 . . . . 0.0 114.846 175.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -114.39 131.75 56.46 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.099 0.959 . . . . 0.0 108.478 171.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.4 p -64.48 -47.6 78.36 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.925 -175.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 m -46.2 130.34 10.34 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.422 2.289 . . . . 0.0 113.075 174.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.34 112.03 17.29 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.934 0.873 . . . . 0.0 109.385 176.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.04 97.55 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 112.086 -2.324 . . . . 0.0 109.744 -171.155 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.1 m -84.4 104.99 14.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.437 178.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.38 92.81 3.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.8 m -97.55 92.12 5.77 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.578 -176.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.8 p -88.96 108.49 19.6 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.068 0.937 . . . . 0.0 111.24 178.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m120 36.33 70.77 0.15 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 112.514 -2.13 . . . . 0.0 114.545 -169.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.31 -28.24 3.85 Favored Glycine 0 N--CA 1.482 1.731 0 CA-C-N 113.884 -1.507 . . . . 0.0 116.161 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -88.57 111.26 21.66 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.1 p -96.92 124.18 40.82 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -170.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.58 140.52 48.29 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.199 -1.819 . . . . 0.0 111.152 171.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -72.4 127.73 33.46 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 120.897 0.379 . . . . 0.0 110.833 175.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.54 -20.75 22.1 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.733 -1.576 . . . . 0.0 115.07 176.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -85.01 -8.97 58.5 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 t -111.21 107.39 16.69 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.307 0.643 . . . . 0.0 112.29 -177.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.9 mt -38.7 -63.15 0.54 Allowed 'General case' 0 N--CA 1.483 1.181 0 O-C-N 125.697 1.873 . . . . 0.0 112.83 170.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -48.72 -55.03 12.57 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.746 1.218 . . . . 0.0 113.371 177.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -56.38 -53.61 55.32 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 178.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tp -62.33 -48.3 80.44 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.833 -178.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -61.89 -19.53 62.77 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 177.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.6 p -114.67 20.18 15.46 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -115.76 135.09 54.36 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.05 0.94 . . . . 0.0 109.408 177.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.7 93.11 0.06 OUTLIER Glycine 0 N--CA 1.48 1.589 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.486 175.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.2 mt -121.7 49.3 1.56 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.717 -1.242 . . . . 0.0 113.18 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 t -118.71 -151.75 0.49 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.184 -170.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -46.14 135.19 7.87 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.057 2.143 . . . . 0.0 113.419 175.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.53 40.15 54.36 Favored Glycine 0 N--CA 1.483 1.784 0 CA-C-N 113.341 -1.754 . . . . 0.0 115.183 175.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.8 m -117.23 127.42 54.08 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.862 0.465 . . . . 0.0 109.973 -174.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.6 t -100.59 115.9 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.0 p -104.25 124.83 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.971 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -92.19 103.24 15.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.762 174.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mp -77.85 89.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.7 t -94.2 90.33 6.31 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.963 -177.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.03 114.58 26.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.481 -176.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.28 107.57 13.13 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.85 -158.61 31.18 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 114.337 -1.301 . . . . 0.0 113.092 173.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.63 -42.46 71.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -173.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 p30 -117.92 50.84 1.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -175.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.298 12.0 pt-20 -54.88 -50.16 69.41 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -172.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -67.99 -33.69 75.11 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.51 -45.83 92.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.927 1.291 . . . . 0.0 110.532 176.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.38 -47.81 84.04 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.4 t -58.88 -55.04 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 117.823 -1.084 . . . . 0.0 112.205 178.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -48.8 -51.77 27.57 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.575 1.172 . . . . 0.0 112.36 -177.131 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -72.45 -46.23 55.89 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -179.157 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.258 76.4 mt -68.7 -26.63 65.38 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -176.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.9 t -57.7 -52.71 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.132 0.973 . . . . 0.0 110.217 168.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -51.04 -56.13 14.05 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.827 1.33 . . . . 0.0 112.751 178.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.7 mt -54.04 -59.16 5.01 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 174.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.4 tpp -52.03 -49.71 62.87 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.98 -33.37 70.36 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -107.76 18.6 21.16 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -171.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.4 mt . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 178.459 . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 . . . . . . . . . 0 0 . 1 . 028 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -142.81 138.89 30.7 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 125.798 1.936 . . . . 0.0 111.243 -171.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -137.41 133.26 34.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 178.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -128.3 150.51 50.03 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.901 1.281 . . . . 0.0 111.378 177.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -111.25 126.35 54.78 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 t -116.94 139.21 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.321 -177.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -97.24 110.27 22.86 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.396 1.093 . . . . 0.0 111.032 174.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 mt -88.94 85.8 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.8 p -103.63 48.57 0.85 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.138 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.46 131.5 23.95 Favored Pre-proline 0 N--CA 1.48 1.046 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.556 -178.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.96 -54.88 3.46 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.927 3.751 . . . . 0.0 116.441 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -90.83 -36.04 14.45 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 169.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.96 -136.76 38.09 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.383 0.992 . . . . 0.0 112.771 174.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.8 tp -92.42 80.06 4.93 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.492 1.139 . . . . 0.0 109.038 -176.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -90.94 -166.14 1.51 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 113.038 -1.892 . . . . 0.0 112.738 177.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.6 p -33.17 -75.18 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.528 2.331 . . . . 0.0 117.155 -174.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.383 22.4 ptt85 -69.13 -31.69 2.88 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 179.322 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -60.81 -40.72 51.58 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.94 1.76 . . . . 0.0 112.626 165.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.32 -42.42 91.36 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.566 0.746 . . . . 0.0 112.958 173.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.03 -42.45 65.7 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 172.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -69.7 -43.94 71.42 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 175.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.61 -42.6 83.6 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.184 0.927 . . . . 0.0 112.119 175.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.73 -57.01 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 124.059 0.944 . . . . 0.0 110.395 173.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -48.27 -46.61 36.04 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 124.538 1.148 . . . . 0.0 112.4 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -68.85 -54.74 14.0 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 124.684 1.24 . . . . 0.0 112.754 179.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.53 66.61 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -53.87 -39.01 65.33 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 173.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.86 -37.01 93.64 Favored Glycine 0 N--CA 1.483 1.768 0 O-C-N 124.775 1.297 . . . . 0.0 113.632 -179.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -76.82 140.08 40.56 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.529 0.731 . . . . 0.0 111.746 178.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.0 p -65.47 -47.22 76.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.353 -174.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 m -49.37 132.0 20.39 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.665 1.586 . . . . 0.0 112.531 178.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -73.74 131.56 41.72 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 119.003 -1.079 . . . . 0.0 109.427 170.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.9 mt -119.37 115.28 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.872 -164.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -103.75 133.47 48.7 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.262 -2.245 . . . . 0.0 108.845 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 t -116.19 94.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 113.66 -1.609 . . . . 0.0 106.857 177.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.4 m -94.56 84.13 4.24 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 112.375 -2.193 . . . . 0.0 109.481 -176.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.3 p -85.19 97.91 10.17 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.152 -177.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.0 m120 45.52 68.61 0.55 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 113.071 -1.877 . . . . 0.0 113.778 -169.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.49 -35.19 2.24 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 113.672 -1.604 . . . . 0.0 114.915 178.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -73.02 98.06 2.45 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.06 0.944 . . . . 0.0 111.205 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.6 p -84.91 124.82 32.07 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.744 -1.571 . . . . 0.0 114.683 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.95 156.63 46.94 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 112.585 -2.098 . . . . 0.0 109.961 167.08 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -80.23 124.7 29.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.481 0.658 . . . . 0.0 110.422 174.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.62 73.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.237 173.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -77.85 13.67 1.3 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.751 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.6 t -135.12 110.42 9.0 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.9 tp -45.04 -74.52 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -54.36 -34.6 61.5 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -66.94 -45.19 78.57 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 tp -68.17 -42.03 80.6 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.432 1.082 . . . . 0.0 112.761 175.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -62.18 -36.33 81.54 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 175.152 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.9 p -88.89 15.79 7.92 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 175.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.0 tp -110.76 130.37 55.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.65 1.18 . . . . 0.0 108.065 177.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.34 86.54 0.33 Allowed Glycine 0 N--CA 1.485 1.916 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.061 -175.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.92 62.2 0.63 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.938 1.351 . . . . 0.0 111.378 176.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 t -123.65 -164.71 1.25 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.006 -169.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -55.51 129.12 37.62 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.392 1.077 . . . . 0.0 112.56 179.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.3 38.66 93.9 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-N 113.215 -1.811 . . . . 0.0 115.084 -179.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 m -105.94 138.32 42.33 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.1 t -114.43 122.39 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 172.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.9 p -116.71 117.59 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -174.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 m -80.38 100.8 8.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 113.309 -1.768 . . . . 0.0 109.015 170.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.6 111.33 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.525 176.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 t -109.08 131.55 54.96 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.668 -177.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.14 125.99 48.61 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.15 1.532 . . . . 0.0 111.971 172.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -118.3 89.55 3.15 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 177.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.1 -156.12 21.84 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-N 113.193 -1.821 . . . . 0.0 112.611 169.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -57.52 -53.82 53.81 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.922 1.289 . . . . 0.0 114.19 -177.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -81.88 46.14 0.97 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 177.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.412 ' CD ' HE22 ' A' ' 71' ' ' GLN . 4.4 pt-20 -55.25 -58.06 9.25 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -176.396 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.412 HE22 ' CD ' ' A' ' 70' ' ' GLU . 10.9 mp0 -64.67 -48.81 73.36 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 171.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -54.75 -49.3 71.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.48 1.512 . . . . 0.0 113.062 -173.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.46 -52.6 64.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.775 0.83 . . . . 0.0 112.88 177.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.4 t -68.97 -49.16 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.887 -175.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -53.06 -50.93 63.34 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.56 1.144 . . . . 0.0 112.65 179.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -61.6 -45.76 92.74 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.942 0.897 . . . . 0.0 112.052 177.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.08 -38.49 90.91 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 177.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.4 t -59.06 -48.45 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.053 0.941 . . . . 0.0 110.295 173.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -56.48 -56.88 15.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.183 0.993 . . . . 0.0 111.199 172.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.71 -43.66 62.91 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.533 1.533 . . . . 0.0 113.501 -177.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.3 tpp -49.53 -47.87 48.62 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.121 1.368 . . . . 0.0 112.654 176.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.08 -24.73 65.99 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -100.32 23.49 10.07 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 mt . . . . . 0 N--CA 1.482 1.167 0 C-N-CA 124.414 1.086 . . . . 0.0 113.834 178.31 . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 ttp . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 . . . . . . . . . 0 0 . 1 . 029 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -116.52 130.15 56.59 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 125.004 1.44 . . . . 0.0 109.449 177.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -124.19 131.26 53.52 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 112.061 -2.336 . . . . 0.0 110.452 -177.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -128.08 98.55 5.16 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 112.986 -1.915 . . . . 0.0 111.779 168.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.22 102.29 1.34 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.878 168.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.38 142.67 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.776 -1.556 . . . . 0.0 113.235 -179.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -87.75 126.91 35.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.079 -1.418 . . . . 0.0 111.767 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.1 mt -75.55 108.59 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.581 169.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -92.38 -16.37 26.05 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.353 -1.749 . . . . 0.0 115.419 178.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.49 126.06 88.69 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.755 176.389 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -49.74 -54.2 5.83 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 124.445 3.43 . . . . 0.0 113.139 -175.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -66.55 -59.05 3.99 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.211 1.805 . . . . 0.0 112.087 170.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.57 -151.59 20.41 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 124.538 1.149 . . . . 0.0 111.86 176.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.5 tp -92.55 70.01 4.94 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.151 -1.524 . . . . 0.0 108.407 -175.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -78.32 -155.58 0.08 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.633 -1.621 . . . . 0.0 114.488 -177.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.8 p -43.28 -70.41 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.654 1.982 . . . . 0.0 114.805 -170.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.327 12.8 ptt180 -73.21 -32.46 1.68 Allowed Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.09 -47.15 21.42 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.732 2.288 . . . . 0.0 113.636 167.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.16 83.56 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 175.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.66 -39.85 68.47 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 174.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -73.1 -42.14 63.29 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -54.76 -41.78 70.87 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 123.68 0.612 . . . . 0.0 111.512 174.079 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.1 t -57.14 -49.71 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.881 0.872 . . . . 0.0 111.61 174.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -52.81 -52.56 56.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.611 0.764 . . . . 0.0 111.378 178.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -67.67 -44.55 77.57 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 124.757 1.286 . . . . 0.0 112.862 -178.503 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.85 -41.9 78.75 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -56.63 -32.48 65.35 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 174.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.88 -13.76 66.86 Favored Glycine 0 CA--C 1.544 1.891 0 O-C-N 125.201 1.563 . . . . 0.0 115.192 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -101.84 138.47 38.76 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.161 0.505 . . . . 0.0 110.478 176.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.459 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 63.3 p -64.3 -41.26 96.95 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.448 -175.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -54.19 141.44 29.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.103 1.761 . . . . 0.0 112.319 174.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -86.19 106.33 17.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.064 0.935 . . . . 0.0 109.377 174.25 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.66 93.16 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.322 -175.089 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.18 129.95 38.81 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 113.732 -1.577 . . . . 0.0 107.753 169.223 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 t -114.35 92.96 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.8 m -93.1 93.22 8.18 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 111.184 -2.734 . . . . 0.0 109.731 -175.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.4 p -101.29 100.26 10.75 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.32 -176.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.3 m120 45.33 70.93 0.31 Allowed 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.005 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.25 -31.02 1.85 Allowed Glycine 0 CA--C 1.546 2.011 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.156 -177.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -80.99 93.71 6.41 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.186 0.993 . . . . 0.0 113.564 -177.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 p -88.68 104.41 16.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 112.726 -2.034 . . . . 0.0 113.907 -179.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.43 134.68 47.96 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.7 175.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.3 t -67.4 127.57 33.17 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 122.272 1.034 . . . . 0.0 113.273 175.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.22 -30.96 71.46 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.414 174.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -72.75 -0.64 13.81 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 178.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.8 t -121.69 129.07 52.49 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.349 0.595 . . . . 0.0 111.879 170.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tp -57.92 -70.48 0.13 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 112.825 -1.989 . . . . 0.0 112.651 -173.072 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.56 -39.17 70.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -56.23 -48.91 75.55 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 172.292 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.3 tp -75.19 -41.62 57.53 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 175.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -56.13 -45.49 79.54 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.644 1.178 . . . . 0.0 113.1 177.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.7 p -75.22 -7.82 54.91 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 175.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 tp -86.37 118.72 25.99 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.175 0.988 . . . . 0.0 109.244 179.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.19 102.26 1.06 Allowed Glycine 0 N--CA 1.485 1.93 0 CA-C-N 113.237 -1.801 . . . . 0.0 113.081 -177.343 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 mt -116.42 96.5 5.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.221 1.008 . . . . 0.0 110.604 -175.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -140.29 171.24 14.44 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.086 0.954 . . . . 0.0 113.175 -165.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -52.77 110.89 0.57 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.834 0.826 . . . . 0.0 111.828 174.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.38 -7.89 30.52 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 112.709 -2.041 . . . . 0.0 115.275 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -75.31 119.9 20.05 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.141 0.97 . . . . 0.0 111.665 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.43 101.3 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 174.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -109.7 119.87 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.964 -174.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -89.63 103.04 15.72 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.535 175.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.0 mp -77.78 91.0 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 168.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -105.65 92.55 4.23 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 112.381 -2.191 . . . . 0.0 111.427 -171.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.41 111.04 23.28 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.188 -176.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.48 122.41 46.24 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.78 -154.91 22.89 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 113.025 -1.898 . . . . 0.0 111.126 -176.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -67.75 -63.92 0.96 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.356 1.463 . . . . 0.0 114.081 -171.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . 0.459 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 12.3 p30 -80.22 40.04 0.47 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.079 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.39 -51.21 56.69 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -66.85 -54.33 23.5 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.053 0.941 . . . . 0.0 112.833 177.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -53.44 -42.57 67.25 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.386 1.475 . . . . 0.0 112.924 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.17 -54.96 40.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.6 0.76 . . . . 0.0 112.575 173.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.5 t -58.25 -51.2 74.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.348 178.089 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -48.2 -65.18 0.61 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.816 1.246 . . . . 0.0 113.173 -179.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -72.78 -27.87 62.26 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -176.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.4 mt -75.1 -41.78 57.92 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 174.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.05 -44.07 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 123.271 0.357 . . . . 0.0 110.477 174.68 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -49.01 -62.05 1.74 Allowed 'General case' 0 N--CA 1.479 1.021 0 O-C-N 125.159 1.537 . . . . 0.0 111.57 169.205 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.64 -46.66 73.97 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.733 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.4 ttp -50.9 -46.85 60.76 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.346 1.458 . . . . 0.0 113.045 178.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.65 76.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.461 1.1 . . . . 0.0 112.706 177.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.67 32.9 0.71 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.753 1.221 . . . . 0.0 114.088 -173.42 . . . . . . . . 1 1 . 1 . 029 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.9 mt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 122.568 1.175 . . . . 0.0 112.4 -179.327 . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ttt . . . . . 0 C--O 1.239 0.535 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 . . . . . . . . . 0 0 . 1 . 030 nuclear orig core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -137.63 141.18 41.22 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 126.021 2.075 . . . . 0.0 111.386 -173.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -125.14 131.16 53.3 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 125.42 1.7 . . . . 0.0 109.475 174.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -126.12 136.43 52.87 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 125.518 1.761 . . . . 0.0 109.872 172.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -115.28 94.2 4.62 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 122.509 1.147 . . . . 0.0 114.058 -169.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.0 m -120.95 159.95 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 113.521 -1.672 . . . . 0.0 114.328 -173.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 p -107.61 155.5 20.07 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.4 mt -103.23 113.76 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 111.211 -2.722 . . . . 0.0 108.401 168.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.7 p -94.84 -30.87 13.98 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 112.269 -2.241 . . . . 0.0 116.659 175.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.8 135.76 89.9 Favored Pre-proline 0 N--CA 1.484 1.269 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.13 -48.68 18.81 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.816 3.677 . . . . 0.0 115.415 -178.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . 0.285 0.4 OUTLIER -95.48 -16.88 21.91 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 170.96 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.88 -128.81 11.71 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.163 1.84 . . . . 0.0 115.576 178.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.0 mt -98.47 54.93 1.07 Allowed 'General case' 0 C--O 1.2 -1.515 0 CA-C-N 111.933 -2.133 . . . . 0.0 112.4 -171.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -68.66 -166.43 0.08 Allowed 'General case' 0 C--N 1.364 1.233 0 CA-C-N 112.031 -2.349 . . . . 0.0 113.217 174.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -54.46 -51.58 64.55 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -164.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.254 43.5 ttt85 -69.61 -50.33 18.93 Favored Pre-proline 0 N--CA 1.479 0.976 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 174.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.35 -38.6 94.16 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.958 2.439 . . . . 0.0 113.613 173.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.14 -35.33 77.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 172.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.26 65.21 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 173.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -68.48 -39.79 81.23 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.149 0.98 . . . . 0.0 111.549 169.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.5 -47.45 83.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.853 0.861 . . . . 0.0 112.028 171.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.5 t -53.47 -56.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.601 1.16 . . . . 0.0 112.023 175.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.91 -61.44 0.85 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.577 1.151 . . . . 0.0 112.389 170.043 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.99 -34.39 77.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -176.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.8 -44.38 96.97 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.867 0.867 . . . . 0.0 112.104 176.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -56.73 -22.68 37.2 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 176.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.97 65.47 Favored Glycine 0 CA--C 1.542 1.728 0 O-C-N 124.741 1.275 . . . . 0.0 111.468 178.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -81.79 148.35 28.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.355 1.074 . . . . 0.0 112.84 -174.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.1 p -70.44 -35.26 73.26 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.274 -176.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.1 m -49.34 148.73 2.48 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.971 1.308 . . . . 0.0 113.457 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -91.98 104.19 16.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 160.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -91.1 113.15 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 112.052 -2.34 . . . . 0.0 106.851 176.115 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -90.98 142.66 27.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.407 173.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.5 t -118.68 106.67 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 112.512 -2.131 . . . . 0.0 108.016 176.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 m -114.06 92.27 3.91 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 112.787 -2.006 . . . . 0.0 109.577 -176.467 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 p -87.58 89.15 7.89 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 122.816 1.293 . . . . 0.0 110.68 179.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.6 m120 46.41 74.96 0.13 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.012 -1.904 . . . . 0.0 112.276 -172.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.75 -22.56 2.23 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 113.125 -1.852 . . . . 0.0 116.544 -179.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -85.86 91.87 8.47 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.854 -0.792 . . . . 0.0 110.0 -177.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.1 p -101.78 127.99 48.32 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -169.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.82 144.81 31.33 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.065 -1.879 . . . . 0.0 110.94 177.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -55.33 130.44 42.43 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 168.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.77 -30.53 44.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.849 1.26 . . . . 0.0 111.581 172.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -74.0 -6.13 45.58 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.03 103.64 14.77 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -171.107 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 tp -49.06 -73.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -176.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -45.26 -48.6 12.81 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.16 1.384 . . . . 0.0 113.922 177.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -52.33 -52.47 53.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 117.125 -1.417 . . . . 0.0 114.157 175.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mp -71.98 -35.94 69.64 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -178.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.86 -31.08 72.04 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 175.014 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.9 p -84.78 -35.48 22.34 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 171.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 tp -67.61 122.92 19.07 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 111.174 -176.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.92 100.14 0.42 Allowed Glycine 0 CA--C 1.54 1.619 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.471 -177.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 mt -125.39 88.44 2.87 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.67 1.188 . . . . 0.0 110.293 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -143.49 -166.62 2.37 Favored 'General case' 0 C--O 1.199 -1.584 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.682 -175.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -56.28 118.31 4.62 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.774 1.23 . . . . 0.0 112.138 -178.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.58 -30.12 10.66 Favored Glycine 0 CA--C 1.544 1.863 0 CA-C-N 112.631 -2.077 . . . . 0.0 113.842 -178.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.04 137.68 55.24 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.874 1.27 . . . . 0.0 113.375 -174.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.5 t -116.77 114.38 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.333 -169.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 p -109.53 96.84 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 112.952 -1.931 . . . . 0.0 112.269 -166.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.6 m -72.07 101.75 2.82 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 111.614 -2.539 . . . . 0.0 108.6 173.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 mt -94.23 112.57 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 123.772 1.748 . . . . 0.0 110.507 -178.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.3 t -123.79 96.03 4.8 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 109.973 -3.285 . . . . 0.0 113.215 -159.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.17 117.7 34.68 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.229 -170.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -120.13 86.96 2.66 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -176.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.24 -164.48 30.46 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 112.34 -2.209 . . . . 0.0 110.048 171.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -34.82 73.59 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -179.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -104.55 43.39 1.1 Allowed 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 -176.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 70' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -55.77 -63.12 1.28 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 -178.892 . . . . . . . . 3 3 . 1 . 030 nuclear orig core ' A' A ' 71' ' ' GLN . . . . . 0.469 ' H ' ' CD ' ' A' ' 70' ' ' GLU . 23.1 mt-30 -62.71 -44.97 94.86 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 173.419 . . . . . . . . 2 2 . 1 . 030 nuclear orig core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -49.08 -50.15 38.15 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.339 1.056 . . . . 0.0 113.124 173.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.42 -55.79 24.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.797 0.839 . . . . 0.0 112.394 -177.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.4 t -62.44 -37.16 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-O 117.759 -1.115 . . . . 0.0 111.992 -177.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.67 -46.78 86.45 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.478 0.487 . . . . 0.0 111.548 178.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -74.27 -32.03 62.77 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.149 -178.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 mt -74.85 -36.83 62.34 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 173.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.45 -38.7 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.525 173.347 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -48.21 -58.69 4.19 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.628 1.205 . . . . 0.0 110.521 163.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -58.41 -48.04 81.96 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 176.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -52.08 -44.67 64.47 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.513 1.525 . . . . 0.0 112.35 174.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.27 -25.34 54.84 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -83.89 -22.05 31.74 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 178.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.0 mt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 -172.586 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 ttp . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -120.7 134.07 55.31 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 125.639 1.837 . . . . 0.0 108.797 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -128.64 153.61 47.1 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.634 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -142.55 121.98 13.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.113 168.39 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -87.72 97.37 10.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 123.199 1.476 . . . . 0.0 111.275 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.57 155.48 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 112.118 -2.31 . . . . 0.0 108.113 -171.145 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 p -120.09 154.76 34.21 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.303 0.573 . . . . 0.0 112.215 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 65.3 mt -103.5 115.16 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.154 -177.784 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 p -99.24 -0.47 41.31 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -94.87 139.83 22.29 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 110.638 -177.089 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -55.5 -68.79 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.655 2.903 . . . . 0.0 114.229 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.72 -35.77 80.84 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.245 1.018 . . . . 0.0 113.23 167.605 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.44 -135.62 19.87 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 124.957 1.411 . . . . 0.0 111.299 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 1.8 tp -92.88 57.45 2.81 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 113.013 -1.594 . . . . 0.0 109.417 -176.009 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -67.73 167.51 13.13 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.817 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.4 p 1.26 -68.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 118.687 2.847 . . . . 0.0 118.687 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.416 7.7 ptt-85 -85.18 -38.82 0.62 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 17.7 Cg_exo -54.91 -41.46 78.36 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.214 2.61 . . . . 0.0 113.436 159.93 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.22 -47.27 81.73 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 171.213 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.26 -44.38 79.64 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 24.4 mt-30 -63.32 -42.05 98.97 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.69 1.196 . . . . 0.0 113.728 174.246 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -62.62 -43.42 98.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.297 0.639 . . . . 0.0 112.119 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 59.2 t -59.66 -48.16 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.56 0.744 . . . . 0.0 111.936 173.258 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 17.2 tttm -43.74 -55.02 4.69 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.29 0.994 . . . . 0.0 111.781 172.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -66.03 -46.85 76.38 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 124.227 0.955 . . . . 0.0 112.674 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.75 70.3 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.814 1.245 . . . . 0.0 114.063 175.337 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -61.17 -29.78 70.0 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.33 19.29 23.95 Favored Glycine 0 N--CA 1.481 1.663 0 O-C-N 124.225 0.953 . . . . 0.0 114.787 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -129.92 143.29 50.73 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.323 1.049 . . . . 0.0 110.669 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.413 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 59.2 p -67.21 -41.46 85.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.987 -179.068 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.8 m -52.32 144.63 12.52 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.591 1.556 . . . . 0.0 113.111 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -86.82 92.38 8.96 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.137 0.97 . . . . 0.0 109.654 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.9 mp -76.96 107.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 112.66 -2.063 . . . . 0.0 109.478 179.389 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.7 m -106.86 137.67 44.47 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.09 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.58 115.07 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 112.48 -2.146 . . . . 0.0 107.398 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.9 m -111.58 97.7 6.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.451 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.6 m -92.94 93.83 8.59 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.169 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m120 48.52 76.97 0.11 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.443 -174.216 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.09 -46.34 2.42 Favored Glycine 0 N--CA 1.488 2.146 0 CA-C-N 113.704 -1.589 . . . . 0.0 114.83 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -76.3 126.94 31.91 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.395 1.078 . . . . 0.0 113.156 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.0 p -108.75 141.2 41.1 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -145.51 135.97 24.14 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.399 167.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.5 t -67.52 127.85 34.25 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.286 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.39 -9.47 48.49 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 112.99 -1.914 . . . . 0.0 111.717 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -95.24 35.61 1.29 Allowed 'General case' 0 CA--C 1.552 1.055 0 O-C-N 121.181 -0.949 . . . . 0.0 111.744 173.167 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 41.5 t -154.29 117.23 4.45 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.334 174.774 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.9 mt -52.51 -61.58 2.19 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.041 175.623 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -52.45 -45.97 66.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.844 1.258 . . . . 0.0 113.751 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.3 mttt -66.39 -43.83 84.73 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 179.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 tp -72.45 -23.95 61.14 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -78.73 -27.19 44.82 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.6 p -86.2 -33.27 20.82 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.6 tp -64.86 131.51 46.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.304 0.642 . . . . 0.0 111.732 174.726 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.83 90.39 0.21 Allowed Glycine 0 N--CA 1.476 1.319 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.91 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 8.7 mt -107.93 76.78 1.07 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.057 0.943 . . . . 0.0 111.985 176.371 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 t -137.73 172.87 12.31 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.444 -1.707 . . . . 0.0 112.331 -168.324 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -35.9 125.56 0.72 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.763 2.025 . . . . 0.0 115.435 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.02 -92.14 1.16 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.372 1.463 . . . . 0.0 110.088 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 11.3 m 24.55 123.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 128.216 2.606 . . . . 0.0 117.895 174.446 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.8 102.3 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 112.358 -2.201 . . . . 0.0 106.226 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.85 106.77 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 113.294 -1.775 . . . . 0.0 112.173 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.0 m -83.47 115.23 21.98 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.945 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.4 mt -93.31 102.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.6 t -116.62 117.72 30.61 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.091 -171.89 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.19 126.29 50.3 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.927 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -127.93 122.75 33.21 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 125.003 1.44 . . . . 0.0 114.18 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.0 -168.01 31.79 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 113.033 -1.894 . . . . 0.0 110.575 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -52.82 -40.65 63.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.413 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 10.9 p30 -111.09 37.66 2.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -175.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -45.94 -58.5 3.5 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -59.62 -51.22 70.75 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.192 1.397 . . . . 0.0 113.859 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -56.72 -41.12 76.91 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.3 1.84 . . . . 0.0 112.387 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.92 -59.84 4.74 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.5 t -59.46 -44.94 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.067 -175.753 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -49.2 -62.54 1.48 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.086 0.954 . . . . 0.0 112.127 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -66.0 -35.48 80.68 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.063 1.345 . . . . 0.0 113.766 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 44.3 mt -69.94 -30.69 68.14 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.534 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.9 t -62.63 -39.9 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.478 0.311 . . . . 0.0 110.322 171.332 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -57.4 -51.32 69.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.236 0.614 . . . . 0.0 112.261 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.5 -45.22 73.22 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 59.8 tpp -59.3 -48.74 80.49 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 172.902 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.21 -31.9 73.0 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -97.79 -27.64 14.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.1 mt -77.36 136.56 38.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 -176.398 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 126.917 2.087 . . . . 0.0 107.873 172.745 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 38.9 ttp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 0.3 OUTLIER -67.94 109.46 3.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 113.756 -1.565 . . . . 0.0 109.86 175.264 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.03 125.25 48.91 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 124.338 1.024 . . . . 0.0 109.403 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.9 mt-30 -129.9 130.86 45.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.298 -1.319 . . . . 0.0 114.357 176.794 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 58.9 mt-10 -98.16 90.45 4.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.173 178.642 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.1 t -96.2 126.48 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.158 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.7 m -102.32 120.31 40.27 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.905 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 76.3 mt -68.6 125.14 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 124.974 1.421 . . . . 0.0 108.051 178.193 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 t -119.25 -22.1 7.26 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -171.334 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.22 142.85 98.07 Favored Pre-proline 0 N--CA 1.48 1.036 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.81 -30.95 78.24 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.436 2.757 . . . . 0.0 113.963 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -72.97 -49.51 28.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.831 0.852 . . . . 0.0 111.489 166.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.57 171.75 45.19 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.376 1.465 . . . . 0.0 112.129 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 37.1 mt -73.53 58.73 0.59 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.432 1.587 . . . . 0.0 110.49 164.6 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -70.19 -147.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 112.7 -2.045 . . . . 0.0 116.298 -166.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -60.49 -54.28 47.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.069 1.347 . . . . 0.0 113.566 -168.594 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -72.9 -36.77 3.6 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 116.57 -1.681 . . . . 0.0 113.517 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.78 -50.33 10.72 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.822 2.348 . . . . 0.0 112.017 165.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.11 -44.18 71.08 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 171.33 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.7 -47.01 77.53 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.058 0.943 . . . . 0.0 113.369 174.418 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -59.43 -46.09 89.71 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 17.0 t80 -63.78 -46.49 84.96 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.234 1.414 . . . . 0.0 113.293 -179.209 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.6 t -56.64 -51.18 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 124.331 1.052 . . . . 0.0 110.461 173.083 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -52.5 -53.97 38.83 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.355 1.462 . . . . 0.0 110.9 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.17 -46.64 88.06 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.696 1.247 . . . . 0.0 114.024 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.78 70.71 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.984 0.914 . . . . 0.0 113.318 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -66.5 -12.18 56.18 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.97 21.21 44.51 Favored Glycine 0 CA--C 1.544 1.888 0 C-N-CA 124.309 0.957 . . . . 0.0 113.455 172.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -122.59 125.15 45.08 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.04 0.936 . . . . 0.0 108.49 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.2 p -57.95 -36.97 73.29 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.825 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 p -59.23 157.97 9.8 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.147 1.779 . . . . 0.0 112.624 168.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -111.76 136.13 51.44 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.386 1.089 . . . . 0.0 112.841 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.4 111.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 111.893 -2.412 . . . . 0.0 112.205 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.2 m -93.21 98.82 11.52 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 112.551 -2.113 . . . . 0.0 107.122 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 46.9 t -109.48 90.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.737 -172.419 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.1 p -104.74 101.8 11.4 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 112.376 -2.193 . . . . 0.0 113.684 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 29.0 t -60.27 103.86 0.27 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.521 166.702 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -19.32 90.12 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.881 2.472 . . . . 0.0 116.885 -172.537 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.08 -72.38 0.26 Allowed Glycine 0 CA--C 1.538 1.53 0 CA-C-N 112.793 -2.003 . . . . 0.0 114.35 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -114.25 144.12 43.74 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -170.066 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.4 m -76.01 130.6 38.66 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.999 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.52 131.29 7.13 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.945 -1.48 . . . . 0.0 112.909 -174.22 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.2 t -89.06 140.85 29.03 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.106 165.443 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.42 -23.2 66.89 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.744 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -82.14 31.17 0.38 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.6 t -160.23 113.32 2.1 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.959 -1.928 . . . . 0.0 109.182 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 29.5 tp -52.98 -62.24 1.78 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.596 -1.638 . . . . 0.0 112.871 -174.191 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -63.77 -32.72 74.32 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 15.9 tttt -68.64 -39.64 80.63 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 123.731 0.644 . . . . 0.0 112.015 179.032 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -70.85 -53.27 15.87 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 123.522 0.514 . . . . 0.0 111.464 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -63.9 -28.15 69.64 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -173.646 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.5 t -71.45 -16.82 62.39 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.3 mm? -86.18 154.44 21.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.621 0.768 . . . . 0.0 111.575 175.951 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.33 94.11 0.04 OUTLIER Glycine 0 N--CA 1.479 1.523 0 C-N-CA 124.695 1.141 . . . . 0.0 112.84 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 62.4 mt -100.38 48.45 0.92 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.887 1.327 . . . . 0.0 110.565 170.716 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 t -132.03 168.94 17.07 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.573 -168.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -55.0 121.73 9.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.351 1.06 . . . . 0.0 111.902 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.51 -29.06 12.08 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 114.481 -1.236 . . . . 0.0 115.275 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.2 p -73.67 136.93 43.84 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 9.3 t -96.72 111.89 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.475 -178.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 m -92.95 101.59 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.235 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 51.8 p -84.77 94.37 8.68 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.292 -176.233 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.7 mt -82.78 98.55 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 112.899 -1.955 . . . . 0.0 109.013 -173.805 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -104.52 134.43 47.72 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.895 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -122.47 132.62 54.43 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -173.2 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.44 136.55 39.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.295 1.038 . . . . 0.0 113.162 174.295 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.8 -177.23 17.15 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 115.691 1.036 . . . . 0.0 115.691 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -54.84 -33.0 61.19 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -110.32 28.27 8.81 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -53.63 -57.62 10.12 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -172.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -54.3 -47.35 72.51 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.909 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -57.73 -41.76 82.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.222 1.409 . . . . 0.0 112.613 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.21 -57.51 12.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.2 1.0 . . . . 0.0 112.599 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -67.96 -36.7 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.166 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -52.85 -57.18 11.08 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.036 0.835 . . . . 0.0 111.173 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -65.66 -40.62 92.65 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.6 -43.16 97.74 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -60.22 -43.67 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 122.893 0.477 . . . . 0.0 111.496 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -55.71 -43.66 76.71 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.853 0.861 . . . . 0.0 111.517 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.08 -56.89 15.66 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.772 0.829 . . . . 0.0 112.888 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 20.3 mtp -47.75 -45.08 28.66 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.613 1.165 . . . . 0.0 113.549 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.83 -43.72 63.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.769 1.627 . . . . 0.0 115.307 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -111.74 15.53 20.91 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mp -116.66 20.71 13.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttp . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -141.02 131.61 25.5 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.76 1.288 . . . . 0.0 109.095 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.7 127.35 49.15 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.799 -171.4 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -126.56 122.5 35.28 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.614 0.721 . . . . 0.0 112.664 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 60.3 mt-10 -79.5 103.24 9.28 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.272 -179.394 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.25 135.58 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.653 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -103.22 128.89 50.07 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.154 -178.305 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 mt -97.95 92.4 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 167.106 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -86.02 -24.72 26.3 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.7 133.98 46.13 Favored Pre-proline 0 N--CA 1.482 1.145 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -58.53 -47.35 19.44 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 123.83 3.02 . . . . 0.0 113.2 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -54.17 -36.37 63.31 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 166.784 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.92 -163.49 24.64 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 125.118 1.511 . . . . 0.0 113.791 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.4 mt -115.61 69.35 0.73 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.481 -1.86 . . . . 0.0 110.271 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -73.71 -175.04 1.93 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 111.864 -2.426 . . . . 0.0 114.976 -166.699 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.4 p -40.3 -40.52 1.17 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.254 9.6 mmm180 -75.34 -48.43 4.16 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 116.139 -1.886 . . . . 0.0 113.48 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -54.64 -47.86 24.46 Favored 'Trans proline' 0 N--CA 1.482 0.826 0 C-N-CA 122.214 1.943 . . . . 0.0 113.877 162.718 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.29 -41.57 72.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.07 -31.59 72.76 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -80.75 -37.53 30.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.581 0.752 . . . . 0.0 112.282 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -57.19 -46.34 82.94 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.255 1.022 . . . . 0.0 111.566 173.903 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.5 t -42.31 -61.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 125.227 1.411 . . . . 0.0 113.14 170.006 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -42.71 -50.03 5.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.986 1.315 . . . . 0.0 113.575 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -66.16 -47.88 72.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.907 0.883 . . . . 0.0 112.992 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.62 71.77 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -50.62 -52.8 36.17 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.09 -27.22 68.55 Favored Glycine 0 CA--C 1.541 1.661 0 O-C-N 125.843 1.964 . . . . 0.0 115.13 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -70.15 110.61 5.26 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -38.45 22.06 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.674 1.59 . . . . 0.0 111.617 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.02 140.31 57.86 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 169.814 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -92.1 101.52 14.05 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.938 1.827 . . . . 0.0 111.55 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 6.9 mm -71.68 82.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 110.22 -3.173 . . . . 0.0 110.108 178.865 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 m -73.69 104.59 4.67 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.795 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.4 t -98.1 85.58 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 112.611 -2.086 . . . . 0.0 106.962 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -86.79 97.69 10.77 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.422 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 5.6 t -70.44 92.15 0.8 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.379 172.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.289 37.7 p30 2.67 101.34 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 110.189 -3.187 . . . . 0.0 117.461 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.37 -87.05 0.42 Allowed Glycine 0 CA--C 1.541 1.685 0 CA-C-N 112.721 -2.036 . . . . 0.0 110.122 -168.053 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 8.1 mptt -94.96 140.07 30.46 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.202 0.525 . . . . 0.0 112.363 -173.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.1 m -78.61 128.56 33.67 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.65 169.54 9.48 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.05 166.833 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -132.71 126.17 31.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.596 0.358 . . . . 0.0 110.781 -176.337 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.05 -30.97 69.55 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.564 1.165 . . . . 0.0 112.925 178.073 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -72.73 -36.13 67.7 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.916 1.287 . . . . 0.0 113.403 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -96.73 102.84 14.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 122.321 1.058 . . . . 0.0 110.794 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.8 tp -44.3 -68.73 0.17 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 111.959 -2.382 . . . . 0.0 114.503 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -63.17 -41.66 99.27 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.2 tttt -55.91 -40.74 73.5 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 171.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 22.3 tp -68.03 -47.54 68.15 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 118.927 -0.559 . . . . 0.0 111.677 172.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -63.66 -23.93 67.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -79.44 -27.98 41.67 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -84.33 168.82 15.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.044 0.938 . . . . 0.0 112.343 176.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.1 117.19 4.77 Favored Glycine 0 CA--C 1.546 2.002 0 C-N-CA 125.256 1.408 . . . . 0.0 113.428 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 31.6 mt -123.7 60.53 1.09 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.405 1.098 . . . . 0.0 109.2 176.583 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 t -153.08 -169.59 3.37 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.259 -160.928 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -49.01 104.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.163 2.185 . . . . 0.0 113.128 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.23 -18.65 56.27 Favored Glycine 0 CA--C 1.547 2.093 0 CA-C-N 112.919 -1.946 . . . . 0.0 114.556 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.4 p -69.61 125.16 25.88 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.266 0.627 . . . . 0.0 111.838 -166.923 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 45.9 t -97.83 122.56 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.802 -178.712 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.5 m -105.04 103.45 15.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.067 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 75.0 p -83.22 88.15 6.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.965 -1.925 . . . . 0.0 109.502 179.122 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.8 mt -72.14 94.19 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 111.622 -2.536 . . . . 0.0 108.625 -172.401 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 t -101.41 84.22 2.58 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.377 -1.738 . . . . 0.0 109.726 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 100.41 5.7 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.624 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.42 136.34 34.83 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.285 -1.325 . . . . 0.0 113.784 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.49 -147.9 16.32 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 112.735 -2.029 . . . . 0.0 114.172 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -67.32 -25.29 65.94 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 -163.723 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -106.74 -1.69 22.37 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 3.8 pt-20 -8.0 -70.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 120.323 3.453 . . . . 0.0 120.323 -177.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.5 OUTLIER -73.24 -48.08 37.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -175.533 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -55.66 -32.91 63.62 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.393 1.477 . . . . 0.0 112.233 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.16 -63.7 1.01 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.724 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 t -55.03 -41.29 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.709 0.804 . . . . 0.0 111.916 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -45.43 -60.8 1.96 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.054 1.342 . . . . 0.0 112.203 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -69.28 -45.84 68.65 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 114.797 -1.092 . . . . 0.0 113.055 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 9.7 mt -61.35 -35.46 77.5 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 -179.746 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.04 -43.54 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.429 0.692 . . . . 0.0 110.655 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -48.92 -48.28 42.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.378 1.071 . . . . 0.0 111.988 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.4 mt -59.73 -59.1 5.98 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 123.914 0.759 . . . . 0.0 113.011 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 mtt -48.61 -27.2 2.65 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.88 67.49 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -123.34 44.99 2.54 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.905 0.859 . . . . 0.0 112.626 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.1 mt -127.1 -28.72 2.84 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 119.626 3.195 . . . . 0.0 119.626 -171.288 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 174.978 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.475 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 18.6 ttp . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -108.0 126.25 52.5 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 124.955 1.409 . . . . 0.0 109.523 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.61 116.02 26.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.815 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -119.2 121.79 40.51 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.694 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -81.54 113.02 19.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 112.743 -2.026 . . . . 0.0 108.72 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.6 t -124.84 141.05 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 113.427 -1.715 . . . . 0.0 108.88 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 40.4 p -113.9 121.01 42.67 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.979 172.12 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.09 126.34 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . 0.315 5.1 t -126.14 55.52 1.48 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -177.453 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -101.74 114.87 65.5 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-N 112.205 -2.271 . . . . 0.0 113.602 -176.92 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.1 Cg_endo -63.72 -35.43 57.73 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.595 2.197 . . . . 0.0 112.126 171.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -52.1 66.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.286 1.834 . . . . 0.0 113.128 168.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.97 146.05 1.25 Allowed Glycine 0 N--CA 1.483 1.806 0 O-C-N 124.706 1.254 . . . . 0.0 115.462 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.25 79.06 9.66 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.169 1.461 . . . . 0.0 111.008 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -67.41 -167.03 0.06 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 112.501 -2.136 . . . . 0.0 114.795 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.7 p -51.86 -45.04 63.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.191 1.796 . . . . 0.0 115.347 -175.103 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.251 13.9 mmm180 -73.04 -45.5 8.31 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 116.44 -1.743 . . . . 0.0 114.337 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.31 -45.8 35.14 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.269 1.979 . . . . 0.0 112.647 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -44.24 79.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 175.007 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.32 99.18 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -64.94 -43.07 93.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.078 0.951 . . . . 0.0 111.14 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -62.02 -41.4 98.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.06 1.344 . . . . 0.0 111.994 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 81.6 t -53.36 -47.49 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.063 0.545 . . . . 0.0 111.545 170.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -60.39 -47.22 87.04 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 119.08 -0.486 . . . . 0.0 112.135 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.08 -42.07 99.56 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.04 89.64 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.421 1.088 . . . . 0.0 113.715 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.9 mmtt -60.95 -28.4 68.94 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 169.418 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.73 -43.77 98.47 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.095 1.331 . . . . 0.0 113.3 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -78.38 147.0 34.28 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.513 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 81.0 p -70.64 -38.53 73.87 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.486 -172.837 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.0 p -64.36 152.5 41.14 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 2.9 tt0 -92.35 107.42 19.2 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.891 1.329 . . . . 0.0 111.288 175.157 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 48.2 mm -75.28 104.94 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 111.043 -2.798 . . . . 0.0 109.825 175.662 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -110.29 114.24 27.54 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.134 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.55 100.97 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.618 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 72.5 m -86.34 97.05 10.2 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.653 174.891 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -76.74 100.59 5.49 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.888 171.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.313 12.6 p-10 -0.55 87.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 -168.188 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.61 -60.73 0.55 Allowed Glycine 0 N--CA 1.483 1.815 0 CA-C-N 111.397 -2.638 . . . . 0.0 111.916 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.61 116.07 31.85 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.6 m -74.78 111.84 10.38 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 113.472 -1.694 . . . . 0.0 114.912 176.787 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.12 112.54 21.87 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.45 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -68.44 115.13 7.5 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.752 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.23 -14.67 62.3 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.333 -1.758 . . . . 0.0 112.269 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 31.9 mttt -81.77 10.44 6.22 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 167.714 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 34.9 t -133.91 127.41 32.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.369 0.668 . . . . 0.0 111.933 169.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 10.1 tp -47.74 -69.14 0.13 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.389 1.876 . . . . 0.0 110.972 175.805 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -51.67 -45.16 63.31 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.221 1.408 . . . . 0.0 113.418 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.6 mttt -64.94 -52.63 55.28 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -178.383 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 tp -63.0 -46.33 88.17 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.78 -0.629 . . . . 0.0 112.319 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -56.72 -32.88 65.96 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -78.87 -2.22 38.75 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.8 mm? -118.22 140.45 49.78 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 176.089 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.27 118.27 6.21 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 113.52 -1.673 . . . . 0.0 113.307 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.3 mp -116.35 87.35 2.67 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 168.483 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -135.3 -132.37 0.15 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.993 -162.093 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.1 tt0 -86.57 134.75 33.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.696 0.798 . . . . 0.0 111.636 176.232 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.28 -61.22 4.43 Favored Glycine 0 N--CA 1.484 1.876 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.763 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 p -3.09 114.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.3 t -100.26 108.03 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 112.45 -2.159 . . . . 0.0 107.325 -174.492 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 15.4 m -113.74 119.78 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.885 -172.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -103.97 104.27 14.22 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.945 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mp -87.0 103.01 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.677 -2.056 . . . . 0.0 107.466 -179.575 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 t -101.24 108.86 20.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.663 173.837 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.66 97.73 9.95 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.825 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.18 100.96 12.68 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.77 -173.5 33.15 Favored Glycine 0 N--CA 1.48 1.592 0 CA-C-N 111.543 -2.572 . . . . 0.0 111.172 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.98 -55.88 28.59 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.513 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 24.8 p30 -81.3 33.73 0.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -178.27 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.475 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 11.5 pt-20 -41.95 -50.1 4.55 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.053 2.141 . . . . 0.0 115.878 -177.725 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.468 ' NE2' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -69.54 -55.45 10.15 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.378 1.471 . . . . 0.0 114.478 -178.454 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -67.44 -33.77 75.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.82 -55.88 25.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.063 -0.972 . . . . 0.0 112.012 173.35 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.0 t -64.1 -45.25 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.98 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -52.34 -54.3 33.43 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.697 1.199 . . . . 0.0 113.847 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.6 t60 -63.01 -40.32 97.41 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 178.262 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.2 mt -67.34 -37.59 83.52 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.47 -46.05 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.304 1.042 . . . . 0.0 111.094 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 40.8 tttp -48.38 -53.44 17.62 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 124.441 1.088 . . . . 0.0 111.382 170.873 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.91 -45.92 91.62 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 45.8 mtm -52.13 -50.94 60.72 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.092 0.87 . . . . 0.0 112.354 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.59 79.88 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.275 12.9 pt-20 -82.5 -18.45 41.53 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.4 mt -108.64 47.96 0.88 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.9 tt0 . . . . . 0 C--O 1.252 1.204 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.476 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.43 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 1.3 mmm . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 . . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -139.3 142.11 37.71 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.94 1.4 . . . . 0.0 110.976 -172.332 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -128.66 130.93 47.91 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 124.809 1.318 . . . . 0.0 110.315 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -112.66 113.06 25.0 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.271 -1.332 . . . . 0.0 111.212 163.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -77.73 92.83 4.2 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.008 -1.905 . . . . 0.0 109.717 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.81 147.05 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 112.249 -2.25 . . . . 0.0 108.762 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -114.22 153.68 29.22 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.031 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mt -115.24 104.81 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 167.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -118.48 53.79 0.96 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.116 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.72 121.64 29.71 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 111.765 -2.471 . . . . 0.0 110.86 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -55.55 -44.4 48.64 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.212 3.274 . . . . 0.0 111.473 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -60.19 -59.57 5.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.394 1.878 . . . . 0.0 112.768 168.095 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.22 -168.22 54.82 Favored Glycine 0 N--CA 1.478 1.485 0 C-N-CA 124.71 1.148 . . . . 0.0 113.955 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 tp -99.64 58.18 1.04 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 124.161 1.934 . . . . 0.0 108.837 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -62.86 -169.6 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 113.099 -1.864 . . . . 0.0 115.61 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.36 -60.25 2.45 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -166.679 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.301 9.4 mmm180 -73.68 -37.84 3.69 Favored Pre-proline 0 N--CA 1.485 1.28 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 177.101 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -54.57 -50.9 11.83 Favored 'Trans proline' 0 N--CA 1.478 0.61 0 C-N-CA 122.854 2.369 . . . . 0.0 113.082 167.052 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.73 -42.98 84.96 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 172.419 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.5 88.72 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -66.7 -43.09 85.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.769 0.827 . . . . 0.0 111.79 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -59.66 -39.49 84.58 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.064 1.745 . . . . 0.0 112.301 172.344 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.2 t -58.51 -51.43 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.107 0.963 . . . . 0.0 111.585 172.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -49.08 -49.74 40.19 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.791 0.682 . . . . 0.0 111.71 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.59 -49.79 71.97 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.314 1.008 . . . . 0.0 113.624 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.96 70.79 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 61.1 mttt -65.33 -26.12 67.9 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 175.488 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.45 -35.82 90.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 124.157 0.911 . . . . 0.0 113.71 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -71.44 154.99 41.12 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.492 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 76.0 p -73.88 -45.33 51.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.404 177.404 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.3 p -70.03 150.24 46.85 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.175 0.99 . . . . 0.0 112.885 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -94.22 101.37 13.35 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.842 1.306 . . . . 0.0 110.541 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.42 111.57 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 110.883 -2.871 . . . . 0.0 110.021 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.02 120.26 41.26 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.176 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 96.9 t -108.78 84.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.282 -174.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.0 m -81.86 110.95 17.63 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.925 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 39.0 t -85.48 99.82 11.47 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.104 179.053 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 14.7 p-10 2.56 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 128.01 2.524 . . . . 0.0 117.462 179.041 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.17 -45.04 1.33 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 112.836 -1.983 . . . . 0.0 113.005 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.4 mttt -123.87 134.95 53.46 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.294 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 m -72.06 137.8 47.4 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 113.954 -1.475 . . . . 0.0 112.943 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -138.07 137.16 37.5 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.024 171.551 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -107.54 118.83 37.77 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.51 0.671 . . . . 0.0 109.808 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.61 -30.98 71.04 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 113.725 -1.58 . . . . 0.0 112.143 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 48.2 tttt -77.28 16.01 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.827 0.851 . . . . 0.0 113.196 176.319 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -154.17 118.87 4.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.56 1.544 . . . . 0.0 112.454 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 55.6 tp -53.37 -71.0 0.08 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.503 -1.681 . . . . 0.0 114.611 -171.782 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -63.13 -31.41 72.55 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.28 -37.7 86.07 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.113 0.565 . . . . 0.0 111.718 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 19.6 tp -72.88 -54.56 8.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.023 0.529 . . . . 0.0 112.366 171.759 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -55.33 -38.29 68.54 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 t -61.19 -18.58 58.93 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -100.64 157.72 16.47 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -176.878 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.85 93.81 0.19 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 113.457 -1.701 . . . . 0.0 113.362 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.3 mt -103.82 56.75 0.73 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.647 -1.276 . . . . 0.0 111.134 173.845 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.5 t -143.03 178.63 7.56 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.52 -168.909 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -52.45 123.22 10.42 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.835 1.254 . . . . 0.0 113.586 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.99 34.18 10.16 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 112.784 -2.007 . . . . 0.0 113.347 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 p -119.3 140.2 50.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.658 0.383 . . . . 0.0 111.934 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 22.7 t -108.49 105.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.5 m -107.34 92.13 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.394 -171.077 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.6 p -78.52 102.44 7.89 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.579 -1.646 . . . . 0.0 110.2 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 58.6 mt -87.14 95.93 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.374 -174.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.5 t -104.21 122.22 44.92 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.827 -1.988 . . . . 0.0 110.913 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -109.42 115.16 29.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.602 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.87 102.86 12.27 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 112.858 -1.973 . . . . 0.0 112.434 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.82 -162.79 28.98 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 112.766 -2.015 . . . . 0.0 113.266 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -63.06 -61.04 2.65 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 -169.466 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.492 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 9.3 p30 -82.12 47.05 1.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 177.358 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.43 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 9.5 pt-20 -48.62 -39.38 23.83 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 112.322 -2.217 . . . . 0.0 116.482 -175.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -87.4 -53.16 4.97 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.351 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 42.4 mttt -66.09 -44.66 83.76 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.302 1.441 . . . . 0.0 113.971 -173.117 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.18 83.53 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.878 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.36 -47.4 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.438 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -47.52 -57.06 5.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.253 1.421 . . . . 0.0 112.929 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -59.48 -46.25 89.32 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 85.2 mt -67.01 -39.31 87.04 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.997 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.76 -46.58 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.588 0.755 . . . . 0.0 110.338 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -50.83 -49.91 57.72 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.663 1.227 . . . . 0.0 111.993 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 95.9 mt -56.9 -54.15 49.84 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.185 0.594 . . . . 0.0 112.514 177.713 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 49.6 ttm -54.28 -42.07 69.6 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.227 1.011 . . . . 0.0 112.739 179.128 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.44 92.6 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.85 22.97 6.72 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.1 mt -118.63 29.19 7.87 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.195 1.398 . . . . 0.0 113.073 171.441 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 -174.66 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -119.69 143.17 47.89 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.857 1.348 . . . . 0.0 111.111 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -127.06 136.06 51.64 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.48 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -133.97 106.85 7.47 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.188 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -78.03 92.76 4.39 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.231 1.491 . . . . 0.0 115.002 176.055 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.4 t -109.35 137.89 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.258 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 p -93.58 147.18 23.23 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -112.85 122.62 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.779 168.322 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 t -115.75 -27.0 7.2 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.609 -1.632 . . . . 0.0 114.84 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.54 137.27 17.21 Favored Pre-proline 0 N--CA 1.493 1.701 0 C-N-CA 124.72 1.208 . . . . 0.0 112.996 172.531 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -54.88 -54.07 5.04 Favored 'Trans proline' 0 CA--C 1.552 1.382 0 C-N-CA 124.468 3.446 . . . . 0.0 114.546 -171.585 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -63.95 -33.18 75.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 68.19 -170.2 38.3 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 124.993 1.282 . . . . 0.0 112.674 -163.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.03 81.89 7.82 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 113.509 -1.345 . . . . 0.0 108.941 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -62.75 175.59 0.8 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.577 -2.101 . . . . 0.0 115.351 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.1 p -58.18 -37.98 75.79 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -167.255 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -70.52 -46.74 18.64 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 116.608 -1.663 . . . . 0.0 113.414 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.78 -45.86 30.29 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.245 2.63 . . . . 0.0 113.457 164.191 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -39.59 72.89 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.14 86.94 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -58.63 -41.96 87.17 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.784 0.833 . . . . 0.0 111.468 172.38 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 29.5 t80 -58.78 -50.93 72.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.987 1.315 . . . . 0.0 111.692 172.86 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -54.77 -42.65 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.351 0.66 . . . . 0.0 112.575 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -52.53 -55.0 25.17 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.779 0.432 . . . . 0.0 111.127 175.019 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -62.57 -43.76 98.01 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.202 0.601 . . . . 0.0 111.546 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.31 78.87 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -51.18 -36.17 39.84 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.75 27.96 12.78 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.724 1.154 . . . . 0.0 115.489 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -117.86 149.93 40.04 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.142 0.577 . . . . 0.0 110.768 165.421 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.507 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 82.3 p -69.23 -45.43 69.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.052 -179.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.5 p -55.23 136.06 49.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.64 1.176 . . . . 0.0 113.498 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -91.51 83.76 5.44 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.616 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . 0.428 ' CD1' ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -64.57 92.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 110.509 -3.041 . . . . 0.0 113.42 176.509 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.51 113.37 21.71 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.626 172.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -98.19 94.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 122.559 1.171 . . . . 0.0 107.97 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 54.3 m -88.81 118.42 28.5 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.453 -1.703 . . . . 0.0 110.877 -173.803 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.3 t -90.15 90.95 8.33 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 112.852 -1.976 . . . . 0.0 111.066 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.26 26.4 p30 32.81 67.47 0.17 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.958 1.703 . . . . 0.0 114.859 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.13 -49.04 1.09 Allowed Glycine 0 N--CA 1.48 1.577 0 CA-C-N 113.043 -1.889 . . . . 0.0 112.93 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -68.15 93.69 0.46 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 m -58.44 106.41 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.489 -1.687 . . . . 0.0 115.431 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.79 97.24 5.35 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.1 -1.409 . . . . 0.0 113.083 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -47.65 106.09 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.717 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 -4.64 37.67 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.459 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -78.54 -15.98 57.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.44 0.696 . . . . 0.0 112.592 163.564 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.8 t -103.49 106.23 16.69 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.226 1.012 . . . . 0.0 110.656 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 4.7 tt -46.06 -40.23 10.42 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 112.336 -2.211 . . . . 0.0 112.931 169.221 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -59.35 -62.97 1.48 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.58 1.152 . . . . 0.0 109.846 174.535 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -57.39 -41.14 79.7 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 5.8 tp -76.15 -37.59 57.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 178.548 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.6 mt-30 -80.43 -15.91 55.66 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 175.778 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.4 t -87.13 -25.79 23.94 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 168.073 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.5 127.27 36.18 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 122.278 1.037 . . . . 0.0 111.834 171.896 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.71 103.38 2.2 Favored Glycine 0 N--CA 1.479 1.561 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.586 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.0 mp -80.8 67.07 6.56 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.24 1.019 . . . . 0.0 109.389 174.775 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.5 t -126.62 156.94 40.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.444 -1.253 . . . . 0.0 113.349 -164.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -18.12 109.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.354 2.262 . . . . 0.0 115.83 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.19 14.1 40.11 Favored Glycine 0 CA--C 1.539 1.536 0 CA-C-N 113.169 -1.832 . . . . 0.0 114.766 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.7 p -103.4 124.87 49.52 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.485 1.136 . . . . 0.0 113.609 173.722 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.7 110.77 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 112.52 -2.127 . . . . 0.0 106.06 165.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 m -102.01 100.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.125 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 35.6 p -77.01 104.73 7.67 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 113.083 -1.871 . . . . 0.0 110.856 176.703 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mt -85.17 94.21 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.439 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.3 t -94.27 102.22 14.22 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 112.816 -1.993 . . . . 0.0 110.716 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.26 100.0 11.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.515 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -97.05 101.33 12.88 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.323 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.67 -164.76 34.27 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 112.195 -2.275 . . . . 0.0 110.501 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -82.1 -47.91 12.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 117.152 2.278 . . . . 0.0 117.152 -174.465 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.507 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 9.6 p30 -80.71 40.52 0.52 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 173.602 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.8 pt-20 -47.78 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.99 2.116 . . . . 0.0 116.243 -173.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -56.66 -36.09 69.16 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 177.997 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -72.01 -46.25 57.89 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.098 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.64 -47.03 87.19 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.117 0.886 . . . . 0.0 111.462 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 78.2 t -58.66 -54.37 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.059 0.944 . . . . 0.0 111.114 177.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -52.83 -51.39 61.07 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.341 1.056 . . . . 0.0 112.978 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -63.61 -41.15 98.33 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 52.2 mt -69.68 -31.56 69.68 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 175.456 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.4 t -68.08 -45.2 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.921 0.889 . . . . 0.0 110.521 171.75 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -50.45 -46.15 56.48 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.376 1.071 . . . . 0.0 111.59 167.791 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 22.6 mt -60.66 -50.35 73.84 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 173.009 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 92.3 mtp -44.72 -48.7 10.75 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.379 1.072 . . . . 0.0 113.381 174.254 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.04 -32.64 74.27 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.27 13.7 pt-20 -100.47 25.57 7.56 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.322 1.058 . . . . 0.0 113.779 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.5 mt -138.06 36.76 2.34 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.724 2.41 . . . . 0.0 111.287 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 N--CA 1.488 1.436 0 C-N-CA 125.202 1.401 . . . . 0.0 107.821 -174.653 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.464 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 9.0 tmm? . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -125.54 134.3 52.04 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 125.336 1.647 . . . . 0.0 108.231 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.59 145.42 45.41 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 124.785 1.303 . . . . 0.0 113.764 -173.503 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -157.14 117.73 3.57 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 125.481 1.738 . . . . 0.0 112.19 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -76.27 132.98 40.18 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.562 169.426 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.17 129.84 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.424 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 p -81.67 143.41 31.91 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.453 -1.248 . . . . 0.0 112.395 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mt -120.44 113.53 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.57 167.684 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 t -100.75 -17.86 16.74 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.25 -1.796 . . . . 0.0 114.371 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.04 143.7 94.67 Favored Pre-proline 0 N--CA 1.477 0.895 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 169.607 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -42.08 -76.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 1 C-N-CA 125.547 4.165 . . . . 0.0 116.095 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -90.56 -22.5 21.25 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.85 -103.09 0.47 Allowed Glycine 0 N--CA 1.479 1.532 0 C-N-CA 125.533 1.54 . . . . 0.0 113.771 169.083 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.8 mt -97.35 66.21 2.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 112.396 -1.902 . . . . 0.0 108.501 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -66.49 -155.52 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 113.709 -1.587 . . . . 0.0 113.629 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -61.03 -49.73 76.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.259 1.424 . . . . 0.0 113.61 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.51 -43.74 53.14 Favored Pre-proline 0 N--CA 1.484 1.271 0 CA-C-O 116.041 -1.933 . . . . 0.0 115.126 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 87.8 Cg_exo -60.59 -40.99 51.37 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.585 2.19 . . . . 0.0 111.977 168.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.83 -44.07 94.24 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 174.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.61 -49.78 71.88 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -56.37 -47.98 77.76 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -50.65 -43.66 57.32 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.984 1.428 . . . . 0.0 113.471 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 23.3 t -59.93 -54.54 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 123.802 0.689 . . . . 0.0 111.175 178.08 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -54.24 -47.24 72.46 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.492 1.12 . . . . 0.0 112.456 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -66.64 -53.76 30.6 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.776 1.298 . . . . 0.0 113.134 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.02 -37.88 67.2 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.261 1.025 . . . . 0.0 113.42 179.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 49.9 mmtt -47.11 -34.0 5.58 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 174.895 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.87 28.93 13.28 Favored Glycine 0 CA--C 1.539 1.534 0 O-C-N 124.866 1.354 . . . . 0.0 114.263 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 71.1 m-85 -113.82 145.54 41.28 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.708 0.803 . . . . 0.0 110.971 168.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.45 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 75.8 p -78.77 -28.85 44.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 124.412 1.07 . . . . 0.0 112.552 -177.785 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.2 p -77.55 139.28 39.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.044 164.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.37 99.34 8.63 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.882 0.849 . . . . 0.0 110.727 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 46.5 mm -61.72 101.7 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 112.035 -2.348 . . . . 0.0 111.022 173.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -100.49 131.84 46.19 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.025 171.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 89.4 t -118.17 91.22 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 m -83.63 137.99 33.55 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.901 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 37.8 t -127.41 92.43 3.5 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 170.874 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.265 20.6 p30 47.47 88.47 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 112.786 -2.006 . . . . 0.0 115.726 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.54 -49.26 2.69 Favored Glycine 0 N--CA 1.483 1.774 0 CA-C-N 113.383 -1.735 . . . . 0.0 114.025 -174.654 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 81.5 mttt -64.37 103.92 0.71 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.822 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 m -88.82 109.74 20.45 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.109 -1.405 . . . . 0.0 114.531 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.74 96.06 5.66 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.703 177.61 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.6 t -59.22 116.01 3.6 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.373 171.544 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.6 -22.74 65.48 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.445 -1.252 . . . . 0.0 114.102 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 98.2 mttt -71.03 0.76 6.8 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 179.523 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.6 t -131.73 118.77 20.4 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.879 0.871 . . . . 0.0 110.538 174.958 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -55.55 -42.82 75.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.655 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.08 -60.7 2.98 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.366 171.358 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 18.5 mtpt -61.26 -30.97 70.79 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 178.518 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 33.3 tp -86.3 -53.92 4.74 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.14 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -67.93 -14.16 62.75 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -173.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -68.25 -32.78 73.2 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 165.955 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 1.1 mm? -76.71 143.44 39.99 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.099 0.952 . . . . 0.0 111.578 172.16 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.82 108.02 3.57 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 113.162 -1.836 . . . . 0.0 110.355 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 mp -105.71 90.48 3.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 125.61 1.418 . . . . 0.0 107.301 175.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -149.57 -172.46 4.15 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.553 -160.779 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -57.13 113.34 1.67 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.064 0.946 . . . . 0.0 111.908 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.5 -35.68 4.9 Favored Glycine 0 N--CA 1.484 1.885 0 CA-C-N 112.301 -2.227 . . . . 0.0 113.595 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.7 p -64.37 101.87 0.48 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.779 0.832 . . . . 0.0 112.217 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.8 t -76.72 101.72 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 113.415 -1.72 . . . . 0.0 106.786 173.461 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.9 m -94.77 128.2 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 112.951 -1.931 . . . . 0.0 112.701 -174.212 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -98.35 109.26 22.05 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.366 -171.802 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 mt -82.41 112.32 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 173.096 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 t -120.46 110.56 16.64 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 111.718 -2.492 . . . . 0.0 108.842 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -102.47 97.16 7.43 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -179.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.04 93.02 9.36 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.17 -163.03 29.4 Favored Glycine 0 CA--C 1.541 1.686 0 CA-C-N 112.645 -2.071 . . . . 0.0 113.83 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -54.76 -60.61 3.13 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 118.926 2.936 . . . . 0.0 118.926 -169.252 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.45 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 14.9 p30 -83.28 36.52 0.52 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 179.016 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.464 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 8.3 pt-20 -40.82 -69.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -61.19 -42.68 99.01 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -178.617 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -67.39 -44.44 78.87 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.11 -37.91 86.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.533 173.816 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 99.4 t -68.64 -47.66 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.334 174.827 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -49.39 -49.94 42.53 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.695 1.198 . . . . 0.0 110.95 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -57.83 -57.13 14.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.28 1.832 . . . . 0.0 112.072 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 -26.31 67.07 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 23.2 t -66.74 -47.63 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 167.559 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -54.37 -52.29 62.1 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.598 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -52.52 -57.41 10.04 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.7 mtt -52.43 -39.79 61.43 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.04 -44.07 73.4 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.543 1.152 . . . . 0.0 113.929 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.314 10.3 pt-20 -72.4 -27.08 62.14 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 40.4 mt -88.6 88.57 7.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -178.479 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.652 1.181 . . . . 0.0 112.74 169.126 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tmm? . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -88.23 130.77 34.99 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.755 0.788 . . . . 0.0 110.023 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.4 tt0 -134.05 142.32 47.53 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.073 -1.876 . . . . 0.0 111.72 -173.04 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -147.71 139.72 24.19 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 124.94 1.4 . . . . 0.0 110.602 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -93.34 131.4 38.53 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.915 0.759 . . . . 0.0 112.535 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.84 136.14 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.611 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.0 p -102.43 108.91 20.4 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 112.588 -2.096 . . . . 0.0 110.631 -179.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 mt -71.19 96.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 113.12 -1.854 . . . . 0.0 107.503 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 t -86.26 -26.91 24.73 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 113.24 -1.8 . . . . 0.0 113.501 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.1 135.36 80.57 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 124.18 0.992 . . . . 0.0 111.219 171.037 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -46.34 -37.65 19.36 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 124.638 3.559 . . . . 0.0 116.435 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.29 -37.06 2.07 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.97 -93.5 0.41 Allowed Glycine 0 N--CA 1.476 1.309 0 O-C-N 124.031 0.832 . . . . 0.0 112.903 163.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.4 mp -94.4 63.43 3.01 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 122.615 1.198 . . . . 0.0 112.574 -178.252 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -72.34 -169.51 0.53 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.291 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.6 p -47.47 -47.72 27.11 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.293 12.6 mmt180 -70.16 -51.7 13.57 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-O 115.398 -2.239 . . . . 0.0 114.932 -179.312 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 92.3 Cg_exo -60.8 -39.24 64.2 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.203 1.936 . . . . 0.0 113.816 172.613 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.54 -47.57 85.61 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.25 0.62 . . . . 0.0 112.639 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.52 85.32 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -66.4 -44.78 82.07 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -54.3 -51.63 64.04 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.261 1.024 . . . . 0.0 111.162 171.328 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 71.6 t -51.62 -51.52 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.465 1.106 . . . . 0.0 111.835 173.205 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -56.04 -53.97 50.6 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.717 1.207 . . . . 0.0 111.214 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -65.42 -43.94 88.94 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.361 1.038 . . . . 0.0 113.089 -178.415 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -40.07 72.65 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -58.53 -14.33 7.76 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 174.005 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.68 -35.49 22.22 Favored Glycine 0 N--CA 1.48 1.63 0 C-N-CA 124.41 1.005 . . . . 0.0 114.74 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -80.8 154.33 27.23 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.849 0.86 . . . . 0.0 113.032 -174.282 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.411 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 71.2 p -69.77 -43.09 72.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 123.984 0.803 . . . . 0.0 111.787 179.597 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.6 p -61.23 145.54 50.88 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.7 mt-10 -83.26 134.05 34.96 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.985 0.898 . . . . 0.0 111.189 167.436 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.6 mm -112.12 106.98 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.074 -166.193 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.66 119.35 33.45 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.248 -1.797 . . . . 0.0 109.438 -174.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 40.1 t -110.21 87.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -175.394 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -77.88 100.65 6.45 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.845 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.2 t -76.7 97.31 4.42 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.099 -1.409 . . . . 0.0 111.716 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 p30 35.12 61.97 0.59 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.86 -76.26 0.3 Allowed Glycine 0 N--CA 1.485 1.919 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.844 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.63 138.84 41.66 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.468 0.652 . . . . 0.0 112.513 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.5 m -99.35 140.13 33.98 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -124.76 134.94 52.62 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 113.571 -1.649 . . . . 0.0 109.232 175.217 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 t -117.26 126.56 52.94 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.95 -15.46 43.61 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 125.488 1.743 . . . . 0.0 113.637 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.4 mmtt -71.87 -6.63 43.14 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 171.904 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -131.26 134.49 46.45 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.63 1.572 . . . . 0.0 109.598 168.17 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 43.7 tp -59.67 -52.38 65.75 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.498 169.633 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -62.92 -49.35 75.13 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 112.912 -1.949 . . . . 0.0 113.644 -175.478 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -65.22 -32.19 73.74 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.846 0.716 . . . . 0.0 112.909 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.2 tp -76.53 -44.93 32.87 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 119.015 -0.517 . . . . 0.0 112.233 175.353 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -59.45 -39.54 83.93 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.5 t -58.83 -39.46 81.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.81 140.79 39.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.329 1.062 . . . . 0.0 113.159 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.27 81.37 0.2 Allowed Glycine 0 CA--C 1.535 1.319 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.274 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 61.8 mt -82.27 60.8 5.17 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 123.626 1.679 . . . . 0.0 110.172 172.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 t -123.32 -178.68 4.06 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 112.495 -2.139 . . . . 0.0 112.477 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -51.68 127.64 21.14 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.774 1.229 . . . . 0.0 112.545 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.71 -32.61 6.61 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 112.962 -1.926 . . . . 0.0 113.468 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.0 p -62.45 116.82 5.42 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 122.474 1.131 . . . . 0.0 113.858 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.2 t -86.75 95.13 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 112.239 -2.255 . . . . 0.0 106.075 174.156 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 31.6 m -95.65 113.45 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 112.608 -2.087 . . . . 0.0 110.365 -176.042 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -91.43 108.74 20.1 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.247 -173.42 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.6 mt -91.17 107.08 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.724 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.5 t -103.12 126.93 50.52 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 112.614 -2.085 . . . . 0.0 111.075 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.09 111.34 21.97 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 124.679 1.237 . . . . 0.0 110.533 168.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -103.05 99.17 9.03 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.04 -159.74 28.68 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.576 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -54.48 39.0 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -173.729 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.411 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 5.3 p30 -83.05 33.49 0.44 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 179.299 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 2.2 pt-20 -45.04 -59.35 2.64 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -175.582 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -65.87 -40.08 91.29 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.091 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -70.31 -43.14 70.94 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.228 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.35 -52.82 64.01 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.461 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.08 -47.05 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.662 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -52.78 -57.55 9.79 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.16 0.984 . . . . 0.0 112.775 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.79 -45.54 93.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.215 1.006 . . . . 0.0 112.816 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 88.1 mt -69.46 -33.44 72.92 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 178.929 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -69.01 -48.4 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.787 0.835 . . . . 0.0 111.456 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -52.0 -45.49 64.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 123.829 0.705 . . . . 0.0 112.046 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.9 tp -52.85 -59.25 4.74 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.687 1.195 . . . . 0.0 112.475 174.089 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 38.7 mtt -47.95 -43.13 29.03 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 173.008 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.89 -45.66 88.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 118.152 -0.928 . . . . 0.0 113.337 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -86.24 -3.18 58.92 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.1 mt -97.66 96.66 8.42 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.912 0.885 . . . . 0.0 111.141 170.747 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 C--O 1.254 1.314 0 CA-C-N 113.655 -1.611 . . . . 0.0 106.993 175.362 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.472 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 . . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -133.13 127.51 34.07 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 124.385 1.053 . . . . 0.0 111.321 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -110.28 146.03 36.37 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.814 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -155.07 125.82 7.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.756 1.222 . . . . 0.0 108.072 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -105.86 96.16 6.3 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 125.04 2.353 . . . . 0.0 113.622 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.7 t -95.73 119.22 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 111.222 -2.717 . . . . 0.0 110.841 -166.318 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 m -74.85 115.67 14.71 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.571 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.25 135.93 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.34 -23.25 4.89 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.37 -1.741 . . . . 0.0 113.856 -173.417 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 138.72 30.5 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.604 1.162 . . . . 0.0 111.386 169.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -39.98 -50.71 3.3 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 C-N-CA 124.66 3.573 . . . . 0.0 117.345 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -116.88 21.95 12.96 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.01 -98.48 0.01 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.352 1.453 . . . . 0.0 113.822 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 19.4 mt -119.1 110.93 17.65 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 113.766 -1.217 . . . . 0.0 111.604 175.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -91.15 -165.8 1.44 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.211 164.28 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -51.47 -43.93 62.28 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.253 11.4 ttm105 -68.98 -45.17 30.56 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.281 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 65.9 Cg_exo -61.26 -30.21 87.68 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.671 2.248 . . . . 0.0 115.169 167.674 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -46.15 84.25 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.759 0.709 . . . . 0.0 112.207 168.143 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.68 -44.93 80.46 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.225 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 43.2 mt-30 -51.94 -53.25 43.39 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.094 0.958 . . . . 0.0 112.971 172.061 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -51.87 -60.52 3.08 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -46.47 -55.88 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.908 1.283 . . . . 0.0 112.707 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -51.97 -47.42 64.84 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 124.563 1.164 . . . . 0.0 112.279 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.01 -56.06 8.92 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.713 1.258 . . . . 0.0 112.688 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.22 -44.46 75.44 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.248 1.819 . . . . 0.0 115.049 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -51.56 -31.98 26.59 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.14 -49.42 78.8 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 125.449 1.718 . . . . 0.0 114.394 173.527 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -60.45 154.74 19.88 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.413 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 67.3 p -86.72 -15.88 38.13 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.838 -177.444 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.4 p -82.94 153.02 25.25 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.718 164.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -94.3 131.89 39.45 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.388 0.675 . . . . 0.0 109.191 173.56 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 mm -112.97 100.47 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.998 -159.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.9 m -104.28 126.34 51.3 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.18 85.82 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.599 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 50.3 m -64.45 120.68 12.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.348 170.847 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 40.8 t -94.0 95.43 9.04 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 174.686 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 24.98 63.98 0.05 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.63 -24.6 8.43 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 117.3 1.68 . . . . 0.0 117.3 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -130.51 140.93 50.5 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 118.656 1.228 . . . . 0.0 109.641 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 77.6 p -101.28 129.44 47.25 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -162.737 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.99 104.05 11.52 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.103 179.278 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -59.34 113.84 2.37 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 169.977 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.48 0.15 43.72 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.59 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 44.8 mttt -89.99 -44.43 9.87 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.533 164.835 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -70.62 116.96 11.54 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.362 0.601 . . . . 0.0 112.016 169.165 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 tp -64.37 -44.76 90.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.241 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -66.25 -34.79 78.81 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.416 1.086 . . . . 0.0 111.693 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 28.7 tttt -76.96 -47.73 20.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 173.652 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 26.9 tp -51.81 -49.37 62.89 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 175.68 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -63.85 -27.37 69.12 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . 0.266 3.6 t -74.09 -20.61 60.21 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 179.502 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.14 135.8 33.16 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.419 1.104 . . . . 0.0 113.001 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.02 90.75 1.1 Allowed Glycine 0 CA--C 1.537 1.466 0 CA-C-N 113.182 -1.826 . . . . 0.0 109.561 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.65 64.64 3.57 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.558 1.17 . . . . 0.0 110.288 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.7 t -108.13 174.73 5.75 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.045 -170.708 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -50.63 137.45 19.71 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.305 1.042 . . . . 0.0 110.667 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.24 -47.19 1.79 Allowed Glycine 0 N--CA 1.481 1.699 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.597 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.8 p -56.92 120.75 8.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.875 0.397 . . . . 0.0 111.275 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 t -86.65 109.63 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 111.837 -2.438 . . . . 0.0 107.917 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 30.5 m -104.95 116.41 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -170.883 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 m -82.8 97.47 8.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.149 0.98 . . . . 0.0 109.006 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mt -74.05 92.16 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 166.858 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -100.13 108.75 20.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 110.129 -3.214 . . . . 0.0 109.578 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.42 100.49 9.77 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.747 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -96.72 89.82 5.07 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -178.936 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.05 -162.7 29.27 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.637 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -56.39 -59.35 5.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 118.721 2.86 . . . . 0.0 118.721 -162.334 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.413 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 14.0 p30 -85.41 50.16 1.9 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 179.339 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.472 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 12.3 pt-20 -51.72 -53.15 42.58 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.193 -2.276 . . . . 0.0 116.079 -174.923 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -43.17 57.16 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.69 -49.78 76.14 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.6 -52.07 42.69 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.918 1.387 . . . . 0.0 112.614 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 86.5 t -53.68 -56.08 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 123.975 0.797 . . . . 0.0 111.795 176.22 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.13 -53.09 62.25 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -52.91 -47.6 67.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.952 1.301 . . . . 0.0 113.969 175.846 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -66.22 -36.71 83.74 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 9.0 t -64.94 -47.21 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 O-C-N 122.336 -0.227 . . . . 0.0 110.698 175.53 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -54.05 -37.74 64.48 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.9 tt -60.99 -51.84 67.53 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.043 0.937 . . . . 0.0 110.014 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 10.6 ttm -60.57 -46.98 88.2 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.393 1.077 . . . . 0.0 113.005 176.879 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.12 -14.79 0.69 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -125.49 45.19 2.64 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 170.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.8 mt -123.38 121.97 37.12 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.258 169.705 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 . . . . . 0 C--O 1.249 1.076 0 O-C-N 125.626 1.829 . . . . 0.0 110.64 171.489 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.5 ttm . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -120.8 140.62 51.47 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.964 1.415 . . . . 0.0 109.576 173.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -128.65 142.67 50.96 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.518 1.136 . . . . 0.0 112.032 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -150.49 119.62 6.75 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.025 1.453 . . . . 0.0 110.799 169.294 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -72.88 126.65 30.44 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.888 -1.506 . . . . 0.0 113.223 173.65 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.12 131.75 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.098 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.9 m -111.34 110.48 20.97 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.73 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.1 mt -72.62 113.9 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.445 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -85.74 -19.08 31.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.388 -1.733 . . . . 0.0 114.844 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -54.87 127.64 62.03 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.554 1.142 . . . . 0.0 113.009 178.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_exo -54.11 -62.3 0.32 Allowed 'Trans proline' 0 N--CA 1.485 0.999 0 C-N-CA 124.602 3.535 . . . . 0.0 113.314 -169.241 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.29 29.62 2.16 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 174.44 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 33.74 -134.06 0.31 Allowed Glycine 0 N--CA 1.479 1.546 0 C-N-CA 127.345 2.402 . . . . 0.0 116.345 -175.613 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.8 122.43 44.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.117 -2.042 . . . . 0.0 109.966 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -109.2 -154.93 0.54 Allowed 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.195 -1.82 . . . . 0.0 113.579 -179.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 15.3 m -61.01 -48.36 82.15 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -166.682 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -63.27 -47.61 84.4 Favored Pre-proline 0 N--CA 1.489 1.502 0 CA-C-O 116.599 -1.667 . . . . 0.0 112.233 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.79 -47.14 28.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.823 2.349 . . . . 0.0 113.48 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.92 -48.26 73.32 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.9 -46.91 84.21 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.118 0.967 . . . . 0.0 113.381 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -57.89 -42.78 85.37 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 -66.28 -49.24 67.78 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 178.55 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 40.6 t -58.07 -35.84 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.448 0.699 . . . . 0.0 112.521 176.166 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -62.81 -65.07 0.74 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.029 0.932 . . . . 0.0 111.014 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.52 -52.76 62.18 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.91 -27.27 68.74 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -176.665 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.0 mttm -58.5 -35.52 72.38 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 169.393 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.66 -31.83 79.31 Favored Glycine 0 N--CA 1.482 1.731 0 O-C-N 125.78 1.925 . . . . 0.0 113.579 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -79.01 142.17 36.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.294 0.638 . . . . 0.0 110.695 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.487 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 70.1 p -64.5 -43.75 93.12 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.64 -177.694 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.2 p -59.68 143.8 49.68 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 114.419 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -90.78 126.3 35.97 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.744 1.259 . . . . 0.0 109.999 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 15.4 mm -98.4 98.56 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 112.765 -2.016 . . . . 0.0 109.71 -169.418 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -83.86 101.28 11.54 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.705 -1.588 . . . . 0.0 107.554 175.756 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.5 t -87.43 77.6 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.9 m -75.45 88.28 2.63 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.339 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.7 t -79.8 86.68 5.34 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.819 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 21.12 81.4 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 111.295 -2.684 . . . . 0.0 115.484 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.37 -63.37 0.28 Allowed Glycine 0 CA--C 1.543 1.81 0 CA-C-N 112.173 -2.285 . . . . 0.0 112.79 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -104.9 133.02 50.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -169.479 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 p -88.71 116.23 26.82 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 113.557 -1.656 . . . . 0.0 115.444 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -102.29 164.96 11.39 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.546 168.847 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -125.69 119.38 27.85 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.305 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -72.57 5.97 2.72 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 124.42 1.075 . . . . 0.0 113.059 170.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 50.9 mtpt -113.89 -15.21 12.4 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 172.923 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.0 t -119.02 120.9 38.58 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.824 0.849 . . . . 0.0 111.685 172.448 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.0 tp -57.44 -61.83 2.21 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.018 -1.447 . . . . 0.0 113.386 -172.391 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -45.37 -50.78 11.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.29 1.436 . . . . 0.0 113.238 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -67.67 -30.93 70.59 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 18.6 tp -72.98 -47.06 48.59 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.513 0.508 . . . . 0.0 111.752 174.822 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -65.99 -31.53 72.48 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.5 t -85.03 33.71 0.54 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.856 1.313 . . . . 0.0 114.351 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.05 140.72 44.03 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.907 171.555 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.7 93.23 0.17 Allowed Glycine 0 N--CA 1.479 1.525 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.256 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 17.0 mt -94.96 57.86 2.14 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.293 1.044 . . . . 0.0 110.721 173.884 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -109.39 176.88 4.92 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.866 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -58.58 126.15 26.38 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.758 0.79 . . . . 0.0 111.888 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.66 16.23 64.23 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 113.385 -1.734 . . . . 0.0 114.925 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.0 p -88.23 120.44 29.59 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.543 0.687 . . . . 0.0 111.313 175.961 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 t -93.54 85.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 112.4 -2.182 . . . . 0.0 107.642 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -80.5 94.46 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 112.129 -2.305 . . . . 0.0 112.382 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.0 m -76.12 100.66 5.06 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.761 172.267 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 67.3 mt -79.23 102.12 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.975 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.8 t -106.56 104.86 14.65 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 111.82 -2.445 . . . . 0.0 110.408 -177.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.59 101.49 13.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.763 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.89 99.56 12.39 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.982 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.09 -169.15 31.99 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-N 112.39 -2.187 . . . . 0.0 111.38 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.42 -48.9 75.91 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 -169.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 3.6 p30 -85.62 42.71 0.98 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 177.169 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -51.77 -48.65 63.65 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.44 -42.88 28.72 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -59.11 -44.19 91.95 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.545 1.138 . . . . 0.0 112.719 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.34 -49.68 70.72 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.192 0.997 . . . . 0.0 113.308 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.3 t -59.84 -55.11 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.47 -179.733 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -47.97 -45.04 30.94 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -70.13 -51.22 33.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 5.7 mt -60.56 -33.86 73.31 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.445 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.65 -54.69 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 124.039 0.837 . . . . 0.0 109.966 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -50.99 -49.98 59.33 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 124.17 0.919 . . . . 0.0 112.988 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.4 mp -61.48 -46.25 90.84 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 179.683 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 44.5 mtt -66.41 -21.67 66.22 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.3 -32.46 16.51 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -74.25 -39.72 62.85 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.35 104.97 12.17 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.251 1.167 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.857 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.427 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 36.8 ttp . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 . . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -124.88 135.64 53.06 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 125.277 1.611 . . . . 0.0 108.246 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -133.97 135.19 43.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.059 -172.41 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -142.76 144.49 32.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.047 1.339 . . . . 0.0 112.185 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.16 141.91 28.31 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.507 169.244 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.5 t -123.73 135.18 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 113.577 -1.647 . . . . 0.0 106.722 160.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.9 m -102.75 113.7 27.32 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.4 mt -72.63 124.69 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 122.317 1.056 . . . . 0.0 108.735 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -127.11 -30.12 2.71 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.868 -171.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.62 121.86 5.48 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 124.258 1.023 . . . . 0.0 111.367 161.483 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 34.1 Cg_endo -53.67 -69.35 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.454 2.769 . . . . 0.0 114.048 -169.877 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -74.55 -24.0 58.87 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.918 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.25 -125.2 17.83 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.999 1.285 . . . . 0.0 113.599 167.238 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.1 mp -96.45 110.43 22.8 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.896 1.331 . . . . 0.0 112.984 -175.656 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -109.6 -169.81 1.54 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 111.95 -2.386 . . . . 0.0 111.203 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 m -27.53 -76.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.394 2.278 . . . . 0.0 115.933 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -62.63 -49.35 83.33 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-O 116.237 -1.84 . . . . 0.0 113.696 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -51.51 -45.95 34.6 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.448 2.765 . . . . 0.0 114.044 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.7 -51.14 68.35 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.289 0.636 . . . . 0.0 112.403 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.28 81.31 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.62 -58.08 8.91 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.44 1.096 . . . . 0.0 111.986 171.565 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.79 -41.69 82.62 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.206 1.003 . . . . 0.0 112.719 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 58.9 t -64.58 -51.06 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.122 0.569 . . . . 0.0 111.642 177.365 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -53.15 -47.94 68.35 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.354 0.662 . . . . 0.0 109.827 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.06 -49.72 66.64 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.01 -45.85 75.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.525 0.73 . . . . 0.0 112.081 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -59.59 -36.08 75.55 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 173.1 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.22 -43.07 93.79 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 124.875 1.359 . . . . 0.0 112.199 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -62.02 145.99 51.48 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.99 0.916 . . . . 0.0 112.554 172.69 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.7 p -79.44 -31.36 42.53 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.232 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.7 p -71.95 141.82 49.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.76 0.824 . . . . 0.0 112.398 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.4 tp10 -72.35 130.62 41.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.479 0.656 . . . . 0.0 110.462 178.009 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 mm -113.43 86.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.369 -1.742 . . . . 0.0 109.303 -164.417 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.1 m -92.54 111.9 23.65 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 112.26 -2.245 . . . . 0.0 108.707 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.51 103.46 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 113.45 -1.705 . . . . 0.0 108.873 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 42.0 m -81.57 98.35 8.28 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.219 176.499 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 10.6 t -95.39 94.16 7.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.16 -179.142 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.288 30.7 p-10 43.51 77.32 0.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 111.053 -2.794 . . . . 0.0 115.628 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.06 -52.59 3.21 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 112.276 -2.238 . . . . 0.0 113.742 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -93.46 134.48 35.67 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.484 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 39.5 p -89.8 148.9 22.94 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 122.526 1.155 . . . . 0.0 113.561 -179.623 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -143.66 122.59 12.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.586 171.185 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.5 t -57.73 107.45 0.45 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.315 0.578 . . . . 0.0 110.059 166.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.78 -23.4 60.15 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.378 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -65.11 3.46 0.6 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.789 -1.551 . . . . 0.0 114.994 168.215 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 31.1 t -125.94 118.04 24.57 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.885 0.874 . . . . 0.0 110.427 175.24 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 31.1 tp -53.41 -47.75 69.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.793 174.841 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -58.22 -51.05 71.35 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.544 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.9 mttt -68.19 -43.69 77.56 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.805 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.41 -45.53 92.72 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.057 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -64.49 -36.45 84.22 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.2 t -74.62 -30.44 61.66 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 177.283 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.2 mm? -83.07 155.6 23.78 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 122.067 0.937 . . . . 0.0 113.475 173.093 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -56.63 121.05 23.17 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 113.776 -1.556 . . . . 0.0 113.433 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 76.1 mt -124.31 36.66 4.57 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.061 1.344 . . . . 0.0 113.355 177.875 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -139.36 160.32 40.1 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -163.036 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 51.1 tt0 -34.52 109.51 0.08 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.618 1.567 . . . . 0.0 113.429 173.663 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.75 -40.8 1.93 Allowed Glycine 0 CA--C 1.534 1.276 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.817 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.7 p -74.89 133.35 41.83 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.57 110.06 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 113.279 -1.782 . . . . 0.0 106.785 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 m -98.7 89.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 125.065 1.478 . . . . 0.0 111.968 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.15 90.16 2.52 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.717 -2.038 . . . . 0.0 110.096 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.3 mt -76.65 111.87 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.275 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.2 t -117.2 124.75 49.87 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.821 -1.536 . . . . 0.0 109.631 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.28 110.66 21.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.365 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 3.3 pt-20 -108.95 110.34 21.62 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.651 -1.158 . . . . 0.0 113.674 177.579 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.82 -158.57 27.77 Favored Glycine 0 N--CA 1.483 1.831 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.002 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.88 -65.76 0.63 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -81.34 45.38 0.85 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.427 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 10.1 pt-20 -51.33 -62.27 1.72 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.683 1.593 . . . . 0.0 114.533 -177.424 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.6 OUTLIER -65.28 -41.98 93.62 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.242 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -56.96 -49.01 77.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.457 1.103 . . . . 0.0 113.52 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.9 -51.64 68.8 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.451 0.701 . . . . 0.0 111.838 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.68 -46.32 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.449 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -49.21 -54.73 15.22 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.21 1.404 . . . . 0.0 112.096 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -69.09 -34.75 75.6 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.5 mt -73.24 -39.9 65.1 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.8 t -58.91 -43.6 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.289 0.636 . . . . 0.0 110.217 170.492 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 34.0 mtpt -56.63 -53.66 55.12 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 171.537 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.3 mt -49.76 -48.77 50.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.06 0.944 . . . . 0.0 113.464 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.9 mmt -59.16 -43.73 92.1 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 176.102 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.36 -40.66 89.91 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -74.18 -19.09 60.66 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 117.203 2.298 . . . . 0.0 117.203 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.3 mt -101.1 88.84 3.62 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 mt-10 . . . . . 0 C--O 1.258 1.519 0 C-N-CA 125.162 1.385 . . . . 0.0 109.37 171.388 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.487 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 1.2 tmt? . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 . . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -141.29 134.07 28.8 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.969 1.418 . . . . 0.0 111.318 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -122.98 139.94 53.55 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.156 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -138.73 140.31 38.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.171 175.06 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -100.63 116.14 31.85 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 122.74 1.257 . . . . 0.0 111.443 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.5 p -122.62 135.72 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 112.88 -1.963 . . . . 0.0 111.286 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -87.91 162.54 16.85 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.494 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.6 mm -115.85 132.38 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 125.234 1.584 . . . . 0.0 106.885 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.77 -29.92 11.19 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.54 132.83 1.69 Allowed Pre-proline 0 N--CA 1.474 0.747 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -54.69 -45.94 37.15 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.915 3.077 . . . . 0.0 112.411 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.424 ' ND2' ' H ' ' A' ' 13' ' ' GLY . 6.2 p-10 -73.03 -64.37 0.98 Allowed 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.531 1.144 . . . . 0.0 112.967 171.344 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . 0.424 ' H ' ' ND2' ' A' ' 12' ' ' ASN . . . 105.61 100.31 2.64 Favored Glycine 0 N--CA 1.475 1.286 0 N-CA-C 110.386 -1.085 . . . . 0.0 110.386 179.28 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 32.21 84.57 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.134 2.173 . . . . 0.0 114.722 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -64.23 169.81 4.25 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.111 1.434 . . . . 0.0 114.213 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 p -59.71 -17.28 33.36 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.261 96.8 mtt180 -80.32 -47.38 1.32 Allowed Pre-proline 0 N--CA 1.478 0.929 0 CA-C-O 116.75 -1.595 . . . . 0.0 114.473 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.66 -37.22 89.16 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 122.097 1.865 . . . . 0.0 113.976 162.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.38 -44.99 89.16 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.08 92.89 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 172.224 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -63.54 -48.1 78.88 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.864 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -45.92 -56.27 5.68 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.54 1.536 . . . . 0.0 113.519 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.01 -43.66 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.185 0.994 . . . . 0.0 112.496 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.35 -50.13 68.96 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -59.58 -48.92 79.78 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.778 1.299 . . . . 0.0 111.257 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.67 -39.36 80.44 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -65.65 -38.02 88.19 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.18 -53.6 35.55 Favored Glycine 0 N--CA 1.482 1.726 0 O-C-N 125.614 1.821 . . . . 0.0 111.794 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -52.34 137.03 30.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 125.322 1.248 . . . . 0.0 110.378 171.652 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.493 ' HG1' ' CD ' ' A' ' 68' ' ' GLU . 2.9 p -74.11 -36.36 64.21 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.145 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.4 m -46.28 146.85 1.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.135 1.774 . . . . 0.0 114.877 170.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -86.05 133.72 33.88 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.792 0.806 . . . . 0.0 109.878 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.0 mm -117.04 97.44 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.165 -164.243 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.0 m -94.77 117.91 30.9 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.4 -176.391 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.0 t -116.88 100.92 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 112.796 -2.002 . . . . 0.0 107.17 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -111.26 102.46 10.87 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.673 -167.352 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.5 m -76.52 91.8 3.39 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.751 170.254 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.263 6.8 p-10 32.24 105.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 118.706 2.854 . . . . 0.0 118.706 -172.424 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.38 -37.37 0.82 Allowed Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 78.1 tttt -94.58 120.05 34.2 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.938 0.895 . . . . 0.0 110.161 -179.294 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.0 m -98.31 124.21 42.83 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -169.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.28 166.6 12.09 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.74 -2.027 . . . . 0.0 109.723 175.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 18.2 t -126.01 132.34 52.03 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 178.232 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.91 -20.43 64.23 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.327 -1.761 . . . . 0.0 113.907 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -66.29 -12.3 55.64 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 84.4 p -136.44 137.26 40.25 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 160.19 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.6 tp -55.11 -39.23 69.13 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 124.121 0.888 . . . . 0.0 111.908 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -46.4 -56.35 6.02 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.04 1.736 . . . . 0.0 113.272 168.822 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 56.1 tttt -76.49 -30.47 57.25 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.9 -65.56 0.66 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -59.99 -23.62 63.78 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -60.88 -26.5 67.46 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 174.407 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 5.4 mt -123.27 85.15 2.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.542 1.137 . . . . 0.0 109.459 169.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.88 135.86 17.72 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 112.949 -1.932 . . . . 0.0 113.135 -173.209 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.0 mp -79.22 101.32 7.93 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 113.47 -1.365 . . . . 0.0 109.715 -179.088 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -129.71 162.23 28.86 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.804 -1.543 . . . . 0.0 111.979 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -58.02 145.74 35.19 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.44 -51.16 4.52 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.95 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -71.38 113.33 8.31 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.907 0.86 . . . . 0.0 111.245 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.0 p -71.43 132.37 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.709 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 p -116.59 123.92 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.08 -177.825 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 m -79.95 120.53 24.28 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.968 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.01 100.33 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 44.6 t -110.18 125.39 52.99 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 112.909 -1.95 . . . . 0.0 112.104 -176.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.15 111.89 18.83 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.547 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.53 103.8 12.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 113.778 -1.555 . . . . 0.0 112.91 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.57 -156.4 26.66 Favored Glycine 0 N--CA 1.479 1.533 0 CA-C-N 111.798 -2.455 . . . . 0.0 109.8 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.493 ' CD ' ' HG1' ' A' ' 30' ' ' THR . 3.2 mp0 -67.3 -49.53 63.84 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.353 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.93 20.44 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.487 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 12.0 pt-20 -41.43 -55.71 2.72 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -171.957 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -75.75 -52.26 10.84 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.939 0.896 . . . . 0.0 112.157 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -48.33 -54.31 14.28 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.421 1.888 . . . . 0.0 113.069 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.92 -51.99 66.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.452 1.101 . . . . 0.0 112.732 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 60.7 t -64.8 -49.24 80.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.734 -178.956 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -53.79 -51.79 62.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.31 1.006 . . . . 0.0 111.025 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -65.17 -43.65 91.04 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.7 mt -64.51 -35.61 81.53 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.4 t -74.08 -35.18 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 123.126 0.57 . . . . 0.0 111.451 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -66.66 -36.01 81.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 171.259 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -55.32 -50.27 70.04 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.515 1.135 . . . . 0.0 109.335 168.221 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 66.0 mtt -58.12 -44.14 87.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.16 -20.62 27.41 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -110.81 -31.73 7.08 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.2 mt -124.41 115.29 20.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.858 1.263 . . . . 0.0 114.079 -173.777 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.9 mt-10 . . . . . 0 C--O 1.258 1.517 0 C-N-CA 125.482 1.513 . . . . 0.0 108.92 169.397 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 tmm? . . . . . 0 C--O 1.239 0.531 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -124.7 128.3 48.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.669 1.23 . . . . 0.0 109.397 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -124.74 138.84 54.26 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.512 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -129.68 140.79 51.04 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.203 172.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -98.78 120.77 39.78 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.683 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 2.4 m -123.22 144.83 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 113.875 -1.512 . . . . 0.0 113.131 176.166 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -105.26 143.81 32.92 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.618 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -114.49 133.16 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.67 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 p -116.95 -41.05 3.06 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.6 132.49 3.79 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 170.262 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.23 -42.67 54.25 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.979 2.453 . . . . 0.0 113.752 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -69.22 -35.18 75.91 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.692 1.245 . . . . 0.0 114.051 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.51 80.66 0.12 Allowed Glycine 0 N--CA 1.473 1.158 0 O-C-N 125.154 1.533 . . . . 0.0 112.431 -176.894 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 8.1 mt 61.16 92.34 0.05 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.211 1.804 . . . . 0.0 112.849 176.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -71.71 -165.66 0.17 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -173.634 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.46 -46.17 9.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.477 2.711 . . . . 0.0 113.692 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.267 68.1 mtt180 -80.52 -42.64 1.31 Allowed Pre-proline 0 N--CA 1.486 1.349 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -177.751 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -53.02 -48.39 22.4 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.903 2.402 . . . . 0.0 113.295 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.81 -47.39 77.24 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.54 -39.34 76.42 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.01 -50.7 71.01 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.856 0.863 . . . . 0.0 112.931 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.8 m-30 -53.66 -41.03 66.4 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.936 0.894 . . . . 0.0 111.759 179.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.3 t -60.3 -59.9 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.605 1.162 . . . . 0.0 111.804 176.266 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -53.31 -48.08 68.72 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.666 0.604 . . . . 0.0 111.699 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -45.89 78.59 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.95 74.61 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 173.678 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -66.16 -45.55 80.55 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.31 -45.65 96.02 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.693 1.616 . . . . 0.0 113.319 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -65.65 147.58 53.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.83 0.852 . . . . 0.0 111.122 167.5 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.495 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 40.5 p -66.79 -56.6 9.72 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.777 1.231 . . . . 0.0 113.664 -178.551 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -46.6 144.96 2.02 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -82.35 117.24 22.27 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.582 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 26.0 mm -94.5 114.61 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.22 -174.604 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.08 120.9 26.71 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 125.419 1.699 . . . . 0.0 110.596 173.492 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.8 t -108.8 86.55 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.9 m -94.0 90.61 6.51 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.225 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 p -76.2 98.59 4.46 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.253 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.255 52.0 p-10 24.09 60.12 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.051 2.14 . . . . 0.0 116.533 -167.109 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.69 -34.93 4.76 Favored Glycine 0 CA--C 1.542 1.747 0 CA-C-N 113.72 -1.582 . . . . 0.0 115.449 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -81.26 96.92 7.42 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.334 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -73.3 89.62 1.59 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.15 158.43 19.77 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.792 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -110.62 120.84 43.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.432 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.93 -32.21 73.66 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.302 1.626 . . . . 0.0 112.637 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -67.89 -9.95 49.12 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.552 1.541 . . . . 0.0 114.201 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 t -121.85 118.22 28.43 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.743 1.217 . . . . 0.0 111.326 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.7 tp -55.38 -47.21 76.17 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 113.55 -1.659 . . . . 0.0 112.621 -179.11 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -60.57 -57.77 11.33 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.973 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -61.47 -43.97 97.93 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.5 tp -57.88 -57.32 13.31 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.514 1.134 . . . . 0.0 112.612 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -71.38 -27.67 63.49 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.5 t -72.77 -24.8 60.99 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 171.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 6.8 mp -104.76 74.46 1.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.968 1.366 . . . . 0.0 110.505 172.082 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.49 152.54 49.83 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 112.428 -2.169 . . . . 0.0 114.611 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -100.39 158.71 15.7 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 112.588 -1.806 . . . . 0.0 109.787 173.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.8 t -161.54 165.87 27.88 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.081 1.352 . . . . 0.0 110.588 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -63.65 125.65 24.98 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.08 -19.29 54.03 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.527 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.6 m -75.98 104.12 6.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.234 0.613 . . . . 0.0 109.393 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.51 137.37 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.724 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.36 123.69 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 122.245 1.022 . . . . 0.0 113.557 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 116.86 28.25 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.111 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.7 mm -92.66 103.93 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.8 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.4 t -115.92 129.52 56.43 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.721 -1.581 . . . . 0.0 111.068 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.88 122.84 40.35 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.547 1.165 . . . . 0.0 111.665 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -96.88 116.67 29.57 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.382 -2.19 . . . . 0.0 114.059 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.38 177.6 10.36 Favored Glycine 0 CA--C 1.541 1.697 0 CA-C-N 111.824 -2.444 . . . . 0.0 113.237 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.257 50.3 mt-10 41.6 -93.24 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 172.045 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.495 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 84.9 m-20 -77.15 -0.64 25.72 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -178.704 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -18.51 -62.91 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -64.93 -57.59 8.37 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.882 0.873 . . . . 0.0 112.882 -175.864 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -62.6 -38.15 89.06 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.583 0.753 . . . . 0.0 112.214 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.87 -57.42 12.12 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.832 . . . . 0.0 112.269 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.89 -49.15 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 118.51 -0.757 . . . . 0.0 111.771 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -49.7 -55.82 12.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.86 0.864 . . . . 0.0 113.255 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -63.67 -48.68 76.18 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.816 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 23.4 mt -61.56 -38.3 86.97 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 178.208 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 10.4 t -65.14 -42.1 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.537 0.735 . . . . 0.0 111.167 174.109 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -60.78 -45.69 93.36 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 118.283 -0.865 . . . . 0.0 112.968 173.093 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.2 mt -52.34 -52.59 52.41 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.574 0.75 . . . . 0.0 112.79 170.779 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.0 mtt -60.09 -33.6 72.32 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.42 -36.1 60.87 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.59 -21.08 28.66 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.3 mt -107.04 145.64 32.11 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.599 1.96 . . . . 0.0 107.97 169.713 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.1 tmm? . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -125.12 131.18 53.31 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 125.093 1.495 . . . . 0.0 110.345 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -135.11 128.27 31.85 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.61 1.194 . . . . 0.0 113.527 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -125.71 127.77 46.74 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 124.823 1.327 . . . . 0.0 112.126 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 8.2 tt0 -84.57 135.89 34.02 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.563 -1.653 . . . . 0.0 112.385 176.91 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.93 142.42 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.173 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.01 136.7 45.22 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.235 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.0 mm -105.93 139.09 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.059 -177.006 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -103.27 -37.51 7.64 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.777 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -48.88 124.49 12.78 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.206 1.002 . . . . 0.0 112.629 -179.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_exo -56.27 -52.03 8.08 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.942 3.095 . . . . 0.0 112.936 -175.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -63.53 -42.61 98.43 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.846 1.258 . . . . 0.0 113.241 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.98 -158.57 51.27 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.013 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.09 80.36 9.2 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 113.404 -1.398 . . . . 0.0 111.465 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -75.92 -169.05 1.0 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.721 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -37.44 -52.42 1.14 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.472 2.309 . . . . 0.0 113.24 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.252 44.5 ttt180 -69.95 -50.84 15.96 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-O 115.881 -2.009 . . . . 0.0 114.537 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 80.1 Cg_exo -63.88 -42.72 18.49 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.64 2.227 . . . . 0.0 113.188 170.13 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.31 -45.29 80.34 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 177.624 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.96 -41.65 68.05 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -70.73 -47.98 56.89 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.246 0.618 . . . . 0.0 111.12 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -57.52 -40.09 77.99 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.131 0.972 . . . . 0.0 113.342 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 98.1 t -56.56 -53.86 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 124.059 0.944 . . . . 0.0 110.71 171.703 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -56.73 -46.35 81.37 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.23 -48.95 79.14 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.18 0.925 . . . . 0.0 112.345 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.28 -40.52 74.4 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.183 0.993 . . . . 0.0 113.477 173.899 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -58.23 -36.34 73.02 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 173.507 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.92 -41.05 56.3 Favored Glycine 0 N--CA 1.483 1.773 0 O-C-N 124.87 1.356 . . . . 0.0 112.522 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -69.94 117.56 11.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.609 1.195 . . . . 0.0 112.41 175.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.5 p -49.11 -49.52 41.53 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.306 -1.77 . . . . 0.0 113.093 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 p -62.8 140.66 58.78 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.704 1.202 . . . . 0.0 113.817 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -77.09 93.17 3.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.619 -175.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 35.5 mm -68.73 84.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 112.788 -2.005 . . . . 0.0 111.276 179.313 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -82.9 115.93 21.98 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.004 -1.907 . . . . 0.0 107.797 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.22 99.84 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.1 m -88.33 99.04 11.95 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.696 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 t -101.45 109.91 21.82 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.605 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.296 37.6 p30 25.26 75.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.687 1.995 . . . . 0.0 115.953 -164.402 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.58 -26.5 4.06 Favored Glycine 0 CA--C 1.544 1.869 0 CA-C-N 112.055 -2.339 . . . . 0.0 115.182 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -84.69 87.98 7.33 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.713 1.244 . . . . 0.0 112.87 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -71.0 104.64 3.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.742 -2.026 . . . . 0.0 113.573 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.41 120.51 23.15 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.876 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 t -56.76 123.8 16.22 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.588 170.272 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.93 -30.56 70.29 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.805 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 82.2 mttt -62.82 -22.21 66.47 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.486 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.6 t -94.35 112.94 24.75 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.878 0.847 . . . . 0.0 108.93 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -46.22 -52.05 13.2 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.254 -1.794 . . . . 0.0 112.981 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -54.34 -46.2 72.85 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.018 -1.447 . . . . 0.0 113.637 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.0 mttt -63.41 -53.42 52.56 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.241 0.963 . . . . 0.0 113.209 -176.434 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.2 tp -64.71 -33.42 75.92 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.135 0.897 . . . . 0.0 113.187 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -63.99 -47.37 80.61 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.4 t -74.35 -19.13 60.56 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.1 tp -73.95 130.64 40.27 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.086 1.355 . . . . 0.0 111.346 177.28 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.39 102.06 1.33 Allowed Glycine 0 N--CA 1.482 1.762 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.823 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.0 mt -113.06 69.3 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.628 0.728 . . . . 0.0 112.818 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 t -145.79 179.88 7.15 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -61.08 138.7 58.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.343 1.057 . . . . 0.0 112.665 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.08 -52.7 3.55 Favored Glycine 0 N--CA 1.481 1.674 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.123 -172.637 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -72.53 97.38 2.1 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.08 1.352 . . . . 0.0 110.522 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.5 p -75.24 142.16 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.151 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.0 p -127.29 125.39 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -170.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -105.64 118.17 35.91 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.602 177.027 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mm -87.25 96.4 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -108.81 128.58 55.02 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 124.721 1.263 . . . . 0.0 111.65 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.25 127.35 35.52 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -118.44 130.9 56.23 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 168.049 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.88 -155.08 22.15 Favored Glycine 0 N--CA 1.483 1.782 0 O-C-N 124.29 0.994 . . . . 0.0 111.472 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.73 -65.9 0.61 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -66.16 14.91 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.0 pt-20 -42.34 -58.83 2.04 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -168.04 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -71.25 -47.22 58.4 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.712 -1.131 . . . . 0.0 114.044 -177.226 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -63.79 -45.54 89.24 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.469 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.26 -43.99 95.68 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.946 0.899 . . . . 0.0 112.086 177.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.8 t -58.34 -57.14 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 116.951 -1.5 . . . . 0.0 110.129 171.897 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -50.71 -49.6 57.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.479 0.712 . . . . 0.0 112.91 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -61.54 -52.21 65.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.364 1.066 . . . . 0.0 112.693 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.03 -27.29 60.87 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -54.94 -44.48 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.07 0.948 . . . . 0.0 110.388 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.81 -61.27 2.52 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.693 1.246 . . . . 0.0 111.12 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -51.13 -37.16 44.43 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 11.0 tpt -53.68 -38.58 64.33 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.054 0.942 . . . . 0.0 113.429 178.461 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.55 -16.53 28.64 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.73 -25.4 16.71 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 44.2 mt -74.31 125.61 28.84 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 N--CA 1.491 1.615 0 C-N-CA 125.303 1.441 . . . . 0.0 111.466 178.12 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tmm? . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -127.06 130.3 49.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.15 1.531 . . . . 0.0 108.145 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -134.74 153.54 51.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.227 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.2 mm-40 -141.76 144.16 33.85 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 126.353 2.283 . . . . 0.0 110.318 173.718 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -113.12 134.39 54.57 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.915 1.385 . . . . 0.0 111.316 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -125.17 124.8 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 111.724 -2.489 . . . . 0.0 113.237 -177.481 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -94.21 123.71 37.77 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 112.65 -2.068 . . . . 0.0 107.732 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.1 mm -95.64 106.22 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.17 -173.06 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.9 p -92.34 -20.87 20.64 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 113.101 -1.863 . . . . 0.0 113.218 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.65 130.82 93.93 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.995 1.318 . . . . 0.0 111.51 179.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -56.57 -34.12 94.54 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.945 3.097 . . . . 0.0 114.733 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -113.82 4.46 15.91 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 38.65 -117.06 0.6 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.874 2.178 . . . . 0.0 115.2 178.984 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.8 mp -109.53 74.01 0.87 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 123.643 1.687 . . . . 0.0 111.507 -177.736 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -75.37 -162.06 0.18 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 111.885 -2.416 . . . . 0.0 112.718 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.2 p -55.9 -44.49 78.28 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 52.2 ttt180 -66.93 -47.81 52.48 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-O 116.702 -1.618 . . . . 0.0 114.377 178.912 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 75.5 Cg_exo -68.16 -40.47 8.7 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.104 2.536 . . . . 0.0 113.571 173.324 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -44.7 72.13 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.11 -41.04 62.15 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 170.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.3 -45.89 68.49 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.258 0.623 . . . . 0.0 111.647 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -60.95 -49.87 75.7 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.07 1.348 . . . . 0.0 113.381 -171.374 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 8.0 p -53.76 -42.57 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.32 1.048 . . . . 0.0 113.492 173.678 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -62.72 -51.77 65.85 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.997 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -57.69 -49.68 75.72 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.412 1.07 . . . . 0.0 111.915 175.88 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.3 -40.17 70.77 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -55.46 -38.56 69.22 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.27 -28.83 73.77 Favored Glycine 0 N--CA 1.483 1.816 0 O-C-N 125.812 1.945 . . . . 0.0 114.786 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 77.1 m-85 -92.45 134.63 34.77 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.3 p -71.28 -42.97 68.07 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.503 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.6 m -44.15 136.4 3.9 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.243 1.817 . . . . 0.0 114.728 168.07 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.81 134.03 35.12 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.213 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.6 mm -111.18 101.14 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.076 -171.748 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.7 p -94.72 120.92 35.73 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.654 1.216 . . . . 0.0 111.927 170.722 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.6 t -97.83 91.7 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 110.901 -2.863 . . . . 0.0 105.846 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -83.59 84.07 7.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 111.987 -2.37 . . . . 0.0 111.057 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.1 t -74.83 90.95 2.39 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.418 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.322 6.7 p30 37.08 69.38 0.22 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 113.157 -1.838 . . . . 0.0 114.767 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 -46.55 2.31 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 112.175 -2.284 . . . . 0.0 114.147 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -76.43 96.75 4.11 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.3 p -83.8 119.31 24.68 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 112.659 -2.064 . . . . 0.0 115.44 -177.983 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -137.42 146.36 44.3 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.065 -1.425 . . . . 0.0 112.256 176.944 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.1 t -62.3 134.57 56.68 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -70.9 -41.31 71.45 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 125.686 1.866 . . . . 0.0 113.114 170.385 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -60.18 -38.35 82.96 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.097 1.359 . . . . 0.0 111.624 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.3 t -76.23 94.5 3.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.896 170.298 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 30.9 tp -51.93 -32.14 31.76 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.726 170.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 64.9 t80 -52.66 -64.23 0.89 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.755 1.222 . . . . 0.0 110.653 170.32 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 94.6 mttt -63.8 -47.36 81.17 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 178.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 23.2 tp -51.15 -46.34 61.98 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 174.743 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -74.27 -41.15 61.73 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 10.6 t -84.63 53.16 2.59 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 122.237 1.017 . . . . 0.0 112.102 174.304 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 17.5 tp -154.67 136.13 14.19 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.409 -172.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.59 108.37 2.46 Favored Glycine 0 N--CA 1.48 1.623 0 C-N-CA 125.275 1.417 . . . . 0.0 113.076 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 11.7 mt -127.68 35.09 4.55 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -177.924 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 t -119.31 178.37 4.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -57.13 139.56 52.1 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.42 -9.91 73.69 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 113.886 -1.506 . . . . 0.0 114.254 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.6 m -102.65 127.5 49.73 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.92 132.74 35.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.279 167.502 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 p -125.2 137.92 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.523 -175.212 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.57 126.5 54.5 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.291 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 51.0 mm -99.08 108.01 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.4 t -113.45 135.21 54.13 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 124.56 1.162 . . . . 0.0 112.137 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.11 146.72 41.02 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.751 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.1 138.62 49.62 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.818 -173.032 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.11 -146.82 18.36 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 114.577 0.591 . . . . 0.0 114.577 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.14 -48.7 53.53 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -169.429 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -107.43 31.63 5.27 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.214 -174.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -60.32 -48.23 82.64 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -171.692 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -70.2 -61.46 1.76 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.023 0.827 . . . . 0.0 112.232 176.082 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 64.5 tttt -49.07 -50.62 35.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.641 1.576 . . . . 0.0 114.256 -177.105 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.5 -55.09 38.11 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 85.4 t -67.9 -47.98 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.942 -174.593 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -45.08 -49.15 11.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.175 1.39 . . . . 0.0 112.747 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -66.91 -55.8 13.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.973 0.909 . . . . 0.0 113.168 173.462 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 97.7 mt -59.72 -28.91 67.74 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -177.296 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 32.5 t -74.09 -45.74 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.288 0.635 . . . . 0.0 112.346 173.703 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -52.61 -37.67 58.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 170.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 46.3 mt -56.83 -33.44 66.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 176.738 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -62.7 -24.48 67.68 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.32 -31.59 24.76 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.192 0.997 . . . . 0.0 113.115 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -91.42 -33.3 15.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 118.37 2.729 . . . . 0.0 118.37 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.5 142.19 30.22 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 C--O 1.263 1.779 0 C-N-CA 127.631 2.372 . . . . 0.0 107.537 172.439 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.9 tmm? . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -122.47 135.82 54.75 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.287 0.992 . . . . 0.0 112.749 -167.038 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -121.34 137.19 54.81 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.859 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -128.13 123.59 34.81 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -96.3 99.0 10.73 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.991 1.432 . . . . 0.0 112.144 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.7 126.17 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 113.539 -1.664 . . . . 0.0 110.408 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 m -83.92 116.83 22.98 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.053 165.03 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.81 125.79 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.874 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 p -117.1 -36.48 3.78 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.173 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.56 113.05 0.94 Allowed Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 125.947 1.699 . . . . 0.0 115.072 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -53.59 -33.03 66.9 Favored 'Trans proline' 0 N--CA 1.483 0.894 0 C-N-CA 124.481 3.454 . . . . 0.0 114.35 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -62.86 -27.24 69.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.82 161.96 11.31 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 123.988 0.804 . . . . 0.0 113.244 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 82.3 mt -79.89 78.04 6.52 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 122.871 1.319 . . . . 0.0 109.245 177.556 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . 0.476 ' HE2' ' C ' ' A' ' 85' ' ' GLU . 25.3 p80 -72.94 -153.65 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.218 -175.223 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 p -51.75 -59.54 4.19 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.205 1.002 . . . . 0.0 113.685 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -55.39 -49.16 94.1 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 115.978 -1.963 . . . . 0.0 114.84 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 78.3 Cg_exo -58.25 -52.05 6.42 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 122.33 2.02 . . . . 0.0 112.473 173.028 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.22 89.58 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.74 -47.73 84.96 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.059 0.944 . . . . 0.0 113.494 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -68.54 -36.82 79.35 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.777 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.8 t80 -64.42 -48.67 74.47 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.549 1.14 . . . . 0.0 112.568 178.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.72 -48.0 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -51.85 -45.0 63.87 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.81 1.244 . . . . 0.0 112.635 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.4 tp10 -75.61 -46.59 30.79 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.658 0.599 . . . . 0.0 112.172 179.772 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.05 -39.87 63.56 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.777 1.231 . . . . 0.0 114.262 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -63.18 -37.27 86.56 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.24 -33.08 73.64 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.053 1.311 . . . . 0.0 114.629 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -86.65 121.75 29.6 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.788 0.804 . . . . 0.0 110.809 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 p -58.18 -39.78 79.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.897 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -47.44 144.25 3.11 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 126.86 2.064 . . . . 0.0 113.496 166.73 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -94.68 122.06 36.9 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.529 1.157 . . . . 0.0 111.529 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 mm -108.63 106.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 112.324 -2.216 . . . . 0.0 106.949 -173.681 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.1 m -103.2 122.72 45.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.113 -176.202 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -101.67 103.84 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 113.534 -1.666 . . . . 0.0 107.01 -174.097 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -104.34 97.79 7.68 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.035 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.8 t -88.36 92.39 9.15 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.548 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.08 61.03 2.49 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 113.753 -1.567 . . . . 0.0 114.184 174.538 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.28 -63.37 0.41 Allowed Glycine 0 CA--C 1.543 1.801 0 CA-C-N 113.65 -1.614 . . . . 0.0 113.222 -168.59 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -68.62 111.02 4.53 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.394 1.093 . . . . 0.0 112.847 -170.6 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.1 p -106.62 117.82 35.06 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.413 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -117.74 143.58 46.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 112.197 -2.274 . . . . 0.0 110.275 173.133 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.8 t -73.96 134.21 43.11 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.12 0.486 . . . . 0.0 109.816 173.501 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.02 68.14 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.06 -0.53 4.59 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.2 t -127.17 111.58 14.15 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.92 1.288 . . . . 0.0 111.067 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.9 tp -59.07 -39.99 83.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.233 1.013 . . . . 0.0 111.552 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -55.53 -50.15 70.76 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.623 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 83.9 mttt -65.19 -45.29 85.43 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.649 0.779 . . . . 0.0 112.943 179.56 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 20.3 tp -63.82 -47.25 81.58 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 124.568 1.168 . . . . 0.0 113.486 178.571 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -70.56 -37.24 73.97 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -74.62 -11.62 60.24 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.1 tp -88.43 143.81 26.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.353 1.061 . . . . 0.0 109.335 -179.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.37 88.78 0.13 Allowed Glycine 0 N--CA 1.484 1.859 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.092 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 93.4 mt -122.35 74.33 1.17 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 123.813 1.768 . . . . 0.0 110.353 176.488 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 t -137.25 175.0 10.0 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.371 -1.741 . . . . 0.0 109.716 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -45.58 150.06 0.53 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.76 34.33 56.55 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 125.155 1.36 . . . . 0.0 115.261 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.3 m -120.99 141.3 50.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.276 11.8 p -111.22 116.4 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.731 0.776 . . . . 0.0 112.524 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.54 129.55 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 112.286 -2.233 . . . . 0.0 112.989 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -103.12 123.12 46.08 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.537 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.0 mm -97.17 94.05 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 113.402 -1.727 . . . . 0.0 108.037 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 12.5 t -88.62 132.52 34.52 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.097 -177.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.71 138.58 24.62 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 16.6 pt-20 -134.0 149.54 51.21 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.612 162.618 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.38 -165.09 24.81 Favored Glycine 0 CA--C 1.54 1.614 0 O-C-N 124.753 1.283 . . . . 0.0 111.429 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -50.81 -75.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.22 1.408 . . . . 0.0 113.184 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.69 74.78 1.54 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.052 0.941 . . . . 0.0 108.621 168.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.22 -64.73 0.82 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.82 -55.41 4.83 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -171.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -42.33 -53.19 4.27 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.371 -1.741 . . . . 0.0 113.717 172.281 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -37.94 78.85 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 t -65.78 -60.42 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -46.28 -47.55 18.23 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.513 1.525 . . . . 0.0 114.62 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -61.18 -51.15 70.22 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.322 1.049 . . . . 0.0 113.155 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 64.0 mt -69.15 -27.87 65.93 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 174.455 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.9 t -63.86 -34.63 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-O 118.957 -0.544 . . . . 0.0 110.738 170.492 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -62.18 -42.2 99.05 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 mp -57.55 -44.07 84.91 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.4 mtt -62.42 -18.9 62.79 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.6 -43.25 7.3 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -74.03 -39.36 63.6 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 15.3 mt -82.86 132.88 35.15 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -171.379 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.476 ' C ' ' HE2' ' A' ' 15' ' ' HIS . 40.0 mt-10 . . . . . 0 N--CA 1.487 1.388 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.203 169.661 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 7.3 mtm . . . . . 0 C--O 1.223 -0.342 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -107.6 109.18 20.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 125.395 1.685 . . . . 0.0 108.254 171.796 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -117.8 125.18 50.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.576 -170.273 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -138.73 129.93 26.97 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.189 -175.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -89.42 116.88 27.93 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.061 -175.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.07 119.86 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.749 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 m -86.17 112.45 21.34 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.732 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.05 122.05 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 114.684 -1.143 . . . . 0.0 110.083 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.4 p -107.23 -0.4 22.66 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.22 117.76 43.08 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.133 0.973 . . . . 0.0 111.723 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.0 Cg_exo -49.67 -41.94 44.36 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 124.75 3.634 . . . . 0.0 114.49 -174.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -57.77 -40.82 80.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.17 50.83 6.05 Favored Glycine 0 CA--C 1.55 2.252 0 O-C-N 123.757 0.661 . . . . 0.0 113.788 -169.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.8 mt 58.81 59.76 2.74 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 126.241 1.816 . . . . 0.0 115.03 175.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.254 28.1 p80 -41.27 -97.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 119.091 2.997 . . . . 0.0 119.091 -163.844 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.5 p -108.49 -64.9 1.18 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.842 0.857 . . . . 0.0 111.214 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.0 ttt180 -51.71 -51.97 65.09 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 125.988 1.715 . . . . 0.0 113.67 175.686 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_exo -64.96 -44.32 10.15 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.431 2.087 . . . . 0.0 113.407 179.485 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.65 -52.03 51.19 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 174.645 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.73 -45.96 92.25 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.655 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 55.1 mt-30 -61.59 -41.73 97.85 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 178.476 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.4 -53.23 60.6 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.09 0.869 . . . . 0.0 111.226 174.793 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.22 -43.42 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 123.663 0.785 . . . . 0.0 111.782 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -48.39 -56.24 8.68 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.57 0.748 . . . . 0.0 111.723 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.73 -40.83 72.54 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.88 -41.61 67.73 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.828 0.851 . . . . 0.0 113.281 172.521 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 69.8 mttt -70.04 -30.61 67.92 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 174.226 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.3 -29.44 74.9 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.911 1.243 . . . . 0.0 113.069 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -86.01 124.33 32.33 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.189 0.995 . . . . 0.0 112.557 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.45 ' HG1' ' CD ' ' A' ' 68' ' ' GLU . 17.0 p -65.65 -42.88 90.88 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.086 170.142 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.1 t -44.1 143.15 1.23 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.168 1.787 . . . . 0.0 112.228 162.753 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -95.27 136.26 35.83 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.056 0.932 . . . . 0.0 112.757 -173.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mm -115.28 101.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.213 -169.292 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.0 m -99.82 130.1 45.99 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.887 173.199 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 t -110.06 107.72 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 m -105.62 122.68 46.54 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.079 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 t -125.3 98.75 5.76 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.437 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 p30 32.47 85.97 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 112.007 -2.36 . . . . 0.0 116.251 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.56 -41.99 3.11 Favored Glycine 0 N--CA 1.478 1.484 0 CA-C-N 112.77 -2.013 . . . . 0.0 114.355 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -92.46 138.59 31.39 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.532 0.682 . . . . 0.0 112.248 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.0 p -116.9 135.62 53.58 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.549 1.14 . . . . 0.0 113.513 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -131.24 131.04 43.63 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.237 173.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 t -81.0 111.24 17.29 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.022 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.28 -26.21 64.75 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.324 -1.762 . . . . 0.0 114.631 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.9 mttt -61.69 -21.01 64.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.857 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 t -105.52 116.23 31.6 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.543 0.687 . . . . 0.0 110.809 167.533 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.8 tp -52.23 -46.31 65.65 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.386 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -50.95 -51.3 53.78 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.185 0.994 . . . . 0.0 112.359 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -63.31 -49.0 75.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 tp -54.08 -43.76 70.6 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.606 1.191 . . . . 0.0 112.468 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -65.16 -31.56 72.8 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 t -93.12 55.78 2.4 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 123.999 1.857 . . . . 0.0 112.142 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 8.5 tp -152.27 150.63 29.99 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.722 -175.361 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.14 76.62 2.13 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 124.231 0.92 . . . . 0.0 113.467 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.65 42.23 1.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.5 t -102.53 170.75 7.85 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.704 -1.589 . . . . 0.0 115.22 -158.674 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 11.9 pt20 -52.17 114.99 1.5 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.342 1.457 . . . . 0.0 113.831 176.77 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.93 -21.39 38.3 Favored Glycine 0 CA--C 1.543 1.802 0 CA-C-N 113.043 -1.89 . . . . 0.0 113.535 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.7 m -72.67 132.16 43.34 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.304 1.05 . . . . 0.0 112.86 -171.758 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.7 p -86.0 110.81 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 113.156 -1.838 . . . . 0.0 108.326 164.066 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.07 129.04 59.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.709 -1.587 . . . . 0.0 110.896 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -91.56 107.66 19.36 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.24 -174.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.18 100.7 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -99.55 100.56 11.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 112.163 -2.289 . . . . 0.0 109.323 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.06 126.69 52.68 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.332 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.4 pt-20 -127.22 138.91 53.21 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.125 176.441 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.02 -141.58 16.97 Favored Glycine 0 N--CA 1.48 1.608 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.659 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . 0.45 ' CD ' ' HG1' ' A' ' 30' ' ' THR . 51.0 mt-10 -46.13 -86.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -174.744 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -82.25 48.46 1.27 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 174.877 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.275 10.8 pt-20 -58.34 -37.27 74.82 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -177.946 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -69.66 -59.59 2.86 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.645 0.778 . . . . 0.0 112.813 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 56.3 tttt -56.66 -47.9 78.75 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.915 1.686 . . . . 0.0 114.168 -176.479 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.99 -41.76 62.41 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 16.9 t -66.28 -55.52 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 123.753 0.658 . . . . 0.0 110.893 -179.325 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -46.5 -49.63 18.18 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.319 1.448 . . . . 0.0 112.794 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -63.0 -50.63 69.97 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.619 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.6 mt -59.39 -37.96 79.3 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.09 -53.64 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.819 0.847 . . . . 0.0 111.173 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -61.13 -46.15 91.75 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.311 1.007 . . . . 0.0 111.733 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -53.66 -50.24 66.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.011 0.924 . . . . 0.0 111.73 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 32.5 mtp -58.17 -46.39 85.81 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.806 1.242 . . . . 0.0 112.903 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.28 -21.76 66.28 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.42 1.79 27.68 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.17 150.87 36.76 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -169.459 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 CA--C 1.545 0.784 0 CA-C-N 111.357 -2.656 . . . . 0.0 105.786 175.985 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.8 mtm . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -127.14 114.54 17.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.252 0.97 . . . . 0.0 111.76 -173.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -123.53 121.57 35.99 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.59 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.01 158.8 31.26 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 113.787 -1.551 . . . . 0.0 112.053 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -104.25 122.22 44.94 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.563 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.43 129.44 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.749 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m -96.38 126.61 41.7 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.105 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.3 mm -76.26 108.46 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -99.94 -16.61 17.91 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.06 120.0 30.96 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.457 1.103 . . . . 0.0 112.891 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -63.5 -45.63 11.15 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.696 2.931 . . . . 0.0 113.914 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -71.53 -36.0 70.88 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.379 0.424 . . . . 0.0 112.14 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.05 179.98 18.02 Favored Glycine 0 N--CA 1.477 1.428 0 O-C-N 124.506 1.129 . . . . 0.0 110.706 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 85.5 mt -99.84 85.11 3.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.593 1.187 . . . . 0.0 110.88 175.659 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.74 -148.41 0.23 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 113.352 -1.749 . . . . 0.0 114.693 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 p -57.57 -55.92 28.64 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -168.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -57.14 -49.13 95.72 Favored Pre-proline 0 CA--C 1.557 1.235 0 CA-C-O 116.927 -1.511 . . . . 0.0 112.568 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -57.92 -50.3 10.64 Favored 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 122.909 2.406 . . . . 0.0 113.903 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.61 -49.33 75.27 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 118.046 -0.978 . . . . 0.0 112.616 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.78 76.94 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.117 0.967 . . . . 0.0 113.274 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -61.71 -51.31 68.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.972 0.909 . . . . 0.0 113.305 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -50.89 71.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.362 1.465 . . . . 0.0 111.832 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.71 -45.81 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.449 1.099 . . . . 0.0 111.616 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -55.73 -47.29 77.16 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.881 0.738 . . . . 0.0 111.408 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.7 tp10 -69.25 -44.57 71.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 178.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.44 -39.79 73.71 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 48.7 mmtt -71.23 -38.79 71.96 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 172.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 -42.95 97.15 Favored Glycine 0 N--CA 1.479 1.512 0 O-C-N 125.294 1.621 . . . . 0.0 112.823 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -73.02 135.54 44.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.864 0.866 . . . . 0.0 110.124 168.99 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.8 p -67.61 -41.55 83.83 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.87 123.36 2.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.074 1.749 . . . . 0.0 115.099 172.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.9 tp10 -81.74 132.0 35.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.908 0.861 . . . . 0.0 111.316 -177.495 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 mm -121.51 110.31 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 113.917 -1.492 . . . . 0.0 111.529 -168.128 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.2 m -102.07 117.6 35.14 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.156 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.5 t -108.72 96.17 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 113.372 -1.74 . . . . 0.0 106.395 -174.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -106.99 109.27 21.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.054 -168.818 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 t -106.5 109.2 21.06 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.766 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 p30 45.88 60.67 3.03 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.376 -1.738 . . . . 0.0 114.688 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.99 -28.87 2.16 Favored Glycine 0 N--CA 1.485 1.919 0 CA-C-N 114.29 -1.323 . . . . 0.0 114.877 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -75.21 105.55 6.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 122.101 0.953 . . . . 0.0 111.1 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.6 p -93.31 114.14 26.51 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.84 148.41 26.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 112.625 -2.079 . . . . 0.0 109.879 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.5 t -103.36 118.46 36.82 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.02 -29.14 56.75 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 125.241 1.588 . . . . 0.0 113.222 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 43.7 mmtt -63.03 -24.34 67.87 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.145 1.378 . . . . 0.0 114.251 179.071 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 t -115.49 117.05 29.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.815 0.446 . . . . 0.0 110.866 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 tp -49.98 -52.7 31.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.116 1.367 . . . . 0.0 112.719 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.08 -36.48 77.46 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.402 1.081 . . . . 0.0 112.745 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -77.59 -44.12 29.44 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.549 0.531 . . . . 0.0 112.047 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.2 tp -62.33 -39.61 93.65 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.636 0.774 . . . . 0.0 112.594 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -60.21 -37.0 78.95 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 t -90.38 59.68 4.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 123.538 1.637 . . . . 0.0 112.025 175.716 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -144.14 153.01 41.69 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.757 -2.02 . . . . 0.0 109.579 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.12 79.68 0.05 OUTLIER Glycine 0 N--CA 1.485 1.916 0 C-N-CA 124.604 1.097 . . . . 0.0 112.844 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 73.5 mt -100.13 42.56 1.1 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.222 1.01 . . . . 0.0 111.98 173.842 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -113.26 156.89 22.52 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 113.352 -1.749 . . . . 0.0 112.179 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -48.98 108.09 0.17 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.558 1.543 . . . . 0.0 114.2 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.02 -23.19 11.71 Favored Glycine 0 CA--C 1.548 2.125 0 CA-C-N 113.277 -1.783 . . . . 0.0 115.495 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -73.42 127.03 31.56 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 117.638 0.719 . . . . 0.0 112.358 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.65 140.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 121.837 0.827 . . . . 0.0 111.803 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.74 131.38 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.985 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.71 109.18 15.88 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.489 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.7 mm -91.43 96.69 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -104.58 113.73 27.5 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.74 1.275 . . . . 0.0 112.054 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.12 131.29 55.89 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.372 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.15 152.59 39.76 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.5 173.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.33 -152.35 19.21 Favored Glycine 0 N--CA 1.48 1.605 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.532 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -42.75 -61.88 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 -173.668 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -104.79 40.56 1.47 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.353 0.661 . . . . 0.0 112.315 -174.371 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -47.77 -48.48 30.08 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -75.05 -48.73 22.52 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.81 -39.35 77.4 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.117 1.367 . . . . 0.0 112.85 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.95 -61.22 2.43 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.918 173.687 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 29.2 t -64.53 -41.69 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 118.384 -0.817 . . . . 0.0 111.216 -176.738 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -51.2 -61.15 2.41 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.133 0.973 . . . . 0.0 112.375 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 67.1 t60 -69.44 -30.52 68.46 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 179.758 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.2 -34.95 79.19 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.06 1.134 . . . . 0.0 114.06 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 63.0 t -65.82 -46.66 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 119.002 -0.523 . . . . 0.0 109.717 169.815 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -51.34 -49.59 61.1 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.042 0.937 . . . . 0.0 111.574 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mt -50.42 -62.11 1.78 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.631 1.173 . . . . 0.0 113.533 171.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 69.0 mtm -57.03 -36.04 70.01 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.97 -32.38 67.2 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -79.59 -17.96 52.7 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.2 mt -85.67 126.38 33.89 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.713 0.805 . . . . 0.0 111.175 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.249 1.026 0 C-N-CA 125.296 1.438 . . . . 0.0 108.173 178.715 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -130.39 116.76 18.72 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.849 1.343 . . . . 0.0 111.391 -176.597 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -123.72 140.93 52.5 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -135.71 139.84 43.97 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 125.089 1.493 . . . . 0.0 113.303 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -84.98 120.01 26.03 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.633 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 66.2 t -126.21 121.5 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.43 -177.291 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -83.51 129.71 34.98 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.108 0.956 . . . . 0.0 110.619 170.747 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.8 mm -107.79 117.89 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 21.9 p -111.45 -2.14 15.65 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 179.78 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.08 121.1 69.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 124.071 0.948 . . . . 0.0 111.947 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -57.78 -44.56 39.78 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 C-N-CA 123.403 2.735 . . . . 0.0 114.018 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -68.88 -34.73 75.91 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.87 -170.18 54.87 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.535 1.54 . . . . 0.0 114.56 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -79.58 74.35 6.24 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 123.24 1.495 . . . . 0.0 113.474 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -102.08 169.98 8.4 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.329 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.9 p 38.9 -104.48 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.507 1.923 . . . . 0.0 115.658 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -78.0 -44.26 2.29 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 115.553 -2.165 . . . . 0.0 112.948 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 15.8 Cg_exo -48.95 -46.88 23.44 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.621 2.214 . . . . 0.0 113.908 168.212 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.83 -54.8 40.71 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.251 0.621 . . . . 0.0 112.531 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.78 -40.85 69.86 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -57.07 -53.63 55.94 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.861 0.865 . . . . 0.0 113.126 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -61.18 -47.76 84.68 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.733 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 83.0 t -57.49 -52.04 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.504 1.122 . . . . 0.0 112.048 176.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -60.44 -47.57 85.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.222 0.609 . . . . 0.0 111.742 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.62 -43.02 99.86 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 124.097 0.873 . . . . 0.0 112.55 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -60.78 -43.01 98.6 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 171.604 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -61.16 -23.67 65.73 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.38 -30.66 49.02 Favored Glycine 0 CA--C 1.548 2.107 0 C-N-CA 124.535 1.064 . . . . 0.0 114.041 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -87.79 124.7 33.88 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 122.109 0.957 . . . . 0.0 112.578 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.6 p -71.36 -4.31 25.46 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 m -93.19 145.39 24.46 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.603 1.161 . . . . 0.0 108.6 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.55 131.16 34.24 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.5 0.667 . . . . 0.0 112.492 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.5 mm -120.89 118.48 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 112.976 -1.92 . . . . 0.0 108.834 -168.736 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 20.2 m -113.53 123.25 49.56 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 112.148 -2.297 . . . . 0.0 110.689 -173.472 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.9 t -99.0 90.45 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 113.52 -1.673 . . . . 0.0 106.49 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.8 m -97.52 112.89 24.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.066 -1.424 . . . . 0.0 112.516 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.3 t -111.49 98.0 7.14 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.184 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 p30 39.35 64.84 0.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 114.043 -1.435 . . . . 0.0 114.822 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.51 -49.9 2.93 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.432 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.02 112.89 2.79 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.295 1.038 . . . . 0.0 111.711 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.2 p -106.99 104.76 14.51 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.903 -1.499 . . . . 0.0 114.214 -171.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.2 144.02 25.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.414 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.9 t -80.04 124.93 29.16 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.647 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.5 -26.42 63.44 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 125.009 1.443 . . . . 0.0 114.515 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 92.2 mttt -83.04 27.47 0.55 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -169.734 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.5 t -145.2 118.27 8.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.777 1.231 . . . . 0.0 113.004 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.7 tp -56.74 -47.01 81.0 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.736 -1.574 . . . . 0.0 112.062 177.07 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -54.56 -51.54 64.93 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 117.961 -1.019 . . . . 0.0 112.07 171.392 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -58.34 -43.05 88.13 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.7 mp -63.89 -52.5 59.61 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 174.235 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -66.46 -27.81 68.1 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 t -79.26 -15.02 58.64 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -107.12 137.38 45.29 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.844 0.831 . . . . 0.0 109.415 -177.461 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.43 71.11 0.65 Allowed Glycine 0 CA--C 1.541 1.681 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.659 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.05 71.91 10.87 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.751 0.786 . . . . 0.0 110.181 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -128.93 -157.56 0.83 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -162.056 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -66.5 102.43 0.89 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.74 1.616 . . . . 0.0 114.806 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 86.64 39.85 7.49 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 112.84 -1.982 . . . . 0.0 112.328 176.947 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 m -105.72 114.73 29.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -95.19 112.03 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.397 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.6 112.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.212 -2.267 . . . . 0.0 111.838 -172.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -78.29 98.85 6.07 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.812 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 27.0 mm -76.35 107.89 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 113.747 -1.57 . . . . 0.0 108.126 176.348 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 23.1 t -101.35 138.47 38.33 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.851 -1.977 . . . . 0.0 111.671 -179.453 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.35 144.48 51.27 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.518 1.127 . . . . 0.0 112.832 174.748 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -143.38 140.18 30.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.148 167.774 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.98 -145.16 15.99 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 115.138 0.815 . . . . 0.0 115.138 173.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -55.44 -66.22 0.45 Allowed 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -169.352 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.25 23.07 10.57 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.777 1.231 . . . . 0.0 112.756 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -32.35 -59.46 0.3 Allowed 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 119.027 2.973 . . . . 0.0 119.027 -168.791 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -60.12 -54.67 43.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -58.77 -43.06 90.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.356 1.463 . . . . 0.0 111.953 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.01 -52.42 50.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.944 0.898 . . . . 0.0 112.658 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . 0.263 17.5 t -71.61 -39.09 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.588 176.385 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -50.31 -50.96 49.13 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.396 1.078 . . . . 0.0 111.923 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -59.18 -53.38 58.92 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.751 1.221 . . . . 0.0 111.63 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.3 mt -57.69 -35.43 70.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 74.2 t -67.03 -46.35 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.987 0.915 . . . . 0.0 110.831 176.858 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -58.53 -48.41 80.95 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.463 0.477 . . . . 0.0 111.006 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.9 tp -51.94 -51.08 59.49 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.979 1.312 . . . . 0.0 112.387 175.097 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.0 mtt -53.12 -27.57 21.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.77 -28.24 16.71 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.57 -23.17 63.51 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 52.6 mt -62.99 143.76 57.47 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.163 0.985 . . . . 0.0 113.649 -177.055 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 . . . . . 0 CA--C 1.557 1.228 0 C-N-CA 126.296 1.838 . . . . 0.0 108.734 -171.762 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -123.73 137.17 54.74 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.895 1.372 . . . . 0.0 111.352 -171.731 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -128.45 141.52 51.37 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 125.376 1.673 . . . . 0.0 112.115 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -132.26 123.32 26.7 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.821 167.367 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 11.9 tt0 -96.64 118.13 32.46 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.073 0.858 . . . . 0.0 110.817 174.34 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.5 m -118.13 134.0 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 112.81 -1.995 . . . . 0.0 113.246 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 m -89.64 86.75 6.79 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.404 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.6 mm -77.16 112.32 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.19 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 p -114.5 39.62 2.76 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 112.686 -2.052 . . . . 0.0 113.019 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -76.54 123.0 87.63 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.188 -172.648 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 98.9 Cg_exo -47.54 -47.14 18.71 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.89 3.727 . . . . 0.0 115.55 -173.295 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -102.56 -50.56 3.54 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 169.334 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.55 -157.1 15.28 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 124.575 1.172 . . . . 0.0 112.568 171.868 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.7 mp -93.13 75.72 4.66 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.83 1.3 . . . . 0.0 112.424 -178.839 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -97.21 -152.23 0.38 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.232 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.6 p -42.96 -71.58 0.08 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -163.663 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -74.16 -44.04 6.11 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-O 116.152 -1.88 . . . . 0.0 114.766 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.2 Cg_exo -56.51 -43.58 53.98 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.579 2.186 . . . . 0.0 113.911 173.929 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.94 88.7 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.982 0.513 . . . . 0.0 112.308 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 -41.97 79.21 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -58.91 -45.88 89.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.188 0.995 . . . . 0.0 113.071 173.379 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -62.35 -48.67 78.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.39 1.076 . . . . 0.0 112.121 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 91.2 t -57.63 -44.73 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.137 0.975 . . . . 0.0 111.962 175.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -54.17 -51.81 63.16 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.797 0.839 . . . . 0.0 111.125 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -69.67 -39.26 77.1 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -44.98 78.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.371 0.668 . . . . 0.0 112.117 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -61.46 -29.39 69.93 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.995 1.479 . . . . 0.0 114.995 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.6 -33.65 87.81 Favored Glycine 0 CA--C 1.544 1.882 0 C-N-CA 124.879 1.228 . . . . 0.0 113.126 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -85.67 139.39 31.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.027 0.931 . . . . 0.0 111.958 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 p -74.4 -45.99 43.21 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.052 172.105 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.3 m -53.43 144.14 17.54 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.127 1.371 . . . . 0.0 113.143 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -92.77 127.09 38.15 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.119 0.961 . . . . 0.0 112.999 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.2 mm -101.27 117.42 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.705 -178.385 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -102.22 119.21 38.44 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 112.049 -2.342 . . . . 0.0 108.632 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.16 99.47 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 113.792 -1.549 . . . . 0.0 107.036 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -113.85 113.76 25.34 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.606 -171.517 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.2 t -119.87 115.06 23.07 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.697 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.282 24.1 p30 35.57 69.92 0.16 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 112.697 -2.047 . . . . 0.0 115.935 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.77 -36.62 3.24 Favored Glycine 0 CA--C 1.545 1.959 0 CA-C-N 112.594 -2.094 . . . . 0.0 114.784 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -78.89 102.3 8.16 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.9 p -84.85 115.29 22.67 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.39 -1.732 . . . . 0.0 114.16 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.83 138.61 45.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.171 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.1 t -90.22 102.14 14.86 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.788 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -51.13 -40.2 57.96 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -176.675 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -63.54 -12.27 31.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 22.7 t -109.13 121.19 44.61 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 173.704 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -53.47 -46.0 69.77 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.042 1.463 . . . . 0.0 112.285 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -57.63 -53.55 56.92 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.809 172.228 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 96.6 mttt -67.28 -31.37 71.64 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -176.292 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 tp -67.55 -55.38 13.66 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.126 0.57 . . . . 0.0 111.732 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.15 -30.32 71.49 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.7 t -63.52 -16.58 61.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 173.028 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -96.52 129.21 43.93 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.51 88.1 0.43 Allowed Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.297 -176.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.24 90.73 4.94 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.188 0.518 . . . . 0.0 111.196 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -136.1 -145.99 0.23 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.772 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -88.35 115.12 25.63 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.18 40.67 2.39 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 112.614 -2.085 . . . . 0.0 113.617 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.6 m -115.58 104.95 12.23 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.8 p -85.46 105.12 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.46 123.89 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 111.582 -2.553 . . . . 0.0 113.077 -171.21 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 115.28 23.25 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 113.396 -1.729 . . . . 0.0 110.009 176.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.6 mm -98.39 103.93 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.3 t -116.31 130.56 56.84 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.097 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.24 141.15 49.18 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.87 130.01 46.31 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.181 -1.827 . . . . 0.0 113.218 169.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.27 -154.09 19.78 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 113.105 -1.861 . . . . 0.0 112.235 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -45.13 -71.25 0.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.253 1.821 . . . . 0.0 115.348 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -93.68 46.95 1.21 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.82 0.848 . . . . 0.0 112.414 -173.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -48.98 -60.6 2.63 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -62.55 -43.82 97.87 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -63.61 -52.46 60.78 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.126 0.97 . . . . 0.0 112.868 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -54.43 -40.5 68.39 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.221 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.43 -62.23 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.067 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -47.99 -53.07 17.34 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.106 1.763 . . . . 0.0 113.297 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -66.68 -41.16 88.56 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.1 mt -68.28 -36.17 78.98 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 172.665 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.39 -45.23 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.911 0.884 . . . . 0.0 110.204 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -52.34 -53.62 42.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.553 1.541 . . . . 0.0 111.018 173.12 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.5 tt -53.33 -55.84 21.52 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.204 1.002 . . . . 0.0 111.866 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.3 ttt -56.3 -48.64 76.25 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.013 1.325 . . . . 0.0 113.767 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.53 -29.12 68.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -99.18 14.65 28.68 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.7 mt -80.85 144.25 32.16 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 . . . . . 0 C--O 1.248 0.997 0 C-N-CA 127.378 2.271 . . . . 0.0 105.045 179.587 . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -124.48 142.5 51.28 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.623 1.202 . . . . 0.0 111.236 -179.361 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -139.46 142.92 37.35 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.666 -1.606 . . . . 0.0 114.527 -174.27 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -131.23 124.16 29.99 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 125.621 1.826 . . . . 0.0 110.888 168.277 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -98.05 128.21 44.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.155 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 m -128.29 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.128 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -88.29 103.2 15.58 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.523 174.221 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.73 102.73 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.03 176.904 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -116.02 13.64 15.92 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 112.259 -2.246 . . . . 0.0 116.063 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.74 134.12 81.84 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 168.721 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.57 -53.54 3.73 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 125.135 3.89 . . . . 0.0 115.293 -169.098 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.27 -39.36 10.1 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 172.629 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.02 -88.17 0.98 Allowed Glycine 0 N--CA 1.483 1.781 0 O-C-N 124.495 1.122 . . . . 0.0 112.385 171.664 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -112.43 73.46 0.82 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.867 1.318 . . . . 0.0 113.343 177.917 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -81.38 -165.04 0.86 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.928 169.075 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.8 p -53.31 -46.09 69.26 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -171.041 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.25 32.8 ttt180 -70.25 -54.8 8.74 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-O 116.689 -1.624 . . . . 0.0 114.274 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 98.0 Cg_exo -56.58 -38.22 95.94 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 122.343 2.029 . . . . 0.0 112.881 173.685 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.66 -56.05 25.89 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.65 -40.8 66.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 175.308 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.7 mt-30 -55.55 -58.47 7.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.516 1.127 . . . . 0.0 112.477 170.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -54.39 -49.4 69.98 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.73 1.269 . . . . 0.0 111.853 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.7 t -57.8 -53.39 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.084 1.353 . . . . 0.0 111.789 177.431 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -58.92 -48.84 80.05 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.033 0.833 . . . . 0.0 112.131 -177.994 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.61 -40.97 80.18 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.677 1.236 . . . . 0.0 112.696 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.34 -39.61 79.93 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 170.41 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 71.4 mttt -64.87 -32.01 73.51 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 175.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.46 -41.04 99.8 Favored Glycine 0 N--CA 1.487 2.092 0 O-C-N 124.587 1.179 . . . . 0.0 112.034 169.064 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -70.7 120.63 16.59 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.705 0.764 . . . . 0.0 112.799 174.543 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.8 p -62.26 -38.05 87.79 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.359 -1.292 . . . . 0.0 112.216 174.741 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.1 m -61.35 153.58 26.37 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 126.634 1.973 . . . . 0.0 111.352 175.168 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -96.52 137.08 36.13 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 122.086 0.946 . . . . 0.0 111.885 -175.352 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 13.7 mm -118.29 106.32 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.179 -166.224 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.2 m -99.25 134.48 42.05 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.436 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 47.3 t -119.66 110.57 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 113.582 -1.644 . . . . 0.0 107.338 177.879 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.7 m -115.53 119.87 37.61 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.718 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t -111.92 99.8 8.39 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.428 171.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 p30 36.38 85.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.94 -41.41 2.19 Favored Glycine 0 N--CA 1.484 1.887 0 CA-C-N 114.265 -1.334 . . . . 0.0 115.097 177.174 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.09 123.08 36.1 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.758 0.79 . . . . 0.0 111.619 177.419 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.0 p -113.08 153.44 28.16 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -173.973 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -114.99 152.93 31.56 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 111.987 -2.37 . . . . 0.0 112.55 -176.408 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.5 t -105.86 105.85 16.08 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.054 175.801 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.58 -32.87 72.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 125.245 1.59 . . . . 0.0 115.139 -170.414 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.3 mttt -71.32 19.09 0.06 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 176.054 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 t -145.16 126.15 14.53 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.958 0.903 . . . . 0.0 111.077 176.614 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.99 -53.18 56.53 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.238 0.961 . . . . 0.0 113.041 173.781 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -54.42 -60.27 3.56 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.625 0.77 . . . . 0.0 112.061 172.011 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 7.0 mttm -68.34 -17.88 64.36 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -173.11 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 27.8 tp -81.3 -65.8 0.97 Allowed 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.396 1.06 . . . . 0.0 111.667 164.888 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -63.45 -19.45 64.73 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -171.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.2 t -51.25 -29.27 13.96 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 168.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 9.4 mp -84.71 139.34 32.07 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.784 1.234 . . . . 0.0 110.499 171.378 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.48 75.23 1.99 Allowed Glycine 0 CA--C 1.541 1.667 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.419 177.757 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 7.3 mt -81.05 79.13 7.78 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.475 1.131 . . . . 0.0 109.459 176.142 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -129.83 -155.37 0.69 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.272 -1.785 . . . . 0.0 110.942 -165.552 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -77.87 120.5 22.84 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.672 -0.643 . . . . 0.0 111.705 172.957 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.72 35.52 8.39 Favored Glycine 0 N--CA 1.487 2.073 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.419 -178.376 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 22.9 m -109.53 91.89 3.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.579 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -74.43 103.49 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.223 167.641 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.67 137.43 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-N 111.502 -2.59 . . . . 0.0 112.168 -173.16 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.57 128.68 45.68 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.073 -1.422 . . . . 0.0 110.262 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mm -101.6 108.36 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.655 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 m -113.54 128.39 56.42 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 125.845 1.966 . . . . 0.0 111.809 -176.765 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.06 122.68 44.84 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.641 177.044 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -114.85 136.82 52.67 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.24 175.233 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.05 -131.03 8.26 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.546 175.859 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.4 -66.77 0.58 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.064 1.346 . . . . 0.0 113.574 -172.047 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 73.9 m-20 -92.88 49.69 1.47 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.975 0.91 . . . . 0.0 111.763 -172.583 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -54.0 -45.24 71.42 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.173 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -68.78 -62.03 1.56 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.698 0.799 . . . . 0.0 111.359 173.742 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 62.6 tttm -48.15 -51.69 23.84 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.804 2.042 . . . . 0.0 113.656 -176.452 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.23 82.4 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.94 -53.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.17 178.835 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -48.48 -50.36 31.94 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.985 1.314 . . . . 0.0 112.508 176.343 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -65.15 -41.43 94.75 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.189 1.395 . . . . 0.0 113.279 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 11.3 mt -80.28 -24.47 40.01 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 177.684 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.91 -41.72 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 168.188 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -52.57 -50.64 62.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.64 1.176 . . . . 0.0 110.889 169.577 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.0 tt -53.6 -49.97 66.64 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.412 1.085 . . . . 0.0 113.01 171.974 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.4 mtt -64.05 -29.55 70.68 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 176.48 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.57 -51.3 24.13 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 174.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.1 60.37 4.86 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.462 1.105 . . . . 0.0 112.371 -174.469 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.3 mt -116.96 138.8 51.31 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.272 1.029 . . . . 0.0 113.75 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 C--O 1.245 0.832 0 C-N-CA 127.009 2.124 . . . . 0.0 106.803 -178.98 . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.416 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 18.5 ttt . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 . . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.18 142.13 50.16 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 125.829 1.956 . . . . 0.0 111.678 -177.625 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.97 151.53 49.11 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.77 1.293 . . . . 0.0 113.371 176.333 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -142.61 128.28 19.22 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.135 167.314 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -91.06 109.95 21.21 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.006 174.631 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 p -118.74 115.75 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.719 -174.176 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -68.53 114.66 7.13 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.481 177.525 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.73 100.05 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 122.285 1.041 . . . . 0.0 110.289 174.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -76.84 -22.44 53.54 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 112.144 -2.298 . . . . 0.0 115.191 172.07 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.84 118.25 24.93 Favored Pre-proline 0 C--O 1.245 0.839 0 C-N-CA 124.518 1.127 . . . . 0.0 110.924 177.986 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.8 Cg_exo -55.59 -53.31 5.86 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 124.194 3.263 . . . . 0.0 111.872 -172.282 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -62.8 -52.52 62.85 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.764 1.626 . . . . 0.0 112.531 170.82 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.91 -156.18 16.97 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 124.57 1.081 . . . . 0.0 111.558 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.7 OUTLIER -113.89 84.95 2.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.962 1.363 . . . . 0.0 110.086 -173.732 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -81.94 -165.8 1.08 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.996 -1.457 . . . . 0.0 113.991 178.508 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.0 p -53.38 -49.28 67.54 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -166.888 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.439 15.8 ptt-85 -65.36 -47.3 70.26 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-O 115.795 -2.05 . . . . 0.0 116.471 178.155 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_exo -65.84 -39.36 20.14 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.832 1.688 . . . . 0.0 113.209 169.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.22 79.76 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.783 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.39 86.01 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 172.901 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -56.68 -45.14 81.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.153 0.981 . . . . 0.0 112.558 174.121 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -56.99 -47.61 80.41 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.744 1.618 . . . . 0.0 111.897 175.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.0 t -65.33 -43.2 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 123.786 0.835 . . . . 0.0 112.522 175.544 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -58.37 -41.95 85.93 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.197 0.599 . . . . 0.0 111.34 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.55 -52.96 48.55 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 125.054 1.471 . . . . 0.0 111.868 169.668 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.81 -38.49 64.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -178.799 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -75.76 10.95 1.52 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 174.268 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.04 -17.57 40.09 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 124.572 1.17 . . . . 0.0 112.389 163.441 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -96.24 125.56 40.84 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.152 0.977 . . . . 0.0 108.973 179.325 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.4 p -62.4 -35.73 80.11 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.987 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.8 m -53.84 150.73 7.19 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.597 1.959 . . . . 0.0 114.973 176.834 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -80.83 89.77 5.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.719 173.675 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -73.94 98.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 109.822 -3.354 . . . . 0.0 114.288 175.903 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.8 m -104.01 128.58 51.59 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 112.261 -2.245 . . . . 0.0 109.512 -178.96 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.5 t -114.52 107.54 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 114.035 -1.439 . . . . 0.0 108.455 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 60.4 m -108.69 104.29 13.55 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.88 -176.908 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.6 p -90.37 54.64 2.81 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 113.797 -1.547 . . . . 0.0 113.548 -177.252 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.6 m120 48.89 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 123.672 1.701 . . . . 0.0 114.758 -174.854 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.91 -32.62 6.43 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 112.481 -2.145 . . . . 0.0 114.055 -178.998 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -111.58 132.93 54.2 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.373 0.669 . . . . 0.0 109.287 -177.301 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -123.13 134.84 54.18 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 122.183 0.992 . . . . 0.0 111.808 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -134.74 125.69 27.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 113.692 -1.595 . . . . 0.0 111.992 174.149 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.0 t -68.58 122.26 18.11 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.725 171.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.76 13.2 0.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.344 -1.298 . . . . 0.0 114.126 176.832 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -77.57 -7.72 56.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 169.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.4 t -133.46 133.66 42.57 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.377 1.071 . . . . 0.0 112.381 174.076 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -57.44 -53.25 60.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.116 1.366 . . . . 0.0 111.131 177.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -56.55 -34.41 67.04 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.107 -1.406 . . . . 0.0 114.559 176.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -58.57 -53.32 59.71 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 175.745 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.04 -32.88 61.66 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 176.941 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.94 -14.88 63.3 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.213 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 p -106.13 18.59 21.81 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 167.407 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.2 tp -114.81 120.89 41.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.366 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.53 70.51 1.93 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.393 -175.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 mt -75.9 94.55 3.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.898 176.327 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -142.33 -174.65 4.18 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -43.05 136.07 2.93 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.884 2.474 . . . . 0.0 113.83 -176.693 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.05 -32.16 3.57 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 113.481 -1.69 . . . . 0.0 115.71 175.555 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.2 p -59.37 120.2 8.86 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.981 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 4.9 t -90.34 77.4 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.599 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.87 113.37 14.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 112.518 -2.128 . . . . 0.0 112.692 -169.59 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -71.51 94.77 1.31 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.716 176.381 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.48 103.97 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 167.224 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -115.67 133.7 55.77 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 112.342 -2.208 . . . . 0.0 110.922 -176.558 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.65 120.06 25.85 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.27 0.981 . . . . 0.0 112.721 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 38.6 mt-10 -115.25 118.05 32.2 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.336 -1.756 . . . . 0.0 111.697 -178.568 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.25 -151.63 21.94 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.314 -178.932 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.52 -67.91 0.43 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -176.699 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -80.95 40.51 0.54 Allowed 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -178.92 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 7.5 pt-20 -46.7 -62.82 1.21 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.462 1.905 . . . . 0.0 115.569 -176.936 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 97.0 mt-30 -64.83 -40.63 95.49 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.676 1.19 . . . . 0.0 113.309 -178.984 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -59.71 -48.5 81.41 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.177 0.991 . . . . 0.0 111.158 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.68 67.84 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.212 0.945 . . . . 0.0 112.918 175.734 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.9 -53.86 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.289 0.636 . . . . 0.0 111.302 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -50.92 -50.8 56.81 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.01 1.324 . . . . 0.0 111.507 -178.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.95 -61.05 2.86 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.972 1.309 . . . . 0.0 111.61 177.933 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.63 -36.66 81.38 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -175.733 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.06 -47.72 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.342 0.657 . . . . 0.0 111.67 176.4 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -59.2 -50.08 75.41 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 123.709 0.631 . . . . 0.0 111.655 175.701 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.0 tp -52.27 -51.61 57.47 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.428 1.491 . . . . 0.0 112.426 175.578 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.4 tpp -52.2 -52.41 52.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.634 1.574 . . . . 0.0 113.002 173.968 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.16 -28.33 66.33 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.915 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.96 -20.13 24.86 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 178.645 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.6 mt -87.21 125.25 34.07 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.512 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--O 1.254 1.322 0 CA-C-N 113.13 -1.85 . . . . 0.0 106.25 179.352 . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 4.2 tmm? . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -141.07 140.05 34.15 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.539 1.149 . . . . 0.0 111.652 173.724 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -132.27 155.82 47.64 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.722 1.264 . . . . 0.0 113.775 176.405 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 7.3 tp-100 -141.65 125.46 17.02 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 124.563 1.165 . . . . 0.0 113.811 165.489 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -81.43 106.19 13.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.871 174.258 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.7 p -124.33 140.12 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.913 -177.416 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 p -99.94 129.01 45.97 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.129 178.072 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.86 122.38 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.429 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -77.96 -35.17 50.57 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 125.655 1.847 . . . . 0.0 114.472 176.94 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.79 123.4 81.47 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 124.472 1.109 . . . . 0.0 113.208 -174.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.86 -50.47 13.97 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.86 3.04 . . . . 0.0 112.022 174.169 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -62.29 -39.23 92.29 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 169.151 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.97 -136.04 12.64 Favored Glycine 0 N--CA 1.481 1.672 0 C-N-CA 124.342 0.973 . . . . 0.0 111.9 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 2.5 mp -115.53 75.14 0.92 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.16 0.981 . . . . 0.0 112.521 174.511 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -75.55 -153.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 113.388 -1.733 . . . . 0.0 111.773 174.793 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.1 p -57.75 -61.1 2.76 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -167.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.357 20.7 ptt-85 -68.9 -38.38 11.3 Favored Pre-proline 0 N--CA 1.48 1.062 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 59.5 Cg_endo -75.75 -37.08 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 CA-C-N 122.816 2.041 . . . . 0.0 113.747 173.225 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.41 98.87 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 169.61 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.81 -44.04 73.48 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 172.688 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -63.18 -47.14 83.86 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.569 0.543 . . . . 0.0 112.442 174.256 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 38.3 t80 -60.74 -47.74 84.93 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.894 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -51.83 -48.95 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.405 1.082 . . . . 0.0 111.765 175.626 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -54.48 -49.16 70.78 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.831 0.707 . . . . 0.0 111.414 179.328 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.07 -49.59 67.08 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.591 1.182 . . . . 0.0 110.959 -178.665 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.35 -42.05 77.13 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 175.003 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -58.44 -31.7 68.0 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.822 0.849 . . . . 0.0 112.615 176.365 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.74 5.55 74.27 Favored Glycine 0 CA--C 1.544 1.901 0 O-C-N 124.919 1.387 . . . . 0.0 115.369 -176.873 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -104.83 141.78 35.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.517 0.658 . . . . 0.0 110.212 169.318 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.525 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 0.0 OUTLIER -56.57 -45.19 81.43 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 119.002 -0.523 . . . . 0.0 111.588 176.596 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.5 m -52.88 136.61 34.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.129 1.772 . . . . 0.0 113.512 179.205 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.78 112.77 10.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 167.553 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.9 mt -104.02 120.37 54.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 112.838 -1.983 . . . . 0.0 108.88 -174.804 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.7 m -123.32 133.37 54.15 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 112.235 -2.257 . . . . 0.0 110.713 -176.672 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 21.9 t -118.11 108.15 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 110.929 -2.85 . . . . 0.0 107.15 -169.206 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.7 m -112.54 103.23 11.29 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 112.876 -1.966 . . . . 0.0 113.035 -175.23 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.2 p -90.6 89.47 7.55 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 112.991 -1.913 . . . . 0.0 111.53 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.6 m120 50.93 63.26 2.31 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 123.406 1.574 . . . . 0.0 114.047 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.69 -25.66 6.43 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-N 113.724 -1.58 . . . . 0.0 115.698 -176.551 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -84.5 121.02 27.0 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 177.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -111.19 139.32 46.67 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -172.35 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.99 145.31 29.69 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.634 166.844 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.0 t -71.26 119.43 15.39 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.999 171.535 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.78 -30.69 67.76 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.083 -1.872 . . . . 0.0 112.908 174.069 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -74.44 15.06 0.38 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 176.813 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.4 t -133.36 138.94 46.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.166 0.986 . . . . 0.0 111.572 170.909 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.8 tp -66.72 -62.36 1.49 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 111.713 -2.494 . . . . 0.0 110.188 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -50.27 -55.62 14.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.524 1.529 . . . . 0.0 111.224 176.609 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -58.56 -53.86 53.59 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.255 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.4 tp -64.79 -46.97 79.81 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -179.111 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -57.07 -37.79 72.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 174.772 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.7 p -86.19 -10.1 55.33 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.47 120.81 22.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.911 0.863 . . . . 0.0 108.869 164.401 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.94 89.3 0.24 Allowed Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.054 1.311 . . . . 0.0 113.558 -176.211 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 58.2 mt -106.0 103.88 13.47 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.571 -179.773 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -130.75 177.22 7.57 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.67 -1.15 . . . . 0.0 113.046 -177.606 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -43.18 120.9 1.98 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.483 1.913 . . . . 0.0 114.03 177.567 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.64 -14.1 14.47 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 117.796 1.878 . . . . 0.0 117.796 177.575 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.6 m -58.9 129.17 40.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.107 1.454 . . . . 0.0 111.278 -179.145 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.22 93.56 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 113.221 -1.809 . . . . 0.0 107.843 -174.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -100.1 111.85 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 113.028 -1.896 . . . . 0.0 112.794 -176.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 m -81.68 102.27 10.6 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.737 175.758 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.2 mt -87.36 103.3 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 172.127 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.2 t -115.58 146.24 41.94 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.813 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.43 132.79 44.6 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.685 1.24 . . . . 0.0 113.734 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -121.3 110.44 16.13 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 112.871 -1.968 . . . . 0.0 112.54 177.939 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.58 -124.84 1.28 Allowed Glycine 0 CA--C 1.536 1.403 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.85 171.936 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -103.17 -53.38 2.83 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.599 -1.3 . . . . 0.0 113.631 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.525 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 46.3 p30 -88.92 46.74 1.42 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 175.803 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.2 pt-20 -55.38 -63.64 1.1 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.352 -1.749 . . . . 0.0 115.485 -178.79 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -67.78 -43.32 80.03 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.41 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -52.43 -47.7 66.22 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.781 1.301 . . . . 0.0 112.157 173.457 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.97 -50.63 67.82 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.65 0.78 . . . . 0.0 112.931 177.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.46 -52.57 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.985 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -48.97 -54.52 15.24 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.329 1.452 . . . . 0.0 111.518 177.507 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -56.66 -46.39 81.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.347 1.459 . . . . 0.0 113.121 -178.914 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.53 -36.03 26.72 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -176.271 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 13.3 t -61.39 -41.33 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.438 0.695 . . . . 0.0 110.745 172.24 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -63.27 -50.04 71.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 172.869 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.6 tp -54.43 -51.9 63.47 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.738 0.649 . . . . 0.0 112.667 175.008 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -59.82 -36.69 77.31 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 176.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.43 89.93 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 174.148 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.04 -30.74 44.29 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.7 mt -64.61 124.43 21.86 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.504 0.722 . . . . 0.0 112.396 178.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 . . . . . 0 C--O 1.261 1.668 0 C-N-CA 125.468 1.507 . . . . 0.0 109.531 176.96 . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.439 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 15.1 tmm? . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -121.08 133.69 55.24 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.335 1.647 . . . . 0.0 107.677 175.13 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -134.9 136.96 42.75 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.803 -1.544 . . . . 0.0 112.667 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -125.85 116.11 21.04 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.844 175.919 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -81.14 100.39 9.04 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.122 -2.308 . . . . 0.0 108.499 175.099 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.6 140.18 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.486 -172.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -73.34 152.08 41.02 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 123.039 1.4 . . . . 0.0 113.242 173.279 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 mt -85.58 110.39 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 164.512 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -88.09 -21.61 24.61 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 112.823 -1.99 . . . . 0.0 115.376 -175.51 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 121.14 56.92 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.091 1.356 . . . . 0.0 112.598 174.524 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -60.34 -52.45 4.01 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.277 2.651 . . . . 0.0 115.509 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -67.61 -31.8 72.09 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.499 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.95 158.35 32.98 Favored Glycine 0 N--CA 1.481 1.674 0 O-C-N 124.525 1.141 . . . . 0.0 112.564 168.399 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.9 mp -78.73 72.44 5.25 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 122.622 1.201 . . . . 0.0 112.92 -175.551 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -67.19 -167.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.97 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 p -46.24 -48.86 17.78 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 -174.655 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.475 35.9 ptt180 -78.22 -39.44 1.74 Allowed Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 177.618 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 79.8 Cg_exo -59.51 -39.2 77.66 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 121.836 1.69 . . . . 0.0 112.055 169.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -61.46 -42.02 98.13 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 173.202 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.19 -44.15 97.24 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.194 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 56.6 tt0 -53.98 -49.76 68.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.057 1.343 . . . . 0.0 111.424 172.679 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -59.85 -36.14 76.23 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.126 -1.397 . . . . 0.0 114.054 175.501 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 97.1 t -64.25 -46.73 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.114 0.566 . . . . 0.0 111.902 179.256 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.52 -49.86 63.97 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.668 0.787 . . . . 0.0 109.78 177.003 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -60.35 -47.29 86.69 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.54 1.536 . . . . 0.0 113.611 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.44 94.03 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 176.225 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -63.5 -30.84 71.9 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.003 0.921 . . . . 0.0 112.587 174.4 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.0 -21.79 61.78 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.916 1.722 . . . . 0.0 115.081 175.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -95.2 155.18 16.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.944 0.898 . . . . 0.0 112.734 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.6 p -78.8 -46.32 19.01 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 117.642 -1.17 . . . . 0.0 112.128 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -54.83 139.13 40.93 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.835 1.254 . . . . 0.0 110.449 175.97 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -78.94 110.11 13.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.963 175.076 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.9 mp -84.61 121.92 37.38 Favored 'Isoleucine or valine' 0 C--O 1.248 0.996 0 CA-C-N 110.751 -2.932 . . . . 0.0 112.149 175.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.3 m -116.54 132.67 56.62 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-N 111.43 -2.623 . . . . 0.0 109.017 174.803 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 6.0 t -113.41 93.32 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.821 -1.99 . . . . 0.0 107.727 -176.945 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -87.81 94.79 9.86 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.596 -178.436 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 t -92.98 95.65 9.61 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.956 -176.299 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 12.7 m120 32.53 81.0 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.759 1.623 . . . . 0.0 114.811 -168.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.11 -49.29 4.2 Favored Glycine 0 N--CA 1.481 1.697 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.235 -174.673 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -67.27 102.12 1.02 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -177.445 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.0 m -91.61 100.36 13.1 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.377 -177.201 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -113.37 143.02 45.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.98 1.371 . . . . 0.0 111.81 174.677 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.4 t -61.58 121.23 12.24 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 112.802 -1.999 . . . . 0.0 111.374 175.049 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.83 -23.68 64.28 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.929 166.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -79.75 -17.68 52.91 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 176.538 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 t -107.95 120.54 42.58 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 177.768 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.2 mt -50.6 -62.84 1.36 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 112.872 -1.967 . . . . 0.0 113.875 -178.657 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -66.37 -13.0 59.97 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -177.087 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 68.7 mmtt -97.31 -37.25 10.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.367 178.992 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.0 tp -75.37 -43.64 49.24 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 170.713 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -58.02 -23.75 55.46 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 176.312 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.8 p -95.06 -14.1 24.58 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 177.634 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 25.2 tp -77.51 134.65 38.26 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.189 0.995 . . . . 0.0 111.833 -176.789 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.39 82.26 0.02 OUTLIER Glycine 0 N--CA 1.481 1.652 0 CA-C-N 113.824 -1.534 . . . . 0.0 112.731 169.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.5 mt -102.1 78.71 1.8 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.686 -1.257 . . . . 0.0 109.811 171.008 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 t -125.74 169.53 12.47 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -174.529 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -47.26 118.03 1.99 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.56 1.544 . . . . 0.0 112.671 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.59 -29.87 11.45 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 112.625 -2.079 . . . . 0.0 113.923 175.579 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 m -66.4 118.49 10.12 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.981 0.896 . . . . 0.0 111.208 -173.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 61.5 t -77.06 107.51 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 112.419 -2.173 . . . . 0.0 109.261 -178.198 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -107.86 118.86 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 113.353 -1.748 . . . . 0.0 111.409 -178.814 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 m -84.3 100.67 11.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.918 174.285 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mt -78.16 110.8 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.23 172.15 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.7 t -119.71 139.49 52.17 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.378 1.049 . . . . 0.0 112.089 -179.495 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.21 112.71 17.38 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 125.131 1.519 . . . . 0.0 110.93 175.917 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -109.01 101.24 10.34 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 112.574 -2.103 . . . . 0.0 110.26 -176.117 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.36 -159.03 24.67 Favored Glycine 0 N--CA 1.48 1.567 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.727 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -39.21 -84.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 -174.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -72.75 45.03 0.14 Allowed 'General case' 0 C--O 1.256 1.417 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.439 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 8.7 pt-20 -49.6 -61.17 2.26 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -177.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -65.78 -45.15 83.56 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.753 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -62.43 -40.49 96.72 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 113.897 -1.501 . . . . 0.0 113.166 178.386 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.23 -52.91 61.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.696 0.398 . . . . 0.0 111.964 -177.228 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 61.3 t -56.43 -61.46 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.419 175.663 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -42.6 -56.88 2.92 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.895 1.278 . . . . 0.0 113.077 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -53.91 -47.34 71.27 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.44 1.496 . . . . 0.0 113.675 177.827 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.1 mt -73.45 -30.65 63.33 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.075 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 12.3 t -64.2 -44.31 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.778 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -61.22 -42.9 99.4 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 176.144 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.28 -62.09 2.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.569 172.786 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 60.0 ttm -49.58 -46.9 49.58 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.96 1.304 . . . . 0.0 113.277 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.19 92.68 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -178.461 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.34 6.28 49.12 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 125.114 1.509 . . . . 0.0 114.711 -175.206 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.0 mt -98.86 137.93 36.72 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 172.301 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 . . . . . 0 C--O 1.255 1.349 0 C-N-CA 127.329 2.252 . . . . 0.0 107.63 173.915 . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' MET . . . . . 0.451 ' H1 ' ' CD ' ' A' ' 70' ' ' GLU . 10.0 tmm? . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 . . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -122.61 139.65 53.69 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.017 0.823 . . . . 0.0 111.491 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -123.95 147.22 47.91 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 113.942 -1.481 . . . . 0.0 111.377 178.877 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -137.55 134.22 35.39 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.539 1.15 . . . . 0.0 110.557 162.645 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -97.84 112.17 24.18 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.717 1.26 . . . . 0.0 108.813 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.36 151.83 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.169 -174.921 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.8 p -106.41 151.68 24.6 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 176.723 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 4.5 mp -81.09 119.91 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.76 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -99.21 -38.65 8.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 112.593 -2.094 . . . . 0.0 114.629 -174.796 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.16 126.13 14.9 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.916 1.286 . . . . 0.0 113.062 176.931 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 87.2 Cg_exo -49.69 -33.85 33.19 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 125.165 3.91 . . . . 0.0 115.035 -177.165 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.431 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 2.5 p30 -96.89 -70.63 0.71 Allowed 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.288 0.992 . . . . 0.0 111.539 171.733 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.42 -174.52 20.33 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 123.688 0.661 . . . . 0.0 113.397 173.367 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.68 73.53 1.51 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 122.79 1.281 . . . . 0.0 113.471 -179.02 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -73.99 -174.15 1.79 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.705 -1.588 . . . . 0.0 113.268 177.259 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -40.65 -48.37 2.91 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -171.844 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.265 48.0 mtm105 -82.97 -47.45 0.83 Allowed Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -175.346 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.23 -36.38 68.95 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 122.592 2.195 . . . . 0.0 113.795 168.746 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.61 91.85 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 171.211 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.5 -42.57 82.99 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 173.686 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -60.26 -49.72 76.5 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 172.99 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -57.01 -44.95 83.31 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.945 0.898 . . . . 0.0 112.068 177.588 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 92.4 t -56.41 -49.52 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.488 0.715 . . . . 0.0 111.67 174.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -51.16 -48.58 61.84 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.209 0.943 . . . . 0.0 112.493 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . 0.462 ' CD ' ' HE2' ' A' ' 76' ' ' HIS . 16.3 tp10 -64.58 -56.48 13.67 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.285 0.991 . . . . 0.0 112.078 175.938 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.74 -34.19 51.58 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -179.109 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 28.6 mtpp -55.18 -28.02 49.98 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 173.879 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.01 16.53 60.26 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 124.202 0.938 . . . . 0.0 115.405 -175.845 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -111.23 145.14 39.25 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.813 0.845 . . . . 0.0 109.318 169.58 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.4 p -63.81 -43.68 95.52 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.133 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.4 m -57.23 148.51 22.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.159 1.784 . . . . 0.0 112.588 176.483 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.73 104.35 14.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.837 1.304 . . . . 0.0 109.132 174.726 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.6 mp -78.58 110.12 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 111.363 -2.653 . . . . 0.0 111.186 -175.468 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.4 m -90.18 95.45 10.21 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 112.879 -1.964 . . . . 0.0 108.137 176.186 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.6 t -84.4 99.35 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 112.418 -2.174 . . . . 0.0 107.348 178.166 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -96.35 104.4 16.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.346 -176.509 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -105.79 100.88 10.42 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.302 -175.607 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.5 m120 37.61 81.01 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.532 1.933 . . . . 0.0 115.404 -169.648 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.35 -39.13 1.43 Allowed Glycine 0 CA--C 1.544 1.887 0 CA-C-N 113.212 -1.813 . . . . 0.0 114.953 -178.791 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -89.15 125.59 35.11 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.649 0.78 . . . . 0.0 111.674 -174.255 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -111.92 142.5 44.23 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -140.56 142.61 35.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.207 -1.36 . . . . 0.0 114.247 173.011 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -61.85 117.77 6.33 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.573 171.786 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.04 -16.44 43.56 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.621 174.651 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -91.77 5.17 50.86 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -176.317 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 38.3 t -127.72 128.39 45.31 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.95 0.9 . . . . 0.0 112.022 -178.966 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 67.7 mt -55.44 -59.85 4.24 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.276 -1.784 . . . . 0.0 111.989 175.858 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -53.16 -45.33 68.41 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.666 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.7 mmtt -62.9 -56.2 19.38 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.96 0.787 . . . . 0.0 112.989 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -70.65 -38.32 73.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -178.817 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -65.22 -11.73 43.89 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.583 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.4 p -119.44 9.78 11.68 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 173.893 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 43.5 tp -84.83 149.5 25.66 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.749 0.82 . . . . 0.0 109.145 176.538 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.78 68.23 0.3 Allowed Glycine 0 CA--C 1.543 1.792 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.556 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.6 mt -102.75 82.96 2.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.123 0.969 . . . . 0.0 111.43 178.039 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.5 t -132.33 164.29 26.77 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.152 -1.84 . . . . 0.0 110.126 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 4.1 tp-100 -48.97 136.41 14.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.326 1.05 . . . . 0.0 113.004 177.373 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.24 -28.13 5.83 Favored Glycine 0 N--CA 1.483 1.823 0 CA-C-N 113.93 -1.487 . . . . 0.0 115.203 175.604 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.8 m -55.53 142.75 32.07 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.151 0.98 . . . . 0.0 112.298 -178.714 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.22 127.01 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.592 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -121.25 116.08 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-O 122.828 1.299 . . . . 0.0 114.034 -178.411 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.78 104.38 16.1 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.431 170.591 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.3 mt -87.11 95.23 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.694 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.9 t -107.11 122.16 45.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.018 -177.218 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.89 110.21 19.31 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 178.042 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 36.5 mt-10 -91.37 122.02 33.61 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 113.038 -1.892 . . . . 0.0 110.573 169.123 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.42 -152.33 24.48 Favored Glycine 0 N--CA 1.475 1.269 0 O-C-N 124.737 1.273 . . . . 0.0 111.692 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -89.97 -60.78 1.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.186 1.394 . . . . 0.0 113.316 -174.927 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -77.58 38.06 0.24 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.837 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' CD ' ' H1 ' ' A' ' 1' ' ' MET . 6.8 pt-20 -48.06 -66.23 0.44 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.559 2.343 . . . . 0.0 114.918 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 57.3 mt-30 -56.25 -46.04 79.79 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.859 1.663 . . . . 0.0 113.374 177.898 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -61.74 -47.54 84.78 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.785 1.234 . . . . 0.0 111.776 -178.435 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.59 -50.82 71.88 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 124.23 0.956 . . . . 0.0 112.39 174.857 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.24 -51.02 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.632 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -48.25 -54.49 13.44 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.453 1.501 . . . . 0.0 112.466 178.785 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . 0.462 ' HE2' ' CD ' ' A' ' 25' ' ' GLU . 82.5 t60 -65.28 -51.67 59.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.191 177.798 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.35 -26.4 68.01 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -176.527 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.0 t -57.02 -45.5 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.724 0.81 . . . . 0.0 111.569 169.87 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -59.09 -52.77 64.32 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.353 1.033 . . . . 0.0 110.978 176.47 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.03 -47.75 74.33 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.698 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 60.9 tpp -52.84 -36.81 59.34 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 174.829 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.11 -28.64 25.44 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -107.84 22.91 15.27 Favored 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -171.262 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 mt -116.79 141.89 47.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--O 1.258 1.53 0 C-N-CA 128.103 2.561 . . . . 0.0 107.73 176.587 . . . . . . . . 0 0 . 1 . 026 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -136.74 141.9 43.03 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.882 1.364 . . . . 0.0 110.76 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -132.12 141.06 49.01 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.249 -179.271 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -133.89 125.0 27.39 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.159 0.912 . . . . 0.0 110.995 176.702 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.6 tt0 -74.09 111.6 9.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.654 172.502 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 95.9 t -128.98 140.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.818 -177.002 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 p -113.22 149.41 33.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.809 0.814 . . . . 0.0 111.313 171.438 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 mt -77.43 123.42 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.066 175.765 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -93.12 -36.0 12.89 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 177.871 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -77.12 133.94 68.26 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 176.15 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 85.8 Cg_exo -58.72 -49.54 11.44 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.859 3.04 . . . . 0.0 112.381 178.397 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.513 HD22 ' CD ' ' A' ' 85' ' ' GLU . 3.8 p-10 -68.82 -44.73 72.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.123 1.769 . . . . 0.0 112.961 171.236 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 67.42 -141.51 39.09 Favored Glycine 0 N--CA 1.475 1.283 0 O-C-N 124.54 1.15 . . . . 0.0 113.153 172.086 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 3.6 tp -92.66 57.92 2.99 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.806 1.288 . . . . 0.0 110.145 -175.278 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -70.99 -162.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.088 176.595 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -47.34 -61.02 2.1 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -167.288 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.407 10.5 ptt180 -64.8 -49.37 69.46 Favored Pre-proline 0 N--CA 1.481 1.115 0 CA-C-O 115.375 -2.25 . . . . 0.0 116.297 -179.735 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_exo -59.33 -42.72 46.69 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.063 2.509 . . . . 0.0 113.03 172.047 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.13 -43.42 74.14 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.746 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.96 87.61 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.779 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -60.88 -45.86 92.9 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.759 1.224 . . . . 0.0 112.005 175.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -57.99 -45.28 87.06 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.233 1.413 . . . . 0.0 112.777 176.153 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 89.0 t -55.43 -47.8 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.355 0.662 . . . . 0.0 111.752 176.407 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -56.99 -46.44 82.27 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.948 0.78 . . . . 0.0 111.933 177.715 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -63.71 -47.26 81.84 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 123.796 0.685 . . . . 0.0 112.332 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.43 74.68 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.338 1.055 . . . . 0.0 113.791 172.876 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -54.35 -33.74 59.68 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 172.33 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.23 25.09 7.29 Favored Glycine 0 N--CA 1.479 1.511 0 C-N-CA 124.518 1.056 . . . . 0.0 114.264 -177.257 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -125.08 145.43 49.93 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.823 1.249 . . . . 0.0 110.469 169.453 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.459 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 56.7 p -66.06 -43.59 86.98 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.76 178.474 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.6 m -54.99 151.16 9.2 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.82 1.648 . . . . 0.0 113.462 174.902 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.29 124.76 43.09 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.663 1.221 . . . . 0.0 109.302 164.151 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.11 99.11 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 111.206 -2.725 . . . . 0.0 109.204 -176.796 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 13.0 m -83.59 115.46 22.14 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 112.422 -2.172 . . . . 0.0 108.678 175.792 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.37 103.83 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 114.031 -1.44 . . . . 0.0 108.746 -177.072 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 m -103.67 103.89 13.86 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.477 -175.018 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.1 t -96.96 97.46 9.28 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.708 176.801 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m120 38.06 79.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.059 -1.882 . . . . 0.0 115.444 -171.541 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.37 -48.69 4.09 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 113.605 -1.634 . . . . 0.0 114.247 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -77.47 119.43 21.05 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.785 0.834 . . . . 0.0 111.198 -176.621 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.7 p -110.1 139.57 45.09 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -173.1 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -133.35 138.93 46.55 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.348 176.388 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.5 t -69.42 118.16 11.95 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.249 170.041 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -23.79 66.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.129 174.721 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -77.86 6.15 8.19 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 175.648 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.8 t -130.36 125.26 34.17 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.782 1.233 . . . . 0.0 112.361 178.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 49.3 mt -53.59 -56.96 12.68 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.992 -1.458 . . . . 0.0 112.221 176.704 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.48 -34.73 77.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.89 -177.511 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 54.7 mmtt -67.72 -56.61 8.6 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 118.972 -0.537 . . . . 0.0 112.181 175.474 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.78 -47.18 84.61 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.744 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.99 -23.34 66.56 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -178.79 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 p -87.89 -25.1 23.43 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 175.668 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.5 tp -74.89 130.63 39.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.075 0.94 . . . . 0.0 111.818 178.518 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.06 95.84 0.18 Allowed Glycine 0 CA--C 1.537 1.451 0 CA-C-N 114.113 -1.403 . . . . 0.0 113.35 177.495 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 mt -105.77 74.7 1.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.322 1.058 . . . . 0.0 111.881 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 t -136.1 142.22 44.28 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.697 -2.047 . . . . 0.0 112.029 -171.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.6 tp-100 2.32 128.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 119.24 3.052 . . . . 0.0 119.24 171.533 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.91 -29.67 0.92 Allowed Glycine 0 N--CA 1.481 1.669 0 CA-C-N 114.003 -1.453 . . . . 0.0 115.981 168.895 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.7 m -61.4 136.53 58.07 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.73 1.212 . . . . 0.0 111.026 -178.318 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.56 110.0 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.521 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.9 p -108.16 92.32 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 112.488 -2.142 . . . . 0.0 109.395 178.799 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 17.1 p -82.69 99.48 9.64 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.302 -177.844 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.8 mp -73.73 109.64 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 112.034 -2.348 . . . . 0.0 109.415 174.794 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.4 t -113.73 109.48 18.64 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.735 -2.03 . . . . 0.0 111.125 -177.479 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.64 123.24 47.82 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 122.408 1.099 . . . . 0.0 112.551 -178.901 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 39.6 tt0 -119.6 91.2 3.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.294 -177.873 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.08 -161.92 30.62 Favored Glycine 0 CA--C 1.548 2.116 0 CA-C-N 112.669 -2.059 . . . . 0.0 110.849 169.807 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.87 -51.18 58.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.459 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 11.8 p30 -79.63 36.81 0.33 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 176.621 . . . . . . . . 2 2 . 1 . 026 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 5.2 pt-20 -39.95 -68.47 0.17 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 128.988 2.915 . . . . 0.0 115.475 -177.879 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -60.02 -41.43 92.15 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.968 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -71.34 -38.69 71.64 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.012 -176.354 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.57 74.9 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.105 0.878 . . . . 0.0 112.741 170.189 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -74.0 -66.03 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.318 176.343 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -42.37 -53.08 4.36 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 126.13 1.772 . . . . 0.0 112.633 -174.028 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -65.25 -45.88 82.82 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.473 -178.503 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.3 -30.45 67.45 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.399 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 70.7 t -59.51 -41.62 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.32 0.648 . . . . 0.0 111.09 171.635 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.89 -53.31 59.42 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.788 0.68 . . . . 0.0 112.24 172.271 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mp -53.87 -44.61 70.56 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.674 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 52.0 tpp -55.9 -43.16 76.99 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.97 1.308 . . . . 0.0 113.669 173.712 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.41 -37.32 37.44 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 179.009 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -98.57 -27.08 14.18 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 119.084 2.994 . . . . 0.0 119.084 -169.945 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.1 mt -76.25 129.8 37.23 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.178 . . . . . . . . 1 1 . 1 . 026 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . 0.513 ' CD ' HD22 ' A' ' 12' ' ' ASN . 11.4 mt-10 . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 117.002 -1.475 . . . . 0.0 114.805 166.279 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 ttp . . . . . 0 C--O 1.237 0.444 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 . . . . . . . . . 0 0 . 1 . 027 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -109.04 120.93 44.0 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.848 1.343 . . . . 0.0 109.074 177.016 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -111.84 120.65 42.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.842 -176.954 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -121.96 122.96 40.56 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.735 177.727 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.45 123.98 32.27 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.608 1.192 . . . . 0.0 112.55 177.534 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 53.6 t -129.16 133.26 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.0 178.911 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.41 118.27 25.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.675 175.423 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.05 116.15 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 170.842 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p -124.24 16.67 9.1 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -178.863 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.68 134.34 39.98 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.255 175.4 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -49.27 -35.06 33.49 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.934 3.089 . . . . 0.0 115.996 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -92.63 -41.82 9.99 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 165.7 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.18 -133.83 48.66 Favored Glycine 0 N--CA 1.474 1.211 0 O-C-N 124.207 0.942 . . . . 0.0 111.564 -176.332 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.6 93.7 9.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.834 0.826 . . . . 0.0 111.132 -176.79 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -105.14 -147.79 0.4 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 113.693 -1.594 . . . . 0.0 113.059 174.025 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.2 p -57.24 -72.34 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.779 1.631 . . . . 0.0 114.785 -166.818 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.34 20.8 ptt180 -62.19 -33.83 13.47 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 176.397 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.5 Cg_exo -57.16 -47.35 23.02 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 122.356 2.037 . . . . 0.0 112.872 166.451 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.67 94.06 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 174.823 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.34 -46.99 69.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 173.742 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -62.7 -49.82 73.56 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.137 0.975 . . . . 0.0 112.174 174.165 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -54.57 -48.32 72.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.278 1.431 . . . . 0.0 111.987 178.953 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.5 t -59.39 -49.88 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 124.145 0.978 . . . . 0.0 112.249 176.492 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -53.23 -52.79 57.8 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 123.868 0.73 . . . . 0.0 110.829 178.826 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -72.33 -38.26 68.69 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 -178.441 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.85 82.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 173.254 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 36.9 mmtt -61.35 -21.17 63.77 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 173.33 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.63 4.16 81.92 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.665 1.126 . . . . 0.0 114.846 175.988 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -114.39 131.75 56.46 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.099 0.959 . . . . 0.0 108.478 171.822 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.4 p -64.48 -47.6 78.36 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.925 -175.523 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 m -46.2 130.34 10.34 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.422 2.289 . . . . 0.0 113.075 174.511 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.34 112.03 17.29 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.934 0.873 . . . . 0.0 109.385 176.597 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 2.1 mp -95.04 97.55 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 112.086 -2.324 . . . . 0.0 109.744 -171.155 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 5.1 m -84.4 104.99 14.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.437 178.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 5.2 t -87.38 92.81 3.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.0 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.8 m -97.55 92.12 5.77 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.578 -176.287 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.8 p -88.96 108.49 19.6 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.068 0.937 . . . . 0.0 111.24 178.411 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m120 36.33 70.77 0.15 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 112.514 -2.13 . . . . 0.0 114.545 -169.083 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.31 -28.24 3.85 Favored Glycine 0 N--CA 1.482 1.731 0 CA-C-N 113.884 -1.507 . . . . 0.0 116.161 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -88.57 111.26 21.66 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.1 p -96.92 124.18 40.82 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -170.979 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.58 140.52 48.29 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.199 -1.819 . . . . 0.0 111.152 171.188 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -72.4 127.73 33.46 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 120.897 0.379 . . . . 0.0 110.833 175.327 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.54 -20.75 22.1 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.733 -1.576 . . . . 0.0 115.07 176.789 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 79.6 mttt -85.01 -8.97 58.5 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.623 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 t -111.21 107.39 16.69 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.307 0.643 . . . . 0.0 112.29 -177.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.9 mt -38.7 -63.15 0.54 Allowed 'General case' 0 N--CA 1.483 1.181 0 O-C-N 125.697 1.873 . . . . 0.0 112.83 170.375 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -48.72 -55.03 12.57 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.746 1.218 . . . . 0.0 113.371 177.706 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 60.9 mttm -56.38 -53.61 55.32 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 178.919 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tp -62.33 -48.3 80.44 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.833 -178.439 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -61.89 -19.53 62.77 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 177.348 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.6 p -114.67 20.18 15.46 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.4 tp -115.76 135.09 54.36 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.05 0.94 . . . . 0.0 109.408 177.005 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.7 93.11 0.06 OUTLIER Glycine 0 N--CA 1.48 1.589 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.486 175.364 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.2 mt -121.7 49.3 1.56 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.717 -1.242 . . . . 0.0 113.18 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 t -118.71 -151.75 0.49 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.184 -170.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -46.14 135.19 7.87 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.057 2.143 . . . . 0.0 113.419 175.634 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.53 40.15 54.36 Favored Glycine 0 N--CA 1.483 1.784 0 CA-C-N 113.341 -1.754 . . . . 0.0 115.183 175.942 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.8 m -117.23 127.42 54.08 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.862 0.465 . . . . 0.0 109.973 -174.928 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.6 t -100.59 115.9 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.335 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.0 p -104.25 124.83 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.971 179.724 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -92.19 103.24 15.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.762 174.39 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mp -77.85 89.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.345 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 40.7 t -94.2 90.33 6.31 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.963 -177.057 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.03 114.58 26.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.481 -176.599 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.28 107.57 13.13 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.85 -158.61 31.18 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 114.337 -1.301 . . . . 0.0 113.092 173.35 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.63 -42.46 71.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -173.074 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 p30 -117.92 50.84 1.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -175.743 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.298 12.0 pt-20 -54.88 -50.16 69.41 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -172.44 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -67.99 -33.69 75.11 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.922 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.51 -45.83 92.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.927 1.291 . . . . 0.0 110.532 176.768 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.38 -47.81 84.04 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.251 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 38.4 t -58.88 -55.04 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 117.823 -1.084 . . . . 0.0 112.205 178.672 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -48.8 -51.77 27.57 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.575 1.172 . . . . 0.0 112.36 -177.131 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 34.4 t60 -72.45 -46.23 55.89 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -179.157 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . 0.258 76.4 mt -68.7 -26.63 65.38 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -176.878 . . . . . . . . 2 2 . 1 . 027 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 38.9 t -57.7 -52.71 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.132 0.973 . . . . 0.0 110.217 168.091 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 56.5 mtmt -51.04 -56.13 14.05 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.827 1.33 . . . . 0.0 112.751 178.734 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.7 mt -54.04 -59.16 5.01 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 174.957 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.4 tpp -52.03 -49.71 62.87 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.263 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.98 -33.37 70.36 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.356 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -107.76 18.6 21.16 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -171.601 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.4 mt -102.1 138.19 39.38 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 178.459 . . . . . . . . 1 1 . 1 . 027 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 127.995 2.518 . . . . 0.0 109.37 169.685 . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 . . . . . . . . . 0 0 . 1 . 028 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -142.81 138.89 30.7 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 125.798 1.936 . . . . 0.0 111.243 -171.024 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -137.41 133.26 34.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 178.004 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -128.3 150.51 50.03 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.901 1.281 . . . . 0.0 111.378 177.825 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -111.25 126.35 54.78 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.743 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 t -116.94 139.21 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.321 -177.502 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 4.0 p -97.24 110.27 22.86 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.396 1.093 . . . . 0.0 111.032 174.996 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 mt -88.94 85.8 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.542 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.8 p -103.63 48.57 0.85 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.138 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.46 131.5 23.95 Favored Pre-proline 0 N--CA 1.48 1.046 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.556 -178.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.96 -54.88 3.46 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.927 3.751 . . . . 0.0 116.441 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -90.83 -36.04 14.45 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 169.587 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.96 -136.76 38.09 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.383 0.992 . . . . 0.0 112.771 174.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.8 tp -92.42 80.06 4.93 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.492 1.139 . . . . 0.0 109.038 -176.722 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -90.94 -166.14 1.51 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 113.038 -1.892 . . . . 0.0 112.738 177.446 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.6 p -33.17 -75.18 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.528 2.331 . . . . 0.0 117.155 -174.786 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.383 22.4 ptt85 -69.13 -31.69 2.88 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 179.322 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.7 Cg_exo -60.81 -40.72 51.58 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.94 1.76 . . . . 0.0 112.626 165.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.32 -42.42 91.36 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.566 0.746 . . . . 0.0 112.958 173.254 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.03 -42.45 65.7 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 172.485 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -69.7 -43.94 71.42 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 175.165 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.61 -42.6 83.6 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.184 0.927 . . . . 0.0 112.119 175.238 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 60.6 t -59.73 -57.01 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 124.059 0.944 . . . . 0.0 110.395 173.05 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -48.27 -46.61 36.04 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 124.538 1.148 . . . . 0.0 112.4 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -68.85 -54.74 14.0 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 124.684 1.24 . . . . 0.0 112.754 179.059 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.53 66.61 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.577 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -53.87 -39.01 65.33 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 173.298 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.86 -37.01 93.64 Favored Glycine 0 N--CA 1.483 1.768 0 O-C-N 124.775 1.297 . . . . 0.0 113.632 -179.412 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.1 m-85 -76.82 140.08 40.56 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.529 0.731 . . . . 0.0 111.746 178.247 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.0 p -65.47 -47.22 76.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.353 -174.294 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 m -49.37 132.0 20.39 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.665 1.586 . . . . 0.0 112.531 178.239 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -73.74 131.56 41.72 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 119.003 -1.079 . . . . 0.0 109.427 170.759 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.9 mt -119.37 115.28 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.872 -164.275 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -103.75 133.47 48.7 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.262 -2.245 . . . . 0.0 108.845 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 t -116.19 94.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 113.66 -1.609 . . . . 0.0 106.857 177.699 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.4 m -94.56 84.13 4.24 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 112.375 -2.193 . . . . 0.0 109.481 -176.923 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.3 p -85.19 97.91 10.17 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.152 -177.976 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.0 m120 45.52 68.61 0.55 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 113.071 -1.877 . . . . 0.0 113.778 -169.651 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.49 -35.19 2.24 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 113.672 -1.604 . . . . 0.0 114.915 178.101 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -73.02 98.06 2.45 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.06 0.944 . . . . 0.0 111.205 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.6 p -84.91 124.82 32.07 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.744 -1.571 . . . . 0.0 114.683 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -132.95 156.63 46.94 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 112.585 -2.098 . . . . 0.0 109.961 167.08 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -80.23 124.7 29.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.481 0.658 . . . . 0.0 110.422 174.187 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.31 -36.62 73.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.237 173.75 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -77.85 13.67 1.3 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.751 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.6 t -135.12 110.42 9.0 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 44.9 tp -45.04 -74.52 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -54.36 -34.6 61.5 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -66.94 -45.19 78.57 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.6 tp -68.17 -42.03 80.6 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.432 1.082 . . . . 0.0 112.761 175.885 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -62.18 -36.33 81.54 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 175.152 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.9 p -88.89 15.79 7.92 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 175.898 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 18.0 tp -110.76 130.37 55.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.65 1.18 . . . . 0.0 108.065 177.005 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.34 86.54 0.33 Allowed Glycine 0 N--CA 1.485 1.916 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.061 -175.594 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.3 mt -106.92 62.2 0.63 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.938 1.351 . . . . 0.0 111.378 176.981 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 t -123.65 -164.71 1.25 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.006 -169.18 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -55.51 129.12 37.62 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.392 1.077 . . . . 0.0 112.56 179.343 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.3 38.66 93.9 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-N 113.215 -1.811 . . . . 0.0 115.084 -179.34 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 m -105.94 138.32 42.33 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.534 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 12.1 t -114.43 122.39 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 172.686 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.9 p -116.71 117.59 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -174.53 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 m -80.38 100.8 8.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 113.309 -1.768 . . . . 0.0 109.015 170.022 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 64.2 mt -92.6 111.33 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.525 176.848 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 t -109.08 131.55 54.96 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.668 -177.533 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.14 125.99 48.61 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.15 1.532 . . . . 0.0 111.971 172.921 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -118.3 89.55 3.15 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 177.224 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.1 -156.12 21.84 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-N 113.193 -1.821 . . . . 0.0 112.611 169.194 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -57.52 -53.82 53.81 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.922 1.289 . . . . 0.0 114.19 -177.552 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -81.88 46.14 0.97 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 177.543 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.412 ' CD ' HE22 ' A' ' 71' ' ' GLN . 4.4 pt-20 -55.25 -58.06 9.25 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -176.396 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.412 HE22 ' CD ' ' A' ' 70' ' ' GLU . 10.9 mp0 -64.67 -48.81 73.36 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 171.649 . . . . . . . . 2 2 . 1 . 028 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 77.9 tttt -54.75 -49.3 71.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.48 1.512 . . . . 0.0 113.062 -173.03 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.46 -52.6 64.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.775 0.83 . . . . 0.0 112.88 177.17 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.4 t -68.97 -49.16 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.887 -175.403 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -53.06 -50.93 63.34 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.56 1.144 . . . . 0.0 112.65 179.296 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -61.6 -45.76 92.74 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.942 0.897 . . . . 0.0 112.052 177.19 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.08 -38.49 90.91 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 177.026 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.4 t -59.06 -48.45 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.053 0.941 . . . . 0.0 110.295 173.845 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -56.48 -56.88 15.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.183 0.993 . . . . 0.0 111.199 172.794 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.71 -43.66 62.91 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.533 1.533 . . . . 0.0 113.501 -177.783 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.3 tpp -49.53 -47.87 48.62 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.121 1.368 . . . . 0.0 112.654 176.613 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.08 -24.73 65.99 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.39 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -100.32 23.49 10.07 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.511 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.3 mt -132.26 130.26 40.68 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.414 1.086 . . . . 0.0 113.834 178.31 . . . . . . . . 1 1 . 1 . 028 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.84 1.656 . . . . 0.0 107.121 176.114 . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 ttp . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 . . . . . . . . . 0 0 . 1 . 029 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -116.52 130.15 56.59 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 125.004 1.44 . . . . 0.0 109.449 177.038 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -124.19 131.26 53.52 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 112.061 -2.336 . . . . 0.0 110.452 -177.546 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -128.08 98.55 5.16 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 112.986 -1.915 . . . . 0.0 111.779 168.095 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.22 102.29 1.34 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.878 168.905 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.38 142.67 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.776 -1.556 . . . . 0.0 113.235 -179.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -87.75 126.91 35.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.079 -1.418 . . . . 0.0 111.767 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 49.1 mt -75.55 108.59 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.581 169.829 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -92.38 -16.37 26.05 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.353 -1.749 . . . . 0.0 115.419 178.056 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.49 126.06 88.69 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.755 176.389 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 89.2 Cg_exo -49.74 -54.2 5.83 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 124.445 3.43 . . . . 0.0 113.139 -175.272 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -66.55 -59.05 3.99 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.211 1.805 . . . . 0.0 112.087 170.184 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.57 -151.59 20.41 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 124.538 1.149 . . . . 0.0 111.86 176.907 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 11.5 tp -92.55 70.01 4.94 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.151 -1.524 . . . . 0.0 108.407 -175.482 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -78.32 -155.58 0.08 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.633 -1.621 . . . . 0.0 114.488 -177.115 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.8 p -43.28 -70.41 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.654 1.982 . . . . 0.0 114.805 -170.813 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.327 12.8 ptt180 -73.21 -32.46 1.68 Allowed Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 179.708 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.6 Cg_exo -58.09 -47.15 21.42 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.732 2.288 . . . . 0.0 113.636 167.698 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.16 83.56 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 175.479 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.66 -39.85 68.47 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 174.641 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -73.1 -42.14 63.29 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.819 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.1 t80 -54.76 -41.78 70.87 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 123.68 0.612 . . . . 0.0 111.512 174.079 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 48.1 t -57.14 -49.71 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.881 0.872 . . . . 0.0 111.61 174.771 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -52.81 -52.56 56.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.611 0.764 . . . . 0.0 111.378 178.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -67.67 -44.55 77.57 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 124.757 1.286 . . . . 0.0 112.862 -178.503 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.85 -41.9 78.75 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.766 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -56.63 -32.48 65.35 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 174.371 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.88 -13.76 66.86 Favored Glycine 0 CA--C 1.544 1.891 0 O-C-N 125.201 1.563 . . . . 0.0 115.192 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -101.84 138.47 38.76 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.161 0.505 . . . . 0.0 110.478 176.673 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.459 ' HG1' ' CG ' ' A' ' 69' ' ' ASP . 63.3 p -64.3 -41.26 96.95 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.448 -175.557 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -54.19 141.44 29.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.103 1.761 . . . . 0.0 112.319 174.781 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -86.19 106.33 17.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.064 0.935 . . . . 0.0 109.377 174.25 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 3.7 mp -85.66 93.16 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.322 -175.089 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.18 129.95 38.81 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 113.732 -1.577 . . . . 0.0 107.753 169.223 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 10.6 t -114.35 92.96 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.59 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.8 m -93.1 93.22 8.18 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 111.184 -2.734 . . . . 0.0 109.731 -175.141 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 99.4 p -101.29 100.26 10.75 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.32 -176.834 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.3 m120 45.33 70.93 0.31 Allowed 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.005 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.25 -31.02 1.85 Allowed Glycine 0 CA--C 1.546 2.011 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.156 -177.108 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -80.99 93.71 6.41 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.186 0.993 . . . . 0.0 113.564 -177.198 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 p -88.68 104.41 16.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 112.726 -2.034 . . . . 0.0 113.907 -179.474 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -129.43 134.68 47.96 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.7 175.369 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.3 t -67.4 127.57 33.17 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 122.272 1.034 . . . . 0.0 113.273 175.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.22 -30.96 71.46 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.414 174.01 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 59.2 mtpt -72.75 -0.64 13.81 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 178.883 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.8 t -121.69 129.07 52.49 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.349 0.595 . . . . 0.0 111.879 170.31 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 1.6 tp -57.92 -70.48 0.13 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 112.825 -1.989 . . . . 0.0 112.651 -173.072 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.56 -39.17 70.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -56.23 -48.91 75.55 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 172.292 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.3 tp -75.19 -41.62 57.53 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 175.644 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -56.13 -45.49 79.54 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.644 1.178 . . . . 0.0 113.1 177.815 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.7 p -75.22 -7.82 54.91 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 175.296 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 16.1 tp -86.37 118.72 25.99 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.175 0.988 . . . . 0.0 109.244 179.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.19 102.26 1.06 Allowed Glycine 0 N--CA 1.485 1.93 0 CA-C-N 113.237 -1.801 . . . . 0.0 113.081 -177.343 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 5.9 mt -116.42 96.5 5.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.221 1.008 . . . . 0.0 110.604 -175.484 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -140.29 171.24 14.44 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.086 0.954 . . . . 0.0 113.175 -165.155 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.7 tt0 -52.77 110.89 0.57 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.834 0.826 . . . . 0.0 111.828 174.085 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.38 -7.89 30.52 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 112.709 -2.041 . . . . 0.0 115.275 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -75.31 119.9 20.05 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.141 0.97 . . . . 0.0 111.665 -179.284 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.43 101.3 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 174.859 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -109.7 119.87 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.964 -174.557 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -89.63 103.04 15.72 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.535 175.261 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.0 mp -77.78 91.0 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 168.073 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -105.65 92.55 4.23 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 112.381 -2.191 . . . . 0.0 111.427 -171.33 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.41 111.04 23.28 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.188 -176.999 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.48 122.41 46.24 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.78 -154.91 22.89 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 113.025 -1.898 . . . . 0.0 111.126 -176.243 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -67.75 -63.92 0.96 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.356 1.463 . . . . 0.0 114.081 -171.547 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . 0.459 ' CG ' ' HG1' ' A' ' 30' ' ' THR . 12.3 p30 -80.22 40.04 0.47 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.079 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.39 -51.21 56.69 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.174 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -66.85 -54.33 23.5 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.053 0.941 . . . . 0.0 112.833 177.824 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -53.44 -42.57 67.25 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.386 1.475 . . . . 0.0 112.924 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.17 -54.96 40.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.6 0.76 . . . . 0.0 112.575 173.721 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.5 t -58.25 -51.2 74.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.348 178.089 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -48.2 -65.18 0.61 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.816 1.246 . . . . 0.0 113.173 -179.409 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -72.78 -27.87 62.26 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -176.444 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.4 mt -75.1 -41.78 57.92 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 174.486 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.05 -44.07 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 123.271 0.357 . . . . 0.0 110.477 174.68 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -49.01 -62.05 1.74 Allowed 'General case' 0 N--CA 1.479 1.021 0 O-C-N 125.159 1.537 . . . . 0.0 111.57 169.205 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.64 -46.66 73.97 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.733 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 24.4 ttp -50.9 -46.85 60.76 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.346 1.458 . . . . 0.0 113.045 178.525 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.65 76.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.461 1.1 . . . . 0.0 112.706 177.779 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.67 32.9 0.71 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.753 1.221 . . . . 0.0 114.088 -173.42 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 34.9 mt -132.36 99.28 4.63 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.568 1.175 . . . . 0.0 112.4 -179.327 . . . . . . . . 1 1 . 1 . 029 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--O 1.255 1.352 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.631 -169.976 . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.7 ttt . . . . . 0 C--O 1.239 0.535 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 . . . . . . . . . 0 0 . 1 . 030 nuclear orig full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -137.63 141.18 41.22 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 126.021 2.075 . . . . 0.0 111.386 -173.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -125.14 131.16 53.3 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 125.42 1.7 . . . . 0.0 109.475 174.753 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -126.12 136.43 52.87 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 125.518 1.761 . . . . 0.0 109.872 172.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -115.28 94.2 4.62 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 122.509 1.147 . . . . 0.0 114.058 -169.928 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.0 m -120.95 159.95 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 113.521 -1.672 . . . . 0.0 114.328 -173.126 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 75.2 p -107.61 155.5 20.07 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -179.349 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.4 mt -103.23 113.76 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 111.211 -2.722 . . . . 0.0 108.401 168.606 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.7 p -94.84 -30.87 13.98 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 112.269 -2.241 . . . . 0.0 116.659 175.214 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -59.8 135.76 89.9 Favored Pre-proline 0 N--CA 1.484 1.269 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.406 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_exo -50.13 -48.68 18.81 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.816 3.677 . . . . 0.0 115.415 -178.646 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . 0.285 0.4 OUTLIER -95.48 -16.88 21.91 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 170.96 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.88 -128.81 11.71 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.163 1.84 . . . . 0.0 115.576 178.277 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 81.0 mt -98.47 54.93 1.07 Allowed 'General case' 0 C--O 1.2 -1.515 0 CA-C-N 111.933 -2.133 . . . . 0.0 112.4 -171.926 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -68.66 -166.43 0.08 Allowed 'General case' 0 C--N 1.364 1.233 0 CA-C-N 112.031 -2.349 . . . . 0.0 113.217 174.914 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -54.46 -51.58 64.55 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -164.993 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.254 43.5 ttt85 -69.61 -50.33 18.93 Favored Pre-proline 0 N--CA 1.479 0.976 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 174.814 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 47.1 Cg_exo -57.35 -38.6 94.16 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.958 2.439 . . . . 0.0 113.613 173.09 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -68.14 -35.33 77.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 172.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.26 65.21 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 173.354 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -68.48 -39.79 81.23 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.149 0.98 . . . . 0.0 111.549 169.582 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.5 -47.45 83.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.853 0.861 . . . . 0.0 112.028 171.267 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 75.5 t -53.47 -56.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.601 1.16 . . . . 0.0 112.023 175.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.91 -61.44 0.85 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.577 1.151 . . . . 0.0 112.389 170.043 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.99 -34.39 77.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -176.156 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.8 -44.38 96.97 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.867 0.867 . . . . 0.0 112.104 176.476 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -56.73 -22.68 37.2 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 176.69 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.97 65.47 Favored Glycine 0 CA--C 1.542 1.728 0 O-C-N 124.741 1.275 . . . . 0.0 111.468 178.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -81.79 148.35 28.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.355 1.074 . . . . 0.0 112.84 -174.933 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.1 p -70.44 -35.26 73.26 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.274 -176.048 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.1 m -49.34 148.73 2.48 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.971 1.308 . . . . 0.0 113.457 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -91.98 104.19 16.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 160.098 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.5 OUTLIER -91.1 113.15 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 112.052 -2.34 . . . . 0.0 106.851 176.115 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 95.9 m -90.98 142.66 27.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.407 173.144 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 37.5 t -118.68 106.67 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 112.512 -2.131 . . . . 0.0 108.016 176.542 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.9 m -114.06 92.27 3.91 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 112.787 -2.006 . . . . 0.0 109.577 -176.467 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 p -87.58 89.15 7.89 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 122.816 1.293 . . . . 0.0 110.68 179.701 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.6 m120 46.41 74.96 0.13 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.012 -1.904 . . . . 0.0 112.276 -172.536 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.75 -22.56 2.23 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 113.125 -1.852 . . . . 0.0 116.544 -179.727 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -85.86 91.87 8.47 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.854 -0.792 . . . . 0.0 110.0 -177.709 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 28.1 p -101.78 127.99 48.32 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -169.109 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.82 144.81 31.33 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.065 -1.879 . . . . 0.0 110.94 177.604 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -55.33 130.44 42.43 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 168.486 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -53.77 -30.53 44.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.849 1.26 . . . . 0.0 111.581 172.371 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -74.0 -6.13 45.58 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -101.03 103.64 14.77 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -171.107 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 tp -49.06 -73.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -176.807 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -45.26 -48.6 12.81 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.16 1.384 . . . . 0.0 113.922 177.657 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 66.0 mmtt -52.33 -52.47 53.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 117.125 -1.417 . . . . 0.0 114.157 175.571 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 6.3 mp -71.98 -35.94 69.64 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -178.556 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.86 -31.08 72.04 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 175.014 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.9 p -84.78 -35.48 22.34 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 171.167 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 tp -67.61 122.92 19.07 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 111.174 -176.823 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.92 100.14 0.42 Allowed Glycine 0 CA--C 1.54 1.619 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.471 -177.446 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 mt -125.39 88.44 2.87 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.67 1.188 . . . . 0.0 110.293 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -143.49 -166.62 2.37 Favored 'General case' 0 C--O 1.199 -1.584 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.682 -175.396 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -56.28 118.31 4.62 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.774 1.23 . . . . 0.0 112.138 -178.399 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.58 -30.12 10.66 Favored Glycine 0 CA--C 1.544 1.863 0 CA-C-N 112.631 -2.077 . . . . 0.0 113.842 -178.697 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.04 137.68 55.24 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.874 1.27 . . . . 0.0 113.375 -174.335 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.5 t -116.77 114.38 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.333 -169.302 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 p -109.53 96.84 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 112.952 -1.931 . . . . 0.0 112.269 -166.704 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 30.6 m -72.07 101.75 2.82 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 111.614 -2.539 . . . . 0.0 108.6 173.425 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.5 mt -94.23 112.57 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 123.772 1.748 . . . . 0.0 110.507 -178.336 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.3 t -123.79 96.03 4.8 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 109.973 -3.285 . . . . 0.0 113.215 -159.514 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.17 117.7 34.68 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.229 -170.046 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -120.13 86.96 2.66 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -176.245 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.24 -164.48 30.46 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 112.34 -2.209 . . . . 0.0 110.048 171.114 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -34.82 73.59 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -179.658 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -104.55 43.39 1.1 Allowed 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 -176.187 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 70' ' ' GLU . . . . . 0.469 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -55.77 -63.12 1.28 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 -178.892 . . . . . . . . 3 3 . 1 . 030 nuclear orig full ' A' A ' 71' ' ' GLN . . . . . 0.469 ' H ' ' CD ' ' A' ' 70' ' ' GLU . 23.1 mt-30 -62.71 -44.97 94.86 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 173.419 . . . . . . . . 2 2 . 1 . 030 nuclear orig full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -49.08 -50.15 38.15 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.339 1.056 . . . . 0.0 113.124 173.63 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.42 -55.79 24.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.797 0.839 . . . . 0.0 112.394 -177.483 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 31.4 t -62.44 -37.16 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-O 117.759 -1.115 . . . . 0.0 111.992 -177.962 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.67 -46.78 86.45 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.478 0.487 . . . . 0.0 111.548 178.659 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -74.27 -32.03 62.77 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.149 -178.852 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 54.2 mt -74.85 -36.83 62.34 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 173.688 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.45 -38.7 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.525 173.347 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -48.21 -58.69 4.19 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.628 1.205 . . . . 0.0 110.521 163.597 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -58.41 -48.04 81.96 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 176.375 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 13.5 tmm? -52.08 -44.67 64.47 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.513 1.525 . . . . 0.0 112.35 174.442 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.27 -25.34 54.84 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.767 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -83.89 -22.05 31.74 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 178.977 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 36.0 mt -93.75 142.43 27.37 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 -172.586 . . . . . . . . 1 1 . 1 . 030 nuclear orig full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 CA--C 1.556 1.196 0 CA-C-N 111.514 -2.584 . . . . 0.0 109.513 -167.766 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 ttp . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -120.7 134.07 55.31 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 125.639 1.837 . . . . 0.0 108.797 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -128.64 153.61 47.1 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.634 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -142.55 121.98 13.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.113 168.39 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -87.72 97.37 10.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 123.199 1.476 . . . . 0.0 111.275 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.57 155.48 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 112.118 -2.31 . . . . 0.0 108.113 -171.145 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 p -120.09 154.76 34.21 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.303 0.573 . . . . 0.0 112.215 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.479 HD12 ' HB ' ' A' ' 59' ' ' THR . 65.3 mt -103.5 115.16 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.154 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 p -99.24 -0.47 41.31 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -94.87 139.83 22.29 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 110.638 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -55.5 -68.79 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.655 2.903 . . . . 0.0 114.229 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.72 -35.77 80.84 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.245 1.018 . . . . 0.0 113.23 167.605 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 74.44 -135.62 19.87 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 124.957 1.411 . . . . 0.0 111.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 1.8 tp -92.88 57.45 2.81 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 113.013 -1.594 . . . . 0.0 109.417 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -67.73 167.51 13.13 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.817 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.4 p 1.26 -68.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 118.687 2.847 . . . . 0.0 118.687 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.416 7.7 ptt-85 -85.18 -38.82 0.62 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 17.7 Cg_exo -54.91 -41.46 78.36 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.214 2.61 . . . . 0.0 113.436 159.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -57.22 -47.27 81.73 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 171.213 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.26 -44.38 79.64 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 24.4 mt-30 -63.32 -42.05 98.97 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.69 1.196 . . . . 0.0 113.728 174.246 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -62.62 -43.42 98.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.297 0.639 . . . . 0.0 112.119 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 19' ' ' ALA . 59.2 t -59.66 -48.16 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.56 0.744 . . . . 0.0 111.936 173.258 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 17.2 tttm -43.74 -55.02 4.69 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.29 0.994 . . . . 0.0 111.781 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -66.03 -46.85 76.38 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 124.227 0.955 . . . . 0.0 112.674 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.75 70.3 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.814 1.245 . . . . 0.0 114.063 175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -61.17 -29.78 70.0 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.33 19.29 23.95 Favored Glycine 0 N--CA 1.481 1.663 0 O-C-N 124.225 0.953 . . . . 0.0 114.787 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -129.92 143.29 50.73 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.323 1.049 . . . . 0.0 110.669 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.2 p -67.21 -41.46 85.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.987 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.8 m -52.32 144.63 12.52 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.591 1.556 . . . . 0.0 113.111 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -86.82 92.38 8.96 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.137 0.97 . . . . 0.0 109.654 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.514 HG21 HD13 ' A' ' 77' ' ' LEU . 3.9 mp -76.96 107.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 112.66 -2.063 . . . . 0.0 109.478 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.7 m -106.86 137.67 44.47 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.09 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.58 115.07 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 112.48 -2.146 . . . . 0.0 107.398 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.9 m -111.58 97.7 6.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.451 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.6 m -92.94 93.83 8.59 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.169 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m120 48.52 76.97 0.11 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.443 -174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.09 -46.34 2.42 Favored Glycine 0 N--CA 1.488 2.146 0 CA-C-N 113.704 -1.589 . . . . 0.0 114.83 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -76.3 126.94 31.91 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.395 1.078 . . . . 0.0 113.156 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.0 p -108.75 141.2 41.1 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -145.51 135.97 24.14 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.399 167.336 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.5 t -67.52 127.85 34.25 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.286 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.39 -9.47 48.49 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 112.99 -1.914 . . . . 0.0 111.717 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -95.24 35.61 1.29 Allowed 'General case' 0 CA--C 1.552 1.055 0 O-C-N 121.181 -0.949 . . . . 0.0 111.744 173.167 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 41.5 t -154.29 117.23 4.45 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.334 174.774 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.401 ' HA ' HG21 ' A' ' 23' ' ' VAL . 44.9 mt -52.51 -61.58 2.19 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.041 175.623 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -52.45 -45.97 66.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.844 1.258 . . . . 0.0 113.751 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.587 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 63.3 mttt -66.39 -43.83 84.73 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 tp -72.45 -23.95 61.14 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -78.73 -27.19 44.82 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.6 p -86.2 -33.27 20.82 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 42' ' ' ALA . 17.6 tp -64.86 131.51 46.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.304 0.642 . . . . 0.0 111.732 174.726 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.83 90.39 0.21 Allowed Glycine 0 N--CA 1.476 1.319 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.91 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 14' ' ' LEU . 8.7 mt -107.93 76.78 1.07 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.057 0.943 . . . . 0.0 111.985 176.371 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 t -137.73 172.87 12.31 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.444 -1.707 . . . . 0.0 112.331 -168.324 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -35.9 125.56 0.72 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.763 2.025 . . . . 0.0 115.435 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.02 -92.14 1.16 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.372 1.463 . . . . 0.0 110.088 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.479 ' HB ' HD12 ' A' ' 8' ' ' ILE . 11.3 m 24.55 123.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 128.216 2.606 . . . . 0.0 117.895 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.8 102.3 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 112.358 -2.201 . . . . 0.0 106.226 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.85 106.77 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 113.294 -1.775 . . . . 0.0 112.173 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.0 m -83.47 115.23 21.98 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.945 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.4 mt -93.31 102.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.6 t -116.62 117.72 30.61 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.091 -171.89 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.19 126.29 50.3 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.927 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -127.93 122.75 33.21 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 125.003 1.44 . . . . 0.0 114.18 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.0 -168.01 31.79 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 113.033 -1.894 . . . . 0.0 110.575 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -52.82 -40.65 63.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -111.09 37.66 2.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -45.94 -58.5 3.5 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -59.62 -51.22 70.75 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.192 1.397 . . . . 0.0 113.859 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -56.72 -41.12 76.91 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.3 1.84 . . . . 0.0 112.387 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.92 -59.84 4.74 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 78' ' ' VAL . 59.5 t -59.46 -44.94 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.067 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -49.2 -62.54 1.48 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.086 0.954 . . . . 0.0 112.127 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -66.0 -35.48 80.68 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.063 1.345 . . . . 0.0 113.766 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.514 HD13 HG21 ' A' ' 33' ' ' ILE . 44.3 mt -69.94 -30.69 68.14 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 74' ' ' VAL . 90.9 t -62.63 -39.9 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.478 0.311 . . . . 0.0 110.322 171.332 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -57.4 -51.32 69.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.236 0.614 . . . . 0.0 112.261 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.5 -45.22 73.22 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.422 ' HE1' HD22 ' A' ' 55' ' ' LEU . 59.8 tpp -59.3 -48.74 80.49 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 172.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.21 -31.9 73.0 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -97.79 -27.64 14.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 17.1 mt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 -176.398 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 38.9 ttp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.485 ' HE1' ' HG3' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -67.94 109.46 3.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 113.756 -1.565 . . . . 0.0 109.86 175.264 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.03 125.25 48.91 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 124.338 1.024 . . . . 0.0 109.403 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.485 ' HG3' ' HE1' ' A' ' 2' ' ' PHE . 4.9 mt-30 -129.9 130.86 45.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.298 -1.319 . . . . 0.0 114.357 176.794 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.753 ' HG2' HG22 ' A' ' 62' ' ' THR . 58.9 mt-10 -98.16 90.45 4.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.173 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.1 t -96.2 126.48 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.158 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 13.7 m -102.32 120.31 40.27 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.579 HG12 HD12 ' A' ' 14' ' ' LEU . 76.3 mt -68.6 125.14 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 124.974 1.421 . . . . 0.0 108.051 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 t -119.25 -22.1 7.26 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -171.334 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.22 142.85 98.07 Favored Pre-proline 0 N--CA 1.48 1.036 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.81 -30.95 78.24 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.436 2.757 . . . . 0.0 113.963 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -72.97 -49.51 28.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.831 0.852 . . . . 0.0 111.489 166.498 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.57 171.75 45.19 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.376 1.465 . . . . 0.0 112.129 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.579 HD12 HG12 ' A' ' 8' ' ' ILE . 37.1 mt -73.53 58.73 0.59 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.432 1.587 . . . . 0.0 110.49 164.6 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -70.19 -147.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 112.7 -2.045 . . . . 0.0 116.298 -166.896 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -60.49 -54.28 47.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.069 1.347 . . . . 0.0 113.566 -168.594 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -72.9 -36.77 3.6 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 116.57 -1.681 . . . . 0.0 113.517 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.78 -50.33 10.72 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.822 2.348 . . . . 0.0 112.017 165.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -54.11 -44.18 71.08 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 171.33 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.7 -47.01 77.53 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.058 0.943 . . . . 0.0 113.369 174.418 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -59.43 -46.09 89.71 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.485 ' HE2' HG21 ' A' ' 35' ' ' VAL . 17.0 t80 -63.78 -46.49 84.96 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.234 1.414 . . . . 0.0 113.293 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 47' ' ' LEU . 71.6 t -56.64 -51.18 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 124.331 1.052 . . . . 0.0 110.461 173.083 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -52.5 -53.97 38.83 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.355 1.462 . . . . 0.0 110.9 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.17 -46.64 88.06 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.696 1.247 . . . . 0.0 114.024 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.78 70.71 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.984 0.914 . . . . 0.0 113.318 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -66.5 -12.18 56.18 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.97 21.21 44.51 Favored Glycine 0 CA--C 1.544 1.888 0 C-N-CA 124.309 0.957 . . . . 0.0 113.455 172.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -122.59 125.15 45.08 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.04 0.936 . . . . 0.0 108.49 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.2 p -57.95 -36.97 73.29 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.825 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 p -59.23 157.97 9.8 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.147 1.779 . . . . 0.0 112.624 168.772 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -111.76 136.13 51.44 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.386 1.089 . . . . 0.0 112.841 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.4 111.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 111.893 -2.412 . . . . 0.0 112.205 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.2 m -93.21 98.82 11.52 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 112.551 -2.113 . . . . 0.0 107.122 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 63' ' ' ILE . 46.9 t -109.48 90.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.737 -172.419 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.1 p -104.74 101.8 11.4 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 112.376 -2.193 . . . . 0.0 113.684 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.522 ' HB3' HD12 ' A' ' 53' ' ' LEU . 29.0 t -60.27 103.86 0.27 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.521 166.702 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -19.32 90.12 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.881 2.472 . . . . 0.0 116.885 -172.537 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.08 -72.38 0.26 Allowed Glycine 0 CA--C 1.538 1.53 0 CA-C-N 112.793 -2.003 . . . . 0.0 114.35 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -114.25 144.12 43.74 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -170.066 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.4 m -76.01 130.6 38.66 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.999 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.52 131.29 7.13 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.945 -1.48 . . . . 0.0 112.909 -174.22 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.2 t -89.06 140.85 29.03 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.106 165.443 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.42 -23.2 66.89 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.744 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -82.14 31.17 0.38 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.6 t -160.23 113.32 2.1 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.959 -1.928 . . . . 0.0 109.182 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.465 ' HA ' HG21 ' A' ' 23' ' ' VAL . 29.5 tp -52.98 -62.24 1.78 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.596 -1.638 . . . . 0.0 112.871 -174.191 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -63.77 -32.72 74.32 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' O ' HD23 ' A' ' 53' ' ' LEU . 15.9 tttt -68.64 -39.64 80.63 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 123.731 0.644 . . . . 0.0 112.015 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -70.85 -53.27 15.87 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 123.522 0.514 . . . . 0.0 111.464 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -63.9 -28.15 69.64 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -173.646 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.5 t -71.45 -16.82 62.39 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.522 HD12 ' HB3' ' A' ' 37' ' ' SER . 4.3 mm? -86.18 154.44 21.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.621 0.768 . . . . 0.0 111.575 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.33 94.11 0.04 OUTLIER Glycine 0 N--CA 1.479 1.523 0 C-N-CA 124.695 1.141 . . . . 0.0 112.84 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' A' ' 19' ' ' ALA . 62.4 mt -100.38 48.45 0.92 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.887 1.327 . . . . 0.0 110.565 170.716 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 t -132.03 168.94 17.07 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.573 -168.339 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -55.0 121.73 9.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.351 1.06 . . . . 0.0 111.902 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.51 -29.06 12.08 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 114.481 -1.236 . . . . 0.0 115.275 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.2 p -73.67 136.93 43.84 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 9.3 t -96.72 111.89 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.475 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 m -92.95 101.59 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.235 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.753 HG22 ' HG2' ' A' ' 5' ' ' GLU . 51.8 p -84.77 94.37 8.68 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.292 -176.233 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.609 HG23 HG22 ' A' ' 35' ' ' VAL . 2.7 mt -82.78 98.55 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 112.899 -1.955 . . . . 0.0 109.013 -173.805 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -104.52 134.43 47.72 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.895 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -122.47 132.62 54.43 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -173.2 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.44 136.55 39.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.295 1.038 . . . . 0.0 113.162 174.295 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.8 -177.23 17.15 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 115.691 1.036 . . . . 0.0 115.691 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -54.84 -33.0 61.19 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -110.32 28.27 8.81 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 2.3 pt-20 -53.63 -57.62 10.12 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -172.223 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.451 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -54.3 -47.35 72.51 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.909 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -57.73 -41.76 82.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.222 1.409 . . . . 0.0 112.613 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.21 -57.51 12.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.2 1.0 . . . . 0.0 112.599 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -67.96 -36.7 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.166 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -52.85 -57.18 11.08 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.036 0.835 . . . . 0.0 111.173 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -65.66 -40.62 92.65 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.6 -43.16 97.74 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -60.22 -43.67 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 122.893 0.477 . . . . 0.0 111.496 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -55.71 -43.66 76.71 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.853 0.861 . . . . 0.0 111.517 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.08 -56.89 15.66 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.772 0.829 . . . . 0.0 112.888 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 20.3 mtp -47.75 -45.08 28.66 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.613 1.165 . . . . 0.0 113.549 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.83 -43.72 63.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.769 1.627 . . . . 0.0 115.307 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -111.74 15.53 20.91 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 172.085 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttp . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -141.02 131.61 25.5 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.76 1.288 . . . . 0.0 109.095 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.7 127.35 49.15 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.799 -171.4 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -126.56 122.5 35.28 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.614 0.721 . . . . 0.0 112.664 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.632 ' HG2' HG22 ' A' ' 62' ' ' THR . 60.3 mt-10 -79.5 103.24 9.28 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.272 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.25 135.58 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.653 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.586 HG23 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -103.22 128.89 50.07 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.154 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 mt -97.95 92.4 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 167.106 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -86.02 -24.72 26.3 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.7 133.98 46.13 Favored Pre-proline 0 N--CA 1.482 1.145 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -58.53 -47.35 19.44 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 123.83 3.02 . . . . 0.0 113.2 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -54.17 -36.37 63.31 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 166.784 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.92 -163.49 24.64 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 125.118 1.511 . . . . 0.0 113.791 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.4 mt -115.61 69.35 0.73 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.481 -1.86 . . . . 0.0 110.271 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -73.71 -175.04 1.93 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 111.864 -2.426 . . . . 0.0 114.976 -166.699 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.4 p -40.3 -40.52 1.17 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.254 9.6 mmm180 -75.34 -48.43 4.16 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 116.139 -1.886 . . . . 0.0 113.48 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -54.64 -47.86 24.46 Favored 'Trans proline' 0 N--CA 1.482 0.826 0 C-N-CA 122.214 1.943 . . . . 0.0 113.877 162.718 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.29 -41.57 72.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.07 -31.59 72.76 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -80.75 -37.53 30.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.581 0.752 . . . . 0.0 112.282 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -57.19 -46.34 82.94 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.255 1.022 . . . . 0.0 111.566 173.903 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.5 t -42.31 -61.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 125.227 1.411 . . . . 0.0 113.14 170.006 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -42.71 -50.03 5.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.986 1.315 . . . . 0.0 113.575 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -66.16 -47.88 72.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.907 0.883 . . . . 0.0 112.992 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.62 71.77 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -50.62 -52.8 36.17 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.09 -27.22 68.55 Favored Glycine 0 CA--C 1.541 1.661 0 O-C-N 125.843 1.964 . . . . 0.0 115.13 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -70.15 110.61 5.26 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -38.45 22.06 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.674 1.59 . . . . 0.0 111.617 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.02 140.31 57.86 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 169.814 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -92.1 101.52 14.05 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.938 1.827 . . . . 0.0 111.55 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 77' ' ' LEU . 6.9 mm -71.68 82.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 110.22 -3.173 . . . . 0.0 110.108 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 m -73.69 104.59 4.67 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.795 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.4 t -98.1 85.58 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 112.611 -2.086 . . . . 0.0 106.962 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -86.79 97.69 10.77 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.422 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.499 ' HB3' HD12 ' A' ' 53' ' ' LEU . 5.6 t -70.44 92.15 0.8 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.379 172.616 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.289 37.7 p30 2.67 101.34 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 110.189 -3.187 . . . . 0.0 117.461 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.37 -87.05 0.42 Allowed Glycine 0 CA--C 1.541 1.685 0 CA-C-N 112.721 -2.036 . . . . 0.0 110.122 -168.053 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HB2' HD11 ' A' ' 53' ' ' LEU . 8.1 mptt -94.96 140.07 30.46 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.202 0.525 . . . . 0.0 112.363 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.1 m -78.61 128.56 33.67 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -117.65 169.54 9.48 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.05 166.833 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -132.71 126.17 31.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.596 0.358 . . . . 0.0 110.781 -176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.551 ' HA ' HD22 ' A' ' 50' ' ' LEU . . . -60.05 -30.97 69.55 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.564 1.165 . . . . 0.0 112.925 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -72.73 -36.13 67.7 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.916 1.287 . . . . 0.0 113.403 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -96.73 102.84 14.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 122.321 1.058 . . . . 0.0 110.794 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.8 tp -44.3 -68.73 0.17 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 111.959 -2.382 . . . . 0.0 114.503 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -63.17 -41.66 99.27 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' A' ' 42' ' ' ALA . 83.2 tttt -55.91 -40.74 73.5 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.551 HD22 ' HA ' ' A' ' 44' ' ' ALA . 22.3 tp -68.03 -47.54 68.15 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 118.927 -0.559 . . . . 0.0 111.677 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -63.66 -23.93 67.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -79.44 -27.98 41.67 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.499 HD12 ' HB3' ' A' ' 37' ' ' SER . 2.7 mm? -84.33 168.82 15.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.044 0.938 . . . . 0.0 112.343 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.1 117.19 4.77 Favored Glycine 0 CA--C 1.546 2.002 0 C-N-CA 125.256 1.408 . . . . 0.0 113.428 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.536 HD11 ' HG ' ' A' ' 50' ' ' LEU . 31.6 mt -123.7 60.53 1.09 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.405 1.098 . . . . 0.0 109.2 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 t -153.08 -169.59 3.37 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.259 -160.928 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -49.01 104.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.163 2.185 . . . . 0.0 113.128 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.23 -18.65 56.27 Favored Glycine 0 CA--C 1.547 2.093 0 CA-C-N 112.919 -1.946 . . . . 0.0 114.556 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.4 p -69.61 125.16 25.88 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.266 0.627 . . . . 0.0 111.838 -166.923 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 7' ' ' THR . 45.9 t -97.83 122.56 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.802 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.5 m -105.04 103.45 15.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.067 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.632 HG22 ' HG2' ' A' ' 5' ' ' GLU . 75.0 p -83.22 88.15 6.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.965 -1.925 . . . . 0.0 109.502 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.8 mt -72.14 94.19 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 111.622 -2.536 . . . . 0.0 108.625 -172.401 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 t -101.41 84.22 2.58 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.377 -1.738 . . . . 0.0 109.726 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 100.41 5.7 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.624 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.42 136.34 34.83 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.285 -1.325 . . . . 0.0 113.784 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.49 -147.9 16.32 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 112.735 -2.029 . . . . 0.0 114.172 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -67.32 -25.29 65.94 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 -163.723 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -106.74 -1.69 22.37 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 3.8 pt-20 -8.0 -70.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 120.323 3.453 . . . . 0.0 120.323 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -73.24 -48.08 37.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -175.533 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -55.66 -32.91 63.62 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.393 1.477 . . . . 0.0 112.233 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.16 -63.7 1.01 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.724 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 t -55.03 -41.29 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.709 0.804 . . . . 0.0 111.916 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -45.43 -60.8 1.96 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.054 1.342 . . . . 0.0 112.203 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -69.28 -45.84 68.65 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 114.797 -1.092 . . . . 0.0 113.055 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.428 HD13 HG21 ' A' ' 33' ' ' ILE . 9.7 mt -61.35 -35.46 77.5 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.04 -43.54 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.429 0.692 . . . . 0.0 110.655 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -48.92 -48.28 42.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.378 1.071 . . . . 0.0 111.988 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.4 mt -59.73 -59.1 5.98 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 123.914 0.759 . . . . 0.0 113.011 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 mtt -48.61 -27.2 2.65 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.88 67.49 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -123.34 44.99 2.54 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.905 0.859 . . . . 0.0 112.626 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 119.626 3.195 . . . . 0.0 119.626 -171.288 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ttp . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -108.0 126.25 52.5 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 124.955 1.409 . . . . 0.0 109.523 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.61 116.02 26.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.815 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -119.2 121.79 40.51 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.694 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -81.54 113.02 19.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 112.743 -2.026 . . . . 0.0 108.72 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.6 t -124.84 141.05 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 113.427 -1.715 . . . . 0.0 108.88 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.474 HG22 HG22 ' A' ' 60' ' ' VAL . 40.4 p -113.9 121.01 42.67 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.979 172.12 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.09 126.34 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 57' ' ' GLN 0.315 5.1 t -126.14 55.52 1.48 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -177.453 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.408 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . . . -101.74 114.87 65.5 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-N 112.205 -2.271 . . . . 0.0 113.602 -176.92 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 10' ' ' ALA . 43.1 Cg_endo -63.72 -35.43 57.73 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.595 2.197 . . . . 0.0 112.126 171.367 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -52.1 66.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.286 1.834 . . . . 0.0 113.128 168.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.97 146.05 1.25 Allowed Glycine 0 N--CA 1.483 1.806 0 O-C-N 124.706 1.254 . . . . 0.0 115.462 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.25 79.06 9.66 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.169 1.461 . . . . 0.0 111.008 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -67.41 -167.03 0.06 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 112.501 -2.136 . . . . 0.0 114.795 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.7 p -51.86 -45.04 63.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.191 1.796 . . . . 0.0 115.347 -175.103 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.251 13.9 mmm180 -73.04 -45.5 8.31 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 116.44 -1.743 . . . . 0.0 114.337 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.31 -45.8 35.14 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.269 1.979 . . . . 0.0 112.647 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.27 -44.24 79.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.32 99.18 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -64.94 -43.07 93.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.078 0.951 . . . . 0.0 111.14 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -62.02 -41.4 98.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.06 1.344 . . . . 0.0 111.994 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 47' ' ' LEU . 81.6 t -53.36 -47.49 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.063 0.545 . . . . 0.0 111.545 170.74 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -60.39 -47.22 87.04 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 119.08 -0.486 . . . . 0.0 112.135 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.08 -42.07 99.56 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.04 89.64 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.421 1.088 . . . . 0.0 113.715 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' ' HG2' ' A' ' 45' ' ' LYS . 52.9 mmtt -60.95 -28.4 68.94 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 169.418 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.73 -43.77 98.47 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.095 1.331 . . . . 0.0 113.3 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -78.38 147.0 34.28 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -70.64 -38.53 73.87 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.486 -172.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.0 p -64.36 152.5 41.14 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.51 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 2.9 tt0 -92.35 107.42 19.2 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.891 1.329 . . . . 0.0 111.288 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.775 HD11 ' HB1' ' A' ' 73' ' ' ALA . 48.2 mm -75.28 104.94 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 111.043 -2.798 . . . . 0.0 109.825 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -110.29 114.24 27.54 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.134 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.55 100.97 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.618 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 72.5 m -86.34 97.05 10.2 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.653 174.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -76.74 100.59 5.49 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.888 171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.313 12.6 p-10 -0.55 87.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 -168.188 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.61 -60.73 0.55 Allowed Glycine 0 N--CA 1.483 1.815 0 CA-C-N 111.397 -2.638 . . . . 0.0 111.916 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.61 116.07 31.85 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 39.6 m -74.78 111.84 10.38 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 113.472 -1.694 . . . . 0.0 114.912 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.12 112.54 21.87 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.45 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -68.44 115.13 7.5 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.752 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.23 -14.67 62.3 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.333 -1.758 . . . . 0.0 112.269 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 32' ' ' GLU . 31.9 mttt -81.77 10.44 6.22 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 34.9 t -133.91 127.41 32.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.369 0.668 . . . . 0.0 111.933 169.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.537 ' HA ' HG21 ' A' ' 23' ' ' VAL . 10.1 tp -47.74 -69.14 0.13 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.389 1.876 . . . . 0.0 110.972 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -51.67 -45.16 63.31 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.221 1.408 . . . . 0.0 113.418 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 40.6 mttt -64.94 -52.63 55.28 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 tp -63.0 -46.33 88.17 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.78 -0.629 . . . . 0.0 112.319 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -56.72 -32.88 65.96 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -78.87 -2.22 38.75 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 53' ' ' LEU . 3.8 mm? -118.22 140.45 49.78 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.27 118.27 6.21 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 113.52 -1.673 . . . . 0.0 113.307 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.561 HD23 HG11 ' A' ' 61' ' ' VAL . 1.3 mp -116.35 87.35 2.67 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 168.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -135.3 -132.37 0.15 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.993 -162.093 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 4.1 tt0 -86.57 134.75 33.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.696 0.798 . . . . 0.0 111.636 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.28 -61.22 4.43 Favored Glycine 0 N--CA 1.484 1.876 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.763 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 p -3.09 114.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 7' ' ' THR . 57.3 t -100.26 108.03 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 112.45 -2.159 . . . . 0.0 107.325 -174.492 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.561 HG11 HD23 ' A' ' 55' ' ' LEU . 15.4 m -113.74 119.78 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.885 -172.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -103.97 104.27 14.22 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.945 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.448 HG23 HG23 ' A' ' 33' ' ' ILE . 4.9 mp -87.0 103.01 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.677 -2.056 . . . . 0.0 107.466 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 t -101.24 108.86 20.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.663 173.837 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.66 97.73 9.95 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.825 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.18 100.96 12.68 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.77 -173.5 33.15 Favored Glycine 0 N--CA 1.48 1.592 0 CA-C-N 111.543 -2.572 . . . . 0.0 111.172 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.98 -55.88 28.59 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -81.3 33.73 0.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -41.95 -50.1 4.55 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.053 2.141 . . . . 0.0 115.878 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -69.54 -55.45 10.15 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.378 1.471 . . . . 0.0 114.478 -178.454 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -67.44 -33.77 75.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.775 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -54.82 -55.88 25.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.063 -0.972 . . . . 0.0 112.012 173.35 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.0 t -64.1 -45.25 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.98 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -52.34 -54.3 33.43 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.697 1.199 . . . . 0.0 113.847 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 85.6 t60 -63.01 -40.32 97.41 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.2 mt -67.34 -37.59 83.52 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.47 -46.05 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.304 1.042 . . . . 0.0 111.094 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 76' ' ' HIS . 40.8 tttp -48.38 -53.44 17.62 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 124.441 1.088 . . . . 0.0 111.382 170.873 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.91 -45.92 91.62 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 45.8 mtm -52.13 -50.94 60.72 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.092 0.87 . . . . 0.0 112.354 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.59 79.88 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.275 12.9 pt-20 -82.5 -18.45 41.53 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.4 mt . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 176.438 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmm . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -139.3 142.11 37.71 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.94 1.4 . . . . 0.0 110.976 -172.332 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -128.66 130.93 47.91 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 124.809 1.318 . . . . 0.0 110.315 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -112.66 113.06 25.0 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.271 -1.332 . . . . 0.0 111.212 163.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -77.73 92.83 4.2 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.008 -1.905 . . . . 0.0 109.717 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.81 147.05 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 112.249 -2.25 . . . . 0.0 108.762 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -114.22 153.68 29.22 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.031 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mt -115.24 104.81 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 167.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -118.48 53.79 0.96 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.116 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.72 121.64 29.71 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 111.765 -2.471 . . . . 0.0 110.86 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -55.55 -44.4 48.64 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.212 3.274 . . . . 0.0 111.473 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -60.19 -59.57 5.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.394 1.878 . . . . 0.0 112.768 168.095 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.22 -168.22 54.82 Favored Glycine 0 N--CA 1.478 1.485 0 C-N-CA 124.71 1.148 . . . . 0.0 113.955 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 tp -99.64 58.18 1.04 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 124.161 1.934 . . . . 0.0 108.837 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -62.86 -169.6 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 113.099 -1.864 . . . . 0.0 115.61 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.36 -60.25 2.45 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -166.679 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HD2' ' HA ' ' A' ' 17' ' ' ARG 0.301 9.4 mmm180 -73.68 -37.84 3.69 Favored Pre-proline 0 N--CA 1.485 1.28 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 177.101 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -54.57 -50.9 11.83 Favored 'Trans proline' 0 N--CA 1.478 0.61 0 C-N-CA 122.854 2.369 . . . . 0.0 113.082 167.052 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -57.73 -42.98 84.96 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 172.419 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.5 88.72 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -66.7 -43.09 85.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.769 0.827 . . . . 0.0 111.79 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -59.66 -39.49 84.58 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.064 1.745 . . . . 0.0 112.301 172.344 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 47' ' ' LEU . 92.2 t -58.51 -51.43 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.107 0.963 . . . . 0.0 111.585 172.045 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -49.08 -49.74 40.19 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.791 0.682 . . . . 0.0 111.71 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.59 -49.79 71.97 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.314 1.008 . . . . 0.0 113.624 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.96 70.79 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 61.1 mttt -65.33 -26.12 67.9 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.45 -35.82 90.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 124.157 0.911 . . . . 0.0 113.71 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -71.44 154.99 41.12 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.0 p -73.88 -45.33 51.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.404 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.3 p -70.03 150.24 46.85 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.175 0.99 . . . . 0.0 112.885 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -94.22 101.37 13.35 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.842 1.306 . . . . 0.0 110.541 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.42 111.57 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 110.883 -2.871 . . . . 0.0 110.021 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.02 120.26 41.26 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.176 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG22 HG12 ' A' ' 63' ' ' ILE . 96.9 t -108.78 84.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.282 -174.574 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.0 m -81.86 110.95 17.63 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.925 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.428 ' HB3' HD12 ' A' ' 53' ' ' LEU . 39.0 t -85.48 99.82 11.47 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.104 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 14.7 p-10 2.56 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 128.01 2.524 . . . . 0.0 117.462 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.17 -45.04 1.33 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 112.836 -1.983 . . . . 0.0 113.005 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.689 ' HB2' HD11 ' A' ' 53' ' ' LEU . 98.4 mttt -123.87 134.95 53.46 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.294 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 m -72.06 137.8 47.4 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 113.954 -1.475 . . . . 0.0 112.943 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.597 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -138.07 137.16 37.5 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.024 171.551 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -107.54 118.83 37.77 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.51 0.671 . . . . 0.0 109.808 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.61 -30.98 71.04 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 113.725 -1.58 . . . . 0.0 112.143 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 48.2 tttt -77.28 16.01 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.827 0.851 . . . . 0.0 113.196 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -154.17 118.87 4.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.56 1.544 . . . . 0.0 112.454 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.586 ' HA ' HG21 ' A' ' 23' ' ' VAL . 55.6 tp -53.37 -71.0 0.08 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.503 -1.681 . . . . 0.0 114.611 -171.782 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -63.13 -31.41 72.55 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.28 -37.7 86.07 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.113 0.565 . . . . 0.0 111.718 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 19.6 tp -72.88 -54.56 8.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.023 0.529 . . . . 0.0 112.366 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -55.33 -38.29 68.54 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 t -61.19 -18.58 58.93 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 40' ' ' LYS . 1.0 OUTLIER -100.64 157.72 16.47 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -176.878 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.85 93.81 0.19 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 113.457 -1.701 . . . . 0.0 113.362 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.488 HD11 ' HG ' ' A' ' 50' ' ' LEU . 27.3 mt -103.82 56.75 0.73 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.647 -1.276 . . . . 0.0 111.134 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.5 t -143.03 178.63 7.56 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.52 -168.909 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -52.45 123.22 10.42 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.835 1.254 . . . . 0.0 113.586 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.99 34.18 10.16 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 112.784 -2.007 . . . . 0.0 113.347 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 p -119.3 140.2 50.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.658 0.383 . . . . 0.0 111.934 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 38' ' ' ASN . 22.7 t -108.49 105.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.5 m -107.34 92.13 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.394 -171.077 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.6 p -78.52 102.44 7.89 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.579 -1.646 . . . . 0.0 110.2 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.445 HG12 HG22 ' A' ' 35' ' ' VAL . 58.6 mt -87.14 95.93 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.374 -174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.5 t -104.21 122.22 44.92 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.827 -1.988 . . . . 0.0 110.913 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -109.42 115.16 29.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.602 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.87 102.86 12.27 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 112.858 -1.973 . . . . 0.0 112.434 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.82 -162.79 28.98 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 112.766 -2.015 . . . . 0.0 113.266 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -63.06 -61.04 2.65 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 -169.466 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -82.12 47.05 1.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -48.62 -39.38 23.83 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 112.322 -2.217 . . . . 0.0 116.482 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -87.4 -53.16 4.97 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.351 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 42.4 mttt -66.09 -44.66 83.76 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.302 1.441 . . . . 0.0 113.971 -173.117 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.18 83.53 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.878 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.36 -47.4 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.438 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -47.52 -57.06 5.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.253 1.421 . . . . 0.0 112.929 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -59.48 -46.25 89.32 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.535 HD23 HD12 ' A' ' 80' ' ' LEU . 85.2 mt -67.01 -39.31 87.04 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.76 -46.58 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.588 0.755 . . . . 0.0 110.338 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -50.83 -49.91 57.72 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.663 1.227 . . . . 0.0 111.993 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.535 HD12 HD23 ' A' ' 77' ' ' LEU . 95.9 mt -56.9 -54.15 49.84 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.185 0.594 . . . . 0.0 112.514 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.419 ' HE3' HD11 ' A' ' 63' ' ' ILE . 49.6 ttm -54.28 -42.07 69.6 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.227 1.011 . . . . 0.0 112.739 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.44 92.6 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.85 22.97 6.72 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 125.195 1.398 . . . . 0.0 113.073 171.441 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -119.69 143.17 47.89 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.857 1.348 . . . . 0.0 111.111 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -127.06 136.06 51.64 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.48 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -133.97 106.85 7.47 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.188 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.622 ' HB3' HG22 ' A' ' 62' ' ' THR . 8.2 pt-20 -78.03 92.76 4.39 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.231 1.491 . . . . 0.0 115.002 176.055 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.4 t -109.35 137.89 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.258 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 p -93.58 147.18 23.23 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -112.85 122.62 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.779 168.322 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 t -115.75 -27.0 7.2 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.609 -1.632 . . . . 0.0 114.84 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.54 137.27 17.21 Favored Pre-proline 0 N--CA 1.493 1.701 0 C-N-CA 124.72 1.208 . . . . 0.0 112.996 172.531 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -54.88 -54.07 5.04 Favored 'Trans proline' 0 CA--C 1.552 1.382 0 C-N-CA 124.468 3.446 . . . . 0.0 114.546 -171.585 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -63.95 -33.18 75.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 56' ' ' THR . . . 68.19 -170.2 38.3 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 124.993 1.282 . . . . 0.0 112.674 -163.889 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.03 81.89 7.82 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 113.509 -1.345 . . . . 0.0 108.941 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -62.75 175.59 0.8 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.577 -2.101 . . . . 0.0 115.351 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.1 p -58.18 -37.98 75.79 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -167.255 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -70.52 -46.74 18.64 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 116.608 -1.663 . . . . 0.0 113.414 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.78 -45.86 30.29 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.245 2.63 . . . . 0.0 113.457 164.191 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -39.59 72.89 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.14 86.94 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -58.63 -41.96 87.17 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.784 0.833 . . . . 0.0 111.468 172.38 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' HE2' ' HG3' ' A' ' 81' ' ' MET . 29.5 t80 -58.78 -50.93 72.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.987 1.315 . . . . 0.0 111.692 172.86 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -54.77 -42.65 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.351 0.66 . . . . 0.0 112.575 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -52.53 -55.0 25.17 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.779 0.432 . . . . 0.0 111.127 175.019 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -62.57 -43.76 98.01 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.202 0.601 . . . . 0.0 111.546 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.31 78.87 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -51.18 -36.17 39.84 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.75 27.96 12.78 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.724 1.154 . . . . 0.0 115.489 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -117.86 149.93 40.04 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.142 0.577 . . . . 0.0 110.768 165.421 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.3 p -69.23 -45.43 69.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.052 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.5 p -55.23 136.06 49.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.64 1.176 . . . . 0.0 113.498 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -91.51 83.76 5.44 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.616 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -64.57 92.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 110.509 -3.041 . . . . 0.0 113.42 176.509 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.51 113.37 21.71 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.626 172.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -98.19 94.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 122.559 1.171 . . . . 0.0 107.97 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.404 ' HB ' ' OG1' ' A' ' 62' ' ' THR . 54.3 m -88.81 118.42 28.5 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.453 -1.703 . . . . 0.0 110.877 -173.803 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.3 t -90.15 90.95 8.33 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 112.852 -1.976 . . . . 0.0 111.066 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.26 26.4 p30 32.81 67.47 0.17 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.958 1.703 . . . . 0.0 114.859 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.13 -49.04 1.09 Allowed Glycine 0 N--CA 1.48 1.577 0 CA-C-N 113.043 -1.889 . . . . 0.0 112.93 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -68.15 93.69 0.46 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 m -58.44 106.41 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.489 -1.687 . . . . 0.0 115.431 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.79 97.24 5.35 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.1 -1.409 . . . . 0.0 113.083 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -47.65 106.09 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.717 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 -4.64 37.67 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.459 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -78.54 -15.98 57.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.44 0.696 . . . . 0.0 112.592 163.564 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.8 t -103.49 106.23 16.69 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.226 1.012 . . . . 0.0 110.656 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.51 ' HG ' HE21 ' A' ' 51' ' ' GLN . 4.7 tt -46.06 -40.23 10.42 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 112.336 -2.211 . . . . 0.0 112.931 169.221 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -59.35 -62.97 1.48 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.58 1.152 . . . . 0.0 109.846 174.535 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -57.39 -41.14 79.7 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HG ' HD11 ' A' ' 55' ' ' LEU . 5.8 tp -76.15 -37.59 57.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLN . . . . . 0.51 HE21 ' HG ' ' A' ' 47' ' ' LEU . 36.6 mt-30 -80.43 -15.91 55.66 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.4 t -87.13 -25.79 23.94 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 168.073 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.5 127.27 36.18 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 122.278 1.037 . . . . 0.0 111.834 171.896 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.71 103.38 2.2 Favored Glycine 0 N--CA 1.479 1.561 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.586 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.42 HD11 ' HG ' ' A' ' 50' ' ' LEU . 4.0 mp -80.8 67.07 6.56 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.24 1.019 . . . . 0.0 109.389 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' THR . . . . . 0.606 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 11.5 t -126.62 156.94 40.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.444 -1.253 . . . . 0.0 113.349 -164.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -18.12 109.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.354 2.262 . . . . 0.0 115.83 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.19 14.1 40.11 Favored Glycine 0 CA--C 1.539 1.536 0 CA-C-N 113.169 -1.832 . . . . 0.0 114.766 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.7 p -103.4 124.87 49.52 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.485 1.136 . . . . 0.0 113.609 173.722 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.7 110.77 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 112.52 -2.127 . . . . 0.0 106.06 165.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 m -102.01 100.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.125 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.622 HG22 ' HB3' ' A' ' 5' ' ' GLU . 35.6 p -77.01 104.73 7.67 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 113.083 -1.871 . . . . 0.0 110.856 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mt -85.17 94.21 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.439 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.3 t -94.27 102.22 14.22 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 112.816 -1.993 . . . . 0.0 110.716 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.26 100.0 11.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.515 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -97.05 101.33 12.88 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.323 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.67 -164.76 34.27 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 112.195 -2.275 . . . . 0.0 110.501 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -82.1 -47.91 12.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 117.152 2.278 . . . . 0.0 117.152 -174.465 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -80.71 40.52 0.52 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.581 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.8 pt-20 -47.78 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.99 2.116 . . . . 0.0 116.243 -173.903 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.581 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -56.66 -36.09 69.16 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 177.997 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -72.01 -46.25 57.89 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.098 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.64 -47.03 87.19 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.117 0.886 . . . . 0.0 111.462 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 78' ' ' VAL . 78.2 t -58.66 -54.37 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.059 0.944 . . . . 0.0 111.114 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -52.83 -51.39 61.07 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.341 1.056 . . . . 0.0 112.978 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -63.61 -41.15 98.33 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.441 HD23 HD12 ' A' ' 80' ' ' LEU . 52.2 mt -69.68 -31.56 69.68 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 74' ' ' VAL . 49.4 t -68.08 -45.2 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.921 0.889 . . . . 0.0 110.521 171.75 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -50.45 -46.15 56.48 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.376 1.071 . . . . 0.0 111.59 167.791 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.441 HD12 HD23 ' A' ' 77' ' ' LEU . 22.6 mt -60.66 -50.35 73.84 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 173.009 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.433 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 92.3 mtp -44.72 -48.7 10.75 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.379 1.072 . . . . 0.0 113.381 174.254 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.04 -32.64 74.27 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.27 13.7 pt-20 -100.47 25.57 7.56 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.322 1.058 . . . . 0.0 113.779 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.5 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 127.724 2.41 . . . . 0.0 111.287 173.935 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 9.0 tmm? . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -125.54 134.3 52.04 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 125.336 1.647 . . . . 0.0 108.231 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.59 145.42 45.41 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 124.785 1.303 . . . . 0.0 113.764 -173.503 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -157.14 117.73 3.57 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 125.481 1.738 . . . . 0.0 112.19 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.487 ' HB2' HG12 ' A' ' 60' ' ' VAL . 11.1 pt-20 -76.27 132.98 40.18 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.562 169.426 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.17 129.84 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.424 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 p -81.67 143.41 31.91 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.453 -1.248 . . . . 0.0 112.395 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mt -120.44 113.53 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.57 167.684 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 t -100.75 -17.86 16.74 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.25 -1.796 . . . . 0.0 114.371 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.04 143.7 94.67 Favored Pre-proline 0 N--CA 1.477 0.895 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 169.607 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -42.08 -76.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 1 C-N-CA 125.547 4.165 . . . . 0.0 116.095 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.56 -22.5 21.25 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.85 -103.09 0.47 Allowed Glycine 0 N--CA 1.479 1.532 0 C-N-CA 125.533 1.54 . . . . 0.0 113.771 169.083 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.8 mt -97.35 66.21 2.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 112.396 -1.902 . . . . 0.0 108.501 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -66.49 -155.52 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 113.709 -1.587 . . . . 0.0 113.629 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -61.03 -49.73 76.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.259 1.424 . . . . 0.0 113.61 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.51 -43.74 53.14 Favored Pre-proline 0 N--CA 1.484 1.271 0 CA-C-O 116.041 -1.933 . . . . 0.0 115.126 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HB3' HD13 ' A' ' 84' ' ' LEU . 87.8 Cg_exo -60.59 -40.99 51.37 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.585 2.19 . . . . 0.0 111.977 168.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -59.83 -44.07 94.24 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.61 -49.78 71.88 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -56.37 -47.98 77.76 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -50.65 -43.66 57.32 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.984 1.428 . . . . 0.0 113.471 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 19' ' ' ALA . 23.3 t -59.93 -54.54 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 123.802 0.689 . . . . 0.0 111.175 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -54.24 -47.24 72.46 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.492 1.12 . . . . 0.0 112.456 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -66.64 -53.76 30.6 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.776 1.298 . . . . 0.0 113.134 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -55.02 -37.88 67.2 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.261 1.025 . . . . 0.0 113.42 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 49.9 mmtt -47.11 -34.0 5.58 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.87 28.93 13.28 Favored Glycine 0 CA--C 1.539 1.534 0 O-C-N 124.866 1.354 . . . . 0.0 114.263 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.543 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 71.1 m-85 -113.82 145.54 41.28 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.708 0.803 . . . . 0.0 110.971 168.537 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.8 p -78.77 -28.85 44.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 124.412 1.07 . . . . 0.0 112.552 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.2 p -77.55 139.28 39.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.044 164.925 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.37 99.34 8.63 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.882 0.849 . . . . 0.0 110.727 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.815 HD11 ' HB1' ' A' ' 73' ' ' ALA . 46.5 mm -61.72 101.7 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 112.035 -2.348 . . . . 0.0 111.022 173.631 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 1.2 m -100.49 131.84 46.19 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.025 171.897 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG11 HD21 ' A' ' 55' ' ' LEU . 89.4 t -118.17 91.22 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 m -83.63 137.99 33.55 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.901 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.41 ' HB2' HG12 ' A' ' 61' ' ' VAL . 37.8 t -127.41 92.43 3.5 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.265 0.4 OUTLIER 47.47 88.47 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 112.786 -2.006 . . . . 0.0 115.726 -176.7 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.54 -49.26 2.69 Favored Glycine 0 N--CA 1.483 1.774 0 CA-C-N 113.383 -1.735 . . . . 0.0 114.025 -174.654 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.57 ' HB3' HD21 ' A' ' 53' ' ' LEU . 81.5 mttt -64.37 103.92 0.71 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 m -88.82 109.74 20.45 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.109 -1.405 . . . . 0.0 114.531 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB2' HD23 ' A' ' 53' ' ' LEU . . . -113.74 96.06 5.66 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.703 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 47.6 t -59.22 116.01 3.6 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.373 171.544 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.6 -22.74 65.48 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.445 -1.252 . . . . 0.0 114.102 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HE2' ' O ' ' A' ' 26' ' ' ALA . 98.2 mttt -71.03 0.76 6.8 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.473 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 40.6 t -131.73 118.77 20.4 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.879 0.871 . . . . 0.0 110.538 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -55.55 -42.82 75.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.655 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.08 -60.7 2.98 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.366 171.358 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 18.5 mtpt -61.26 -30.97 70.79 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.491 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 33.3 tp -86.3 -53.92 4.74 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -67.93 -14.16 62.75 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -173.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -68.25 -32.78 73.2 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 165.955 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 40' ' ' LYS . 1.1 mm? -76.71 143.44 39.99 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.099 0.952 . . . . 0.0 111.578 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.82 108.02 3.57 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 113.162 -1.836 . . . . 0.0 110.355 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.422 HD21 HG11 ' A' ' 35' ' ' VAL . 6.2 mp -105.71 90.48 3.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 125.61 1.418 . . . . 0.0 107.301 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -149.57 -172.46 4.15 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.553 -160.779 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -57.13 113.34 1.67 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.064 0.946 . . . . 0.0 111.908 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.5 -35.68 4.9 Favored Glycine 0 N--CA 1.484 1.885 0 CA-C-N 112.301 -2.227 . . . . 0.0 113.595 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.7 p -64.37 101.87 0.48 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.779 0.832 . . . . 0.0 112.217 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 5' ' ' GLU . 11.8 t -76.72 101.72 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 113.415 -1.72 . . . . 0.0 106.786 173.461 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 37' ' ' SER . 9.9 m -94.77 128.2 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 112.951 -1.931 . . . . 0.0 112.701 -174.212 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -98.35 109.26 22.05 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.366 -171.802 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 mt -82.41 112.32 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 173.096 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 t -120.46 110.56 16.64 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 111.718 -2.492 . . . . 0.0 108.842 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -102.47 97.16 7.43 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.04 93.02 9.36 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.17 -163.03 29.4 Favored Glycine 0 CA--C 1.541 1.686 0 CA-C-N 112.645 -2.071 . . . . 0.0 113.83 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -54.76 -60.61 3.13 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 118.926 2.936 . . . . 0.0 118.926 -169.252 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -83.28 36.52 0.52 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.543 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.3 pt-20 -40.82 -69.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.543 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -61.19 -42.68 99.01 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -178.617 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -67.39 -44.44 78.87 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.815 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -62.11 -37.91 86.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.533 173.816 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 78' ' ' VAL . 99.4 t -68.64 -47.66 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.334 174.827 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -49.39 -49.94 42.53 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.695 1.198 . . . . 0.0 110.95 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -57.83 -57.13 14.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.28 1.832 . . . . 0.0 112.072 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 -26.31 67.07 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 74' ' ' VAL . 23.2 t -66.74 -47.63 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 167.559 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -54.37 -52.29 62.1 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.598 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -52.52 -57.41 10.04 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.7 mtt -52.43 -39.79 61.43 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.04 -44.07 73.4 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.543 1.152 . . . . 0.0 113.929 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.314 10.3 pt-20 -72.4 -27.08 62.14 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 18' ' ' PRO . 40.4 mt . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tmm? . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -88.23 130.77 34.99 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.755 0.788 . . . . 0.0 110.023 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' GLN . . . . . 0.472 ' HG2' HG22 ' A' ' 62' ' ' THR . 15.4 tt0 -134.05 142.32 47.53 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.073 -1.876 . . . . 0.0 111.72 -173.04 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -147.71 139.72 24.19 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 124.94 1.4 . . . . 0.0 110.602 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -93.34 131.4 38.53 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.915 0.759 . . . . 0.0 112.535 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.84 136.14 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.611 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.63 HG22 HG22 ' A' ' 60' ' ' VAL . 17.0 p -102.43 108.91 20.4 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 112.588 -2.096 . . . . 0.0 110.631 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 mt -71.19 96.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 113.12 -1.854 . . . . 0.0 107.503 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 t -86.26 -26.91 24.73 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 113.24 -1.8 . . . . 0.0 113.501 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.1 135.36 80.57 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 124.18 0.992 . . . . 0.0 111.219 171.037 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -46.34 -37.65 19.36 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 124.638 3.559 . . . . 0.0 116.435 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.29 -37.06 2.07 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.97 -93.5 0.41 Allowed Glycine 0 N--CA 1.476 1.309 0 O-C-N 124.031 0.832 . . . . 0.0 112.903 163.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 6.4 mp -94.4 63.43 3.01 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 122.615 1.198 . . . . 0.0 112.574 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -72.34 -169.51 0.53 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.291 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.6 p -47.47 -47.72 27.11 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.293 12.6 mmt180 -70.16 -51.7 13.57 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-O 115.398 -2.239 . . . . 0.0 114.932 -179.312 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.567 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 92.3 Cg_exo -60.8 -39.24 64.2 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.203 1.936 . . . . 0.0 113.816 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.54 -47.57 85.61 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.25 0.62 . . . . 0.0 112.639 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.52 85.32 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -66.4 -44.78 82.07 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HE1' ' HG3' ' A' ' 81' ' ' MET . 0.9 OUTLIER -54.3 -51.63 64.04 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.261 1.024 . . . . 0.0 111.162 171.328 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 47' ' ' LEU . 71.6 t -51.62 -51.52 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.465 1.106 . . . . 0.0 111.835 173.205 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -56.04 -53.97 50.6 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.717 1.207 . . . . 0.0 111.214 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HB3' HD21 ' A' ' 77' ' ' LEU . 7.9 tp10 -65.42 -43.94 88.94 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.361 1.038 . . . . 0.0 113.089 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -40.07 72.65 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -58.53 -14.33 7.76 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 174.005 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.68 -35.49 22.22 Favored Glycine 0 N--CA 1.48 1.63 0 C-N-CA 124.41 1.005 . . . . 0.0 114.74 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -80.8 154.33 27.23 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.849 0.86 . . . . 0.0 113.032 -174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -69.77 -43.09 72.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 123.984 0.803 . . . . 0.0 111.787 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.6 p -61.23 145.54 50.88 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 8.7 mt-10 -83.26 134.05 34.96 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.985 0.898 . . . . 0.0 111.189 167.436 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.6 mm -112.12 106.98 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.074 -166.193 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.66 119.35 33.45 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.248 -1.797 . . . . 0.0 109.438 -174.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.44 HG12 ' HB ' ' A' ' 61' ' ' VAL . 40.1 t -110.21 87.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -77.88 100.65 6.45 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.845 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.2 t -76.7 97.31 4.42 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.099 -1.409 . . . . 0.0 111.716 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 p30 35.12 61.97 0.59 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.86 -76.26 0.3 Allowed Glycine 0 N--CA 1.485 1.919 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.844 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.63 138.84 41.66 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.468 0.652 . . . . 0.0 112.513 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.5 m -99.35 140.13 33.98 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -124.76 134.94 52.62 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 113.571 -1.649 . . . . 0.0 109.232 175.217 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 t -117.26 126.56 52.94 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.95 -15.46 43.61 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 125.488 1.743 . . . . 0.0 113.637 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 32' ' ' GLU . 30.4 mmtt -71.87 -6.63 43.14 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 171.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -131.26 134.49 46.45 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.63 1.572 . . . . 0.0 109.598 168.17 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.581 ' HA ' HG21 ' A' ' 23' ' ' VAL . 43.7 tp -59.67 -52.38 65.75 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.498 169.633 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -62.92 -49.35 75.13 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 112.912 -1.949 . . . . 0.0 113.644 -175.478 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -65.22 -32.19 73.74 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.846 0.716 . . . . 0.0 112.909 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.551 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 12.2 tp -76.53 -44.93 32.87 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 119.015 -0.517 . . . . 0.0 112.233 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -59.45 -39.54 83.93 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.5 t -58.83 -39.46 81.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.81 140.79 39.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.329 1.062 . . . . 0.0 113.159 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.27 81.37 0.2 Allowed Glycine 0 CA--C 1.535 1.319 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.274 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.436 HD23 HG11 ' A' ' 61' ' ' VAL . 61.8 mt -82.27 60.8 5.17 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 123.626 1.679 . . . . 0.0 110.172 172.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 t -123.32 -178.68 4.06 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 112.495 -2.139 . . . . 0.0 112.477 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -51.68 127.64 21.14 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.774 1.229 . . . . 0.0 112.545 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.71 -32.61 6.61 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 112.962 -1.926 . . . . 0.0 113.468 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.0 p -62.45 116.82 5.42 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 122.474 1.131 . . . . 0.0 113.858 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.63 HG22 HG22 ' A' ' 7' ' ' THR . 4.2 t -86.75 95.13 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 112.239 -2.255 . . . . 0.0 106.075 174.156 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.44 ' HB ' HG12 ' A' ' 35' ' ' VAL . 31.6 m -95.65 113.45 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 112.608 -2.087 . . . . 0.0 110.365 -176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 3' ' ' GLN . 0.9 OUTLIER -91.43 108.74 20.1 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.247 -173.42 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.6 mt -91.17 107.08 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.724 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.5 t -103.12 126.93 50.52 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 112.614 -2.085 . . . . 0.0 111.075 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.09 111.34 21.97 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 124.679 1.237 . . . . 0.0 110.533 168.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -103.05 99.17 9.03 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.04 -159.74 28.68 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.576 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -54.48 39.0 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -173.729 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -83.05 33.49 0.44 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 2.2 pt-20 -45.04 -59.35 2.64 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.43 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -65.87 -40.08 91.29 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.091 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -70.31 -43.14 70.94 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.228 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.35 -52.82 64.01 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.461 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.08 -47.05 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.662 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -52.78 -57.55 9.79 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.16 0.984 . . . . 0.0 112.775 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.79 -45.54 93.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.215 1.006 . . . . 0.0 112.816 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 88.1 mt -69.46 -33.44 72.92 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -69.01 -48.4 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.787 0.835 . . . . 0.0 111.456 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -52.0 -45.49 64.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 123.829 0.705 . . . . 0.0 112.046 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.9 tp -52.85 -59.25 4.74 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.687 1.195 . . . . 0.0 112.475 174.089 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.523 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 38.7 mtt -47.95 -43.13 29.03 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 173.008 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.89 -45.66 88.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 118.152 -0.928 . . . . 0.0 113.337 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -86.24 -3.18 58.92 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.484 1.231 0 C-N-CA 123.912 0.885 . . . . 0.0 111.141 170.747 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.476 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -133.13 127.51 34.07 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 124.385 1.053 . . . . 0.0 111.321 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -110.28 146.03 36.37 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.814 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -155.07 125.82 7.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.756 1.222 . . . . 0.0 108.072 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -105.86 96.16 6.3 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 125.04 2.353 . . . . 0.0 113.622 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.7 t -95.73 119.22 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 111.222 -2.717 . . . . 0.0 110.841 -166.318 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 m -74.85 115.67 14.71 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.571 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.25 135.93 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.34 -23.25 4.89 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.37 -1.741 . . . . 0.0 113.856 -173.417 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 138.72 30.5 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.604 1.162 . . . . 0.0 111.386 169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -39.98 -50.71 3.3 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 C-N-CA 124.66 3.573 . . . . 0.0 117.345 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -116.88 21.95 12.96 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.01 -98.48 0.01 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.352 1.453 . . . . 0.0 113.822 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.549 HD21 ' HG3' ' A' ' 81' ' ' MET . 19.4 mt -119.1 110.93 17.65 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 113.766 -1.217 . . . . 0.0 111.604 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -91.15 -165.8 1.44 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.211 164.28 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -51.47 -43.93 62.28 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.253 11.4 ttm105 -68.98 -45.17 30.56 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.281 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.555 ' HG3' HD22 ' A' ' 84' ' ' LEU . 65.9 Cg_exo -61.26 -30.21 87.68 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.671 2.248 . . . . 0.0 115.169 167.674 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -46.15 84.25 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.759 0.709 . . . . 0.0 112.207 168.143 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.68 -44.93 80.46 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.225 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 18' ' ' PRO . 43.2 mt-30 -51.94 -53.25 43.39 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.094 0.958 . . . . 0.0 112.971 172.061 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -51.87 -60.52 3.08 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -46.47 -55.88 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.908 1.283 . . . . 0.0 112.707 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -51.97 -47.42 64.84 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 124.563 1.164 . . . . 0.0 112.279 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.01 -56.06 8.92 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.713 1.258 . . . . 0.0 112.688 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.22 -44.46 75.44 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.248 1.819 . . . . 0.0 115.049 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -51.56 -31.98 26.59 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.14 -49.42 78.8 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 125.449 1.718 . . . . 0.0 114.394 173.527 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -60.45 154.74 19.88 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -86.72 -15.88 38.13 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.838 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.4 p -82.94 153.02 25.25 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.718 164.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.421 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -94.3 131.89 39.45 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.388 0.675 . . . . 0.0 109.191 173.56 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 mm -112.97 100.47 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.998 -159.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.9 m -104.28 126.34 51.3 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.18 85.82 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.599 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 50.3 m -64.45 120.68 12.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.348 170.847 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.567 ' HA ' HG12 ' A' ' 61' ' ' VAL . 40.8 t -94.0 95.43 9.04 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 24.98 63.98 0.05 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.63 -24.6 8.43 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 117.3 1.68 . . . . 0.0 117.3 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -130.51 140.93 50.5 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 118.656 1.228 . . . . 0.0 109.641 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 77.6 p -101.28 129.44 47.25 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -162.737 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.684 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -114.99 104.05 11.52 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.103 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -59.34 113.84 2.37 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 169.977 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.48 0.15 43.72 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.59 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 32' ' ' GLU . 44.8 mttt -89.99 -44.43 9.87 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.533 164.835 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -70.62 116.96 11.54 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.362 0.601 . . . . 0.0 112.016 169.165 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 tp -64.37 -44.76 90.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.241 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -66.25 -34.79 78.81 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.416 1.086 . . . . 0.0 111.693 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' O ' HG22 ' A' ' 52' ' ' THR . 28.7 tttt -76.96 -47.73 20.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.684 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 26.9 tp -51.81 -49.37 62.89 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -63.85 -27.37 69.12 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 49' ' ' LYS 0.266 3.6 t -74.09 -20.61 60.21 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.14 135.8 33.16 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.419 1.104 . . . . 0.0 113.001 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.02 90.75 1.1 Allowed Glycine 0 CA--C 1.537 1.466 0 CA-C-N 113.182 -1.826 . . . . 0.0 109.561 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.65 64.64 3.57 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.558 1.17 . . . . 0.0 110.288 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.7 t -108.13 174.73 5.75 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.045 -170.708 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -50.63 137.45 19.71 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.305 1.042 . . . . 0.0 110.667 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.24 -47.19 1.79 Allowed Glycine 0 N--CA 1.481 1.699 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.597 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.8 p -56.92 120.75 8.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.875 0.397 . . . . 0.0 111.275 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 t -86.65 109.63 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 111.837 -2.438 . . . . 0.0 107.917 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 37' ' ' SER . 30.5 m -104.95 116.41 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -170.883 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 m -82.8 97.47 8.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.149 0.98 . . . . 0.0 109.006 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.456 HD12 HG22 ' A' ' 78' ' ' VAL . 16.2 mt -74.05 92.16 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 166.858 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -100.13 108.75 20.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 110.129 -3.214 . . . . 0.0 109.578 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.42 100.49 9.77 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.747 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 7.6 pt-20 -96.72 89.82 5.07 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.05 -162.7 29.27 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.637 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -56.39 -59.35 5.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 118.721 2.86 . . . . 0.0 118.721 -162.334 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -85.41 50.16 1.9 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -51.72 -53.15 42.58 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.193 -2.276 . . . . 0.0 116.079 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -43.17 57.16 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.69 -49.78 76.14 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.6 -52.07 42.69 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.918 1.387 . . . . 0.0 112.614 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.567 ' O ' HG23 ' A' ' 78' ' ' VAL . 86.5 t -53.68 -56.08 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 123.975 0.797 . . . . 0.0 111.795 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.13 -53.09 62.25 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -52.91 -47.6 67.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.952 1.301 . . . . 0.0 113.969 175.846 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -66.22 -36.71 83.74 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 74' ' ' VAL . 9.0 t -64.94 -47.21 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 O-C-N 122.336 -0.227 . . . . 0.0 110.698 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -54.05 -37.74 64.48 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.9 tt -60.99 -51.84 67.53 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.043 0.937 . . . . 0.0 110.014 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.549 ' HG3' HD21 ' A' ' 14' ' ' LEU . 10.6 ttm -60.57 -46.98 88.2 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.393 1.077 . . . . 0.0 113.005 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.12 -14.79 0.69 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -125.49 45.19 2.64 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 170.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.555 HD22 ' HG3' ' A' ' 18' ' ' PRO . 44.8 mt . . . . . 0 N--CA 1.476 0.85 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.258 169.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.5 ttm . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -120.8 140.62 51.47 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.964 1.415 . . . . 0.0 109.576 173.683 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -128.65 142.67 50.96 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.518 1.136 . . . . 0.0 112.032 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -150.49 119.62 6.75 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.025 1.453 . . . . 0.0 110.799 169.294 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 11.7 pt-20 -72.88 126.65 30.44 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.888 -1.506 . . . . 0.0 113.223 173.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.12 131.75 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.098 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.9 m -111.34 110.48 20.97 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.73 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.1 mt -72.62 113.9 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.445 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -85.74 -19.08 31.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.388 -1.733 . . . . 0.0 114.844 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -54.87 127.64 62.03 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.554 1.142 . . . . 0.0 113.009 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 52.3 Cg_exo -54.11 -62.3 0.32 Allowed 'Trans proline' 0 N--CA 1.485 0.999 0 C-N-CA 124.602 3.535 . . . . 0.0 113.314 -169.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -94.29 29.62 2.16 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . 33.74 -134.06 0.31 Allowed Glycine 0 N--CA 1.479 1.546 0 C-N-CA 127.345 2.402 . . . . 0.0 116.345 -175.613 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.8 122.43 44.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.117 -2.042 . . . . 0.0 109.966 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' HIS . . . . . 0.425 ' HB2' ' H ' ' A' ' 16' ' ' THR . 2.2 p80 -109.2 -154.93 0.54 Allowed 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.195 -1.82 . . . . 0.0 113.579 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' THR . . . . . 0.425 ' H ' ' HB2' ' A' ' 15' ' ' HIS . 15.3 m -61.01 -48.36 82.15 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -166.682 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -63.27 -47.61 84.4 Favored Pre-proline 0 N--CA 1.489 1.502 0 CA-C-O 116.599 -1.667 . . . . 0.0 112.233 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.79 -47.14 28.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.823 2.349 . . . . 0.0 113.48 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.92 -48.26 73.32 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.9 -46.91 84.21 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.118 0.967 . . . . 0.0 113.381 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -57.89 -42.78 85.37 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.576 ' HE1' ' HB3' ' A' ' 80' ' ' LEU . 21.7 m-85 -66.28 -49.24 67.78 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 47' ' ' LEU . 40.6 t -58.07 -35.84 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.448 0.699 . . . . 0.0 112.521 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -62.81 -65.07 0.74 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.029 0.932 . . . . 0.0 111.014 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.52 -52.76 62.18 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 44' ' ' ALA . . . -64.91 -27.27 68.74 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -176.665 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 38.0 mttm -58.5 -35.52 72.38 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 169.393 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.66 -31.83 79.31 Favored Glycine 0 N--CA 1.482 1.731 0 O-C-N 125.78 1.925 . . . . 0.0 113.579 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -79.01 142.17 36.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.294 0.638 . . . . 0.0 110.695 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.1 p -64.5 -43.75 93.12 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.64 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.2 p -59.68 143.8 49.68 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 114.419 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -90.78 126.3 35.97 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.744 1.259 . . . . 0.0 109.999 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.549 HG21 HD13 ' A' ' 77' ' ' LEU . 15.4 mm -98.4 98.56 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 112.765 -2.016 . . . . 0.0 109.71 -169.418 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 0.2 OUTLIER -83.86 101.28 11.54 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.705 -1.588 . . . . 0.0 107.554 175.756 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.5 t -87.43 77.6 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.9 m -75.45 88.28 2.63 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.339 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.7 t -79.8 86.68 5.34 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.819 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 21.12 81.4 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 111.295 -2.684 . . . . 0.0 115.484 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.37 -63.37 0.28 Allowed Glycine 0 CA--C 1.543 1.81 0 CA-C-N 112.173 -2.285 . . . . 0.0 112.79 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -104.9 133.02 50.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -169.479 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 p -88.71 116.23 26.82 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 113.557 -1.656 . . . . 0.0 115.444 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.463 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -102.29 164.96 11.39 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.546 168.847 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -125.69 119.38 27.85 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.305 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -72.57 5.97 2.72 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 124.42 1.075 . . . . 0.0 113.059 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 27' ' ' LYS . 50.9 mtpt -113.89 -15.21 12.4 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 172.923 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.0 t -119.02 120.9 38.58 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.824 0.849 . . . . 0.0 111.685 172.448 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.62 ' HA ' HG21 ' A' ' 23' ' ' VAL . 20.0 tp -57.44 -61.83 2.21 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.018 -1.447 . . . . 0.0 113.386 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -45.37 -50.78 11.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.29 1.436 . . . . 0.0 113.238 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -67.67 -30.93 70.59 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 18.6 tp -72.98 -47.06 48.59 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.513 0.508 . . . . 0.0 111.752 174.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -65.99 -31.53 72.48 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.5 t -85.03 33.71 0.54 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.856 1.313 . . . . 0.0 114.351 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.05 140.72 44.03 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.907 171.555 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.7 93.23 0.17 Allowed Glycine 0 N--CA 1.479 1.525 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.256 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.414 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 17.0 mt -94.96 57.86 2.14 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.293 1.044 . . . . 0.0 110.721 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -109.39 176.88 4.92 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.866 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -58.58 126.15 26.38 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.758 0.79 . . . . 0.0 111.888 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.66 16.23 64.23 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 113.385 -1.734 . . . . 0.0 114.925 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.0 p -88.23 120.44 29.59 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.543 0.687 . . . . 0.0 111.313 175.961 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 t -93.54 85.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 112.4 -2.182 . . . . 0.0 107.642 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -80.5 94.46 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 112.129 -2.305 . . . . 0.0 112.382 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 17.0 m -76.12 100.66 5.06 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.761 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.507 HG22 HG22 ' A' ' 74' ' ' VAL . 67.3 mt -79.23 102.12 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.975 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.404 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 47.8 t -106.56 104.86 14.65 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 111.82 -2.445 . . . . 0.0 110.408 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.59 101.49 13.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.763 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.89 99.56 12.39 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.982 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.09 -169.15 31.99 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-N 112.39 -2.187 . . . . 0.0 111.38 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.42 -48.9 75.91 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 -169.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -85.62 42.71 0.98 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -51.77 -48.65 63.65 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.44 -42.88 28.72 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -59.11 -44.19 91.95 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.545 1.138 . . . . 0.0 112.719 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.34 -49.68 70.72 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.192 0.997 . . . . 0.0 113.308 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 63' ' ' ILE . 76.3 t -59.84 -55.11 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.47 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -47.97 -45.04 30.94 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -70.13 -51.22 33.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.549 HD13 HG21 ' A' ' 33' ' ' ILE . 5.7 mt -60.56 -33.86 73.31 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.65 -54.69 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 124.039 0.837 . . . . 0.0 109.966 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -50.99 -49.98 59.33 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 124.17 0.919 . . . . 0.0 112.988 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.576 ' HB3' ' HE1' ' A' ' 22' ' ' PHE . 9.4 mp -61.48 -46.25 90.84 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 44.5 mtt -66.41 -21.67 66.22 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.3 -32.46 16.51 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -74.25 -39.72 62.85 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 178.545 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.8 ttp . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -124.88 135.64 53.06 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 125.277 1.611 . . . . 0.0 108.246 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -133.97 135.19 43.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.059 -172.41 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -142.76 144.49 32.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.047 1.339 . . . . 0.0 112.185 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.16 141.91 28.31 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.507 169.244 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 81' ' ' MET . 44.5 t -123.73 135.18 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 113.577 -1.647 . . . . 0.0 106.722 160.929 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.9 m -102.75 113.7 27.32 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.4 mt -72.63 124.69 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 122.317 1.056 . . . . 0.0 108.735 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -127.11 -30.12 2.71 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.868 -171.413 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.62 121.86 5.48 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 124.258 1.023 . . . . 0.0 111.367 161.483 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 34.1 Cg_endo -53.67 -69.35 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.454 2.769 . . . . 0.0 114.048 -169.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.55 -24.0 58.87 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.918 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.25 -125.2 17.83 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.999 1.285 . . . . 0.0 113.599 167.238 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.674 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 5.1 mp -96.45 110.43 22.8 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.896 1.331 . . . . 0.0 112.984 -175.656 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -109.6 -169.81 1.54 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 111.95 -2.386 . . . . 0.0 111.203 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 m -27.53 -76.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.394 2.278 . . . . 0.0 115.933 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -62.63 -49.35 83.33 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-O 116.237 -1.84 . . . . 0.0 113.696 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -51.51 -45.95 34.6 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.448 2.765 . . . . 0.0 114.044 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.7 -51.14 68.35 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.289 0.636 . . . . 0.0 112.403 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.28 81.31 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.62 -58.08 8.91 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.44 1.096 . . . . 0.0 111.986 171.565 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.79 -41.69 82.62 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.206 1.003 . . . . 0.0 112.719 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.608 HG21 ' HA ' ' A' ' 47' ' ' LEU . 58.9 t -64.58 -51.06 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.122 0.569 . . . . 0.0 111.642 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -53.15 -47.94 68.35 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.354 0.662 . . . . 0.0 109.827 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.06 -49.72 66.64 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.01 -45.85 75.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.525 0.73 . . . . 0.0 112.081 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -59.59 -36.08 75.55 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 173.1 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.22 -43.07 93.79 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 124.875 1.359 . . . . 0.0 112.199 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -62.02 145.99 51.48 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.99 0.916 . . . . 0.0 112.554 172.69 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.7 p -79.44 -31.36 42.53 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.232 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.7 p -71.95 141.82 49.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.76 0.824 . . . . 0.0 112.398 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.484 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 16.4 tp10 -72.35 130.62 41.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.479 0.656 . . . . 0.0 110.462 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 mm -113.43 86.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.369 -1.742 . . . . 0.0 109.303 -164.417 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.1 m -92.54 111.9 23.65 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 112.26 -2.245 . . . . 0.0 108.707 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.51 103.46 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 113.45 -1.705 . . . . 0.0 108.873 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 42.0 m -81.57 98.35 8.28 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.219 176.499 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' ' 53' ' ' LEU . 10.6 t -95.39 94.16 7.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.16 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.288 30.7 p-10 43.51 77.32 0.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 111.053 -2.794 . . . . 0.0 115.628 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.06 -52.59 3.21 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 112.276 -2.238 . . . . 0.0 113.742 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -93.46 134.48 35.67 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.484 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 39.5 p -89.8 148.9 22.94 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 122.526 1.155 . . . . 0.0 113.561 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -143.66 122.59 12.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.586 171.185 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.5 t -57.73 107.45 0.45 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.315 0.578 . . . . 0.0 110.059 166.291 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.78 -23.4 60.15 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.378 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -65.11 3.46 0.6 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.789 -1.551 . . . . 0.0 114.994 168.215 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 31.1 t -125.94 118.04 24.57 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.885 0.874 . . . . 0.0 110.427 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.608 ' HA ' HG21 ' A' ' 23' ' ' VAL . 31.1 tp -53.41 -47.75 69.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.793 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -58.22 -51.05 71.35 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.544 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 63.9 mttt -68.19 -43.69 77.56 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.41 -45.53 92.72 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.057 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -64.49 -36.45 84.22 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 49' ' ' LYS . 5.2 t -74.62 -30.44 61.66 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 37' ' ' SER . 3.2 mm? -83.07 155.6 23.78 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 122.067 0.937 . . . . 0.0 113.475 173.093 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -56.63 121.05 23.17 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 113.776 -1.556 . . . . 0.0 113.433 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.674 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 76.1 mt -124.31 36.66 4.57 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.061 1.344 . . . . 0.0 113.355 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -139.36 160.32 40.1 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -163.036 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.433 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 51.1 tt0 -34.52 109.51 0.08 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.618 1.567 . . . . 0.0 113.429 173.663 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.75 -40.8 1.93 Allowed Glycine 0 CA--C 1.534 1.276 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.817 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.7 p -74.89 133.35 41.83 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.57 110.06 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 113.279 -1.782 . . . . 0.0 106.785 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 m -98.7 89.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 125.065 1.478 . . . . 0.0 111.968 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.15 90.16 2.52 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.717 -2.038 . . . . 0.0 110.096 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.3 mt -76.65 111.87 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.275 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.2 t -117.2 124.75 49.87 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.821 -1.536 . . . . 0.0 109.631 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.28 110.66 21.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.365 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 3.3 pt-20 -108.95 110.34 21.62 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.651 -1.158 . . . . 0.0 113.674 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.82 -158.57 27.77 Favored Glycine 0 N--CA 1.483 1.831 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.002 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.88 -65.76 0.63 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -81.34 45.38 0.85 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 10.1 pt-20 -51.33 -62.27 1.72 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.683 1.593 . . . . 0.0 114.533 -177.424 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.406 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.6 OUTLIER -65.28 -41.98 93.62 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.242 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -56.96 -49.01 77.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.457 1.103 . . . . 0.0 113.52 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.9 -51.64 68.8 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.451 0.701 . . . . 0.0 111.838 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.68 -46.32 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.449 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -49.21 -54.73 15.22 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.21 1.404 . . . . 0.0 112.096 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -69.09 -34.75 75.6 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.5 mt -73.24 -39.9 65.1 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.8 t -58.91 -43.6 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.289 0.636 . . . . 0.0 110.217 170.492 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 79' ' ' LYS . 34.0 mtpt -56.63 -53.66 55.12 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 171.537 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.3 mt -49.76 -48.77 50.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.06 0.944 . . . . 0.0 113.464 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.609 ' HB3' HG11 ' A' ' 6' ' ' VAL . 11.9 mmt -59.16 -43.73 92.1 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.36 -40.66 89.91 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -74.18 -19.09 60.66 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 117.203 2.298 . . . . 0.0 117.203 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 CA--C 1.554 1.117 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -172.53 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -141.29 134.07 28.8 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.969 1.418 . . . . 0.0 111.318 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -122.98 139.94 53.55 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.156 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.491 ' HB2' HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -138.73 140.31 38.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.171 175.06 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -100.63 116.14 31.85 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 122.74 1.257 . . . . 0.0 111.443 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.5 p -122.62 135.72 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 112.88 -1.963 . . . . 0.0 111.286 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -87.91 162.54 16.85 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.494 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.6 mm -115.85 132.38 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 125.234 1.584 . . . . 0.0 106.885 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.77 -29.92 11.19 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.54 132.83 1.69 Allowed Pre-proline 0 N--CA 1.474 0.747 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -54.69 -45.94 37.15 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.915 3.077 . . . . 0.0 112.411 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -73.03 -64.37 0.98 Allowed 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.531 1.144 . . . . 0.0 112.967 171.344 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.61 100.31 2.64 Favored Glycine 0 N--CA 1.475 1.286 0 N-CA-C 110.386 -1.085 . . . . 0.0 110.386 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 32.21 84.57 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.134 2.173 . . . . 0.0 114.722 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -64.23 169.81 4.25 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.111 1.434 . . . . 0.0 114.213 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 p -59.71 -17.28 33.36 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.261 96.8 mtt180 -80.32 -47.38 1.32 Allowed Pre-proline 0 N--CA 1.478 0.929 0 CA-C-O 116.75 -1.595 . . . . 0.0 114.473 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.66 -37.22 89.16 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 122.097 1.865 . . . . 0.0 113.976 162.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.38 -44.99 89.16 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.08 92.89 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 172.224 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -63.54 -48.1 78.88 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.864 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -45.92 -56.27 5.68 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.54 1.536 . . . . 0.0 113.519 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.01 -43.66 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.185 0.994 . . . . 0.0 112.496 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.35 -50.13 68.96 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -59.58 -48.92 79.78 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.778 1.299 . . . . 0.0 111.257 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.67 -39.36 80.44 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -65.65 -38.02 88.19 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.18 -53.6 35.55 Favored Glycine 0 N--CA 1.482 1.726 0 O-C-N 125.614 1.821 . . . . 0.0 111.794 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -52.34 137.03 30.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 125.322 1.248 . . . . 0.0 110.378 171.652 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 p -74.11 -36.36 64.21 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.4 m -46.28 146.85 1.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.135 1.774 . . . . 0.0 114.877 170.735 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -86.05 133.72 33.88 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.792 0.806 . . . . 0.0 109.878 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.0 mm -117.04 97.44 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.165 -164.243 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 57.0 m -94.77 117.91 30.9 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.4 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.0 t -116.88 100.92 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 112.796 -2.002 . . . . 0.0 107.17 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -111.26 102.46 10.87 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.673 -167.352 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.5 m -76.52 91.8 3.39 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.751 170.254 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.263 6.8 p-10 32.24 105.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 118.706 2.854 . . . . 0.0 118.706 -172.424 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.38 -37.37 0.82 Allowed Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.634 ' HD3' HD21 ' A' ' 53' ' ' LEU . 78.1 tttt -94.58 120.05 34.2 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.938 0.895 . . . . 0.0 110.161 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.0 m -98.31 124.21 42.83 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -169.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 49' ' ' LYS . . . -117.28 166.6 12.09 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.74 -2.027 . . . . 0.0 109.723 175.659 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.645 ' HB3' ' HD3' ' A' ' 49' ' ' LYS . 18.2 t -126.01 132.34 52.03 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.91 -20.43 64.23 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.327 -1.761 . . . . 0.0 113.907 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -66.29 -12.3 55.64 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 84.4 p -136.44 137.26 40.25 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 160.19 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.6 tp -55.11 -39.23 69.13 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 124.121 0.888 . . . . 0.0 111.908 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -46.4 -56.35 6.02 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.04 1.736 . . . . 0.0 113.272 168.822 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.645 ' HD3' ' HB3' ' A' ' 43' ' ' SER . 56.1 tttt -76.49 -30.47 57.25 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.9 -65.56 0.66 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -59.99 -23.62 63.78 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -60.88 -26.5 67.46 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 174.407 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.634 HD21 ' HD3' ' A' ' 40' ' ' LYS . 5.4 mt -123.27 85.15 2.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.542 1.137 . . . . 0.0 109.459 169.173 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.88 135.86 17.72 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 112.949 -1.932 . . . . 0.0 113.135 -173.209 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.46 HD23 HG11 ' A' ' 61' ' ' VAL . 5.0 mp -79.22 101.32 7.93 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 113.47 -1.365 . . . . 0.0 109.715 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -129.71 162.23 28.86 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.804 -1.543 . . . . 0.0 111.979 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -58.02 145.74 35.19 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.44 -51.16 4.52 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.95 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -71.38 113.33 8.31 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.907 0.86 . . . . 0.0 111.245 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.0 p -71.43 132.37 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.709 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.46 HG11 HD23 ' A' ' 55' ' ' LEU . 14.8 p -116.59 123.92 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.08 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 m -79.95 120.53 24.28 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.968 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.01 100.33 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.487 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 44.6 t -110.18 125.39 52.99 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 112.909 -1.95 . . . . 0.0 112.104 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.15 111.89 18.83 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.547 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.53 103.8 12.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 113.778 -1.555 . . . . 0.0 112.91 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.57 -156.4 26.66 Favored Glycine 0 N--CA 1.479 1.533 0 CA-C-N 111.798 -2.455 . . . . 0.0 109.8 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.3 -49.53 63.84 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.93 20.44 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -41.43 -55.71 2.72 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -171.957 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -75.75 -52.26 10.84 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.939 0.896 . . . . 0.0 112.157 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -48.33 -54.31 14.28 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.421 1.888 . . . . 0.0 113.069 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.92 -51.99 66.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.452 1.101 . . . . 0.0 112.732 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 4' ' ' GLN . 60.7 t -64.8 -49.24 80.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.734 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -53.79 -51.79 62.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.31 1.006 . . . . 0.0 111.025 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -65.17 -43.65 91.04 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.7 mt -64.51 -35.61 81.53 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.4 t -74.08 -35.18 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 123.126 0.57 . . . . 0.0 111.451 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -66.66 -36.01 81.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 171.259 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -55.32 -50.27 70.04 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.515 1.135 . . . . 0.0 109.335 168.221 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 66.0 mtt -58.12 -44.14 87.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.16 -20.62 27.41 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -110.81 -31.73 7.08 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 N--CA 1.481 1.113 0 C-N-CA 124.858 1.263 . . . . 0.0 114.079 -173.777 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 tmm? . . . . . 0 C--O 1.239 0.531 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -124.7 128.3 48.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.669 1.23 . . . . 0.0 109.397 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -124.74 138.84 54.26 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.512 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -129.68 140.79 51.04 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.203 172.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -98.78 120.77 39.78 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.683 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 HG13 ' A' ' 78' ' ' VAL . 2.4 m -123.22 144.83 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 113.875 -1.512 . . . . 0.0 113.131 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -105.26 143.81 32.92 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.618 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -114.49 133.16 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.67 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 p -116.95 -41.05 3.06 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.6 132.49 3.79 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 170.262 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.23 -42.67 54.25 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.979 2.453 . . . . 0.0 113.752 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -69.22 -35.18 75.91 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.692 1.245 . . . . 0.0 114.051 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.51 80.66 0.12 Allowed Glycine 0 N--CA 1.473 1.158 0 O-C-N 125.154 1.533 . . . . 0.0 112.431 -176.894 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.485 HD22 ' HZ ' ' A' ' 22' ' ' PHE . 8.1 mt 61.16 92.34 0.05 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.211 1.804 . . . . 0.0 112.849 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -71.71 -165.66 0.17 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -173.634 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.46 -46.17 9.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.477 2.711 . . . . 0.0 113.692 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.267 68.1 mtt180 -80.52 -42.64 1.31 Allowed Pre-proline 0 N--CA 1.486 1.349 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -53.02 -48.39 22.4 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.903 2.402 . . . . 0.0 113.295 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.81 -47.39 77.24 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.54 -39.34 76.42 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.01 -50.7 71.01 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.856 0.863 . . . . 0.0 112.931 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.485 ' HZ ' HD22 ' A' ' 14' ' ' LEU . 11.8 m-30 -53.66 -41.03 66.4 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.936 0.894 . . . . 0.0 111.759 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.415 HG21 HD12 ' A' ' 47' ' ' LEU . 45.3 t -60.3 -59.9 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.605 1.162 . . . . 0.0 111.804 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -53.31 -48.08 68.72 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.666 0.604 . . . . 0.0 111.699 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -45.89 78.59 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.95 74.61 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 173.678 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -66.16 -45.55 80.55 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.31 -45.65 96.02 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.693 1.616 . . . . 0.0 113.319 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -65.65 147.58 53.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.83 0.852 . . . . 0.0 111.122 167.5 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 p -66.79 -56.6 9.72 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.777 1.231 . . . . 0.0 113.664 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -46.6 144.96 2.02 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -82.35 117.24 22.27 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.582 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 77' ' ' LEU . 26.0 mm -94.5 114.61 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.22 -174.604 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.08 120.9 26.71 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 125.419 1.699 . . . . 0.0 110.596 173.492 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.8 t -108.8 86.55 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.9 m -94.0 90.61 6.51 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.225 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 p -76.2 98.59 4.46 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.253 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.255 52.0 p-10 24.09 60.12 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.051 2.14 . . . . 0.0 116.533 -167.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.69 -34.93 4.76 Favored Glycine 0 CA--C 1.542 1.747 0 CA-C-N 113.72 -1.582 . . . . 0.0 115.449 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 40' ' ' LYS . . . . . 0.597 ' HB3' HD23 ' A' ' 53' ' ' LEU . 97.8 mttt -81.26 96.92 7.42 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.334 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -73.3 89.62 1.59 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.15 158.43 19.77 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.792 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -110.62 120.84 43.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.432 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.93 -32.21 73.66 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.302 1.626 . . . . 0.0 112.637 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -67.89 -9.95 49.12 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.552 1.541 . . . . 0.0 114.201 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 t -121.85 118.22 28.43 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.743 1.217 . . . . 0.0 111.326 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 23' ' ' VAL . 30.7 tp -55.38 -47.21 76.17 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 113.55 -1.659 . . . . 0.0 112.621 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -60.57 -57.77 11.33 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.973 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -61.47 -43.97 97.93 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.5 tp -57.88 -57.32 13.31 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.514 1.134 . . . . 0.0 112.612 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -71.38 -27.67 63.49 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.593 HG23 HD12 ' A' ' 53' ' ' LEU . 10.5 t -72.77 -24.8 60.99 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 171.098 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.597 HD23 ' HB3' ' A' ' 40' ' ' LYS . 6.8 mp -104.76 74.46 1.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.968 1.366 . . . . 0.0 110.505 172.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.49 152.54 49.83 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 112.428 -2.169 . . . . 0.0 114.611 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -100.39 158.71 15.7 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 112.588 -1.806 . . . . 0.0 109.787 173.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.8 t -161.54 165.87 27.88 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.081 1.352 . . . . 0.0 110.588 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -63.65 125.65 24.98 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.08 -19.29 54.03 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.527 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.6 m -75.98 104.12 6.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.234 0.613 . . . . 0.0 109.393 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.51 137.37 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.724 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.36 123.69 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 122.245 1.022 . . . . 0.0 113.557 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 116.86 28.25 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.111 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.7 mm -92.66 103.93 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.8 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.4 t -115.92 129.52 56.43 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.721 -1.581 . . . . 0.0 111.068 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.88 122.84 40.35 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.547 1.165 . . . . 0.0 111.665 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -96.88 116.67 29.57 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.382 -2.19 . . . . 0.0 114.059 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.38 177.6 10.36 Favored Glycine 0 CA--C 1.541 1.697 0 CA-C-N 111.824 -2.444 . . . . 0.0 113.237 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.257 50.3 mt-10 41.6 -93.24 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 172.045 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -77.15 -0.64 25.72 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -18.51 -62.91 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -64.93 -57.59 8.37 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.882 0.873 . . . . 0.0 112.882 -175.864 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -62.6 -38.15 89.06 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.583 0.753 . . . . 0.0 112.214 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.87 -57.42 12.12 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.832 . . . . 0.0 112.269 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.89 -49.15 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 118.51 -0.757 . . . . 0.0 111.771 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -49.7 -55.82 12.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.86 0.864 . . . . 0.0 113.255 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -63.67 -48.68 76.18 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.816 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.487 HD13 HG21 ' A' ' 33' ' ' ILE . 23.4 mt -61.56 -38.3 86.97 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.437 HG13 HG11 ' A' ' 6' ' ' VAL . 10.4 t -65.14 -42.1 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.537 0.735 . . . . 0.0 111.167 174.109 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -60.78 -45.69 93.36 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 118.283 -0.865 . . . . 0.0 112.968 173.093 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.2 mt -52.34 -52.59 52.41 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.574 0.75 . . . . 0.0 112.79 170.779 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.0 mtt -60.09 -33.6 72.32 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.42 -36.1 60.87 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.59 -21.08 28.66 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.3 mt . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -174.931 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.785 ' HG2' ' HB3' ' A' ' 66' ' ' GLU . 2.1 tmm? . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -125.12 131.18 53.31 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 125.093 1.495 . . . . 0.0 110.345 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -135.11 128.27 31.85 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.61 1.194 . . . . 0.0 113.527 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -125.71 127.77 46.74 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 124.823 1.327 . . . . 0.0 112.126 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 8.2 tt0 -84.57 135.89 34.02 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.563 -1.653 . . . . 0.0 112.385 176.91 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.93 142.42 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.173 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.01 136.7 45.22 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.235 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.748 HD11 ' HG3' ' A' ' 81' ' ' MET . 38.0 mm -105.93 139.09 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.059 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -103.27 -37.51 7.64 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.777 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -48.88 124.49 12.78 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.206 1.002 . . . . 0.0 112.629 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 72.7 Cg_exo -56.27 -52.03 8.08 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.942 3.095 . . . . 0.0 112.936 -175.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -63.53 -42.61 98.43 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.846 1.258 . . . . 0.0 113.241 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.98 -158.57 51.27 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.013 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.09 80.36 9.2 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 113.404 -1.398 . . . . 0.0 111.465 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -75.92 -169.05 1.0 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.721 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -37.44 -52.42 1.14 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.472 2.309 . . . . 0.0 113.24 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.252 44.5 ttt180 -69.95 -50.84 15.96 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-O 115.881 -2.009 . . . . 0.0 114.537 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 80.1 Cg_exo -63.88 -42.72 18.49 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.64 2.227 . . . . 0.0 113.188 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.31 -45.29 80.34 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.96 -41.65 68.05 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -70.73 -47.98 56.89 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.246 0.618 . . . . 0.0 111.12 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -57.52 -40.09 77.99 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.131 0.972 . . . . 0.0 113.342 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 19' ' ' ALA . 98.1 t -56.56 -53.86 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 124.059 0.944 . . . . 0.0 110.71 171.703 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -56.73 -46.35 81.37 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.23 -48.95 79.14 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.18 0.925 . . . . 0.0 112.345 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.459 ' O ' ' HE2' ' A' ' 45' ' ' LYS . . . -56.28 -40.52 74.4 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.183 0.993 . . . . 0.0 113.477 173.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -58.23 -36.34 73.02 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 173.507 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.92 -41.05 56.3 Favored Glycine 0 N--CA 1.483 1.773 0 O-C-N 124.87 1.356 . . . . 0.0 112.522 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -69.94 117.56 11.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.609 1.195 . . . . 0.0 112.41 175.049 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.5 p -49.11 -49.52 41.53 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.306 -1.77 . . . . 0.0 113.093 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 p -62.8 140.66 58.78 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.704 1.202 . . . . 0.0 113.817 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -77.09 93.17 3.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.619 -175.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.531 HD11 ' HB1' ' A' ' 73' ' ' ALA . 35.5 mm -68.73 84.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 112.788 -2.005 . . . . 0.0 111.276 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -82.9 115.93 21.98 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.004 -1.907 . . . . 0.0 107.797 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.22 99.84 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.1 m -88.33 99.04 11.95 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.696 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 t -101.45 109.91 21.82 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.605 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.296 0.1 OUTLIER 25.26 75.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.687 1.995 . . . . 0.0 115.953 -164.402 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.58 -26.5 4.06 Favored Glycine 0 CA--C 1.544 1.869 0 CA-C-N 112.055 -2.339 . . . . 0.0 115.182 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -84.69 87.98 7.33 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.713 1.244 . . . . 0.0 112.87 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -71.0 104.64 3.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.742 -2.026 . . . . 0.0 113.573 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.469 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -131.41 120.51 23.15 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 t -56.76 123.8 16.22 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.588 170.272 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.93 -30.56 70.29 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.805 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 26' ' ' ALA . 82.2 mttt -62.82 -22.21 66.47 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.6 t -94.35 112.94 24.75 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.878 0.847 . . . . 0.0 108.93 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -46.22 -52.05 13.2 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.254 -1.794 . . . . 0.0 112.981 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -54.34 -46.2 72.85 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.018 -1.447 . . . . 0.0 113.637 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 74.0 mttt -63.41 -53.42 52.56 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.241 0.963 . . . . 0.0 113.209 -176.434 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.2 tp -64.71 -33.42 75.92 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.135 0.897 . . . . 0.0 113.187 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -63.99 -47.37 80.61 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.4 t -74.35 -19.13 60.56 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 42' ' ' ALA . 17.1 tp -73.95 130.64 40.27 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.086 1.355 . . . . 0.0 111.346 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.39 102.06 1.33 Allowed Glycine 0 N--CA 1.482 1.762 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.823 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.0 mt -113.06 69.3 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.628 0.728 . . . . 0.0 112.818 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 t -145.79 179.88 7.15 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -61.08 138.7 58.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.343 1.057 . . . . 0.0 112.665 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.08 -52.7 3.55 Favored Glycine 0 N--CA 1.481 1.674 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.123 -172.637 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -72.53 97.38 2.1 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.08 1.352 . . . . 0.0 110.522 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.5 p -75.24 142.16 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.151 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.584 HG21 ' HE2' ' A' ' 81' ' ' MET . 9.0 p -127.29 125.39 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -170.77 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -105.64 118.17 35.91 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.602 177.027 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mm -87.25 96.4 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -108.81 128.58 55.02 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 124.721 1.263 . . . . 0.0 111.65 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.25 127.35 35.52 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.785 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 9.0 pt-20 -118.44 130.9 56.23 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 168.049 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.88 -155.08 22.15 Favored Glycine 0 N--CA 1.483 1.782 0 O-C-N 124.29 0.994 . . . . 0.0 111.472 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.73 -65.9 0.61 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -66.16 14.91 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' A' ' 71' ' ' GLN . 7.0 pt-20 -42.34 -58.83 2.04 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -168.04 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.448 ' HG3' ' HG3' ' A' ' 70' ' ' GLU . 36.3 mt-30 -71.25 -47.22 58.4 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.712 -1.131 . . . . 0.0 114.044 -177.226 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -63.79 -45.54 89.24 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.469 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.26 -43.99 95.68 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.946 0.899 . . . . 0.0 112.086 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.8 t -58.34 -57.14 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 116.951 -1.5 . . . . 0.0 110.129 171.897 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -50.71 -49.6 57.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.479 0.712 . . . . 0.0 112.91 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -61.54 -52.21 65.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.364 1.066 . . . . 0.0 112.693 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.03 -27.29 60.87 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -54.94 -44.48 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.07 0.948 . . . . 0.0 110.388 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.81 -61.27 2.52 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.693 1.246 . . . . 0.0 111.12 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -51.13 -37.16 44.43 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.748 ' HG3' HD11 ' A' ' 8' ' ' ILE . 11.0 tpt -53.68 -38.58 64.33 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.054 0.942 . . . . 0.0 113.429 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.55 -16.53 28.64 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.73 -25.4 16.71 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 44.2 mt . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tmm? . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -127.06 130.3 49.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.15 1.531 . . . . 0.0 108.145 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -134.74 153.54 51.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.227 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.493 ' CB ' HG21 ' A' ' 78' ' ' VAL . 19.2 mm-40 -141.76 144.16 33.85 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 126.353 2.283 . . . . 0.0 110.318 173.718 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -113.12 134.39 54.57 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.915 1.385 . . . . 0.0 111.316 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -125.17 124.8 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 111.724 -2.489 . . . . 0.0 113.237 -177.481 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -94.21 123.71 37.77 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 112.65 -2.068 . . . . 0.0 107.732 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.1 mm -95.64 106.22 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.17 -173.06 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.9 p -92.34 -20.87 20.64 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 113.101 -1.863 . . . . 0.0 113.218 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -62.65 130.82 93.93 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.995 1.318 . . . . 0.0 111.51 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -56.57 -34.12 94.54 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.945 3.097 . . . . 0.0 114.733 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -113.82 4.46 15.91 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 38.65 -117.06 0.6 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.874 2.178 . . . . 0.0 115.2 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 4.8 mp -109.53 74.01 0.87 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 123.643 1.687 . . . . 0.0 111.507 -177.736 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -75.37 -162.06 0.18 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 111.885 -2.416 . . . . 0.0 112.718 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.2 p -55.9 -44.49 78.28 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.403 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 52.2 ttt180 -66.93 -47.81 52.48 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-O 116.702 -1.618 . . . . 0.0 114.377 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 75.5 Cg_exo -68.16 -40.47 8.7 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.104 2.536 . . . . 0.0 113.571 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -44.7 72.13 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.11 -41.04 62.15 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 170.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.3 -45.89 68.49 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.258 0.623 . . . . 0.0 111.647 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -60.95 -49.87 75.7 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.07 1.348 . . . . 0.0 113.381 -171.374 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 47' ' ' LEU . 8.0 p -53.76 -42.57 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.32 1.048 . . . . 0.0 113.492 173.678 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -62.72 -51.77 65.85 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.997 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.515 ' HG3' ' HE2' ' A' ' 29' ' ' PHE . 6.6 tp10 -57.69 -49.68 75.72 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.412 1.07 . . . . 0.0 111.915 175.88 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.3 -40.17 70.77 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -55.46 -38.56 69.22 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.27 -28.83 73.77 Favored Glycine 0 N--CA 1.483 1.816 0 O-C-N 125.812 1.945 . . . . 0.0 114.786 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.566 ' HE1' ' HE2' ' A' ' 72' ' ' LYS . 77.1 m-85 -92.45 134.63 34.77 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.3 p -71.28 -42.97 68.07 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.503 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.6 m -44.15 136.4 3.9 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.243 1.817 . . . . 0.0 114.728 168.07 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.81 134.03 35.12 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.213 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.6 mm -111.18 101.14 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.076 -171.748 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 41' ' ' SER . 7.7 p -94.72 120.92 35.73 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.654 1.216 . . . . 0.0 111.927 170.722 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.6 t -97.83 91.7 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 110.901 -2.863 . . . . 0.0 105.846 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -83.59 84.07 7.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 111.987 -2.37 . . . . 0.0 111.057 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.1 t -74.83 90.95 2.39 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.418 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.322 6.7 p30 37.08 69.38 0.22 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 113.157 -1.838 . . . . 0.0 114.767 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 -46.55 2.31 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 112.175 -2.284 . . . . 0.0 114.147 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -76.43 96.75 4.11 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 13.3 p -83.8 119.31 24.68 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 112.659 -2.064 . . . . 0.0 115.44 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.74 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -137.42 146.36 44.3 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.065 -1.425 . . . . 0.0 112.256 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.1 t -62.3 134.57 56.68 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.494 ' HA ' HD13 ' A' ' 50' ' ' LEU . . . -70.9 -41.31 71.45 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 125.686 1.866 . . . . 0.0 113.114 170.385 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -60.18 -38.35 82.96 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.097 1.359 . . . . 0.0 111.624 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.3 t -76.23 94.5 3.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.896 170.298 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.509 HD13 HG11 ' A' ' 23' ' ' VAL . 30.9 tp -51.93 -32.14 31.76 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.726 170.275 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 48' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 52' ' ' THR . 64.9 t80 -52.66 -64.23 0.89 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.755 1.222 . . . . 0.0 110.653 170.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.74 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 94.6 mttt -63.8 -47.36 81.17 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 44' ' ' ALA . 23.2 tp -51.15 -46.34 61.98 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 174.743 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -74.27 -41.15 61.73 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 48' ' ' PHE . 10.6 t -84.63 53.16 2.59 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 122.237 1.017 . . . . 0.0 112.102 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 17.5 tp -154.67 136.13 14.19 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.409 -172.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.59 108.37 2.46 Favored Glycine 0 N--CA 1.48 1.623 0 C-N-CA 125.275 1.417 . . . . 0.0 113.076 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 11.7 mt -127.68 35.09 4.55 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 t -119.31 178.37 4.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -57.13 139.56 52.1 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.42 -9.91 73.69 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 113.886 -1.506 . . . . 0.0 114.254 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.6 m -102.65 127.5 49.73 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.92 132.74 35.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.279 167.502 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.546 HG13 HG23 ' A' ' 6' ' ' VAL . 11.5 p -125.2 137.92 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.523 -175.212 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.57 126.5 54.5 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.291 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.541 HG22 HG22 ' A' ' 74' ' ' VAL . 51.0 mm -99.08 108.01 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.4 t -113.45 135.21 54.13 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 124.56 1.162 . . . . 0.0 112.137 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.11 146.72 41.02 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.751 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.1 138.62 49.62 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.818 -173.032 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.11 -146.82 18.36 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 114.577 0.591 . . . . 0.0 114.577 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.14 -48.7 53.53 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -169.429 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -107.43 31.63 5.27 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.214 -174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -60.32 -48.23 82.64 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -171.692 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -70.2 -61.46 1.76 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.023 0.827 . . . . 0.0 112.232 176.082 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.566 ' HE2' ' HE1' ' A' ' 29' ' ' PHE . 64.5 tttt -49.07 -50.62 35.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.641 1.576 . . . . 0.0 114.256 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.5 -55.09 38.11 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 63' ' ' ILE . 85.4 t -67.9 -47.98 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.942 -174.593 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -45.08 -49.15 11.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.175 1.39 . . . . 0.0 112.747 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -66.91 -55.8 13.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.973 0.909 . . . . 0.0 113.168 173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.519 HD23 HD12 ' A' ' 80' ' ' LEU . 97.7 mt -59.72 -28.91 67.74 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -177.296 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.493 HG21 ' CB ' ' A' ' 4' ' ' GLN . 32.5 t -74.09 -45.74 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.288 0.635 . . . . 0.0 112.346 173.703 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -52.61 -37.67 58.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 170.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.519 HD12 HD23 ' A' ' 77' ' ' LEU . 46.3 mt -56.83 -33.44 66.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -62.7 -24.48 67.68 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.32 -31.59 24.76 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.192 0.997 . . . . 0.0 113.115 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -91.42 -33.3 15.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 118.37 2.729 . . . . 0.0 118.37 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 178.418 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.894 ' HG2' ' HB3' ' A' ' 66' ' ' GLU . 7.9 tmm? . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -122.47 135.82 54.75 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.287 0.992 . . . . 0.0 112.749 -167.038 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -121.34 137.19 54.81 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.859 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -128.13 123.59 34.81 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -96.3 99.0 10.73 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.991 1.432 . . . . 0.0 112.144 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.7 126.17 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 113.539 -1.664 . . . . 0.0 110.408 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 m -83.92 116.83 22.98 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.053 165.03 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.81 125.79 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.874 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 p -117.1 -36.48 3.78 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.173 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.56 113.05 0.94 Allowed Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 125.947 1.699 . . . . 0.0 115.072 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -53.59 -33.03 66.9 Favored 'Trans proline' 0 N--CA 1.483 0.894 0 C-N-CA 124.481 3.454 . . . . 0.0 114.35 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -62.86 -27.24 69.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.82 161.96 11.31 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 123.988 0.804 . . . . 0.0 113.244 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 55' ' ' LEU . 82.3 mt -79.89 78.04 6.52 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 122.871 1.319 . . . . 0.0 109.245 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -72.94 -153.65 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.218 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 p -51.75 -59.54 4.19 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.205 1.002 . . . . 0.0 113.685 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -55.39 -49.16 94.1 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 115.978 -1.963 . . . . 0.0 114.84 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HG3' ' HB3' ' A' ' 84' ' ' LEU . 78.3 Cg_exo -58.25 -52.05 6.42 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 122.33 2.02 . . . . 0.0 112.473 173.028 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.22 89.58 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.74 -47.73 84.96 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.059 0.944 . . . . 0.0 113.494 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -68.54 -36.82 79.35 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.777 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB3' HD21 ' A' ' 50' ' ' LEU . 11.8 t80 -64.42 -48.67 74.47 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.549 1.14 . . . . 0.0 112.568 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.72 -48.0 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -51.85 -45.0 63.87 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.81 1.244 . . . . 0.0 112.635 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.687 ' HB3' HD21 ' A' ' 77' ' ' LEU . 4.4 tp10 -75.61 -46.59 30.79 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.658 0.599 . . . . 0.0 112.172 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.05 -39.87 63.56 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.777 1.231 . . . . 0.0 114.262 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -63.18 -37.27 86.56 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.24 -33.08 73.64 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.053 1.311 . . . . 0.0 114.629 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -86.65 121.75 29.6 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.788 0.804 . . . . 0.0 110.809 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 p -58.18 -39.78 79.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.897 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -47.44 144.25 3.11 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 126.86 2.064 . . . . 0.0 113.496 166.73 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -94.68 122.06 36.9 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.529 1.157 . . . . 0.0 111.529 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 mm -108.63 106.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 112.324 -2.216 . . . . 0.0 106.949 -173.681 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 98.1 m -103.2 122.72 45.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.113 -176.202 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -101.67 103.84 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 113.534 -1.666 . . . . 0.0 107.01 -174.097 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -104.34 97.79 7.68 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.035 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.8 t -88.36 92.39 9.15 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.548 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.08 61.03 2.49 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 113.753 -1.567 . . . . 0.0 114.184 174.538 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.28 -63.37 0.41 Allowed Glycine 0 CA--C 1.543 1.801 0 CA-C-N 113.65 -1.614 . . . . 0.0 113.222 -168.59 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -68.62 111.02 4.53 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.394 1.093 . . . . 0.0 112.847 -170.6 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.1 p -106.62 117.82 35.06 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.413 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.724 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -117.74 143.58 46.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 112.197 -2.274 . . . . 0.0 110.275 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.8 t -73.96 134.21 43.11 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.12 0.486 . . . . 0.0 109.816 173.501 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.02 68.14 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.06 -0.53 4.59 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.2 t -127.17 111.58 14.15 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.92 1.288 . . . . 0.0 111.067 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.9 tp -59.07 -39.99 83.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.233 1.013 . . . . 0.0 111.552 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -55.53 -50.15 70.76 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.623 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.724 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 83.9 mttt -65.19 -45.29 85.43 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.649 0.779 . . . . 0.0 112.943 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 22' ' ' PHE . 20.3 tp -63.82 -47.25 81.58 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 124.568 1.168 . . . . 0.0 113.486 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -70.56 -37.24 73.97 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -74.62 -11.62 60.24 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 42' ' ' ALA . 15.1 tp -88.43 143.81 26.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.353 1.061 . . . . 0.0 109.335 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.37 88.78 0.13 Allowed Glycine 0 N--CA 1.484 1.859 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.092 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.424 ' HB3' HD12 ' A' ' 14' ' ' LEU . 93.4 mt -122.35 74.33 1.17 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 123.813 1.768 . . . . 0.0 110.353 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 t -137.25 175.0 10.0 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.371 -1.741 . . . . 0.0 109.716 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -45.58 150.06 0.53 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.76 34.33 56.55 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 125.155 1.36 . . . . 0.0 115.261 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.3 m -120.99 141.3 50.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.276 11.8 p -111.22 116.4 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.731 0.776 . . . . 0.0 112.524 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.54 129.55 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 112.286 -2.233 . . . . 0.0 112.989 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -103.12 123.12 46.08 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.537 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.0 mm -97.17 94.05 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 113.402 -1.727 . . . . 0.0 108.037 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.509 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 12.5 t -88.62 132.52 34.52 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.097 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.71 138.58 24.62 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.894 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 16.6 pt-20 -134.0 149.54 51.21 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.612 162.618 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.38 -165.09 24.81 Favored Glycine 0 CA--C 1.54 1.614 0 O-C-N 124.753 1.283 . . . . 0.0 111.429 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -50.81 -75.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.22 1.408 . . . . 0.0 113.184 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.69 74.78 1.54 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.052 0.941 . . . . 0.0 108.621 168.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.22 -64.73 0.82 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.82 -55.41 4.83 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -171.077 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -42.33 -53.19 4.27 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.371 -1.741 . . . . 0.0 113.717 172.281 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -37.94 78.85 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 t -65.78 -60.42 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -46.28 -47.55 18.23 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.513 1.525 . . . . 0.0 114.62 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -61.18 -51.15 70.22 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.322 1.049 . . . . 0.0 113.155 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.687 HD21 ' HB3' ' A' ' 25' ' ' GLU . 64.0 mt -69.15 -27.87 65.93 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 174.455 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.9 t -63.86 -34.63 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-O 118.957 -0.544 . . . . 0.0 110.738 170.492 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -62.18 -42.2 99.05 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 mp -57.55 -44.07 84.91 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.4 mtt -62.42 -18.9 62.79 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.6 -43.25 7.3 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -74.03 -39.36 63.6 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 18' ' ' PRO . 15.3 mt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -171.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.566 ' HG2' ' HB3' ' A' ' 66' ' ' GLU . 7.3 mtm . . . . . 0 C--O 1.223 -0.342 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -107.6 109.18 20.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 125.395 1.685 . . . . 0.0 108.254 171.796 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -117.8 125.18 50.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.576 -170.273 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.46 ' HB3' HG11 ' A' ' 74' ' ' VAL . 33.1 tt0 -138.73 129.93 26.97 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.189 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.486 ' HB3' HG22 ' A' ' 60' ' ' VAL . 46.5 mt-10 -89.42 116.88 27.93 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.061 -175.698 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.07 119.86 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.749 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 m -86.17 112.45 21.34 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.732 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.05 122.05 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 114.684 -1.143 . . . . 0.0 110.083 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.4 p -107.23 -0.4 22.66 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.22 117.76 43.08 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.133 0.973 . . . . 0.0 111.723 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HA ' ' HB3' ' A' ' 57' ' ' GLN . 85.0 Cg_exo -49.67 -41.94 44.36 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 124.75 3.634 . . . . 0.0 114.49 -174.305 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -57.77 -40.82 80.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.17 50.83 6.05 Favored Glycine 0 CA--C 1.55 2.252 0 O-C-N 123.757 0.661 . . . . 0.0 113.788 -169.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.8 mt 58.81 59.76 2.74 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 126.241 1.816 . . . . 0.0 115.03 175.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.254 28.1 p80 -41.27 -97.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 119.091 2.997 . . . . 0.0 119.091 -163.844 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.5 p -108.49 -64.9 1.18 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.842 0.857 . . . . 0.0 111.214 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 22.0 ttt180 -51.71 -51.97 65.09 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 125.988 1.715 . . . . 0.0 113.67 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 52.9 Cg_exo -64.96 -44.32 10.15 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.431 2.087 . . . . 0.0 113.407 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.65 -52.03 51.19 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 174.645 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.73 -45.96 92.25 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.655 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.411 ' OE1' ' HG2' ' A' ' 17' ' ' ARG . 55.1 mt-30 -61.59 -41.73 97.85 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.4 -53.23 60.6 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.09 0.869 . . . . 0.0 111.226 174.793 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.22 -43.42 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 123.663 0.785 . . . . 0.0 111.782 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -48.39 -56.24 8.68 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.57 0.748 . . . . 0.0 111.723 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.73 -40.83 72.54 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.88 -41.61 67.73 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.828 0.851 . . . . 0.0 113.281 172.521 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 69.8 mttt -70.04 -30.61 67.92 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 174.226 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.3 -29.44 74.9 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.911 1.243 . . . . 0.0 113.069 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -86.01 124.33 32.33 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.189 0.995 . . . . 0.0 112.557 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.0 p -65.65 -42.88 90.88 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.086 170.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.1 t -44.1 143.15 1.23 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.168 1.787 . . . . 0.0 112.228 162.753 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -95.27 136.26 35.83 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.056 0.932 . . . . 0.0 112.757 -173.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mm -115.28 101.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.213 -169.292 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.0 m -99.82 130.1 45.99 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.887 173.199 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 t -110.06 107.72 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 m -105.62 122.68 46.54 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.079 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 t -125.3 98.75 5.76 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.437 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 p30 32.47 85.97 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 112.007 -2.36 . . . . 0.0 116.251 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.56 -41.99 3.11 Favored Glycine 0 N--CA 1.478 1.484 0 CA-C-N 112.77 -2.013 . . . . 0.0 114.355 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -92.46 138.59 31.39 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.532 0.682 . . . . 0.0 112.248 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.0 p -116.9 135.62 53.58 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.549 1.14 . . . . 0.0 113.513 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.459 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -131.24 131.04 43.63 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.237 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 t -81.0 111.24 17.29 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.022 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.28 -26.21 64.75 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.324 -1.762 . . . . 0.0 114.631 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 91.9 mttt -61.69 -21.01 64.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 t -105.52 116.23 31.6 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.543 0.687 . . . . 0.0 110.809 167.533 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.8 tp -52.23 -46.31 65.65 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.386 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -50.95 -51.3 53.78 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.185 0.994 . . . . 0.0 112.359 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -63.31 -49.0 75.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 tp -54.08 -43.76 70.6 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.606 1.191 . . . . 0.0 112.468 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.16 -31.56 72.8 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 t -93.12 55.78 2.4 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 123.999 1.857 . . . . 0.0 112.142 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.459 HD22 ' HB3' ' A' ' 42' ' ' ALA . 8.5 tp -152.27 150.63 29.99 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.722 -175.361 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.14 76.62 2.13 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 124.231 0.92 . . . . 0.0 113.467 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.65 42.23 1.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.5 t -102.53 170.75 7.85 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.704 -1.589 . . . . 0.0 115.22 -158.674 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 11.9 pt20 -52.17 114.99 1.5 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.342 1.457 . . . . 0.0 113.831 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.93 -21.39 38.3 Favored Glycine 0 CA--C 1.543 1.802 0 CA-C-N 113.043 -1.89 . . . . 0.0 113.535 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.7 m -72.67 132.16 43.34 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.304 1.05 . . . . 0.0 112.86 -171.758 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 5' ' ' GLU . 8.7 p -86.0 110.81 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 113.156 -1.838 . . . . 0.0 108.326 164.066 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.07 129.04 59.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.709 -1.587 . . . . 0.0 110.896 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -91.56 107.66 19.36 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.24 -174.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.18 100.7 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -99.55 100.56 11.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 112.163 -2.289 . . . . 0.0 109.323 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.06 126.69 52.68 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.332 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.566 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 7.4 pt-20 -127.22 138.91 53.21 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.125 176.441 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.02 -141.58 16.97 Favored Glycine 0 N--CA 1.48 1.608 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.659 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -46.13 -86.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -174.744 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 72' ' ' LYS . 2.3 m-20 -82.25 48.46 1.27 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 174.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.275 10.8 pt-20 -58.34 -37.27 74.82 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -177.946 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -69.66 -59.59 2.86 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.645 0.778 . . . . 0.0 112.813 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 56.3 tttt -56.66 -47.9 78.75 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.915 1.686 . . . . 0.0 114.168 -176.479 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.99 -41.76 62.41 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.46 HG11 ' HB3' ' A' ' 4' ' ' GLN . 16.9 t -66.28 -55.52 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 123.753 0.658 . . . . 0.0 110.893 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -46.5 -49.63 18.18 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.319 1.448 . . . . 0.0 112.794 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -63.0 -50.63 69.97 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.619 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.6 mt -59.39 -37.96 79.3 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.09 -53.64 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.819 0.847 . . . . 0.0 111.173 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -61.13 -46.15 91.75 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.311 1.007 . . . . 0.0 111.733 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -53.66 -50.24 66.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.011 0.924 . . . . 0.0 111.73 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 32.5 mtp -58.17 -46.39 85.81 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.806 1.242 . . . . 0.0 112.903 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.28 -21.76 66.28 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.42 1.79 27.68 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -169.459 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.8 mtm . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -127.14 114.54 17.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.252 0.97 . . . . 0.0 111.76 -173.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -123.53 121.57 35.99 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.59 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.01 158.8 31.26 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 113.787 -1.551 . . . . 0.0 112.053 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -104.25 122.22 44.94 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.563 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.43 129.44 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.749 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m -96.38 126.61 41.7 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.105 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.3 mm -76.26 108.46 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -99.94 -16.61 17.91 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.06 120.0 30.96 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.457 1.103 . . . . 0.0 112.891 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -63.5 -45.63 11.15 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.696 2.931 . . . . 0.0 113.914 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -71.53 -36.0 70.88 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.379 0.424 . . . . 0.0 112.14 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.05 179.98 18.02 Favored Glycine 0 N--CA 1.477 1.428 0 O-C-N 124.506 1.129 . . . . 0.0 110.706 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 85.5 mt -99.84 85.11 3.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.593 1.187 . . . . 0.0 110.88 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.74 -148.41 0.23 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 113.352 -1.749 . . . . 0.0 114.693 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 p -57.57 -55.92 28.64 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -168.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -57.14 -49.13 95.72 Favored Pre-proline 0 CA--C 1.557 1.235 0 CA-C-O 116.927 -1.511 . . . . 0.0 112.568 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -57.92 -50.3 10.64 Favored 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 122.909 2.406 . . . . 0.0 113.903 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.61 -49.33 75.27 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 118.046 -0.978 . . . . 0.0 112.616 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.78 76.94 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.117 0.967 . . . . 0.0 113.274 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -61.71 -51.31 68.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.972 0.909 . . . . 0.0 113.305 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -50.89 71.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.362 1.465 . . . . 0.0 111.832 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.71 -45.81 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.449 1.099 . . . . 0.0 111.616 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -55.73 -47.29 77.16 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.881 0.738 . . . . 0.0 111.408 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HG2' ' CD2' ' A' ' 76' ' ' HIS . 1.7 tp10 -69.25 -44.57 71.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.44 -39.79 73.71 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 48.7 mmtt -71.23 -38.79 71.96 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 172.752 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 -42.95 97.15 Favored Glycine 0 N--CA 1.479 1.512 0 O-C-N 125.294 1.621 . . . . 0.0 112.823 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -73.02 135.54 44.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.864 0.866 . . . . 0.0 110.124 168.99 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.8 p -67.61 -41.55 83.83 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.87 123.36 2.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.074 1.749 . . . . 0.0 115.099 172.9 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 32' ' ' GLU . . . . . 0.42 ' OE2' ' HG3' ' A' ' 45' ' ' LYS . 22.9 tp10 -81.74 132.0 35.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.908 0.861 . . . . 0.0 111.316 -177.495 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 mm -121.51 110.31 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 113.917 -1.492 . . . . 0.0 111.529 -168.128 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.2 m -102.07 117.6 35.14 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.156 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.5 t -108.72 96.17 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 113.372 -1.74 . . . . 0.0 106.395 -174.027 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -106.99 109.27 21.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.054 -168.818 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 t -106.5 109.2 21.06 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.766 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 p30 45.88 60.67 3.03 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.376 -1.738 . . . . 0.0 114.688 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.99 -28.87 2.16 Favored Glycine 0 N--CA 1.485 1.919 0 CA-C-N 114.29 -1.323 . . . . 0.0 114.877 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -75.21 105.55 6.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 122.101 0.953 . . . . 0.0 111.1 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.6 p -93.31 114.14 26.51 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.84 148.41 26.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 112.625 -2.079 . . . . 0.0 109.879 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.5 t -103.36 118.46 36.82 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.02 -29.14 56.75 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 125.241 1.588 . . . . 0.0 113.222 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 43.7 mmtt -63.03 -24.34 67.87 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.145 1.378 . . . . 0.0 114.251 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 t -115.49 117.05 29.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.815 0.446 . . . . 0.0 110.866 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 tp -49.98 -52.7 31.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.116 1.367 . . . . 0.0 112.719 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.08 -36.48 77.46 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.402 1.081 . . . . 0.0 112.745 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -77.59 -44.12 29.44 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.549 0.531 . . . . 0.0 112.047 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.2 tp -62.33 -39.61 93.65 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.636 0.774 . . . . 0.0 112.594 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -60.21 -37.0 78.95 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 t -90.38 59.68 4.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 123.538 1.637 . . . . 0.0 112.025 175.716 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -144.14 153.01 41.69 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.757 -2.02 . . . . 0.0 109.579 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.12 79.68 0.05 OUTLIER Glycine 0 N--CA 1.485 1.916 0 C-N-CA 124.604 1.097 . . . . 0.0 112.844 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 73.5 mt -100.13 42.56 1.1 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.222 1.01 . . . . 0.0 111.98 173.842 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -113.26 156.89 22.52 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 113.352 -1.749 . . . . 0.0 112.179 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -48.98 108.09 0.17 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.558 1.543 . . . . 0.0 114.2 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.02 -23.19 11.71 Favored Glycine 0 CA--C 1.548 2.125 0 CA-C-N 113.277 -1.783 . . . . 0.0 115.495 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -73.42 127.03 31.56 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 117.638 0.719 . . . . 0.0 112.358 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.65 140.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 121.837 0.827 . . . . 0.0 111.803 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.74 131.38 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.985 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.71 109.18 15.88 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.489 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.7 mm -91.43 96.69 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -104.58 113.73 27.5 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.74 1.275 . . . . 0.0 112.054 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.12 131.29 55.89 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.372 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.15 152.59 39.76 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.5 173.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.33 -152.35 19.21 Favored Glycine 0 N--CA 1.48 1.605 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.532 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -42.75 -61.88 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 -173.668 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -104.79 40.56 1.47 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.353 0.661 . . . . 0.0 112.315 -174.371 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -47.77 -48.48 30.08 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -75.05 -48.73 22.52 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.81 -39.35 77.4 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.117 1.367 . . . . 0.0 112.85 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.95 -61.22 2.43 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.918 173.687 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 78' ' ' VAL . 29.2 t -64.53 -41.69 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 118.384 -0.817 . . . . 0.0 111.216 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -51.2 -61.15 2.41 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.133 0.973 . . . . 0.0 112.375 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.453 ' CD2' ' HG2' ' A' ' 25' ' ' GLU . 67.1 t60 -69.44 -30.52 68.46 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.2 -34.95 79.19 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.06 1.134 . . . . 0.0 114.06 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 74' ' ' VAL . 63.0 t -65.82 -46.66 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 119.002 -0.523 . . . . 0.0 109.717 169.815 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -51.34 -49.59 61.1 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.042 0.937 . . . . 0.0 111.574 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mt -50.42 -62.11 1.78 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.631 1.173 . . . . 0.0 113.533 171.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 69.0 mtm -57.03 -36.04 70.01 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.97 -32.38 67.2 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -79.59 -17.96 52.7 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 123.713 0.805 . . . . 0.0 111.175 174.756 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -130.39 116.76 18.72 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.849 1.343 . . . . 0.0 111.391 -176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -123.72 140.93 52.5 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -135.71 139.84 43.97 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 125.089 1.493 . . . . 0.0 113.303 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -84.98 120.01 26.03 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.633 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.417 HG21 HG22 ' A' ' 78' ' ' VAL . 66.2 t -126.21 121.5 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.43 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -83.51 129.71 34.98 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.108 0.956 . . . . 0.0 110.619 170.747 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.8 mm -107.79 117.89 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' THR . . . . . 0.408 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 21.9 p -111.45 -2.14 15.65 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.08 121.1 69.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 124.071 0.948 . . . . 0.0 111.947 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -57.78 -44.56 39.78 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 C-N-CA 123.403 2.735 . . . . 0.0 114.018 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -68.88 -34.73 75.91 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.87 -170.18 54.87 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.535 1.54 . . . . 0.0 114.56 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -79.58 74.35 6.24 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 123.24 1.495 . . . . 0.0 113.474 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -102.08 169.98 8.4 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.329 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.9 p 38.9 -104.48 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.507 1.923 . . . . 0.0 115.658 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -78.0 -44.26 2.29 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 115.553 -2.165 . . . . 0.0 112.948 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.528 ' HA ' HD22 ' A' ' 84' ' ' LEU . 15.8 Cg_exo -48.95 -46.88 23.44 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.621 2.214 . . . . 0.0 113.908 168.212 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.83 -54.8 40.71 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.251 0.621 . . . . 0.0 112.531 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.78 -40.85 69.86 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -57.07 -53.63 55.94 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.861 0.865 . . . . 0.0 113.126 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -61.18 -47.76 84.68 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.733 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 47' ' ' LEU . 83.0 t -57.49 -52.04 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.504 1.122 . . . . 0.0 112.048 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -60.44 -47.57 85.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.222 0.609 . . . . 0.0 111.742 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.62 -43.02 99.86 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 124.097 0.873 . . . . 0.0 112.55 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.411 ' O ' ' HE2' ' A' ' 45' ' ' LYS . . . -60.78 -43.01 98.6 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 171.604 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -61.16 -23.67 65.73 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.38 -30.66 49.02 Favored Glycine 0 CA--C 1.548 2.107 0 C-N-CA 124.535 1.064 . . . . 0.0 114.041 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -87.79 124.7 33.88 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 122.109 0.957 . . . . 0.0 112.578 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.6 p -71.36 -4.31 25.46 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 m -93.19 145.39 24.46 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.603 1.161 . . . . 0.0 108.6 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.55 131.16 34.24 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.5 0.667 . . . . 0.0 112.492 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.5 mm -120.89 118.48 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 112.976 -1.92 . . . . 0.0 108.834 -168.736 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 20.2 m -113.53 123.25 49.56 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 112.148 -2.297 . . . . 0.0 110.689 -173.472 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.9 t -99.0 90.45 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 113.52 -1.673 . . . . 0.0 106.49 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.8 m -97.52 112.89 24.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.066 -1.424 . . . . 0.0 112.516 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.3 t -111.49 98.0 7.14 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.184 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 p30 39.35 64.84 0.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 114.043 -1.435 . . . . 0.0 114.822 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.51 -49.9 2.93 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.432 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.02 112.89 2.79 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.295 1.038 . . . . 0.0 111.711 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.2 p -106.99 104.76 14.51 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.903 -1.499 . . . . 0.0 114.214 -171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.2 144.02 25.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.414 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.9 t -80.04 124.93 29.16 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.647 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.5 -26.42 63.44 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 125.009 1.443 . . . . 0.0 114.515 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 26' ' ' ALA . 92.2 mttt -83.04 27.47 0.55 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -169.734 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.5 t -145.2 118.27 8.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.777 1.231 . . . . 0.0 113.004 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.453 ' HA ' HG21 ' A' ' 23' ' ' VAL . 44.7 tp -56.74 -47.01 81.0 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.736 -1.574 . . . . 0.0 112.062 177.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -54.56 -51.54 64.93 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 117.961 -1.019 . . . . 0.0 112.07 171.392 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -58.34 -43.05 88.13 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD22 HG23 ' A' ' 23' ' ' VAL . 4.7 mp -63.89 -52.5 59.61 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 174.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -66.46 -27.81 68.1 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 t -79.26 -15.02 58.64 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -107.12 137.38 45.29 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.844 0.831 . . . . 0.0 109.415 -177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.43 71.11 0.65 Allowed Glycine 0 CA--C 1.541 1.681 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.659 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.05 71.91 10.87 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.751 0.786 . . . . 0.0 110.181 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -128.93 -157.56 0.83 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -162.056 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -66.5 102.43 0.89 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.74 1.616 . . . . 0.0 114.806 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' H ' ' HA ' ' A' ' 9' ' ' THR . . . 86.64 39.85 7.49 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 112.84 -1.982 . . . . 0.0 112.328 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 m -105.72 114.73 29.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -95.19 112.03 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.397 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.6 112.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.212 -2.267 . . . . 0.0 111.838 -172.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -78.29 98.85 6.07 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.812 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.4 HG22 HG22 ' A' ' 74' ' ' VAL . 27.0 mm -76.35 107.89 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 113.747 -1.57 . . . . 0.0 108.126 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.559 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 23.1 t -101.35 138.47 38.33 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.851 -1.977 . . . . 0.0 111.671 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 74' ' ' VAL . . . -131.35 144.48 51.27 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.518 1.127 . . . . 0.0 112.832 174.748 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -143.38 140.18 30.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.148 167.774 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.98 -145.16 15.99 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 115.138 0.815 . . . . 0.0 115.138 173.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -55.44 -66.22 0.45 Allowed 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -169.352 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.25 23.07 10.57 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.777 1.231 . . . . 0.0 112.756 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -32.35 -59.46 0.3 Allowed 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 119.027 2.973 . . . . 0.0 119.027 -168.791 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -60.12 -54.67 43.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -58.77 -43.06 90.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.356 1.463 . . . . 0.0 111.953 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.01 -52.42 50.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.944 0.898 . . . . 0.0 112.658 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 65' ' ' ALA 0.263 17.5 t -71.61 -39.09 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.588 176.385 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -50.31 -50.96 49.13 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.396 1.078 . . . . 0.0 111.923 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -59.18 -53.38 58.92 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.751 1.221 . . . . 0.0 111.63 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.3 mt -57.69 -35.43 70.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.417 HG22 HG21 ' A' ' 6' ' ' VAL . 74.2 t -67.03 -46.35 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.987 0.915 . . . . 0.0 110.831 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -58.53 -48.41 80.95 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.463 0.477 . . . . 0.0 111.006 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.9 tp -51.94 -51.08 59.49 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.979 1.312 . . . . 0.0 112.387 175.097 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.0 mtt -53.12 -27.57 21.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.77 -28.24 16.71 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.57 -23.17 63.51 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 18' ' ' PRO . 52.6 mt . . . . . 0 N--CA 1.492 1.628 0 C-N-CA 124.163 0.985 . . . . 0.0 113.649 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -123.73 137.17 54.74 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.895 1.372 . . . . 0.0 111.352 -171.731 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -128.45 141.52 51.37 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 125.376 1.673 . . . . 0.0 112.115 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -132.26 123.32 26.7 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.821 167.367 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HG2' HG22 ' A' ' 60' ' ' VAL . 11.9 tt0 -96.64 118.13 32.46 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.073 0.858 . . . . 0.0 110.817 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.5 m -118.13 134.0 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 112.81 -1.995 . . . . 0.0 113.246 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 m -89.64 86.75 6.79 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.404 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.6 mm -77.16 112.32 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.19 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 p -114.5 39.62 2.76 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 112.686 -2.052 . . . . 0.0 113.019 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -76.54 123.0 87.63 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.188 -172.648 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 98.9 Cg_exo -47.54 -47.14 18.71 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.89 3.727 . . . . 0.0 115.55 -173.295 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -102.56 -50.56 3.54 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 169.334 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.55 -157.1 15.28 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 124.575 1.172 . . . . 0.0 112.568 171.868 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 5.7 mp -93.13 75.72 4.66 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.83 1.3 . . . . 0.0 112.424 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -97.21 -152.23 0.38 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.232 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.6 p -42.96 -71.58 0.08 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -163.663 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -74.16 -44.04 6.11 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-O 116.152 -1.88 . . . . 0.0 114.766 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 73.2 Cg_exo -56.51 -43.58 53.98 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.579 2.186 . . . . 0.0 113.911 173.929 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.94 88.7 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.982 0.513 . . . . 0.0 112.308 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 -41.97 79.21 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.959 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -58.91 -45.88 89.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.188 0.995 . . . . 0.0 113.071 173.379 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -62.35 -48.67 78.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.39 1.076 . . . . 0.0 112.121 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 44' ' ' ALA . 91.2 t -57.63 -44.73 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.137 0.975 . . . . 0.0 111.962 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -54.17 -51.81 63.16 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.797 0.839 . . . . 0.0 111.125 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -69.67 -39.26 77.1 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -44.98 78.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.371 0.668 . . . . 0.0 112.117 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -61.46 -29.39 69.93 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.995 1.479 . . . . 0.0 114.995 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.6 -33.65 87.81 Favored Glycine 0 CA--C 1.544 1.882 0 C-N-CA 124.879 1.228 . . . . 0.0 113.126 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -85.67 139.39 31.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.027 0.931 . . . . 0.0 111.958 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 p -74.4 -45.99 43.21 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.052 172.105 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.3 m -53.43 144.14 17.54 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.127 1.371 . . . . 0.0 113.143 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -92.77 127.09 38.15 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.119 0.961 . . . . 0.0 112.999 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.531 HD11 ' HB1' ' A' ' 73' ' ' ALA . 37.2 mm -101.27 117.42 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.705 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -102.22 119.21 38.44 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 112.049 -2.342 . . . . 0.0 108.632 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.16 99.47 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 113.792 -1.549 . . . . 0.0 107.036 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -113.85 113.76 25.34 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.606 -171.517 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.2 t -119.87 115.06 23.07 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.697 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.282 24.1 p30 35.57 69.92 0.16 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 112.697 -2.047 . . . . 0.0 115.935 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.77 -36.62 3.24 Favored Glycine 0 CA--C 1.545 1.959 0 CA-C-N 112.594 -2.094 . . . . 0.0 114.784 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -78.89 102.3 8.16 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.9 p -84.85 115.29 22.67 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.39 -1.732 . . . . 0.0 114.16 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.83 138.61 45.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.171 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.1 t -90.22 102.14 14.86 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.788 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -51.13 -40.2 57.96 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -176.675 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -63.54 -12.27 31.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 22.7 t -109.13 121.19 44.61 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 173.704 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -53.47 -46.0 69.77 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.042 1.463 . . . . 0.0 112.285 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -57.63 -53.55 56.92 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.809 172.228 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 96.6 mttt -67.28 -31.37 71.64 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -176.292 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 tp -67.55 -55.38 13.66 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.126 0.57 . . . . 0.0 111.732 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.15 -30.32 71.49 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 49' ' ' LYS . 14.7 t -63.52 -16.58 61.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 173.028 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -96.52 129.21 43.93 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.51 88.1 0.43 Allowed Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.297 -176.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.24 90.73 4.94 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.188 0.518 . . . . 0.0 111.196 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -136.1 -145.99 0.23 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.772 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -88.35 115.12 25.63 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.18 40.67 2.39 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 112.614 -2.085 . . . . 0.0 113.617 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.6 m -115.58 104.95 12.23 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.45 HG22 ' HG2' ' A' ' 5' ' ' GLU . 4.8 p -85.46 105.12 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.771 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.46 123.89 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 111.582 -2.553 . . . . 0.0 113.077 -171.21 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 115.28 23.25 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 113.396 -1.729 . . . . 0.0 110.009 176.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.6 mm -98.39 103.93 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.3 t -116.31 130.56 56.84 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.097 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -119.24 141.15 49.18 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.87 130.01 46.31 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.181 -1.827 . . . . 0.0 113.218 169.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.27 -154.09 19.78 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 113.105 -1.861 . . . . 0.0 112.235 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -45.13 -71.25 0.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.253 1.821 . . . . 0.0 115.348 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -93.68 46.95 1.21 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.82 0.848 . . . . 0.0 112.414 -173.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -48.98 -60.6 2.63 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -62.55 -43.82 97.87 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -63.61 -52.46 60.78 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.126 0.97 . . . . 0.0 112.868 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -54.43 -40.5 68.39 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.43 -62.23 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.067 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -47.99 -53.07 17.34 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.106 1.763 . . . . 0.0 113.297 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -66.68 -41.16 88.56 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.1 mt -68.28 -36.17 78.98 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 172.665 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.39 -45.23 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.911 0.884 . . . . 0.0 110.204 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -52.34 -53.62 42.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.553 1.541 . . . . 0.0 111.018 173.12 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.5 tt -53.33 -55.84 21.52 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.204 1.002 . . . . 0.0 111.866 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.3 ttt -56.3 -48.64 76.25 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.013 1.325 . . . . 0.0 113.767 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.53 -29.12 68.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -99.18 14.65 28.68 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.7 mt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -178.212 . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -124.48 142.5 51.28 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.623 1.202 . . . . 0.0 111.236 -179.361 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -139.46 142.92 37.35 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.666 -1.606 . . . . 0.0 114.527 -174.27 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -131.23 124.16 29.99 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 125.621 1.826 . . . . 0.0 110.888 168.277 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -98.05 128.21 44.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.155 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 m -128.29 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.128 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -88.29 103.2 15.58 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.523 174.221 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.73 102.73 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.03 176.904 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -116.02 13.64 15.92 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 112.259 -2.246 . . . . 0.0 116.063 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.74 134.12 81.84 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 168.721 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.57 -53.54 3.73 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 125.135 3.89 . . . . 0.0 115.293 -169.098 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.27 -39.36 10.1 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 172.629 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.02 -88.17 0.98 Allowed Glycine 0 N--CA 1.483 1.781 0 O-C-N 124.495 1.122 . . . . 0.0 112.385 171.664 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 6.8 mp -112.43 73.46 0.82 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.867 1.318 . . . . 0.0 113.343 177.917 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -81.38 -165.04 0.86 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.928 169.075 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.8 p -53.31 -46.09 69.26 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -171.041 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.25 32.8 ttt180 -70.25 -54.8 8.74 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-O 116.689 -1.624 . . . . 0.0 114.274 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.456 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 98.0 Cg_exo -56.58 -38.22 95.94 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 122.343 2.029 . . . . 0.0 112.881 173.685 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.66 -56.05 25.89 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.65 -40.8 66.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 175.308 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.497 ' HB3' HD11 ' A' ' 80' ' ' LEU . 33.7 mt-30 -55.55 -58.47 7.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.516 1.127 . . . . 0.0 112.477 170.859 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -54.39 -49.4 69.98 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.73 1.269 . . . . 0.0 111.853 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.7 t -57.8 -53.39 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.084 1.353 . . . . 0.0 111.789 177.431 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -58.92 -48.84 80.05 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.033 0.833 . . . . 0.0 112.131 -177.994 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.61 -40.97 80.18 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.677 1.236 . . . . 0.0 112.696 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' O ' ' HE2' ' A' ' 45' ' ' LYS . . . -58.34 -39.61 79.93 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 170.41 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' A' ' 45' ' ' LYS . 71.4 mttt -64.87 -32.01 73.51 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 175.148 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.46 -41.04 99.8 Favored Glycine 0 N--CA 1.487 2.092 0 O-C-N 124.587 1.179 . . . . 0.0 112.034 169.064 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -70.7 120.63 16.59 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.705 0.764 . . . . 0.0 112.799 174.543 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.8 p -62.26 -38.05 87.79 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.359 -1.292 . . . . 0.0 112.216 174.741 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.1 m -61.35 153.58 26.37 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 126.634 1.973 . . . . 0.0 111.352 175.168 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -96.52 137.08 36.13 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 122.086 0.946 . . . . 0.0 111.885 -175.352 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.451 HG21 HD13 ' A' ' 77' ' ' LEU . 13.7 mm -118.29 106.32 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.179 -166.224 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.2 m -99.25 134.48 42.05 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.436 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 47.3 t -119.66 110.57 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 113.582 -1.644 . . . . 0.0 107.338 177.879 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.7 m -115.53 119.87 37.61 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.718 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t -111.92 99.8 8.39 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.428 171.923 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 p30 36.38 85.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.94 -41.41 2.19 Favored Glycine 0 N--CA 1.484 1.887 0 CA-C-N 114.265 -1.334 . . . . 0.0 115.097 177.174 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.09 123.08 36.1 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.758 0.79 . . . . 0.0 111.619 177.419 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.0 p -113.08 153.44 28.16 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -173.973 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -114.99 152.93 31.56 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 111.987 -2.37 . . . . 0.0 112.55 -176.408 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 43' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 49' ' ' LYS . 26.5 t -105.86 105.85 16.08 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.054 175.801 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.58 -32.87 72.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 125.245 1.59 . . . . 0.0 115.139 -170.414 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.532 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 91.3 mttt -71.32 19.09 0.06 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 176.054 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 t -145.16 126.15 14.53 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.958 0.903 . . . . 0.0 111.077 176.614 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.99 -53.18 56.53 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.238 0.961 . . . . 0.0 113.041 173.781 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -54.42 -60.27 3.56 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.625 0.77 . . . . 0.0 112.061 172.011 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 7.0 mttm -68.34 -17.88 64.36 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -173.11 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.49 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 27.8 tp -81.3 -65.8 0.97 Allowed 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.396 1.06 . . . . 0.0 111.667 164.888 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -63.45 -19.45 64.73 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -171.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' THR . . . . . 0.458 HG23 HD12 ' A' ' 53' ' ' LEU . 9.2 t -51.25 -29.27 13.96 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 168.48 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 42' ' ' ALA . 9.4 mp -84.71 139.34 32.07 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.784 1.234 . . . . 0.0 110.499 171.378 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.48 75.23 1.99 Allowed Glycine 0 CA--C 1.541 1.667 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.419 177.757 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.421 ' HA ' HG21 ' A' ' 59' ' ' THR . 7.3 mt -81.05 79.13 7.78 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.475 1.131 . . . . 0.0 109.459 176.142 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -129.83 -155.37 0.69 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.272 -1.785 . . . . 0.0 110.942 -165.552 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -77.87 120.5 22.84 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.672 -0.643 . . . . 0.0 111.705 172.957 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.72 35.52 8.39 Favored Glycine 0 N--CA 1.487 2.073 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.419 -178.376 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.421 HG21 ' HA ' ' A' ' 55' ' ' LEU . 22.9 m -109.53 91.89 3.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.579 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -74.43 103.49 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.223 167.641 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.67 137.43 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-N 111.502 -2.59 . . . . 0.0 112.168 -173.16 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.57 128.68 45.68 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.073 -1.422 . . . . 0.0 110.262 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mm -101.6 108.36 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.655 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 m -113.54 128.39 56.42 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 125.845 1.966 . . . . 0.0 111.809 -176.765 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.06 122.68 44.84 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.641 177.044 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -114.85 136.82 52.67 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.24 175.233 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.05 -131.03 8.26 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.546 175.859 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.4 -66.77 0.58 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.064 1.346 . . . . 0.0 113.574 -172.047 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 72' ' ' LYS . 73.9 m-20 -92.88 49.69 1.47 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.975 0.91 . . . . 0.0 111.763 -172.583 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -54.0 -45.24 71.42 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.173 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -68.78 -62.03 1.56 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.698 0.799 . . . . 0.0 111.359 173.742 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 62.6 tttm -48.15 -51.69 23.84 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.804 2.042 . . . . 0.0 113.656 -176.452 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.23 82.4 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.94 -53.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.17 178.835 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -48.48 -50.36 31.94 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.985 1.314 . . . . 0.0 112.508 176.343 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -65.15 -41.43 94.75 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.189 1.395 . . . . 0.0 113.279 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 33' ' ' ILE . 11.3 mt -80.28 -24.47 40.01 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 177.684 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.91 -41.72 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 168.188 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -52.57 -50.64 62.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.64 1.176 . . . . 0.0 110.889 169.577 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 21' ' ' GLN . 6.0 tt -53.6 -49.97 66.64 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.412 1.085 . . . . 0.0 113.01 171.974 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.4 mtt -64.05 -29.55 70.68 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 176.48 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.57 -51.3 24.13 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 174.001 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.1 60.37 4.86 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.462 1.105 . . . . 0.0 112.371 -174.469 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.479 1.005 0 C-N-CA 124.272 1.029 . . . . 0.0 113.75 -179.481 . . . . . . . . 0 0 . 1 . 022 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.672 ' HG3' ' HG2' ' A' ' 66' ' ' GLU . 18.5 ttt . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.18 142.13 50.16 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 125.829 1.956 . . . . 0.0 111.678 -177.625 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.97 151.53 49.11 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.77 1.293 . . . . 0.0 113.371 176.333 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -142.61 128.28 19.22 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.135 167.314 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.552 ' HB3' HG12 ' A' ' 60' ' ' VAL . 50.0 mt-10 -91.06 109.95 21.21 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.006 174.631 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 p -118.74 115.75 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.719 -174.176 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -68.53 114.66 7.13 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.481 177.525 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.73 100.05 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 122.285 1.041 . . . . 0.0 110.289 174.287 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -76.84 -22.44 53.54 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 112.144 -2.298 . . . . 0.0 115.191 172.07 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -57.84 118.25 24.93 Favored Pre-proline 0 C--O 1.245 0.839 0 C-N-CA 124.518 1.127 . . . . 0.0 110.924 177.986 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 68.8 Cg_exo -55.59 -53.31 5.86 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 124.194 3.263 . . . . 0.0 111.872 -172.282 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -62.8 -52.52 62.85 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.764 1.626 . . . . 0.0 112.531 170.82 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.91 -156.18 16.97 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 124.57 1.081 . . . . 0.0 111.558 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.596 ' HG ' ' HB2' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -113.89 84.95 2.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.962 1.363 . . . . 0.0 110.086 -173.732 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -81.94 -165.8 1.08 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.996 -1.457 . . . . 0.0 113.991 178.508 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.0 p -53.38 -49.28 67.54 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -166.888 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.776 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.439 15.8 ptt-85 -65.36 -47.3 70.26 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-O 115.795 -2.05 . . . . 0.0 116.471 178.155 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.776 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 73.8 Cg_exo -65.84 -39.36 20.14 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.832 1.688 . . . . 0.0 113.209 169.824 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.22 79.76 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.783 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.39 86.01 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 172.901 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -56.68 -45.14 81.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.153 0.981 . . . . 0.0 112.558 174.121 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -56.99 -47.61 80.41 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.744 1.618 . . . . 0.0 111.897 175.836 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 44' ' ' ALA . 97.0 t -65.33 -43.2 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 123.786 0.835 . . . . 0.0 112.522 175.544 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -58.37 -41.95 85.93 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.197 0.599 . . . . 0.0 111.34 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.55 -52.96 48.55 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 125.054 1.471 . . . . 0.0 111.868 169.668 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.81 -38.49 64.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -178.799 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -75.76 10.95 1.52 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 174.268 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.04 -17.57 40.09 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 124.572 1.17 . . . . 0.0 112.389 163.441 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -96.24 125.56 40.84 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.152 0.977 . . . . 0.0 108.973 179.325 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.4 p -62.4 -35.73 80.11 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.987 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.8 m -53.84 150.73 7.19 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.597 1.959 . . . . 0.0 114.973 176.834 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -80.83 89.77 5.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.719 173.675 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.496 HD13 ' HB3' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -73.94 98.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 109.822 -3.354 . . . . 0.0 114.288 175.903 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.8 m -104.01 128.58 51.59 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 112.261 -2.245 . . . . 0.0 109.512 -178.96 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.5 t -114.52 107.54 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 114.035 -1.439 . . . . 0.0 108.455 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.405 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 60.4 m -108.69 104.29 13.55 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.88 -176.908 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.6 p -90.37 54.64 2.81 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 113.797 -1.547 . . . . 0.0 113.548 -177.252 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.6 m120 48.89 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 123.672 1.701 . . . . 0.0 114.758 -174.854 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.91 -32.62 6.43 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 112.481 -2.145 . . . . 0.0 114.055 -178.998 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -111.58 132.93 54.2 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.373 0.669 . . . . 0.0 109.287 -177.301 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -123.13 134.84 54.18 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 122.183 0.992 . . . . 0.0 111.808 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -134.74 125.69 27.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 113.692 -1.595 . . . . 0.0 111.992 174.149 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.0 t -68.58 122.26 18.11 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.725 171.366 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.496 ' HB3' HD13 ' A' ' 33' ' ' ILE . . . -74.76 13.2 0.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.344 -1.298 . . . . 0.0 114.126 176.832 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -77.57 -7.72 56.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 169.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.4 t -133.46 133.66 42.57 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.377 1.071 . . . . 0.0 112.381 174.076 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -57.44 -53.25 60.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.116 1.366 . . . . 0.0 111.131 177.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -56.55 -34.41 67.04 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.107 -1.406 . . . . 0.0 114.559 176.118 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -58.57 -53.32 59.71 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 175.745 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.04 -32.88 61.66 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 176.941 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.94 -14.88 63.3 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.213 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 p -106.13 18.59 21.81 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 167.407 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.497 HD22 ' HB3' ' A' ' 42' ' ' ALA . 14.2 tp -114.81 120.89 41.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.366 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.53 70.51 1.93 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.393 -175.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 mt -75.9 94.55 3.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.898 176.327 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -142.33 -174.65 4.18 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -43.05 136.07 2.93 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.884 2.474 . . . . 0.0 113.83 -176.693 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.05 -32.16 3.57 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 113.481 -1.69 . . . . 0.0 115.71 175.555 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.2 p -59.37 120.2 8.86 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.981 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' A' ' 5' ' ' GLU . 4.9 t -90.34 77.4 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.599 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.87 113.37 14.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 112.518 -2.128 . . . . 0.0 112.692 -169.59 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.405 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 0.7 OUTLIER -71.51 94.77 1.31 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.716 176.381 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.48 103.97 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 167.224 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -115.67 133.7 55.77 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 112.342 -2.208 . . . . 0.0 110.922 -176.558 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.65 120.06 25.85 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.27 0.981 . . . . 0.0 112.721 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.672 ' HG2' ' HG3' ' A' ' 1' ' ' MET . 38.6 mt-10 -115.25 118.05 32.2 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.336 -1.756 . . . . 0.0 111.697 -178.568 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.25 -151.63 21.94 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.314 -178.932 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.52 -67.91 0.43 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -176.699 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -80.95 40.51 0.54 Allowed 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -178.92 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.569 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 7.5 pt-20 -46.7 -62.82 1.21 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.462 1.905 . . . . 0.0 115.569 -176.936 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.569 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 97.0 mt-30 -64.83 -40.63 95.49 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.676 1.19 . . . . 0.0 113.309 -178.984 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -59.71 -48.5 81.41 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.177 0.991 . . . . 0.0 111.158 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.68 67.84 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.212 0.945 . . . . 0.0 112.918 175.734 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.9 -53.86 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.289 0.636 . . . . 0.0 111.302 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -50.92 -50.8 56.81 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.01 1.324 . . . . 0.0 111.507 -178.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.95 -61.05 2.86 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.972 1.309 . . . . 0.0 111.61 177.933 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.63 -36.66 81.38 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -175.733 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.06 -47.72 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.342 0.657 . . . . 0.0 111.67 176.4 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -59.2 -50.08 75.41 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 123.709 0.631 . . . . 0.0 111.655 175.701 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.0 tp -52.27 -51.61 57.47 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.428 1.491 . . . . 0.0 112.426 175.578 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.4 tpp -52.2 -52.41 52.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.634 1.574 . . . . 0.0 113.002 173.968 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.16 -28.33 66.33 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.915 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.96 -20.13 24.86 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 178.645 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.6 mt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.512 . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.494 ' HG2' ' HG2' ' A' ' 66' ' ' GLU . 4.2 tmm? . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -141.07 140.05 34.15 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.539 1.149 . . . . 0.0 111.652 173.724 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -132.27 155.82 47.64 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.722 1.264 . . . . 0.0 113.775 176.405 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 4' ' ' GLN . . . . . 0.643 ' HB3' HG21 ' A' ' 78' ' ' VAL . 7.3 tp-100 -141.65 125.46 17.02 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 124.563 1.165 . . . . 0.0 113.811 165.489 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -81.43 106.19 13.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.871 174.258 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.7 p -124.33 140.12 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.913 -177.416 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 p -99.94 129.01 45.97 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.129 178.072 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.86 122.38 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.429 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -77.96 -35.17 50.57 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 125.655 1.847 . . . . 0.0 114.472 176.94 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.79 123.4 81.47 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 124.472 1.109 . . . . 0.0 113.208 -174.812 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.86 -50.47 13.97 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.86 3.04 . . . . 0.0 112.022 174.169 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -62.29 -39.23 92.29 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 169.151 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.97 -136.04 12.64 Favored Glycine 0 N--CA 1.481 1.672 0 C-N-CA 124.342 0.973 . . . . 0.0 111.9 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.404 ' HG ' ' HB2' ' A' ' 18' ' ' PRO . 2.5 mp -115.53 75.14 0.92 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.16 0.981 . . . . 0.0 112.521 174.511 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -75.55 -153.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 113.388 -1.733 . . . . 0.0 111.773 174.793 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.1 p -57.75 -61.1 2.76 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -167.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.357 20.7 ptt-85 -68.9 -38.38 11.3 Favored Pre-proline 0 N--CA 1.48 1.062 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 59.5 Cg_endo -75.75 -37.08 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 CA-C-N 122.816 2.041 . . . . 0.0 113.747 173.225 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.41 98.87 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 169.61 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.81 -44.04 73.48 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 172.688 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -63.18 -47.14 83.86 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.569 0.543 . . . . 0.0 112.442 174.256 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE2' ' HG3' ' A' ' 81' ' ' MET . 38.3 t80 -60.74 -47.74 84.93 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.894 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -51.83 -48.95 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.405 1.082 . . . . 0.0 111.765 175.626 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -54.48 -49.16 70.78 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.831 0.707 . . . . 0.0 111.414 179.328 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.07 -49.59 67.08 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.591 1.182 . . . . 0.0 110.959 -178.665 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.35 -42.05 77.13 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 175.003 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -58.44 -31.7 68.0 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.822 0.849 . . . . 0.0 112.615 176.365 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.74 5.55 74.27 Favored Glycine 0 CA--C 1.544 1.901 0 O-C-N 124.919 1.387 . . . . 0.0 115.369 -176.873 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -104.83 141.78 35.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.517 0.658 . . . . 0.0 110.212 169.318 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -45.19 81.43 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 119.002 -0.523 . . . . 0.0 111.588 176.596 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.5 m -52.88 136.61 34.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.129 1.772 . . . . 0.0 113.512 179.205 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.78 112.77 10.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 167.553 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.9 mt -104.02 120.37 54.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 112.838 -1.983 . . . . 0.0 108.88 -174.804 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.7 m -123.32 133.37 54.15 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 112.235 -2.257 . . . . 0.0 110.713 -176.672 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG13 ' CG2' ' A' ' 61' ' ' VAL . 21.9 t -118.11 108.15 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 110.929 -2.85 . . . . 0.0 107.15 -169.206 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.7 m -112.54 103.23 11.29 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 112.876 -1.966 . . . . 0.0 113.035 -175.23 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.2 p -90.6 89.47 7.55 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 112.991 -1.913 . . . . 0.0 111.53 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.6 m120 50.93 63.26 2.31 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 123.406 1.574 . . . . 0.0 114.047 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.69 -25.66 6.43 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-N 113.724 -1.58 . . . . 0.0 115.698 -176.551 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -84.5 121.02 27.0 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 177.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -111.19 139.32 46.67 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -172.35 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.99 145.31 29.69 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.634 166.844 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.0 t -71.26 119.43 15.39 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.999 171.535 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.554 ' HA ' HD13 ' A' ' 50' ' ' LEU . . . -58.78 -30.69 67.76 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.083 -1.872 . . . . 0.0 112.908 174.069 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -74.44 15.06 0.38 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 176.813 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.4 t -133.36 138.94 46.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.166 0.986 . . . . 0.0 111.572 170.909 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.8 tp -66.72 -62.36 1.49 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 111.713 -2.494 . . . . 0.0 110.188 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -50.27 -55.62 14.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.524 1.529 . . . . 0.0 111.224 176.609 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -58.56 -53.86 53.59 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.255 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 44' ' ' ALA . 11.4 tp -64.79 -46.97 79.81 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -179.111 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -57.07 -37.79 72.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 174.772 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.7 p -86.19 -10.1 55.33 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.47 120.81 22.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.911 0.863 . . . . 0.0 108.869 164.401 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.94 89.3 0.24 Allowed Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.054 1.311 . . . . 0.0 113.558 -176.211 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD13 ' HE1' ' A' ' 81' ' ' MET . 58.2 mt -106.0 103.88 13.47 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.571 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -130.75 177.22 7.57 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.67 -1.15 . . . . 0.0 113.046 -177.606 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -43.18 120.9 1.98 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.483 1.913 . . . . 0.0 114.03 177.567 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.64 -14.1 14.47 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 117.796 1.878 . . . . 0.0 117.796 177.575 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.6 m -58.9 129.17 40.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.107 1.454 . . . . 0.0 111.278 -179.145 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.22 93.56 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 113.221 -1.809 . . . . 0.0 107.843 -174.725 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' CG2' HG13 ' A' ' 35' ' ' VAL . 8.7 p -100.1 111.85 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 113.028 -1.896 . . . . 0.0 112.794 -176.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 m -81.68 102.27 10.6 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.737 175.758 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.2 mt -87.36 103.3 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 172.127 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.2 t -115.58 146.24 41.94 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.813 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.43 132.79 44.6 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.685 1.24 . . . . 0.0 113.734 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HG2' ' HG2' ' A' ' 1' ' ' MET . 46.3 mt-10 -121.3 110.44 16.13 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 112.871 -1.968 . . . . 0.0 112.54 177.939 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.58 -124.84 1.28 Allowed Glycine 0 CA--C 1.536 1.403 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.85 171.936 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -103.17 -53.38 2.83 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.599 -1.3 . . . . 0.0 113.631 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -88.92 46.74 1.42 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 175.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.2 pt-20 -55.38 -63.64 1.1 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.352 -1.749 . . . . 0.0 115.485 -178.79 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.414 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 35.3 mt-30 -67.78 -43.32 80.03 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.41 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -52.43 -47.7 66.22 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.781 1.301 . . . . 0.0 112.157 173.457 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.97 -50.63 67.82 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.65 0.78 . . . . 0.0 112.931 177.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.46 -52.57 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.985 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -48.97 -54.52 15.24 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.329 1.452 . . . . 0.0 111.518 177.507 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -56.66 -46.39 81.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.347 1.459 . . . . 0.0 113.121 -178.914 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.53 -36.03 26.72 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -176.271 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.643 HG21 ' HB3' ' A' ' 4' ' ' GLN . 13.3 t -61.39 -41.33 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.438 0.695 . . . . 0.0 110.745 172.24 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -63.27 -50.04 71.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 172.869 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.6 tp -54.43 -51.9 63.47 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.738 0.649 . . . . 0.0 112.667 175.008 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.59 ' HE1' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -59.82 -36.69 77.31 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 176.648 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.43 89.93 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 174.148 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.04 -30.74 44.29 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.7 mt . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 123.504 0.722 . . . . 0.0 112.396 178.533 . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tmm? . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -121.08 133.69 55.24 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.335 1.647 . . . . 0.0 107.677 175.13 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -134.9 136.96 42.75 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.803 -1.544 . . . . 0.0 112.667 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -125.85 116.11 21.04 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.844 175.919 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -81.14 100.39 9.04 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.122 -2.308 . . . . 0.0 108.499 175.099 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.6 140.18 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.486 -172.807 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -73.34 152.08 41.02 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 123.039 1.4 . . . . 0.0 113.242 173.279 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 mt -85.58 110.39 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 164.512 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -88.09 -21.61 24.61 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 112.823 -1.99 . . . . 0.0 115.376 -175.51 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 121.14 56.92 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.091 1.356 . . . . 0.0 112.598 174.524 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -60.34 -52.45 4.01 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.277 2.651 . . . . 0.0 115.509 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -67.61 -31.8 72.09 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.499 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.95 158.35 32.98 Favored Glycine 0 N--CA 1.481 1.674 0 O-C-N 124.525 1.141 . . . . 0.0 112.564 168.399 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.9 mp -78.73 72.44 5.25 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 122.622 1.201 . . . . 0.0 112.92 -175.551 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -67.19 -167.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.97 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 p -46.24 -48.86 17.78 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 -174.655 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.475 35.9 ptt180 -78.22 -39.44 1.74 Allowed Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 177.618 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 79.8 Cg_exo -59.51 -39.2 77.66 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 121.836 1.69 . . . . 0.0 112.055 169.803 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.46 -42.02 98.13 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 173.202 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.19 -44.15 97.24 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.194 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -53.98 -49.76 68.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.057 1.343 . . . . 0.0 111.424 172.679 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -59.85 -36.14 76.23 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.126 -1.397 . . . . 0.0 114.054 175.501 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 19' ' ' ALA . 97.1 t -64.25 -46.73 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.114 0.566 . . . . 0.0 111.902 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.52 -49.86 63.97 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.668 0.787 . . . . 0.0 109.78 177.003 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -60.35 -47.29 86.69 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.54 1.536 . . . . 0.0 113.611 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.44 94.03 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 176.225 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -63.5 -30.84 71.9 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.003 0.921 . . . . 0.0 112.587 174.4 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.0 -21.79 61.78 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.916 1.722 . . . . 0.0 115.081 175.764 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -95.2 155.18 16.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.944 0.898 . . . . 0.0 112.734 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.6 p -78.8 -46.32 19.01 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 117.642 -1.17 . . . . 0.0 112.128 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -54.83 139.13 40.93 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.835 1.254 . . . . 0.0 110.449 175.97 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -78.94 110.11 13.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.963 175.076 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' SER . 2.9 mp -84.61 121.92 37.38 Favored 'Isoleucine or valine' 0 C--O 1.248 0.996 0 CA-C-N 110.751 -2.932 . . . . 0.0 112.149 175.504 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.3 m -116.54 132.67 56.62 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-N 111.43 -2.623 . . . . 0.0 109.017 174.803 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.558 HG13 HG21 ' A' ' 61' ' ' VAL . 6.0 t -113.41 93.32 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.821 -1.99 . . . . 0.0 107.727 -176.945 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -87.81 94.79 9.86 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.596 -178.436 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 t -92.98 95.65 9.61 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.956 -176.299 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 38' ' ' ASN . . . . . 0.566 HD21 ' HB ' ' A' ' 60' ' ' VAL . 12.7 m120 32.53 81.0 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.759 1.623 . . . . 0.0 114.811 -168.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.11 -49.29 4.2 Favored Glycine 0 N--CA 1.481 1.697 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.235 -174.673 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -67.27 102.12 1.02 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -177.445 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.0 m -91.61 100.36 13.1 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.377 -177.201 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.762 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -113.37 143.02 45.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.98 1.371 . . . . 0.0 111.81 174.677 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.4 t -61.58 121.23 12.24 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 112.802 -1.999 . . . . 0.0 111.374 175.049 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.83 -23.68 64.28 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.929 166.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -79.75 -17.68 52.91 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 176.538 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 t -107.95 120.54 42.58 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 177.768 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.2 mt -50.6 -62.84 1.36 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 112.872 -1.967 . . . . 0.0 113.875 -178.657 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -66.37 -13.0 59.97 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -177.087 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 68.7 mmtt -97.31 -37.25 10.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.367 178.992 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 50' ' ' LEU . 13.0 tp -75.37 -43.64 49.24 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 170.713 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -58.02 -23.75 55.46 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 176.312 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.8 p -95.06 -14.1 24.58 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 177.634 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.762 HD22 ' HB3' ' A' ' 42' ' ' ALA . 25.2 tp -77.51 134.65 38.26 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.189 0.995 . . . . 0.0 111.833 -176.789 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.39 82.26 0.02 OUTLIER Glycine 0 N--CA 1.481 1.652 0 CA-C-N 113.824 -1.534 . . . . 0.0 112.731 169.579 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.5 mt -102.1 78.71 1.8 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.686 -1.257 . . . . 0.0 109.811 171.008 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 t -125.74 169.53 12.47 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -174.529 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -47.26 118.03 1.99 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.56 1.544 . . . . 0.0 112.671 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.59 -29.87 11.45 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 112.625 -2.079 . . . . 0.0 113.923 175.579 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 m -66.4 118.49 10.12 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.981 0.896 . . . . 0.0 111.208 -173.461 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' HD21 ' A' ' 38' ' ' ASN . 61.5 t -77.06 107.51 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 112.419 -2.173 . . . . 0.0 109.261 -178.198 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.558 HG21 HG13 ' A' ' 35' ' ' VAL . 12.6 p -107.86 118.86 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 113.353 -1.748 . . . . 0.0 111.409 -178.814 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 m -84.3 100.67 11.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.918 174.285 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mt -78.16 110.8 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.23 172.15 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 13.7 t -119.71 139.49 52.17 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.378 1.049 . . . . 0.0 112.089 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.21 112.71 17.38 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 125.131 1.519 . . . . 0.0 110.93 175.917 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -109.01 101.24 10.34 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 112.574 -2.103 . . . . 0.0 110.26 -176.117 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.36 -159.03 24.67 Favored Glycine 0 N--CA 1.48 1.567 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.727 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -39.21 -84.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 -174.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -72.75 45.03 0.14 Allowed 'General case' 0 C--O 1.256 1.417 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -49.6 -61.17 2.26 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -177.015 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -65.78 -45.15 83.56 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.753 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -62.43 -40.49 96.72 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 113.897 -1.501 . . . . 0.0 113.166 178.386 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.23 -52.91 61.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.696 0.398 . . . . 0.0 111.964 -177.228 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 78' ' ' VAL . 61.3 t -56.43 -61.46 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.419 175.663 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -42.6 -56.88 2.92 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.895 1.278 . . . . 0.0 113.077 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -53.91 -47.34 71.27 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.44 1.496 . . . . 0.0 113.675 177.827 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.1 mt -73.45 -30.65 63.33 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.075 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 74' ' ' VAL . 12.3 t -64.2 -44.31 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.778 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -61.22 -42.9 99.4 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 176.144 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.28 -62.09 2.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.569 172.786 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 60.0 ttm -49.58 -46.9 49.58 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.96 1.304 . . . . 0.0 113.277 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.19 92.68 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -178.461 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.34 6.28 49.12 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 125.114 1.509 . . . . 0.0 114.711 -175.206 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.0 mt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 172.301 . . . . . . . . 0 0 . 1 . 025 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.518 ' HG2' ' HG2' ' A' ' 66' ' ' GLU . 10.0 tmm? . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -122.61 139.65 53.69 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.017 0.823 . . . . 0.0 111.491 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -123.95 147.22 47.91 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 113.942 -1.481 . . . . 0.0 111.377 178.877 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -137.55 134.22 35.39 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.539 1.15 . . . . 0.0 110.557 162.645 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -97.84 112.17 24.18 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.717 1.26 . . . . 0.0 108.813 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.36 151.83 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.169 -174.921 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.8 p -106.41 151.68 24.6 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 176.723 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.507 HD13 ' HB ' ' A' ' 59' ' ' THR . 4.5 mp -81.09 119.91 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.76 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -99.21 -38.65 8.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 112.593 -2.094 . . . . 0.0 114.629 -174.796 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.16 126.13 14.9 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.916 1.286 . . . . 0.0 113.062 176.931 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HA ' HE21 ' A' ' 57' ' ' GLN . 87.2 Cg_exo -49.69 -33.85 33.19 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 125.165 3.91 . . . . 0.0 115.035 -177.165 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -96.89 -70.63 0.71 Allowed 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.288 0.992 . . . . 0.0 111.539 171.733 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.42 -174.52 20.33 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 123.688 0.661 . . . . 0.0 113.397 173.367 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.68 73.53 1.51 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 122.79 1.281 . . . . 0.0 113.471 -179.02 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -73.99 -174.15 1.79 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.705 -1.588 . . . . 0.0 113.268 177.259 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -40.65 -48.37 2.91 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -171.844 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.265 48.0 mtm105 -82.97 -47.45 0.83 Allowed Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -175.346 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.23 -36.38 68.95 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 122.592 2.195 . . . . 0.0 113.795 168.746 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.61 91.85 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 171.211 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.5 -42.57 82.99 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 173.686 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -60.26 -49.72 76.5 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 172.99 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -57.01 -44.95 83.31 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.945 0.898 . . . . 0.0 112.068 177.588 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.417 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 92.4 t -56.41 -49.52 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.488 0.715 . . . . 0.0 111.67 174.123 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -51.16 -48.58 61.84 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.209 0.943 . . . . 0.0 112.493 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -64.58 -56.48 13.67 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.285 0.991 . . . . 0.0 112.078 175.938 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.74 -34.19 51.58 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -179.109 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 28.6 mtpp -55.18 -28.02 49.98 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 173.879 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.01 16.53 60.26 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 124.202 0.938 . . . . 0.0 115.405 -175.845 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -111.23 145.14 39.25 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.813 0.845 . . . . 0.0 109.318 169.58 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.4 p -63.81 -43.68 95.52 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.133 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.4 m -57.23 148.51 22.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.159 1.784 . . . . 0.0 112.588 176.483 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.73 104.35 14.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.837 1.304 . . . . 0.0 109.132 174.726 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 33' ' ' ILE . 2.6 mp -78.58 110.12 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 111.363 -2.653 . . . . 0.0 111.186 -175.468 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.4 m -90.18 95.45 10.21 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 112.879 -1.964 . . . . 0.0 108.137 176.186 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.6 t -84.4 99.35 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 112.418 -2.174 . . . . 0.0 107.348 178.166 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -96.35 104.4 16.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.346 -176.509 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -105.79 100.88 10.42 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.302 -175.607 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.5 m120 37.61 81.01 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.532 1.933 . . . . 0.0 115.404 -169.648 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.35 -39.13 1.43 Allowed Glycine 0 CA--C 1.544 1.887 0 CA-C-N 113.212 -1.813 . . . . 0.0 114.953 -178.791 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -89.15 125.59 35.11 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.649 0.78 . . . . 0.0 111.674 -174.255 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -111.92 142.5 44.23 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.568 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -140.56 142.61 35.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.207 -1.36 . . . . 0.0 114.247 173.011 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -61.85 117.77 6.33 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.573 171.786 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 50' ' ' LEU . . . -61.04 -16.44 43.56 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.621 174.651 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -91.77 5.17 50.86 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -176.317 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 38.3 t -127.72 128.39 45.31 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.95 0.9 . . . . 0.0 112.022 -178.966 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 67.7 mt -55.44 -59.85 4.24 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.276 -1.784 . . . . 0.0 111.989 175.858 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -53.16 -45.33 68.41 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.666 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.55 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 42.7 mmtt -62.9 -56.2 19.38 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.96 0.787 . . . . 0.0 112.989 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -70.65 -38.32 73.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -178.817 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -65.22 -11.73 43.89 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.583 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.4 p -119.44 9.78 11.68 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 173.893 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 42' ' ' ALA . 43.5 tp -84.83 149.5 25.66 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.749 0.82 . . . . 0.0 109.145 176.538 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.78 68.23 0.3 Allowed Glycine 0 CA--C 1.543 1.792 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.556 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.6 mt -102.75 82.96 2.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.123 0.969 . . . . 0.0 111.43 178.039 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.5 t -132.33 164.29 26.77 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.152 -1.84 . . . . 0.0 110.126 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.411 HE21 ' HA ' ' A' ' 11' ' ' PRO . 4.1 tp-100 -48.97 136.41 14.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.326 1.05 . . . . 0.0 113.004 177.373 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.24 -28.13 5.83 Favored Glycine 0 N--CA 1.483 1.823 0 CA-C-N 113.93 -1.487 . . . . 0.0 115.203 175.604 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.507 ' HB ' HD13 ' A' ' 8' ' ' ILE . 8.8 m -55.53 142.75 32.07 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.151 0.98 . . . . 0.0 112.298 -178.714 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.22 127.01 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.592 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -121.25 116.08 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-O 122.828 1.299 . . . . 0.0 114.034 -178.411 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.78 104.38 16.1 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.431 170.591 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.3 mt -87.11 95.23 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.694 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.9 t -107.11 122.16 45.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.018 -177.218 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.89 110.21 19.31 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 178.042 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.518 ' HG2' ' HG2' ' A' ' 1' ' ' MET . 36.5 mt-10 -91.37 122.02 33.61 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 113.038 -1.892 . . . . 0.0 110.573 169.123 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.42 -152.33 24.48 Favored Glycine 0 N--CA 1.475 1.269 0 O-C-N 124.737 1.273 . . . . 0.0 111.692 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -89.97 -60.78 1.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.186 1.394 . . . . 0.0 113.316 -174.927 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -77.58 38.06 0.24 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.837 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.663 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.8 pt-20 -48.06 -66.23 0.44 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.559 2.343 . . . . 0.0 114.918 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.663 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 57.3 mt-30 -56.25 -46.04 79.79 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.859 1.663 . . . . 0.0 113.374 177.898 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -61.74 -47.54 84.78 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.785 1.234 . . . . 0.0 111.776 -178.435 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.59 -50.82 71.88 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 124.23 0.956 . . . . 0.0 112.39 174.857 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.24 -51.02 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.632 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -48.25 -54.49 13.44 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.453 1.501 . . . . 0.0 112.466 178.785 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -65.28 -51.67 59.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.191 177.798 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.35 -26.4 68.01 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -176.527 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.0 t -57.02 -45.5 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.724 0.81 . . . . 0.0 111.569 169.87 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -59.09 -52.77 64.32 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.353 1.033 . . . . 0.0 110.978 176.47 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.03 -47.75 74.33 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.698 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 60.9 tpp -52.84 -36.81 59.34 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 174.829 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.11 -28.64 25.44 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -107.84 22.91 15.27 Favored 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -171.262 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 mt . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 179.69 . . . . . . . . 0 0 . 1 . 026 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG2' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -136.74 141.9 43.03 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.882 1.364 . . . . 0.0 110.76 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -132.12 141.06 49.01 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.249 -179.271 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -133.89 125.0 27.39 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.159 0.912 . . . . 0.0 110.995 176.702 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HA ' HG22 ' A' ' 62' ' ' THR . 36.6 tt0 -74.09 111.6 9.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.654 172.502 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG21 HG22 ' A' ' 78' ' ' VAL . 95.9 t -128.98 140.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.818 -177.002 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 p -113.22 149.41 33.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.809 0.814 . . . . 0.0 111.313 171.438 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 mt -77.43 123.42 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.066 175.765 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -93.12 -36.0 12.89 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 177.871 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -77.12 133.94 68.26 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 176.15 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.737 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 85.8 Cg_exo -58.72 -49.54 11.44 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.859 3.04 . . . . 0.0 112.381 178.397 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -68.82 -44.73 72.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.123 1.769 . . . . 0.0 112.961 171.236 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 67.42 -141.51 39.09 Favored Glycine 0 N--CA 1.475 1.283 0 O-C-N 124.54 1.15 . . . . 0.0 113.153 172.086 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 81' ' ' MET . 3.6 tp -92.66 57.92 2.99 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.806 1.288 . . . . 0.0 110.145 -175.278 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -70.99 -162.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.088 176.595 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -47.34 -61.02 2.1 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -167.288 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.761 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.407 10.5 ptt180 -64.8 -49.37 69.46 Favored Pre-proline 0 N--CA 1.481 1.115 0 CA-C-O 115.375 -2.25 . . . . 0.0 116.297 -179.735 . . . . . . . . 3 3 . 1 . 026 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.761 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 86.1 Cg_exo -59.33 -42.72 46.69 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.063 2.509 . . . . 0.0 113.03 172.047 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.13 -43.42 74.14 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.746 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.96 87.61 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.779 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -60.88 -45.86 92.9 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.759 1.224 . . . . 0.0 112.005 175.189 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -57.99 -45.28 87.06 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.233 1.413 . . . . 0.0 112.777 176.153 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.476 HG21 ' HA ' ' A' ' 47' ' ' LEU . 89.0 t -55.43 -47.8 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.355 0.662 . . . . 0.0 111.752 176.407 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -56.99 -46.44 82.27 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.948 0.78 . . . . 0.0 111.933 177.715 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -63.71 -47.26 81.84 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 123.796 0.685 . . . . 0.0 112.332 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.43 74.68 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.338 1.055 . . . . 0.0 113.791 172.876 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -54.35 -33.74 59.68 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 172.33 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.23 25.09 7.29 Favored Glycine 0 N--CA 1.479 1.511 0 C-N-CA 124.518 1.056 . . . . 0.0 114.264 -177.257 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -125.08 145.43 49.93 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.823 1.249 . . . . 0.0 110.469 169.453 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.7 p -66.06 -43.59 86.98 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.76 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.6 m -54.99 151.16 9.2 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.82 1.648 . . . . 0.0 113.462 174.902 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.29 124.76 43.09 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.663 1.221 . . . . 0.0 109.302 164.151 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.11 99.11 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 111.206 -2.725 . . . . 0.0 109.204 -176.796 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 13.0 m -83.59 115.46 22.14 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 112.422 -2.172 . . . . 0.0 108.678 175.792 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.37 103.83 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 114.031 -1.44 . . . . 0.0 108.746 -177.072 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 m -103.67 103.89 13.86 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.477 -175.018 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.1 t -96.96 97.46 9.28 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.708 176.801 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m120 38.06 79.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.059 -1.882 . . . . 0.0 115.444 -171.541 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.37 -48.69 4.09 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 113.605 -1.634 . . . . 0.0 114.247 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -77.47 119.43 21.05 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.785 0.834 . . . . 0.0 111.198 -176.621 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.7 p -110.1 139.57 45.09 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -173.1 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -133.35 138.93 46.55 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.348 176.388 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.5 t -69.42 118.16 11.95 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.249 170.041 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -23.79 66.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.129 174.721 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -77.86 6.15 8.19 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 175.648 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.8 t -130.36 125.26 34.17 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.782 1.233 . . . . 0.0 112.361 178.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.476 ' HA ' HG21 ' A' ' 23' ' ' VAL . 49.3 mt -53.59 -56.96 12.68 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.992 -1.458 . . . . 0.0 112.221 176.704 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.48 -34.73 77.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.89 -177.511 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 54.7 mmtt -67.72 -56.61 8.6 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 118.972 -0.537 . . . . 0.0 112.181 175.474 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.78 -47.18 84.61 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.744 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.99 -23.34 66.56 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -178.79 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 p -87.89 -25.1 23.43 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 175.668 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.5 tp -74.89 130.63 39.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.075 0.94 . . . . 0.0 111.818 178.518 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.06 95.84 0.18 Allowed Glycine 0 CA--C 1.537 1.451 0 CA-C-N 114.113 -1.403 . . . . 0.0 113.35 177.495 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 mt -105.77 74.7 1.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.322 1.058 . . . . 0.0 111.881 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 t -136.1 142.22 44.28 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.697 -2.047 . . . . 0.0 112.029 -171.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.737 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 6.6 tp-100 2.32 128.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 119.24 3.052 . . . . 0.0 119.24 171.533 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.91 -29.67 0.92 Allowed Glycine 0 N--CA 1.481 1.669 0 CA-C-N 114.003 -1.453 . . . . 0.0 115.981 168.895 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.7 m -61.4 136.53 58.07 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.73 1.212 . . . . 0.0 111.026 -178.318 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.56 110.0 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.521 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.9 p -108.16 92.32 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 112.488 -2.142 . . . . 0.0 109.395 178.799 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 5' ' ' GLU . 17.1 p -82.69 99.48 9.64 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.302 -177.844 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.8 mp -73.73 109.64 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 112.034 -2.348 . . . . 0.0 109.415 174.794 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.448 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 47.4 t -113.73 109.48 18.64 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.735 -2.03 . . . . 0.0 111.125 -177.479 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.64 123.24 47.82 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 122.408 1.099 . . . . 0.0 112.551 -178.901 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.428 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 39.6 tt0 -119.6 91.2 3.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.294 -177.873 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.08 -161.92 30.62 Favored Glycine 0 CA--C 1.548 2.116 0 CA-C-N 112.669 -2.059 . . . . 0.0 110.849 169.807 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.87 -51.18 58.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -79.63 36.81 0.33 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 176.621 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 70' ' ' GLU . . . . . 0.627 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 5.2 pt-20 -39.95 -68.47 0.17 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 128.988 2.915 . . . . 0.0 115.475 -177.879 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 71' ' ' GLN . . . . . 0.627 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 37.9 mt-30 -60.02 -41.43 92.15 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.968 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -71.34 -38.69 71.64 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.012 -176.354 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.57 74.9 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.105 0.878 . . . . 0.0 112.741 170.189 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -74.0 -66.03 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.318 176.343 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -42.37 -53.08 4.36 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 126.13 1.772 . . . . 0.0 112.633 -174.028 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -65.25 -45.88 82.82 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.473 -178.503 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.3 -30.45 67.45 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.399 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 6' ' ' VAL . 70.7 t -59.51 -41.62 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.32 0.648 . . . . 0.0 111.09 171.635 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.89 -53.31 59.42 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.788 0.68 . . . . 0.0 112.24 172.271 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mp -53.87 -44.61 70.56 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.674 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.449 ' HA ' HD13 ' A' ' 14' ' ' LEU . 52.0 tpp -55.9 -43.16 76.99 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.97 1.308 . . . . 0.0 113.669 173.712 . . . . . . . . 2 2 . 1 . 026 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.41 -37.32 37.44 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 179.009 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -98.57 -27.08 14.18 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 119.084 2.994 . . . . 0.0 119.084 -169.945 . . . . . . . . 1 1 . 1 . 026 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 17.1 mt . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.178 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 ttp . . . . . 0 C--O 1.237 0.444 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 . . . . . . . . . 0 0 . 1 . 027 nuclear build core ' A' A ' 2' ' ' PHE . . . . . 0.507 ' HD2' HG21 ' A' ' 74' ' ' VAL . 28.7 t80 -109.04 120.93 44.0 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.848 1.343 . . . . 0.0 109.074 177.016 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -111.84 120.65 42.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.842 -176.954 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -121.96 122.96 40.56 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.735 177.727 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.45 123.98 32.27 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.608 1.192 . . . . 0.0 112.55 177.534 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 6' ' ' VAL . . . . . 0.441 HG21 HG13 ' A' ' 78' ' ' VAL . 53.6 t -129.16 133.26 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.0 178.911 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.41 118.27 25.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.675 175.423 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.05 116.15 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 170.842 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p -124.24 16.67 9.1 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -178.863 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.68 134.34 39.98 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.255 175.4 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -49.27 -35.06 33.49 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.934 3.089 . . . . 0.0 115.996 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -92.63 -41.82 9.99 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 165.7 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.18 -133.83 48.66 Favored Glycine 0 N--CA 1.474 1.211 0 O-C-N 124.207 0.942 . . . . 0.0 111.564 -176.332 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.6 93.7 9.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.834 0.826 . . . . 0.0 111.132 -176.79 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -105.14 -147.79 0.4 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 113.693 -1.594 . . . . 0.0 113.059 174.025 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.2 p -57.24 -72.34 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.779 1.631 . . . . 0.0 114.785 -166.818 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.724 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.34 20.8 ptt180 -62.19 -33.83 13.47 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 176.397 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.724 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 45.5 Cg_exo -57.16 -47.35 23.02 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 122.356 2.037 . . . . 0.0 112.872 166.451 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.67 94.06 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 174.823 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.34 -46.99 69.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 173.742 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -62.7 -49.82 73.56 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.137 0.975 . . . . 0.0 112.174 174.165 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -54.57 -48.32 72.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.278 1.431 . . . . 0.0 111.987 178.953 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.5 t -59.39 -49.88 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 124.145 0.978 . . . . 0.0 112.249 176.492 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -53.23 -52.79 57.8 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 123.868 0.73 . . . . 0.0 110.829 178.826 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -72.33 -38.26 68.69 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 -178.441 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.85 82.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 173.254 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 36.9 mmtt -61.35 -21.17 63.77 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 173.33 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.63 4.16 81.92 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.665 1.126 . . . . 0.0 114.846 175.988 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -114.39 131.75 56.46 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.099 0.959 . . . . 0.0 108.478 171.822 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.4 p -64.48 -47.6 78.36 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.925 -175.523 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 m -46.2 130.34 10.34 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.422 2.289 . . . . 0.0 113.075 174.511 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.34 112.03 17.29 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.934 0.873 . . . . 0.0 109.385 176.597 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.52 HG21 HD12 ' A' ' 77' ' ' LEU . 2.1 mp -95.04 97.55 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 112.086 -2.324 . . . . 0.0 109.744 -171.155 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 5.1 m -84.4 104.99 14.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.437 178.768 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.479 HG13 HG21 ' A' ' 61' ' ' VAL . 5.2 t -87.38 92.81 3.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.0 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.8 m -97.55 92.12 5.77 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.578 -176.287 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.8 p -88.96 108.49 19.6 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.068 0.937 . . . . 0.0 111.24 178.411 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m120 36.33 70.77 0.15 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 112.514 -2.13 . . . . 0.0 114.545 -169.083 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.31 -28.24 3.85 Favored Glycine 0 N--CA 1.482 1.731 0 CA-C-N 113.884 -1.507 . . . . 0.0 116.161 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -88.57 111.26 21.66 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.1 p -96.92 124.18 40.82 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -170.979 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -132.58 140.52 48.29 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.199 -1.819 . . . . 0.0 111.152 171.188 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -72.4 127.73 33.46 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 120.897 0.379 . . . . 0.0 110.833 175.327 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.54 -20.75 22.1 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.733 -1.576 . . . . 0.0 115.07 176.789 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 79.6 mttt -85.01 -8.97 58.5 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.623 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 t -111.21 107.39 16.69 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.307 0.643 . . . . 0.0 112.29 -177.364 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.9 mt -38.7 -63.15 0.54 Allowed 'General case' 0 N--CA 1.483 1.181 0 O-C-N 125.697 1.873 . . . . 0.0 112.83 170.375 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -48.72 -55.03 12.57 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.746 1.218 . . . . 0.0 113.371 177.706 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.646 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 60.9 mttm -56.38 -53.61 55.32 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 178.919 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tp -62.33 -48.3 80.44 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.833 -178.439 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -61.89 -19.53 62.77 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 177.348 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.6 p -114.67 20.18 15.46 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' A' ' 42' ' ' ALA . 16.4 tp -115.76 135.09 54.36 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.05 0.94 . . . . 0.0 109.408 177.005 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.7 93.11 0.06 OUTLIER Glycine 0 N--CA 1.48 1.589 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.486 175.364 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.2 mt -121.7 49.3 1.56 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.717 -1.242 . . . . 0.0 113.18 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 t -118.71 -151.75 0.49 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.184 -170.734 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -46.14 135.19 7.87 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.057 2.143 . . . . 0.0 113.419 175.634 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.53 40.15 54.36 Favored Glycine 0 N--CA 1.483 1.784 0 CA-C-N 113.341 -1.754 . . . . 0.0 115.183 175.942 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.8 m -117.23 127.42 54.08 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.862 0.465 . . . . 0.0 109.973 -174.928 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.6 t -100.59 115.9 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.335 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.479 HG21 HG13 ' A' ' 35' ' ' VAL . 13.0 p -104.25 124.83 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.971 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -92.19 103.24 15.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.762 174.39 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mp -77.85 89.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.345 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.479 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 40.7 t -94.2 90.33 6.31 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.963 -177.057 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.03 114.58 26.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.481 -176.599 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.28 107.57 13.13 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.85 -158.61 31.18 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 114.337 -1.301 . . . . 0.0 113.092 173.35 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.63 -42.46 71.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -173.074 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 p30 -117.92 50.84 1.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -175.743 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.298 12.0 pt-20 -54.88 -50.16 69.41 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -172.44 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -67.99 -33.69 75.11 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.922 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.51 -45.83 92.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.927 1.291 . . . . 0.0 110.532 176.768 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.38 -47.81 84.04 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.251 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.507 HG21 ' HD2' ' A' ' 2' ' ' PHE . 38.4 t -58.88 -55.04 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 117.823 -1.084 . . . . 0.0 112.205 178.672 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -48.8 -51.77 27.57 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.575 1.172 . . . . 0.0 112.36 -177.131 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 34.4 t60 -72.45 -46.23 55.89 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -179.157 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.52 HD12 HG21 ' A' ' 33' ' ' ILE 0.258 76.4 mt -68.7 -26.63 65.38 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -176.878 . . . . . . . . 3 3 . 1 . 027 nuclear build core ' A' A ' 78' ' ' VAL . . . . . 0.441 HG13 HG21 ' A' ' 6' ' ' VAL . 38.9 t -57.7 -52.71 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.132 0.973 . . . . 0.0 110.217 168.091 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 76' ' ' HIS . 56.5 mtmt -51.04 -56.13 14.05 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.827 1.33 . . . . 0.0 112.751 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.7 mt -54.04 -59.16 5.01 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 174.957 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.437 ' HG2' HG11 ' A' ' 61' ' ' VAL . 53.4 tpp -52.03 -49.71 62.87 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.263 . . . . . . . . 2 2 . 1 . 027 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.98 -33.37 70.36 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.356 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -107.76 18.6 21.16 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -171.601 . . . . . . . . 1 1 . 1 . 027 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 18' ' ' PRO . 16.4 mt . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 . . . . . . . . . 0 0 . 1 . 028 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -142.81 138.89 30.7 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 125.798 1.936 . . . . 0.0 111.243 -171.024 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -137.41 133.26 34.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 178.004 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -128.3 150.51 50.03 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.901 1.281 . . . . 0.0 111.378 177.825 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -111.25 126.35 54.78 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.743 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 t -116.94 139.21 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.321 -177.502 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.53 HG22 HG22 ' A' ' 60' ' ' VAL . 4.0 p -97.24 110.27 22.86 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.396 1.093 . . . . 0.0 111.032 174.996 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 mt -88.94 85.8 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.542 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.8 p -103.63 48.57 0.85 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.138 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.46 131.5 23.95 Favored Pre-proline 0 N--CA 1.48 1.046 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.556 -178.224 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.96 -54.88 3.46 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.927 3.751 . . . . 0.0 116.441 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -90.83 -36.04 14.45 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 169.587 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.96 -136.76 38.09 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.383 0.992 . . . . 0.0 112.771 174.18 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.715 HD23 HD13 ' A' ' 55' ' ' LEU . 5.8 tp -92.42 80.06 4.93 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.492 1.139 . . . . 0.0 109.038 -176.722 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 53.8 p-80 -90.94 -166.14 1.51 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 113.038 -1.892 . . . . 0.0 112.738 177.446 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.6 p -33.17 -75.18 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.528 2.331 . . . . 0.0 117.155 -174.786 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.57 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.383 22.4 ptt85 -69.13 -31.69 2.88 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 179.322 . . . . . . . . 3 3 . 1 . 028 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.57 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 47.7 Cg_exo -60.81 -40.72 51.58 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.94 1.76 . . . . 0.0 112.626 165.19 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -59.32 -42.42 91.36 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.566 0.746 . . . . 0.0 112.958 173.254 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.03 -42.45 65.7 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 172.485 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -69.7 -43.94 71.42 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 175.165 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.61 -42.6 83.6 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.184 0.927 . . . . 0.0 112.119 175.238 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 47' ' ' LEU . 60.6 t -59.73 -57.01 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 124.059 0.944 . . . . 0.0 110.395 173.05 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -48.27 -46.61 36.04 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 124.538 1.148 . . . . 0.0 112.4 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -68.85 -54.74 14.0 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 124.684 1.24 . . . . 0.0 112.754 179.059 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.53 66.61 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.577 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -53.87 -39.01 65.33 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 173.298 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.86 -37.01 93.64 Favored Glycine 0 N--CA 1.483 1.768 0 O-C-N 124.775 1.297 . . . . 0.0 113.632 -179.412 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 29' ' ' PHE . . . . . 0.602 ' HE1' ' HE2' ' A' ' 72' ' ' LYS . 72.1 m-85 -76.82 140.08 40.56 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.529 0.731 . . . . 0.0 111.746 178.247 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.0 p -65.47 -47.22 76.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.353 -174.294 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 m -49.37 132.0 20.39 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.665 1.586 . . . . 0.0 112.531 178.239 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -73.74 131.56 41.72 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 119.003 -1.079 . . . . 0.0 109.427 170.759 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.9 mt -119.37 115.28 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.872 -164.275 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -103.75 133.47 48.7 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.262 -2.245 . . . . 0.0 108.845 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.676 HG13 HG21 ' A' ' 61' ' ' VAL . 10.6 t -116.19 94.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 113.66 -1.609 . . . . 0.0 106.857 177.699 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.4 m -94.56 84.13 4.24 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 112.375 -2.193 . . . . 0.0 109.481 -176.923 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.3 p -85.19 97.91 10.17 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.152 -177.976 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.0 m120 45.52 68.61 0.55 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 113.071 -1.877 . . . . 0.0 113.778 -169.651 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.49 -35.19 2.24 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 113.672 -1.604 . . . . 0.0 114.915 178.101 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -73.02 98.06 2.45 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.06 0.944 . . . . 0.0 111.205 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.6 p -84.91 124.82 32.07 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.744 -1.571 . . . . 0.0 114.683 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.722 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -132.95 156.63 46.94 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 112.585 -2.098 . . . . 0.0 109.961 167.08 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -80.23 124.7 29.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.481 0.658 . . . . 0.0 110.422 174.187 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.465 ' HB2' HG23 ' A' ' 35' ' ' VAL . . . -58.31 -36.62 73.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.237 173.75 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -77.85 13.67 1.3 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.751 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.6 t -135.12 110.42 9.0 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.582 ' HA ' HG21 ' A' ' 23' ' ' VAL . 44.9 tp -45.04 -74.52 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.005 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -54.36 -34.6 61.5 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -66.94 -45.19 78.57 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 44' ' ' ALA . 14.6 tp -68.17 -42.03 80.6 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.432 1.082 . . . . 0.0 112.761 175.885 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -62.18 -36.33 81.54 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 175.152 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.9 p -88.89 15.79 7.92 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 175.898 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.722 HD22 ' HB3' ' A' ' 42' ' ' ALA . 18.0 tp -110.76 130.37 55.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.65 1.18 . . . . 0.0 108.065 177.005 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.34 86.54 0.33 Allowed Glycine 0 N--CA 1.485 1.916 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.061 -175.594 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.715 HD13 HD23 ' A' ' 14' ' ' LEU . 5.3 mt -106.92 62.2 0.63 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.938 1.351 . . . . 0.0 111.378 176.981 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 t -123.65 -164.71 1.25 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.006 -169.18 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -55.51 129.12 37.62 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.392 1.077 . . . . 0.0 112.56 179.343 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.3 38.66 93.9 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-N 113.215 -1.811 . . . . 0.0 115.084 -179.34 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 m -105.94 138.32 42.33 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.534 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.53 HG22 HG22 ' A' ' 7' ' ' THR . 12.1 t -114.43 122.39 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 172.686 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.676 HG21 HG13 ' A' ' 35' ' ' VAL . 14.9 p -116.71 117.59 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -174.53 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 m -80.38 100.8 8.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 113.309 -1.768 . . . . 0.0 109.015 170.022 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.467 HG12 HG22 ' A' ' 35' ' ' VAL . 64.2 mt -92.6 111.33 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.525 176.848 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 t -109.08 131.55 54.96 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.668 -177.533 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.14 125.99 48.61 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.15 1.532 . . . . 0.0 111.971 172.921 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -118.3 89.55 3.15 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 177.224 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.1 -156.12 21.84 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-N 113.193 -1.821 . . . . 0.0 112.611 169.194 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -57.52 -53.82 53.81 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.922 1.289 . . . . 0.0 114.19 -177.552 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -81.88 46.14 0.97 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 177.543 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -55.25 -58.06 9.25 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -176.396 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -64.67 -48.81 73.36 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 171.649 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 72' ' ' LYS . . . . . 0.602 ' HE2' ' HE1' ' A' ' 29' ' ' PHE . 77.9 tttt -54.75 -49.3 71.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.48 1.512 . . . . 0.0 113.062 -173.03 . . . . . . . . 2 2 . 1 . 028 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.46 -52.6 64.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.775 0.83 . . . . 0.0 112.88 177.17 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.4 t -68.97 -49.16 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.887 -175.403 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -53.06 -50.93 63.34 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.56 1.144 . . . . 0.0 112.65 179.296 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -61.6 -45.76 92.74 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.942 0.897 . . . . 0.0 112.052 177.19 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.08 -38.49 90.91 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 177.026 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.4 t -59.06 -48.45 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.053 0.941 . . . . 0.0 110.295 173.845 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -56.48 -56.88 15.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.183 0.993 . . . . 0.0 111.199 172.794 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.71 -43.66 62.91 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.533 1.533 . . . . 0.0 113.501 -177.783 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.3 tpp -49.53 -47.87 48.62 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.121 1.368 . . . . 0.0 112.654 176.613 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.08 -24.73 65.99 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.39 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -100.32 23.49 10.07 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.511 . . . . . . . . 1 1 . 1 . 028 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 34.3 mt . . . . . 0 N--CA 1.482 1.167 0 C-N-CA 124.414 1.086 . . . . 0.0 113.834 178.31 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 ttp . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 . . . . . . . . . 0 0 . 1 . 029 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -116.52 130.15 56.59 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 125.004 1.44 . . . . 0.0 109.449 177.038 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -124.19 131.26 53.52 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 112.061 -2.336 . . . . 0.0 110.452 -177.546 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -128.08 98.55 5.16 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 112.986 -1.915 . . . . 0.0 111.779 168.095 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.22 102.29 1.34 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.878 168.905 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.38 142.67 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.776 -1.556 . . . . 0.0 113.235 -179.272 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -87.75 126.91 35.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.079 -1.418 . . . . 0.0 111.767 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 8' ' ' ILE . . . . . 0.483 HD12 ' HB ' ' A' ' 59' ' ' THR . 49.1 mt -75.55 108.59 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.581 169.829 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -92.38 -16.37 26.05 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.353 -1.749 . . . . 0.0 115.419 178.056 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.49 126.06 88.69 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.755 176.389 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 89.2 Cg_exo -49.74 -54.2 5.83 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 124.445 3.43 . . . . 0.0 113.139 -175.272 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -66.55 -59.05 3.99 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.211 1.805 . . . . 0.0 112.087 170.184 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.57 -151.59 20.41 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 124.538 1.149 . . . . 0.0 111.86 176.907 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.799 HD23 HD13 ' A' ' 55' ' ' LEU . 11.5 tp -92.55 70.01 4.94 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.151 -1.524 . . . . 0.0 108.407 -175.482 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -78.32 -155.58 0.08 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.633 -1.621 . . . . 0.0 114.488 -177.115 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.8 p -43.28 -70.41 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.654 1.982 . . . . 0.0 114.805 -170.813 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.327 12.8 ptt180 -73.21 -32.46 1.68 Allowed Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.565 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 47.6 Cg_exo -58.09 -47.15 21.42 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.732 2.288 . . . . 0.0 113.636 167.698 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -57.88 -47.16 83.56 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 175.479 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.66 -39.85 68.47 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 174.641 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -73.1 -42.14 63.29 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.819 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 22' ' ' PHE . . . . . 0.539 ' HE2' ' HB2' ' A' ' 81' ' ' MET . 12.1 t80 -54.76 -41.78 70.87 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 123.68 0.612 . . . . 0.0 111.512 174.079 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 47' ' ' LEU . 48.1 t -57.14 -49.71 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.881 0.872 . . . . 0.0 111.61 174.771 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -52.81 -52.56 56.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.611 0.764 . . . . 0.0 111.378 178.296 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -67.67 -44.55 77.57 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 124.757 1.286 . . . . 0.0 112.862 -178.503 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.85 -41.9 78.75 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.766 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -56.63 -32.48 65.35 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 174.371 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.88 -13.76 66.86 Favored Glycine 0 CA--C 1.544 1.891 0 O-C-N 125.201 1.563 . . . . 0.0 115.192 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -101.84 138.47 38.76 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.161 0.505 . . . . 0.0 110.478 176.673 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.3 p -64.3 -41.26 96.95 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.448 -175.557 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -54.19 141.44 29.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.103 1.761 . . . . 0.0 112.319 174.781 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -86.19 106.33 17.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.064 0.935 . . . . 0.0 109.377 174.25 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.521 HD12 ' HD2' ' A' ' 45' ' ' LYS . 3.7 mp -85.66 93.16 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.322 -175.089 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.18 129.95 38.81 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 113.732 -1.577 . . . . 0.0 107.753 169.223 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG13 ' CG2' ' A' ' 61' ' ' VAL . 10.6 t -114.35 92.96 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.59 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.8 m -93.1 93.22 8.18 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 111.184 -2.734 . . . . 0.0 109.731 -175.141 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB2' ' CG2' ' A' ' 59' ' ' THR . 99.4 p -101.29 100.26 10.75 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.32 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.3 m120 45.33 70.93 0.31 Allowed 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.005 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.25 -31.02 1.85 Allowed Glycine 0 CA--C 1.546 2.011 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.156 -177.108 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -80.99 93.71 6.41 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.186 0.993 . . . . 0.0 113.564 -177.198 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 p -88.68 104.41 16.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 112.726 -2.034 . . . . 0.0 113.907 -179.474 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -129.43 134.68 47.96 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.7 175.369 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.3 t -67.4 127.57 33.17 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 122.272 1.034 . . . . 0.0 113.273 175.296 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.22 -30.96 71.46 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.414 174.01 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HD2' HD12 ' A' ' 33' ' ' ILE . 59.2 mtpt -72.75 -0.64 13.81 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 178.883 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.8 t -121.69 129.07 52.49 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.349 0.595 . . . . 0.0 111.879 170.31 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HA ' HG21 ' A' ' 23' ' ' VAL . 1.6 tp -57.92 -70.48 0.13 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 112.825 -1.989 . . . . 0.0 112.651 -173.072 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.56 -39.17 70.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -56.23 -48.91 75.55 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 172.292 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.3 tp -75.19 -41.62 57.53 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 175.644 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -56.13 -45.49 79.54 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.644 1.178 . . . . 0.0 113.1 177.815 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.7 p -75.22 -7.82 54.91 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 175.296 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 53' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 42' ' ' ALA . 16.1 tp -86.37 118.72 25.99 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.175 0.988 . . . . 0.0 109.244 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.19 102.26 1.06 Allowed Glycine 0 N--CA 1.485 1.93 0 CA-C-N 113.237 -1.801 . . . . 0.0 113.081 -177.343 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 55' ' ' LEU . . . . . 0.799 HD13 HD23 ' A' ' 14' ' ' LEU . 5.9 mt -116.42 96.5 5.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.221 1.008 . . . . 0.0 110.604 -175.484 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -140.29 171.24 14.44 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.086 0.954 . . . . 0.0 113.175 -165.155 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 57' ' ' GLN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 33.8 tt0 -52.77 110.89 0.57 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.834 0.826 . . . . 0.0 111.828 174.085 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.38 -7.89 30.52 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 112.709 -2.041 . . . . 0.0 115.275 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 59' ' ' THR . . . . . 0.483 ' HB ' HD12 ' A' ' 8' ' ' ILE . 7.2 m -75.31 119.9 20.05 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.141 0.97 . . . . 0.0 111.665 -179.284 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.43 101.3 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 174.859 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG2' HG13 ' A' ' 35' ' ' VAL . 14.5 p -109.7 119.87 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.964 -174.557 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -89.63 103.04 15.72 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.535 175.261 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.0 mp -77.78 91.0 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 168.073 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -105.65 92.55 4.23 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 112.381 -2.191 . . . . 0.0 111.427 -171.33 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.41 111.04 23.28 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.188 -176.999 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.48 122.41 46.24 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.78 -154.91 22.89 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 113.025 -1.898 . . . . 0.0 111.126 -176.243 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -67.75 -63.92 0.96 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.356 1.463 . . . . 0.0 114.081 -171.547 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -80.22 40.04 0.47 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.079 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.39 -51.21 56.69 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.174 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -66.85 -54.33 23.5 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.053 0.941 . . . . 0.0 112.833 177.824 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -53.44 -42.57 67.25 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.386 1.475 . . . . 0.0 112.924 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.17 -54.96 40.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.6 0.76 . . . . 0.0 112.575 173.721 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.5 t -58.25 -51.2 74.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.348 178.089 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -48.2 -65.18 0.61 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.816 1.246 . . . . 0.0 113.173 -179.409 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -72.78 -27.87 62.26 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -176.444 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.4 mt -75.1 -41.78 57.92 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 174.486 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.05 -44.07 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 123.271 0.357 . . . . 0.0 110.477 174.68 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -49.01 -62.05 1.74 Allowed 'General case' 0 N--CA 1.479 1.021 0 O-C-N 125.159 1.537 . . . . 0.0 111.57 169.205 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.64 -46.66 73.97 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.733 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.539 ' HB2' ' HE2' ' A' ' 22' ' ' PHE . 24.4 ttp -50.9 -46.85 60.76 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.346 1.458 . . . . 0.0 113.045 178.525 . . . . . . . . 2 2 . 1 . 029 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.65 76.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.461 1.1 . . . . 0.0 112.706 177.779 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.67 32.9 0.71 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.753 1.221 . . . . 0.0 114.088 -173.42 . . . . . . . . 1 1 . 1 . 029 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 34.9 mt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 122.568 1.175 . . . . 0.0 112.4 -179.327 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 1' ' ' MET . . . . . 0.44 ' HG3' ' HB3' ' A' ' 66' ' ' GLU . 17.7 ttt . . . . . 0 C--O 1.239 0.535 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 . . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -137.63 141.18 41.22 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 126.021 2.075 . . . . 0.0 111.386 -173.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -125.14 131.16 53.3 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 125.42 1.7 . . . . 0.0 109.475 174.753 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -126.12 136.43 52.87 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 125.518 1.761 . . . . 0.0 109.872 172.604 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -115.28 94.2 4.62 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 122.509 1.147 . . . . 0.0 114.058 -169.928 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.0 m -120.95 159.95 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 113.521 -1.672 . . . . 0.0 114.328 -173.126 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 7' ' ' THR . . . . . 0.752 HG22 HG22 ' A' ' 60' ' ' VAL . 75.2 p -107.61 155.5 20.07 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -179.349 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.4 mt -103.23 113.76 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 111.211 -2.722 . . . . 0.0 108.401 168.606 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.7 p -94.84 -30.87 13.98 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 112.269 -2.241 . . . . 0.0 116.659 175.214 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -59.8 135.76 89.9 Favored Pre-proline 0 N--CA 1.484 1.269 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.406 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 76.9 Cg_exo -50.13 -48.68 18.81 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.816 3.677 . . . . 0.0 115.415 -178.646 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . 0.285 26.6 p30 -95.48 -16.88 21.91 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 170.96 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 46.88 -128.81 11.71 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.163 1.84 . . . . 0.0 115.576 178.277 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 14' ' ' LEU . . . . . 0.549 HD11 ' HG2' ' A' ' 81' ' ' MET . 81.0 mt -98.47 54.93 1.07 Allowed 'General case' 0 C--O 1.2 -1.515 0 CA-C-N 111.933 -2.133 . . . . 0.0 112.4 -171.926 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -68.66 -166.43 0.08 Allowed 'General case' 0 C--N 1.364 1.233 0 CA-C-N 112.031 -2.349 . . . . 0.0 113.217 174.914 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -54.46 -51.58 64.55 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -164.993 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.254 43.5 ttt85 -69.61 -50.33 18.93 Favored Pre-proline 0 N--CA 1.479 0.976 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 174.814 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 47.1 Cg_exo -57.35 -38.6 94.16 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.958 2.439 . . . . 0.0 113.613 173.09 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 50' ' ' LEU . . . -68.14 -35.33 77.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 172.688 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.26 65.21 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 173.354 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 21' ' ' GLN . . . . . 0.547 ' NE2' HD11 ' A' ' 84' ' ' LEU . 42.0 tt0 -68.48 -39.79 81.23 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.149 0.98 . . . . 0.0 111.549 169.582 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.5 -47.45 83.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.853 0.861 . . . . 0.0 112.028 171.267 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 23' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 44' ' ' ALA . 75.5 t -53.47 -56.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.601 1.16 . . . . 0.0 112.023 175.336 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.91 -61.44 0.85 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.577 1.151 . . . . 0.0 112.389 170.043 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.99 -34.39 77.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -176.156 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.8 -44.38 96.97 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.867 0.867 . . . . 0.0 112.104 176.476 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -56.73 -22.68 37.2 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 176.69 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.97 65.47 Favored Glycine 0 CA--C 1.542 1.728 0 O-C-N 124.741 1.275 . . . . 0.0 111.468 178.701 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -81.79 148.35 28.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.355 1.074 . . . . 0.0 112.84 -174.933 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.1 p -70.44 -35.26 73.26 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.274 -176.048 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.1 m -49.34 148.73 2.48 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.971 1.308 . . . . 0.0 113.457 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -91.98 104.19 16.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 160.098 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 33' ' ' ILE . . . . . 0.66 ' H ' HD12 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -91.1 113.15 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 112.052 -2.34 . . . . 0.0 106.851 176.115 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 34' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 95.9 m -90.98 142.66 27.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.407 173.144 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 44' ' ' ALA . 37.5 t -118.68 106.67 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 112.512 -2.131 . . . . 0.0 108.016 176.542 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 36' ' ' THR . . . . . 0.63 HG23 ' HB3' ' A' ' 41' ' ' SER . 3.9 m -114.06 92.27 3.91 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 112.787 -2.006 . . . . 0.0 109.577 -176.467 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 p -87.58 89.15 7.89 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 122.816 1.293 . . . . 0.0 110.68 179.701 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.6 m120 46.41 74.96 0.13 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.012 -1.904 . . . . 0.0 112.276 -172.536 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.75 -22.56 2.23 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 113.125 -1.852 . . . . 0.0 116.544 -179.727 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -85.86 91.87 8.47 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.854 -0.792 . . . . 0.0 110.0 -177.709 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 41' ' ' SER . . . . . 0.63 ' HB3' HG23 ' A' ' 36' ' ' THR . 28.1 p -101.78 127.99 48.32 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -169.109 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.82 144.81 31.33 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.065 -1.879 . . . . 0.0 110.94 177.604 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -55.33 130.44 42.43 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 168.486 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 44' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -53.77 -30.53 44.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.849 1.26 . . . . 0.0 111.581 172.371 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -74.0 -6.13 45.58 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 46' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -101.03 103.64 14.77 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -171.107 . . . . . . . . 3 3 . 1 . 030 nuclear build core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 tp -49.06 -73.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -176.807 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -45.26 -48.6 12.81 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.16 1.384 . . . . 0.0 113.922 177.657 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 49' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 66.0 mmtt -52.33 -52.47 53.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 117.125 -1.417 . . . . 0.0 114.157 175.571 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 6.3 mp -71.98 -35.94 69.64 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -178.556 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.86 -31.08 72.04 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 175.014 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.9 p -84.78 -35.48 22.34 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 171.167 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 tp -67.61 122.92 19.07 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 111.174 -176.823 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.92 100.14 0.42 Allowed Glycine 0 CA--C 1.54 1.619 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.471 -177.446 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 mt -125.39 88.44 2.87 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.67 1.188 . . . . 0.0 110.293 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -143.49 -166.62 2.37 Favored 'General case' 0 C--O 1.199 -1.584 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.682 -175.396 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -56.28 118.31 4.62 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.774 1.23 . . . . 0.0 112.138 -178.399 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.58 -30.12 10.66 Favored Glycine 0 CA--C 1.544 1.863 0 CA-C-N 112.631 -2.077 . . . . 0.0 113.842 -178.697 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.04 137.68 55.24 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.874 1.27 . . . . 0.0 113.375 -174.335 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 60' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 7' ' ' THR . 11.5 t -116.77 114.38 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.333 -169.302 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 p -109.53 96.84 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 112.952 -1.931 . . . . 0.0 112.269 -166.704 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 62' ' ' THR . . . . . 0.515 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 30.6 m -72.07 101.75 2.82 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 111.614 -2.539 . . . . 0.0 108.6 173.425 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 63' ' ' ILE . . . . . 0.509 HG22 HG22 ' A' ' 74' ' ' VAL . 5.5 mt -94.23 112.57 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 123.772 1.748 . . . . 0.0 110.507 -178.336 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 64' ' ' SER . . . . . 0.649 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 13.3 t -123.79 96.03 4.8 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 109.973 -3.285 . . . . 0.0 113.215 -159.514 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.17 117.7 34.68 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.229 -170.046 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 66' ' ' GLU . . . . . 0.44 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 9.0 pt-20 -120.13 86.96 2.66 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -176.245 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.24 -164.48 30.46 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 112.34 -2.209 . . . . 0.0 110.048 171.114 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -34.82 73.59 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -179.658 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -104.55 43.39 1.1 Allowed 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 -176.187 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -63.12 1.28 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 -178.892 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -62.71 -44.97 94.86 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -49.08 -50.15 38.15 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.339 1.056 . . . . 0.0 113.124 173.63 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.42 -55.79 24.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.797 0.839 . . . . 0.0 112.394 -177.483 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 74' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 63' ' ' ILE . 31.4 t -62.44 -37.16 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-O 117.759 -1.115 . . . . 0.0 111.992 -177.962 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.67 -46.78 86.45 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.478 0.487 . . . . 0.0 111.548 178.659 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 76' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 67.3 t60 -74.27 -32.03 62.77 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.149 -178.852 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 77' ' ' LEU . . . . . 0.456 ' CD1' HG21 ' A' ' 33' ' ' ILE . 54.2 mt -74.85 -36.83 62.34 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 173.688 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.45 -38.7 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.525 173.347 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 76' ' ' HIS . 77.1 tttt -48.21 -58.69 4.19 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.628 1.205 . . . . 0.0 110.521 163.597 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -58.41 -48.04 81.96 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 176.375 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 81' ' ' MET . . . . . 0.549 ' HG2' HD11 ' A' ' 14' ' ' LEU . 13.5 tmm? -52.08 -44.67 64.47 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.513 1.525 . . . . 0.0 112.35 174.442 . . . . . . . . 2 2 . 1 . 030 nuclear build core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.27 -25.34 54.84 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.767 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -83.89 -22.05 31.74 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 178.977 . . . . . . . . 1 1 . 1 . 030 nuclear build core ' A' A ' 84' ' ' LEU . . . . . 0.547 HD11 ' NE2' ' A' ' 21' ' ' GLN . 36.0 mt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 ttp . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -120.7 134.07 55.31 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 125.639 1.837 . . . . 0.0 108.797 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 21.9 mt-30 -128.64 153.61 47.1 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.634 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -142.55 121.98 13.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.113 168.39 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -87.72 97.37 10.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 123.199 1.476 . . . . 0.0 111.275 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.57 155.48 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 112.118 -2.31 . . . . 0.0 108.113 -171.145 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 p -120.09 154.76 34.21 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.303 0.573 . . . . 0.0 112.215 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.479 HD12 ' HB ' ' A' ' 59' ' ' THR . 65.3 mt -103.5 115.16 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.154 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 p -99.24 -0.47 41.31 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -94.87 139.83 22.29 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 110.638 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -55.5 -68.79 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.655 2.903 . . . . 0.0 114.229 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -62.72 -35.77 80.84 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.245 1.018 . . . . 0.0 113.23 167.605 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 74.44 -135.62 19.87 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 124.957 1.411 . . . . 0.0 111.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 1.8 tp -92.88 57.45 2.81 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 113.013 -1.594 . . . . 0.0 109.417 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -67.73 167.51 13.13 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.817 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.4 p 1.26 -68.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 118.687 2.847 . . . . 0.0 118.687 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.416 7.7 ptt-85 -85.18 -38.82 0.62 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 17.7 Cg_exo -54.91 -41.46 78.36 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.214 2.61 . . . . 0.0 113.436 159.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -57.22 -47.27 81.73 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 171.213 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.26 -44.38 79.64 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 24.4 mt-30 -63.32 -42.05 98.97 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.69 1.196 . . . . 0.0 113.728 174.246 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -62.62 -43.42 98.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.297 0.639 . . . . 0.0 112.119 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 19' ' ' ALA . 59.2 t -59.66 -48.16 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.56 0.744 . . . . 0.0 111.936 173.258 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 17.2 tttm -43.74 -55.02 4.69 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.29 0.994 . . . . 0.0 111.781 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -66.03 -46.85 76.38 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 124.227 0.955 . . . . 0.0 112.674 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.75 70.3 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.814 1.245 . . . . 0.0 114.063 175.337 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -61.17 -29.78 70.0 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.33 19.29 23.95 Favored Glycine 0 N--CA 1.481 1.663 0 O-C-N 124.225 0.953 . . . . 0.0 114.787 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -129.92 143.29 50.73 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.323 1.049 . . . . 0.0 110.669 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.2 p -67.21 -41.46 85.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.987 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.8 m -52.32 144.63 12.52 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.591 1.556 . . . . 0.0 113.111 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -86.82 92.38 8.96 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.137 0.97 . . . . 0.0 109.654 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.514 HG21 HD13 ' A' ' 77' ' ' LEU . 3.9 mp -76.96 107.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 112.66 -2.063 . . . . 0.0 109.478 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.7 m -106.86 137.67 44.47 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.09 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.58 115.07 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 112.48 -2.146 . . . . 0.0 107.398 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.9 m -111.58 97.7 6.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.451 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.6 m -92.94 93.83 8.59 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.169 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m120 48.52 76.97 0.11 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.443 -174.216 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.09 -46.34 2.42 Favored Glycine 0 N--CA 1.488 2.146 0 CA-C-N 113.704 -1.589 . . . . 0.0 114.83 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -76.3 126.94 31.91 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.395 1.078 . . . . 0.0 113.156 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.0 p -108.75 141.2 41.1 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -145.51 135.97 24.14 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.399 167.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.5 t -67.52 127.85 34.25 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.286 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.39 -9.47 48.49 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 112.99 -1.914 . . . . 0.0 111.717 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -95.24 35.61 1.29 Allowed 'General case' 0 CA--C 1.552 1.055 0 O-C-N 121.181 -0.949 . . . . 0.0 111.744 173.167 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 41.5 t -154.29 117.23 4.45 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.334 174.774 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' HA ' HG21 ' A' ' 23' ' ' VAL . 44.9 mt -52.51 -61.58 2.19 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.041 175.623 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -52.45 -45.97 66.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.844 1.258 . . . . 0.0 113.751 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.587 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 63.3 mttt -66.39 -43.83 84.73 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 tp -72.45 -23.95 61.14 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -78.73 -27.19 44.82 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.6 p -86.2 -33.27 20.82 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 42' ' ' ALA . 17.6 tp -64.86 131.51 46.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.304 0.642 . . . . 0.0 111.732 174.726 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.83 90.39 0.21 Allowed Glycine 0 N--CA 1.476 1.319 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.91 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 14' ' ' LEU . 8.7 mt -107.93 76.78 1.07 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.057 0.943 . . . . 0.0 111.985 176.371 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 t -137.73 172.87 12.31 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.444 -1.707 . . . . 0.0 112.331 -168.324 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -35.9 125.56 0.72 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.763 2.025 . . . . 0.0 115.435 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.02 -92.14 1.16 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.372 1.463 . . . . 0.0 110.088 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.479 ' HB ' HD12 ' A' ' 8' ' ' ILE . 11.3 m 24.55 123.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 128.216 2.606 . . . . 0.0 117.895 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.8 102.3 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 112.358 -2.201 . . . . 0.0 106.226 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.85 106.77 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 113.294 -1.775 . . . . 0.0 112.173 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.0 m -83.47 115.23 21.98 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.945 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.4 mt -93.31 102.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.6 t -116.62 117.72 30.61 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.091 -171.89 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.19 126.29 50.3 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.927 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -127.93 122.75 33.21 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 125.003 1.44 . . . . 0.0 114.18 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.0 -168.01 31.79 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 113.033 -1.894 . . . . 0.0 110.575 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -52.82 -40.65 63.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -111.09 37.66 2.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -45.94 -58.5 3.5 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -59.62 -51.22 70.75 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.192 1.397 . . . . 0.0 113.859 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -56.72 -41.12 76.91 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.3 1.84 . . . . 0.0 112.387 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.92 -59.84 4.74 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 78' ' ' VAL . 59.5 t -59.46 -44.94 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.067 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -49.2 -62.54 1.48 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.086 0.954 . . . . 0.0 112.127 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -66.0 -35.48 80.68 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.063 1.345 . . . . 0.0 113.766 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.514 HD13 HG21 ' A' ' 33' ' ' ILE . 44.3 mt -69.94 -30.69 68.14 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 74' ' ' VAL . 90.9 t -62.63 -39.9 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.478 0.311 . . . . 0.0 110.322 171.332 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -57.4 -51.32 69.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.236 0.614 . . . . 0.0 112.261 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.5 -45.22 73.22 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.422 ' HE1' HD22 ' A' ' 55' ' ' LEU . 59.8 tpp -59.3 -48.74 80.49 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 172.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.21 -31.9 73.0 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -97.79 -27.64 14.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 17.1 mt -77.36 136.56 38.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 126.917 2.087 . . . . 0.0 107.873 172.745 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 38.9 ttp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.485 ' HE1' ' HG3' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -67.94 109.46 3.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 113.756 -1.565 . . . . 0.0 109.86 175.264 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.03 125.25 48.91 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 124.338 1.024 . . . . 0.0 109.403 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.485 ' HG3' ' HE1' ' A' ' 2' ' ' PHE . 4.9 mt-30 -129.9 130.86 45.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.298 -1.319 . . . . 0.0 114.357 176.794 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.753 ' HG2' HG22 ' A' ' 62' ' ' THR . 58.9 mt-10 -98.16 90.45 4.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.173 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.1 t -96.2 126.48 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.158 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 13.7 m -102.32 120.31 40.27 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.579 HG12 HD12 ' A' ' 14' ' ' LEU . 76.3 mt -68.6 125.14 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 124.974 1.421 . . . . 0.0 108.051 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 t -119.25 -22.1 7.26 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -171.334 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.22 142.85 98.07 Favored Pre-proline 0 N--CA 1.48 1.036 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.81 -30.95 78.24 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.436 2.757 . . . . 0.0 113.963 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -72.97 -49.51 28.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.831 0.852 . . . . 0.0 111.489 166.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.57 171.75 45.19 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.376 1.465 . . . . 0.0 112.129 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.579 HD12 HG12 ' A' ' 8' ' ' ILE . 37.1 mt -73.53 58.73 0.59 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.432 1.587 . . . . 0.0 110.49 164.6 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -70.19 -147.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 112.7 -2.045 . . . . 0.0 116.298 -166.896 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -60.49 -54.28 47.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.069 1.347 . . . . 0.0 113.566 -168.594 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -72.9 -36.77 3.6 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 116.57 -1.681 . . . . 0.0 113.517 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.78 -50.33 10.72 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.822 2.348 . . . . 0.0 112.017 165.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -54.11 -44.18 71.08 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 171.33 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.7 -47.01 77.53 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.058 0.943 . . . . 0.0 113.369 174.418 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -59.43 -46.09 89.71 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.485 ' HE2' HG21 ' A' ' 35' ' ' VAL . 17.0 t80 -63.78 -46.49 84.96 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.234 1.414 . . . . 0.0 113.293 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 47' ' ' LEU . 71.6 t -56.64 -51.18 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 124.331 1.052 . . . . 0.0 110.461 173.083 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -52.5 -53.97 38.83 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.355 1.462 . . . . 0.0 110.9 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.17 -46.64 88.06 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.696 1.247 . . . . 0.0 114.024 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.78 70.71 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.984 0.914 . . . . 0.0 113.318 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -66.5 -12.18 56.18 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.97 21.21 44.51 Favored Glycine 0 CA--C 1.544 1.888 0 C-N-CA 124.309 0.957 . . . . 0.0 113.455 172.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -122.59 125.15 45.08 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.04 0.936 . . . . 0.0 108.49 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.2 p -57.95 -36.97 73.29 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.825 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 p -59.23 157.97 9.8 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.147 1.779 . . . . 0.0 112.624 168.772 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -111.76 136.13 51.44 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.386 1.089 . . . . 0.0 112.841 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.4 111.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 111.893 -2.412 . . . . 0.0 112.205 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.2 m -93.21 98.82 11.52 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 112.551 -2.113 . . . . 0.0 107.122 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 63' ' ' ILE . 46.9 t -109.48 90.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.737 -172.419 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.1 p -104.74 101.8 11.4 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 112.376 -2.193 . . . . 0.0 113.684 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.522 ' HB3' HD12 ' A' ' 53' ' ' LEU . 29.0 t -60.27 103.86 0.27 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.521 166.702 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -19.32 90.12 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.881 2.472 . . . . 0.0 116.885 -172.537 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.08 -72.38 0.26 Allowed Glycine 0 CA--C 1.538 1.53 0 CA-C-N 112.793 -2.003 . . . . 0.0 114.35 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -114.25 144.12 43.74 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -170.066 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.4 m -76.01 130.6 38.66 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.999 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.52 131.29 7.13 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.945 -1.48 . . . . 0.0 112.909 -174.22 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.2 t -89.06 140.85 29.03 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.106 165.443 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.42 -23.2 66.89 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.744 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -82.14 31.17 0.38 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.6 t -160.23 113.32 2.1 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.959 -1.928 . . . . 0.0 109.182 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.465 ' HA ' HG21 ' A' ' 23' ' ' VAL . 29.5 tp -52.98 -62.24 1.78 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.596 -1.638 . . . . 0.0 112.871 -174.191 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -63.77 -32.72 74.32 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' O ' HD23 ' A' ' 53' ' ' LEU . 15.9 tttt -68.64 -39.64 80.63 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 123.731 0.644 . . . . 0.0 112.015 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -70.85 -53.27 15.87 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 123.522 0.514 . . . . 0.0 111.464 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -63.9 -28.15 69.64 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -173.646 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.5 t -71.45 -16.82 62.39 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.522 HD12 ' HB3' ' A' ' 37' ' ' SER . 4.3 mm? -86.18 154.44 21.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.621 0.768 . . . . 0.0 111.575 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.33 94.11 0.04 OUTLIER Glycine 0 N--CA 1.479 1.523 0 C-N-CA 124.695 1.141 . . . . 0.0 112.84 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' A' ' 19' ' ' ALA . 62.4 mt -100.38 48.45 0.92 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.887 1.327 . . . . 0.0 110.565 170.716 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 t -132.03 168.94 17.07 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.573 -168.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -55.0 121.73 9.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.351 1.06 . . . . 0.0 111.902 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.51 -29.06 12.08 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 114.481 -1.236 . . . . 0.0 115.275 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.2 p -73.67 136.93 43.84 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 9.3 t -96.72 111.89 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.475 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 m -92.95 101.59 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.235 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.753 HG22 ' HG2' ' A' ' 5' ' ' GLU . 51.8 p -84.77 94.37 8.68 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.292 -176.233 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.609 HG23 HG22 ' A' ' 35' ' ' VAL . 2.7 mt -82.78 98.55 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 112.899 -1.955 . . . . 0.0 109.013 -173.805 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -104.52 134.43 47.72 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.895 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -122.47 132.62 54.43 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -173.2 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.44 136.55 39.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.295 1.038 . . . . 0.0 113.162 174.295 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.8 -177.23 17.15 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 115.691 1.036 . . . . 0.0 115.691 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -54.84 -33.0 61.19 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -110.32 28.27 8.81 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 2.3 pt-20 -53.63 -57.62 10.12 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -172.223 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.451 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -54.3 -47.35 72.51 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.909 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -57.73 -41.76 82.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.222 1.409 . . . . 0.0 112.613 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.21 -57.51 12.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.2 1.0 . . . . 0.0 112.599 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -67.96 -36.7 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.166 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -52.85 -57.18 11.08 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.036 0.835 . . . . 0.0 111.173 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -65.66 -40.62 92.65 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.6 -43.16 97.74 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -60.22 -43.67 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 122.893 0.477 . . . . 0.0 111.496 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -55.71 -43.66 76.71 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.853 0.861 . . . . 0.0 111.517 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.08 -56.89 15.66 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.772 0.829 . . . . 0.0 112.888 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 20.3 mtp -47.75 -45.08 28.66 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.613 1.165 . . . . 0.0 113.549 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.83 -43.72 63.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.769 1.627 . . . . 0.0 115.307 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -111.74 15.53 20.91 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mp -116.66 20.71 13.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttp . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -141.02 131.61 25.5 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.76 1.288 . . . . 0.0 109.095 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.7 127.35 49.15 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.799 -171.4 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -126.56 122.5 35.28 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.614 0.721 . . . . 0.0 112.664 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.632 ' HG2' HG22 ' A' ' 62' ' ' THR . 60.3 mt-10 -79.5 103.24 9.28 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.272 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.25 135.58 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.653 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.586 HG23 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -103.22 128.89 50.07 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.154 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 mt -97.95 92.4 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 167.106 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -86.02 -24.72 26.3 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.7 133.98 46.13 Favored Pre-proline 0 N--CA 1.482 1.145 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -58.53 -47.35 19.44 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 123.83 3.02 . . . . 0.0 113.2 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -54.17 -36.37 63.31 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 166.784 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.92 -163.49 24.64 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 125.118 1.511 . . . . 0.0 113.791 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.4 mt -115.61 69.35 0.73 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.481 -1.86 . . . . 0.0 110.271 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -73.71 -175.04 1.93 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 111.864 -2.426 . . . . 0.0 114.976 -166.699 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.4 p -40.3 -40.52 1.17 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.254 9.6 mmm180 -75.34 -48.43 4.16 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 116.139 -1.886 . . . . 0.0 113.48 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -54.64 -47.86 24.46 Favored 'Trans proline' 0 N--CA 1.482 0.826 0 C-N-CA 122.214 1.943 . . . . 0.0 113.877 162.718 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.29 -41.57 72.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.07 -31.59 72.76 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -80.75 -37.53 30.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.581 0.752 . . . . 0.0 112.282 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -57.19 -46.34 82.94 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.255 1.022 . . . . 0.0 111.566 173.903 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.5 t -42.31 -61.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 125.227 1.411 . . . . 0.0 113.14 170.006 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -42.71 -50.03 5.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.986 1.315 . . . . 0.0 113.575 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -66.16 -47.88 72.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.907 0.883 . . . . 0.0 112.992 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.62 71.77 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -50.62 -52.8 36.17 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.09 -27.22 68.55 Favored Glycine 0 CA--C 1.541 1.661 0 O-C-N 125.843 1.964 . . . . 0.0 115.13 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -70.15 110.61 5.26 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -38.45 22.06 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.674 1.59 . . . . 0.0 111.617 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.02 140.31 57.86 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 169.814 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -92.1 101.52 14.05 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.938 1.827 . . . . 0.0 111.55 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 77' ' ' LEU . 6.9 mm -71.68 82.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 110.22 -3.173 . . . . 0.0 110.108 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 m -73.69 104.59 4.67 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.795 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.4 t -98.1 85.58 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 112.611 -2.086 . . . . 0.0 106.962 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -86.79 97.69 10.77 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.422 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.499 ' HB3' HD12 ' A' ' 53' ' ' LEU . 5.6 t -70.44 92.15 0.8 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.379 172.616 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.289 37.7 p30 2.67 101.34 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 110.189 -3.187 . . . . 0.0 117.461 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.37 -87.05 0.42 Allowed Glycine 0 CA--C 1.541 1.685 0 CA-C-N 112.721 -2.036 . . . . 0.0 110.122 -168.053 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HB2' HD11 ' A' ' 53' ' ' LEU . 8.1 mptt -94.96 140.07 30.46 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.202 0.525 . . . . 0.0 112.363 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.1 m -78.61 128.56 33.67 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -117.65 169.54 9.48 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.05 166.833 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -132.71 126.17 31.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.596 0.358 . . . . 0.0 110.781 -176.337 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.551 ' HA ' HD22 ' A' ' 50' ' ' LEU . . . -60.05 -30.97 69.55 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.564 1.165 . . . . 0.0 112.925 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -72.73 -36.13 67.7 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.916 1.287 . . . . 0.0 113.403 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -96.73 102.84 14.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 122.321 1.058 . . . . 0.0 110.794 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.8 tp -44.3 -68.73 0.17 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 111.959 -2.382 . . . . 0.0 114.503 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -63.17 -41.66 99.27 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' A' ' 42' ' ' ALA . 83.2 tttt -55.91 -40.74 73.5 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.551 HD22 ' HA ' ' A' ' 44' ' ' ALA . 22.3 tp -68.03 -47.54 68.15 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 118.927 -0.559 . . . . 0.0 111.677 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -63.66 -23.93 67.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -79.44 -27.98 41.67 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.499 HD12 ' HB3' ' A' ' 37' ' ' SER . 2.7 mm? -84.33 168.82 15.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.044 0.938 . . . . 0.0 112.343 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.1 117.19 4.77 Favored Glycine 0 CA--C 1.546 2.002 0 C-N-CA 125.256 1.408 . . . . 0.0 113.428 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.536 HD11 ' HG ' ' A' ' 50' ' ' LEU . 31.6 mt -123.7 60.53 1.09 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.405 1.098 . . . . 0.0 109.2 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 t -153.08 -169.59 3.37 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.259 -160.928 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -49.01 104.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.163 2.185 . . . . 0.0 113.128 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.23 -18.65 56.27 Favored Glycine 0 CA--C 1.547 2.093 0 CA-C-N 112.919 -1.946 . . . . 0.0 114.556 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.4 p -69.61 125.16 25.88 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.266 0.627 . . . . 0.0 111.838 -166.923 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 7' ' ' THR . 45.9 t -97.83 122.56 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.802 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.5 m -105.04 103.45 15.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.067 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.632 HG22 ' HG2' ' A' ' 5' ' ' GLU . 75.0 p -83.22 88.15 6.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.965 -1.925 . . . . 0.0 109.502 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.8 mt -72.14 94.19 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 111.622 -2.536 . . . . 0.0 108.625 -172.401 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 t -101.41 84.22 2.58 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.377 -1.738 . . . . 0.0 109.726 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 100.41 5.7 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.624 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.42 136.34 34.83 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.285 -1.325 . . . . 0.0 113.784 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.49 -147.9 16.32 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 112.735 -2.029 . . . . 0.0 114.172 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -67.32 -25.29 65.94 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 -163.723 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -106.74 -1.69 22.37 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 3.8 pt-20 -8.0 -70.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 120.323 3.453 . . . . 0.0 120.323 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -73.24 -48.08 37.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -175.533 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -55.66 -32.91 63.62 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.393 1.477 . . . . 0.0 112.233 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.16 -63.7 1.01 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.724 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 t -55.03 -41.29 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.709 0.804 . . . . 0.0 111.916 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -45.43 -60.8 1.96 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.054 1.342 . . . . 0.0 112.203 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -69.28 -45.84 68.65 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 114.797 -1.092 . . . . 0.0 113.055 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.428 HD13 HG21 ' A' ' 33' ' ' ILE . 9.7 mt -61.35 -35.46 77.5 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.04 -43.54 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.429 0.692 . . . . 0.0 110.655 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -48.92 -48.28 42.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.378 1.071 . . . . 0.0 111.988 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.4 mt -59.73 -59.1 5.98 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 123.914 0.759 . . . . 0.0 113.011 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 mtt -48.61 -27.2 2.65 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.88 67.49 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -123.34 44.99 2.54 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.905 0.859 . . . . 0.0 112.626 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.1 mt -127.1 -28.72 2.84 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 119.626 3.195 . . . . 0.0 119.626 -171.288 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 174.978 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ttp . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -108.0 126.25 52.5 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 124.955 1.409 . . . . 0.0 109.523 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.61 116.02 26.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.815 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -119.2 121.79 40.51 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.694 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -81.54 113.02 19.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 112.743 -2.026 . . . . 0.0 108.72 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.6 t -124.84 141.05 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 113.427 -1.715 . . . . 0.0 108.88 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.474 HG22 HG22 ' A' ' 60' ' ' VAL . 40.4 p -113.9 121.01 42.67 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.979 172.12 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.09 126.34 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 57' ' ' GLN 0.315 5.1 t -126.14 55.52 1.48 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -177.453 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.735 ' HB2' ' HG3' ' A' ' 85' ' ' GLU . . . -101.74 114.87 65.5 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-N 112.205 -2.271 . . . . 0.0 113.602 -176.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 10' ' ' ALA . 43.1 Cg_endo -63.72 -35.43 57.73 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.595 2.197 . . . . 0.0 112.126 171.367 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -52.1 66.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.286 1.834 . . . . 0.0 113.128 168.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.97 146.05 1.25 Allowed Glycine 0 N--CA 1.483 1.806 0 O-C-N 124.706 1.254 . . . . 0.0 115.462 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.25 79.06 9.66 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.169 1.461 . . . . 0.0 111.008 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -67.41 -167.03 0.06 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 112.501 -2.136 . . . . 0.0 114.795 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.7 p -51.86 -45.04 63.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.191 1.796 . . . . 0.0 115.347 -175.103 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.251 13.9 mmm180 -73.04 -45.5 8.31 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 116.44 -1.743 . . . . 0.0 114.337 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.31 -45.8 35.14 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.269 1.979 . . . . 0.0 112.647 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.27 -44.24 79.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.32 99.18 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -64.94 -43.07 93.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.078 0.951 . . . . 0.0 111.14 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -62.02 -41.4 98.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.06 1.344 . . . . 0.0 111.994 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 47' ' ' LEU . 81.6 t -53.36 -47.49 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.063 0.545 . . . . 0.0 111.545 170.74 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -60.39 -47.22 87.04 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 119.08 -0.486 . . . . 0.0 112.135 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.08 -42.07 99.56 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.04 89.64 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.421 1.088 . . . . 0.0 113.715 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' ' HG2' ' A' ' 45' ' ' LYS . 52.9 mmtt -60.95 -28.4 68.94 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 169.418 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.73 -43.77 98.47 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.095 1.331 . . . . 0.0 113.3 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -78.38 147.0 34.28 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -70.64 -38.53 73.87 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.486 -172.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.0 p -64.36 152.5 41.14 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.51 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 2.9 tt0 -92.35 107.42 19.2 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.891 1.329 . . . . 0.0 111.288 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.775 HD11 ' HB1' ' A' ' 73' ' ' ALA . 48.2 mm -75.28 104.94 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 111.043 -2.798 . . . . 0.0 109.825 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -110.29 114.24 27.54 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.134 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.55 100.97 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.618 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 72.5 m -86.34 97.05 10.2 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.653 174.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -76.74 100.59 5.49 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.888 171.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.313 12.6 p-10 -0.55 87.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 -168.188 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.61 -60.73 0.55 Allowed Glycine 0 N--CA 1.483 1.815 0 CA-C-N 111.397 -2.638 . . . . 0.0 111.916 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.61 116.07 31.85 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 39.6 m -74.78 111.84 10.38 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 113.472 -1.694 . . . . 0.0 114.912 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.12 112.54 21.87 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.45 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -68.44 115.13 7.5 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.752 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.23 -14.67 62.3 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.333 -1.758 . . . . 0.0 112.269 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 32' ' ' GLU . 31.9 mttt -81.77 10.44 6.22 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 34.9 t -133.91 127.41 32.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.369 0.668 . . . . 0.0 111.933 169.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.537 ' HA ' HG21 ' A' ' 23' ' ' VAL . 10.1 tp -47.74 -69.14 0.13 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.389 1.876 . . . . 0.0 110.972 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -51.67 -45.16 63.31 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.221 1.408 . . . . 0.0 113.418 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 40.6 mttt -64.94 -52.63 55.28 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 tp -63.0 -46.33 88.17 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.78 -0.629 . . . . 0.0 112.319 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -56.72 -32.88 65.96 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -78.87 -2.22 38.75 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 53' ' ' LEU . 3.8 mm? -118.22 140.45 49.78 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.27 118.27 6.21 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 113.52 -1.673 . . . . 0.0 113.307 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.561 HD23 HG11 ' A' ' 61' ' ' VAL . 1.3 mp -116.35 87.35 2.67 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 168.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -135.3 -132.37 0.15 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.993 -162.093 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 4.1 tt0 -86.57 134.75 33.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.696 0.798 . . . . 0.0 111.636 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.28 -61.22 4.43 Favored Glycine 0 N--CA 1.484 1.876 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.763 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 p -3.09 114.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 7' ' ' THR . 57.3 t -100.26 108.03 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 112.45 -2.159 . . . . 0.0 107.325 -174.492 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.561 HG11 HD23 ' A' ' 55' ' ' LEU . 15.4 m -113.74 119.78 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.885 -172.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -103.97 104.27 14.22 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.945 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.448 HG23 HG23 ' A' ' 33' ' ' ILE . 4.9 mp -87.0 103.01 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.677 -2.056 . . . . 0.0 107.466 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 t -101.24 108.86 20.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.663 173.837 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.66 97.73 9.95 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.825 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.18 100.96 12.68 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.77 -173.5 33.15 Favored Glycine 0 N--CA 1.48 1.592 0 CA-C-N 111.543 -2.572 . . . . 0.0 111.172 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.98 -55.88 28.59 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -81.3 33.73 0.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -41.95 -50.1 4.55 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.053 2.141 . . . . 0.0 115.878 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -69.54 -55.45 10.15 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.378 1.471 . . . . 0.0 114.478 -178.454 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -67.44 -33.77 75.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.775 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -54.82 -55.88 25.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.063 -0.972 . . . . 0.0 112.012 173.35 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.0 t -64.1 -45.25 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.98 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -52.34 -54.3 33.43 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.697 1.199 . . . . 0.0 113.847 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 85.6 t60 -63.01 -40.32 97.41 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.2 mt -67.34 -37.59 83.52 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.47 -46.05 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.304 1.042 . . . . 0.0 111.094 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 76' ' ' HIS . 40.8 tttp -48.38 -53.44 17.62 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 124.441 1.088 . . . . 0.0 111.382 170.873 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.91 -45.92 91.62 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 45.8 mtm -52.13 -50.94 60.72 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.092 0.87 . . . . 0.0 112.354 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.59 79.88 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.275 12.9 pt-20 -82.5 -18.45 41.53 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.4 mt -108.64 47.96 0.88 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.735 ' HG3' ' HB2' ' A' ' 10' ' ' ALA . 28.9 tt0 . . . . . 0 C--O 1.252 1.204 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmm . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -139.3 142.11 37.71 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.94 1.4 . . . . 0.0 110.976 -172.332 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -128.66 130.93 47.91 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 124.809 1.318 . . . . 0.0 110.315 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -112.66 113.06 25.0 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.271 -1.332 . . . . 0.0 111.212 163.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -77.73 92.83 4.2 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.008 -1.905 . . . . 0.0 109.717 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.81 147.05 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 112.249 -2.25 . . . . 0.0 108.762 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -114.22 153.68 29.22 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.031 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mt -115.24 104.81 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 167.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -118.48 53.79 0.96 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.116 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.483 ' HB2' ' HG3' ' A' ' 85' ' ' GLU . . . -119.72 121.64 29.71 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 111.765 -2.471 . . . . 0.0 110.86 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -55.55 -44.4 48.64 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.212 3.274 . . . . 0.0 111.473 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -60.19 -59.57 5.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.394 1.878 . . . . 0.0 112.768 168.095 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.22 -168.22 54.82 Favored Glycine 0 N--CA 1.478 1.485 0 C-N-CA 124.71 1.148 . . . . 0.0 113.955 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 tp -99.64 58.18 1.04 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 124.161 1.934 . . . . 0.0 108.837 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p-80 -62.86 -169.6 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 113.099 -1.864 . . . . 0.0 115.61 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.36 -60.25 2.45 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -166.679 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HD2' ' HA ' ' A' ' 17' ' ' ARG 0.301 9.4 mmm180 -73.68 -37.84 3.69 Favored Pre-proline 0 N--CA 1.485 1.28 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 177.101 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -54.57 -50.9 11.83 Favored 'Trans proline' 0 N--CA 1.478 0.61 0 C-N-CA 122.854 2.369 . . . . 0.0 113.082 167.052 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -57.73 -42.98 84.96 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 172.419 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.5 88.72 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -66.7 -43.09 85.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.769 0.827 . . . . 0.0 111.79 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -59.66 -39.49 84.58 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.064 1.745 . . . . 0.0 112.301 172.344 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 47' ' ' LEU . 92.2 t -58.51 -51.43 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.107 0.963 . . . . 0.0 111.585 172.045 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -49.08 -49.74 40.19 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.791 0.682 . . . . 0.0 111.71 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.59 -49.79 71.97 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.314 1.008 . . . . 0.0 113.624 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.96 70.79 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 61.1 mttt -65.33 -26.12 67.9 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.45 -35.82 90.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 124.157 0.911 . . . . 0.0 113.71 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -71.44 154.99 41.12 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.0 p -73.88 -45.33 51.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.404 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.3 p -70.03 150.24 46.85 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.175 0.99 . . . . 0.0 112.885 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -94.22 101.37 13.35 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.842 1.306 . . . . 0.0 110.541 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.42 111.57 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 110.883 -2.871 . . . . 0.0 110.021 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.02 120.26 41.26 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.176 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG22 HG12 ' A' ' 63' ' ' ILE . 96.9 t -108.78 84.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.282 -174.574 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.0 m -81.86 110.95 17.63 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.925 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.428 ' HB3' HD12 ' A' ' 53' ' ' LEU . 39.0 t -85.48 99.82 11.47 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.104 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 14.7 p-10 2.56 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 128.01 2.524 . . . . 0.0 117.462 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.17 -45.04 1.33 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 112.836 -1.983 . . . . 0.0 113.005 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.689 ' HB2' HD11 ' A' ' 53' ' ' LEU . 98.4 mttt -123.87 134.95 53.46 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.294 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 m -72.06 137.8 47.4 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 113.954 -1.475 . . . . 0.0 112.943 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.597 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -138.07 137.16 37.5 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.024 171.551 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -107.54 118.83 37.77 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.51 0.671 . . . . 0.0 109.808 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.61 -30.98 71.04 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 113.725 -1.58 . . . . 0.0 112.143 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 48.2 tttt -77.28 16.01 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.827 0.851 . . . . 0.0 113.196 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -154.17 118.87 4.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.56 1.544 . . . . 0.0 112.454 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.586 ' HA ' HG21 ' A' ' 23' ' ' VAL . 55.6 tp -53.37 -71.0 0.08 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.503 -1.681 . . . . 0.0 114.611 -171.782 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -63.13 -31.41 72.55 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.28 -37.7 86.07 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.113 0.565 . . . . 0.0 111.718 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 19.6 tp -72.88 -54.56 8.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.023 0.529 . . . . 0.0 112.366 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -55.33 -38.29 68.54 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 t -61.19 -18.58 58.93 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 40' ' ' LYS . 1.0 OUTLIER -100.64 157.72 16.47 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -176.878 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.85 93.81 0.19 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 113.457 -1.701 . . . . 0.0 113.362 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.488 HD11 ' HG ' ' A' ' 50' ' ' LEU . 27.3 mt -103.82 56.75 0.73 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.647 -1.276 . . . . 0.0 111.134 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.5 t -143.03 178.63 7.56 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.52 -168.909 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -52.45 123.22 10.42 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.835 1.254 . . . . 0.0 113.586 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.99 34.18 10.16 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 112.784 -2.007 . . . . 0.0 113.347 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 p -119.3 140.2 50.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.658 0.383 . . . . 0.0 111.934 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 38' ' ' ASN . 22.7 t -108.49 105.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.5 m -107.34 92.13 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.394 -171.077 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.6 p -78.52 102.44 7.89 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.579 -1.646 . . . . 0.0 110.2 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.445 HG12 HG22 ' A' ' 35' ' ' VAL . 58.6 mt -87.14 95.93 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.374 -174.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.5 t -104.21 122.22 44.92 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.827 -1.988 . . . . 0.0 110.913 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -109.42 115.16 29.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.602 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.87 102.86 12.27 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 112.858 -1.973 . . . . 0.0 112.434 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.82 -162.79 28.98 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 112.766 -2.015 . . . . 0.0 113.266 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -63.06 -61.04 2.65 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 -169.466 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -82.12 47.05 1.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -48.62 -39.38 23.83 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 112.322 -2.217 . . . . 0.0 116.482 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -87.4 -53.16 4.97 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.351 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 42.4 mttt -66.09 -44.66 83.76 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.302 1.441 . . . . 0.0 113.971 -173.117 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.18 83.53 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.878 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.36 -47.4 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.438 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -47.52 -57.06 5.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.253 1.421 . . . . 0.0 112.929 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -59.48 -46.25 89.32 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.535 HD23 HD12 ' A' ' 80' ' ' LEU . 85.2 mt -67.01 -39.31 87.04 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.76 -46.58 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.588 0.755 . . . . 0.0 110.338 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -50.83 -49.91 57.72 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.663 1.227 . . . . 0.0 111.993 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.535 HD12 HD23 ' A' ' 77' ' ' LEU . 95.9 mt -56.9 -54.15 49.84 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.185 0.594 . . . . 0.0 112.514 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.419 ' HE3' HD11 ' A' ' 63' ' ' ILE . 49.6 ttm -54.28 -42.07 69.6 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.227 1.011 . . . . 0.0 112.739 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.44 92.6 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.85 22.97 6.72 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.1 mt -118.63 29.19 7.87 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.195 1.398 . . . . 0.0 113.073 171.441 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.483 ' HG3' ' HB2' ' A' ' 10' ' ' ALA . 26.1 tt0 . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -119.69 143.17 47.89 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.857 1.348 . . . . 0.0 111.111 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -127.06 136.06 51.64 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.48 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -133.97 106.85 7.47 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.188 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.622 ' HB3' HG22 ' A' ' 62' ' ' THR . 8.2 pt-20 -78.03 92.76 4.39 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.231 1.491 . . . . 0.0 115.002 176.055 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.4 t -109.35 137.89 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.258 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 p -93.58 147.18 23.23 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -112.85 122.62 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.779 168.322 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 t -115.75 -27.0 7.2 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.609 -1.632 . . . . 0.0 114.84 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.54 137.27 17.21 Favored Pre-proline 0 N--CA 1.493 1.701 0 C-N-CA 124.72 1.208 . . . . 0.0 112.996 172.531 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -54.88 -54.07 5.04 Favored 'Trans proline' 0 CA--C 1.552 1.382 0 C-N-CA 124.468 3.446 . . . . 0.0 114.546 -171.585 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -63.95 -33.18 75.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 56' ' ' THR . . . 68.19 -170.2 38.3 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 124.993 1.282 . . . . 0.0 112.674 -163.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.03 81.89 7.82 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 113.509 -1.345 . . . . 0.0 108.941 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -62.75 175.59 0.8 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.577 -2.101 . . . . 0.0 115.351 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.1 p -58.18 -37.98 75.79 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -167.255 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -70.52 -46.74 18.64 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 116.608 -1.663 . . . . 0.0 113.414 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.78 -45.86 30.29 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.245 2.63 . . . . 0.0 113.457 164.191 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -39.59 72.89 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.14 86.94 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -58.63 -41.96 87.17 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.784 0.833 . . . . 0.0 111.468 172.38 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' HE2' ' HG3' ' A' ' 81' ' ' MET . 29.5 t80 -58.78 -50.93 72.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.987 1.315 . . . . 0.0 111.692 172.86 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -54.77 -42.65 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.351 0.66 . . . . 0.0 112.575 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -52.53 -55.0 25.17 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.779 0.432 . . . . 0.0 111.127 175.019 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -62.57 -43.76 98.01 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.202 0.601 . . . . 0.0 111.546 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.31 78.87 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -51.18 -36.17 39.84 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.75 27.96 12.78 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.724 1.154 . . . . 0.0 115.489 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -117.86 149.93 40.04 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.142 0.577 . . . . 0.0 110.768 165.421 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.3 p -69.23 -45.43 69.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.052 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.5 p -55.23 136.06 49.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.64 1.176 . . . . 0.0 113.498 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -91.51 83.76 5.44 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.616 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -64.57 92.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 110.509 -3.041 . . . . 0.0 113.42 176.509 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.51 113.37 21.71 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.626 172.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -98.19 94.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 122.559 1.171 . . . . 0.0 107.97 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.404 ' HB ' ' OG1' ' A' ' 62' ' ' THR . 54.3 m -88.81 118.42 28.5 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.453 -1.703 . . . . 0.0 110.877 -173.803 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.3 t -90.15 90.95 8.33 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 112.852 -1.976 . . . . 0.0 111.066 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.26 26.4 p30 32.81 67.47 0.17 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.958 1.703 . . . . 0.0 114.859 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.13 -49.04 1.09 Allowed Glycine 0 N--CA 1.48 1.577 0 CA-C-N 113.043 -1.889 . . . . 0.0 112.93 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -68.15 93.69 0.46 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 m -58.44 106.41 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.489 -1.687 . . . . 0.0 115.431 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.79 97.24 5.35 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.1 -1.409 . . . . 0.0 113.083 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -47.65 106.09 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.717 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 -4.64 37.67 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.459 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -78.54 -15.98 57.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.44 0.696 . . . . 0.0 112.592 163.564 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.8 t -103.49 106.23 16.69 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.226 1.012 . . . . 0.0 110.656 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.51 ' HG ' HE21 ' A' ' 51' ' ' GLN . 4.7 tt -46.06 -40.23 10.42 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 112.336 -2.211 . . . . 0.0 112.931 169.221 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -59.35 -62.97 1.48 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.58 1.152 . . . . 0.0 109.846 174.535 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -57.39 -41.14 79.7 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HG ' HD11 ' A' ' 55' ' ' LEU . 5.8 tp -76.15 -37.59 57.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLN . . . . . 0.51 HE21 ' HG ' ' A' ' 47' ' ' LEU . 36.6 mt-30 -80.43 -15.91 55.66 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.4 t -87.13 -25.79 23.94 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 168.073 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.5 127.27 36.18 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 122.278 1.037 . . . . 0.0 111.834 171.896 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.71 103.38 2.2 Favored Glycine 0 N--CA 1.479 1.561 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.586 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.42 HD11 ' HG ' ' A' ' 50' ' ' LEU . 4.0 mp -80.8 67.07 6.56 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.24 1.019 . . . . 0.0 109.389 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' THR . . . . . 0.606 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 11.5 t -126.62 156.94 40.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.444 -1.253 . . . . 0.0 113.349 -164.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -18.12 109.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.354 2.262 . . . . 0.0 115.83 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.19 14.1 40.11 Favored Glycine 0 CA--C 1.539 1.536 0 CA-C-N 113.169 -1.832 . . . . 0.0 114.766 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.7 p -103.4 124.87 49.52 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.485 1.136 . . . . 0.0 113.609 173.722 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.7 110.77 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 112.52 -2.127 . . . . 0.0 106.06 165.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 m -102.01 100.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.125 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.622 HG22 ' HB3' ' A' ' 5' ' ' GLU . 35.6 p -77.01 104.73 7.67 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 113.083 -1.871 . . . . 0.0 110.856 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mt -85.17 94.21 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.439 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.3 t -94.27 102.22 14.22 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 112.816 -1.993 . . . . 0.0 110.716 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.26 100.0 11.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.515 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -97.05 101.33 12.88 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.323 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.67 -164.76 34.27 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 112.195 -2.275 . . . . 0.0 110.501 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -82.1 -47.91 12.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 117.152 2.278 . . . . 0.0 117.152 -174.465 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -80.71 40.52 0.52 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.581 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.8 pt-20 -47.78 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.99 2.116 . . . . 0.0 116.243 -173.903 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.581 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -56.66 -36.09 69.16 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 177.997 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -72.01 -46.25 57.89 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.098 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.64 -47.03 87.19 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.117 0.886 . . . . 0.0 111.462 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 78' ' ' VAL . 78.2 t -58.66 -54.37 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.059 0.944 . . . . 0.0 111.114 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -52.83 -51.39 61.07 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.341 1.056 . . . . 0.0 112.978 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -63.61 -41.15 98.33 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.441 HD23 HD12 ' A' ' 80' ' ' LEU . 52.2 mt -69.68 -31.56 69.68 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 175.456 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 74' ' ' VAL . 49.4 t -68.08 -45.2 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.921 0.889 . . . . 0.0 110.521 171.75 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -50.45 -46.15 56.48 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.376 1.071 . . . . 0.0 111.59 167.791 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.441 HD12 HD23 ' A' ' 77' ' ' LEU . 22.6 mt -60.66 -50.35 73.84 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 173.009 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.433 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 92.3 mtp -44.72 -48.7 10.75 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.379 1.072 . . . . 0.0 113.381 174.254 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.04 -32.64 74.27 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.27 13.7 pt-20 -100.47 25.57 7.56 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.322 1.058 . . . . 0.0 113.779 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.5 mt -138.06 36.76 2.34 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.724 2.41 . . . . 0.0 111.287 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 N--CA 1.488 1.436 0 C-N-CA 125.202 1.401 . . . . 0.0 107.821 -174.653 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 9.0 tmm? . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -125.54 134.3 52.04 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 125.336 1.647 . . . . 0.0 108.231 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.59 145.42 45.41 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 124.785 1.303 . . . . 0.0 113.764 -173.503 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -157.14 117.73 3.57 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 125.481 1.738 . . . . 0.0 112.19 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.487 ' HB2' HG12 ' A' ' 60' ' ' VAL . 11.1 pt-20 -76.27 132.98 40.18 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.562 169.426 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.17 129.84 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.424 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 p -81.67 143.41 31.91 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.453 -1.248 . . . . 0.0 112.395 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mt -120.44 113.53 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.57 167.684 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 t -100.75 -17.86 16.74 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.25 -1.796 . . . . 0.0 114.371 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.04 143.7 94.67 Favored Pre-proline 0 N--CA 1.477 0.895 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 169.607 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -42.08 -76.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 1 C-N-CA 125.547 4.165 . . . . 0.0 116.095 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -90.56 -22.5 21.25 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.85 -103.09 0.47 Allowed Glycine 0 N--CA 1.479 1.532 0 C-N-CA 125.533 1.54 . . . . 0.0 113.771 169.083 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.8 mt -97.35 66.21 2.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 112.396 -1.902 . . . . 0.0 108.501 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -66.49 -155.52 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 113.709 -1.587 . . . . 0.0 113.629 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -61.03 -49.73 76.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.259 1.424 . . . . 0.0 113.61 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.51 -43.74 53.14 Favored Pre-proline 0 N--CA 1.484 1.271 0 CA-C-O 116.041 -1.933 . . . . 0.0 115.126 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HB3' HD13 ' A' ' 84' ' ' LEU . 87.8 Cg_exo -60.59 -40.99 51.37 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.585 2.19 . . . . 0.0 111.977 168.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -59.83 -44.07 94.24 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.61 -49.78 71.88 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -56.37 -47.98 77.76 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -50.65 -43.66 57.32 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.984 1.428 . . . . 0.0 113.471 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 19' ' ' ALA . 23.3 t -59.93 -54.54 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 123.802 0.689 . . . . 0.0 111.175 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -54.24 -47.24 72.46 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.492 1.12 . . . . 0.0 112.456 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -66.64 -53.76 30.6 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.776 1.298 . . . . 0.0 113.134 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -55.02 -37.88 67.2 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.261 1.025 . . . . 0.0 113.42 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 49.9 mmtt -47.11 -34.0 5.58 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.87 28.93 13.28 Favored Glycine 0 CA--C 1.539 1.534 0 O-C-N 124.866 1.354 . . . . 0.0 114.263 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.543 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 71.1 m-85 -113.82 145.54 41.28 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.708 0.803 . . . . 0.0 110.971 168.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.8 p -78.77 -28.85 44.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 124.412 1.07 . . . . 0.0 112.552 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.2 p -77.55 139.28 39.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.044 164.925 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.37 99.34 8.63 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.882 0.849 . . . . 0.0 110.727 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.815 HD11 ' HB1' ' A' ' 73' ' ' ALA . 46.5 mm -61.72 101.7 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 112.035 -2.348 . . . . 0.0 111.022 173.631 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 1.2 m -100.49 131.84 46.19 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.025 171.897 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG11 HD21 ' A' ' 55' ' ' LEU . 89.4 t -118.17 91.22 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 m -83.63 137.99 33.55 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.901 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.41 ' HB2' HG12 ' A' ' 61' ' ' VAL . 37.8 t -127.41 92.43 3.5 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.265 0.4 OUTLIER 47.47 88.47 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 112.786 -2.006 . . . . 0.0 115.726 -176.7 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.54 -49.26 2.69 Favored Glycine 0 N--CA 1.483 1.774 0 CA-C-N 113.383 -1.735 . . . . 0.0 114.025 -174.654 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.57 ' HB3' HD21 ' A' ' 53' ' ' LEU . 81.5 mttt -64.37 103.92 0.71 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 m -88.82 109.74 20.45 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.109 -1.405 . . . . 0.0 114.531 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB2' HD23 ' A' ' 53' ' ' LEU . . . -113.74 96.06 5.66 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.703 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 47.6 t -59.22 116.01 3.6 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.373 171.544 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.6 -22.74 65.48 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.445 -1.252 . . . . 0.0 114.102 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HE2' ' O ' ' A' ' 26' ' ' ALA . 98.2 mttt -71.03 0.76 6.8 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.473 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 40.6 t -131.73 118.77 20.4 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.879 0.871 . . . . 0.0 110.538 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -55.55 -42.82 75.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.655 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.08 -60.7 2.98 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.366 171.358 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 18.5 mtpt -61.26 -30.97 70.79 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.491 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 33.3 tp -86.3 -53.92 4.74 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -67.93 -14.16 62.75 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -173.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -68.25 -32.78 73.2 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 165.955 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 40' ' ' LYS . 1.1 mm? -76.71 143.44 39.99 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.099 0.952 . . . . 0.0 111.578 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.82 108.02 3.57 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 113.162 -1.836 . . . . 0.0 110.355 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.422 HD21 HG11 ' A' ' 35' ' ' VAL . 6.2 mp -105.71 90.48 3.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 125.61 1.418 . . . . 0.0 107.301 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -149.57 -172.46 4.15 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.553 -160.779 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -57.13 113.34 1.67 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.064 0.946 . . . . 0.0 111.908 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.5 -35.68 4.9 Favored Glycine 0 N--CA 1.484 1.885 0 CA-C-N 112.301 -2.227 . . . . 0.0 113.595 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.7 p -64.37 101.87 0.48 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.779 0.832 . . . . 0.0 112.217 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 5' ' ' GLU . 11.8 t -76.72 101.72 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 113.415 -1.72 . . . . 0.0 106.786 173.461 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 37' ' ' SER . 9.9 m -94.77 128.2 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 112.951 -1.931 . . . . 0.0 112.701 -174.212 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -98.35 109.26 22.05 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.366 -171.802 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 mt -82.41 112.32 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 173.096 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 t -120.46 110.56 16.64 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 111.718 -2.492 . . . . 0.0 108.842 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -102.47 97.16 7.43 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.04 93.02 9.36 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.17 -163.03 29.4 Favored Glycine 0 CA--C 1.541 1.686 0 CA-C-N 112.645 -2.071 . . . . 0.0 113.83 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -54.76 -60.61 3.13 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 118.926 2.936 . . . . 0.0 118.926 -169.252 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -83.28 36.52 0.52 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.543 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.3 pt-20 -40.82 -69.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.543 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -61.19 -42.68 99.01 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -178.617 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -67.39 -44.44 78.87 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.815 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -62.11 -37.91 86.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.533 173.816 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 78' ' ' VAL . 99.4 t -68.64 -47.66 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.334 174.827 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -49.39 -49.94 42.53 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.695 1.198 . . . . 0.0 110.95 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -57.83 -57.13 14.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.28 1.832 . . . . 0.0 112.072 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 -26.31 67.07 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 74' ' ' VAL . 23.2 t -66.74 -47.63 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 167.559 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -54.37 -52.29 62.1 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.598 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -52.52 -57.41 10.04 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.7 mtt -52.43 -39.79 61.43 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.04 -44.07 73.4 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.543 1.152 . . . . 0.0 113.929 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.314 10.3 pt-20 -72.4 -27.08 62.14 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 18' ' ' PRO . 40.4 mt -88.6 88.57 7.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.652 1.181 . . . . 0.0 112.74 169.126 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tmm? . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -88.23 130.77 34.99 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.755 0.788 . . . . 0.0 110.023 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' GLN . . . . . 0.472 ' HG2' HG22 ' A' ' 62' ' ' THR . 15.4 tt0 -134.05 142.32 47.53 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.073 -1.876 . . . . 0.0 111.72 -173.04 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -147.71 139.72 24.19 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 124.94 1.4 . . . . 0.0 110.602 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -93.34 131.4 38.53 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.915 0.759 . . . . 0.0 112.535 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.84 136.14 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.611 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.63 HG22 HG22 ' A' ' 60' ' ' VAL . 17.0 p -102.43 108.91 20.4 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 112.588 -2.096 . . . . 0.0 110.631 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 mt -71.19 96.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 113.12 -1.854 . . . . 0.0 107.503 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 t -86.26 -26.91 24.73 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 113.24 -1.8 . . . . 0.0 113.501 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.1 135.36 80.57 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 124.18 0.992 . . . . 0.0 111.219 171.037 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -46.34 -37.65 19.36 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 124.638 3.559 . . . . 0.0 116.435 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.29 -37.06 2.07 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.97 -93.5 0.41 Allowed Glycine 0 N--CA 1.476 1.309 0 O-C-N 124.031 0.832 . . . . 0.0 112.903 163.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 6.4 mp -94.4 63.43 3.01 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 122.615 1.198 . . . . 0.0 112.574 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -72.34 -169.51 0.53 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.291 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.6 p -47.47 -47.72 27.11 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.293 12.6 mmt180 -70.16 -51.7 13.57 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-O 115.398 -2.239 . . . . 0.0 114.932 -179.312 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.567 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 92.3 Cg_exo -60.8 -39.24 64.2 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.203 1.936 . . . . 0.0 113.816 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.54 -47.57 85.61 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.25 0.62 . . . . 0.0 112.639 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.52 85.32 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -66.4 -44.78 82.07 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HE1' ' HG3' ' A' ' 81' ' ' MET . 0.9 OUTLIER -54.3 -51.63 64.04 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.261 1.024 . . . . 0.0 111.162 171.328 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 47' ' ' LEU . 71.6 t -51.62 -51.52 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.465 1.106 . . . . 0.0 111.835 173.205 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -56.04 -53.97 50.6 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.717 1.207 . . . . 0.0 111.214 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HB3' HD21 ' A' ' 77' ' ' LEU . 7.9 tp10 -65.42 -43.94 88.94 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.361 1.038 . . . . 0.0 113.089 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -40.07 72.65 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -58.53 -14.33 7.76 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 174.005 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.68 -35.49 22.22 Favored Glycine 0 N--CA 1.48 1.63 0 C-N-CA 124.41 1.005 . . . . 0.0 114.74 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -80.8 154.33 27.23 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.849 0.86 . . . . 0.0 113.032 -174.282 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -69.77 -43.09 72.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 123.984 0.803 . . . . 0.0 111.787 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.6 p -61.23 145.54 50.88 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 8.7 mt-10 -83.26 134.05 34.96 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.985 0.898 . . . . 0.0 111.189 167.436 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.6 mm -112.12 106.98 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.074 -166.193 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.66 119.35 33.45 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.248 -1.797 . . . . 0.0 109.438 -174.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.44 HG12 ' HB ' ' A' ' 61' ' ' VAL . 40.1 t -110.21 87.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -77.88 100.65 6.45 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.845 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.2 t -76.7 97.31 4.42 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.099 -1.409 . . . . 0.0 111.716 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 p30 35.12 61.97 0.59 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.86 -76.26 0.3 Allowed Glycine 0 N--CA 1.485 1.919 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.844 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.63 138.84 41.66 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.468 0.652 . . . . 0.0 112.513 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.5 m -99.35 140.13 33.98 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -124.76 134.94 52.62 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 113.571 -1.649 . . . . 0.0 109.232 175.217 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 t -117.26 126.56 52.94 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.95 -15.46 43.61 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 125.488 1.743 . . . . 0.0 113.637 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 32' ' ' GLU . 30.4 mmtt -71.87 -6.63 43.14 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 171.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -131.26 134.49 46.45 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.63 1.572 . . . . 0.0 109.598 168.17 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.581 ' HA ' HG21 ' A' ' 23' ' ' VAL . 43.7 tp -59.67 -52.38 65.75 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.498 169.633 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -62.92 -49.35 75.13 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 112.912 -1.949 . . . . 0.0 113.644 -175.478 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -65.22 -32.19 73.74 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.846 0.716 . . . . 0.0 112.909 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.551 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 12.2 tp -76.53 -44.93 32.87 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 119.015 -0.517 . . . . 0.0 112.233 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -59.45 -39.54 83.93 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.5 t -58.83 -39.46 81.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.81 140.79 39.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.329 1.062 . . . . 0.0 113.159 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.27 81.37 0.2 Allowed Glycine 0 CA--C 1.535 1.319 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.274 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.436 HD23 HG11 ' A' ' 61' ' ' VAL . 61.8 mt -82.27 60.8 5.17 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 123.626 1.679 . . . . 0.0 110.172 172.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 t -123.32 -178.68 4.06 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 112.495 -2.139 . . . . 0.0 112.477 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -51.68 127.64 21.14 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.774 1.229 . . . . 0.0 112.545 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.71 -32.61 6.61 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 112.962 -1.926 . . . . 0.0 113.468 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.0 p -62.45 116.82 5.42 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 122.474 1.131 . . . . 0.0 113.858 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.63 HG22 HG22 ' A' ' 7' ' ' THR . 4.2 t -86.75 95.13 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 112.239 -2.255 . . . . 0.0 106.075 174.156 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.44 ' HB ' HG12 ' A' ' 35' ' ' VAL . 31.6 m -95.65 113.45 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 112.608 -2.087 . . . . 0.0 110.365 -176.042 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 3' ' ' GLN . 0.9 OUTLIER -91.43 108.74 20.1 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.247 -173.42 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.6 mt -91.17 107.08 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.724 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.5 t -103.12 126.93 50.52 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 112.614 -2.085 . . . . 0.0 111.075 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.09 111.34 21.97 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 124.679 1.237 . . . . 0.0 110.533 168.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -103.05 99.17 9.03 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.04 -159.74 28.68 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.576 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -54.48 39.0 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -173.729 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -83.05 33.49 0.44 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 2.2 pt-20 -45.04 -59.35 2.64 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.43 ' CD ' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -65.87 -40.08 91.29 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.091 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -70.31 -43.14 70.94 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.228 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.35 -52.82 64.01 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.461 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.08 -47.05 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.662 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -52.78 -57.55 9.79 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.16 0.984 . . . . 0.0 112.775 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.79 -45.54 93.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.215 1.006 . . . . 0.0 112.816 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 88.1 mt -69.46 -33.44 72.92 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -69.01 -48.4 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.787 0.835 . . . . 0.0 111.456 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -52.0 -45.49 64.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 123.829 0.705 . . . . 0.0 112.046 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.9 tp -52.85 -59.25 4.74 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.687 1.195 . . . . 0.0 112.475 174.089 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.523 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 38.7 mtt -47.95 -43.13 29.03 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 173.008 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.89 -45.66 88.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 118.152 -0.928 . . . . 0.0 113.337 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -86.24 -3.18 58.92 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.1 mt -97.66 96.66 8.42 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.912 0.885 . . . . 0.0 111.141 170.747 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 C--O 1.254 1.314 0 CA-C-N 113.655 -1.611 . . . . 0.0 106.993 175.362 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.476 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 . . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -133.13 127.51 34.07 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 124.385 1.053 . . . . 0.0 111.321 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -110.28 146.03 36.37 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.814 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -155.07 125.82 7.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.756 1.222 . . . . 0.0 108.072 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -105.86 96.16 6.3 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 125.04 2.353 . . . . 0.0 113.622 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.7 t -95.73 119.22 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 111.222 -2.717 . . . . 0.0 110.841 -166.318 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 m -74.85 115.67 14.71 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.571 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.25 135.93 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.34 -23.25 4.89 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.37 -1.741 . . . . 0.0 113.856 -173.417 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 138.72 30.5 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.604 1.162 . . . . 0.0 111.386 169.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -39.98 -50.71 3.3 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 C-N-CA 124.66 3.573 . . . . 0.0 117.345 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -116.88 21.95 12.96 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.01 -98.48 0.01 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.352 1.453 . . . . 0.0 113.822 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.549 HD21 ' HG3' ' A' ' 81' ' ' MET . 19.4 mt -119.1 110.93 17.65 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 113.766 -1.217 . . . . 0.0 111.604 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -91.15 -165.8 1.44 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.211 164.28 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -51.47 -43.93 62.28 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.253 11.4 ttm105 -68.98 -45.17 30.56 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.281 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.555 ' HG3' HD22 ' A' ' 84' ' ' LEU . 65.9 Cg_exo -61.26 -30.21 87.68 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.671 2.248 . . . . 0.0 115.169 167.674 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -46.15 84.25 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.759 0.709 . . . . 0.0 112.207 168.143 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.68 -44.93 80.46 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.225 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 18' ' ' PRO . 43.2 mt-30 -51.94 -53.25 43.39 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.094 0.958 . . . . 0.0 112.971 172.061 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -51.87 -60.52 3.08 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -46.47 -55.88 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.908 1.283 . . . . 0.0 112.707 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -51.97 -47.42 64.84 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 124.563 1.164 . . . . 0.0 112.279 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.01 -56.06 8.92 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.713 1.258 . . . . 0.0 112.688 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.22 -44.46 75.44 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.248 1.819 . . . . 0.0 115.049 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -51.56 -31.98 26.59 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.14 -49.42 78.8 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 125.449 1.718 . . . . 0.0 114.394 173.527 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -60.45 154.74 19.88 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -86.72 -15.88 38.13 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.838 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.4 p -82.94 153.02 25.25 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.718 164.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.421 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -94.3 131.89 39.45 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.388 0.675 . . . . 0.0 109.191 173.56 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 mm -112.97 100.47 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.998 -159.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.9 m -104.28 126.34 51.3 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.18 85.82 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.599 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 50.3 m -64.45 120.68 12.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.348 170.847 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.567 ' HA ' HG12 ' A' ' 61' ' ' VAL . 40.8 t -94.0 95.43 9.04 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 24.98 63.98 0.05 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.63 -24.6 8.43 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 117.3 1.68 . . . . 0.0 117.3 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -130.51 140.93 50.5 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 118.656 1.228 . . . . 0.0 109.641 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 77.6 p -101.28 129.44 47.25 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -162.737 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.684 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -114.99 104.05 11.52 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.103 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -59.34 113.84 2.37 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 169.977 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.48 0.15 43.72 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.59 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 32' ' ' GLU . 44.8 mttt -89.99 -44.43 9.87 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.533 164.835 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -70.62 116.96 11.54 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.362 0.601 . . . . 0.0 112.016 169.165 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 tp -64.37 -44.76 90.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.241 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -66.25 -34.79 78.81 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.416 1.086 . . . . 0.0 111.693 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' O ' HG22 ' A' ' 52' ' ' THR . 28.7 tttt -76.96 -47.73 20.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.684 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 26.9 tp -51.81 -49.37 62.89 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -63.85 -27.37 69.12 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 49' ' ' LYS 0.266 3.6 t -74.09 -20.61 60.21 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.14 135.8 33.16 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.419 1.104 . . . . 0.0 113.001 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.02 90.75 1.1 Allowed Glycine 0 CA--C 1.537 1.466 0 CA-C-N 113.182 -1.826 . . . . 0.0 109.561 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.65 64.64 3.57 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.558 1.17 . . . . 0.0 110.288 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.7 t -108.13 174.73 5.75 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.045 -170.708 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -50.63 137.45 19.71 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.305 1.042 . . . . 0.0 110.667 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.24 -47.19 1.79 Allowed Glycine 0 N--CA 1.481 1.699 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.597 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.8 p -56.92 120.75 8.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.875 0.397 . . . . 0.0 111.275 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 t -86.65 109.63 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 111.837 -2.438 . . . . 0.0 107.917 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 37' ' ' SER . 30.5 m -104.95 116.41 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -170.883 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 m -82.8 97.47 8.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.149 0.98 . . . . 0.0 109.006 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.456 HD12 HG22 ' A' ' 78' ' ' VAL . 16.2 mt -74.05 92.16 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 166.858 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -100.13 108.75 20.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 110.129 -3.214 . . . . 0.0 109.578 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.42 100.49 9.77 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.747 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 7.6 pt-20 -96.72 89.82 5.07 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.05 -162.7 29.27 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.637 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -56.39 -59.35 5.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 118.721 2.86 . . . . 0.0 118.721 -162.334 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -85.41 50.16 1.9 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -51.72 -53.15 42.58 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.193 -2.276 . . . . 0.0 116.079 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -43.17 57.16 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.69 -49.78 76.14 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.6 -52.07 42.69 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.918 1.387 . . . . 0.0 112.614 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.567 ' O ' HG23 ' A' ' 78' ' ' VAL . 86.5 t -53.68 -56.08 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 123.975 0.797 . . . . 0.0 111.795 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.13 -53.09 62.25 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -52.91 -47.6 67.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.952 1.301 . . . . 0.0 113.969 175.846 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -66.22 -36.71 83.74 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 74' ' ' VAL . 9.0 t -64.94 -47.21 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 O-C-N 122.336 -0.227 . . . . 0.0 110.698 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -54.05 -37.74 64.48 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.9 tt -60.99 -51.84 67.53 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.043 0.937 . . . . 0.0 110.014 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.549 ' HG3' HD21 ' A' ' 14' ' ' LEU . 10.6 ttm -60.57 -46.98 88.2 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.393 1.077 . . . . 0.0 113.005 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.12 -14.79 0.69 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -125.49 45.19 2.64 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 170.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.555 HD22 ' HG3' ' A' ' 18' ' ' PRO . 44.8 mt -123.38 121.97 37.12 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.258 169.705 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 . . . . . 0 C--O 1.249 1.076 0 O-C-N 125.626 1.829 . . . . 0.0 110.64 171.489 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.5 ttm . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -120.8 140.62 51.47 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.964 1.415 . . . . 0.0 109.576 173.683 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -128.65 142.67 50.96 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.518 1.136 . . . . 0.0 112.032 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -150.49 119.62 6.75 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.025 1.453 . . . . 0.0 110.799 169.294 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 11.7 pt-20 -72.88 126.65 30.44 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.888 -1.506 . . . . 0.0 113.223 173.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.12 131.75 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.098 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.9 m -111.34 110.48 20.97 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.73 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.1 mt -72.62 113.9 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.445 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -85.74 -19.08 31.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.388 -1.733 . . . . 0.0 114.844 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -54.87 127.64 62.03 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.554 1.142 . . . . 0.0 113.009 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 52.3 Cg_exo -54.11 -62.3 0.32 Allowed 'Trans proline' 0 N--CA 1.485 0.999 0 C-N-CA 124.602 3.535 . . . . 0.0 113.314 -169.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.2 p-10 -94.29 29.62 2.16 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 174.44 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . 33.74 -134.06 0.31 Allowed Glycine 0 N--CA 1.479 1.546 0 C-N-CA 127.345 2.402 . . . . 0.0 116.345 -175.613 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.8 122.43 44.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.117 -2.042 . . . . 0.0 109.966 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' HIS . . . . . 0.425 ' HB2' ' H ' ' A' ' 16' ' ' THR . 2.2 p80 -109.2 -154.93 0.54 Allowed 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.195 -1.82 . . . . 0.0 113.579 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' THR . . . . . 0.425 ' H ' ' HB2' ' A' ' 15' ' ' HIS . 15.3 m -61.01 -48.36 82.15 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -166.682 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -63.27 -47.61 84.4 Favored Pre-proline 0 N--CA 1.489 1.502 0 CA-C-O 116.599 -1.667 . . . . 0.0 112.233 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.79 -47.14 28.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.823 2.349 . . . . 0.0 113.48 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.92 -48.26 73.32 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.9 -46.91 84.21 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.118 0.967 . . . . 0.0 113.381 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -57.89 -42.78 85.37 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.576 ' HE1' ' HB3' ' A' ' 80' ' ' LEU . 21.7 m-85 -66.28 -49.24 67.78 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 47' ' ' LEU . 40.6 t -58.07 -35.84 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.448 0.699 . . . . 0.0 112.521 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -62.81 -65.07 0.74 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.029 0.932 . . . . 0.0 111.014 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.52 -52.76 62.18 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 44' ' ' ALA . . . -64.91 -27.27 68.74 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -176.665 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 38.0 mttm -58.5 -35.52 72.38 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 169.393 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.66 -31.83 79.31 Favored Glycine 0 N--CA 1.482 1.731 0 O-C-N 125.78 1.925 . . . . 0.0 113.579 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -79.01 142.17 36.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.294 0.638 . . . . 0.0 110.695 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.1 p -64.5 -43.75 93.12 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.64 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.2 p -59.68 143.8 49.68 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 114.419 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -90.78 126.3 35.97 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.744 1.259 . . . . 0.0 109.999 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.549 HG21 HD13 ' A' ' 77' ' ' LEU . 15.4 mm -98.4 98.56 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 112.765 -2.016 . . . . 0.0 109.71 -169.418 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 0.2 OUTLIER -83.86 101.28 11.54 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.705 -1.588 . . . . 0.0 107.554 175.756 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.5 t -87.43 77.6 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.9 m -75.45 88.28 2.63 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.339 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.7 t -79.8 86.68 5.34 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.819 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 21.12 81.4 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 111.295 -2.684 . . . . 0.0 115.484 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.37 -63.37 0.28 Allowed Glycine 0 CA--C 1.543 1.81 0 CA-C-N 112.173 -2.285 . . . . 0.0 112.79 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -104.9 133.02 50.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -169.479 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 p -88.71 116.23 26.82 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 113.557 -1.656 . . . . 0.0 115.444 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.463 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -102.29 164.96 11.39 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.546 168.847 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -125.69 119.38 27.85 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.305 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -72.57 5.97 2.72 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 124.42 1.075 . . . . 0.0 113.059 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 27' ' ' LYS . 50.9 mtpt -113.89 -15.21 12.4 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 172.923 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.0 t -119.02 120.9 38.58 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.824 0.849 . . . . 0.0 111.685 172.448 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.62 ' HA ' HG21 ' A' ' 23' ' ' VAL . 20.0 tp -57.44 -61.83 2.21 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.018 -1.447 . . . . 0.0 113.386 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -45.37 -50.78 11.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.29 1.436 . . . . 0.0 113.238 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -67.67 -30.93 70.59 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 18.6 tp -72.98 -47.06 48.59 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.513 0.508 . . . . 0.0 111.752 174.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -65.99 -31.53 72.48 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.5 t -85.03 33.71 0.54 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.856 1.313 . . . . 0.0 114.351 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.05 140.72 44.03 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.907 171.555 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.7 93.23 0.17 Allowed Glycine 0 N--CA 1.479 1.525 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.256 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.414 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 17.0 mt -94.96 57.86 2.14 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.293 1.044 . . . . 0.0 110.721 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -109.39 176.88 4.92 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.866 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -58.58 126.15 26.38 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.758 0.79 . . . . 0.0 111.888 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.66 16.23 64.23 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 113.385 -1.734 . . . . 0.0 114.925 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.0 p -88.23 120.44 29.59 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.543 0.687 . . . . 0.0 111.313 175.961 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 t -93.54 85.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 112.4 -2.182 . . . . 0.0 107.642 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -80.5 94.46 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 112.129 -2.305 . . . . 0.0 112.382 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 17.0 m -76.12 100.66 5.06 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.761 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.507 HG22 HG22 ' A' ' 74' ' ' VAL . 67.3 mt -79.23 102.12 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.975 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.404 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 47.8 t -106.56 104.86 14.65 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 111.82 -2.445 . . . . 0.0 110.408 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.59 101.49 13.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.763 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.89 99.56 12.39 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.982 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.09 -169.15 31.99 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-N 112.39 -2.187 . . . . 0.0 111.38 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.42 -48.9 75.91 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 -169.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -85.62 42.71 0.98 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -51.77 -48.65 63.65 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.44 -42.88 28.72 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -59.11 -44.19 91.95 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.545 1.138 . . . . 0.0 112.719 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.34 -49.68 70.72 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.192 0.997 . . . . 0.0 113.308 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 63' ' ' ILE . 76.3 t -59.84 -55.11 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.47 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -47.97 -45.04 30.94 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -70.13 -51.22 33.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.549 HD13 HG21 ' A' ' 33' ' ' ILE . 5.7 mt -60.56 -33.86 73.31 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.65 -54.69 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 124.039 0.837 . . . . 0.0 109.966 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -50.99 -49.98 59.33 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 124.17 0.919 . . . . 0.0 112.988 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.576 ' HB3' ' HE1' ' A' ' 22' ' ' PHE . 9.4 mp -61.48 -46.25 90.84 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 44.5 mtt -66.41 -21.67 66.22 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.3 -32.46 16.51 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -74.25 -39.72 62.85 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.35 104.97 12.17 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.251 1.167 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.857 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.8 ttp . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -124.88 135.64 53.06 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 125.277 1.611 . . . . 0.0 108.246 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -133.97 135.19 43.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.059 -172.41 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -142.76 144.49 32.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.047 1.339 . . . . 0.0 112.185 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.16 141.91 28.31 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.507 169.244 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 81' ' ' MET . 44.5 t -123.73 135.18 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 113.577 -1.647 . . . . 0.0 106.722 160.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.9 m -102.75 113.7 27.32 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.4 mt -72.63 124.69 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 122.317 1.056 . . . . 0.0 108.735 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -127.11 -30.12 2.71 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.868 -171.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' A' ' 85' ' ' GLU . . . -45.62 121.86 5.48 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 124.258 1.023 . . . . 0.0 111.367 161.483 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 34.1 Cg_endo -53.67 -69.35 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.454 2.769 . . . . 0.0 114.048 -169.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -74.55 -24.0 58.87 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.918 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.25 -125.2 17.83 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.999 1.285 . . . . 0.0 113.599 167.238 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.674 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 5.1 mp -96.45 110.43 22.8 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.896 1.331 . . . . 0.0 112.984 -175.656 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -109.6 -169.81 1.54 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 111.95 -2.386 . . . . 0.0 111.203 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 m -27.53 -76.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.394 2.278 . . . . 0.0 115.933 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -62.63 -49.35 83.33 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-O 116.237 -1.84 . . . . 0.0 113.696 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -51.51 -45.95 34.6 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.448 2.765 . . . . 0.0 114.044 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.7 -51.14 68.35 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.289 0.636 . . . . 0.0 112.403 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.28 81.31 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.62 -58.08 8.91 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.44 1.096 . . . . 0.0 111.986 171.565 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.79 -41.69 82.62 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.206 1.003 . . . . 0.0 112.719 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.608 HG21 ' HA ' ' A' ' 47' ' ' LEU . 58.9 t -64.58 -51.06 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.122 0.569 . . . . 0.0 111.642 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -53.15 -47.94 68.35 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.354 0.662 . . . . 0.0 109.827 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.06 -49.72 66.64 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.01 -45.85 75.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.525 0.73 . . . . 0.0 112.081 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -59.59 -36.08 75.55 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 173.1 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.22 -43.07 93.79 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 124.875 1.359 . . . . 0.0 112.199 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -62.02 145.99 51.48 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.99 0.916 . . . . 0.0 112.554 172.69 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.7 p -79.44 -31.36 42.53 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.232 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.7 p -71.95 141.82 49.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.76 0.824 . . . . 0.0 112.398 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.484 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 16.4 tp10 -72.35 130.62 41.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.479 0.656 . . . . 0.0 110.462 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 mm -113.43 86.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.369 -1.742 . . . . 0.0 109.303 -164.417 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.1 m -92.54 111.9 23.65 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 112.26 -2.245 . . . . 0.0 108.707 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.51 103.46 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 113.45 -1.705 . . . . 0.0 108.873 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 42.0 m -81.57 98.35 8.28 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.219 176.499 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' ' 53' ' ' LEU . 10.6 t -95.39 94.16 7.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.16 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.288 30.7 p-10 43.51 77.32 0.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 111.053 -2.794 . . . . 0.0 115.628 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.06 -52.59 3.21 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 112.276 -2.238 . . . . 0.0 113.742 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -93.46 134.48 35.67 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.484 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 39.5 p -89.8 148.9 22.94 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 122.526 1.155 . . . . 0.0 113.561 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -143.66 122.59 12.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.586 171.185 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.5 t -57.73 107.45 0.45 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.315 0.578 . . . . 0.0 110.059 166.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.78 -23.4 60.15 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.378 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -65.11 3.46 0.6 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.789 -1.551 . . . . 0.0 114.994 168.215 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 31.1 t -125.94 118.04 24.57 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.885 0.874 . . . . 0.0 110.427 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.608 ' HA ' HG21 ' A' ' 23' ' ' VAL . 31.1 tp -53.41 -47.75 69.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.793 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -58.22 -51.05 71.35 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.544 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 63.9 mttt -68.19 -43.69 77.56 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.41 -45.53 92.72 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.057 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -64.49 -36.45 84.22 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 49' ' ' LYS . 5.2 t -74.62 -30.44 61.66 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 37' ' ' SER . 3.2 mm? -83.07 155.6 23.78 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 122.067 0.937 . . . . 0.0 113.475 173.093 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -56.63 121.05 23.17 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 113.776 -1.556 . . . . 0.0 113.433 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.674 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 76.1 mt -124.31 36.66 4.57 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.061 1.344 . . . . 0.0 113.355 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -139.36 160.32 40.1 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -163.036 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.433 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 51.1 tt0 -34.52 109.51 0.08 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.618 1.567 . . . . 0.0 113.429 173.663 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.75 -40.8 1.93 Allowed Glycine 0 CA--C 1.534 1.276 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.817 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.7 p -74.89 133.35 41.83 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.57 110.06 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 113.279 -1.782 . . . . 0.0 106.785 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 m -98.7 89.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 125.065 1.478 . . . . 0.0 111.968 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.15 90.16 2.52 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.717 -2.038 . . . . 0.0 110.096 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.3 mt -76.65 111.87 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.275 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.2 t -117.2 124.75 49.87 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.821 -1.536 . . . . 0.0 109.631 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.28 110.66 21.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.365 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 3.3 pt-20 -108.95 110.34 21.62 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.651 -1.158 . . . . 0.0 113.674 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.82 -158.57 27.77 Favored Glycine 0 N--CA 1.483 1.831 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.002 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.88 -65.76 0.63 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -81.34 45.38 0.85 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 10.1 pt-20 -51.33 -62.27 1.72 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.683 1.593 . . . . 0.0 114.533 -177.424 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.406 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.6 OUTLIER -65.28 -41.98 93.62 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.242 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -56.96 -49.01 77.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.457 1.103 . . . . 0.0 113.52 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.9 -51.64 68.8 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.451 0.701 . . . . 0.0 111.838 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.68 -46.32 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.449 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -49.21 -54.73 15.22 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.21 1.404 . . . . 0.0 112.096 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -69.09 -34.75 75.6 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.5 mt -73.24 -39.9 65.1 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.8 t -58.91 -43.6 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.289 0.636 . . . . 0.0 110.217 170.492 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 79' ' ' LYS . 34.0 mtpt -56.63 -53.66 55.12 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 171.537 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.3 mt -49.76 -48.77 50.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.06 0.944 . . . . 0.0 113.464 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.609 ' HB3' HG11 ' A' ' 6' ' ' VAL . 11.9 mmt -59.16 -43.73 92.1 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.36 -40.66 89.91 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -74.18 -19.09 60.66 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 117.203 2.298 . . . . 0.0 117.203 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.3 mt -101.1 88.84 3.62 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 10' ' ' ALA . 23.9 mt-10 . . . . . 0 C--O 1.258 1.519 0 C-N-CA 125.162 1.385 . . . . 0.0 109.37 171.388 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -141.29 134.07 28.8 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.969 1.418 . . . . 0.0 111.318 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -122.98 139.94 53.55 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.156 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.491 ' HB2' HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -138.73 140.31 38.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.171 175.06 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -100.63 116.14 31.85 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 122.74 1.257 . . . . 0.0 111.443 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.5 p -122.62 135.72 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 112.88 -1.963 . . . . 0.0 111.286 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -87.91 162.54 16.85 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.494 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.6 mm -115.85 132.38 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 125.234 1.584 . . . . 0.0 106.885 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.77 -29.92 11.19 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.904 ' HB2' ' HB3' ' A' ' 85' ' ' GLU . . . -40.54 132.83 1.69 Allowed Pre-proline 0 N--CA 1.474 0.747 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -54.69 -45.94 37.15 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.915 3.077 . . . . 0.0 112.411 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -73.03 -64.37 0.98 Allowed 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.531 1.144 . . . . 0.0 112.967 171.344 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.61 100.31 2.64 Favored Glycine 0 N--CA 1.475 1.286 0 N-CA-C 110.386 -1.085 . . . . 0.0 110.386 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 32.21 84.57 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.134 2.173 . . . . 0.0 114.722 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -64.23 169.81 4.25 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.111 1.434 . . . . 0.0 114.213 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 p -59.71 -17.28 33.36 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.261 96.8 mtt180 -80.32 -47.38 1.32 Allowed Pre-proline 0 N--CA 1.478 0.929 0 CA-C-O 116.75 -1.595 . . . . 0.0 114.473 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.66 -37.22 89.16 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 122.097 1.865 . . . . 0.0 113.976 162.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.38 -44.99 89.16 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.08 92.89 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 172.224 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -63.54 -48.1 78.88 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.864 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -45.92 -56.27 5.68 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.54 1.536 . . . . 0.0 113.519 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.01 -43.66 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.185 0.994 . . . . 0.0 112.496 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.35 -50.13 68.96 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -59.58 -48.92 79.78 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.778 1.299 . . . . 0.0 111.257 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.67 -39.36 80.44 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -65.65 -38.02 88.19 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.18 -53.6 35.55 Favored Glycine 0 N--CA 1.482 1.726 0 O-C-N 125.614 1.821 . . . . 0.0 111.794 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -52.34 137.03 30.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 125.322 1.248 . . . . 0.0 110.378 171.652 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 p -74.11 -36.36 64.21 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.4 m -46.28 146.85 1.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.135 1.774 . . . . 0.0 114.877 170.735 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -86.05 133.72 33.88 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.792 0.806 . . . . 0.0 109.878 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.0 mm -117.04 97.44 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.165 -164.243 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 57.0 m -94.77 117.91 30.9 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.4 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.0 t -116.88 100.92 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 112.796 -2.002 . . . . 0.0 107.17 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -111.26 102.46 10.87 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.673 -167.352 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.5 m -76.52 91.8 3.39 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.751 170.254 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.263 6.8 p-10 32.24 105.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 118.706 2.854 . . . . 0.0 118.706 -172.424 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.38 -37.37 0.82 Allowed Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.634 ' HD3' HD21 ' A' ' 53' ' ' LEU . 78.1 tttt -94.58 120.05 34.2 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.938 0.895 . . . . 0.0 110.161 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.0 m -98.31 124.21 42.83 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -169.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 49' ' ' LYS . . . -117.28 166.6 12.09 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.74 -2.027 . . . . 0.0 109.723 175.659 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.645 ' HB3' ' HD3' ' A' ' 49' ' ' LYS . 18.2 t -126.01 132.34 52.03 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.91 -20.43 64.23 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.327 -1.761 . . . . 0.0 113.907 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -66.29 -12.3 55.64 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 84.4 p -136.44 137.26 40.25 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 160.19 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.6 tp -55.11 -39.23 69.13 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 124.121 0.888 . . . . 0.0 111.908 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -46.4 -56.35 6.02 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.04 1.736 . . . . 0.0 113.272 168.822 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.645 ' HD3' ' HB3' ' A' ' 43' ' ' SER . 56.1 tttt -76.49 -30.47 57.25 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.9 -65.56 0.66 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -59.99 -23.62 63.78 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -60.88 -26.5 67.46 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 174.407 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.634 HD21 ' HD3' ' A' ' 40' ' ' LYS . 5.4 mt -123.27 85.15 2.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.542 1.137 . . . . 0.0 109.459 169.173 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.88 135.86 17.72 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 112.949 -1.932 . . . . 0.0 113.135 -173.209 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.46 HD23 HG11 ' A' ' 61' ' ' VAL . 5.0 mp -79.22 101.32 7.93 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 113.47 -1.365 . . . . 0.0 109.715 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -129.71 162.23 28.86 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.804 -1.543 . . . . 0.0 111.979 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -58.02 145.74 35.19 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.44 -51.16 4.52 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.95 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -71.38 113.33 8.31 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.907 0.86 . . . . 0.0 111.245 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.0 p -71.43 132.37 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.709 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.46 HG11 HD23 ' A' ' 55' ' ' LEU . 14.8 p -116.59 123.92 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.08 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 m -79.95 120.53 24.28 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.968 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.01 100.33 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.487 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 44.6 t -110.18 125.39 52.99 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 112.909 -1.95 . . . . 0.0 112.104 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.15 111.89 18.83 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.547 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.53 103.8 12.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 113.778 -1.555 . . . . 0.0 112.91 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.57 -156.4 26.66 Favored Glycine 0 N--CA 1.479 1.533 0 CA-C-N 111.798 -2.455 . . . . 0.0 109.8 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.3 -49.53 63.84 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.93 20.44 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -41.43 -55.71 2.72 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -171.957 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -75.75 -52.26 10.84 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.939 0.896 . . . . 0.0 112.157 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -48.33 -54.31 14.28 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.421 1.888 . . . . 0.0 113.069 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.92 -51.99 66.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.452 1.101 . . . . 0.0 112.732 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 4' ' ' GLN . 60.7 t -64.8 -49.24 80.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.734 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -53.79 -51.79 62.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.31 1.006 . . . . 0.0 111.025 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -65.17 -43.65 91.04 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.7 mt -64.51 -35.61 81.53 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.4 t -74.08 -35.18 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 123.126 0.57 . . . . 0.0 111.451 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -66.66 -36.01 81.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 171.259 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -55.32 -50.27 70.04 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.515 1.135 . . . . 0.0 109.335 168.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 66.0 mtt -58.12 -44.14 87.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.16 -20.62 27.41 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -110.81 -31.73 7.08 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.2 mt -124.41 115.29 20.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.858 1.263 . . . . 0.0 114.079 -173.777 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' GLU . . . . . 0.904 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 16.9 mt-10 . . . . . 0 C--O 1.258 1.517 0 C-N-CA 125.482 1.513 . . . . 0.0 108.92 169.397 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 tmm? . . . . . 0 C--O 1.239 0.531 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -124.7 128.3 48.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.669 1.23 . . . . 0.0 109.397 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -124.74 138.84 54.26 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.512 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -129.68 140.79 51.04 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.203 172.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -98.78 120.77 39.78 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.683 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 HG13 ' A' ' 78' ' ' VAL . 2.4 m -123.22 144.83 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 113.875 -1.512 . . . . 0.0 113.131 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -105.26 143.81 32.92 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.618 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -114.49 133.16 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.67 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 p -116.95 -41.05 3.06 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.6 132.49 3.79 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 170.262 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.23 -42.67 54.25 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.979 2.453 . . . . 0.0 113.752 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -69.22 -35.18 75.91 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.692 1.245 . . . . 0.0 114.051 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.51 80.66 0.12 Allowed Glycine 0 N--CA 1.473 1.158 0 O-C-N 125.154 1.533 . . . . 0.0 112.431 -176.894 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.485 HD22 ' HZ ' ' A' ' 22' ' ' PHE . 8.1 mt 61.16 92.34 0.05 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.211 1.804 . . . . 0.0 112.849 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -71.71 -165.66 0.17 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -173.634 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.46 -46.17 9.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.477 2.711 . . . . 0.0 113.692 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.267 68.1 mtt180 -80.52 -42.64 1.31 Allowed Pre-proline 0 N--CA 1.486 1.349 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -177.751 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -53.02 -48.39 22.4 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.903 2.402 . . . . 0.0 113.295 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.81 -47.39 77.24 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.54 -39.34 76.42 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.01 -50.7 71.01 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.856 0.863 . . . . 0.0 112.931 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.485 ' HZ ' HD22 ' A' ' 14' ' ' LEU . 11.8 m-30 -53.66 -41.03 66.4 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.936 0.894 . . . . 0.0 111.759 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.415 HG21 HD12 ' A' ' 47' ' ' LEU . 45.3 t -60.3 -59.9 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.605 1.162 . . . . 0.0 111.804 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -53.31 -48.08 68.72 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.666 0.604 . . . . 0.0 111.699 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -45.89 78.59 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.95 74.61 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 173.678 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -66.16 -45.55 80.55 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.31 -45.65 96.02 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.693 1.616 . . . . 0.0 113.319 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -65.65 147.58 53.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.83 0.852 . . . . 0.0 111.122 167.5 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 p -66.79 -56.6 9.72 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.777 1.231 . . . . 0.0 113.664 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -46.6 144.96 2.02 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -82.35 117.24 22.27 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.582 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 77' ' ' LEU . 26.0 mm -94.5 114.61 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.22 -174.604 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.08 120.9 26.71 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 125.419 1.699 . . . . 0.0 110.596 173.492 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.8 t -108.8 86.55 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.9 m -94.0 90.61 6.51 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.225 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 p -76.2 98.59 4.46 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.253 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.255 52.0 p-10 24.09 60.12 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.051 2.14 . . . . 0.0 116.533 -167.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.69 -34.93 4.76 Favored Glycine 0 CA--C 1.542 1.747 0 CA-C-N 113.72 -1.582 . . . . 0.0 115.449 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 40' ' ' LYS . . . . . 0.597 ' HB3' HD23 ' A' ' 53' ' ' LEU . 97.8 mttt -81.26 96.92 7.42 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.334 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -73.3 89.62 1.59 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.15 158.43 19.77 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.792 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -110.62 120.84 43.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.432 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.93 -32.21 73.66 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.302 1.626 . . . . 0.0 112.637 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -67.89 -9.95 49.12 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.552 1.541 . . . . 0.0 114.201 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 t -121.85 118.22 28.43 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.743 1.217 . . . . 0.0 111.326 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 23' ' ' VAL . 30.7 tp -55.38 -47.21 76.17 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 113.55 -1.659 . . . . 0.0 112.621 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -60.57 -57.77 11.33 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.973 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -61.47 -43.97 97.93 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.5 tp -57.88 -57.32 13.31 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.514 1.134 . . . . 0.0 112.612 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -71.38 -27.67 63.49 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.593 HG23 HD12 ' A' ' 53' ' ' LEU . 10.5 t -72.77 -24.8 60.99 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 171.098 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.597 HD23 ' HB3' ' A' ' 40' ' ' LYS . 6.8 mp -104.76 74.46 1.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.968 1.366 . . . . 0.0 110.505 172.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.49 152.54 49.83 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 112.428 -2.169 . . . . 0.0 114.611 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -100.39 158.71 15.7 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 112.588 -1.806 . . . . 0.0 109.787 173.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.8 t -161.54 165.87 27.88 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.081 1.352 . . . . 0.0 110.588 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -63.65 125.65 24.98 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.08 -19.29 54.03 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.527 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.6 m -75.98 104.12 6.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.234 0.613 . . . . 0.0 109.393 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.51 137.37 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.724 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.36 123.69 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 122.245 1.022 . . . . 0.0 113.557 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 116.86 28.25 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.111 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.7 mm -92.66 103.93 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.8 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.4 t -115.92 129.52 56.43 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.721 -1.581 . . . . 0.0 111.068 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.88 122.84 40.35 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.547 1.165 . . . . 0.0 111.665 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -96.88 116.67 29.57 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.382 -2.19 . . . . 0.0 114.059 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.38 177.6 10.36 Favored Glycine 0 CA--C 1.541 1.697 0 CA-C-N 111.824 -2.444 . . . . 0.0 113.237 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.257 50.3 mt-10 41.6 -93.24 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 172.045 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -77.15 -0.64 25.72 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -18.51 -62.91 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -64.93 -57.59 8.37 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.882 0.873 . . . . 0.0 112.882 -175.864 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -62.6 -38.15 89.06 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.583 0.753 . . . . 0.0 112.214 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.87 -57.42 12.12 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.832 . . . . 0.0 112.269 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.89 -49.15 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 118.51 -0.757 . . . . 0.0 111.771 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -49.7 -55.82 12.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.86 0.864 . . . . 0.0 113.255 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -63.67 -48.68 76.18 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.816 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.487 HD13 HG21 ' A' ' 33' ' ' ILE . 23.4 mt -61.56 -38.3 86.97 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.437 HG13 HG11 ' A' ' 6' ' ' VAL . 10.4 t -65.14 -42.1 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.537 0.735 . . . . 0.0 111.167 174.109 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -60.78 -45.69 93.36 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 118.283 -0.865 . . . . 0.0 112.968 173.093 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.2 mt -52.34 -52.59 52.41 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.574 0.75 . . . . 0.0 112.79 170.779 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.0 mtt -60.09 -33.6 72.32 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.42 -36.1 60.87 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.59 -21.08 28.66 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.3 mt -107.04 145.64 32.11 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.599 1.96 . . . . 0.0 107.97 169.713 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.785 ' HG2' ' HB3' ' A' ' 66' ' ' GLU . 2.1 tmm? . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -125.12 131.18 53.31 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 125.093 1.495 . . . . 0.0 110.345 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -135.11 128.27 31.85 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.61 1.194 . . . . 0.0 113.527 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -125.71 127.77 46.74 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 124.823 1.327 . . . . 0.0 112.126 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 8.2 tt0 -84.57 135.89 34.02 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.563 -1.653 . . . . 0.0 112.385 176.91 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.93 142.42 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.173 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.01 136.7 45.22 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.235 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.748 HD11 ' HG3' ' A' ' 81' ' ' MET . 38.0 mm -105.93 139.09 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.059 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -103.27 -37.51 7.64 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.777 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -48.88 124.49 12.78 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.206 1.002 . . . . 0.0 112.629 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 72.7 Cg_exo -56.27 -52.03 8.08 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.942 3.095 . . . . 0.0 112.936 -175.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -63.53 -42.61 98.43 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.846 1.258 . . . . 0.0 113.241 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.98 -158.57 51.27 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.013 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.09 80.36 9.2 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 113.404 -1.398 . . . . 0.0 111.465 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.6 p-80 -75.92 -169.05 1.0 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.721 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -37.44 -52.42 1.14 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.472 2.309 . . . . 0.0 113.24 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.252 44.5 ttt180 -69.95 -50.84 15.96 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-O 115.881 -2.009 . . . . 0.0 114.537 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 80.1 Cg_exo -63.88 -42.72 18.49 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.64 2.227 . . . . 0.0 113.188 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.31 -45.29 80.34 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.96 -41.65 68.05 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 12.3 tt0 -70.73 -47.98 56.89 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.246 0.618 . . . . 0.0 111.12 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -57.52 -40.09 77.99 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.131 0.972 . . . . 0.0 113.342 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 19' ' ' ALA . 98.1 t -56.56 -53.86 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 124.059 0.944 . . . . 0.0 110.71 171.703 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -56.73 -46.35 81.37 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.23 -48.95 79.14 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.18 0.925 . . . . 0.0 112.345 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.459 ' O ' ' HE2' ' A' ' 45' ' ' LYS . . . -56.28 -40.52 74.4 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.183 0.993 . . . . 0.0 113.477 173.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -58.23 -36.34 73.02 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 173.507 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.92 -41.05 56.3 Favored Glycine 0 N--CA 1.483 1.773 0 O-C-N 124.87 1.356 . . . . 0.0 112.522 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -69.94 117.56 11.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.609 1.195 . . . . 0.0 112.41 175.049 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.5 p -49.11 -49.52 41.53 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.306 -1.77 . . . . 0.0 113.093 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 p -62.8 140.66 58.78 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.704 1.202 . . . . 0.0 113.817 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -77.09 93.17 3.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.619 -175.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.531 HD11 ' HB1' ' A' ' 73' ' ' ALA . 35.5 mm -68.73 84.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 112.788 -2.005 . . . . 0.0 111.276 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -82.9 115.93 21.98 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.004 -1.907 . . . . 0.0 107.797 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.22 99.84 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.1 m -88.33 99.04 11.95 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.696 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 t -101.45 109.91 21.82 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.605 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.296 0.1 OUTLIER 25.26 75.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.687 1.995 . . . . 0.0 115.953 -164.402 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.58 -26.5 4.06 Favored Glycine 0 CA--C 1.544 1.869 0 CA-C-N 112.055 -2.339 . . . . 0.0 115.182 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -84.69 87.98 7.33 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.713 1.244 . . . . 0.0 112.87 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -71.0 104.64 3.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.742 -2.026 . . . . 0.0 113.573 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.469 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -131.41 120.51 23.15 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 t -56.76 123.8 16.22 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.588 170.272 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.93 -30.56 70.29 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.805 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 26' ' ' ALA . 82.2 mttt -62.82 -22.21 66.47 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.6 t -94.35 112.94 24.75 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.878 0.847 . . . . 0.0 108.93 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -46.22 -52.05 13.2 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.254 -1.794 . . . . 0.0 112.981 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -54.34 -46.2 72.85 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.018 -1.447 . . . . 0.0 113.637 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 74.0 mttt -63.41 -53.42 52.56 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.241 0.963 . . . . 0.0 113.209 -176.434 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.2 tp -64.71 -33.42 75.92 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.135 0.897 . . . . 0.0 113.187 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -63.99 -47.37 80.61 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.4 t -74.35 -19.13 60.56 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 42' ' ' ALA . 17.1 tp -73.95 130.64 40.27 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.086 1.355 . . . . 0.0 111.346 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.39 102.06 1.33 Allowed Glycine 0 N--CA 1.482 1.762 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.823 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.0 mt -113.06 69.3 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.628 0.728 . . . . 0.0 112.818 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 t -145.79 179.88 7.15 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -61.08 138.7 58.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.343 1.057 . . . . 0.0 112.665 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.08 -52.7 3.55 Favored Glycine 0 N--CA 1.481 1.674 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.123 -172.637 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -72.53 97.38 2.1 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.08 1.352 . . . . 0.0 110.522 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.5 p -75.24 142.16 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.151 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.584 HG21 ' HE2' ' A' ' 81' ' ' MET . 9.0 p -127.29 125.39 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -170.77 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -105.64 118.17 35.91 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.602 177.027 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mm -87.25 96.4 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -108.81 128.58 55.02 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 124.721 1.263 . . . . 0.0 111.65 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.25 127.35 35.52 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.785 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 9.0 pt-20 -118.44 130.9 56.23 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 168.049 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.88 -155.08 22.15 Favored Glycine 0 N--CA 1.483 1.782 0 O-C-N 124.29 0.994 . . . . 0.0 111.472 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.73 -65.9 0.61 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -66.16 14.91 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' A' ' 71' ' ' GLN . 7.0 pt-20 -42.34 -58.83 2.04 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -168.04 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.448 ' HG3' ' HG3' ' A' ' 70' ' ' GLU . 36.3 mt-30 -71.25 -47.22 58.4 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.712 -1.131 . . . . 0.0 114.044 -177.226 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -63.79 -45.54 89.24 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.469 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.26 -43.99 95.68 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.946 0.899 . . . . 0.0 112.086 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.8 t -58.34 -57.14 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 116.951 -1.5 . . . . 0.0 110.129 171.897 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -50.71 -49.6 57.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.479 0.712 . . . . 0.0 112.91 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -61.54 -52.21 65.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.364 1.066 . . . . 0.0 112.693 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.03 -27.29 60.87 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -54.94 -44.48 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.07 0.948 . . . . 0.0 110.388 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.81 -61.27 2.52 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.693 1.246 . . . . 0.0 111.12 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -51.13 -37.16 44.43 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.748 ' HG3' HD11 ' A' ' 8' ' ' ILE . 11.0 tpt -53.68 -38.58 64.33 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.054 0.942 . . . . 0.0 113.429 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.55 -16.53 28.64 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.73 -25.4 16.71 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 44.2 mt -74.31 125.61 28.84 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 N--CA 1.491 1.615 0 C-N-CA 125.303 1.441 . . . . 0.0 111.466 178.12 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tmm? . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -127.06 130.3 49.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.15 1.531 . . . . 0.0 108.145 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -134.74 153.54 51.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.227 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.493 ' CB ' HG21 ' A' ' 78' ' ' VAL . 19.2 mm-40 -141.76 144.16 33.85 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 126.353 2.283 . . . . 0.0 110.318 173.718 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -113.12 134.39 54.57 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.915 1.385 . . . . 0.0 111.316 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -125.17 124.8 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 111.724 -2.489 . . . . 0.0 113.237 -177.481 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -94.21 123.71 37.77 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 112.65 -2.068 . . . . 0.0 107.732 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.1 mm -95.64 106.22 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.17 -173.06 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.9 p -92.34 -20.87 20.64 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 113.101 -1.863 . . . . 0.0 113.218 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -62.65 130.82 93.93 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.995 1.318 . . . . 0.0 111.51 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -56.57 -34.12 94.54 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.945 3.097 . . . . 0.0 114.733 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -113.82 4.46 15.91 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 38.65 -117.06 0.6 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.874 2.178 . . . . 0.0 115.2 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 4.8 mp -109.53 74.01 0.87 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 123.643 1.687 . . . . 0.0 111.507 -177.736 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -75.37 -162.06 0.18 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 111.885 -2.416 . . . . 0.0 112.718 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.2 p -55.9 -44.49 78.28 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.403 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 52.2 ttt180 -66.93 -47.81 52.48 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-O 116.702 -1.618 . . . . 0.0 114.377 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 75.5 Cg_exo -68.16 -40.47 8.7 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.104 2.536 . . . . 0.0 113.571 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -44.7 72.13 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.11 -41.04 62.15 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 170.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.3 -45.89 68.49 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.258 0.623 . . . . 0.0 111.647 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -60.95 -49.87 75.7 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.07 1.348 . . . . 0.0 113.381 -171.374 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 47' ' ' LEU . 8.0 p -53.76 -42.57 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.32 1.048 . . . . 0.0 113.492 173.678 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -62.72 -51.77 65.85 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.997 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.515 ' HG3' ' HE2' ' A' ' 29' ' ' PHE . 6.6 tp10 -57.69 -49.68 75.72 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.412 1.07 . . . . 0.0 111.915 175.88 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.3 -40.17 70.77 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -55.46 -38.56 69.22 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.27 -28.83 73.77 Favored Glycine 0 N--CA 1.483 1.816 0 O-C-N 125.812 1.945 . . . . 0.0 114.786 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.566 ' HE1' ' HE2' ' A' ' 72' ' ' LYS . 77.1 m-85 -92.45 134.63 34.77 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.3 p -71.28 -42.97 68.07 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.503 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.6 m -44.15 136.4 3.9 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.243 1.817 . . . . 0.0 114.728 168.07 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.81 134.03 35.12 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.213 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.6 mm -111.18 101.14 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.076 -171.748 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 41' ' ' SER . 7.7 p -94.72 120.92 35.73 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.654 1.216 . . . . 0.0 111.927 170.722 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.6 t -97.83 91.7 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 110.901 -2.863 . . . . 0.0 105.846 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -83.59 84.07 7.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 111.987 -2.37 . . . . 0.0 111.057 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.1 t -74.83 90.95 2.39 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.418 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.322 6.7 p30 37.08 69.38 0.22 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 113.157 -1.838 . . . . 0.0 114.767 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 -46.55 2.31 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 112.175 -2.284 . . . . 0.0 114.147 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -76.43 96.75 4.11 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 13.3 p -83.8 119.31 24.68 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 112.659 -2.064 . . . . 0.0 115.44 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.74 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -137.42 146.36 44.3 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.065 -1.425 . . . . 0.0 112.256 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.1 t -62.3 134.57 56.68 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.494 ' HA ' HD13 ' A' ' 50' ' ' LEU . . . -70.9 -41.31 71.45 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 125.686 1.866 . . . . 0.0 113.114 170.385 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -60.18 -38.35 82.96 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.097 1.359 . . . . 0.0 111.624 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.3 t -76.23 94.5 3.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.896 170.298 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.509 HD13 HG11 ' A' ' 23' ' ' VAL . 30.9 tp -51.93 -32.14 31.76 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.726 170.275 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 52' ' ' THR . 64.9 t80 -52.66 -64.23 0.89 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.755 1.222 . . . . 0.0 110.653 170.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.74 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 94.6 mttt -63.8 -47.36 81.17 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 44' ' ' ALA . 23.2 tp -51.15 -46.34 61.98 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 174.743 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -74.27 -41.15 61.73 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 48' ' ' PHE . 10.6 t -84.63 53.16 2.59 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 122.237 1.017 . . . . 0.0 112.102 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 17.5 tp -154.67 136.13 14.19 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.409 -172.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.59 108.37 2.46 Favored Glycine 0 N--CA 1.48 1.623 0 C-N-CA 125.275 1.417 . . . . 0.0 113.076 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 11.7 mt -127.68 35.09 4.55 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 t -119.31 178.37 4.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -57.13 139.56 52.1 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.42 -9.91 73.69 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 113.886 -1.506 . . . . 0.0 114.254 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.6 m -102.65 127.5 49.73 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.92 132.74 35.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.279 167.502 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.546 HG13 HG23 ' A' ' 6' ' ' VAL . 11.5 p -125.2 137.92 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.523 -175.212 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.57 126.5 54.5 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.291 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.541 HG22 HG22 ' A' ' 74' ' ' VAL . 51.0 mm -99.08 108.01 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.4 t -113.45 135.21 54.13 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 124.56 1.162 . . . . 0.0 112.137 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.11 146.72 41.02 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.751 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.1 138.62 49.62 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.818 -173.032 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.11 -146.82 18.36 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 114.577 0.591 . . . . 0.0 114.577 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.14 -48.7 53.53 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -169.429 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -107.43 31.63 5.27 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.214 -174.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -60.32 -48.23 82.64 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -171.692 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -70.2 -61.46 1.76 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.023 0.827 . . . . 0.0 112.232 176.082 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.566 ' HE2' ' HE1' ' A' ' 29' ' ' PHE . 64.5 tttt -49.07 -50.62 35.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.641 1.576 . . . . 0.0 114.256 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.5 -55.09 38.11 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 63' ' ' ILE . 85.4 t -67.9 -47.98 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.942 -174.593 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -45.08 -49.15 11.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.175 1.39 . . . . 0.0 112.747 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -66.91 -55.8 13.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.973 0.909 . . . . 0.0 113.168 173.462 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.519 HD23 HD12 ' A' ' 80' ' ' LEU . 97.7 mt -59.72 -28.91 67.74 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -177.296 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.493 HG21 ' CB ' ' A' ' 4' ' ' GLN . 32.5 t -74.09 -45.74 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.288 0.635 . . . . 0.0 112.346 173.703 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -52.61 -37.67 58.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 170.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.519 HD12 HD23 ' A' ' 77' ' ' LEU . 46.3 mt -56.83 -33.44 66.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -62.7 -24.48 67.68 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.32 -31.59 24.76 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.192 0.997 . . . . 0.0 113.115 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -91.42 -33.3 15.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 118.37 2.729 . . . . 0.0 118.37 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.5 142.19 30.22 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 C--O 1.263 1.779 0 C-N-CA 127.631 2.372 . . . . 0.0 107.537 172.439 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.894 ' HG2' ' HB3' ' A' ' 66' ' ' GLU . 7.9 tmm? . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -122.47 135.82 54.75 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.287 0.992 . . . . 0.0 112.749 -167.038 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -121.34 137.19 54.81 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.859 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -128.13 123.59 34.81 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -96.3 99.0 10.73 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.991 1.432 . . . . 0.0 112.144 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.7 126.17 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 113.539 -1.664 . . . . 0.0 110.408 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 m -83.92 116.83 22.98 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.053 165.03 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.81 125.79 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.874 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 p -117.1 -36.48 3.78 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.173 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.56 113.05 0.94 Allowed Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 125.947 1.699 . . . . 0.0 115.072 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -53.59 -33.03 66.9 Favored 'Trans proline' 0 N--CA 1.483 0.894 0 C-N-CA 124.481 3.454 . . . . 0.0 114.35 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -62.86 -27.24 69.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.82 161.96 11.31 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 123.988 0.804 . . . . 0.0 113.244 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 55' ' ' LEU . 82.3 mt -79.89 78.04 6.52 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 122.871 1.319 . . . . 0.0 109.245 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -72.94 -153.65 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.218 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 p -51.75 -59.54 4.19 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.205 1.002 . . . . 0.0 113.685 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -55.39 -49.16 94.1 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 115.978 -1.963 . . . . 0.0 114.84 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HG3' ' HB3' ' A' ' 84' ' ' LEU . 78.3 Cg_exo -58.25 -52.05 6.42 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 122.33 2.02 . . . . 0.0 112.473 173.028 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.22 89.58 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.74 -47.73 84.96 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.059 0.944 . . . . 0.0 113.494 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -68.54 -36.82 79.35 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.777 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB3' HD21 ' A' ' 50' ' ' LEU . 11.8 t80 -64.42 -48.67 74.47 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.549 1.14 . . . . 0.0 112.568 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.72 -48.0 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -51.85 -45.0 63.87 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.81 1.244 . . . . 0.0 112.635 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.687 ' HB3' HD21 ' A' ' 77' ' ' LEU . 4.4 tp10 -75.61 -46.59 30.79 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.658 0.599 . . . . 0.0 112.172 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.05 -39.87 63.56 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.777 1.231 . . . . 0.0 114.262 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -63.18 -37.27 86.56 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.24 -33.08 73.64 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.053 1.311 . . . . 0.0 114.629 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -86.65 121.75 29.6 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.788 0.804 . . . . 0.0 110.809 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 p -58.18 -39.78 79.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.897 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -47.44 144.25 3.11 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 126.86 2.064 . . . . 0.0 113.496 166.73 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -94.68 122.06 36.9 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.529 1.157 . . . . 0.0 111.529 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 mm -108.63 106.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 112.324 -2.216 . . . . 0.0 106.949 -173.681 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 98.1 m -103.2 122.72 45.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.113 -176.202 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -101.67 103.84 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 113.534 -1.666 . . . . 0.0 107.01 -174.097 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -104.34 97.79 7.68 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.035 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.8 t -88.36 92.39 9.15 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.548 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.08 61.03 2.49 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 113.753 -1.567 . . . . 0.0 114.184 174.538 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.28 -63.37 0.41 Allowed Glycine 0 CA--C 1.543 1.801 0 CA-C-N 113.65 -1.614 . . . . 0.0 113.222 -168.59 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -68.62 111.02 4.53 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.394 1.093 . . . . 0.0 112.847 -170.6 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.1 p -106.62 117.82 35.06 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.413 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.724 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -117.74 143.58 46.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 112.197 -2.274 . . . . 0.0 110.275 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.8 t -73.96 134.21 43.11 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.12 0.486 . . . . 0.0 109.816 173.501 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.02 68.14 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.06 -0.53 4.59 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.2 t -127.17 111.58 14.15 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.92 1.288 . . . . 0.0 111.067 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.9 tp -59.07 -39.99 83.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.233 1.013 . . . . 0.0 111.552 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -55.53 -50.15 70.76 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.623 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.724 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 83.9 mttt -65.19 -45.29 85.43 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.649 0.779 . . . . 0.0 112.943 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 22' ' ' PHE . 20.3 tp -63.82 -47.25 81.58 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 124.568 1.168 . . . . 0.0 113.486 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -70.56 -37.24 73.97 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -74.62 -11.62 60.24 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 42' ' ' ALA . 15.1 tp -88.43 143.81 26.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.353 1.061 . . . . 0.0 109.335 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.37 88.78 0.13 Allowed Glycine 0 N--CA 1.484 1.859 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.092 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.424 ' HB3' HD12 ' A' ' 14' ' ' LEU . 93.4 mt -122.35 74.33 1.17 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 123.813 1.768 . . . . 0.0 110.353 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 t -137.25 175.0 10.0 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.371 -1.741 . . . . 0.0 109.716 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -45.58 150.06 0.53 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.76 34.33 56.55 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 125.155 1.36 . . . . 0.0 115.261 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.3 m -120.99 141.3 50.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.276 11.8 p -111.22 116.4 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.731 0.776 . . . . 0.0 112.524 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.54 129.55 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 112.286 -2.233 . . . . 0.0 112.989 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -103.12 123.12 46.08 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.537 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.0 mm -97.17 94.05 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 113.402 -1.727 . . . . 0.0 108.037 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.509 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 12.5 t -88.62 132.52 34.52 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.097 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.71 138.58 24.62 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.894 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 16.6 pt-20 -134.0 149.54 51.21 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.612 162.618 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.38 -165.09 24.81 Favored Glycine 0 CA--C 1.54 1.614 0 O-C-N 124.753 1.283 . . . . 0.0 111.429 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -50.81 -75.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.22 1.408 . . . . 0.0 113.184 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.69 74.78 1.54 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.052 0.941 . . . . 0.0 108.621 168.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.22 -64.73 0.82 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.82 -55.41 4.83 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -171.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -42.33 -53.19 4.27 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.371 -1.741 . . . . 0.0 113.717 172.281 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -37.94 78.85 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 t -65.78 -60.42 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -46.28 -47.55 18.23 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.513 1.525 . . . . 0.0 114.62 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -61.18 -51.15 70.22 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.322 1.049 . . . . 0.0 113.155 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.687 HD21 ' HB3' ' A' ' 25' ' ' GLU . 64.0 mt -69.15 -27.87 65.93 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 174.455 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.9 t -63.86 -34.63 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-O 118.957 -0.544 . . . . 0.0 110.738 170.492 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -62.18 -42.2 99.05 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 mp -57.55 -44.07 84.91 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.4 mtt -62.42 -18.9 62.79 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.6 -43.25 7.3 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -74.03 -39.36 63.6 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 18' ' ' PRO . 15.3 mt -82.86 132.88 35.15 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -171.379 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 N--CA 1.487 1.388 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.203 169.661 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.566 ' HG2' ' HB3' ' A' ' 66' ' ' GLU . 7.3 mtm . . . . . 0 C--O 1.223 -0.342 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -107.6 109.18 20.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 125.395 1.685 . . . . 0.0 108.254 171.796 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -117.8 125.18 50.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.576 -170.273 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.46 ' HB3' HG11 ' A' ' 74' ' ' VAL . 33.1 tt0 -138.73 129.93 26.97 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.189 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.486 ' HB3' HG22 ' A' ' 60' ' ' VAL . 46.5 mt-10 -89.42 116.88 27.93 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.061 -175.698 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.07 119.86 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.749 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 m -86.17 112.45 21.34 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.732 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.05 122.05 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 114.684 -1.143 . . . . 0.0 110.083 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.4 p -107.23 -0.4 22.66 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.22 117.76 43.08 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.133 0.973 . . . . 0.0 111.723 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HA ' ' HB3' ' A' ' 57' ' ' GLN . 85.0 Cg_exo -49.67 -41.94 44.36 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 124.75 3.634 . . . . 0.0 114.49 -174.305 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -57.77 -40.82 80.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.17 50.83 6.05 Favored Glycine 0 CA--C 1.55 2.252 0 O-C-N 123.757 0.661 . . . . 0.0 113.788 -169.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.8 mt 58.81 59.76 2.74 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 126.241 1.816 . . . . 0.0 115.03 175.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.254 28.1 p80 -41.27 -97.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 119.091 2.997 . . . . 0.0 119.091 -163.844 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.5 p -108.49 -64.9 1.18 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.842 0.857 . . . . 0.0 111.214 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 22.0 ttt180 -51.71 -51.97 65.09 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 125.988 1.715 . . . . 0.0 113.67 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 52.9 Cg_exo -64.96 -44.32 10.15 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.431 2.087 . . . . 0.0 113.407 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.65 -52.03 51.19 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 174.645 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.73 -45.96 92.25 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.655 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.411 ' OE1' ' HG2' ' A' ' 17' ' ' ARG . 55.1 mt-30 -61.59 -41.73 97.85 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.4 -53.23 60.6 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.09 0.869 . . . . 0.0 111.226 174.793 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.22 -43.42 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 123.663 0.785 . . . . 0.0 111.782 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -48.39 -56.24 8.68 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.57 0.748 . . . . 0.0 111.723 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.73 -40.83 72.54 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.88 -41.61 67.73 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.828 0.851 . . . . 0.0 113.281 172.521 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 69.8 mttt -70.04 -30.61 67.92 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 174.226 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.3 -29.44 74.9 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.911 1.243 . . . . 0.0 113.069 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -86.01 124.33 32.33 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.189 0.995 . . . . 0.0 112.557 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.0 p -65.65 -42.88 90.88 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.086 170.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.1 t -44.1 143.15 1.23 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.168 1.787 . . . . 0.0 112.228 162.753 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -95.27 136.26 35.83 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.056 0.932 . . . . 0.0 112.757 -173.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mm -115.28 101.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.213 -169.292 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.0 m -99.82 130.1 45.99 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.887 173.199 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 t -110.06 107.72 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 m -105.62 122.68 46.54 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.079 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 t -125.3 98.75 5.76 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.437 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 p30 32.47 85.97 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 112.007 -2.36 . . . . 0.0 116.251 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.56 -41.99 3.11 Favored Glycine 0 N--CA 1.478 1.484 0 CA-C-N 112.77 -2.013 . . . . 0.0 114.355 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -92.46 138.59 31.39 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.532 0.682 . . . . 0.0 112.248 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.0 p -116.9 135.62 53.58 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.549 1.14 . . . . 0.0 113.513 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.459 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -131.24 131.04 43.63 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.237 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 t -81.0 111.24 17.29 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.022 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.28 -26.21 64.75 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.324 -1.762 . . . . 0.0 114.631 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 91.9 mttt -61.69 -21.01 64.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 t -105.52 116.23 31.6 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.543 0.687 . . . . 0.0 110.809 167.533 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.8 tp -52.23 -46.31 65.65 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.386 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -50.95 -51.3 53.78 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.185 0.994 . . . . 0.0 112.359 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -63.31 -49.0 75.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 tp -54.08 -43.76 70.6 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.606 1.191 . . . . 0.0 112.468 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.3 mt-30 -65.16 -31.56 72.8 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 t -93.12 55.78 2.4 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 123.999 1.857 . . . . 0.0 112.142 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.459 HD22 ' HB3' ' A' ' 42' ' ' ALA . 8.5 tp -152.27 150.63 29.99 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.722 -175.361 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.14 76.62 2.13 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 124.231 0.92 . . . . 0.0 113.467 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.65 42.23 1.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.5 t -102.53 170.75 7.85 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.704 -1.589 . . . . 0.0 115.22 -158.674 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 11.9 pt20 -52.17 114.99 1.5 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.342 1.457 . . . . 0.0 113.831 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.93 -21.39 38.3 Favored Glycine 0 CA--C 1.543 1.802 0 CA-C-N 113.043 -1.89 . . . . 0.0 113.535 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.7 m -72.67 132.16 43.34 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.304 1.05 . . . . 0.0 112.86 -171.758 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 5' ' ' GLU . 8.7 p -86.0 110.81 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 113.156 -1.838 . . . . 0.0 108.326 164.066 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.07 129.04 59.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.709 -1.587 . . . . 0.0 110.896 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -91.56 107.66 19.36 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.24 -174.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.18 100.7 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -99.55 100.56 11.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 112.163 -2.289 . . . . 0.0 109.323 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.06 126.69 52.68 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.332 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.566 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 7.4 pt-20 -127.22 138.91 53.21 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.125 176.441 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.02 -141.58 16.97 Favored Glycine 0 N--CA 1.48 1.608 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.659 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -46.13 -86.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -174.744 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 72' ' ' LYS . 2.3 m-20 -82.25 48.46 1.27 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 174.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.275 10.8 pt-20 -58.34 -37.27 74.82 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -177.946 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -69.66 -59.59 2.86 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.645 0.778 . . . . 0.0 112.813 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 56.3 tttt -56.66 -47.9 78.75 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.915 1.686 . . . . 0.0 114.168 -176.479 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.99 -41.76 62.41 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.46 HG11 ' HB3' ' A' ' 4' ' ' GLN . 16.9 t -66.28 -55.52 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 123.753 0.658 . . . . 0.0 110.893 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -46.5 -49.63 18.18 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.319 1.448 . . . . 0.0 112.794 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -63.0 -50.63 69.97 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.619 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.6 mt -59.39 -37.96 79.3 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.09 -53.64 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.819 0.847 . . . . 0.0 111.173 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -61.13 -46.15 91.75 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.311 1.007 . . . . 0.0 111.733 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -53.66 -50.24 66.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.011 0.924 . . . . 0.0 111.73 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 32.5 mtp -58.17 -46.39 85.81 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.806 1.242 . . . . 0.0 112.903 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.28 -21.76 66.28 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.42 1.79 27.68 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.17 150.87 36.76 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -169.459 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 CA--C 1.545 0.784 0 CA-C-N 111.357 -2.656 . . . . 0.0 105.786 175.985 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.8 mtm . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -127.14 114.54 17.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.252 0.97 . . . . 0.0 111.76 -173.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -123.53 121.57 35.99 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.59 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.01 158.8 31.26 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 113.787 -1.551 . . . . 0.0 112.053 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -104.25 122.22 44.94 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.563 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.43 129.44 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.749 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m -96.38 126.61 41.7 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.105 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.3 mm -76.26 108.46 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -99.94 -16.61 17.91 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.06 120.0 30.96 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.457 1.103 . . . . 0.0 112.891 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -63.5 -45.63 11.15 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.696 2.931 . . . . 0.0 113.914 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -71.53 -36.0 70.88 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.379 0.424 . . . . 0.0 112.14 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.05 179.98 18.02 Favored Glycine 0 N--CA 1.477 1.428 0 O-C-N 124.506 1.129 . . . . 0.0 110.706 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 85.5 mt -99.84 85.11 3.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.593 1.187 . . . . 0.0 110.88 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.74 -148.41 0.23 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 113.352 -1.749 . . . . 0.0 114.693 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 p -57.57 -55.92 28.64 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -168.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -57.14 -49.13 95.72 Favored Pre-proline 0 CA--C 1.557 1.235 0 CA-C-O 116.927 -1.511 . . . . 0.0 112.568 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -57.92 -50.3 10.64 Favored 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 122.909 2.406 . . . . 0.0 113.903 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.61 -49.33 75.27 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 118.046 -0.978 . . . . 0.0 112.616 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.78 76.94 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.117 0.967 . . . . 0.0 113.274 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -61.71 -51.31 68.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.972 0.909 . . . . 0.0 113.305 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -50.89 71.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.362 1.465 . . . . 0.0 111.832 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.71 -45.81 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.449 1.099 . . . . 0.0 111.616 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -55.73 -47.29 77.16 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.881 0.738 . . . . 0.0 111.408 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HG2' ' CD2' ' A' ' 76' ' ' HIS . 1.7 tp10 -69.25 -44.57 71.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.44 -39.79 73.71 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 48.7 mmtt -71.23 -38.79 71.96 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 172.752 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 -42.95 97.15 Favored Glycine 0 N--CA 1.479 1.512 0 O-C-N 125.294 1.621 . . . . 0.0 112.823 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -73.02 135.54 44.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.864 0.866 . . . . 0.0 110.124 168.99 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.8 p -67.61 -41.55 83.83 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.87 123.36 2.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.074 1.749 . . . . 0.0 115.099 172.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 32' ' ' GLU . . . . . 0.42 ' OE2' ' HG3' ' A' ' 45' ' ' LYS . 22.9 tp10 -81.74 132.0 35.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.908 0.861 . . . . 0.0 111.316 -177.495 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 mm -121.51 110.31 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 113.917 -1.492 . . . . 0.0 111.529 -168.128 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.2 m -102.07 117.6 35.14 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.156 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.5 t -108.72 96.17 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 113.372 -1.74 . . . . 0.0 106.395 -174.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -106.99 109.27 21.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.054 -168.818 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 t -106.5 109.2 21.06 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.766 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 p30 45.88 60.67 3.03 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.376 -1.738 . . . . 0.0 114.688 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.99 -28.87 2.16 Favored Glycine 0 N--CA 1.485 1.919 0 CA-C-N 114.29 -1.323 . . . . 0.0 114.877 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -75.21 105.55 6.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 122.101 0.953 . . . . 0.0 111.1 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.6 p -93.31 114.14 26.51 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.84 148.41 26.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 112.625 -2.079 . . . . 0.0 109.879 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.5 t -103.36 118.46 36.82 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.02 -29.14 56.75 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 125.241 1.588 . . . . 0.0 113.222 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 43.7 mmtt -63.03 -24.34 67.87 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.145 1.378 . . . . 0.0 114.251 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 t -115.49 117.05 29.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.815 0.446 . . . . 0.0 110.866 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 tp -49.98 -52.7 31.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.116 1.367 . . . . 0.0 112.719 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.08 -36.48 77.46 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.402 1.081 . . . . 0.0 112.745 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -77.59 -44.12 29.44 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.549 0.531 . . . . 0.0 112.047 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.2 tp -62.33 -39.61 93.65 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.636 0.774 . . . . 0.0 112.594 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -60.21 -37.0 78.95 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 t -90.38 59.68 4.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 123.538 1.637 . . . . 0.0 112.025 175.716 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -144.14 153.01 41.69 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.757 -2.02 . . . . 0.0 109.579 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.12 79.68 0.05 OUTLIER Glycine 0 N--CA 1.485 1.916 0 C-N-CA 124.604 1.097 . . . . 0.0 112.844 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 73.5 mt -100.13 42.56 1.1 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.222 1.01 . . . . 0.0 111.98 173.842 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -113.26 156.89 22.52 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 113.352 -1.749 . . . . 0.0 112.179 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -48.98 108.09 0.17 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.558 1.543 . . . . 0.0 114.2 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.02 -23.19 11.71 Favored Glycine 0 CA--C 1.548 2.125 0 CA-C-N 113.277 -1.783 . . . . 0.0 115.495 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -73.42 127.03 31.56 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 117.638 0.719 . . . . 0.0 112.358 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.65 140.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 121.837 0.827 . . . . 0.0 111.803 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.74 131.38 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.985 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.71 109.18 15.88 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.489 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.7 mm -91.43 96.69 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -104.58 113.73 27.5 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.74 1.275 . . . . 0.0 112.054 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.12 131.29 55.89 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.372 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.15 152.59 39.76 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.5 173.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.33 -152.35 19.21 Favored Glycine 0 N--CA 1.48 1.605 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.532 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -42.75 -61.88 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 -173.668 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -104.79 40.56 1.47 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.353 0.661 . . . . 0.0 112.315 -174.371 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -47.77 -48.48 30.08 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -75.05 -48.73 22.52 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.81 -39.35 77.4 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.117 1.367 . . . . 0.0 112.85 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.95 -61.22 2.43 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.918 173.687 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 78' ' ' VAL . 29.2 t -64.53 -41.69 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 118.384 -0.817 . . . . 0.0 111.216 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -51.2 -61.15 2.41 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.133 0.973 . . . . 0.0 112.375 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.453 ' CD2' ' HG2' ' A' ' 25' ' ' GLU . 67.1 t60 -69.44 -30.52 68.46 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.2 -34.95 79.19 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.06 1.134 . . . . 0.0 114.06 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 74' ' ' VAL . 63.0 t -65.82 -46.66 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 119.002 -0.523 . . . . 0.0 109.717 169.815 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -51.34 -49.59 61.1 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.042 0.937 . . . . 0.0 111.574 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mt -50.42 -62.11 1.78 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.631 1.173 . . . . 0.0 113.533 171.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 69.0 mtm -57.03 -36.04 70.01 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.97 -32.38 67.2 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -79.59 -17.96 52.7 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.2 mt -85.67 126.38 33.89 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.713 0.805 . . . . 0.0 111.175 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.249 1.026 0 C-N-CA 125.296 1.438 . . . . 0.0 108.173 178.715 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -130.39 116.76 18.72 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.849 1.343 . . . . 0.0 111.391 -176.597 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -123.72 140.93 52.5 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -135.71 139.84 43.97 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 125.089 1.493 . . . . 0.0 113.303 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -84.98 120.01 26.03 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.633 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.417 HG21 HG22 ' A' ' 78' ' ' VAL . 66.2 t -126.21 121.5 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.43 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -83.51 129.71 34.98 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.108 0.956 . . . . 0.0 110.619 170.747 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.8 mm -107.79 117.89 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' THR . . . . . 0.408 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 21.9 p -111.45 -2.14 15.65 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.08 121.1 69.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 124.071 0.948 . . . . 0.0 111.947 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -57.78 -44.56 39.78 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 C-N-CA 123.403 2.735 . . . . 0.0 114.018 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -68.88 -34.73 75.91 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.87 -170.18 54.87 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.535 1.54 . . . . 0.0 114.56 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -79.58 74.35 6.24 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 123.24 1.495 . . . . 0.0 113.474 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -102.08 169.98 8.4 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.329 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.9 p 38.9 -104.48 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.507 1.923 . . . . 0.0 115.658 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -78.0 -44.26 2.29 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 115.553 -2.165 . . . . 0.0 112.948 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.528 ' HA ' HD22 ' A' ' 84' ' ' LEU . 15.8 Cg_exo -48.95 -46.88 23.44 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.621 2.214 . . . . 0.0 113.908 168.212 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.83 -54.8 40.71 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.251 0.621 . . . . 0.0 112.531 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.78 -40.85 69.86 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -57.07 -53.63 55.94 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.861 0.865 . . . . 0.0 113.126 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -61.18 -47.76 84.68 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.733 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 47' ' ' LEU . 83.0 t -57.49 -52.04 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.504 1.122 . . . . 0.0 112.048 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -60.44 -47.57 85.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.222 0.609 . . . . 0.0 111.742 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.62 -43.02 99.86 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 124.097 0.873 . . . . 0.0 112.55 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.411 ' O ' ' HE2' ' A' ' 45' ' ' LYS . . . -60.78 -43.01 98.6 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 171.604 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -61.16 -23.67 65.73 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.38 -30.66 49.02 Favored Glycine 0 CA--C 1.548 2.107 0 C-N-CA 124.535 1.064 . . . . 0.0 114.041 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -87.79 124.7 33.88 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 122.109 0.957 . . . . 0.0 112.578 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.6 p -71.36 -4.31 25.46 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 m -93.19 145.39 24.46 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.603 1.161 . . . . 0.0 108.6 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.55 131.16 34.24 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.5 0.667 . . . . 0.0 112.492 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.5 mm -120.89 118.48 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 112.976 -1.92 . . . . 0.0 108.834 -168.736 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 20.2 m -113.53 123.25 49.56 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 112.148 -2.297 . . . . 0.0 110.689 -173.472 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.9 t -99.0 90.45 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 113.52 -1.673 . . . . 0.0 106.49 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.8 m -97.52 112.89 24.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.066 -1.424 . . . . 0.0 112.516 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.3 t -111.49 98.0 7.14 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.184 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 p30 39.35 64.84 0.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 114.043 -1.435 . . . . 0.0 114.822 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.51 -49.9 2.93 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.432 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.02 112.89 2.79 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.295 1.038 . . . . 0.0 111.711 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.2 p -106.99 104.76 14.51 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.903 -1.499 . . . . 0.0 114.214 -171.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.2 144.02 25.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.414 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.9 t -80.04 124.93 29.16 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.647 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.5 -26.42 63.44 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 125.009 1.443 . . . . 0.0 114.515 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 26' ' ' ALA . 92.2 mttt -83.04 27.47 0.55 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -169.734 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.5 t -145.2 118.27 8.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.777 1.231 . . . . 0.0 113.004 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.453 ' HA ' HG21 ' A' ' 23' ' ' VAL . 44.7 tp -56.74 -47.01 81.0 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.736 -1.574 . . . . 0.0 112.062 177.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -54.56 -51.54 64.93 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 117.961 -1.019 . . . . 0.0 112.07 171.392 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -58.34 -43.05 88.13 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD22 HG23 ' A' ' 23' ' ' VAL . 4.7 mp -63.89 -52.5 59.61 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 174.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -66.46 -27.81 68.1 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 t -79.26 -15.02 58.64 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -107.12 137.38 45.29 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.844 0.831 . . . . 0.0 109.415 -177.461 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.43 71.11 0.65 Allowed Glycine 0 CA--C 1.541 1.681 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.659 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.05 71.91 10.87 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.751 0.786 . . . . 0.0 110.181 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -128.93 -157.56 0.83 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -162.056 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -66.5 102.43 0.89 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.74 1.616 . . . . 0.0 114.806 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' H ' ' HA ' ' A' ' 9' ' ' THR . . . 86.64 39.85 7.49 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 112.84 -1.982 . . . . 0.0 112.328 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 m -105.72 114.73 29.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -95.19 112.03 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.397 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.6 112.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.212 -2.267 . . . . 0.0 111.838 -172.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -78.29 98.85 6.07 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.812 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.4 HG22 HG22 ' A' ' 74' ' ' VAL . 27.0 mm -76.35 107.89 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 113.747 -1.57 . . . . 0.0 108.126 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.559 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 23.1 t -101.35 138.47 38.33 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.851 -1.977 . . . . 0.0 111.671 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 74' ' ' VAL . . . -131.35 144.48 51.27 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.518 1.127 . . . . 0.0 112.832 174.748 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -143.38 140.18 30.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.148 167.774 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.98 -145.16 15.99 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 115.138 0.815 . . . . 0.0 115.138 173.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -55.44 -66.22 0.45 Allowed 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -169.352 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.25 23.07 10.57 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.777 1.231 . . . . 0.0 112.756 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -32.35 -59.46 0.3 Allowed 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 119.027 2.973 . . . . 0.0 119.027 -168.791 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -60.12 -54.67 43.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -58.77 -43.06 90.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.356 1.463 . . . . 0.0 111.953 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.01 -52.42 50.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.944 0.898 . . . . 0.0 112.658 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 65' ' ' ALA 0.263 17.5 t -71.61 -39.09 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.588 176.385 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -50.31 -50.96 49.13 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.396 1.078 . . . . 0.0 111.923 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -59.18 -53.38 58.92 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.751 1.221 . . . . 0.0 111.63 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.3 mt -57.69 -35.43 70.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.417 HG22 HG21 ' A' ' 6' ' ' VAL . 74.2 t -67.03 -46.35 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.987 0.915 . . . . 0.0 110.831 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -58.53 -48.41 80.95 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.463 0.477 . . . . 0.0 111.006 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.9 tp -51.94 -51.08 59.49 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.979 1.312 . . . . 0.0 112.387 175.097 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.0 mtt -53.12 -27.57 21.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.77 -28.24 16.71 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.57 -23.17 63.51 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 18' ' ' PRO . 52.6 mt -62.99 143.76 57.47 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.163 0.985 . . . . 0.0 113.649 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 . . . . . 0 CA--C 1.557 1.228 0 C-N-CA 126.296 1.838 . . . . 0.0 108.734 -171.762 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -123.73 137.17 54.74 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.895 1.372 . . . . 0.0 111.352 -171.731 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -128.45 141.52 51.37 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 125.376 1.673 . . . . 0.0 112.115 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -132.26 123.32 26.7 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.821 167.367 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HG2' HG22 ' A' ' 60' ' ' VAL . 11.9 tt0 -96.64 118.13 32.46 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.073 0.858 . . . . 0.0 110.817 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.5 m -118.13 134.0 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 112.81 -1.995 . . . . 0.0 113.246 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 m -89.64 86.75 6.79 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.404 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.6 mm -77.16 112.32 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.19 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 p -114.5 39.62 2.76 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 112.686 -2.052 . . . . 0.0 113.019 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -76.54 123.0 87.63 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.188 -172.648 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 98.9 Cg_exo -47.54 -47.14 18.71 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.89 3.727 . . . . 0.0 115.55 -173.295 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 75.8 m-20 -102.56 -50.56 3.54 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 169.334 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.55 -157.1 15.28 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 124.575 1.172 . . . . 0.0 112.568 171.868 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 5.7 mp -93.13 75.72 4.66 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.83 1.3 . . . . 0.0 112.424 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -97.21 -152.23 0.38 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.232 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.6 p -42.96 -71.58 0.08 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -163.663 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -74.16 -44.04 6.11 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-O 116.152 -1.88 . . . . 0.0 114.766 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 73.2 Cg_exo -56.51 -43.58 53.98 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.579 2.186 . . . . 0.0 113.911 173.929 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.94 88.7 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.982 0.513 . . . . 0.0 112.308 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 -41.97 79.21 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -58.91 -45.88 89.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.188 0.995 . . . . 0.0 113.071 173.379 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -62.35 -48.67 78.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.39 1.076 . . . . 0.0 112.121 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 44' ' ' ALA . 91.2 t -57.63 -44.73 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.137 0.975 . . . . 0.0 111.962 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -54.17 -51.81 63.16 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.797 0.839 . . . . 0.0 111.125 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -69.67 -39.26 77.1 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -44.98 78.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.371 0.668 . . . . 0.0 112.117 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -61.46 -29.39 69.93 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.995 1.479 . . . . 0.0 114.995 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.6 -33.65 87.81 Favored Glycine 0 CA--C 1.544 1.882 0 C-N-CA 124.879 1.228 . . . . 0.0 113.126 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -85.67 139.39 31.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.027 0.931 . . . . 0.0 111.958 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 p -74.4 -45.99 43.21 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.052 172.105 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.3 m -53.43 144.14 17.54 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.127 1.371 . . . . 0.0 113.143 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -92.77 127.09 38.15 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.119 0.961 . . . . 0.0 112.999 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.531 HD11 ' HB1' ' A' ' 73' ' ' ALA . 37.2 mm -101.27 117.42 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.705 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -102.22 119.21 38.44 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 112.049 -2.342 . . . . 0.0 108.632 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.16 99.47 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 113.792 -1.549 . . . . 0.0 107.036 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -113.85 113.76 25.34 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.606 -171.517 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.2 t -119.87 115.06 23.07 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.697 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.282 24.1 p30 35.57 69.92 0.16 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 112.697 -2.047 . . . . 0.0 115.935 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.77 -36.62 3.24 Favored Glycine 0 CA--C 1.545 1.959 0 CA-C-N 112.594 -2.094 . . . . 0.0 114.784 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -78.89 102.3 8.16 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.9 p -84.85 115.29 22.67 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.39 -1.732 . . . . 0.0 114.16 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.83 138.61 45.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.171 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.1 t -90.22 102.14 14.86 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.788 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -51.13 -40.2 57.96 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -176.675 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -63.54 -12.27 31.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 22.7 t -109.13 121.19 44.61 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 173.704 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -53.47 -46.0 69.77 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.042 1.463 . . . . 0.0 112.285 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -57.63 -53.55 56.92 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.809 172.228 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 96.6 mttt -67.28 -31.37 71.64 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -176.292 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 tp -67.55 -55.38 13.66 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.126 0.57 . . . . 0.0 111.732 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.15 -30.32 71.49 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 49' ' ' LYS . 14.7 t -63.52 -16.58 61.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 173.028 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -96.52 129.21 43.93 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.51 88.1 0.43 Allowed Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.297 -176.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.24 90.73 4.94 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.188 0.518 . . . . 0.0 111.196 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -136.1 -145.99 0.23 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.772 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -88.35 115.12 25.63 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.18 40.67 2.39 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 112.614 -2.085 . . . . 0.0 113.617 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.6 m -115.58 104.95 12.23 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.45 HG22 ' HG2' ' A' ' 5' ' ' GLU . 4.8 p -85.46 105.12 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.771 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.46 123.89 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 111.582 -2.553 . . . . 0.0 113.077 -171.21 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 115.28 23.25 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 113.396 -1.729 . . . . 0.0 110.009 176.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.6 mm -98.39 103.93 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.3 t -116.31 130.56 56.84 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.097 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -119.24 141.15 49.18 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.87 130.01 46.31 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.181 -1.827 . . . . 0.0 113.218 169.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.27 -154.09 19.78 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 113.105 -1.861 . . . . 0.0 112.235 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -45.13 -71.25 0.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.253 1.821 . . . . 0.0 115.348 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -93.68 46.95 1.21 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.82 0.848 . . . . 0.0 112.414 -173.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -48.98 -60.6 2.63 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -62.55 -43.82 97.87 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -63.61 -52.46 60.78 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.126 0.97 . . . . 0.0 112.868 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -54.43 -40.5 68.39 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.43 -62.23 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.067 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -47.99 -53.07 17.34 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.106 1.763 . . . . 0.0 113.297 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -66.68 -41.16 88.56 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.1 mt -68.28 -36.17 78.98 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 172.665 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.39 -45.23 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.911 0.884 . . . . 0.0 110.204 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -52.34 -53.62 42.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.553 1.541 . . . . 0.0 111.018 173.12 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.5 tt -53.33 -55.84 21.52 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.204 1.002 . . . . 0.0 111.866 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.3 ttt -56.3 -48.64 76.25 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.013 1.325 . . . . 0.0 113.767 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.53 -29.12 68.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -99.18 14.65 28.68 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.7 mt -80.85 144.25 32.16 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 . . . . . 0 C--O 1.248 0.997 0 C-N-CA 127.378 2.271 . . . . 0.0 105.045 179.587 . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 . . . . . . . . . 0 0 . 1 . 021 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -124.48 142.5 51.28 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.623 1.202 . . . . 0.0 111.236 -179.361 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -139.46 142.92 37.35 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.666 -1.606 . . . . 0.0 114.527 -174.27 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -131.23 124.16 29.99 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 125.621 1.826 . . . . 0.0 110.888 168.277 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -98.05 128.21 44.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.155 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 m -128.29 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.128 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -88.29 103.2 15.58 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.523 174.221 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.73 102.73 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.03 176.904 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -116.02 13.64 15.92 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 112.259 -2.246 . . . . 0.0 116.063 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.74 134.12 81.84 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 168.721 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.57 -53.54 3.73 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 125.135 3.89 . . . . 0.0 115.293 -169.098 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.27 -39.36 10.1 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 172.629 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.02 -88.17 0.98 Allowed Glycine 0 N--CA 1.483 1.781 0 O-C-N 124.495 1.122 . . . . 0.0 112.385 171.664 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 6.8 mp -112.43 73.46 0.82 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.867 1.318 . . . . 0.0 113.343 177.917 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -81.38 -165.04 0.86 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.928 169.075 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.8 p -53.31 -46.09 69.26 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -171.041 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.25 32.8 ttt180 -70.25 -54.8 8.74 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-O 116.689 -1.624 . . . . 0.0 114.274 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.456 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 98.0 Cg_exo -56.58 -38.22 95.94 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 122.343 2.029 . . . . 0.0 112.881 173.685 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.66 -56.05 25.89 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.65 -40.8 66.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 175.308 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.497 ' HB3' HD11 ' A' ' 80' ' ' LEU . 33.7 mt-30 -55.55 -58.47 7.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.516 1.127 . . . . 0.0 112.477 170.859 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -54.39 -49.4 69.98 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.73 1.269 . . . . 0.0 111.853 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.7 t -57.8 -53.39 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.084 1.353 . . . . 0.0 111.789 177.431 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -58.92 -48.84 80.05 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.033 0.833 . . . . 0.0 112.131 -177.994 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.61 -40.97 80.18 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.677 1.236 . . . . 0.0 112.696 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' O ' ' HE2' ' A' ' 45' ' ' LYS . . . -58.34 -39.61 79.93 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 170.41 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' A' ' 45' ' ' LYS . 71.4 mttt -64.87 -32.01 73.51 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 175.148 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.46 -41.04 99.8 Favored Glycine 0 N--CA 1.487 2.092 0 O-C-N 124.587 1.179 . . . . 0.0 112.034 169.064 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -70.7 120.63 16.59 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.705 0.764 . . . . 0.0 112.799 174.543 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.8 p -62.26 -38.05 87.79 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.359 -1.292 . . . . 0.0 112.216 174.741 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.1 m -61.35 153.58 26.37 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 126.634 1.973 . . . . 0.0 111.352 175.168 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -96.52 137.08 36.13 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 122.086 0.946 . . . . 0.0 111.885 -175.352 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.451 HG21 HD13 ' A' ' 77' ' ' LEU . 13.7 mm -118.29 106.32 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.179 -166.224 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.2 m -99.25 134.48 42.05 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.436 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 47.3 t -119.66 110.57 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 113.582 -1.644 . . . . 0.0 107.338 177.879 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.7 m -115.53 119.87 37.61 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.718 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t -111.92 99.8 8.39 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.428 171.923 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 p30 36.38 85.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.94 -41.41 2.19 Favored Glycine 0 N--CA 1.484 1.887 0 CA-C-N 114.265 -1.334 . . . . 0.0 115.097 177.174 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.09 123.08 36.1 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.758 0.79 . . . . 0.0 111.619 177.419 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.0 p -113.08 153.44 28.16 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -173.973 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -114.99 152.93 31.56 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 111.987 -2.37 . . . . 0.0 112.55 -176.408 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 43' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 49' ' ' LYS . 26.5 t -105.86 105.85 16.08 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.054 175.801 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.58 -32.87 72.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 125.245 1.59 . . . . 0.0 115.139 -170.414 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.532 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 91.3 mttt -71.32 19.09 0.06 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 176.054 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 t -145.16 126.15 14.53 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.958 0.903 . . . . 0.0 111.077 176.614 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.99 -53.18 56.53 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.238 0.961 . . . . 0.0 113.041 173.781 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -54.42 -60.27 3.56 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.625 0.77 . . . . 0.0 112.061 172.011 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 7.0 mttm -68.34 -17.88 64.36 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -173.11 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.49 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 27.8 tp -81.3 -65.8 0.97 Allowed 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.396 1.06 . . . . 0.0 111.667 164.888 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -63.45 -19.45 64.73 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -171.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' THR . . . . . 0.458 HG23 HD12 ' A' ' 53' ' ' LEU . 9.2 t -51.25 -29.27 13.96 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 168.48 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 42' ' ' ALA . 9.4 mp -84.71 139.34 32.07 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.784 1.234 . . . . 0.0 110.499 171.378 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.48 75.23 1.99 Allowed Glycine 0 CA--C 1.541 1.667 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.419 177.757 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.421 ' HA ' HG21 ' A' ' 59' ' ' THR . 7.3 mt -81.05 79.13 7.78 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.475 1.131 . . . . 0.0 109.459 176.142 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -129.83 -155.37 0.69 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.272 -1.785 . . . . 0.0 110.942 -165.552 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -77.87 120.5 22.84 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.672 -0.643 . . . . 0.0 111.705 172.957 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.72 35.52 8.39 Favored Glycine 0 N--CA 1.487 2.073 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.419 -178.376 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.421 HG21 ' HA ' ' A' ' 55' ' ' LEU . 22.9 m -109.53 91.89 3.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.579 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -74.43 103.49 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.223 167.641 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.67 137.43 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-N 111.502 -2.59 . . . . 0.0 112.168 -173.16 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.57 128.68 45.68 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.073 -1.422 . . . . 0.0 110.262 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mm -101.6 108.36 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.655 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 m -113.54 128.39 56.42 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 125.845 1.966 . . . . 0.0 111.809 -176.765 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.06 122.68 44.84 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.641 177.044 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -114.85 136.82 52.67 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.24 175.233 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.05 -131.03 8.26 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.546 175.859 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.4 -66.77 0.58 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.064 1.346 . . . . 0.0 113.574 -172.047 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 72' ' ' LYS . 73.9 m-20 -92.88 49.69 1.47 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.975 0.91 . . . . 0.0 111.763 -172.583 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -54.0 -45.24 71.42 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.173 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -68.78 -62.03 1.56 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.698 0.799 . . . . 0.0 111.359 173.742 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 62.6 tttm -48.15 -51.69 23.84 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.804 2.042 . . . . 0.0 113.656 -176.452 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.23 82.4 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.94 -53.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.17 178.835 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -48.48 -50.36 31.94 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.985 1.314 . . . . 0.0 112.508 176.343 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -65.15 -41.43 94.75 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.189 1.395 . . . . 0.0 113.279 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 33' ' ' ILE . 11.3 mt -80.28 -24.47 40.01 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 177.684 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.91 -41.72 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 168.188 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -52.57 -50.64 62.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.64 1.176 . . . . 0.0 110.889 169.577 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 21' ' ' GLN . 6.0 tt -53.6 -49.97 66.64 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.412 1.085 . . . . 0.0 113.01 171.974 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.4 mtt -64.05 -29.55 70.68 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 176.48 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.57 -51.3 24.13 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 174.001 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.1 60.37 4.86 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.462 1.105 . . . . 0.0 112.371 -174.469 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.3 mt -116.96 138.8 51.31 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.272 1.029 . . . . 0.0 113.75 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 C--O 1.245 0.832 0 C-N-CA 127.009 2.124 . . . . 0.0 106.803 -178.98 . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.672 ' HG3' ' HG2' ' A' ' 66' ' ' GLU . 18.5 ttt . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 . . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.18 142.13 50.16 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 125.829 1.956 . . . . 0.0 111.678 -177.625 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.97 151.53 49.11 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.77 1.293 . . . . 0.0 113.371 176.333 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -142.61 128.28 19.22 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.135 167.314 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.552 ' HB3' HG12 ' A' ' 60' ' ' VAL . 50.0 mt-10 -91.06 109.95 21.21 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.006 174.631 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 p -118.74 115.75 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.719 -174.176 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -68.53 114.66 7.13 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.481 177.525 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.73 100.05 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 122.285 1.041 . . . . 0.0 110.289 174.287 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -76.84 -22.44 53.54 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 112.144 -2.298 . . . . 0.0 115.191 172.07 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -57.84 118.25 24.93 Favored Pre-proline 0 C--O 1.245 0.839 0 C-N-CA 124.518 1.127 . . . . 0.0 110.924 177.986 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 68.8 Cg_exo -55.59 -53.31 5.86 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 124.194 3.263 . . . . 0.0 111.872 -172.282 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -62.8 -52.52 62.85 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.764 1.626 . . . . 0.0 112.531 170.82 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.91 -156.18 16.97 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 124.57 1.081 . . . . 0.0 111.558 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.596 ' HG ' ' HB2' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -113.89 84.95 2.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.962 1.363 . . . . 0.0 110.086 -173.732 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -81.94 -165.8 1.08 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.996 -1.457 . . . . 0.0 113.991 178.508 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.0 p -53.38 -49.28 67.54 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -166.888 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.776 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.439 15.8 ptt-85 -65.36 -47.3 70.26 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-O 115.795 -2.05 . . . . 0.0 116.471 178.155 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.776 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 73.8 Cg_exo -65.84 -39.36 20.14 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.832 1.688 . . . . 0.0 113.209 169.824 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.22 79.76 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.783 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.39 86.01 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 172.901 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -56.68 -45.14 81.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.153 0.981 . . . . 0.0 112.558 174.121 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -56.99 -47.61 80.41 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.744 1.618 . . . . 0.0 111.897 175.836 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 44' ' ' ALA . 97.0 t -65.33 -43.2 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 123.786 0.835 . . . . 0.0 112.522 175.544 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -58.37 -41.95 85.93 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.197 0.599 . . . . 0.0 111.34 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.55 -52.96 48.55 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 125.054 1.471 . . . . 0.0 111.868 169.668 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.81 -38.49 64.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -178.799 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -75.76 10.95 1.52 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 174.268 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.04 -17.57 40.09 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 124.572 1.17 . . . . 0.0 112.389 163.441 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -96.24 125.56 40.84 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.152 0.977 . . . . 0.0 108.973 179.325 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.4 p -62.4 -35.73 80.11 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.987 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.8 m -53.84 150.73 7.19 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.597 1.959 . . . . 0.0 114.973 176.834 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -80.83 89.77 5.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.719 173.675 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.496 HD13 ' HB3' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -73.94 98.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 109.822 -3.354 . . . . 0.0 114.288 175.903 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.8 m -104.01 128.58 51.59 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 112.261 -2.245 . . . . 0.0 109.512 -178.96 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.5 t -114.52 107.54 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 114.035 -1.439 . . . . 0.0 108.455 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.405 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 60.4 m -108.69 104.29 13.55 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.88 -176.908 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.6 p -90.37 54.64 2.81 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 113.797 -1.547 . . . . 0.0 113.548 -177.252 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.6 m120 48.89 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 123.672 1.701 . . . . 0.0 114.758 -174.854 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.91 -32.62 6.43 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 112.481 -2.145 . . . . 0.0 114.055 -178.998 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -111.58 132.93 54.2 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.373 0.669 . . . . 0.0 109.287 -177.301 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -123.13 134.84 54.18 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 122.183 0.992 . . . . 0.0 111.808 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -134.74 125.69 27.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 113.692 -1.595 . . . . 0.0 111.992 174.149 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.0 t -68.58 122.26 18.11 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.725 171.366 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.496 ' HB3' HD13 ' A' ' 33' ' ' ILE . . . -74.76 13.2 0.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.344 -1.298 . . . . 0.0 114.126 176.832 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -77.57 -7.72 56.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 169.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.4 t -133.46 133.66 42.57 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.377 1.071 . . . . 0.0 112.381 174.076 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -57.44 -53.25 60.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.116 1.366 . . . . 0.0 111.131 177.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -56.55 -34.41 67.04 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.107 -1.406 . . . . 0.0 114.559 176.118 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -58.57 -53.32 59.71 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 175.745 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.04 -32.88 61.66 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 176.941 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.94 -14.88 63.3 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.213 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 p -106.13 18.59 21.81 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 167.407 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.497 HD22 ' HB3' ' A' ' 42' ' ' ALA . 14.2 tp -114.81 120.89 41.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.366 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.53 70.51 1.93 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.393 -175.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 mt -75.9 94.55 3.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.898 176.327 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -142.33 -174.65 4.18 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 49.3 tp60 -43.05 136.07 2.93 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.884 2.474 . . . . 0.0 113.83 -176.693 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.05 -32.16 3.57 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 113.481 -1.69 . . . . 0.0 115.71 175.555 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.2 p -59.37 120.2 8.86 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.981 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' A' ' 5' ' ' GLU . 4.9 t -90.34 77.4 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.599 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.87 113.37 14.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 112.518 -2.128 . . . . 0.0 112.692 -169.59 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.405 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 0.7 OUTLIER -71.51 94.77 1.31 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.716 176.381 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.48 103.97 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 167.224 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -115.67 133.7 55.77 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 112.342 -2.208 . . . . 0.0 110.922 -176.558 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.65 120.06 25.85 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.27 0.981 . . . . 0.0 112.721 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.672 ' HG2' ' HG3' ' A' ' 1' ' ' MET . 38.6 mt-10 -115.25 118.05 32.2 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.336 -1.756 . . . . 0.0 111.697 -178.568 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.25 -151.63 21.94 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.314 -178.932 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.52 -67.91 0.43 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -176.699 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -80.95 40.51 0.54 Allowed 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -178.92 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.569 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 7.5 pt-20 -46.7 -62.82 1.21 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.462 1.905 . . . . 0.0 115.569 -176.936 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.569 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 97.0 mt-30 -64.83 -40.63 95.49 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.676 1.19 . . . . 0.0 113.309 -178.984 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -59.71 -48.5 81.41 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.177 0.991 . . . . 0.0 111.158 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.68 67.84 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.212 0.945 . . . . 0.0 112.918 175.734 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.9 -53.86 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.289 0.636 . . . . 0.0 111.302 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -50.92 -50.8 56.81 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.01 1.324 . . . . 0.0 111.507 -178.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.95 -61.05 2.86 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.972 1.309 . . . . 0.0 111.61 177.933 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.63 -36.66 81.38 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -175.733 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.06 -47.72 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.342 0.657 . . . . 0.0 111.67 176.4 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -59.2 -50.08 75.41 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 123.709 0.631 . . . . 0.0 111.655 175.701 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.0 tp -52.27 -51.61 57.47 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.428 1.491 . . . . 0.0 112.426 175.578 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.4 tpp -52.2 -52.41 52.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.634 1.574 . . . . 0.0 113.002 173.968 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.16 -28.33 66.33 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.915 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.96 -20.13 24.86 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 178.645 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.6 mt -87.21 125.25 34.07 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.512 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--O 1.254 1.322 0 CA-C-N 113.13 -1.85 . . . . 0.0 106.25 179.352 . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HG2' ' HG2' ' A' ' 66' ' ' GLU . 4.2 tmm? . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 . . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -141.07 140.05 34.15 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.539 1.149 . . . . 0.0 111.652 173.724 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -132.27 155.82 47.64 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.722 1.264 . . . . 0.0 113.775 176.405 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 4' ' ' GLN . . . . . 0.643 ' HB3' HG21 ' A' ' 78' ' ' VAL . 7.3 tp-100 -141.65 125.46 17.02 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 124.563 1.165 . . . . 0.0 113.811 165.489 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -81.43 106.19 13.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.871 174.258 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.7 p -124.33 140.12 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.913 -177.416 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 p -99.94 129.01 45.97 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.129 178.072 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.86 122.38 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.429 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -77.96 -35.17 50.57 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 125.655 1.847 . . . . 0.0 114.472 176.94 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.79 123.4 81.47 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 124.472 1.109 . . . . 0.0 113.208 -174.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.86 -50.47 13.97 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.86 3.04 . . . . 0.0 112.022 174.169 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -62.29 -39.23 92.29 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 169.151 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.97 -136.04 12.64 Favored Glycine 0 N--CA 1.481 1.672 0 C-N-CA 124.342 0.973 . . . . 0.0 111.9 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.404 ' HG ' ' HB2' ' A' ' 18' ' ' PRO . 2.5 mp -115.53 75.14 0.92 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.16 0.981 . . . . 0.0 112.521 174.511 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 55.4 p-80 -75.55 -153.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 113.388 -1.733 . . . . 0.0 111.773 174.793 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.1 p -57.75 -61.1 2.76 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -167.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.357 20.7 ptt-85 -68.9 -38.38 11.3 Favored Pre-proline 0 N--CA 1.48 1.062 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 59.5 Cg_endo -75.75 -37.08 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 CA-C-N 122.816 2.041 . . . . 0.0 113.747 173.225 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.41 98.87 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 169.61 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.81 -44.04 73.48 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 172.688 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 9.9 tt0 -63.18 -47.14 83.86 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.569 0.543 . . . . 0.0 112.442 174.256 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE2' ' HG3' ' A' ' 81' ' ' MET . 38.3 t80 -60.74 -47.74 84.93 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.894 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -51.83 -48.95 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.405 1.082 . . . . 0.0 111.765 175.626 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -54.48 -49.16 70.78 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.831 0.707 . . . . 0.0 111.414 179.328 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.07 -49.59 67.08 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.591 1.182 . . . . 0.0 110.959 -178.665 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.35 -42.05 77.13 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 175.003 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -58.44 -31.7 68.0 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.822 0.849 . . . . 0.0 112.615 176.365 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.74 5.55 74.27 Favored Glycine 0 CA--C 1.544 1.901 0 O-C-N 124.919 1.387 . . . . 0.0 115.369 -176.873 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -104.83 141.78 35.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.517 0.658 . . . . 0.0 110.212 169.318 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -45.19 81.43 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 119.002 -0.523 . . . . 0.0 111.588 176.596 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.5 m -52.88 136.61 34.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.129 1.772 . . . . 0.0 113.512 179.205 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.78 112.77 10.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 167.553 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.9 mt -104.02 120.37 54.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 112.838 -1.983 . . . . 0.0 108.88 -174.804 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.7 m -123.32 133.37 54.15 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 112.235 -2.257 . . . . 0.0 110.713 -176.672 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG13 ' CG2' ' A' ' 61' ' ' VAL . 21.9 t -118.11 108.15 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 110.929 -2.85 . . . . 0.0 107.15 -169.206 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.7 m -112.54 103.23 11.29 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 112.876 -1.966 . . . . 0.0 113.035 -175.23 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.2 p -90.6 89.47 7.55 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 112.991 -1.913 . . . . 0.0 111.53 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.6 m120 50.93 63.26 2.31 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 123.406 1.574 . . . . 0.0 114.047 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.69 -25.66 6.43 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-N 113.724 -1.58 . . . . 0.0 115.698 -176.551 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -84.5 121.02 27.0 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 177.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -111.19 139.32 46.67 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -172.35 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.99 145.31 29.69 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.634 166.844 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.0 t -71.26 119.43 15.39 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.999 171.535 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.554 ' HA ' HD13 ' A' ' 50' ' ' LEU . . . -58.78 -30.69 67.76 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.083 -1.872 . . . . 0.0 112.908 174.069 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -74.44 15.06 0.38 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 176.813 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.4 t -133.36 138.94 46.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.166 0.986 . . . . 0.0 111.572 170.909 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.8 tp -66.72 -62.36 1.49 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 111.713 -2.494 . . . . 0.0 110.188 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -50.27 -55.62 14.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.524 1.529 . . . . 0.0 111.224 176.609 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -58.56 -53.86 53.59 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.255 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 44' ' ' ALA . 11.4 tp -64.79 -46.97 79.81 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -179.111 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -57.07 -37.79 72.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 174.772 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.7 p -86.19 -10.1 55.33 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.47 120.81 22.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.911 0.863 . . . . 0.0 108.869 164.401 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.94 89.3 0.24 Allowed Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.054 1.311 . . . . 0.0 113.558 -176.211 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD13 ' HE1' ' A' ' 81' ' ' MET . 58.2 mt -106.0 103.88 13.47 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.571 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -130.75 177.22 7.57 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.67 -1.15 . . . . 0.0 113.046 -177.606 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -43.18 120.9 1.98 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.483 1.913 . . . . 0.0 114.03 177.567 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.64 -14.1 14.47 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 117.796 1.878 . . . . 0.0 117.796 177.575 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.6 m -58.9 129.17 40.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.107 1.454 . . . . 0.0 111.278 -179.145 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.22 93.56 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 113.221 -1.809 . . . . 0.0 107.843 -174.725 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' CG2' HG13 ' A' ' 35' ' ' VAL . 8.7 p -100.1 111.85 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 113.028 -1.896 . . . . 0.0 112.794 -176.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 m -81.68 102.27 10.6 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.737 175.758 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.2 mt -87.36 103.3 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 172.127 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.2 t -115.58 146.24 41.94 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.813 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.43 132.79 44.6 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.685 1.24 . . . . 0.0 113.734 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HG2' ' HG2' ' A' ' 1' ' ' MET . 46.3 mt-10 -121.3 110.44 16.13 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 112.871 -1.968 . . . . 0.0 112.54 177.939 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.58 -124.84 1.28 Allowed Glycine 0 CA--C 1.536 1.403 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.85 171.936 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -103.17 -53.38 2.83 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.599 -1.3 . . . . 0.0 113.631 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -88.92 46.74 1.42 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 175.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.2 pt-20 -55.38 -63.64 1.1 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.352 -1.749 . . . . 0.0 115.485 -178.79 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.414 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 35.3 mt-30 -67.78 -43.32 80.03 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.41 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -52.43 -47.7 66.22 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.781 1.301 . . . . 0.0 112.157 173.457 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.97 -50.63 67.82 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.65 0.78 . . . . 0.0 112.931 177.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.46 -52.57 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.985 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -48.97 -54.52 15.24 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.329 1.452 . . . . 0.0 111.518 177.507 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -56.66 -46.39 81.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.347 1.459 . . . . 0.0 113.121 -178.914 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.53 -36.03 26.72 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -176.271 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.643 HG21 ' HB3' ' A' ' 4' ' ' GLN . 13.3 t -61.39 -41.33 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.438 0.695 . . . . 0.0 110.745 172.24 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -63.27 -50.04 71.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 172.869 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.6 tp -54.43 -51.9 63.47 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.738 0.649 . . . . 0.0 112.667 175.008 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.59 ' HE1' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -59.82 -36.69 77.31 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 176.648 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.43 89.93 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 174.148 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.04 -30.74 44.29 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.7 mt -64.61 124.43 21.86 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.504 0.722 . . . . 0.0 112.396 178.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 . . . . . 0 C--O 1.261 1.668 0 C-N-CA 125.468 1.507 . . . . 0.0 109.531 176.96 . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tmm? . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -121.08 133.69 55.24 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.335 1.647 . . . . 0.0 107.677 175.13 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -134.9 136.96 42.75 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.803 -1.544 . . . . 0.0 112.667 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -125.85 116.11 21.04 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.844 175.919 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -81.14 100.39 9.04 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.122 -2.308 . . . . 0.0 108.499 175.099 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.6 140.18 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.486 -172.807 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -73.34 152.08 41.02 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 123.039 1.4 . . . . 0.0 113.242 173.279 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 mt -85.58 110.39 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 164.512 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -88.09 -21.61 24.61 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 112.823 -1.99 . . . . 0.0 115.376 -175.51 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 121.14 56.92 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.091 1.356 . . . . 0.0 112.598 174.524 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -60.34 -52.45 4.01 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.277 2.651 . . . . 0.0 115.509 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -67.61 -31.8 72.09 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.499 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.95 158.35 32.98 Favored Glycine 0 N--CA 1.481 1.674 0 O-C-N 124.525 1.141 . . . . 0.0 112.564 168.399 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.9 mp -78.73 72.44 5.25 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 122.622 1.201 . . . . 0.0 112.92 -175.551 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -67.19 -167.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.97 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 p -46.24 -48.86 17.78 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 -174.655 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.475 35.9 ptt180 -78.22 -39.44 1.74 Allowed Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 177.618 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 79.8 Cg_exo -59.51 -39.2 77.66 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 121.836 1.69 . . . . 0.0 112.055 169.803 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.46 -42.02 98.13 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 173.202 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.19 -44.15 97.24 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.194 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 7.7 tt0 -53.98 -49.76 68.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.057 1.343 . . . . 0.0 111.424 172.679 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -59.85 -36.14 76.23 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.126 -1.397 . . . . 0.0 114.054 175.501 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 19' ' ' ALA . 97.1 t -64.25 -46.73 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.114 0.566 . . . . 0.0 111.902 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.52 -49.86 63.97 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.668 0.787 . . . . 0.0 109.78 177.003 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -60.35 -47.29 86.69 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.54 1.536 . . . . 0.0 113.611 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.44 94.03 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 176.225 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -63.5 -30.84 71.9 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.003 0.921 . . . . 0.0 112.587 174.4 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.0 -21.79 61.78 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.916 1.722 . . . . 0.0 115.081 175.764 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -95.2 155.18 16.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.944 0.898 . . . . 0.0 112.734 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.6 p -78.8 -46.32 19.01 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 117.642 -1.17 . . . . 0.0 112.128 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -54.83 139.13 40.93 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.835 1.254 . . . . 0.0 110.449 175.97 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -78.94 110.11 13.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.963 175.076 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' SER . 2.9 mp -84.61 121.92 37.38 Favored 'Isoleucine or valine' 0 C--O 1.248 0.996 0 CA-C-N 110.751 -2.932 . . . . 0.0 112.149 175.504 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.3 m -116.54 132.67 56.62 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-N 111.43 -2.623 . . . . 0.0 109.017 174.803 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.558 HG13 HG21 ' A' ' 61' ' ' VAL . 6.0 t -113.41 93.32 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.821 -1.99 . . . . 0.0 107.727 -176.945 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -87.81 94.79 9.86 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.596 -178.436 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 t -92.98 95.65 9.61 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.956 -176.299 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 38' ' ' ASN . . . . . 0.566 HD21 ' HB ' ' A' ' 60' ' ' VAL . 12.7 m120 32.53 81.0 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.759 1.623 . . . . 0.0 114.811 -168.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.11 -49.29 4.2 Favored Glycine 0 N--CA 1.481 1.697 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.235 -174.673 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -67.27 102.12 1.02 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -177.445 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.0 m -91.61 100.36 13.1 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.377 -177.201 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.762 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -113.37 143.02 45.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.98 1.371 . . . . 0.0 111.81 174.677 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.4 t -61.58 121.23 12.24 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 112.802 -1.999 . . . . 0.0 111.374 175.049 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.83 -23.68 64.28 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.929 166.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -79.75 -17.68 52.91 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 176.538 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 t -107.95 120.54 42.58 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 177.768 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.2 mt -50.6 -62.84 1.36 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 112.872 -1.967 . . . . 0.0 113.875 -178.657 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -66.37 -13.0 59.97 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -177.087 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 68.7 mmtt -97.31 -37.25 10.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.367 178.992 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.41 ' HA ' HD12 ' A' ' 50' ' ' LEU . 13.0 tp -75.37 -43.64 49.24 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 170.713 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -58.02 -23.75 55.46 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 176.312 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.8 p -95.06 -14.1 24.58 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 177.634 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.762 HD22 ' HB3' ' A' ' 42' ' ' ALA . 25.2 tp -77.51 134.65 38.26 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.189 0.995 . . . . 0.0 111.833 -176.789 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.39 82.26 0.02 OUTLIER Glycine 0 N--CA 1.481 1.652 0 CA-C-N 113.824 -1.534 . . . . 0.0 112.731 169.579 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.5 mt -102.1 78.71 1.8 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.686 -1.257 . . . . 0.0 109.811 171.008 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 t -125.74 169.53 12.47 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -174.529 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -47.26 118.03 1.99 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.56 1.544 . . . . 0.0 112.671 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.59 -29.87 11.45 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 112.625 -2.079 . . . . 0.0 113.923 175.579 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 m -66.4 118.49 10.12 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.981 0.896 . . . . 0.0 111.208 -173.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' HD21 ' A' ' 38' ' ' ASN . 61.5 t -77.06 107.51 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 112.419 -2.173 . . . . 0.0 109.261 -178.198 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.558 HG21 HG13 ' A' ' 35' ' ' VAL . 12.6 p -107.86 118.86 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 113.353 -1.748 . . . . 0.0 111.409 -178.814 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 m -84.3 100.67 11.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.918 174.285 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mt -78.16 110.8 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.23 172.15 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 13.7 t -119.71 139.49 52.17 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.378 1.049 . . . . 0.0 112.089 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.21 112.71 17.38 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 125.131 1.519 . . . . 0.0 110.93 175.917 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -109.01 101.24 10.34 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 112.574 -2.103 . . . . 0.0 110.26 -176.117 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.36 -159.03 24.67 Favored Glycine 0 N--CA 1.48 1.567 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.727 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -39.21 -84.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 -174.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -72.75 45.03 0.14 Allowed 'General case' 0 C--O 1.256 1.417 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -49.6 -61.17 2.26 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -177.015 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -65.78 -45.15 83.56 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.753 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -62.43 -40.49 96.72 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 113.897 -1.501 . . . . 0.0 113.166 178.386 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.23 -52.91 61.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.696 0.398 . . . . 0.0 111.964 -177.228 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 78' ' ' VAL . 61.3 t -56.43 -61.46 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.419 175.663 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -42.6 -56.88 2.92 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.895 1.278 . . . . 0.0 113.077 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -53.91 -47.34 71.27 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.44 1.496 . . . . 0.0 113.675 177.827 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.1 mt -73.45 -30.65 63.33 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.075 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 74' ' ' VAL . 12.3 t -64.2 -44.31 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.778 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -61.22 -42.9 99.4 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 176.144 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.28 -62.09 2.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.569 172.786 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 60.0 ttm -49.58 -46.9 49.58 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.96 1.304 . . . . 0.0 113.277 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.19 92.68 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -178.461 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.34 6.28 49.12 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 125.114 1.509 . . . . 0.0 114.711 -175.206 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 16.0 mt -98.86 137.93 36.72 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 172.301 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 . . . . . 0 C--O 1.255 1.349 0 C-N-CA 127.329 2.252 . . . . 0.0 107.63 173.915 . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.518 ' HG2' ' HG2' ' A' ' 66' ' ' GLU . 10.0 tmm? . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 . . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -122.61 139.65 53.69 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.017 0.823 . . . . 0.0 111.491 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -123.95 147.22 47.91 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 113.942 -1.481 . . . . 0.0 111.377 178.877 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -137.55 134.22 35.39 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.539 1.15 . . . . 0.0 110.557 162.645 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -97.84 112.17 24.18 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.717 1.26 . . . . 0.0 108.813 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.36 151.83 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.169 -174.921 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.8 p -106.41 151.68 24.6 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 176.723 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.507 HD13 ' HB ' ' A' ' 59' ' ' THR . 4.5 mp -81.09 119.91 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.76 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -99.21 -38.65 8.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 112.593 -2.094 . . . . 0.0 114.629 -174.796 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.16 126.13 14.9 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.916 1.286 . . . . 0.0 113.062 176.931 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HA ' HE21 ' A' ' 57' ' ' GLN . 87.2 Cg_exo -49.69 -33.85 33.19 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 125.165 3.91 . . . . 0.0 115.035 -177.165 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -96.89 -70.63 0.71 Allowed 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.288 0.992 . . . . 0.0 111.539 171.733 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.42 -174.52 20.33 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 123.688 0.661 . . . . 0.0 113.397 173.367 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.68 73.53 1.51 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 122.79 1.281 . . . . 0.0 113.471 -179.02 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -73.99 -174.15 1.79 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.705 -1.588 . . . . 0.0 113.268 177.259 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -40.65 -48.37 2.91 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -171.844 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.265 48.0 mtm105 -82.97 -47.45 0.83 Allowed Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -175.346 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.23 -36.38 68.95 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 122.592 2.195 . . . . 0.0 113.795 168.746 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.61 91.85 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 171.211 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.5 -42.57 82.99 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 173.686 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -60.26 -49.72 76.5 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 172.99 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -57.01 -44.95 83.31 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.945 0.898 . . . . 0.0 112.068 177.588 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.417 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 92.4 t -56.41 -49.52 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.488 0.715 . . . . 0.0 111.67 174.123 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -51.16 -48.58 61.84 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.209 0.943 . . . . 0.0 112.493 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -64.58 -56.48 13.67 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.285 0.991 . . . . 0.0 112.078 175.938 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.74 -34.19 51.58 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -179.109 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 28.6 mtpp -55.18 -28.02 49.98 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 173.879 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.01 16.53 60.26 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 124.202 0.938 . . . . 0.0 115.405 -175.845 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -111.23 145.14 39.25 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.813 0.845 . . . . 0.0 109.318 169.58 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.4 p -63.81 -43.68 95.52 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.133 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.4 m -57.23 148.51 22.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.159 1.784 . . . . 0.0 112.588 176.483 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.73 104.35 14.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.837 1.304 . . . . 0.0 109.132 174.726 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.532 ' H ' HD12 ' A' ' 33' ' ' ILE . 2.6 mp -78.58 110.12 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 111.363 -2.653 . . . . 0.0 111.186 -175.468 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.4 m -90.18 95.45 10.21 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 112.879 -1.964 . . . . 0.0 108.137 176.186 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.6 t -84.4 99.35 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 112.418 -2.174 . . . . 0.0 107.348 178.166 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -96.35 104.4 16.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.346 -176.509 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -105.79 100.88 10.42 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.302 -175.607 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.5 m120 37.61 81.01 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.532 1.933 . . . . 0.0 115.404 -169.648 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.35 -39.13 1.43 Allowed Glycine 0 CA--C 1.544 1.887 0 CA-C-N 113.212 -1.813 . . . . 0.0 114.953 -178.791 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -89.15 125.59 35.11 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.649 0.78 . . . . 0.0 111.674 -174.255 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -111.92 142.5 44.23 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.568 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -140.56 142.61 35.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.207 -1.36 . . . . 0.0 114.247 173.011 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -61.85 117.77 6.33 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.573 171.786 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 50' ' ' LEU . . . -61.04 -16.44 43.56 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.621 174.651 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -91.77 5.17 50.86 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -176.317 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 38.3 t -127.72 128.39 45.31 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.95 0.9 . . . . 0.0 112.022 -178.966 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 67.7 mt -55.44 -59.85 4.24 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.276 -1.784 . . . . 0.0 111.989 175.858 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -53.16 -45.33 68.41 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.666 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.55 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 42.7 mmtt -62.9 -56.2 19.38 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.96 0.787 . . . . 0.0 112.989 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -70.65 -38.32 73.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -178.817 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -65.22 -11.73 43.89 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.583 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.4 p -119.44 9.78 11.68 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 173.893 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 42' ' ' ALA . 43.5 tp -84.83 149.5 25.66 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.749 0.82 . . . . 0.0 109.145 176.538 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.78 68.23 0.3 Allowed Glycine 0 CA--C 1.543 1.792 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.556 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.6 mt -102.75 82.96 2.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.123 0.969 . . . . 0.0 111.43 178.039 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.5 t -132.33 164.29 26.77 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.152 -1.84 . . . . 0.0 110.126 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.411 HE21 ' HA ' ' A' ' 11' ' ' PRO . 4.1 tp-100 -48.97 136.41 14.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.326 1.05 . . . . 0.0 113.004 177.373 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.24 -28.13 5.83 Favored Glycine 0 N--CA 1.483 1.823 0 CA-C-N 113.93 -1.487 . . . . 0.0 115.203 175.604 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.507 ' HB ' HD13 ' A' ' 8' ' ' ILE . 8.8 m -55.53 142.75 32.07 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.151 0.98 . . . . 0.0 112.298 -178.714 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.22 127.01 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.592 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -121.25 116.08 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-O 122.828 1.299 . . . . 0.0 114.034 -178.411 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.78 104.38 16.1 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.431 170.591 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.3 mt -87.11 95.23 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.694 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.9 t -107.11 122.16 45.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.018 -177.218 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.89 110.21 19.31 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 178.042 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.518 ' HG2' ' HG2' ' A' ' 1' ' ' MET . 36.5 mt-10 -91.37 122.02 33.61 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 113.038 -1.892 . . . . 0.0 110.573 169.123 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.42 -152.33 24.48 Favored Glycine 0 N--CA 1.475 1.269 0 O-C-N 124.737 1.273 . . . . 0.0 111.692 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -89.97 -60.78 1.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.186 1.394 . . . . 0.0 113.316 -174.927 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -77.58 38.06 0.24 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.837 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.663 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.8 pt-20 -48.06 -66.23 0.44 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.559 2.343 . . . . 0.0 114.918 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.663 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 57.3 mt-30 -56.25 -46.04 79.79 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.859 1.663 . . . . 0.0 113.374 177.898 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -61.74 -47.54 84.78 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.785 1.234 . . . . 0.0 111.776 -178.435 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.59 -50.82 71.88 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 124.23 0.956 . . . . 0.0 112.39 174.857 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.24 -51.02 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.632 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -48.25 -54.49 13.44 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.453 1.501 . . . . 0.0 112.466 178.785 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -65.28 -51.67 59.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.191 177.798 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.35 -26.4 68.01 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -176.527 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.0 t -57.02 -45.5 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.724 0.81 . . . . 0.0 111.569 169.87 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -59.09 -52.77 64.32 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.353 1.033 . . . . 0.0 110.978 176.47 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.03 -47.75 74.33 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.698 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 60.9 tpp -52.84 -36.81 59.34 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 174.829 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.11 -28.64 25.44 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -107.84 22.91 15.27 Favored 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -171.262 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 mt -116.79 141.89 47.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--O 1.258 1.53 0 C-N-CA 128.103 2.561 . . . . 0.0 107.73 176.587 . . . . . . . . 0 0 . 1 . 026 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG2' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -136.74 141.9 43.03 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.882 1.364 . . . . 0.0 110.76 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -132.12 141.06 49.01 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.249 -179.271 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -133.89 125.0 27.39 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.159 0.912 . . . . 0.0 110.995 176.702 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HA ' HG22 ' A' ' 62' ' ' THR . 36.6 tt0 -74.09 111.6 9.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.654 172.502 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG21 HG22 ' A' ' 78' ' ' VAL . 95.9 t -128.98 140.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.818 -177.002 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 p -113.22 149.41 33.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.809 0.814 . . . . 0.0 111.313 171.438 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 mt -77.43 123.42 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.066 175.765 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -93.12 -36.0 12.89 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 177.871 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -77.12 133.94 68.26 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 176.15 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.737 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 85.8 Cg_exo -58.72 -49.54 11.44 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.859 3.04 . . . . 0.0 112.381 178.397 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -68.82 -44.73 72.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.123 1.769 . . . . 0.0 112.961 171.236 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 67.42 -141.51 39.09 Favored Glycine 0 N--CA 1.475 1.283 0 O-C-N 124.54 1.15 . . . . 0.0 113.153 172.086 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 81' ' ' MET . 3.6 tp -92.66 57.92 2.99 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.806 1.288 . . . . 0.0 110.145 -175.278 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 54.2 p-80 -70.99 -162.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.088 176.595 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -47.34 -61.02 2.1 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -167.288 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.761 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.407 10.5 ptt180 -64.8 -49.37 69.46 Favored Pre-proline 0 N--CA 1.481 1.115 0 CA-C-O 115.375 -2.25 . . . . 0.0 116.297 -179.735 . . . . . . . . 3 3 . 1 . 026 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.761 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 86.1 Cg_exo -59.33 -42.72 46.69 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.063 2.509 . . . . 0.0 113.03 172.047 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.13 -43.42 74.14 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.746 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.96 87.61 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.779 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -60.88 -45.86 92.9 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.759 1.224 . . . . 0.0 112.005 175.189 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -57.99 -45.28 87.06 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.233 1.413 . . . . 0.0 112.777 176.153 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.476 HG21 ' HA ' ' A' ' 47' ' ' LEU . 89.0 t -55.43 -47.8 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.355 0.662 . . . . 0.0 111.752 176.407 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -56.99 -46.44 82.27 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.948 0.78 . . . . 0.0 111.933 177.715 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -63.71 -47.26 81.84 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 123.796 0.685 . . . . 0.0 112.332 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.43 74.68 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.338 1.055 . . . . 0.0 113.791 172.876 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -54.35 -33.74 59.68 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 172.33 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.23 25.09 7.29 Favored Glycine 0 N--CA 1.479 1.511 0 C-N-CA 124.518 1.056 . . . . 0.0 114.264 -177.257 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -125.08 145.43 49.93 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.823 1.249 . . . . 0.0 110.469 169.453 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.7 p -66.06 -43.59 86.98 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.76 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.6 m -54.99 151.16 9.2 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.82 1.648 . . . . 0.0 113.462 174.902 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.29 124.76 43.09 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.663 1.221 . . . . 0.0 109.302 164.151 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.11 99.11 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 111.206 -2.725 . . . . 0.0 109.204 -176.796 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 13.0 m -83.59 115.46 22.14 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 112.422 -2.172 . . . . 0.0 108.678 175.792 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.37 103.83 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 114.031 -1.44 . . . . 0.0 108.746 -177.072 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 m -103.67 103.89 13.86 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.477 -175.018 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.1 t -96.96 97.46 9.28 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.708 176.801 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m120 38.06 79.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.059 -1.882 . . . . 0.0 115.444 -171.541 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.37 -48.69 4.09 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 113.605 -1.634 . . . . 0.0 114.247 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -77.47 119.43 21.05 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.785 0.834 . . . . 0.0 111.198 -176.621 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.7 p -110.1 139.57 45.09 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -173.1 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -133.35 138.93 46.55 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.348 176.388 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.5 t -69.42 118.16 11.95 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.249 170.041 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -23.79 66.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.129 174.721 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -77.86 6.15 8.19 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 175.648 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.8 t -130.36 125.26 34.17 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.782 1.233 . . . . 0.0 112.361 178.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.476 ' HA ' HG21 ' A' ' 23' ' ' VAL . 49.3 mt -53.59 -56.96 12.68 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.992 -1.458 . . . . 0.0 112.221 176.704 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.48 -34.73 77.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.89 -177.511 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 54.7 mmtt -67.72 -56.61 8.6 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 118.972 -0.537 . . . . 0.0 112.181 175.474 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.78 -47.18 84.61 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.744 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.99 -23.34 66.56 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -178.79 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 p -87.89 -25.1 23.43 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 175.668 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.5 tp -74.89 130.63 39.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.075 0.94 . . . . 0.0 111.818 178.518 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.06 95.84 0.18 Allowed Glycine 0 CA--C 1.537 1.451 0 CA-C-N 114.113 -1.403 . . . . 0.0 113.35 177.495 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 mt -105.77 74.7 1.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.322 1.058 . . . . 0.0 111.881 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 t -136.1 142.22 44.28 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.697 -2.047 . . . . 0.0 112.029 -171.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.737 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 6.6 tp-100 2.32 128.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 119.24 3.052 . . . . 0.0 119.24 171.533 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.91 -29.67 0.92 Allowed Glycine 0 N--CA 1.481 1.669 0 CA-C-N 114.003 -1.453 . . . . 0.0 115.981 168.895 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.7 m -61.4 136.53 58.07 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.73 1.212 . . . . 0.0 111.026 -178.318 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.56 110.0 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.521 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.9 p -108.16 92.32 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 112.488 -2.142 . . . . 0.0 109.395 178.799 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 5' ' ' GLU . 17.1 p -82.69 99.48 9.64 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.302 -177.844 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.8 mp -73.73 109.64 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 112.034 -2.348 . . . . 0.0 109.415 174.794 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.448 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 47.4 t -113.73 109.48 18.64 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.735 -2.03 . . . . 0.0 111.125 -177.479 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.64 123.24 47.82 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 122.408 1.099 . . . . 0.0 112.551 -178.901 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.428 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 39.6 tt0 -119.6 91.2 3.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.294 -177.873 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.08 -161.92 30.62 Favored Glycine 0 CA--C 1.548 2.116 0 CA-C-N 112.669 -2.059 . . . . 0.0 110.849 169.807 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.87 -51.18 58.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -79.63 36.81 0.33 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 176.621 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 70' ' ' GLU . . . . . 0.627 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 5.2 pt-20 -39.95 -68.47 0.17 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 128.988 2.915 . . . . 0.0 115.475 -177.879 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 71' ' ' GLN . . . . . 0.627 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 37.9 mt-30 -60.02 -41.43 92.15 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.968 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -71.34 -38.69 71.64 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.012 -176.354 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.57 74.9 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.105 0.878 . . . . 0.0 112.741 170.189 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -74.0 -66.03 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.318 176.343 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -42.37 -53.08 4.36 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 126.13 1.772 . . . . 0.0 112.633 -174.028 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -65.25 -45.88 82.82 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.473 -178.503 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.3 -30.45 67.45 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.399 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 6' ' ' VAL . 70.7 t -59.51 -41.62 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.32 0.648 . . . . 0.0 111.09 171.635 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.89 -53.31 59.42 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.788 0.68 . . . . 0.0 112.24 172.271 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mp -53.87 -44.61 70.56 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.674 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.449 ' HA ' HD13 ' A' ' 14' ' ' LEU . 52.0 tpp -55.9 -43.16 76.99 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.97 1.308 . . . . 0.0 113.669 173.712 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.41 -37.32 37.44 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 179.009 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -98.57 -27.08 14.18 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 119.084 2.994 . . . . 0.0 119.084 -169.945 . . . . . . . . 1 1 . 1 . 026 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 17.1 mt -76.25 129.8 37.23 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.178 . . . . . . . . 2 2 . 1 . 026 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 117.002 -1.475 . . . . 0.0 114.805 166.279 . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 ttp . . . . . 0 C--O 1.237 0.444 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 . . . . . . . . . 0 0 . 1 . 027 nuclear build full ' A' A ' 2' ' ' PHE . . . . . 0.507 ' HD2' HG21 ' A' ' 74' ' ' VAL . 28.7 t80 -109.04 120.93 44.0 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.848 1.343 . . . . 0.0 109.074 177.016 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -111.84 120.65 42.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.842 -176.954 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -121.96 122.96 40.56 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.735 177.727 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.45 123.98 32.27 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.608 1.192 . . . . 0.0 112.55 177.534 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 6' ' ' VAL . . . . . 0.441 HG21 HG13 ' A' ' 78' ' ' VAL . 53.6 t -129.16 133.26 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.0 178.911 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.41 118.27 25.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.675 175.423 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.05 116.15 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 170.842 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p -124.24 16.67 9.1 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -178.863 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.68 134.34 39.98 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.255 175.4 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -49.27 -35.06 33.49 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.934 3.089 . . . . 0.0 115.996 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 p30 -92.63 -41.82 9.99 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 165.7 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.18 -133.83 48.66 Favored Glycine 0 N--CA 1.474 1.211 0 O-C-N 124.207 0.942 . . . . 0.0 111.564 -176.332 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.6 93.7 9.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.834 0.826 . . . . 0.0 111.132 -176.79 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -105.14 -147.79 0.4 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 113.693 -1.594 . . . . 0.0 113.059 174.025 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.2 p -57.24 -72.34 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.779 1.631 . . . . 0.0 114.785 -166.818 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.724 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.34 20.8 ptt180 -62.19 -33.83 13.47 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 176.397 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.724 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 45.5 Cg_exo -57.16 -47.35 23.02 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 122.356 2.037 . . . . 0.0 112.872 166.451 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.67 94.06 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 174.823 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.34 -46.99 69.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 173.742 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -62.7 -49.82 73.56 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.137 0.975 . . . . 0.0 112.174 174.165 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -54.57 -48.32 72.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.278 1.431 . . . . 0.0 111.987 178.953 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.5 t -59.39 -49.88 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 124.145 0.978 . . . . 0.0 112.249 176.492 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -53.23 -52.79 57.8 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 123.868 0.73 . . . . 0.0 110.829 178.826 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -72.33 -38.26 68.69 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 -178.441 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.85 82.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 173.254 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 36.9 mmtt -61.35 -21.17 63.77 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 173.33 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.63 4.16 81.92 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.665 1.126 . . . . 0.0 114.846 175.988 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -114.39 131.75 56.46 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.099 0.959 . . . . 0.0 108.478 171.822 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.4 p -64.48 -47.6 78.36 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.925 -175.523 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 m -46.2 130.34 10.34 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.422 2.289 . . . . 0.0 113.075 174.511 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.34 112.03 17.29 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.934 0.873 . . . . 0.0 109.385 176.597 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.52 HG21 HD12 ' A' ' 77' ' ' LEU . 2.1 mp -95.04 97.55 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 112.086 -2.324 . . . . 0.0 109.744 -171.155 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 5.1 m -84.4 104.99 14.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.437 178.768 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.479 HG13 HG21 ' A' ' 61' ' ' VAL . 5.2 t -87.38 92.81 3.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.0 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.8 m -97.55 92.12 5.77 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.578 -176.287 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.8 p -88.96 108.49 19.6 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.068 0.937 . . . . 0.0 111.24 178.411 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m120 36.33 70.77 0.15 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 112.514 -2.13 . . . . 0.0 114.545 -169.083 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.31 -28.24 3.85 Favored Glycine 0 N--CA 1.482 1.731 0 CA-C-N 113.884 -1.507 . . . . 0.0 116.161 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -88.57 111.26 21.66 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.1 p -96.92 124.18 40.82 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -170.979 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -132.58 140.52 48.29 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.199 -1.819 . . . . 0.0 111.152 171.188 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -72.4 127.73 33.46 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 120.897 0.379 . . . . 0.0 110.833 175.327 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.54 -20.75 22.1 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.733 -1.576 . . . . 0.0 115.07 176.789 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 79.6 mttt -85.01 -8.97 58.5 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.623 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 t -111.21 107.39 16.69 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.307 0.643 . . . . 0.0 112.29 -177.364 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.9 mt -38.7 -63.15 0.54 Allowed 'General case' 0 N--CA 1.483 1.181 0 O-C-N 125.697 1.873 . . . . 0.0 112.83 170.375 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -48.72 -55.03 12.57 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.746 1.218 . . . . 0.0 113.371 177.706 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.646 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 60.9 mttm -56.38 -53.61 55.32 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 178.919 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tp -62.33 -48.3 80.44 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.833 -178.439 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -61.89 -19.53 62.77 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 177.348 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.6 p -114.67 20.18 15.46 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' A' ' 42' ' ' ALA . 16.4 tp -115.76 135.09 54.36 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.05 0.94 . . . . 0.0 109.408 177.005 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.7 93.11 0.06 OUTLIER Glycine 0 N--CA 1.48 1.589 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.486 175.364 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.2 mt -121.7 49.3 1.56 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.717 -1.242 . . . . 0.0 113.18 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 t -118.71 -151.75 0.49 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.184 -170.734 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -46.14 135.19 7.87 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.057 2.143 . . . . 0.0 113.419 175.634 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.53 40.15 54.36 Favored Glycine 0 N--CA 1.483 1.784 0 CA-C-N 113.341 -1.754 . . . . 0.0 115.183 175.942 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.8 m -117.23 127.42 54.08 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.862 0.465 . . . . 0.0 109.973 -174.928 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.6 t -100.59 115.9 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.335 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.479 HG21 HG13 ' A' ' 35' ' ' VAL . 13.0 p -104.25 124.83 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.971 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -92.19 103.24 15.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.762 174.39 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mp -77.85 89.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.345 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.479 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 40.7 t -94.2 90.33 6.31 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.963 -177.057 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.03 114.58 26.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.481 -176.599 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.28 107.57 13.13 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.85 -158.61 31.18 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 114.337 -1.301 . . . . 0.0 113.092 173.35 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.63 -42.46 71.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -173.074 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 p30 -117.92 50.84 1.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -175.743 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.298 12.0 pt-20 -54.88 -50.16 69.41 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -172.44 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -67.99 -33.69 75.11 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.922 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.51 -45.83 92.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.927 1.291 . . . . 0.0 110.532 176.768 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.38 -47.81 84.04 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.251 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.507 HG21 ' HD2' ' A' ' 2' ' ' PHE . 38.4 t -58.88 -55.04 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 117.823 -1.084 . . . . 0.0 112.205 178.672 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -48.8 -51.77 27.57 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.575 1.172 . . . . 0.0 112.36 -177.131 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 34.4 t60 -72.45 -46.23 55.89 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -179.157 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.52 HD12 HG21 ' A' ' 33' ' ' ILE 0.258 76.4 mt -68.7 -26.63 65.38 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -176.878 . . . . . . . . 3 3 . 1 . 027 nuclear build full ' A' A ' 78' ' ' VAL . . . . . 0.441 HG13 HG21 ' A' ' 6' ' ' VAL . 38.9 t -57.7 -52.71 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.132 0.973 . . . . 0.0 110.217 168.091 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 76' ' ' HIS . 56.5 mtmt -51.04 -56.13 14.05 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.827 1.33 . . . . 0.0 112.751 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.7 mt -54.04 -59.16 5.01 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 174.957 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.437 ' HG2' HG11 ' A' ' 61' ' ' VAL . 53.4 tpp -52.03 -49.71 62.87 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.263 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.98 -33.37 70.36 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.356 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -107.76 18.6 21.16 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -171.601 . . . . . . . . 1 1 . 1 . 027 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 18' ' ' PRO . 16.4 mt -102.1 138.19 39.38 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 178.459 . . . . . . . . 2 2 . 1 . 027 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 127.995 2.518 . . . . 0.0 109.37 169.685 . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 . . . . . . . . . 0 0 . 1 . 028 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -142.81 138.89 30.7 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 125.798 1.936 . . . . 0.0 111.243 -171.024 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -137.41 133.26 34.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 178.004 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -128.3 150.51 50.03 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.901 1.281 . . . . 0.0 111.378 177.825 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -111.25 126.35 54.78 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.743 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 t -116.94 139.21 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.321 -177.502 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.53 HG22 HG22 ' A' ' 60' ' ' VAL . 4.0 p -97.24 110.27 22.86 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.396 1.093 . . . . 0.0 111.032 174.996 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 mt -88.94 85.8 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.542 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.8 p -103.63 48.57 0.85 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.138 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.46 131.5 23.95 Favored Pre-proline 0 N--CA 1.48 1.046 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.556 -178.224 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.96 -54.88 3.46 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.927 3.751 . . . . 0.0 116.441 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.7 p30 -90.83 -36.04 14.45 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 169.587 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.96 -136.76 38.09 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.383 0.992 . . . . 0.0 112.771 174.18 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.715 HD23 HD13 ' A' ' 55' ' ' LEU . 5.8 tp -92.42 80.06 4.93 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.492 1.139 . . . . 0.0 109.038 -176.722 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -90.94 -166.14 1.51 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 113.038 -1.892 . . . . 0.0 112.738 177.446 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.6 p -33.17 -75.18 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.528 2.331 . . . . 0.0 117.155 -174.786 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.57 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.383 22.4 ptt85 -69.13 -31.69 2.88 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 179.322 . . . . . . . . 3 3 . 1 . 028 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.57 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 47.7 Cg_exo -60.81 -40.72 51.58 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.94 1.76 . . . . 0.0 112.626 165.19 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -59.32 -42.42 91.36 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.566 0.746 . . . . 0.0 112.958 173.254 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.03 -42.45 65.7 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 172.485 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -69.7 -43.94 71.42 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 175.165 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.61 -42.6 83.6 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.184 0.927 . . . . 0.0 112.119 175.238 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 47' ' ' LEU . 60.6 t -59.73 -57.01 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 124.059 0.944 . . . . 0.0 110.395 173.05 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -48.27 -46.61 36.04 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 124.538 1.148 . . . . 0.0 112.4 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -68.85 -54.74 14.0 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 124.684 1.24 . . . . 0.0 112.754 179.059 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.53 66.61 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.577 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -53.87 -39.01 65.33 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 173.298 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.86 -37.01 93.64 Favored Glycine 0 N--CA 1.483 1.768 0 O-C-N 124.775 1.297 . . . . 0.0 113.632 -179.412 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 29' ' ' PHE . . . . . 0.602 ' HE1' ' HE2' ' A' ' 72' ' ' LYS . 72.1 m-85 -76.82 140.08 40.56 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.529 0.731 . . . . 0.0 111.746 178.247 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.0 p -65.47 -47.22 76.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.353 -174.294 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 m -49.37 132.0 20.39 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.665 1.586 . . . . 0.0 112.531 178.239 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -73.74 131.56 41.72 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 119.003 -1.079 . . . . 0.0 109.427 170.759 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.9 mt -119.37 115.28 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.872 -164.275 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -103.75 133.47 48.7 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.262 -2.245 . . . . 0.0 108.845 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.676 HG13 HG21 ' A' ' 61' ' ' VAL . 10.6 t -116.19 94.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 113.66 -1.609 . . . . 0.0 106.857 177.699 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.4 m -94.56 84.13 4.24 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 112.375 -2.193 . . . . 0.0 109.481 -176.923 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.3 p -85.19 97.91 10.17 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.152 -177.976 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.0 m120 45.52 68.61 0.55 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 113.071 -1.877 . . . . 0.0 113.778 -169.651 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.49 -35.19 2.24 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 113.672 -1.604 . . . . 0.0 114.915 178.101 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -73.02 98.06 2.45 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.06 0.944 . . . . 0.0 111.205 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.6 p -84.91 124.82 32.07 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.744 -1.571 . . . . 0.0 114.683 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.722 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -132.95 156.63 46.94 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 112.585 -2.098 . . . . 0.0 109.961 167.08 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -80.23 124.7 29.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.481 0.658 . . . . 0.0 110.422 174.187 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' HB2' HG23 ' A' ' 35' ' ' VAL . . . -58.31 -36.62 73.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.237 173.75 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -77.85 13.67 1.3 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.751 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.6 t -135.12 110.42 9.0 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.582 ' HA ' HG21 ' A' ' 23' ' ' VAL . 44.9 tp -45.04 -74.52 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.005 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -54.36 -34.6 61.5 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -66.94 -45.19 78.57 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 44' ' ' ALA . 14.6 tp -68.17 -42.03 80.6 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.432 1.082 . . . . 0.0 112.761 175.885 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -62.18 -36.33 81.54 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 175.152 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.9 p -88.89 15.79 7.92 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 175.898 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.722 HD22 ' HB3' ' A' ' 42' ' ' ALA . 18.0 tp -110.76 130.37 55.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.65 1.18 . . . . 0.0 108.065 177.005 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.34 86.54 0.33 Allowed Glycine 0 N--CA 1.485 1.916 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.061 -175.594 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.715 HD13 HD23 ' A' ' 14' ' ' LEU . 5.3 mt -106.92 62.2 0.63 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.938 1.351 . . . . 0.0 111.378 176.981 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 t -123.65 -164.71 1.25 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.006 -169.18 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -55.51 129.12 37.62 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.392 1.077 . . . . 0.0 112.56 179.343 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.3 38.66 93.9 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-N 113.215 -1.811 . . . . 0.0 115.084 -179.34 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 m -105.94 138.32 42.33 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.534 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.53 HG22 HG22 ' A' ' 7' ' ' THR . 12.1 t -114.43 122.39 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 172.686 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.676 HG21 HG13 ' A' ' 35' ' ' VAL . 14.9 p -116.71 117.59 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -174.53 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 m -80.38 100.8 8.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 113.309 -1.768 . . . . 0.0 109.015 170.022 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.467 HG12 HG22 ' A' ' 35' ' ' VAL . 64.2 mt -92.6 111.33 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.525 176.848 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 t -109.08 131.55 54.96 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.668 -177.533 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.14 125.99 48.61 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.15 1.532 . . . . 0.0 111.971 172.921 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -118.3 89.55 3.15 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 177.224 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.1 -156.12 21.84 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-N 113.193 -1.821 . . . . 0.0 112.611 169.194 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -57.52 -53.82 53.81 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.922 1.289 . . . . 0.0 114.19 -177.552 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -81.88 46.14 0.97 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 177.543 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 4.4 pt-20 -55.25 -58.06 9.25 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -176.396 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 2.4 mp0 -64.67 -48.81 73.36 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 171.649 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 72' ' ' LYS . . . . . 0.602 ' HE2' ' HE1' ' A' ' 29' ' ' PHE . 77.9 tttt -54.75 -49.3 71.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.48 1.512 . . . . 0.0 113.062 -173.03 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.46 -52.6 64.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.775 0.83 . . . . 0.0 112.88 177.17 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.4 t -68.97 -49.16 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.887 -175.403 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -53.06 -50.93 63.34 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.56 1.144 . . . . 0.0 112.65 179.296 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -61.6 -45.76 92.74 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.942 0.897 . . . . 0.0 112.052 177.19 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.08 -38.49 90.91 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 177.026 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.4 t -59.06 -48.45 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.053 0.941 . . . . 0.0 110.295 173.845 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -56.48 -56.88 15.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.183 0.993 . . . . 0.0 111.199 172.794 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.71 -43.66 62.91 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.533 1.533 . . . . 0.0 113.501 -177.783 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.3 tpp -49.53 -47.87 48.62 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.121 1.368 . . . . 0.0 112.654 176.613 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.08 -24.73 65.99 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.39 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -100.32 23.49 10.07 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.511 . . . . . . . . 1 1 . 1 . 028 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 34.3 mt -132.26 130.26 40.68 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.414 1.086 . . . . 0.0 113.834 178.31 . . . . . . . . 2 2 . 1 . 028 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.84 1.656 . . . . 0.0 107.121 176.114 . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 ttp . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 . . . . . . . . . 0 0 . 1 . 029 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -116.52 130.15 56.59 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 125.004 1.44 . . . . 0.0 109.449 177.038 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -124.19 131.26 53.52 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 112.061 -2.336 . . . . 0.0 110.452 -177.546 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -128.08 98.55 5.16 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 112.986 -1.915 . . . . 0.0 111.779 168.095 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.22 102.29 1.34 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.878 168.905 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.38 142.67 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.776 -1.556 . . . . 0.0 113.235 -179.272 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -87.75 126.91 35.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.079 -1.418 . . . . 0.0 111.767 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 8' ' ' ILE . . . . . 0.483 HD12 ' HB ' ' A' ' 59' ' ' THR . 49.1 mt -75.55 108.59 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.581 169.829 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -92.38 -16.37 26.05 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.353 -1.749 . . . . 0.0 115.419 178.056 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.49 126.06 88.69 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.755 176.389 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 89.2 Cg_exo -49.74 -54.2 5.83 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 124.445 3.43 . . . . 0.0 113.139 -175.272 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -66.55 -59.05 3.99 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.211 1.805 . . . . 0.0 112.087 170.184 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.57 -151.59 20.41 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 124.538 1.149 . . . . 0.0 111.86 176.907 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.799 HD23 HD13 ' A' ' 55' ' ' LEU . 11.5 tp -92.55 70.01 4.94 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.151 -1.524 . . . . 0.0 108.407 -175.482 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -78.32 -155.58 0.08 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.633 -1.621 . . . . 0.0 114.488 -177.115 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.8 p -43.28 -70.41 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.654 1.982 . . . . 0.0 114.805 -170.813 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.327 12.8 ptt180 -73.21 -32.46 1.68 Allowed Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.565 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 47.6 Cg_exo -58.09 -47.15 21.42 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.732 2.288 . . . . 0.0 113.636 167.698 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -57.88 -47.16 83.56 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 175.479 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.66 -39.85 68.47 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 174.641 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.2 tt0 -73.1 -42.14 63.29 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.819 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 22' ' ' PHE . . . . . 0.539 ' HE2' ' HB2' ' A' ' 81' ' ' MET . 12.1 t80 -54.76 -41.78 70.87 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 123.68 0.612 . . . . 0.0 111.512 174.079 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 47' ' ' LEU . 48.1 t -57.14 -49.71 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.881 0.872 . . . . 0.0 111.61 174.771 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -52.81 -52.56 56.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.611 0.764 . . . . 0.0 111.378 178.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -67.67 -44.55 77.57 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 124.757 1.286 . . . . 0.0 112.862 -178.503 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.85 -41.9 78.75 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.766 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -56.63 -32.48 65.35 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 174.371 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.88 -13.76 66.86 Favored Glycine 0 CA--C 1.544 1.891 0 O-C-N 125.201 1.563 . . . . 0.0 115.192 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -101.84 138.47 38.76 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.161 0.505 . . . . 0.0 110.478 176.673 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.3 p -64.3 -41.26 96.95 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.448 -175.557 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -54.19 141.44 29.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.103 1.761 . . . . 0.0 112.319 174.781 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -86.19 106.33 17.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.064 0.935 . . . . 0.0 109.377 174.25 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.521 HD12 ' HD2' ' A' ' 45' ' ' LYS . 3.7 mp -85.66 93.16 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.322 -175.089 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.18 129.95 38.81 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 113.732 -1.577 . . . . 0.0 107.753 169.223 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG13 ' CG2' ' A' ' 61' ' ' VAL . 10.6 t -114.35 92.96 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.59 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.8 m -93.1 93.22 8.18 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 111.184 -2.734 . . . . 0.0 109.731 -175.141 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB2' ' CG2' ' A' ' 59' ' ' THR . 99.4 p -101.29 100.26 10.75 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.32 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.3 m120 45.33 70.93 0.31 Allowed 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.005 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.25 -31.02 1.85 Allowed Glycine 0 CA--C 1.546 2.011 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.156 -177.108 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -80.99 93.71 6.41 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.186 0.993 . . . . 0.0 113.564 -177.198 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 p -88.68 104.41 16.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 112.726 -2.034 . . . . 0.0 113.907 -179.474 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -129.43 134.68 47.96 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.7 175.369 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.3 t -67.4 127.57 33.17 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 122.272 1.034 . . . . 0.0 113.273 175.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.22 -30.96 71.46 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.414 174.01 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HD2' HD12 ' A' ' 33' ' ' ILE . 59.2 mtpt -72.75 -0.64 13.81 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 178.883 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.8 t -121.69 129.07 52.49 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.349 0.595 . . . . 0.0 111.879 170.31 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HA ' HG21 ' A' ' 23' ' ' VAL . 1.6 tp -57.92 -70.48 0.13 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 112.825 -1.989 . . . . 0.0 112.651 -173.072 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.56 -39.17 70.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -56.23 -48.91 75.55 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 172.292 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.3 tp -75.19 -41.62 57.53 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 175.644 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -56.13 -45.49 79.54 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.644 1.178 . . . . 0.0 113.1 177.815 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.7 p -75.22 -7.82 54.91 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 175.296 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 53' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 42' ' ' ALA . 16.1 tp -86.37 118.72 25.99 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.175 0.988 . . . . 0.0 109.244 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.19 102.26 1.06 Allowed Glycine 0 N--CA 1.485 1.93 0 CA-C-N 113.237 -1.801 . . . . 0.0 113.081 -177.343 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 55' ' ' LEU . . . . . 0.799 HD13 HD23 ' A' ' 14' ' ' LEU . 5.9 mt -116.42 96.5 5.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.221 1.008 . . . . 0.0 110.604 -175.484 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -140.29 171.24 14.44 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.086 0.954 . . . . 0.0 113.175 -165.155 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 57' ' ' GLN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 33.8 tt0 -52.77 110.89 0.57 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.834 0.826 . . . . 0.0 111.828 174.085 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.38 -7.89 30.52 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 112.709 -2.041 . . . . 0.0 115.275 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 59' ' ' THR . . . . . 0.483 ' HB ' HD12 ' A' ' 8' ' ' ILE . 7.2 m -75.31 119.9 20.05 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.141 0.97 . . . . 0.0 111.665 -179.284 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.43 101.3 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 174.859 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG2' HG13 ' A' ' 35' ' ' VAL . 14.5 p -109.7 119.87 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.964 -174.557 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -89.63 103.04 15.72 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.535 175.261 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.0 mp -77.78 91.0 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 168.073 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -105.65 92.55 4.23 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 112.381 -2.191 . . . . 0.0 111.427 -171.33 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.41 111.04 23.28 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.188 -176.999 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.48 122.41 46.24 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.78 -154.91 22.89 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 113.025 -1.898 . . . . 0.0 111.126 -176.243 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -67.75 -63.92 0.96 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.356 1.463 . . . . 0.0 114.081 -171.547 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -80.22 40.04 0.47 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.079 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.39 -51.21 56.69 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.174 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -66.85 -54.33 23.5 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.053 0.941 . . . . 0.0 112.833 177.824 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -53.44 -42.57 67.25 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.386 1.475 . . . . 0.0 112.924 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.17 -54.96 40.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.6 0.76 . . . . 0.0 112.575 173.721 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.5 t -58.25 -51.2 74.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.348 178.089 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -48.2 -65.18 0.61 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.816 1.246 . . . . 0.0 113.173 -179.409 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -72.78 -27.87 62.26 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -176.444 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.4 mt -75.1 -41.78 57.92 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 174.486 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.05 -44.07 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 123.271 0.357 . . . . 0.0 110.477 174.68 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -49.01 -62.05 1.74 Allowed 'General case' 0 N--CA 1.479 1.021 0 O-C-N 125.159 1.537 . . . . 0.0 111.57 169.205 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.64 -46.66 73.97 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.733 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.539 ' HB2' ' HE2' ' A' ' 22' ' ' PHE . 24.4 ttp -50.9 -46.85 60.76 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.346 1.458 . . . . 0.0 113.045 178.525 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.65 76.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.461 1.1 . . . . 0.0 112.706 177.779 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.67 32.9 0.71 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.753 1.221 . . . . 0.0 114.088 -173.42 . . . . . . . . 1 1 . 1 . 029 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 34.9 mt -132.36 99.28 4.63 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.568 1.175 . . . . 0.0 112.4 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--O 1.255 1.352 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.631 -169.976 . . . . . . . . 0 0 . 1 . 030 nuclear build full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HG3' ' HB3' ' A' ' 66' ' ' GLU . 17.7 ttt . . . . . 0 C--O 1.239 0.535 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 . . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -137.63 141.18 41.22 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 126.021 2.075 . . . . 0.0 111.386 -173.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -125.14 131.16 53.3 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 125.42 1.7 . . . . 0.0 109.475 174.753 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -126.12 136.43 52.87 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 125.518 1.761 . . . . 0.0 109.872 172.604 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -115.28 94.2 4.62 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 122.509 1.147 . . . . 0.0 114.058 -169.928 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.0 m -120.95 159.95 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 113.521 -1.672 . . . . 0.0 114.328 -173.126 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 7' ' ' THR . . . . . 0.752 HG22 HG22 ' A' ' 60' ' ' VAL . 75.2 p -107.61 155.5 20.07 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -179.349 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.4 mt -103.23 113.76 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 111.211 -2.722 . . . . 0.0 108.401 168.606 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.7 p -94.84 -30.87 13.98 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 112.269 -2.241 . . . . 0.0 116.659 175.214 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -59.8 135.76 89.9 Favored Pre-proline 0 N--CA 1.484 1.269 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.406 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 76.9 Cg_exo -50.13 -48.68 18.81 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.816 3.677 . . . . 0.0 115.415 -178.646 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . 0.285 0.4 OUTLIER -95.48 -16.88 21.91 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 170.96 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 46.88 -128.81 11.71 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.163 1.84 . . . . 0.0 115.576 178.277 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 14' ' ' LEU . . . . . 0.549 HD11 ' HG2' ' A' ' 81' ' ' MET . 81.0 mt -98.47 54.93 1.07 Allowed 'General case' 0 C--O 1.2 -1.515 0 CA-C-N 111.933 -2.133 . . . . 0.0 112.4 -171.926 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -68.66 -166.43 0.08 Allowed 'General case' 0 C--N 1.364 1.233 0 CA-C-N 112.031 -2.349 . . . . 0.0 113.217 174.914 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -54.46 -51.58 64.55 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -164.993 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.254 43.5 ttt85 -69.61 -50.33 18.93 Favored Pre-proline 0 N--CA 1.479 0.976 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 174.814 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 47.1 Cg_exo -57.35 -38.6 94.16 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.958 2.439 . . . . 0.0 113.613 173.09 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 50' ' ' LEU . . . -68.14 -35.33 77.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 172.688 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.26 65.21 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 173.354 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 21' ' ' GLN . . . . . 0.547 ' NE2' HD11 ' A' ' 84' ' ' LEU . 42.0 tt0 -68.48 -39.79 81.23 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.149 0.98 . . . . 0.0 111.549 169.582 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.5 -47.45 83.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.853 0.861 . . . . 0.0 112.028 171.267 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 44' ' ' ALA . 75.5 t -53.47 -56.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.601 1.16 . . . . 0.0 112.023 175.336 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.91 -61.44 0.85 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.577 1.151 . . . . 0.0 112.389 170.043 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.99 -34.39 77.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -176.156 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.8 -44.38 96.97 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.867 0.867 . . . . 0.0 112.104 176.476 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -56.73 -22.68 37.2 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 176.69 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.97 65.47 Favored Glycine 0 CA--C 1.542 1.728 0 O-C-N 124.741 1.275 . . . . 0.0 111.468 178.701 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -81.79 148.35 28.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.355 1.074 . . . . 0.0 112.84 -174.933 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.1 p -70.44 -35.26 73.26 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.274 -176.048 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.1 m -49.34 148.73 2.48 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.971 1.308 . . . . 0.0 113.457 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -91.98 104.19 16.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 160.098 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 33' ' ' ILE . . . . . 0.66 ' H ' HD12 ' A' ' 33' ' ' ILE . 0.5 OUTLIER -91.1 113.15 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 112.052 -2.34 . . . . 0.0 106.851 176.115 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 34' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 95.9 m -90.98 142.66 27.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.407 173.144 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 44' ' ' ALA . 37.5 t -118.68 106.67 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 112.512 -2.131 . . . . 0.0 108.016 176.542 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 36' ' ' THR . . . . . 0.63 HG23 ' HB3' ' A' ' 41' ' ' SER . 3.9 m -114.06 92.27 3.91 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 112.787 -2.006 . . . . 0.0 109.577 -176.467 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 p -87.58 89.15 7.89 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 122.816 1.293 . . . . 0.0 110.68 179.701 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.6 m120 46.41 74.96 0.13 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.012 -1.904 . . . . 0.0 112.276 -172.536 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.75 -22.56 2.23 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 113.125 -1.852 . . . . 0.0 116.544 -179.727 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -85.86 91.87 8.47 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.854 -0.792 . . . . 0.0 110.0 -177.709 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 41' ' ' SER . . . . . 0.63 ' HB3' HG23 ' A' ' 36' ' ' THR . 28.1 p -101.78 127.99 48.32 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -169.109 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.82 144.81 31.33 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.065 -1.879 . . . . 0.0 110.94 177.604 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -55.33 130.44 42.43 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 168.486 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 44' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -53.77 -30.53 44.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.849 1.26 . . . . 0.0 111.581 172.371 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -74.0 -6.13 45.58 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 46' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -101.03 103.64 14.77 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -171.107 . . . . . . . . 3 3 . 1 . 030 nuclear build full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 tp -49.06 -73.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -176.807 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -45.26 -48.6 12.81 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.16 1.384 . . . . 0.0 113.922 177.657 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 49' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 66.0 mmtt -52.33 -52.47 53.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 117.125 -1.417 . . . . 0.0 114.157 175.571 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 6.3 mp -71.98 -35.94 69.64 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -178.556 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.86 -31.08 72.04 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 175.014 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.9 p -84.78 -35.48 22.34 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 171.167 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 tp -67.61 122.92 19.07 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 111.174 -176.823 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.92 100.14 0.42 Allowed Glycine 0 CA--C 1.54 1.619 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.471 -177.446 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 mt -125.39 88.44 2.87 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.67 1.188 . . . . 0.0 110.293 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -143.49 -166.62 2.37 Favored 'General case' 0 C--O 1.199 -1.584 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.682 -175.396 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -56.28 118.31 4.62 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.774 1.23 . . . . 0.0 112.138 -178.399 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.58 -30.12 10.66 Favored Glycine 0 CA--C 1.544 1.863 0 CA-C-N 112.631 -2.077 . . . . 0.0 113.842 -178.697 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.04 137.68 55.24 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.874 1.27 . . . . 0.0 113.375 -174.335 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 60' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 7' ' ' THR . 11.5 t -116.77 114.38 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.333 -169.302 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 p -109.53 96.84 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 112.952 -1.931 . . . . 0.0 112.269 -166.704 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 62' ' ' THR . . . . . 0.515 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 30.6 m -72.07 101.75 2.82 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 111.614 -2.539 . . . . 0.0 108.6 173.425 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 63' ' ' ILE . . . . . 0.509 HG22 HG22 ' A' ' 74' ' ' VAL . 5.5 mt -94.23 112.57 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 123.772 1.748 . . . . 0.0 110.507 -178.336 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 64' ' ' SER . . . . . 0.649 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 13.3 t -123.79 96.03 4.8 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 109.973 -3.285 . . . . 0.0 113.215 -159.514 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.17 117.7 34.68 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.229 -170.046 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 66' ' ' GLU . . . . . 0.44 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 9.0 pt-20 -120.13 86.96 2.66 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -176.245 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.24 -164.48 30.46 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 112.34 -2.209 . . . . 0.0 110.048 171.114 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -34.82 73.59 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -179.658 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -104.55 43.39 1.1 Allowed 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 -176.187 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -63.12 1.28 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 -178.892 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -62.71 -44.97 94.86 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -49.08 -50.15 38.15 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.339 1.056 . . . . 0.0 113.124 173.63 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.42 -55.79 24.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.797 0.839 . . . . 0.0 112.394 -177.483 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 74' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 63' ' ' ILE . 31.4 t -62.44 -37.16 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-O 117.759 -1.115 . . . . 0.0 111.992 -177.962 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.67 -46.78 86.45 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.478 0.487 . . . . 0.0 111.548 178.659 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 76' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 67.3 t60 -74.27 -32.03 62.77 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.149 -178.852 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 77' ' ' LEU . . . . . 0.456 ' CD1' HG21 ' A' ' 33' ' ' ILE . 54.2 mt -74.85 -36.83 62.34 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 173.688 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.45 -38.7 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.525 173.347 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 76' ' ' HIS . 77.1 tttt -48.21 -58.69 4.19 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.628 1.205 . . . . 0.0 110.521 163.597 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -58.41 -48.04 81.96 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 176.375 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 81' ' ' MET . . . . . 0.549 ' HG2' HD11 ' A' ' 14' ' ' LEU . 13.5 tmm? -52.08 -44.67 64.47 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.513 1.525 . . . . 0.0 112.35 174.442 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.27 -25.34 54.84 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.767 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -83.89 -22.05 31.74 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 178.977 . . . . . . . . 1 1 . 1 . 030 nuclear build full ' A' A ' 84' ' ' LEU . . . . . 0.547 HD11 ' NE2' ' A' ' 21' ' ' GLN . 36.0 mt -93.75 142.43 27.37 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 -172.586 . . . . . . . . 2 2 . 1 . 030 nuclear build full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 CA--C 1.556 1.196 0 CA-C-N 111.514 -2.584 . . . . 0.0 109.513 -167.766 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 ttp . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -120.7 134.07 55.31 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 125.639 1.837 . . . . 0.0 108.797 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -128.64 153.61 47.1 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.634 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -142.55 121.98 13.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.113 168.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -87.72 97.37 10.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 123.199 1.476 . . . . 0.0 111.275 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.57 155.48 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 112.118 -2.31 . . . . 0.0 108.113 -171.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 p -120.09 154.76 34.21 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.303 0.573 . . . . 0.0 112.215 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.479 HD12 ' HB ' ' A' ' 59' ' ' THR . 65.3 mt -103.5 115.16 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.154 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 p -99.24 -0.47 41.31 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -94.87 139.83 22.29 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 110.638 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -55.5 -68.79 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.655 2.903 . . . . 0.0 114.229 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -62.72 -35.77 80.84 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.245 1.018 . . . . 0.0 113.23 167.605 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 74.44 -135.62 19.87 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 124.957 1.411 . . . . 0.0 111.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 1.8 tp -92.88 57.45 2.81 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 113.013 -1.594 . . . . 0.0 109.417 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -67.73 167.51 13.13 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.817 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.4 p 1.26 -68.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 118.687 2.847 . . . . 0.0 118.687 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.416 7.7 ptt-85 -85.18 -38.82 0.62 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 17.7 Cg_exo -54.91 -41.46 78.36 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.214 2.61 . . . . 0.0 113.436 159.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -57.22 -47.27 81.73 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 171.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.26 -44.38 79.64 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 24.4 mt-30 -63.32 -42.05 98.97 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.69 1.196 . . . . 0.0 113.728 174.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -62.62 -43.42 98.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.297 0.639 . . . . 0.0 112.119 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 19' ' ' ALA . 59.2 t -59.66 -48.16 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.56 0.744 . . . . 0.0 111.936 173.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 17.2 tttm -43.74 -55.02 4.69 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.29 0.994 . . . . 0.0 111.781 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -66.03 -46.85 76.38 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 124.227 0.955 . . . . 0.0 112.674 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.75 70.3 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.814 1.245 . . . . 0.0 114.063 175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -61.17 -29.78 70.0 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.33 19.29 23.95 Favored Glycine 0 N--CA 1.481 1.663 0 O-C-N 124.225 0.953 . . . . 0.0 114.787 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -129.92 143.29 50.73 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.323 1.049 . . . . 0.0 110.669 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.2 p -67.21 -41.46 85.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.987 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.8 m -52.32 144.63 12.52 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.591 1.556 . . . . 0.0 113.111 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -86.82 92.38 8.96 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.137 0.97 . . . . 0.0 109.654 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.514 HG21 HD13 ' A' ' 77' ' ' LEU . 3.9 mp -76.96 107.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 112.66 -2.063 . . . . 0.0 109.478 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.7 m -106.86 137.67 44.47 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.09 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.58 115.07 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 112.48 -2.146 . . . . 0.0 107.398 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.9 m -111.58 97.7 6.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.451 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.6 m -92.94 93.83 8.59 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.169 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m120 48.52 76.97 0.11 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.443 -174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.09 -46.34 2.42 Favored Glycine 0 N--CA 1.488 2.146 0 CA-C-N 113.704 -1.589 . . . . 0.0 114.83 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -76.3 126.94 31.91 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.395 1.078 . . . . 0.0 113.156 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.0 p -108.75 141.2 41.1 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -145.51 135.97 24.14 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.399 167.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.5 t -67.52 127.85 34.25 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.286 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.39 -9.47 48.49 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 112.99 -1.914 . . . . 0.0 111.717 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -95.24 35.61 1.29 Allowed 'General case' 0 CA--C 1.552 1.055 0 O-C-N 121.181 -0.949 . . . . 0.0 111.744 173.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 41.5 t -154.29 117.23 4.45 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.334 174.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.401 ' HA ' HG21 ' A' ' 23' ' ' VAL . 44.9 mt -52.51 -61.58 2.19 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.041 175.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -52.45 -45.97 66.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.844 1.258 . . . . 0.0 113.751 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.587 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 63.3 mttt -66.39 -43.83 84.73 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 tp -72.45 -23.95 61.14 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -78.73 -27.19 44.82 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.6 p -86.2 -33.27 20.82 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 42' ' ' ALA . 17.6 tp -64.86 131.51 46.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.304 0.642 . . . . 0.0 111.732 174.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.83 90.39 0.21 Allowed Glycine 0 N--CA 1.476 1.319 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.91 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 14' ' ' LEU . 8.7 mt -107.93 76.78 1.07 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.057 0.943 . . . . 0.0 111.985 176.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 t -137.73 172.87 12.31 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.444 -1.707 . . . . 0.0 112.331 -168.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -35.9 125.56 0.72 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.763 2.025 . . . . 0.0 115.435 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.02 -92.14 1.16 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.372 1.463 . . . . 0.0 110.088 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.479 ' HB ' HD12 ' A' ' 8' ' ' ILE . 11.3 m 24.55 123.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 128.216 2.606 . . . . 0.0 117.895 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.8 102.3 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 112.358 -2.201 . . . . 0.0 106.226 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.85 106.77 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 113.294 -1.775 . . . . 0.0 112.173 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.0 m -83.47 115.23 21.98 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.945 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.4 mt -93.31 102.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.6 t -116.62 117.72 30.61 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.091 -171.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.19 126.29 50.3 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.927 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -127.93 122.75 33.21 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 125.003 1.44 . . . . 0.0 114.18 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.0 -168.01 31.79 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 113.033 -1.894 . . . . 0.0 110.575 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -52.82 -40.65 63.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -111.09 37.66 2.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -45.94 -58.5 3.5 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -59.62 -51.22 70.75 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.192 1.397 . . . . 0.0 113.859 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -56.72 -41.12 76.91 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.3 1.84 . . . . 0.0 112.387 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.92 -59.84 4.74 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 78' ' ' VAL . 59.5 t -59.46 -44.94 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.067 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -49.2 -62.54 1.48 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.086 0.954 . . . . 0.0 112.127 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -66.0 -35.48 80.68 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.063 1.345 . . . . 0.0 113.766 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.514 HD13 HG21 ' A' ' 33' ' ' ILE . 44.3 mt -69.94 -30.69 68.14 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 74' ' ' VAL . 90.9 t -62.63 -39.9 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.478 0.311 . . . . 0.0 110.322 171.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -57.4 -51.32 69.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.236 0.614 . . . . 0.0 112.261 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.5 -45.22 73.22 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.422 ' HE1' HD22 ' A' ' 55' ' ' LEU . 59.8 tpp -59.3 -48.74 80.49 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 172.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.21 -31.9 73.0 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -97.79 -27.64 14.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 17.1 mt . . . . . 0 N--CA 1.483 1.183 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 -176.398 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 38.9 ttp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.485 ' HE1' ' HG3' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -67.94 109.46 3.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 113.756 -1.565 . . . . 0.0 109.86 175.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.03 125.25 48.91 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 124.338 1.024 . . . . 0.0 109.403 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.485 ' HG3' ' HE1' ' A' ' 2' ' ' PHE . 5.9 mt-30 -129.9 130.86 45.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.298 -1.319 . . . . 0.0 114.357 176.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.753 ' HG2' HG22 ' A' ' 62' ' ' THR . 58.9 mt-10 -98.16 90.45 4.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.173 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.1 t -96.2 126.48 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.158 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 13.7 m -102.32 120.31 40.27 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.579 HG12 HD12 ' A' ' 14' ' ' LEU . 76.3 mt -68.6 125.14 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 124.974 1.421 . . . . 0.0 108.051 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 t -119.25 -22.1 7.26 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -171.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.22 142.85 98.07 Favored Pre-proline 0 N--CA 1.48 1.036 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.81 -30.95 78.24 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.436 2.757 . . . . 0.0 113.963 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -72.97 -49.51 28.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.831 0.852 . . . . 0.0 111.489 166.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.57 171.75 45.19 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.376 1.465 . . . . 0.0 112.129 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.579 HD12 HG12 ' A' ' 8' ' ' ILE . 37.1 mt -73.53 58.73 0.59 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.432 1.587 . . . . 0.0 110.49 164.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -70.19 -147.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 112.7 -2.045 . . . . 0.0 116.298 -166.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -60.49 -54.28 47.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.069 1.347 . . . . 0.0 113.566 -168.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -72.9 -36.77 3.6 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 116.57 -1.681 . . . . 0.0 113.517 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.78 -50.33 10.72 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.822 2.348 . . . . 0.0 112.017 165.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -54.11 -44.18 71.08 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 171.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.7 -47.01 77.53 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.058 0.943 . . . . 0.0 113.369 174.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -59.43 -46.09 89.71 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.485 ' HE2' HG21 ' A' ' 35' ' ' VAL . 17.0 t80 -63.78 -46.49 84.96 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.234 1.414 . . . . 0.0 113.293 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 47' ' ' LEU . 71.6 t -56.64 -51.18 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 124.331 1.052 . . . . 0.0 110.461 173.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -52.5 -53.97 38.83 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.355 1.462 . . . . 0.0 110.9 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.17 -46.64 88.06 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.696 1.247 . . . . 0.0 114.024 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.78 70.71 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.984 0.914 . . . . 0.0 113.318 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -66.5 -12.18 56.18 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.97 21.21 44.51 Favored Glycine 0 CA--C 1.544 1.888 0 C-N-CA 124.309 0.957 . . . . 0.0 113.455 172.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -122.59 125.15 45.08 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.04 0.936 . . . . 0.0 108.49 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.2 p -57.95 -36.97 73.29 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.825 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 p -59.23 157.97 9.8 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.147 1.779 . . . . 0.0 112.624 168.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -111.76 136.13 51.44 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.386 1.089 . . . . 0.0 112.841 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.4 111.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 111.893 -2.412 . . . . 0.0 112.205 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.2 m -93.21 98.82 11.52 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 112.551 -2.113 . . . . 0.0 107.122 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 63' ' ' ILE . 46.9 t -109.48 90.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.737 -172.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.1 p -104.74 101.8 11.4 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 112.376 -2.193 . . . . 0.0 113.684 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.522 ' HB3' HD12 ' A' ' 53' ' ' LEU . 29.0 t -60.27 103.86 0.27 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.521 166.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -19.32 90.12 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.881 2.472 . . . . 0.0 116.885 -172.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.08 -72.38 0.26 Allowed Glycine 0 CA--C 1.538 1.53 0 CA-C-N 112.793 -2.003 . . . . 0.0 114.35 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -114.25 144.12 43.74 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -170.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.4 m -76.01 130.6 38.66 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.52 131.29 7.13 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.945 -1.48 . . . . 0.0 112.909 -174.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.2 t -89.06 140.85 29.03 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.106 165.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.42 -23.2 66.89 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.744 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -82.14 31.17 0.38 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.6 t -160.23 113.32 2.1 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.959 -1.928 . . . . 0.0 109.182 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.465 ' HA ' HG21 ' A' ' 23' ' ' VAL . 29.5 tp -52.98 -62.24 1.78 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.596 -1.638 . . . . 0.0 112.871 -174.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -63.77 -32.72 74.32 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.429 ' O ' HD23 ' A' ' 53' ' ' LEU . 15.9 tttt -68.64 -39.64 80.63 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 123.731 0.644 . . . . 0.0 112.015 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -70.85 -53.27 15.87 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 123.522 0.514 . . . . 0.0 111.464 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -63.9 -28.15 69.64 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -173.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.5 t -71.45 -16.82 62.39 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.522 HD12 ' HB3' ' A' ' 37' ' ' SER . 4.3 mm? -86.18 154.44 21.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.621 0.768 . . . . 0.0 111.575 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.33 94.11 0.04 OUTLIER Glycine 0 N--CA 1.479 1.523 0 C-N-CA 124.695 1.141 . . . . 0.0 112.84 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' A' ' 19' ' ' ALA . 62.4 mt -100.38 48.45 0.92 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.887 1.327 . . . . 0.0 110.565 170.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 t -132.03 168.94 17.07 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.573 -168.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -55.0 121.73 9.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.351 1.06 . . . . 0.0 111.902 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.51 -29.06 12.08 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 114.481 -1.236 . . . . 0.0 115.275 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.2 p -73.67 136.93 43.84 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 9.3 t -96.72 111.89 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.475 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 m -92.95 101.59 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.235 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.753 HG22 ' HG2' ' A' ' 5' ' ' GLU . 51.8 p -84.77 94.37 8.68 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.292 -176.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.609 HG23 HG22 ' A' ' 35' ' ' VAL . 2.7 mt -82.78 98.55 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 112.899 -1.955 . . . . 0.0 109.013 -173.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -104.52 134.43 47.72 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.895 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -122.47 132.62 54.43 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -173.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.44 136.55 39.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.295 1.038 . . . . 0.0 113.162 174.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.8 -177.23 17.15 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 115.691 1.036 . . . . 0.0 115.691 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -54.84 -33.0 61.19 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -110.32 28.27 8.81 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 2.3 pt-20 -53.63 -57.62 10.12 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -172.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.451 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -54.3 -47.35 72.51 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -57.73 -41.76 82.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.222 1.409 . . . . 0.0 112.613 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.21 -57.51 12.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.2 1.0 . . . . 0.0 112.599 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -67.96 -36.7 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.166 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -52.85 -57.18 11.08 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.036 0.835 . . . . 0.0 111.173 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -65.66 -40.62 92.65 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.6 -43.16 97.74 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -60.22 -43.67 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 122.893 0.477 . . . . 0.0 111.496 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -55.71 -43.66 76.71 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.853 0.861 . . . . 0.0 111.517 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.08 -56.89 15.66 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.772 0.829 . . . . 0.0 112.888 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 20.3 mtp -47.75 -45.08 28.66 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.613 1.165 . . . . 0.0 113.549 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.83 -43.72 63.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.769 1.627 . . . . 0.0 115.307 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -111.74 15.53 20.91 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mp . . . . . 0 N--CA 1.484 1.268 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 172.085 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttp . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -141.02 131.61 25.5 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.76 1.288 . . . . 0.0 109.095 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.7 127.35 49.15 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.799 -171.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -126.56 122.5 35.28 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.614 0.721 . . . . 0.0 112.664 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.632 ' HG2' HG22 ' A' ' 62' ' ' THR . 60.3 mt-10 -79.5 103.24 9.28 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.272 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.25 135.58 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.653 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.586 HG23 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -103.22 128.89 50.07 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.154 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 mt -97.95 92.4 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 167.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -86.02 -24.72 26.3 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.7 133.98 46.13 Favored Pre-proline 0 N--CA 1.482 1.145 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -58.53 -47.35 19.44 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 123.83 3.02 . . . . 0.0 113.2 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -54.17 -36.37 63.31 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 166.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.92 -163.49 24.64 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 125.118 1.511 . . . . 0.0 113.791 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.4 mt -115.61 69.35 0.73 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.481 -1.86 . . . . 0.0 110.271 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -73.71 -175.04 1.93 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 111.864 -2.426 . . . . 0.0 114.976 -166.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.4 p -40.3 -40.52 1.17 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.254 9.6 mmm180 -75.34 -48.43 4.16 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 116.139 -1.886 . . . . 0.0 113.48 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -54.64 -47.86 24.46 Favored 'Trans proline' 0 N--CA 1.482 0.826 0 C-N-CA 122.214 1.943 . . . . 0.0 113.877 162.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.29 -41.57 72.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.07 -31.59 72.76 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -80.75 -37.53 30.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.581 0.752 . . . . 0.0 112.282 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -57.19 -46.34 82.94 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.255 1.022 . . . . 0.0 111.566 173.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.5 t -42.31 -61.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 125.227 1.411 . . . . 0.0 113.14 170.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -42.71 -50.03 5.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.986 1.315 . . . . 0.0 113.575 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -66.16 -47.88 72.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.907 0.883 . . . . 0.0 112.992 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.62 71.77 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -50.62 -52.8 36.17 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.09 -27.22 68.55 Favored Glycine 0 CA--C 1.541 1.661 0 O-C-N 125.843 1.964 . . . . 0.0 115.13 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -70.15 110.61 5.26 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -38.45 22.06 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.674 1.59 . . . . 0.0 111.617 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.02 140.31 57.86 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 169.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -92.1 101.52 14.05 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.938 1.827 . . . . 0.0 111.55 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 77' ' ' LEU . 6.9 mm -71.68 82.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 110.22 -3.173 . . . . 0.0 110.108 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 m -73.69 104.59 4.67 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.795 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.4 t -98.1 85.58 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 112.611 -2.086 . . . . 0.0 106.962 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -86.79 97.69 10.77 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.422 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.499 ' HB3' HD12 ' A' ' 53' ' ' LEU . 5.6 t -70.44 92.15 0.8 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.379 172.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.289 37.7 p30 2.67 101.34 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 110.189 -3.187 . . . . 0.0 117.461 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.37 -87.05 0.42 Allowed Glycine 0 CA--C 1.541 1.685 0 CA-C-N 112.721 -2.036 . . . . 0.0 110.122 -168.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HB2' HD11 ' A' ' 53' ' ' LEU . 8.1 mptt -94.96 140.07 30.46 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.202 0.525 . . . . 0.0 112.363 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.1 m -78.61 128.56 33.67 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -117.65 169.54 9.48 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.05 166.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -132.71 126.17 31.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.596 0.358 . . . . 0.0 110.781 -176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.551 ' HA ' HD22 ' A' ' 50' ' ' LEU . . . -60.05 -30.97 69.55 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.564 1.165 . . . . 0.0 112.925 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -72.73 -36.13 67.7 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.916 1.287 . . . . 0.0 113.403 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -96.73 102.84 14.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 122.321 1.058 . . . . 0.0 110.794 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.8 tp -44.3 -68.73 0.17 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 111.959 -2.382 . . . . 0.0 114.503 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -63.17 -41.66 99.27 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' A' ' 42' ' ' ALA . 83.2 tttt -55.91 -40.74 73.5 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.551 HD22 ' HA ' ' A' ' 44' ' ' ALA . 22.3 tp -68.03 -47.54 68.15 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 118.927 -0.559 . . . . 0.0 111.677 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -63.66 -23.93 67.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -79.44 -27.98 41.67 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.499 HD12 ' HB3' ' A' ' 37' ' ' SER . 2.7 mm? -84.33 168.82 15.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.044 0.938 . . . . 0.0 112.343 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.1 117.19 4.77 Favored Glycine 0 CA--C 1.546 2.002 0 C-N-CA 125.256 1.408 . . . . 0.0 113.428 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.536 HD11 ' HG ' ' A' ' 50' ' ' LEU . 31.6 mt -123.7 60.53 1.09 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.405 1.098 . . . . 0.0 109.2 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 t -153.08 -169.59 3.37 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.259 -160.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -49.01 104.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.163 2.185 . . . . 0.0 113.128 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.23 -18.65 56.27 Favored Glycine 0 CA--C 1.547 2.093 0 CA-C-N 112.919 -1.946 . . . . 0.0 114.556 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.4 p -69.61 125.16 25.88 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.266 0.627 . . . . 0.0 111.838 -166.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 7' ' ' THR . 45.9 t -97.83 122.56 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.802 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.5 m -105.04 103.45 15.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.067 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.632 HG22 ' HG2' ' A' ' 5' ' ' GLU . 75.0 p -83.22 88.15 6.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.965 -1.925 . . . . 0.0 109.502 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.8 mt -72.14 94.19 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 111.622 -2.536 . . . . 0.0 108.625 -172.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 t -101.41 84.22 2.58 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.377 -1.738 . . . . 0.0 109.726 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 100.41 5.7 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.624 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.42 136.34 34.83 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.285 -1.325 . . . . 0.0 113.784 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.49 -147.9 16.32 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 112.735 -2.029 . . . . 0.0 114.172 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -67.32 -25.29 65.94 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 -163.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -106.74 -1.69 22.37 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 3.8 pt-20 -8.0 -70.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 120.323 3.453 . . . . 0.0 120.323 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -73.24 -48.08 37.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -175.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -55.66 -32.91 63.62 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.393 1.477 . . . . 0.0 112.233 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.16 -63.7 1.01 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.724 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 t -55.03 -41.29 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.709 0.804 . . . . 0.0 111.916 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -45.43 -60.8 1.96 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.054 1.342 . . . . 0.0 112.203 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -69.28 -45.84 68.65 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 114.797 -1.092 . . . . 0.0 113.055 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.428 HD13 HG21 ' A' ' 33' ' ' ILE . 9.7 mt -61.35 -35.46 77.5 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.04 -43.54 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.429 0.692 . . . . 0.0 110.655 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -48.92 -48.28 42.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.378 1.071 . . . . 0.0 111.988 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.4 mt -59.73 -59.1 5.98 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 123.914 0.759 . . . . 0.0 113.011 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 mtt -48.61 -27.2 2.65 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.88 67.49 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -123.34 44.99 2.54 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.905 0.859 . . . . 0.0 112.626 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.482 1.174 0 N-CA-C 119.626 3.195 . . . . 0.0 119.626 -171.288 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ttp . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -108.0 126.25 52.5 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 124.955 1.409 . . . . 0.0 109.523 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.61 116.02 26.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.815 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -119.2 121.79 40.51 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.694 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -81.54 113.02 19.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 112.743 -2.026 . . . . 0.0 108.72 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.6 t -124.84 141.05 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 113.427 -1.715 . . . . 0.0 108.88 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.474 HG22 HG22 ' A' ' 60' ' ' VAL . 40.4 p -113.9 121.01 42.67 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.979 172.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.09 126.34 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 57' ' ' GLN 0.315 5.1 t -126.14 55.52 1.48 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -177.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.408 ' HA ' ' HD2' ' A' ' 11' ' ' PRO . . . -101.74 114.87 65.5 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-N 112.205 -2.271 . . . . 0.0 113.602 -176.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 10' ' ' ALA . 43.1 Cg_endo -63.72 -35.43 57.73 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.595 2.197 . . . . 0.0 112.126 171.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -52.1 66.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.286 1.834 . . . . 0.0 113.128 168.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.97 146.05 1.25 Allowed Glycine 0 N--CA 1.483 1.806 0 O-C-N 124.706 1.254 . . . . 0.0 115.462 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.25 79.06 9.66 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.169 1.461 . . . . 0.0 111.008 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -67.41 -167.03 0.06 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 112.501 -2.136 . . . . 0.0 114.795 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.7 p -51.86 -45.04 63.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.191 1.796 . . . . 0.0 115.347 -175.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.251 13.9 mmm180 -73.04 -45.5 8.31 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 116.44 -1.743 . . . . 0.0 114.337 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.31 -45.8 35.14 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.269 1.979 . . . . 0.0 112.647 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.453 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.27 -44.24 79.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.32 99.18 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -64.94 -43.07 93.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.078 0.951 . . . . 0.0 111.14 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -62.02 -41.4 98.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.06 1.344 . . . . 0.0 111.994 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 47' ' ' LEU . 81.6 t -53.36 -47.49 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.063 0.545 . . . . 0.0 111.545 170.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -60.39 -47.22 87.04 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 119.08 -0.486 . . . . 0.0 112.135 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.08 -42.07 99.56 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.04 89.64 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.421 1.088 . . . . 0.0 113.715 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' ' HG2' ' A' ' 45' ' ' LYS . 52.9 mmtt -60.95 -28.4 68.94 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 169.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.73 -43.77 98.47 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.095 1.331 . . . . 0.0 113.3 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -78.38 147.0 34.28 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -70.64 -38.53 73.87 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.486 -172.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.0 p -64.36 152.5 41.14 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.51 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 2.9 tt0 -92.35 107.42 19.2 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.891 1.329 . . . . 0.0 111.288 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.775 HD11 ' HB1' ' A' ' 73' ' ' ALA . 48.2 mm -75.28 104.94 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 111.043 -2.798 . . . . 0.0 109.825 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -110.29 114.24 27.54 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.134 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.55 100.97 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.618 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 72.5 m -86.34 97.05 10.2 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.653 174.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -76.74 100.59 5.49 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.888 171.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.313 12.6 p-10 -0.55 87.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 -168.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.61 -60.73 0.55 Allowed Glycine 0 N--CA 1.483 1.815 0 CA-C-N 111.397 -2.638 . . . . 0.0 111.916 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.61 116.07 31.85 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 39.6 m -74.78 111.84 10.38 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 113.472 -1.694 . . . . 0.0 114.912 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.12 112.54 21.87 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.45 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -68.44 115.13 7.5 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.752 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.23 -14.67 62.3 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.333 -1.758 . . . . 0.0 112.269 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 32' ' ' GLU . 31.9 mttt -81.77 10.44 6.22 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 34.9 t -133.91 127.41 32.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.369 0.668 . . . . 0.0 111.933 169.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.537 ' HA ' HG21 ' A' ' 23' ' ' VAL . 10.1 tp -47.74 -69.14 0.13 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.389 1.876 . . . . 0.0 110.972 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -51.67 -45.16 63.31 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.221 1.408 . . . . 0.0 113.418 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 40.6 mttt -64.94 -52.63 55.28 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 tp -63.0 -46.33 88.17 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.78 -0.629 . . . . 0.0 112.319 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -56.72 -32.88 65.96 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -78.87 -2.22 38.75 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 53' ' ' LEU . 3.8 mm? -118.22 140.45 49.78 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.27 118.27 6.21 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 113.52 -1.673 . . . . 0.0 113.307 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.561 HD23 HG11 ' A' ' 61' ' ' VAL . 1.3 mp -116.35 87.35 2.67 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 168.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -135.3 -132.37 0.15 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.993 -162.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 4.1 tt0 -86.57 134.75 33.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.696 0.798 . . . . 0.0 111.636 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.28 -61.22 4.43 Favored Glycine 0 N--CA 1.484 1.876 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.763 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 p -3.09 114.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 7' ' ' THR . 57.3 t -100.26 108.03 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 112.45 -2.159 . . . . 0.0 107.325 -174.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.561 HG11 HD23 ' A' ' 55' ' ' LEU . 15.4 m -113.74 119.78 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.885 -172.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -103.97 104.27 14.22 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.945 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.448 HG23 HG23 ' A' ' 33' ' ' ILE . 4.9 mp -87.0 103.01 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.677 -2.056 . . . . 0.0 107.466 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 t -101.24 108.86 20.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.663 173.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.66 97.73 9.95 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.825 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.18 100.96 12.68 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.77 -173.5 33.15 Favored Glycine 0 N--CA 1.48 1.592 0 CA-C-N 111.543 -2.572 . . . . 0.0 111.172 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.98 -55.88 28.59 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -81.3 33.73 0.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -41.95 -50.1 4.55 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.053 2.141 . . . . 0.0 115.878 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -69.54 -55.45 10.15 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.378 1.471 . . . . 0.0 114.478 -178.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -67.44 -33.77 75.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.775 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -54.82 -55.88 25.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.063 -0.972 . . . . 0.0 112.012 173.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.0 t -64.1 -45.25 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.98 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -52.34 -54.3 33.43 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.697 1.199 . . . . 0.0 113.847 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 85.6 t60 -63.01 -40.32 97.41 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.2 mt -67.34 -37.59 83.52 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.47 -46.05 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.304 1.042 . . . . 0.0 111.094 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 76' ' ' HIS . 40.8 tttp -48.38 -53.44 17.62 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 124.441 1.088 . . . . 0.0 111.382 170.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.91 -45.92 91.62 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 45.8 mtm -52.13 -50.94 60.72 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.092 0.87 . . . . 0.0 112.354 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.59 79.88 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.275 12.9 pt-20 -82.5 -18.45 41.53 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.4 mt . . . . . 0 N--CA 1.481 1.081 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 176.438 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmm . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -139.3 142.11 37.71 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.94 1.4 . . . . 0.0 110.976 -172.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -128.66 130.93 47.91 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 124.809 1.318 . . . . 0.0 110.315 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -112.66 113.06 25.0 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.271 -1.332 . . . . 0.0 111.212 163.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -77.73 92.83 4.2 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.008 -1.905 . . . . 0.0 109.717 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.81 147.05 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 112.249 -2.25 . . . . 0.0 108.762 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -114.22 153.68 29.22 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.031 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mt -115.24 104.81 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 167.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -118.48 53.79 0.96 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.116 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -119.72 121.64 29.71 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 111.765 -2.471 . . . . 0.0 110.86 -177.816 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -55.55 -44.4 48.64 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.212 3.274 . . . . 0.0 111.473 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -60.19 -59.57 5.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.394 1.878 . . . . 0.0 112.768 168.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.22 -168.22 54.82 Favored Glycine 0 N--CA 1.478 1.485 0 C-N-CA 124.71 1.148 . . . . 0.0 113.955 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 tp -99.64 58.18 1.04 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 124.161 1.934 . . . . 0.0 108.837 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -62.86 -169.6 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 113.099 -1.864 . . . . 0.0 115.61 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.36 -60.25 2.45 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -166.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HD2' ' HA ' ' A' ' 17' ' ' ARG 0.301 9.4 mmm180 -73.68 -37.84 3.69 Favored Pre-proline 0 N--CA 1.485 1.28 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 177.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -54.57 -50.9 11.83 Favored 'Trans proline' 0 N--CA 1.478 0.61 0 C-N-CA 122.854 2.369 . . . . 0.0 113.082 167.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -57.73 -42.98 84.96 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 172.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.5 88.72 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -66.7 -43.09 85.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.769 0.827 . . . . 0.0 111.79 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -59.66 -39.49 84.58 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.064 1.745 . . . . 0.0 112.301 172.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 47' ' ' LEU . 92.2 t -58.51 -51.43 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.107 0.963 . . . . 0.0 111.585 172.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -49.08 -49.74 40.19 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.791 0.682 . . . . 0.0 111.71 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.59 -49.79 71.97 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.314 1.008 . . . . 0.0 113.624 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.96 70.79 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 61.1 mttt -65.33 -26.12 67.9 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.45 -35.82 90.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 124.157 0.911 . . . . 0.0 113.71 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -71.44 154.99 41.12 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.0 p -73.88 -45.33 51.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.404 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.3 p -70.03 150.24 46.85 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.175 0.99 . . . . 0.0 112.885 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -94.22 101.37 13.35 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.842 1.306 . . . . 0.0 110.541 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.42 111.57 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 110.883 -2.871 . . . . 0.0 110.021 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.02 120.26 41.26 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.176 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG22 HG12 ' A' ' 63' ' ' ILE . 96.9 t -108.78 84.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.282 -174.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.0 m -81.86 110.95 17.63 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.925 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.428 ' HB3' HD12 ' A' ' 53' ' ' LEU . 39.0 t -85.48 99.82 11.47 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.104 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 14.7 p-10 2.56 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 128.01 2.524 . . . . 0.0 117.462 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.17 -45.04 1.33 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 112.836 -1.983 . . . . 0.0 113.005 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.689 ' HB2' HD11 ' A' ' 53' ' ' LEU . 98.4 mttt -123.87 134.95 53.46 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 m -72.06 137.8 47.4 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 113.954 -1.475 . . . . 0.0 112.943 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.597 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -138.07 137.16 37.5 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.024 171.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -107.54 118.83 37.77 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.51 0.671 . . . . 0.0 109.808 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.61 -30.98 71.04 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 113.725 -1.58 . . . . 0.0 112.143 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.511 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 48.2 tttt -77.28 16.01 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.827 0.851 . . . . 0.0 113.196 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -154.17 118.87 4.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.56 1.544 . . . . 0.0 112.454 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.586 ' HA ' HG21 ' A' ' 23' ' ' VAL . 55.6 tp -53.37 -71.0 0.08 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.503 -1.681 . . . . 0.0 114.611 -171.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -63.13 -31.41 72.55 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.28 -37.7 86.07 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.113 0.565 . . . . 0.0 111.718 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 19.6 tp -72.88 -54.56 8.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.023 0.529 . . . . 0.0 112.366 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -55.33 -38.29 68.54 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 t -61.19 -18.58 58.93 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 40' ' ' LYS . 1.0 OUTLIER -100.64 157.72 16.47 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -176.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.85 93.81 0.19 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 113.457 -1.701 . . . . 0.0 113.362 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.488 HD11 ' HG ' ' A' ' 50' ' ' LEU . 27.3 mt -103.82 56.75 0.73 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.647 -1.276 . . . . 0.0 111.134 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.5 t -143.03 178.63 7.56 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.52 -168.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -52.45 123.22 10.42 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.835 1.254 . . . . 0.0 113.586 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.99 34.18 10.16 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 112.784 -2.007 . . . . 0.0 113.347 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 p -119.3 140.2 50.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.658 0.383 . . . . 0.0 111.934 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 38' ' ' ASN . 22.7 t -108.49 105.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.5 m -107.34 92.13 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.394 -171.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.6 p -78.52 102.44 7.89 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.579 -1.646 . . . . 0.0 110.2 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.445 HG12 HG22 ' A' ' 35' ' ' VAL . 58.6 mt -87.14 95.93 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.374 -174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.5 t -104.21 122.22 44.92 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.827 -1.988 . . . . 0.0 110.913 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -109.42 115.16 29.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.602 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.87 102.86 12.27 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 112.858 -1.973 . . . . 0.0 112.434 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.82 -162.79 28.98 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 112.766 -2.015 . . . . 0.0 113.266 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -63.06 -61.04 2.65 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 -169.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -82.12 47.05 1.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -48.62 -39.38 23.83 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 112.322 -2.217 . . . . 0.0 116.482 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -87.4 -53.16 4.97 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 42.4 mttt -66.09 -44.66 83.76 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.302 1.441 . . . . 0.0 113.971 -173.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.18 83.53 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.878 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.36 -47.4 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.438 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -47.52 -57.06 5.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.253 1.421 . . . . 0.0 112.929 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -59.48 -46.25 89.32 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.535 HD23 HD12 ' A' ' 80' ' ' LEU . 85.2 mt -67.01 -39.31 87.04 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.76 -46.58 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.588 0.755 . . . . 0.0 110.338 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -50.83 -49.91 57.72 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.663 1.227 . . . . 0.0 111.993 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.535 HD12 HD23 ' A' ' 77' ' ' LEU . 95.9 mt -56.9 -54.15 49.84 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.185 0.594 . . . . 0.0 112.514 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.419 ' HE3' HD11 ' A' ' 63' ' ' ILE . 49.6 ttm -54.28 -42.07 69.6 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.227 1.011 . . . . 0.0 112.739 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.44 92.6 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.85 22.97 6.72 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.1 mt . . . . . 0 N--CA 1.481 1.079 0 C-N-CA 125.195 1.398 . . . . 0.0 113.073 171.441 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -119.69 143.17 47.89 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.857 1.348 . . . . 0.0 111.111 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -127.06 136.06 51.64 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.48 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -133.97 106.85 7.47 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.188 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.622 ' HB3' HG22 ' A' ' 62' ' ' THR . 8.2 pt-20 -78.03 92.76 4.39 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.231 1.491 . . . . 0.0 115.002 176.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.4 t -109.35 137.89 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.258 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 p -93.58 147.18 23.23 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -112.85 122.62 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.779 168.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 t -115.75 -27.0 7.2 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.609 -1.632 . . . . 0.0 114.84 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.54 137.27 17.21 Favored Pre-proline 0 N--CA 1.493 1.701 0 C-N-CA 124.72 1.208 . . . . 0.0 112.996 172.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -54.88 -54.07 5.04 Favored 'Trans proline' 0 CA--C 1.552 1.382 0 C-N-CA 124.468 3.446 . . . . 0.0 114.546 -171.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -63.95 -33.18 75.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 56' ' ' THR . . . 68.19 -170.2 38.3 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 124.993 1.282 . . . . 0.0 112.674 -163.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.03 81.89 7.82 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 113.509 -1.345 . . . . 0.0 108.941 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -62.75 175.59 0.8 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.577 -2.101 . . . . 0.0 115.351 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.1 p -58.18 -37.98 75.79 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -167.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -70.52 -46.74 18.64 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 116.608 -1.663 . . . . 0.0 113.414 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.78 -45.86 30.29 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.245 2.63 . . . . 0.0 113.457 164.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -39.59 72.89 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.14 86.94 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -58.63 -41.96 87.17 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.784 0.833 . . . . 0.0 111.468 172.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.433 ' HE2' ' HG3' ' A' ' 81' ' ' MET . 29.5 t80 -58.78 -50.93 72.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.987 1.315 . . . . 0.0 111.692 172.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -54.77 -42.65 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.351 0.66 . . . . 0.0 112.575 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -52.53 -55.0 25.17 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.779 0.432 . . . . 0.0 111.127 175.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -62.57 -43.76 98.01 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.202 0.601 . . . . 0.0 111.546 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.31 78.87 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -51.18 -36.17 39.84 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.75 27.96 12.78 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.724 1.154 . . . . 0.0 115.489 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -117.86 149.93 40.04 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.142 0.577 . . . . 0.0 110.768 165.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.3 p -69.23 -45.43 69.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.052 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.5 p -55.23 136.06 49.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.64 1.176 . . . . 0.0 113.498 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -91.51 83.76 5.44 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.616 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -64.57 92.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 110.509 -3.041 . . . . 0.0 113.42 176.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.51 113.37 21.71 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.626 172.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -98.19 94.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 122.559 1.171 . . . . 0.0 107.97 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.404 ' HB ' ' OG1' ' A' ' 62' ' ' THR . 54.3 m -88.81 118.42 28.5 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.453 -1.703 . . . . 0.0 110.877 -173.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.3 t -90.15 90.95 8.33 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 112.852 -1.976 . . . . 0.0 111.066 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.26 26.4 p30 32.81 67.47 0.17 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.958 1.703 . . . . 0.0 114.859 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.13 -49.04 1.09 Allowed Glycine 0 N--CA 1.48 1.577 0 CA-C-N 113.043 -1.889 . . . . 0.0 112.93 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -68.15 93.69 0.46 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 m -58.44 106.41 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.489 -1.687 . . . . 0.0 115.431 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.79 97.24 5.35 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.1 -1.409 . . . . 0.0 113.083 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -47.65 106.09 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.717 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 -4.64 37.67 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.459 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -78.54 -15.98 57.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.44 0.696 . . . . 0.0 112.592 163.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.8 t -103.49 106.23 16.69 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.226 1.012 . . . . 0.0 110.656 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.51 ' HG ' HE21 ' A' ' 51' ' ' GLN . 4.7 tt -46.06 -40.23 10.42 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 112.336 -2.211 . . . . 0.0 112.931 169.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -59.35 -62.97 1.48 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.58 1.152 . . . . 0.0 109.846 174.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -57.39 -41.14 79.7 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HG ' HD11 ' A' ' 55' ' ' LEU . 5.8 tp -76.15 -37.59 57.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . 0.51 HE21 ' HG ' ' A' ' 47' ' ' LEU . 36.6 mt-30 -80.43 -15.91 55.66 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.4 t -87.13 -25.79 23.94 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 168.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.5 127.27 36.18 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 122.278 1.037 . . . . 0.0 111.834 171.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.71 103.38 2.2 Favored Glycine 0 N--CA 1.479 1.561 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.586 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.42 HD11 ' HG ' ' A' ' 50' ' ' LEU . 4.0 mp -80.8 67.07 6.56 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.24 1.019 . . . . 0.0 109.389 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . 0.606 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 11.5 t -126.62 156.94 40.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.444 -1.253 . . . . 0.0 113.349 -164.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -18.12 109.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.354 2.262 . . . . 0.0 115.83 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.19 14.1 40.11 Favored Glycine 0 CA--C 1.539 1.536 0 CA-C-N 113.169 -1.832 . . . . 0.0 114.766 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.7 p -103.4 124.87 49.52 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.485 1.136 . . . . 0.0 113.609 173.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.7 110.77 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 112.52 -2.127 . . . . 0.0 106.06 165.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 m -102.01 100.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.125 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.622 HG22 ' HB3' ' A' ' 5' ' ' GLU . 35.6 p -77.01 104.73 7.67 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 113.083 -1.871 . . . . 0.0 110.856 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mt -85.17 94.21 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.439 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.3 t -94.27 102.22 14.22 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 112.816 -1.993 . . . . 0.0 110.716 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.26 100.0 11.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.515 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -97.05 101.33 12.88 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.323 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.67 -164.76 34.27 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 112.195 -2.275 . . . . 0.0 110.501 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -82.1 -47.91 12.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 117.152 2.278 . . . . 0.0 117.152 -174.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -80.71 40.52 0.52 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.581 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.8 pt-20 -47.78 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.99 2.116 . . . . 0.0 116.243 -173.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.581 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -56.66 -36.09 69.16 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 177.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -72.01 -46.25 57.89 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.098 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.64 -47.03 87.19 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.117 0.886 . . . . 0.0 111.462 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 78' ' ' VAL . 78.2 t -58.66 -54.37 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.059 0.944 . . . . 0.0 111.114 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -52.83 -51.39 61.07 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.341 1.056 . . . . 0.0 112.978 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -63.61 -41.15 98.33 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.441 HD23 HD12 ' A' ' 80' ' ' LEU . 52.2 mt -69.68 -31.56 69.68 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 74' ' ' VAL . 49.4 t -68.08 -45.2 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.921 0.889 . . . . 0.0 110.521 171.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -50.45 -46.15 56.48 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.376 1.071 . . . . 0.0 111.59 167.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.441 HD12 HD23 ' A' ' 77' ' ' LEU . 22.6 mt -60.66 -50.35 73.84 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 173.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.433 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 92.3 mtp -44.72 -48.7 10.75 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.379 1.072 . . . . 0.0 113.381 174.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.04 -32.64 74.27 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.27 13.7 pt-20 -100.47 25.57 7.56 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.322 1.058 . . . . 0.0 113.779 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.5 mt . . . . . 0 CA--C 1.547 0.858 0 C-N-CA 127.724 2.41 . . . . 0.0 111.287 173.935 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 9.0 tmm? . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -125.54 134.3 52.04 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 125.336 1.647 . . . . 0.0 108.231 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.59 145.42 45.41 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 124.785 1.303 . . . . 0.0 113.764 -173.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -157.14 117.73 3.57 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 125.481 1.738 . . . . 0.0 112.19 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.487 ' HB2' HG12 ' A' ' 60' ' ' VAL . 11.1 pt-20 -76.27 132.98 40.18 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.562 169.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.17 129.84 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.424 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 p -81.67 143.41 31.91 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.453 -1.248 . . . . 0.0 112.395 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mt -120.44 113.53 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.57 167.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 t -100.75 -17.86 16.74 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.25 -1.796 . . . . 0.0 114.371 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.04 143.7 94.67 Favored Pre-proline 0 N--CA 1.477 0.895 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 169.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -42.08 -76.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 1 C-N-CA 125.547 4.165 . . . . 0.0 116.095 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -90.56 -22.5 21.25 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.85 -103.09 0.47 Allowed Glycine 0 N--CA 1.479 1.532 0 C-N-CA 125.533 1.54 . . . . 0.0 113.771 169.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.8 mt -97.35 66.21 2.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 112.396 -1.902 . . . . 0.0 108.501 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -66.49 -155.52 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 113.709 -1.587 . . . . 0.0 113.629 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -61.03 -49.73 76.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.259 1.424 . . . . 0.0 113.61 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.51 -43.74 53.14 Favored Pre-proline 0 N--CA 1.484 1.271 0 CA-C-O 116.041 -1.933 . . . . 0.0 115.126 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HB3' HD13 ' A' ' 84' ' ' LEU . 87.8 Cg_exo -60.59 -40.99 51.37 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.585 2.19 . . . . 0.0 111.977 168.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -59.83 -44.07 94.24 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.61 -49.78 71.88 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -56.37 -47.98 77.76 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -50.65 -43.66 57.32 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.984 1.428 . . . . 0.0 113.471 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 19' ' ' ALA . 23.3 t -59.93 -54.54 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 123.802 0.689 . . . . 0.0 111.175 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -54.24 -47.24 72.46 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.492 1.12 . . . . 0.0 112.456 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -66.64 -53.76 30.6 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.776 1.298 . . . . 0.0 113.134 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -55.02 -37.88 67.2 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.261 1.025 . . . . 0.0 113.42 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 49.9 mmtt -47.11 -34.0 5.58 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.87 28.93 13.28 Favored Glycine 0 CA--C 1.539 1.534 0 O-C-N 124.866 1.354 . . . . 0.0 114.263 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.543 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 71.1 m-85 -113.82 145.54 41.28 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.708 0.803 . . . . 0.0 110.971 168.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.8 p -78.77 -28.85 44.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 124.412 1.07 . . . . 0.0 112.552 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.2 p -77.55 139.28 39.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.044 164.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.37 99.34 8.63 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.882 0.849 . . . . 0.0 110.727 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.815 HD11 ' HB1' ' A' ' 73' ' ' ALA . 46.5 mm -61.72 101.7 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 112.035 -2.348 . . . . 0.0 111.022 173.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 1.2 m -100.49 131.84 46.19 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.025 171.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG11 HD21 ' A' ' 55' ' ' LEU . 89.4 t -118.17 91.22 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 m -83.63 137.99 33.55 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.901 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.41 ' HB2' HG12 ' A' ' 61' ' ' VAL . 37.8 t -127.41 92.43 3.5 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.265 20.6 p30 47.47 88.47 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 112.786 -2.006 . . . . 0.0 115.726 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.54 -49.26 2.69 Favored Glycine 0 N--CA 1.483 1.774 0 CA-C-N 113.383 -1.735 . . . . 0.0 114.025 -174.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.57 ' HB3' HD21 ' A' ' 53' ' ' LEU . 81.5 mttt -64.37 103.92 0.71 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 m -88.82 109.74 20.45 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.109 -1.405 . . . . 0.0 114.531 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB2' HD23 ' A' ' 53' ' ' LEU . . . -113.74 96.06 5.66 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.703 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 47.6 t -59.22 116.01 3.6 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.373 171.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.6 -22.74 65.48 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.445 -1.252 . . . . 0.0 114.102 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HE2' ' O ' ' A' ' 26' ' ' ALA . 98.2 mttt -71.03 0.76 6.8 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.473 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 40.6 t -131.73 118.77 20.4 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.879 0.871 . . . . 0.0 110.538 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -55.55 -42.82 75.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.655 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.08 -60.7 2.98 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.366 171.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 18.5 mtpt -61.26 -30.97 70.79 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.491 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 33.3 tp -86.3 -53.92 4.74 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -67.93 -14.16 62.75 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -173.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -68.25 -32.78 73.2 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 165.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 40' ' ' LYS . 1.1 mm? -76.71 143.44 39.99 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.099 0.952 . . . . 0.0 111.578 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.82 108.02 3.57 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 113.162 -1.836 . . . . 0.0 110.355 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.422 HD21 HG11 ' A' ' 35' ' ' VAL . 6.2 mp -105.71 90.48 3.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 125.61 1.418 . . . . 0.0 107.301 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -149.57 -172.46 4.15 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.553 -160.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -57.13 113.34 1.67 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.064 0.946 . . . . 0.0 111.908 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.5 -35.68 4.9 Favored Glycine 0 N--CA 1.484 1.885 0 CA-C-N 112.301 -2.227 . . . . 0.0 113.595 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.7 p -64.37 101.87 0.48 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.779 0.832 . . . . 0.0 112.217 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 5' ' ' GLU . 11.8 t -76.72 101.72 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 113.415 -1.72 . . . . 0.0 106.786 173.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 37' ' ' SER . 9.9 m -94.77 128.2 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 112.951 -1.931 . . . . 0.0 112.701 -174.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -98.35 109.26 22.05 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.366 -171.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 mt -82.41 112.32 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 173.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 t -120.46 110.56 16.64 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 111.718 -2.492 . . . . 0.0 108.842 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -102.47 97.16 7.43 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.04 93.02 9.36 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.17 -163.03 29.4 Favored Glycine 0 CA--C 1.541 1.686 0 CA-C-N 112.645 -2.071 . . . . 0.0 113.83 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -54.76 -60.61 3.13 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 118.926 2.936 . . . . 0.0 118.926 -169.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -83.28 36.52 0.52 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.543 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.3 pt-20 -40.82 -69.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.543 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -61.19 -42.68 99.01 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -178.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -67.39 -44.44 78.87 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.815 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -62.11 -37.91 86.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.533 173.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 78' ' ' VAL . 99.4 t -68.64 -47.66 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.334 174.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -49.39 -49.94 42.53 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.695 1.198 . . . . 0.0 110.95 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -57.83 -57.13 14.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.28 1.832 . . . . 0.0 112.072 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 -26.31 67.07 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 74' ' ' VAL . 23.2 t -66.74 -47.63 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 167.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -54.37 -52.29 62.1 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.598 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -52.52 -57.41 10.04 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.7 mtt -52.43 -39.79 61.43 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.04 -44.07 73.4 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.543 1.152 . . . . 0.0 113.929 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.314 10.3 pt-20 -72.4 -27.08 62.14 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 18' ' ' PRO . 40.4 mt . . . . . 0 N--CA 1.487 1.398 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -178.479 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tmm? . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -88.23 130.77 34.99 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.755 0.788 . . . . 0.0 110.023 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . 0.472 ' HG2' HG22 ' A' ' 62' ' ' THR . 15.4 tt0 -134.05 142.32 47.53 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.073 -1.876 . . . . 0.0 111.72 -173.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -147.71 139.72 24.19 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 124.94 1.4 . . . . 0.0 110.602 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -93.34 131.4 38.53 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.915 0.759 . . . . 0.0 112.535 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.84 136.14 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.611 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.63 HG22 HG22 ' A' ' 60' ' ' VAL . 17.0 p -102.43 108.91 20.4 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 112.588 -2.096 . . . . 0.0 110.631 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 mt -71.19 96.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 113.12 -1.854 . . . . 0.0 107.503 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 t -86.26 -26.91 24.73 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 113.24 -1.8 . . . . 0.0 113.501 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.1 135.36 80.57 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 124.18 0.992 . . . . 0.0 111.219 171.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -46.34 -37.65 19.36 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 124.638 3.559 . . . . 0.0 116.435 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.29 -37.06 2.07 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.97 -93.5 0.41 Allowed Glycine 0 N--CA 1.476 1.309 0 O-C-N 124.031 0.832 . . . . 0.0 112.903 163.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 6.4 mp -94.4 63.43 3.01 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 122.615 1.198 . . . . 0.0 112.574 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -72.34 -169.51 0.53 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.291 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.6 p -47.47 -47.72 27.11 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.293 12.6 mmt180 -70.16 -51.7 13.57 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-O 115.398 -2.239 . . . . 0.0 114.932 -179.312 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.567 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 92.3 Cg_exo -60.8 -39.24 64.2 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.203 1.936 . . . . 0.0 113.816 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.54 -47.57 85.61 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.25 0.62 . . . . 0.0 112.639 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.52 85.32 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -66.4 -44.78 82.07 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HE1' ' HG3' ' A' ' 81' ' ' MET . 0.9 OUTLIER -54.3 -51.63 64.04 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.261 1.024 . . . . 0.0 111.162 171.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 47' ' ' LEU . 71.6 t -51.62 -51.52 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.465 1.106 . . . . 0.0 111.835 173.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -56.04 -53.97 50.6 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.717 1.207 . . . . 0.0 111.214 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HB3' HD21 ' A' ' 77' ' ' LEU . 7.9 tp10 -65.42 -43.94 88.94 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.361 1.038 . . . . 0.0 113.089 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -40.07 72.65 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -58.53 -14.33 7.76 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 174.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.68 -35.49 22.22 Favored Glycine 0 N--CA 1.48 1.63 0 C-N-CA 124.41 1.005 . . . . 0.0 114.74 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -80.8 154.33 27.23 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.849 0.86 . . . . 0.0 113.032 -174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -69.77 -43.09 72.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 123.984 0.803 . . . . 0.0 111.787 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.6 p -61.23 145.54 50.88 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 8.7 mt-10 -83.26 134.05 34.96 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.985 0.898 . . . . 0.0 111.189 167.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.6 mm -112.12 106.98 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.074 -166.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.66 119.35 33.45 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.248 -1.797 . . . . 0.0 109.438 -174.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.44 HG12 ' HB ' ' A' ' 61' ' ' VAL . 40.1 t -110.21 87.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -77.88 100.65 6.45 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.845 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.2 t -76.7 97.31 4.42 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.099 -1.409 . . . . 0.0 111.716 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 p30 35.12 61.97 0.59 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.86 -76.26 0.3 Allowed Glycine 0 N--CA 1.485 1.919 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.844 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.63 138.84 41.66 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.468 0.652 . . . . 0.0 112.513 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.5 m -99.35 140.13 33.98 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -124.76 134.94 52.62 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 113.571 -1.649 . . . . 0.0 109.232 175.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 t -117.26 126.56 52.94 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.95 -15.46 43.61 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 125.488 1.743 . . . . 0.0 113.637 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 32' ' ' GLU . 30.4 mmtt -71.87 -6.63 43.14 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 171.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -131.26 134.49 46.45 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.63 1.572 . . . . 0.0 109.598 168.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.581 ' HA ' HG21 ' A' ' 23' ' ' VAL . 43.7 tp -59.67 -52.38 65.75 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.498 169.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -62.92 -49.35 75.13 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 112.912 -1.949 . . . . 0.0 113.644 -175.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -65.22 -32.19 73.74 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.846 0.716 . . . . 0.0 112.909 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.551 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 12.2 tp -76.53 -44.93 32.87 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 119.015 -0.517 . . . . 0.0 112.233 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -59.45 -39.54 83.93 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.5 t -58.83 -39.46 81.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.81 140.79 39.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.329 1.062 . . . . 0.0 113.159 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.27 81.37 0.2 Allowed Glycine 0 CA--C 1.535 1.319 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.274 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.436 HD23 HG11 ' A' ' 61' ' ' VAL . 61.8 mt -82.27 60.8 5.17 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 123.626 1.679 . . . . 0.0 110.172 172.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 t -123.32 -178.68 4.06 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 112.495 -2.139 . . . . 0.0 112.477 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -51.68 127.64 21.14 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.774 1.229 . . . . 0.0 112.545 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.71 -32.61 6.61 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 112.962 -1.926 . . . . 0.0 113.468 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.0 p -62.45 116.82 5.42 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 122.474 1.131 . . . . 0.0 113.858 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.63 HG22 HG22 ' A' ' 7' ' ' THR . 4.2 t -86.75 95.13 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 112.239 -2.255 . . . . 0.0 106.075 174.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.44 ' HB ' HG12 ' A' ' 35' ' ' VAL . 31.6 m -95.65 113.45 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 112.608 -2.087 . . . . 0.0 110.365 -176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 3' ' ' GLN . 0.9 OUTLIER -91.43 108.74 20.1 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.247 -173.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.6 mt -91.17 107.08 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.724 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.5 t -103.12 126.93 50.52 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 112.614 -2.085 . . . . 0.0 111.075 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.09 111.34 21.97 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 124.679 1.237 . . . . 0.0 110.533 168.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -103.05 99.17 9.03 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.04 -159.74 28.68 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.576 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -54.48 39.0 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -173.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -83.05 33.49 0.44 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 2.2 pt-20 -45.04 -59.35 2.64 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.43 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -65.87 -40.08 91.29 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -70.31 -43.14 70.94 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.228 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.35 -52.82 64.01 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.461 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.08 -47.05 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.662 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -52.78 -57.55 9.79 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.16 0.984 . . . . 0.0 112.775 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.79 -45.54 93.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.215 1.006 . . . . 0.0 112.816 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 88.1 mt -69.46 -33.44 72.92 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -69.01 -48.4 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.787 0.835 . . . . 0.0 111.456 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -52.0 -45.49 64.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 123.829 0.705 . . . . 0.0 112.046 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.9 tp -52.85 -59.25 4.74 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.687 1.195 . . . . 0.0 112.475 174.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.523 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 38.7 mtt -47.95 -43.13 29.03 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 173.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.89 -45.66 88.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 118.152 -0.928 . . . . 0.0 113.337 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -86.24 -3.18 58.92 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.1 mt . . . . . 0 N--CA 1.484 1.231 0 C-N-CA 123.912 0.885 . . . . 0.0 111.141 170.747 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.476 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -133.13 127.51 34.07 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 124.385 1.053 . . . . 0.0 111.321 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -110.28 146.03 36.37 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.814 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -155.07 125.82 7.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.756 1.222 . . . . 0.0 108.072 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -105.86 96.16 6.3 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 125.04 2.353 . . . . 0.0 113.622 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.7 t -95.73 119.22 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 111.222 -2.717 . . . . 0.0 110.841 -166.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 m -74.85 115.67 14.71 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.571 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.25 135.93 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.34 -23.25 4.89 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.37 -1.741 . . . . 0.0 113.856 -173.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 138.72 30.5 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.604 1.162 . . . . 0.0 111.386 169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -39.98 -50.71 3.3 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 C-N-CA 124.66 3.573 . . . . 0.0 117.345 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -116.88 21.95 12.96 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.01 -98.48 0.01 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.352 1.453 . . . . 0.0 113.822 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.549 HD21 ' HG3' ' A' ' 81' ' ' MET . 19.4 mt -119.1 110.93 17.65 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 113.766 -1.217 . . . . 0.0 111.604 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -91.15 -165.8 1.44 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.211 164.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -51.47 -43.93 62.28 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.253 11.4 ttm105 -68.98 -45.17 30.56 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.281 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.555 ' HG3' HD22 ' A' ' 84' ' ' LEU . 65.9 Cg_exo -61.26 -30.21 87.68 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.671 2.248 . . . . 0.0 115.169 167.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -46.15 84.25 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.759 0.709 . . . . 0.0 112.207 168.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.68 -44.93 80.46 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.225 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 18' ' ' PRO . 43.2 mt-30 -51.94 -53.25 43.39 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.094 0.958 . . . . 0.0 112.971 172.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -51.87 -60.52 3.08 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -46.47 -55.88 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.908 1.283 . . . . 0.0 112.707 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -51.97 -47.42 64.84 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 124.563 1.164 . . . . 0.0 112.279 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.01 -56.06 8.92 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.713 1.258 . . . . 0.0 112.688 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.22 -44.46 75.44 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.248 1.819 . . . . 0.0 115.049 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -51.56 -31.98 26.59 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.14 -49.42 78.8 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 125.449 1.718 . . . . 0.0 114.394 173.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -60.45 154.74 19.88 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -86.72 -15.88 38.13 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.838 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.4 p -82.94 153.02 25.25 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.718 164.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.421 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -94.3 131.89 39.45 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.388 0.675 . . . . 0.0 109.191 173.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 mm -112.97 100.47 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.998 -159.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.9 m -104.28 126.34 51.3 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.18 85.82 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.599 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 50.3 m -64.45 120.68 12.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.348 170.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.567 ' HA ' HG12 ' A' ' 61' ' ' VAL . 40.8 t -94.0 95.43 9.04 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 24.98 63.98 0.05 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.63 -24.6 8.43 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 117.3 1.68 . . . . 0.0 117.3 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -130.51 140.93 50.5 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 118.656 1.228 . . . . 0.0 109.641 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 77.6 p -101.28 129.44 47.25 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -162.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.684 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -114.99 104.05 11.52 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.103 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -59.34 113.84 2.37 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 169.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.48 0.15 43.72 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.59 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 32' ' ' GLU . 44.8 mttt -89.99 -44.43 9.87 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.533 164.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -70.62 116.96 11.54 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.362 0.601 . . . . 0.0 112.016 169.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 tp -64.37 -44.76 90.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.241 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -66.25 -34.79 78.81 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.416 1.086 . . . . 0.0 111.693 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.479 ' O ' HG22 ' A' ' 52' ' ' THR . 28.7 tttt -76.96 -47.73 20.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.684 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 26.9 tp -51.81 -49.37 62.89 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -63.85 -27.37 69.12 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 49' ' ' LYS 0.266 3.6 t -74.09 -20.61 60.21 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.14 135.8 33.16 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.419 1.104 . . . . 0.0 113.001 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.02 90.75 1.1 Allowed Glycine 0 CA--C 1.537 1.466 0 CA-C-N 113.182 -1.826 . . . . 0.0 109.561 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.65 64.64 3.57 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.558 1.17 . . . . 0.0 110.288 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.7 t -108.13 174.73 5.75 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.045 -170.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -50.63 137.45 19.71 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.305 1.042 . . . . 0.0 110.667 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.24 -47.19 1.79 Allowed Glycine 0 N--CA 1.481 1.699 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.597 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.8 p -56.92 120.75 8.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.875 0.397 . . . . 0.0 111.275 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 t -86.65 109.63 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 111.837 -2.438 . . . . 0.0 107.917 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 37' ' ' SER . 30.5 m -104.95 116.41 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -170.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 m -82.8 97.47 8.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.149 0.98 . . . . 0.0 109.006 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.456 HD12 HG22 ' A' ' 78' ' ' VAL . 16.2 mt -74.05 92.16 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 166.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -100.13 108.75 20.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 110.129 -3.214 . . . . 0.0 109.578 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.42 100.49 9.77 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.747 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 7.6 pt-20 -96.72 89.82 5.07 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.05 -162.7 29.27 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.637 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -56.39 -59.35 5.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 118.721 2.86 . . . . 0.0 118.721 -162.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -85.41 50.16 1.9 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -51.72 -53.15 42.58 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.193 -2.276 . . . . 0.0 116.079 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -43.17 57.16 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.69 -49.78 76.14 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.6 -52.07 42.69 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.918 1.387 . . . . 0.0 112.614 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.567 ' O ' HG23 ' A' ' 78' ' ' VAL . 86.5 t -53.68 -56.08 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 123.975 0.797 . . . . 0.0 111.795 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.13 -53.09 62.25 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -52.91 -47.6 67.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.952 1.301 . . . . 0.0 113.969 175.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -66.22 -36.71 83.74 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 74' ' ' VAL . 9.0 t -64.94 -47.21 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 O-C-N 122.336 -0.227 . . . . 0.0 110.698 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -54.05 -37.74 64.48 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.9 tt -60.99 -51.84 67.53 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.043 0.937 . . . . 0.0 110.014 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.549 ' HG3' HD21 ' A' ' 14' ' ' LEU . 10.6 ttm -60.57 -46.98 88.2 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.393 1.077 . . . . 0.0 113.005 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.12 -14.79 0.69 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -125.49 45.19 2.64 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 170.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.555 HD22 ' HG3' ' A' ' 18' ' ' PRO . 44.8 mt . . . . . 0 N--CA 1.476 0.85 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.258 169.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.5 ttm . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -120.8 140.62 51.47 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.964 1.415 . . . . 0.0 109.576 173.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -128.65 142.67 50.96 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.518 1.136 . . . . 0.0 112.032 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -150.49 119.62 6.75 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.025 1.453 . . . . 0.0 110.799 169.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 11.7 pt-20 -72.88 126.65 30.44 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.888 -1.506 . . . . 0.0 113.223 173.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.12 131.75 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.098 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.9 m -111.34 110.48 20.97 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.73 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.1 mt -72.62 113.9 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.445 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -85.74 -19.08 31.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.388 -1.733 . . . . 0.0 114.844 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -54.87 127.64 62.03 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.554 1.142 . . . . 0.0 113.009 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 52.3 Cg_exo -54.11 -62.3 0.32 Allowed 'Trans proline' 0 N--CA 1.485 0.999 0 C-N-CA 124.602 3.535 . . . . 0.0 113.314 -169.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.29 29.62 2.16 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 174.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . 33.74 -134.06 0.31 Allowed Glycine 0 N--CA 1.479 1.546 0 C-N-CA 127.345 2.402 . . . . 0.0 116.345 -175.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.8 122.43 44.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.117 -2.042 . . . . 0.0 109.966 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . 0.425 ' HB2' ' H ' ' A' ' 16' ' ' THR . 2.2 p80 -109.2 -154.93 0.54 Allowed 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.195 -1.82 . . . . 0.0 113.579 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . 0.425 ' H ' ' HB2' ' A' ' 15' ' ' HIS . 15.3 m -61.01 -48.36 82.15 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -166.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -63.27 -47.61 84.4 Favored Pre-proline 0 N--CA 1.489 1.502 0 CA-C-O 116.599 -1.667 . . . . 0.0 112.233 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.79 -47.14 28.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.823 2.349 . . . . 0.0 113.48 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.92 -48.26 73.32 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.9 -46.91 84.21 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.118 0.967 . . . . 0.0 113.381 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -57.89 -42.78 85.37 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.576 ' HE1' ' HB3' ' A' ' 80' ' ' LEU . 21.7 m-85 -66.28 -49.24 67.78 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 47' ' ' LEU . 40.6 t -58.07 -35.84 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.448 0.699 . . . . 0.0 112.521 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -62.81 -65.07 0.74 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.029 0.932 . . . . 0.0 111.014 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.52 -52.76 62.18 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 44' ' ' ALA . . . -64.91 -27.27 68.74 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -176.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 38.0 mttm -58.5 -35.52 72.38 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 169.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.66 -31.83 79.31 Favored Glycine 0 N--CA 1.482 1.731 0 O-C-N 125.78 1.925 . . . . 0.0 113.579 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -79.01 142.17 36.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.294 0.638 . . . . 0.0 110.695 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.1 p -64.5 -43.75 93.12 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.64 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.2 p -59.68 143.8 49.68 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 114.419 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -90.78 126.3 35.97 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.744 1.259 . . . . 0.0 109.999 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.549 HG21 HD13 ' A' ' 77' ' ' LEU . 15.4 mm -98.4 98.56 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 112.765 -2.016 . . . . 0.0 109.71 -169.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 0.2 OUTLIER -83.86 101.28 11.54 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.705 -1.588 . . . . 0.0 107.554 175.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.5 t -87.43 77.6 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.9 m -75.45 88.28 2.63 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.339 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.7 t -79.8 86.68 5.34 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.819 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 21.12 81.4 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 111.295 -2.684 . . . . 0.0 115.484 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.37 -63.37 0.28 Allowed Glycine 0 CA--C 1.543 1.81 0 CA-C-N 112.173 -2.285 . . . . 0.0 112.79 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -104.9 133.02 50.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -169.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 p -88.71 116.23 26.82 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 113.557 -1.656 . . . . 0.0 115.444 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.463 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -102.29 164.96 11.39 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.546 168.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -125.69 119.38 27.85 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.305 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -72.57 5.97 2.72 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 124.42 1.075 . . . . 0.0 113.059 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 27' ' ' LYS . 50.9 mtpt -113.89 -15.21 12.4 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 172.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.0 t -119.02 120.9 38.58 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.824 0.849 . . . . 0.0 111.685 172.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.62 ' HA ' HG21 ' A' ' 23' ' ' VAL . 20.0 tp -57.44 -61.83 2.21 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.018 -1.447 . . . . 0.0 113.386 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -45.37 -50.78 11.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.29 1.436 . . . . 0.0 113.238 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -67.67 -30.93 70.59 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.463 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 18.6 tp -72.98 -47.06 48.59 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.513 0.508 . . . . 0.0 111.752 174.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -65.99 -31.53 72.48 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.5 t -85.03 33.71 0.54 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.856 1.313 . . . . 0.0 114.351 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.05 140.72 44.03 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.907 171.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.7 93.23 0.17 Allowed Glycine 0 N--CA 1.479 1.525 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.256 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.414 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 17.0 mt -94.96 57.86 2.14 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.293 1.044 . . . . 0.0 110.721 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -109.39 176.88 4.92 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.866 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -58.58 126.15 26.38 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.758 0.79 . . . . 0.0 111.888 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.66 16.23 64.23 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 113.385 -1.734 . . . . 0.0 114.925 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.0 p -88.23 120.44 29.59 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.543 0.687 . . . . 0.0 111.313 175.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 t -93.54 85.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 112.4 -2.182 . . . . 0.0 107.642 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -80.5 94.46 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 112.129 -2.305 . . . . 0.0 112.382 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 17.0 m -76.12 100.66 5.06 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.761 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.507 HG22 HG22 ' A' ' 74' ' ' VAL . 67.3 mt -79.23 102.12 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.975 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.404 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 47.8 t -106.56 104.86 14.65 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 111.82 -2.445 . . . . 0.0 110.408 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.59 101.49 13.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.763 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.89 99.56 12.39 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.982 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.09 -169.15 31.99 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-N 112.39 -2.187 . . . . 0.0 111.38 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.42 -48.9 75.91 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 -169.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -85.62 42.71 0.98 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -51.77 -48.65 63.65 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.44 -42.88 28.72 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -59.11 -44.19 91.95 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.545 1.138 . . . . 0.0 112.719 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.34 -49.68 70.72 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.192 0.997 . . . . 0.0 113.308 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 63' ' ' ILE . 76.3 t -59.84 -55.11 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.47 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -47.97 -45.04 30.94 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -70.13 -51.22 33.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.549 HD13 HG21 ' A' ' 33' ' ' ILE . 5.7 mt -60.56 -33.86 73.31 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.65 -54.69 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 124.039 0.837 . . . . 0.0 109.966 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -50.99 -49.98 59.33 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 124.17 0.919 . . . . 0.0 112.988 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.576 ' HB3' ' HE1' ' A' ' 22' ' ' PHE . 9.4 mp -61.48 -46.25 90.84 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 44.5 mtt -66.41 -21.67 66.22 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.3 -32.46 16.51 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -74.25 -39.72 62.85 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt . . . . . 0 N--CA 1.481 1.097 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 178.545 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.8 ttp . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -124.88 135.64 53.06 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 125.277 1.611 . . . . 0.0 108.246 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -133.97 135.19 43.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.059 -172.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -142.76 144.49 32.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.047 1.339 . . . . 0.0 112.185 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.16 141.91 28.31 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.507 169.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 81' ' ' MET . 44.5 t -123.73 135.18 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 113.577 -1.647 . . . . 0.0 106.722 160.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.9 m -102.75 113.7 27.32 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.4 mt -72.63 124.69 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 122.317 1.056 . . . . 0.0 108.735 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -127.11 -30.12 2.71 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.868 -171.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -45.62 121.86 5.48 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 124.258 1.023 . . . . 0.0 111.367 161.483 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 34.1 Cg_endo -53.67 -69.35 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.454 2.769 . . . . 0.0 114.048 -169.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.425 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -74.55 -24.0 58.87 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.25 -125.2 17.83 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.999 1.285 . . . . 0.0 113.599 167.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.674 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 5.1 mp -96.45 110.43 22.8 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.896 1.331 . . . . 0.0 112.984 -175.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -109.6 -169.81 1.54 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 111.95 -2.386 . . . . 0.0 111.203 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 m -27.53 -76.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.394 2.278 . . . . 0.0 115.933 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -62.63 -49.35 83.33 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-O 116.237 -1.84 . . . . 0.0 113.696 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -51.51 -45.95 34.6 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.448 2.765 . . . . 0.0 114.044 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.7 -51.14 68.35 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.289 0.636 . . . . 0.0 112.403 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.28 81.31 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.62 -58.08 8.91 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.44 1.096 . . . . 0.0 111.986 171.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.79 -41.69 82.62 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.206 1.003 . . . . 0.0 112.719 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.608 HG21 ' HA ' ' A' ' 47' ' ' LEU . 58.9 t -64.58 -51.06 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.122 0.569 . . . . 0.0 111.642 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -53.15 -47.94 68.35 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.354 0.662 . . . . 0.0 109.827 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.06 -49.72 66.64 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.01 -45.85 75.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.525 0.73 . . . . 0.0 112.081 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -59.59 -36.08 75.55 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 173.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.22 -43.07 93.79 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 124.875 1.359 . . . . 0.0 112.199 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -62.02 145.99 51.48 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.99 0.916 . . . . 0.0 112.554 172.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.7 p -79.44 -31.36 42.53 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.232 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.7 p -71.95 141.82 49.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.76 0.824 . . . . 0.0 112.398 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.484 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 16.4 tp10 -72.35 130.62 41.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.479 0.656 . . . . 0.0 110.462 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 mm -113.43 86.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.369 -1.742 . . . . 0.0 109.303 -164.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.1 m -92.54 111.9 23.65 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 112.26 -2.245 . . . . 0.0 108.707 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.51 103.46 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 113.45 -1.705 . . . . 0.0 108.873 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 42.0 m -81.57 98.35 8.28 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.219 176.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' ' 53' ' ' LEU . 10.6 t -95.39 94.16 7.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.16 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.288 30.7 p-10 43.51 77.32 0.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 111.053 -2.794 . . . . 0.0 115.628 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.06 -52.59 3.21 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 112.276 -2.238 . . . . 0.0 113.742 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -93.46 134.48 35.67 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 39.5 p -89.8 148.9 22.94 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 122.526 1.155 . . . . 0.0 113.561 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -143.66 122.59 12.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.586 171.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.5 t -57.73 107.45 0.45 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.315 0.578 . . . . 0.0 110.059 166.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.78 -23.4 60.15 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.378 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -65.11 3.46 0.6 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.789 -1.551 . . . . 0.0 114.994 168.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 31.1 t -125.94 118.04 24.57 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.885 0.874 . . . . 0.0 110.427 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.608 ' HA ' HG21 ' A' ' 23' ' ' VAL . 31.1 tp -53.41 -47.75 69.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.793 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -58.22 -51.05 71.35 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.544 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 63.9 mttt -68.19 -43.69 77.56 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.41 -45.53 92.72 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.057 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -64.49 -36.45 84.22 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 49' ' ' LYS . 5.2 t -74.62 -30.44 61.66 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 37' ' ' SER . 3.2 mm? -83.07 155.6 23.78 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 122.067 0.937 . . . . 0.0 113.475 173.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -56.63 121.05 23.17 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 113.776 -1.556 . . . . 0.0 113.433 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.674 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 76.1 mt -124.31 36.66 4.57 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.061 1.344 . . . . 0.0 113.355 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -139.36 160.32 40.1 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -163.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.433 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 51.1 tt0 -34.52 109.51 0.08 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.618 1.567 . . . . 0.0 113.429 173.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.75 -40.8 1.93 Allowed Glycine 0 CA--C 1.534 1.276 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.817 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.7 p -74.89 133.35 41.83 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.57 110.06 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 113.279 -1.782 . . . . 0.0 106.785 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 m -98.7 89.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 125.065 1.478 . . . . 0.0 111.968 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.15 90.16 2.52 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.717 -2.038 . . . . 0.0 110.096 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.3 mt -76.65 111.87 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.275 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.2 t -117.2 124.75 49.87 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.821 -1.536 . . . . 0.0 109.631 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.28 110.66 21.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.365 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 3.3 pt-20 -108.95 110.34 21.62 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.651 -1.158 . . . . 0.0 113.674 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.82 -158.57 27.77 Favored Glycine 0 N--CA 1.483 1.831 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.002 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.88 -65.76 0.63 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -81.34 45.38 0.85 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 10.1 pt-20 -51.33 -62.27 1.72 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.683 1.593 . . . . 0.0 114.533 -177.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.406 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.6 OUTLIER -65.28 -41.98 93.62 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -56.96 -49.01 77.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.457 1.103 . . . . 0.0 113.52 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.9 -51.64 68.8 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.451 0.701 . . . . 0.0 111.838 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.68 -46.32 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.449 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -49.21 -54.73 15.22 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.21 1.404 . . . . 0.0 112.096 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -69.09 -34.75 75.6 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.5 mt -73.24 -39.9 65.1 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.8 t -58.91 -43.6 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.289 0.636 . . . . 0.0 110.217 170.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 79' ' ' LYS . 34.0 mtpt -56.63 -53.66 55.12 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 171.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.3 mt -49.76 -48.77 50.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.06 0.944 . . . . 0.0 113.464 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.609 ' HB3' HG11 ' A' ' 6' ' ' VAL . 11.9 mmt -59.16 -43.73 92.1 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.36 -40.66 89.91 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -74.18 -19.09 60.66 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 117.203 2.298 . . . . 0.0 117.203 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.3 mt . . . . . 0 CA--C 1.554 1.117 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -172.53 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -141.29 134.07 28.8 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.969 1.418 . . . . 0.0 111.318 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -122.98 139.94 53.55 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.156 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.491 ' HB2' HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -138.73 140.31 38.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.171 175.06 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -100.63 116.14 31.85 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 122.74 1.257 . . . . 0.0 111.443 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.5 p -122.62 135.72 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 112.88 -1.963 . . . . 0.0 111.286 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -87.91 162.54 16.85 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.494 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.6 mm -115.85 132.38 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 125.234 1.584 . . . . 0.0 106.885 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.77 -29.92 11.19 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.54 132.83 1.69 Allowed Pre-proline 0 N--CA 1.474 0.747 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 177.422 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -54.69 -45.94 37.15 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.915 3.077 . . . . 0.0 112.411 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -73.03 -64.37 0.98 Allowed 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.531 1.144 . . . . 0.0 112.967 171.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.61 100.31 2.64 Favored Glycine 0 N--CA 1.475 1.286 0 N-CA-C 110.386 -1.085 . . . . 0.0 110.386 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 32.21 84.57 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.134 2.173 . . . . 0.0 114.722 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -64.23 169.81 4.25 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.111 1.434 . . . . 0.0 114.213 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 p -59.71 -17.28 33.36 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.261 96.8 mtt180 -80.32 -47.38 1.32 Allowed Pre-proline 0 N--CA 1.478 0.929 0 CA-C-O 116.75 -1.595 . . . . 0.0 114.473 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.66 -37.22 89.16 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 122.097 1.865 . . . . 0.0 113.976 162.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.38 -44.99 89.16 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.08 92.89 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 172.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -63.54 -48.1 78.88 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.864 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -45.92 -56.27 5.68 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.54 1.536 . . . . 0.0 113.519 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.01 -43.66 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.185 0.994 . . . . 0.0 112.496 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.35 -50.13 68.96 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -59.58 -48.92 79.78 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.778 1.299 . . . . 0.0 111.257 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.67 -39.36 80.44 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -65.65 -38.02 88.19 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.18 -53.6 35.55 Favored Glycine 0 N--CA 1.482 1.726 0 O-C-N 125.614 1.821 . . . . 0.0 111.794 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -52.34 137.03 30.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 125.322 1.248 . . . . 0.0 110.378 171.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 p -74.11 -36.36 64.21 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.4 m -46.28 146.85 1.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.135 1.774 . . . . 0.0 114.877 170.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -86.05 133.72 33.88 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.792 0.806 . . . . 0.0 109.878 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.0 mm -117.04 97.44 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.165 -164.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 57.0 m -94.77 117.91 30.9 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.4 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.0 t -116.88 100.92 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 112.796 -2.002 . . . . 0.0 107.17 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -111.26 102.46 10.87 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.673 -167.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.5 m -76.52 91.8 3.39 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.751 170.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.263 6.8 p-10 32.24 105.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 118.706 2.854 . . . . 0.0 118.706 -172.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.38 -37.37 0.82 Allowed Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.634 ' HD3' HD21 ' A' ' 53' ' ' LEU . 78.1 tttt -94.58 120.05 34.2 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.938 0.895 . . . . 0.0 110.161 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.0 m -98.31 124.21 42.83 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -169.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 49' ' ' LYS . . . -117.28 166.6 12.09 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.74 -2.027 . . . . 0.0 109.723 175.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.645 ' HB3' ' HD3' ' A' ' 49' ' ' LYS . 18.2 t -126.01 132.34 52.03 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.91 -20.43 64.23 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.327 -1.761 . . . . 0.0 113.907 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -66.29 -12.3 55.64 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 84.4 p -136.44 137.26 40.25 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 160.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.6 tp -55.11 -39.23 69.13 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 124.121 0.888 . . . . 0.0 111.908 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -46.4 -56.35 6.02 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.04 1.736 . . . . 0.0 113.272 168.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.645 ' HD3' ' HB3' ' A' ' 43' ' ' SER . 56.1 tttt -76.49 -30.47 57.25 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.9 -65.56 0.66 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -59.99 -23.62 63.78 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -60.88 -26.5 67.46 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 174.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.634 HD21 ' HD3' ' A' ' 40' ' ' LYS . 5.4 mt -123.27 85.15 2.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.542 1.137 . . . . 0.0 109.459 169.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.88 135.86 17.72 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 112.949 -1.932 . . . . 0.0 113.135 -173.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.46 HD23 HG11 ' A' ' 61' ' ' VAL . 5.0 mp -79.22 101.32 7.93 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 113.47 -1.365 . . . . 0.0 109.715 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -129.71 162.23 28.86 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.804 -1.543 . . . . 0.0 111.979 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -58.02 145.74 35.19 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.44 -51.16 4.52 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.95 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -71.38 113.33 8.31 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.907 0.86 . . . . 0.0 111.245 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.0 p -71.43 132.37 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.709 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.46 HG11 HD23 ' A' ' 55' ' ' LEU . 14.8 p -116.59 123.92 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.08 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 m -79.95 120.53 24.28 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.968 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.01 100.33 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.487 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 44.6 t -110.18 125.39 52.99 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 112.909 -1.95 . . . . 0.0 112.104 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.15 111.89 18.83 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.547 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.53 103.8 12.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 113.778 -1.555 . . . . 0.0 112.91 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.57 -156.4 26.66 Favored Glycine 0 N--CA 1.479 1.533 0 CA-C-N 111.798 -2.455 . . . . 0.0 109.8 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.3 -49.53 63.84 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.93 20.44 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -41.43 -55.71 2.72 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -171.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -75.75 -52.26 10.84 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.939 0.896 . . . . 0.0 112.157 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -48.33 -54.31 14.28 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.421 1.888 . . . . 0.0 113.069 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.92 -51.99 66.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.452 1.101 . . . . 0.0 112.732 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 4' ' ' GLN . 60.7 t -64.8 -49.24 80.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.734 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -53.79 -51.79 62.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.31 1.006 . . . . 0.0 111.025 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -65.17 -43.65 91.04 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.7 mt -64.51 -35.61 81.53 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.4 t -74.08 -35.18 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 123.126 0.57 . . . . 0.0 111.451 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -66.66 -36.01 81.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 171.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -55.32 -50.27 70.04 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.515 1.135 . . . . 0.0 109.335 168.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 66.0 mtt -58.12 -44.14 87.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.16 -20.62 27.41 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -110.81 -31.73 7.08 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.2 mt . . . . . 0 N--CA 1.481 1.113 0 C-N-CA 124.858 1.263 . . . . 0.0 114.079 -173.777 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 tmm? . . . . . 0 C--O 1.239 0.531 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -124.7 128.3 48.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.669 1.23 . . . . 0.0 109.397 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -124.74 138.84 54.26 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.512 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -129.68 140.79 51.04 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.203 172.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -98.78 120.77 39.78 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.683 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 HG13 ' A' ' 78' ' ' VAL . 2.4 m -123.22 144.83 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 113.875 -1.512 . . . . 0.0 113.131 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -105.26 143.81 32.92 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.618 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -114.49 133.16 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.67 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 p -116.95 -41.05 3.06 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.6 132.49 3.79 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 170.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.23 -42.67 54.25 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.979 2.453 . . . . 0.0 113.752 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -69.22 -35.18 75.91 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.692 1.245 . . . . 0.0 114.051 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.51 80.66 0.12 Allowed Glycine 0 N--CA 1.473 1.158 0 O-C-N 125.154 1.533 . . . . 0.0 112.431 -176.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.485 HD22 ' HZ ' ' A' ' 22' ' ' PHE . 8.1 mt 61.16 92.34 0.05 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.211 1.804 . . . . 0.0 112.849 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -71.71 -165.66 0.17 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -173.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.46 -46.17 9.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.477 2.711 . . . . 0.0 113.692 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.267 68.1 mtt180 -80.52 -42.64 1.31 Allowed Pre-proline 0 N--CA 1.486 1.349 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -53.02 -48.39 22.4 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.903 2.402 . . . . 0.0 113.295 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.81 -47.39 77.24 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.54 -39.34 76.42 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.01 -50.7 71.01 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.856 0.863 . . . . 0.0 112.931 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.485 ' HZ ' HD22 ' A' ' 14' ' ' LEU . 11.8 m-30 -53.66 -41.03 66.4 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.936 0.894 . . . . 0.0 111.759 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.415 HG21 HD12 ' A' ' 47' ' ' LEU . 45.3 t -60.3 -59.9 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.605 1.162 . . . . 0.0 111.804 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -53.31 -48.08 68.72 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.666 0.604 . . . . 0.0 111.699 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -45.89 78.59 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.95 74.61 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 173.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -66.16 -45.55 80.55 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.31 -45.65 96.02 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.693 1.616 . . . . 0.0 113.319 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -65.65 147.58 53.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.83 0.852 . . . . 0.0 111.122 167.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 p -66.79 -56.6 9.72 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.777 1.231 . . . . 0.0 113.664 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -46.6 144.96 2.02 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -82.35 117.24 22.27 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.582 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 77' ' ' LEU . 26.0 mm -94.5 114.61 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.22 -174.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.08 120.9 26.71 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 125.419 1.699 . . . . 0.0 110.596 173.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.8 t -108.8 86.55 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.9 m -94.0 90.61 6.51 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.225 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 p -76.2 98.59 4.46 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.253 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.255 52.0 p-10 24.09 60.12 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.051 2.14 . . . . 0.0 116.533 -167.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.69 -34.93 4.76 Favored Glycine 0 CA--C 1.542 1.747 0 CA-C-N 113.72 -1.582 . . . . 0.0 115.449 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . 0.597 ' HB3' HD23 ' A' ' 53' ' ' LEU . 97.8 mttt -81.26 96.92 7.42 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -73.3 89.62 1.59 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.15 158.43 19.77 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.792 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -110.62 120.84 43.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.432 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.93 -32.21 73.66 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.302 1.626 . . . . 0.0 112.637 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -67.89 -9.95 49.12 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.552 1.541 . . . . 0.0 114.201 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 t -121.85 118.22 28.43 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.743 1.217 . . . . 0.0 111.326 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 23' ' ' VAL . 30.7 tp -55.38 -47.21 76.17 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 113.55 -1.659 . . . . 0.0 112.621 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -60.57 -57.77 11.33 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.973 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -61.47 -43.97 97.93 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.5 tp -57.88 -57.32 13.31 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.514 1.134 . . . . 0.0 112.612 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -71.38 -27.67 63.49 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.593 HG23 HD12 ' A' ' 53' ' ' LEU . 10.5 t -72.77 -24.8 60.99 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 171.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.597 HD23 ' HB3' ' A' ' 40' ' ' LYS . 6.8 mp -104.76 74.46 1.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.968 1.366 . . . . 0.0 110.505 172.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.49 152.54 49.83 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 112.428 -2.169 . . . . 0.0 114.611 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -100.39 158.71 15.7 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 112.588 -1.806 . . . . 0.0 109.787 173.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.8 t -161.54 165.87 27.88 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.081 1.352 . . . . 0.0 110.588 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -63.65 125.65 24.98 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.08 -19.29 54.03 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.527 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.6 m -75.98 104.12 6.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.234 0.613 . . . . 0.0 109.393 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.51 137.37 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.724 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.36 123.69 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 122.245 1.022 . . . . 0.0 113.557 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 116.86 28.25 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.111 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.7 mm -92.66 103.93 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.4 t -115.92 129.52 56.43 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.721 -1.581 . . . . 0.0 111.068 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.88 122.84 40.35 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.547 1.165 . . . . 0.0 111.665 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -96.88 116.67 29.57 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.382 -2.19 . . . . 0.0 114.059 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.38 177.6 10.36 Favored Glycine 0 CA--C 1.541 1.697 0 CA-C-N 111.824 -2.444 . . . . 0.0 113.237 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.257 50.3 mt-10 41.6 -93.24 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 172.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -77.15 -0.64 25.72 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -18.51 -62.91 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -64.93 -57.59 8.37 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.882 0.873 . . . . 0.0 112.882 -175.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -62.6 -38.15 89.06 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.583 0.753 . . . . 0.0 112.214 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.87 -57.42 12.12 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.832 . . . . 0.0 112.269 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.89 -49.15 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 118.51 -0.757 . . . . 0.0 111.771 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -49.7 -55.82 12.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.86 0.864 . . . . 0.0 113.255 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -63.67 -48.68 76.18 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.816 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.487 HD13 HG21 ' A' ' 33' ' ' ILE . 23.4 mt -61.56 -38.3 86.97 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.437 HG13 HG11 ' A' ' 6' ' ' VAL . 10.4 t -65.14 -42.1 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.537 0.735 . . . . 0.0 111.167 174.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -60.78 -45.69 93.36 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 118.283 -0.865 . . . . 0.0 112.968 173.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.2 mt -52.34 -52.59 52.41 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.574 0.75 . . . . 0.0 112.79 170.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.0 mtt -60.09 -33.6 72.32 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.42 -36.1 60.87 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.59 -21.08 28.66 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.3 mt . . . . . 0 N--CA 1.471 0.616 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -174.931 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.785 ' HG2' ' HB3' ' A' ' 66' ' ' GLU . 2.1 tmm? . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -125.12 131.18 53.31 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 125.093 1.495 . . . . 0.0 110.345 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -135.11 128.27 31.85 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.61 1.194 . . . . 0.0 113.527 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -125.71 127.77 46.74 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 124.823 1.327 . . . . 0.0 112.126 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 8.2 tt0 -84.57 135.89 34.02 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.563 -1.653 . . . . 0.0 112.385 176.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.93 142.42 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.173 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.01 136.7 45.22 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.235 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.748 HD11 ' HG3' ' A' ' 81' ' ' MET . 38.0 mm -105.93 139.09 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.059 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -103.27 -37.51 7.64 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.777 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -48.88 124.49 12.78 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.206 1.002 . . . . 0.0 112.629 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 72.7 Cg_exo -56.27 -52.03 8.08 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.942 3.095 . . . . 0.0 112.936 -175.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -63.53 -42.61 98.43 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.846 1.258 . . . . 0.0 113.241 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.98 -158.57 51.27 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.013 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.09 80.36 9.2 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 113.404 -1.398 . . . . 0.0 111.465 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -75.92 -169.05 1.0 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.721 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -37.44 -52.42 1.14 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.472 2.309 . . . . 0.0 113.24 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.252 44.5 ttt180 -69.95 -50.84 15.96 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-O 115.881 -2.009 . . . . 0.0 114.537 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.498 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 80.1 Cg_exo -63.88 -42.72 18.49 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.64 2.227 . . . . 0.0 113.188 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.31 -45.29 80.34 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.96 -41.65 68.05 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -70.73 -47.98 56.89 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.246 0.618 . . . . 0.0 111.12 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -57.52 -40.09 77.99 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.131 0.972 . . . . 0.0 113.342 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 19' ' ' ALA . 98.1 t -56.56 -53.86 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 124.059 0.944 . . . . 0.0 110.71 171.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -56.73 -46.35 81.37 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.23 -48.95 79.14 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.18 0.925 . . . . 0.0 112.345 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.459 ' O ' ' HE2' ' A' ' 45' ' ' LYS . . . -56.28 -40.52 74.4 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.183 0.993 . . . . 0.0 113.477 173.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -58.23 -36.34 73.02 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 173.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.92 -41.05 56.3 Favored Glycine 0 N--CA 1.483 1.773 0 O-C-N 124.87 1.356 . . . . 0.0 112.522 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -69.94 117.56 11.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.609 1.195 . . . . 0.0 112.41 175.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.5 p -49.11 -49.52 41.53 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.306 -1.77 . . . . 0.0 113.093 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 p -62.8 140.66 58.78 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.704 1.202 . . . . 0.0 113.817 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -77.09 93.17 3.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.619 -175.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.531 HD11 ' HB1' ' A' ' 73' ' ' ALA . 35.5 mm -68.73 84.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 112.788 -2.005 . . . . 0.0 111.276 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -82.9 115.93 21.98 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.004 -1.907 . . . . 0.0 107.797 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.22 99.84 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.1 m -88.33 99.04 11.95 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.696 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 t -101.45 109.91 21.82 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.605 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.296 37.6 p30 25.26 75.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.687 1.995 . . . . 0.0 115.953 -164.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.58 -26.5 4.06 Favored Glycine 0 CA--C 1.544 1.869 0 CA-C-N 112.055 -2.339 . . . . 0.0 115.182 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -84.69 87.98 7.33 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.713 1.244 . . . . 0.0 112.87 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -71.0 104.64 3.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.742 -2.026 . . . . 0.0 113.573 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.469 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -131.41 120.51 23.15 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 t -56.76 123.8 16.22 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.588 170.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.93 -30.56 70.29 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.805 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 26' ' ' ALA . 82.2 mttt -62.82 -22.21 66.47 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.6 t -94.35 112.94 24.75 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.878 0.847 . . . . 0.0 108.93 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -46.22 -52.05 13.2 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.254 -1.794 . . . . 0.0 112.981 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -54.34 -46.2 72.85 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.018 -1.447 . . . . 0.0 113.637 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 74.0 mttt -63.41 -53.42 52.56 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.241 0.963 . . . . 0.0 113.209 -176.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.2 tp -64.71 -33.42 75.92 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.135 0.897 . . . . 0.0 113.187 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -63.99 -47.37 80.61 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.4 t -74.35 -19.13 60.56 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 42' ' ' ALA . 17.1 tp -73.95 130.64 40.27 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.086 1.355 . . . . 0.0 111.346 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.39 102.06 1.33 Allowed Glycine 0 N--CA 1.482 1.762 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.823 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.0 mt -113.06 69.3 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.628 0.728 . . . . 0.0 112.818 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 t -145.79 179.88 7.15 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -61.08 138.7 58.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.343 1.057 . . . . 0.0 112.665 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.08 -52.7 3.55 Favored Glycine 0 N--CA 1.481 1.674 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.123 -172.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -72.53 97.38 2.1 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.08 1.352 . . . . 0.0 110.522 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.5 p -75.24 142.16 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.151 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.584 HG21 ' HE2' ' A' ' 81' ' ' MET . 9.0 p -127.29 125.39 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -170.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -105.64 118.17 35.91 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.602 177.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mm -87.25 96.4 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -108.81 128.58 55.02 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 124.721 1.263 . . . . 0.0 111.65 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.25 127.35 35.52 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.785 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 9.0 pt-20 -118.44 130.9 56.23 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 168.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.88 -155.08 22.15 Favored Glycine 0 N--CA 1.483 1.782 0 O-C-N 124.29 0.994 . . . . 0.0 111.472 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.73 -65.9 0.61 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -66.16 14.91 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' A' ' 71' ' ' GLN . 7.0 pt-20 -42.34 -58.83 2.04 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -168.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.448 ' HG3' ' HG3' ' A' ' 70' ' ' GLU . 36.3 mt-30 -71.25 -47.22 58.4 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.712 -1.131 . . . . 0.0 114.044 -177.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -63.79 -45.54 89.24 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.469 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.26 -43.99 95.68 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.946 0.899 . . . . 0.0 112.086 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.8 t -58.34 -57.14 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 116.951 -1.5 . . . . 0.0 110.129 171.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -50.71 -49.6 57.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.479 0.712 . . . . 0.0 112.91 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -61.54 -52.21 65.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.364 1.066 . . . . 0.0 112.693 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.03 -27.29 60.87 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -54.94 -44.48 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.07 0.948 . . . . 0.0 110.388 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.81 -61.27 2.52 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.693 1.246 . . . . 0.0 111.12 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -51.13 -37.16 44.43 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.748 ' HG3' HD11 ' A' ' 8' ' ' ILE . 11.0 tpt -53.68 -38.58 64.33 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.054 0.942 . . . . 0.0 113.429 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.55 -16.53 28.64 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.73 -25.4 16.71 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 44.2 mt . . . . . 0 N--CA 1.482 1.132 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 179.909 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tmm? . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -127.06 130.3 49.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.15 1.531 . . . . 0.0 108.145 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -134.74 153.54 51.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.227 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.493 ' CB ' HG21 ' A' ' 78' ' ' VAL . 19.2 mm-40 -141.76 144.16 33.85 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 126.353 2.283 . . . . 0.0 110.318 173.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -113.12 134.39 54.57 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.915 1.385 . . . . 0.0 111.316 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -125.17 124.8 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 111.724 -2.489 . . . . 0.0 113.237 -177.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -94.21 123.71 37.77 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 112.65 -2.068 . . . . 0.0 107.732 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.1 mm -95.64 106.22 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.17 -173.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.9 p -92.34 -20.87 20.64 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 113.101 -1.863 . . . . 0.0 113.218 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -62.65 130.82 93.93 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.995 1.318 . . . . 0.0 111.51 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -56.57 -34.12 94.54 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.945 3.097 . . . . 0.0 114.733 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -113.82 4.46 15.91 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 38.65 -117.06 0.6 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.874 2.178 . . . . 0.0 115.2 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 4.8 mp -109.53 74.01 0.87 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 123.643 1.687 . . . . 0.0 111.507 -177.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -75.37 -162.06 0.18 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 111.885 -2.416 . . . . 0.0 112.718 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.2 p -55.9 -44.49 78.28 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.403 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 52.2 ttt180 -66.93 -47.81 52.48 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-O 116.702 -1.618 . . . . 0.0 114.377 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 75.5 Cg_exo -68.16 -40.47 8.7 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.104 2.536 . . . . 0.0 113.571 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -44.7 72.13 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.11 -41.04 62.15 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 170.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.3 -45.89 68.49 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.258 0.623 . . . . 0.0 111.647 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -60.95 -49.87 75.7 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.07 1.348 . . . . 0.0 113.381 -171.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 47' ' ' LEU . 8.0 p -53.76 -42.57 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.32 1.048 . . . . 0.0 113.492 173.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -62.72 -51.77 65.85 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.997 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.515 ' HG3' ' HE2' ' A' ' 29' ' ' PHE . 6.6 tp10 -57.69 -49.68 75.72 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.412 1.07 . . . . 0.0 111.915 175.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.3 -40.17 70.77 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -55.46 -38.56 69.22 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.27 -28.83 73.77 Favored Glycine 0 N--CA 1.483 1.816 0 O-C-N 125.812 1.945 . . . . 0.0 114.786 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.566 ' HE1' ' HE2' ' A' ' 72' ' ' LYS . 77.1 m-85 -92.45 134.63 34.77 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.3 p -71.28 -42.97 68.07 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.503 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.6 m -44.15 136.4 3.9 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.243 1.817 . . . . 0.0 114.728 168.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.81 134.03 35.12 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.213 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.6 mm -111.18 101.14 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.076 -171.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 41' ' ' SER . 7.7 p -94.72 120.92 35.73 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.654 1.216 . . . . 0.0 111.927 170.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.6 t -97.83 91.7 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 110.901 -2.863 . . . . 0.0 105.846 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -83.59 84.07 7.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 111.987 -2.37 . . . . 0.0 111.057 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.1 t -74.83 90.95 2.39 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.418 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.322 6.7 p30 37.08 69.38 0.22 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 113.157 -1.838 . . . . 0.0 114.767 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 -46.55 2.31 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 112.175 -2.284 . . . . 0.0 114.147 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -76.43 96.75 4.11 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 13.3 p -83.8 119.31 24.68 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 112.659 -2.064 . . . . 0.0 115.44 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.74 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -137.42 146.36 44.3 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.065 -1.425 . . . . 0.0 112.256 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.1 t -62.3 134.57 56.68 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.494 ' HA ' HD13 ' A' ' 50' ' ' LEU . . . -70.9 -41.31 71.45 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 125.686 1.866 . . . . 0.0 113.114 170.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -60.18 -38.35 82.96 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.097 1.359 . . . . 0.0 111.624 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.3 t -76.23 94.5 3.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.896 170.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.509 HD13 HG11 ' A' ' 23' ' ' VAL . 30.9 tp -51.93 -32.14 31.76 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.726 170.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 52' ' ' THR . 64.9 t80 -52.66 -64.23 0.89 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.755 1.222 . . . . 0.0 110.653 170.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.74 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 94.6 mttt -63.8 -47.36 81.17 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 44' ' ' ALA . 23.2 tp -51.15 -46.34 61.98 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 174.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -74.27 -41.15 61.73 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 48' ' ' PHE . 10.6 t -84.63 53.16 2.59 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 122.237 1.017 . . . . 0.0 112.102 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 17.5 tp -154.67 136.13 14.19 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.409 -172.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.59 108.37 2.46 Favored Glycine 0 N--CA 1.48 1.623 0 C-N-CA 125.275 1.417 . . . . 0.0 113.076 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 11.7 mt -127.68 35.09 4.55 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 t -119.31 178.37 4.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -57.13 139.56 52.1 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.42 -9.91 73.69 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 113.886 -1.506 . . . . 0.0 114.254 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.6 m -102.65 127.5 49.73 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.92 132.74 35.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.279 167.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.546 HG13 HG23 ' A' ' 6' ' ' VAL . 11.5 p -125.2 137.92 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.523 -175.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.57 126.5 54.5 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.291 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.541 HG22 HG22 ' A' ' 74' ' ' VAL . 51.0 mm -99.08 108.01 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.4 t -113.45 135.21 54.13 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 124.56 1.162 . . . . 0.0 112.137 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.11 146.72 41.02 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.751 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.1 138.62 49.62 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.818 -173.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.11 -146.82 18.36 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 114.577 0.591 . . . . 0.0 114.577 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.14 -48.7 53.53 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -169.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -107.43 31.63 5.27 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.214 -174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -60.32 -48.23 82.64 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -171.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -70.2 -61.46 1.76 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.023 0.827 . . . . 0.0 112.232 176.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.566 ' HE2' ' HE1' ' A' ' 29' ' ' PHE . 64.5 tttt -49.07 -50.62 35.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.641 1.576 . . . . 0.0 114.256 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.5 -55.09 38.11 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 63' ' ' ILE . 85.4 t -67.9 -47.98 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.942 -174.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -45.08 -49.15 11.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.175 1.39 . . . . 0.0 112.747 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -66.91 -55.8 13.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.973 0.909 . . . . 0.0 113.168 173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.519 HD23 HD12 ' A' ' 80' ' ' LEU . 97.7 mt -59.72 -28.91 67.74 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -177.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.493 HG21 ' CB ' ' A' ' 4' ' ' GLN . 32.5 t -74.09 -45.74 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.288 0.635 . . . . 0.0 112.346 173.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -52.61 -37.67 58.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 170.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.519 HD12 HD23 ' A' ' 77' ' ' LEU . 46.3 mt -56.83 -33.44 66.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -62.7 -24.48 67.68 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.32 -31.59 24.76 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.192 0.997 . . . . 0.0 113.115 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -91.42 -33.3 15.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 118.37 2.729 . . . . 0.0 118.37 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.9 mt . . . . . 0 N--CA 1.484 1.242 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 178.418 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.894 ' HG2' ' HB3' ' A' ' 66' ' ' GLU . 7.9 tmm? . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -122.47 135.82 54.75 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.287 0.992 . . . . 0.0 112.749 -167.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -121.34 137.19 54.81 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.859 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -128.13 123.59 34.81 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -96.3 99.0 10.73 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.991 1.432 . . . . 0.0 112.144 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.7 126.17 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 113.539 -1.664 . . . . 0.0 110.408 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 m -83.92 116.83 22.98 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.053 165.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.81 125.79 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 p -117.1 -36.48 3.78 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.56 113.05 0.94 Allowed Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 125.947 1.699 . . . . 0.0 115.072 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -53.59 -33.03 66.9 Favored 'Trans proline' 0 N--CA 1.483 0.894 0 C-N-CA 124.481 3.454 . . . . 0.0 114.35 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -62.86 -27.24 69.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.82 161.96 11.31 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 123.988 0.804 . . . . 0.0 113.244 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 55' ' ' LEU . 82.3 mt -79.89 78.04 6.52 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 122.871 1.319 . . . . 0.0 109.245 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -72.94 -153.65 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.218 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 p -51.75 -59.54 4.19 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.205 1.002 . . . . 0.0 113.685 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -55.39 -49.16 94.1 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 115.978 -1.963 . . . . 0.0 114.84 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HG3' ' HB3' ' A' ' 84' ' ' LEU . 78.3 Cg_exo -58.25 -52.05 6.42 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 122.33 2.02 . . . . 0.0 112.473 173.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.22 89.58 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.74 -47.73 84.96 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.059 0.944 . . . . 0.0 113.494 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -68.54 -36.82 79.35 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.777 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB3' HD21 ' A' ' 50' ' ' LEU . 11.8 t80 -64.42 -48.67 74.47 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.549 1.14 . . . . 0.0 112.568 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.72 -48.0 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -51.85 -45.0 63.87 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.81 1.244 . . . . 0.0 112.635 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.687 ' HB3' HD21 ' A' ' 77' ' ' LEU . 4.4 tp10 -75.61 -46.59 30.79 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.658 0.599 . . . . 0.0 112.172 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.05 -39.87 63.56 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.777 1.231 . . . . 0.0 114.262 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -63.18 -37.27 86.56 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.24 -33.08 73.64 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.053 1.311 . . . . 0.0 114.629 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -86.65 121.75 29.6 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.788 0.804 . . . . 0.0 110.809 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 p -58.18 -39.78 79.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.897 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -47.44 144.25 3.11 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 126.86 2.064 . . . . 0.0 113.496 166.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -94.68 122.06 36.9 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.529 1.157 . . . . 0.0 111.529 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 mm -108.63 106.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 112.324 -2.216 . . . . 0.0 106.949 -173.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 98.1 m -103.2 122.72 45.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.113 -176.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -101.67 103.84 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 113.534 -1.666 . . . . 0.0 107.01 -174.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -104.34 97.79 7.68 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.035 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.8 t -88.36 92.39 9.15 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.548 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.08 61.03 2.49 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 113.753 -1.567 . . . . 0.0 114.184 174.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.28 -63.37 0.41 Allowed Glycine 0 CA--C 1.543 1.801 0 CA-C-N 113.65 -1.614 . . . . 0.0 113.222 -168.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -68.62 111.02 4.53 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.394 1.093 . . . . 0.0 112.847 -170.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.1 p -106.62 117.82 35.06 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.413 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.724 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -117.74 143.58 46.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 112.197 -2.274 . . . . 0.0 110.275 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.8 t -73.96 134.21 43.11 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.12 0.486 . . . . 0.0 109.816 173.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.02 68.14 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.06 -0.53 4.59 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.2 t -127.17 111.58 14.15 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.92 1.288 . . . . 0.0 111.067 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.9 tp -59.07 -39.99 83.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.233 1.013 . . . . 0.0 111.552 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -55.53 -50.15 70.76 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.623 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.724 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 83.9 mttt -65.19 -45.29 85.43 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.649 0.779 . . . . 0.0 112.943 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 22' ' ' PHE . 20.3 tp -63.82 -47.25 81.58 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 124.568 1.168 . . . . 0.0 113.486 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -70.56 -37.24 73.97 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -74.62 -11.62 60.24 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 42' ' ' ALA . 15.1 tp -88.43 143.81 26.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.353 1.061 . . . . 0.0 109.335 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.37 88.78 0.13 Allowed Glycine 0 N--CA 1.484 1.859 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.092 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.424 ' HB3' HD12 ' A' ' 14' ' ' LEU . 93.4 mt -122.35 74.33 1.17 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 123.813 1.768 . . . . 0.0 110.353 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 t -137.25 175.0 10.0 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.371 -1.741 . . . . 0.0 109.716 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -45.58 150.06 0.53 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.76 34.33 56.55 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 125.155 1.36 . . . . 0.0 115.261 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.3 m -120.99 141.3 50.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.276 11.8 p -111.22 116.4 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.731 0.776 . . . . 0.0 112.524 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.54 129.55 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 112.286 -2.233 . . . . 0.0 112.989 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -103.12 123.12 46.08 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.537 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.0 mm -97.17 94.05 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 113.402 -1.727 . . . . 0.0 108.037 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.509 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 12.5 t -88.62 132.52 34.52 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.097 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.71 138.58 24.62 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.894 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 16.6 pt-20 -134.0 149.54 51.21 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.612 162.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.38 -165.09 24.81 Favored Glycine 0 CA--C 1.54 1.614 0 O-C-N 124.753 1.283 . . . . 0.0 111.429 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -50.81 -75.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.22 1.408 . . . . 0.0 113.184 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.69 74.78 1.54 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.052 0.941 . . . . 0.0 108.621 168.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.22 -64.73 0.82 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.82 -55.41 4.83 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -171.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -42.33 -53.19 4.27 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.371 -1.741 . . . . 0.0 113.717 172.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -37.94 78.85 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 t -65.78 -60.42 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -46.28 -47.55 18.23 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.513 1.525 . . . . 0.0 114.62 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -61.18 -51.15 70.22 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.322 1.049 . . . . 0.0 113.155 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.687 HD21 ' HB3' ' A' ' 25' ' ' GLU . 64.0 mt -69.15 -27.87 65.93 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 174.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.9 t -63.86 -34.63 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-O 118.957 -0.544 . . . . 0.0 110.738 170.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -62.18 -42.2 99.05 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 mp -57.55 -44.07 84.91 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.4 mtt -62.42 -18.9 62.79 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.6 -43.25 7.3 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -74.03 -39.36 63.6 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 18' ' ' PRO . 15.3 mt . . . . . 0 N--CA 1.47 0.546 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -171.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.566 ' HG2' ' HB3' ' A' ' 66' ' ' GLU . 7.3 mtm . . . . . 0 C--O 1.223 -0.342 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -107.6 109.18 20.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 125.395 1.685 . . . . 0.0 108.254 171.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -117.8 125.18 50.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.576 -170.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.46 ' HB3' HG11 ' A' ' 74' ' ' VAL . 33.1 tt0 -138.73 129.93 26.97 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.189 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.486 ' HB3' HG22 ' A' ' 60' ' ' VAL . 46.5 mt-10 -89.42 116.88 27.93 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.061 -175.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.07 119.86 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.749 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 m -86.17 112.45 21.34 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.732 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.05 122.05 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 114.684 -1.143 . . . . 0.0 110.083 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.4 p -107.23 -0.4 22.66 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.22 117.76 43.08 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.133 0.973 . . . . 0.0 111.723 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HA ' ' HB3' ' A' ' 57' ' ' GLN . 85.0 Cg_exo -49.67 -41.94 44.36 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 124.75 3.634 . . . . 0.0 114.49 -174.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -57.77 -40.82 80.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.17 50.83 6.05 Favored Glycine 0 CA--C 1.55 2.252 0 O-C-N 123.757 0.661 . . . . 0.0 113.788 -169.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.8 mt 58.81 59.76 2.74 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 126.241 1.816 . . . . 0.0 115.03 175.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.254 28.1 p80 -41.27 -97.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 119.091 2.997 . . . . 0.0 119.091 -163.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.5 p -108.49 -64.9 1.18 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.842 0.857 . . . . 0.0 111.214 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 22.0 ttt180 -51.71 -51.97 65.09 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 125.988 1.715 . . . . 0.0 113.67 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 52.9 Cg_exo -64.96 -44.32 10.15 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.431 2.087 . . . . 0.0 113.407 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.65 -52.03 51.19 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 174.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.73 -45.96 92.25 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.411 ' OE1' ' HG2' ' A' ' 17' ' ' ARG . 55.1 mt-30 -61.59 -41.73 97.85 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.4 -53.23 60.6 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.09 0.869 . . . . 0.0 111.226 174.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.22 -43.42 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 123.663 0.785 . . . . 0.0 111.782 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -48.39 -56.24 8.68 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.57 0.748 . . . . 0.0 111.723 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.73 -40.83 72.54 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.88 -41.61 67.73 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.828 0.851 . . . . 0.0 113.281 172.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 69.8 mttt -70.04 -30.61 67.92 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 174.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.3 -29.44 74.9 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.911 1.243 . . . . 0.0 113.069 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -86.01 124.33 32.33 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.189 0.995 . . . . 0.0 112.557 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.0 p -65.65 -42.88 90.88 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.086 170.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.1 t -44.1 143.15 1.23 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.168 1.787 . . . . 0.0 112.228 162.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -95.27 136.26 35.83 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.056 0.932 . . . . 0.0 112.757 -173.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mm -115.28 101.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.213 -169.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.0 m -99.82 130.1 45.99 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.887 173.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 t -110.06 107.72 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 m -105.62 122.68 46.54 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.079 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 t -125.3 98.75 5.76 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.437 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 p30 32.47 85.97 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 112.007 -2.36 . . . . 0.0 116.251 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.56 -41.99 3.11 Favored Glycine 0 N--CA 1.478 1.484 0 CA-C-N 112.77 -2.013 . . . . 0.0 114.355 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -92.46 138.59 31.39 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.532 0.682 . . . . 0.0 112.248 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.0 p -116.9 135.62 53.58 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.549 1.14 . . . . 0.0 113.513 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.459 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -131.24 131.04 43.63 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.237 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 t -81.0 111.24 17.29 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.022 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.28 -26.21 64.75 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.324 -1.762 . . . . 0.0 114.631 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 91.9 mttt -61.69 -21.01 64.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 t -105.52 116.23 31.6 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.543 0.687 . . . . 0.0 110.809 167.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.8 tp -52.23 -46.31 65.65 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.386 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -50.95 -51.3 53.78 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.185 0.994 . . . . 0.0 112.359 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -63.31 -49.0 75.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 tp -54.08 -43.76 70.6 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.606 1.191 . . . . 0.0 112.468 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -65.16 -31.56 72.8 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 t -93.12 55.78 2.4 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 123.999 1.857 . . . . 0.0 112.142 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.459 HD22 ' HB3' ' A' ' 42' ' ' ALA . 8.5 tp -152.27 150.63 29.99 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.722 -175.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.14 76.62 2.13 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 124.231 0.92 . . . . 0.0 113.467 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.65 42.23 1.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.5 t -102.53 170.75 7.85 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.704 -1.589 . . . . 0.0 115.22 -158.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 11.9 pt20 -52.17 114.99 1.5 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.342 1.457 . . . . 0.0 113.831 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.93 -21.39 38.3 Favored Glycine 0 CA--C 1.543 1.802 0 CA-C-N 113.043 -1.89 . . . . 0.0 113.535 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.7 m -72.67 132.16 43.34 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.304 1.05 . . . . 0.0 112.86 -171.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 5' ' ' GLU . 8.7 p -86.0 110.81 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 113.156 -1.838 . . . . 0.0 108.326 164.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.07 129.04 59.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.709 -1.587 . . . . 0.0 110.896 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -91.56 107.66 19.36 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.24 -174.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.18 100.7 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -99.55 100.56 11.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 112.163 -2.289 . . . . 0.0 109.323 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.06 126.69 52.68 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.332 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.566 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 7.4 pt-20 -127.22 138.91 53.21 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.125 176.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.02 -141.58 16.97 Favored Glycine 0 N--CA 1.48 1.608 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.659 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -46.13 -86.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -174.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 72' ' ' LYS . 2.3 m-20 -82.25 48.46 1.27 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 174.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.275 10.8 pt-20 -58.34 -37.27 74.82 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -177.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -69.66 -59.59 2.86 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.645 0.778 . . . . 0.0 112.813 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 56.3 tttt -56.66 -47.9 78.75 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.915 1.686 . . . . 0.0 114.168 -176.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.99 -41.76 62.41 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.46 HG11 ' HB3' ' A' ' 4' ' ' GLN . 16.9 t -66.28 -55.52 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 123.753 0.658 . . . . 0.0 110.893 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -46.5 -49.63 18.18 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.319 1.448 . . . . 0.0 112.794 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -63.0 -50.63 69.97 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.619 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.6 mt -59.39 -37.96 79.3 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.09 -53.64 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.819 0.847 . . . . 0.0 111.173 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -61.13 -46.15 91.75 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.311 1.007 . . . . 0.0 111.733 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -53.66 -50.24 66.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.011 0.924 . . . . 0.0 111.73 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 32.5 mtp -58.17 -46.39 85.81 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.806 1.242 . . . . 0.0 112.903 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.28 -21.76 66.28 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.42 1.79 27.68 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.3 mt . . . . . 0 N--CA 1.48 1.065 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -169.459 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.8 mtm . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -127.14 114.54 17.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.252 0.97 . . . . 0.0 111.76 -173.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -123.53 121.57 35.99 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.59 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.01 158.8 31.26 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 113.787 -1.551 . . . . 0.0 112.053 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -104.25 122.22 44.94 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.563 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.43 129.44 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.749 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m -96.38 126.61 41.7 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.105 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.3 mm -76.26 108.46 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -99.94 -16.61 17.91 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.06 120.0 30.96 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.457 1.103 . . . . 0.0 112.891 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -63.5 -45.63 11.15 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.696 2.931 . . . . 0.0 113.914 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -71.53 -36.0 70.88 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.379 0.424 . . . . 0.0 112.14 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.05 179.98 18.02 Favored Glycine 0 N--CA 1.477 1.428 0 O-C-N 124.506 1.129 . . . . 0.0 110.706 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 85.5 mt -99.84 85.11 3.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.593 1.187 . . . . 0.0 110.88 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.74 -148.41 0.23 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 113.352 -1.749 . . . . 0.0 114.693 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 p -57.57 -55.92 28.64 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -168.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -57.14 -49.13 95.72 Favored Pre-proline 0 CA--C 1.557 1.235 0 CA-C-O 116.927 -1.511 . . . . 0.0 112.568 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -57.92 -50.3 10.64 Favored 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 122.909 2.406 . . . . 0.0 113.903 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.61 -49.33 75.27 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 118.046 -0.978 . . . . 0.0 112.616 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.78 76.94 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.117 0.967 . . . . 0.0 113.274 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -61.71 -51.31 68.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.972 0.909 . . . . 0.0 113.305 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -50.89 71.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.362 1.465 . . . . 0.0 111.832 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.71 -45.81 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.449 1.099 . . . . 0.0 111.616 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -55.73 -47.29 77.16 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.881 0.738 . . . . 0.0 111.408 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HG2' ' CD2' ' A' ' 76' ' ' HIS . 1.7 tp10 -69.25 -44.57 71.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.44 -39.79 73.71 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 48.7 mmtt -71.23 -38.79 71.96 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 172.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 -42.95 97.15 Favored Glycine 0 N--CA 1.479 1.512 0 O-C-N 125.294 1.621 . . . . 0.0 112.823 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -73.02 135.54 44.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.864 0.866 . . . . 0.0 110.124 168.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.8 p -67.61 -41.55 83.83 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.87 123.36 2.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.074 1.749 . . . . 0.0 115.099 172.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . 0.42 ' OE2' ' HG3' ' A' ' 45' ' ' LYS . 22.9 tp10 -81.74 132.0 35.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.908 0.861 . . . . 0.0 111.316 -177.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 mm -121.51 110.31 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 113.917 -1.492 . . . . 0.0 111.529 -168.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.2 m -102.07 117.6 35.14 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.156 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.5 t -108.72 96.17 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 113.372 -1.74 . . . . 0.0 106.395 -174.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -106.99 109.27 21.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.054 -168.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 t -106.5 109.2 21.06 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.766 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 p30 45.88 60.67 3.03 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.376 -1.738 . . . . 0.0 114.688 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.99 -28.87 2.16 Favored Glycine 0 N--CA 1.485 1.919 0 CA-C-N 114.29 -1.323 . . . . 0.0 114.877 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -75.21 105.55 6.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 122.101 0.953 . . . . 0.0 111.1 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.6 p -93.31 114.14 26.51 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.84 148.41 26.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 112.625 -2.079 . . . . 0.0 109.879 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.5 t -103.36 118.46 36.82 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.02 -29.14 56.75 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 125.241 1.588 . . . . 0.0 113.222 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 43.7 mmtt -63.03 -24.34 67.87 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.145 1.378 . . . . 0.0 114.251 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 t -115.49 117.05 29.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.815 0.446 . . . . 0.0 110.866 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 tp -49.98 -52.7 31.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.116 1.367 . . . . 0.0 112.719 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.08 -36.48 77.46 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.402 1.081 . . . . 0.0 112.745 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -77.59 -44.12 29.44 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.549 0.531 . . . . 0.0 112.047 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.2 tp -62.33 -39.61 93.65 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.636 0.774 . . . . 0.0 112.594 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -60.21 -37.0 78.95 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 t -90.38 59.68 4.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 123.538 1.637 . . . . 0.0 112.025 175.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -144.14 153.01 41.69 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.757 -2.02 . . . . 0.0 109.579 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.12 79.68 0.05 OUTLIER Glycine 0 N--CA 1.485 1.916 0 C-N-CA 124.604 1.097 . . . . 0.0 112.844 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 73.5 mt -100.13 42.56 1.1 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.222 1.01 . . . . 0.0 111.98 173.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -113.26 156.89 22.52 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 113.352 -1.749 . . . . 0.0 112.179 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -48.98 108.09 0.17 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.558 1.543 . . . . 0.0 114.2 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.02 -23.19 11.71 Favored Glycine 0 CA--C 1.548 2.125 0 CA-C-N 113.277 -1.783 . . . . 0.0 115.495 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -73.42 127.03 31.56 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 117.638 0.719 . . . . 0.0 112.358 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.65 140.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 121.837 0.827 . . . . 0.0 111.803 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.74 131.38 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.985 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.71 109.18 15.88 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.489 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.7 mm -91.43 96.69 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -104.58 113.73 27.5 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.74 1.275 . . . . 0.0 112.054 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.12 131.29 55.89 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.372 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.15 152.59 39.76 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.5 173.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.33 -152.35 19.21 Favored Glycine 0 N--CA 1.48 1.605 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.532 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -42.75 -61.88 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 -173.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -104.79 40.56 1.47 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.353 0.661 . . . . 0.0 112.315 -174.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -47.77 -48.48 30.08 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -75.05 -48.73 22.52 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.81 -39.35 77.4 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.117 1.367 . . . . 0.0 112.85 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.95 -61.22 2.43 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.918 173.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 78' ' ' VAL . 29.2 t -64.53 -41.69 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 118.384 -0.817 . . . . 0.0 111.216 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -51.2 -61.15 2.41 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.133 0.973 . . . . 0.0 112.375 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.453 ' CD2' ' HG2' ' A' ' 25' ' ' GLU . 67.1 t60 -69.44 -30.52 68.46 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.2 -34.95 79.19 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.06 1.134 . . . . 0.0 114.06 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 74' ' ' VAL . 63.0 t -65.82 -46.66 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 119.002 -0.523 . . . . 0.0 109.717 169.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -51.34 -49.59 61.1 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.042 0.937 . . . . 0.0 111.574 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mt -50.42 -62.11 1.78 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.631 1.173 . . . . 0.0 113.533 171.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 69.0 mtm -57.03 -36.04 70.01 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.97 -32.38 67.2 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -79.59 -17.96 52.7 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.2 mt . . . . . 0 N--CA 1.475 0.798 0 C-N-CA 123.713 0.805 . . . . 0.0 111.175 174.756 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -130.39 116.76 18.72 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.849 1.343 . . . . 0.0 111.391 -176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -123.72 140.93 52.5 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -135.71 139.84 43.97 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 125.089 1.493 . . . . 0.0 113.303 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -84.98 120.01 26.03 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.633 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.417 HG21 HG22 ' A' ' 78' ' ' VAL . 66.2 t -126.21 121.5 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.43 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -83.51 129.71 34.98 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.108 0.956 . . . . 0.0 110.619 170.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.8 mm -107.79 117.89 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . 0.408 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 21.9 p -111.45 -2.14 15.65 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.08 121.1 69.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 124.071 0.948 . . . . 0.0 111.947 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -57.78 -44.56 39.78 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 C-N-CA 123.403 2.735 . . . . 0.0 114.018 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -68.88 -34.73 75.91 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.87 -170.18 54.87 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.535 1.54 . . . . 0.0 114.56 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -79.58 74.35 6.24 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 123.24 1.495 . . . . 0.0 113.474 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -102.08 169.98 8.4 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.329 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.9 p 38.9 -104.48 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.507 1.923 . . . . 0.0 115.658 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -78.0 -44.26 2.29 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 115.553 -2.165 . . . . 0.0 112.948 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.528 ' HA ' HD22 ' A' ' 84' ' ' LEU . 15.8 Cg_exo -48.95 -46.88 23.44 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.621 2.214 . . . . 0.0 113.908 168.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.83 -54.8 40.71 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.251 0.621 . . . . 0.0 112.531 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.78 -40.85 69.86 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -57.07 -53.63 55.94 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.861 0.865 . . . . 0.0 113.126 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -61.18 -47.76 84.68 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.733 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 47' ' ' LEU . 83.0 t -57.49 -52.04 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.504 1.122 . . . . 0.0 112.048 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -60.44 -47.57 85.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.222 0.609 . . . . 0.0 111.742 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.62 -43.02 99.86 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 124.097 0.873 . . . . 0.0 112.55 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.411 ' O ' ' HE2' ' A' ' 45' ' ' LYS . . . -60.78 -43.01 98.6 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 171.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -61.16 -23.67 65.73 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.38 -30.66 49.02 Favored Glycine 0 CA--C 1.548 2.107 0 C-N-CA 124.535 1.064 . . . . 0.0 114.041 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -87.79 124.7 33.88 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 122.109 0.957 . . . . 0.0 112.578 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.6 p -71.36 -4.31 25.46 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 m -93.19 145.39 24.46 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.603 1.161 . . . . 0.0 108.6 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.55 131.16 34.24 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.5 0.667 . . . . 0.0 112.492 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.5 mm -120.89 118.48 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 112.976 -1.92 . . . . 0.0 108.834 -168.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 20.2 m -113.53 123.25 49.56 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 112.148 -2.297 . . . . 0.0 110.689 -173.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.9 t -99.0 90.45 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 113.52 -1.673 . . . . 0.0 106.49 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.8 m -97.52 112.89 24.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.066 -1.424 . . . . 0.0 112.516 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.3 t -111.49 98.0 7.14 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.184 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 p30 39.35 64.84 0.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 114.043 -1.435 . . . . 0.0 114.822 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.51 -49.9 2.93 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.432 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.02 112.89 2.79 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.295 1.038 . . . . 0.0 111.711 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.2 p -106.99 104.76 14.51 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.903 -1.499 . . . . 0.0 114.214 -171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.2 144.02 25.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.414 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.9 t -80.04 124.93 29.16 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.647 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.5 -26.42 63.44 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 125.009 1.443 . . . . 0.0 114.515 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 26' ' ' ALA . 92.2 mttt -83.04 27.47 0.55 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -169.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.5 t -145.2 118.27 8.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.777 1.231 . . . . 0.0 113.004 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.453 ' HA ' HG21 ' A' ' 23' ' ' VAL . 44.7 tp -56.74 -47.01 81.0 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.736 -1.574 . . . . 0.0 112.062 177.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -54.56 -51.54 64.93 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 117.961 -1.019 . . . . 0.0 112.07 171.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -58.34 -43.05 88.13 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.42 HD22 HG23 ' A' ' 23' ' ' VAL . 4.7 mp -63.89 -52.5 59.61 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 174.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -66.46 -27.81 68.1 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 t -79.26 -15.02 58.64 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -107.12 137.38 45.29 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.844 0.831 . . . . 0.0 109.415 -177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.43 71.11 0.65 Allowed Glycine 0 CA--C 1.541 1.681 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.659 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.05 71.91 10.87 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.751 0.786 . . . . 0.0 110.181 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -128.93 -157.56 0.83 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -162.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -66.5 102.43 0.89 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.74 1.616 . . . . 0.0 114.806 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . 0.408 ' H ' ' HA ' ' A' ' 9' ' ' THR . . . 86.64 39.85 7.49 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 112.84 -1.982 . . . . 0.0 112.328 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 m -105.72 114.73 29.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -95.19 112.03 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.397 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.6 112.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.212 -2.267 . . . . 0.0 111.838 -172.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -78.29 98.85 6.07 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.812 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.4 HG22 HG22 ' A' ' 74' ' ' VAL . 27.0 mm -76.35 107.89 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 113.747 -1.57 . . . . 0.0 108.126 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.559 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 23.1 t -101.35 138.47 38.33 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.851 -1.977 . . . . 0.0 111.671 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 74' ' ' VAL . . . -131.35 144.48 51.27 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.518 1.127 . . . . 0.0 112.832 174.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -143.38 140.18 30.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.148 167.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.98 -145.16 15.99 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 115.138 0.815 . . . . 0.0 115.138 173.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -55.44 -66.22 0.45 Allowed 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -169.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.25 23.07 10.57 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.777 1.231 . . . . 0.0 112.756 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -32.35 -59.46 0.3 Allowed 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 119.027 2.973 . . . . 0.0 119.027 -168.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -60.12 -54.67 43.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -58.77 -43.06 90.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.356 1.463 . . . . 0.0 111.953 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.01 -52.42 50.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.944 0.898 . . . . 0.0 112.658 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 65' ' ' ALA 0.263 17.5 t -71.61 -39.09 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.588 176.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -50.31 -50.96 49.13 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.396 1.078 . . . . 0.0 111.923 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -59.18 -53.38 58.92 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.751 1.221 . . . . 0.0 111.63 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.3 mt -57.69 -35.43 70.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.417 HG22 HG21 ' A' ' 6' ' ' VAL . 74.2 t -67.03 -46.35 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.987 0.915 . . . . 0.0 110.831 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -58.53 -48.41 80.95 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.463 0.477 . . . . 0.0 111.006 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.9 tp -51.94 -51.08 59.49 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.979 1.312 . . . . 0.0 112.387 175.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.0 mtt -53.12 -27.57 21.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.77 -28.24 16.71 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.57 -23.17 63.51 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 18' ' ' PRO . 52.6 mt . . . . . 0 N--CA 1.492 1.628 0 C-N-CA 124.163 0.985 . . . . 0.0 113.649 -177.055 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -123.73 137.17 54.74 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.895 1.372 . . . . 0.0 111.352 -171.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -128.45 141.52 51.37 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 125.376 1.673 . . . . 0.0 112.115 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -132.26 123.32 26.7 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.821 167.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HG2' HG22 ' A' ' 60' ' ' VAL . 11.9 tt0 -96.64 118.13 32.46 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.073 0.858 . . . . 0.0 110.817 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.5 m -118.13 134.0 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 112.81 -1.995 . . . . 0.0 113.246 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 m -89.64 86.75 6.79 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.404 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.6 mm -77.16 112.32 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.19 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 p -114.5 39.62 2.76 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 112.686 -2.052 . . . . 0.0 113.019 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -76.54 123.0 87.63 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.188 -172.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 98.9 Cg_exo -47.54 -47.14 18.71 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.89 3.727 . . . . 0.0 115.55 -173.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -102.56 -50.56 3.54 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 169.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.55 -157.1 15.28 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 124.575 1.172 . . . . 0.0 112.568 171.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 5.7 mp -93.13 75.72 4.66 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.83 1.3 . . . . 0.0 112.424 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -97.21 -152.23 0.38 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.232 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.6 p -42.96 -71.58 0.08 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -163.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -74.16 -44.04 6.11 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-O 116.152 -1.88 . . . . 0.0 114.766 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 73.2 Cg_exo -56.51 -43.58 53.98 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.579 2.186 . . . . 0.0 113.911 173.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.94 88.7 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.982 0.513 . . . . 0.0 112.308 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 -41.97 79.21 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -58.91 -45.88 89.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.188 0.995 . . . . 0.0 113.071 173.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -62.35 -48.67 78.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.39 1.076 . . . . 0.0 112.121 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 44' ' ' ALA . 91.2 t -57.63 -44.73 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.137 0.975 . . . . 0.0 111.962 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -54.17 -51.81 63.16 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.797 0.839 . . . . 0.0 111.125 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -69.67 -39.26 77.1 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -44.98 78.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.371 0.668 . . . . 0.0 112.117 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -61.46 -29.39 69.93 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.995 1.479 . . . . 0.0 114.995 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.6 -33.65 87.81 Favored Glycine 0 CA--C 1.544 1.882 0 C-N-CA 124.879 1.228 . . . . 0.0 113.126 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -85.67 139.39 31.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.027 0.931 . . . . 0.0 111.958 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 p -74.4 -45.99 43.21 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.052 172.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.3 m -53.43 144.14 17.54 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.127 1.371 . . . . 0.0 113.143 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -92.77 127.09 38.15 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.119 0.961 . . . . 0.0 112.999 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.531 HD11 ' HB1' ' A' ' 73' ' ' ALA . 37.2 mm -101.27 117.42 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.705 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -102.22 119.21 38.44 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 112.049 -2.342 . . . . 0.0 108.632 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.16 99.47 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 113.792 -1.549 . . . . 0.0 107.036 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -113.85 113.76 25.34 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.606 -171.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.2 t -119.87 115.06 23.07 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.697 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.282 24.1 p30 35.57 69.92 0.16 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 112.697 -2.047 . . . . 0.0 115.935 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.77 -36.62 3.24 Favored Glycine 0 CA--C 1.545 1.959 0 CA-C-N 112.594 -2.094 . . . . 0.0 114.784 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -78.89 102.3 8.16 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.9 p -84.85 115.29 22.67 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.39 -1.732 . . . . 0.0 114.16 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.83 138.61 45.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.171 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.1 t -90.22 102.14 14.86 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.788 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -51.13 -40.2 57.96 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -176.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -63.54 -12.27 31.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 22.7 t -109.13 121.19 44.61 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 173.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -53.47 -46.0 69.77 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.042 1.463 . . . . 0.0 112.285 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -57.63 -53.55 56.92 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.809 172.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 96.6 mttt -67.28 -31.37 71.64 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -176.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 tp -67.55 -55.38 13.66 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.126 0.57 . . . . 0.0 111.732 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.15 -30.32 71.49 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 49' ' ' LYS . 14.7 t -63.52 -16.58 61.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 173.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -96.52 129.21 43.93 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.51 88.1 0.43 Allowed Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.297 -176.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.24 90.73 4.94 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.188 0.518 . . . . 0.0 111.196 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -136.1 -145.99 0.23 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.772 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -88.35 115.12 25.63 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.18 40.67 2.39 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 112.614 -2.085 . . . . 0.0 113.617 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.6 m -115.58 104.95 12.23 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.45 HG22 ' HG2' ' A' ' 5' ' ' GLU . 4.8 p -85.46 105.12 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.46 123.89 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 111.582 -2.553 . . . . 0.0 113.077 -171.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 115.28 23.25 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 113.396 -1.729 . . . . 0.0 110.009 176.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.6 mm -98.39 103.93 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.3 t -116.31 130.56 56.84 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.097 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -119.24 141.15 49.18 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.87 130.01 46.31 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.181 -1.827 . . . . 0.0 113.218 169.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.27 -154.09 19.78 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 113.105 -1.861 . . . . 0.0 112.235 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -45.13 -71.25 0.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.253 1.821 . . . . 0.0 115.348 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -93.68 46.95 1.21 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.82 0.848 . . . . 0.0 112.414 -173.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -48.98 -60.6 2.63 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -62.55 -43.82 97.87 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -63.61 -52.46 60.78 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.126 0.97 . . . . 0.0 112.868 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -54.43 -40.5 68.39 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.43 -62.23 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.067 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -47.99 -53.07 17.34 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.106 1.763 . . . . 0.0 113.297 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -66.68 -41.16 88.56 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.1 mt -68.28 -36.17 78.98 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 172.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.39 -45.23 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.911 0.884 . . . . 0.0 110.204 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -52.34 -53.62 42.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.553 1.541 . . . . 0.0 111.018 173.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.5 tt -53.33 -55.84 21.52 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.204 1.002 . . . . 0.0 111.866 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.3 ttt -56.3 -48.64 76.25 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.013 1.325 . . . . 0.0 113.767 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.53 -29.12 68.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -99.18 14.65 28.68 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.7 mt . . . . . 0 N--CA 1.486 1.338 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -178.212 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -124.48 142.5 51.28 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.623 1.202 . . . . 0.0 111.236 -179.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -139.46 142.92 37.35 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.666 -1.606 . . . . 0.0 114.527 -174.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -131.23 124.16 29.99 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 125.621 1.826 . . . . 0.0 110.888 168.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -98.05 128.21 44.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.155 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 m -128.29 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.128 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -88.29 103.2 15.58 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.523 174.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.73 102.73 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.03 176.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -116.02 13.64 15.92 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 112.259 -2.246 . . . . 0.0 116.063 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.74 134.12 81.84 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 168.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.57 -53.54 3.73 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 125.135 3.89 . . . . 0.0 115.293 -169.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.27 -39.36 10.1 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 172.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.02 -88.17 0.98 Allowed Glycine 0 N--CA 1.483 1.781 0 O-C-N 124.495 1.122 . . . . 0.0 112.385 171.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 6.8 mp -112.43 73.46 0.82 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.867 1.318 . . . . 0.0 113.343 177.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -81.38 -165.04 0.86 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.928 169.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.8 p -53.31 -46.09 69.26 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -171.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.25 32.8 ttt180 -70.25 -54.8 8.74 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-O 116.689 -1.624 . . . . 0.0 114.274 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.456 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 98.0 Cg_exo -56.58 -38.22 95.94 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 122.343 2.029 . . . . 0.0 112.881 173.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.66 -56.05 25.89 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.65 -40.8 66.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 175.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.497 ' HB3' HD11 ' A' ' 80' ' ' LEU . 33.7 mt-30 -55.55 -58.47 7.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.516 1.127 . . . . 0.0 112.477 170.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -54.39 -49.4 69.98 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.73 1.269 . . . . 0.0 111.853 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.7 t -57.8 -53.39 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.084 1.353 . . . . 0.0 111.789 177.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -58.92 -48.84 80.05 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.033 0.833 . . . . 0.0 112.131 -177.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.61 -40.97 80.18 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.677 1.236 . . . . 0.0 112.696 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . 0.526 ' O ' ' HE2' ' A' ' 45' ' ' LYS . . . -58.34 -39.61 79.93 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 170.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' A' ' 45' ' ' LYS . 71.4 mttt -64.87 -32.01 73.51 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 175.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.46 -41.04 99.8 Favored Glycine 0 N--CA 1.487 2.092 0 O-C-N 124.587 1.179 . . . . 0.0 112.034 169.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -70.7 120.63 16.59 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.705 0.764 . . . . 0.0 112.799 174.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.8 p -62.26 -38.05 87.79 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.359 -1.292 . . . . 0.0 112.216 174.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.1 m -61.35 153.58 26.37 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 126.634 1.973 . . . . 0.0 111.352 175.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -96.52 137.08 36.13 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 122.086 0.946 . . . . 0.0 111.885 -175.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.451 HG21 HD13 ' A' ' 77' ' ' LEU . 13.7 mm -118.29 106.32 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.179 -166.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.2 m -99.25 134.48 42.05 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.436 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 47.3 t -119.66 110.57 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 113.582 -1.644 . . . . 0.0 107.338 177.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.7 m -115.53 119.87 37.61 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t -111.92 99.8 8.39 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.428 171.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 p30 36.38 85.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.94 -41.41 2.19 Favored Glycine 0 N--CA 1.484 1.887 0 CA-C-N 114.265 -1.334 . . . . 0.0 115.097 177.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.09 123.08 36.1 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.758 0.79 . . . . 0.0 111.619 177.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.0 p -113.08 153.44 28.16 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -173.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -114.99 152.93 31.56 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 111.987 -2.37 . . . . 0.0 112.55 -176.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 49' ' ' LYS . 26.5 t -105.86 105.85 16.08 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.054 175.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.58 -32.87 72.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 125.245 1.59 . . . . 0.0 115.139 -170.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.532 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 91.3 mttt -71.32 19.09 0.06 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 176.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 t -145.16 126.15 14.53 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.958 0.903 . . . . 0.0 111.077 176.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.99 -53.18 56.53 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.238 0.961 . . . . 0.0 113.041 173.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -54.42 -60.27 3.56 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.625 0.77 . . . . 0.0 112.061 172.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 7.0 mttm -68.34 -17.88 64.36 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -173.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.49 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 27.8 tp -81.3 -65.8 0.97 Allowed 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.396 1.06 . . . . 0.0 111.667 164.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -63.45 -19.45 64.73 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -171.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . 0.458 HG23 HD12 ' A' ' 53' ' ' LEU . 9.2 t -51.25 -29.27 13.96 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 168.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 42' ' ' ALA . 9.4 mp -84.71 139.34 32.07 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.784 1.234 . . . . 0.0 110.499 171.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.48 75.23 1.99 Allowed Glycine 0 CA--C 1.541 1.667 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.419 177.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.421 ' HA ' HG21 ' A' ' 59' ' ' THR . 7.3 mt -81.05 79.13 7.78 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.475 1.131 . . . . 0.0 109.459 176.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -129.83 -155.37 0.69 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.272 -1.785 . . . . 0.0 110.942 -165.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -77.87 120.5 22.84 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.672 -0.643 . . . . 0.0 111.705 172.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.72 35.52 8.39 Favored Glycine 0 N--CA 1.487 2.073 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.419 -178.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.421 HG21 ' HA ' ' A' ' 55' ' ' LEU . 22.9 m -109.53 91.89 3.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -74.43 103.49 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.223 167.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.67 137.43 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-N 111.502 -2.59 . . . . 0.0 112.168 -173.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.57 128.68 45.68 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.073 -1.422 . . . . 0.0 110.262 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mm -101.6 108.36 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 m -113.54 128.39 56.42 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 125.845 1.966 . . . . 0.0 111.809 -176.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.06 122.68 44.84 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.641 177.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -114.85 136.82 52.67 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.24 175.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.05 -131.03 8.26 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.546 175.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.4 -66.77 0.58 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.064 1.346 . . . . 0.0 113.574 -172.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 72' ' ' LYS . 73.9 m-20 -92.88 49.69 1.47 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.975 0.91 . . . . 0.0 111.763 -172.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -54.0 -45.24 71.42 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -68.78 -62.03 1.56 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.698 0.799 . . . . 0.0 111.359 173.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 62.6 tttm -48.15 -51.69 23.84 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.804 2.042 . . . . 0.0 113.656 -176.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.23 82.4 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.94 -53.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.17 178.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -48.48 -50.36 31.94 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.985 1.314 . . . . 0.0 112.508 176.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -65.15 -41.43 94.75 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.189 1.395 . . . . 0.0 113.279 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 33' ' ' ILE . 11.3 mt -80.28 -24.47 40.01 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 177.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.91 -41.72 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 168.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -52.57 -50.64 62.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.64 1.176 . . . . 0.0 110.889 169.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 21' ' ' GLN . 6.0 tt -53.6 -49.97 66.64 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.412 1.085 . . . . 0.0 113.01 171.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.4 mtt -64.05 -29.55 70.68 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 176.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.57 -51.3 24.13 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 174.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.1 60.37 4.86 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.462 1.105 . . . . 0.0 112.371 -174.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.479 1.005 0 C-N-CA 124.272 1.029 . . . . 0.0 113.75 -179.481 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.672 ' HG3' ' HG2' ' A' ' 66' ' ' GLU . 18.5 ttt . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.18 142.13 50.16 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 125.829 1.956 . . . . 0.0 111.678 -177.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.97 151.53 49.11 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.77 1.293 . . . . 0.0 113.371 176.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -142.61 128.28 19.22 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.135 167.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.552 ' HB3' HG12 ' A' ' 60' ' ' VAL . 50.0 mt-10 -91.06 109.95 21.21 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.006 174.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 p -118.74 115.75 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.719 -174.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -68.53 114.66 7.13 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.481 177.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.73 100.05 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 122.285 1.041 . . . . 0.0 110.289 174.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -76.84 -22.44 53.54 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 112.144 -2.298 . . . . 0.0 115.191 172.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -57.84 118.25 24.93 Favored Pre-proline 0 C--O 1.245 0.839 0 C-N-CA 124.518 1.127 . . . . 0.0 110.924 177.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 68.8 Cg_exo -55.59 -53.31 5.86 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 124.194 3.263 . . . . 0.0 111.872 -172.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -62.8 -52.52 62.85 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.764 1.626 . . . . 0.0 112.531 170.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.91 -156.18 16.97 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 124.57 1.081 . . . . 0.0 111.558 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.596 ' HG ' ' HB2' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -113.89 84.95 2.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.962 1.363 . . . . 0.0 110.086 -173.732 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -81.94 -165.8 1.08 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.996 -1.457 . . . . 0.0 113.991 178.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.0 p -53.38 -49.28 67.54 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -166.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.776 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.439 15.8 ptt-85 -65.36 -47.3 70.26 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-O 115.795 -2.05 . . . . 0.0 116.471 178.155 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.776 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 73.8 Cg_exo -65.84 -39.36 20.14 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.832 1.688 . . . . 0.0 113.209 169.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.22 79.76 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.39 86.01 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 172.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -56.68 -45.14 81.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.153 0.981 . . . . 0.0 112.558 174.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -56.99 -47.61 80.41 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.744 1.618 . . . . 0.0 111.897 175.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 44' ' ' ALA . 97.0 t -65.33 -43.2 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 123.786 0.835 . . . . 0.0 112.522 175.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -58.37 -41.95 85.93 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.197 0.599 . . . . 0.0 111.34 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.55 -52.96 48.55 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 125.054 1.471 . . . . 0.0 111.868 169.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.81 -38.49 64.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -178.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -75.76 10.95 1.52 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 174.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.04 -17.57 40.09 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 124.572 1.17 . . . . 0.0 112.389 163.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -96.24 125.56 40.84 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.152 0.977 . . . . 0.0 108.973 179.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.4 p -62.4 -35.73 80.11 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.987 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.8 m -53.84 150.73 7.19 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.597 1.959 . . . . 0.0 114.973 176.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -80.83 89.77 5.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.719 173.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.496 HD13 ' HB3' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -73.94 98.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 109.822 -3.354 . . . . 0.0 114.288 175.903 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.8 m -104.01 128.58 51.59 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 112.261 -2.245 . . . . 0.0 109.512 -178.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.5 t -114.52 107.54 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 114.035 -1.439 . . . . 0.0 108.455 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.405 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 60.4 m -108.69 104.29 13.55 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.88 -176.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.6 p -90.37 54.64 2.81 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 113.797 -1.547 . . . . 0.0 113.548 -177.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.6 m120 48.89 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 123.672 1.701 . . . . 0.0 114.758 -174.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.91 -32.62 6.43 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 112.481 -2.145 . . . . 0.0 114.055 -178.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -111.58 132.93 54.2 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.373 0.669 . . . . 0.0 109.287 -177.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -123.13 134.84 54.18 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 122.183 0.992 . . . . 0.0 111.808 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -134.74 125.69 27.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 113.692 -1.595 . . . . 0.0 111.992 174.149 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.0 t -68.58 122.26 18.11 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.725 171.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.496 ' HB3' HD13 ' A' ' 33' ' ' ILE . . . -74.76 13.2 0.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.344 -1.298 . . . . 0.0 114.126 176.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -77.57 -7.72 56.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 169.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.4 t -133.46 133.66 42.57 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.377 1.071 . . . . 0.0 112.381 174.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -57.44 -53.25 60.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.116 1.366 . . . . 0.0 111.131 177.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -56.55 -34.41 67.04 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.107 -1.406 . . . . 0.0 114.559 176.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -58.57 -53.32 59.71 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 175.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.04 -32.88 61.66 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 176.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.94 -14.88 63.3 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 p -106.13 18.59 21.81 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 167.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.497 HD22 ' HB3' ' A' ' 42' ' ' ALA . 14.2 tp -114.81 120.89 41.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.53 70.51 1.93 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.393 -175.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 mt -75.9 94.55 3.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.898 176.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -142.33 -174.65 4.18 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -43.05 136.07 2.93 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.884 2.474 . . . . 0.0 113.83 -176.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.05 -32.16 3.57 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 113.481 -1.69 . . . . 0.0 115.71 175.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.2 p -59.37 120.2 8.86 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' A' ' 5' ' ' GLU . 4.9 t -90.34 77.4 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.87 113.37 14.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 112.518 -2.128 . . . . 0.0 112.692 -169.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.405 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 0.7 OUTLIER -71.51 94.77 1.31 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.716 176.381 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.48 103.97 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 167.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -115.67 133.7 55.77 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 112.342 -2.208 . . . . 0.0 110.922 -176.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.65 120.06 25.85 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.27 0.981 . . . . 0.0 112.721 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.672 ' HG2' ' HG3' ' A' ' 1' ' ' MET . 38.6 mt-10 -115.25 118.05 32.2 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.336 -1.756 . . . . 0.0 111.697 -178.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.25 -151.63 21.94 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.314 -178.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.52 -67.91 0.43 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -176.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -80.95 40.51 0.54 Allowed 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -178.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.569 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 7.5 pt-20 -46.7 -62.82 1.21 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.462 1.905 . . . . 0.0 115.569 -176.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.569 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 97.0 mt-30 -64.83 -40.63 95.49 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.676 1.19 . . . . 0.0 113.309 -178.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -59.71 -48.5 81.41 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.177 0.991 . . . . 0.0 111.158 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.68 67.84 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.212 0.945 . . . . 0.0 112.918 175.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.9 -53.86 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.289 0.636 . . . . 0.0 111.302 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -50.92 -50.8 56.81 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.01 1.324 . . . . 0.0 111.507 -178.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.95 -61.05 2.86 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.972 1.309 . . . . 0.0 111.61 177.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.63 -36.66 81.38 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -175.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.06 -47.72 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.342 0.657 . . . . 0.0 111.67 176.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -59.2 -50.08 75.41 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 123.709 0.631 . . . . 0.0 111.655 175.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.0 tp -52.27 -51.61 57.47 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.428 1.491 . . . . 0.0 112.426 175.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.4 tpp -52.2 -52.41 52.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.634 1.574 . . . . 0.0 113.002 173.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.16 -28.33 66.33 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.96 -20.13 24.86 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 178.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.6 mt . . . . . 0 N--CA 1.48 1.038 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.512 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.494 ' HG2' ' HG2' ' A' ' 66' ' ' GLU . 4.2 tmm? . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -141.07 140.05 34.15 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.539 1.149 . . . . 0.0 111.652 173.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -132.27 155.82 47.64 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.722 1.264 . . . . 0.0 113.775 176.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . 0.643 ' HB3' HG21 ' A' ' 78' ' ' VAL . 7.3 tp-100 -141.65 125.46 17.02 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 124.563 1.165 . . . . 0.0 113.811 165.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -81.43 106.19 13.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.871 174.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.7 p -124.33 140.12 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.913 -177.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 p -99.94 129.01 45.97 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.129 178.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.86 122.38 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.429 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -77.96 -35.17 50.57 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 125.655 1.847 . . . . 0.0 114.472 176.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.79 123.4 81.47 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 124.472 1.109 . . . . 0.0 113.208 -174.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.86 -50.47 13.97 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.86 3.04 . . . . 0.0 112.022 174.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -62.29 -39.23 92.29 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 169.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.97 -136.04 12.64 Favored Glycine 0 N--CA 1.481 1.672 0 C-N-CA 124.342 0.973 . . . . 0.0 111.9 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.404 ' HG ' ' HB2' ' A' ' 18' ' ' PRO . 2.5 mp -115.53 75.14 0.92 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.16 0.981 . . . . 0.0 112.521 174.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -75.55 -153.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 113.388 -1.733 . . . . 0.0 111.773 174.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.1 p -57.75 -61.1 2.76 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -167.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.357 20.7 ptt-85 -68.9 -38.38 11.3 Favored Pre-proline 0 N--CA 1.48 1.062 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 59.5 Cg_endo -75.75 -37.08 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 CA-C-N 122.816 2.041 . . . . 0.0 113.747 173.225 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.41 98.87 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 169.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.81 -44.04 73.48 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 172.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -63.18 -47.14 83.86 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.569 0.543 . . . . 0.0 112.442 174.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE2' ' HG3' ' A' ' 81' ' ' MET . 38.3 t80 -60.74 -47.74 84.93 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -51.83 -48.95 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.405 1.082 . . . . 0.0 111.765 175.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -54.48 -49.16 70.78 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.831 0.707 . . . . 0.0 111.414 179.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.07 -49.59 67.08 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.591 1.182 . . . . 0.0 110.959 -178.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.35 -42.05 77.13 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 175.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -58.44 -31.7 68.0 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.822 0.849 . . . . 0.0 112.615 176.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.74 5.55 74.27 Favored Glycine 0 CA--C 1.544 1.901 0 O-C-N 124.919 1.387 . . . . 0.0 115.369 -176.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -104.83 141.78 35.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.517 0.658 . . . . 0.0 110.212 169.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -45.19 81.43 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 119.002 -0.523 . . . . 0.0 111.588 176.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.5 m -52.88 136.61 34.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.129 1.772 . . . . 0.0 113.512 179.205 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.78 112.77 10.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 167.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.9 mt -104.02 120.37 54.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 112.838 -1.983 . . . . 0.0 108.88 -174.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.7 m -123.32 133.37 54.15 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 112.235 -2.257 . . . . 0.0 110.713 -176.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.425 HG13 ' CG2' ' A' ' 61' ' ' VAL . 21.9 t -118.11 108.15 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 110.929 -2.85 . . . . 0.0 107.15 -169.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.7 m -112.54 103.23 11.29 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 112.876 -1.966 . . . . 0.0 113.035 -175.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.2 p -90.6 89.47 7.55 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 112.991 -1.913 . . . . 0.0 111.53 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.6 m120 50.93 63.26 2.31 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 123.406 1.574 . . . . 0.0 114.047 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.69 -25.66 6.43 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-N 113.724 -1.58 . . . . 0.0 115.698 -176.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -84.5 121.02 27.0 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 177.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -111.19 139.32 46.67 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -172.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.99 145.31 29.69 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.634 166.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.0 t -71.26 119.43 15.39 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.999 171.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.554 ' HA ' HD13 ' A' ' 50' ' ' LEU . . . -58.78 -30.69 67.76 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.083 -1.872 . . . . 0.0 112.908 174.069 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -74.44 15.06 0.38 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 176.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.4 t -133.36 138.94 46.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.166 0.986 . . . . 0.0 111.572 170.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.8 tp -66.72 -62.36 1.49 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 111.713 -2.494 . . . . 0.0 110.188 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -50.27 -55.62 14.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.524 1.529 . . . . 0.0 111.224 176.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -58.56 -53.86 53.59 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 44' ' ' ALA . 11.4 tp -64.79 -46.97 79.81 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -179.111 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -57.07 -37.79 72.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 174.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.7 p -86.19 -10.1 55.33 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.47 120.81 22.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.911 0.863 . . . . 0.0 108.869 164.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.94 89.3 0.24 Allowed Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.054 1.311 . . . . 0.0 113.558 -176.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.59 HD13 ' HE1' ' A' ' 81' ' ' MET . 58.2 mt -106.0 103.88 13.47 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.571 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -130.75 177.22 7.57 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.67 -1.15 . . . . 0.0 113.046 -177.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -43.18 120.9 1.98 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.483 1.913 . . . . 0.0 114.03 177.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.64 -14.1 14.47 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 117.796 1.878 . . . . 0.0 117.796 177.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.6 m -58.9 129.17 40.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.107 1.454 . . . . 0.0 111.278 -179.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.22 93.56 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 113.221 -1.809 . . . . 0.0 107.843 -174.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.425 ' CG2' HG13 ' A' ' 35' ' ' VAL . 8.7 p -100.1 111.85 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 113.028 -1.896 . . . . 0.0 112.794 -176.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 m -81.68 102.27 10.6 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.737 175.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.2 mt -87.36 103.3 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 172.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.2 t -115.58 146.24 41.94 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.813 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.43 132.79 44.6 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.685 1.24 . . . . 0.0 113.734 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HG2' ' HG2' ' A' ' 1' ' ' MET . 46.3 mt-10 -121.3 110.44 16.13 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 112.871 -1.968 . . . . 0.0 112.54 177.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.58 -124.84 1.28 Allowed Glycine 0 CA--C 1.536 1.403 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.85 171.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -103.17 -53.38 2.83 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.599 -1.3 . . . . 0.0 113.631 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -88.92 46.74 1.42 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 175.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.2 pt-20 -55.38 -63.64 1.1 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.352 -1.749 . . . . 0.0 115.485 -178.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.414 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 35.3 mt-30 -67.78 -43.32 80.03 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -52.43 -47.7 66.22 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.781 1.301 . . . . 0.0 112.157 173.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.97 -50.63 67.82 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.65 0.78 . . . . 0.0 112.931 177.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.46 -52.57 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.985 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -48.97 -54.52 15.24 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.329 1.452 . . . . 0.0 111.518 177.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -56.66 -46.39 81.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.347 1.459 . . . . 0.0 113.121 -178.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.53 -36.03 26.72 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -176.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.643 HG21 ' HB3' ' A' ' 4' ' ' GLN . 13.3 t -61.39 -41.33 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.438 0.695 . . . . 0.0 110.745 172.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -63.27 -50.04 71.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 172.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.6 tp -54.43 -51.9 63.47 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.738 0.649 . . . . 0.0 112.667 175.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.59 ' HE1' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -59.82 -36.69 77.31 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 176.648 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.43 89.93 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 174.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.04 -30.74 44.29 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.7 mt . . . . . 0 N--CA 1.486 1.367 0 C-N-CA 123.504 0.722 . . . . 0.0 112.396 178.533 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tmm? . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -121.08 133.69 55.24 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.335 1.647 . . . . 0.0 107.677 175.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -134.9 136.96 42.75 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.803 -1.544 . . . . 0.0 112.667 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -125.85 116.11 21.04 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.844 175.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -81.14 100.39 9.04 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.122 -2.308 . . . . 0.0 108.499 175.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.6 140.18 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.486 -172.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -73.34 152.08 41.02 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 123.039 1.4 . . . . 0.0 113.242 173.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 mt -85.58 110.39 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 164.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -88.09 -21.61 24.61 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 112.823 -1.99 . . . . 0.0 115.376 -175.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 121.14 56.92 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.091 1.356 . . . . 0.0 112.598 174.524 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -60.34 -52.45 4.01 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.277 2.651 . . . . 0.0 115.509 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -67.61 -31.8 72.09 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.95 158.35 32.98 Favored Glycine 0 N--CA 1.481 1.674 0 O-C-N 124.525 1.141 . . . . 0.0 112.564 168.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.9 mp -78.73 72.44 5.25 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 122.622 1.201 . . . . 0.0 112.92 -175.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -67.19 -167.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.97 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 p -46.24 -48.86 17.78 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 -174.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.475 35.9 ptt180 -78.22 -39.44 1.74 Allowed Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 177.618 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 79.8 Cg_exo -59.51 -39.2 77.66 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 121.836 1.69 . . . . 0.0 112.055 169.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.46 -42.02 98.13 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 173.202 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.19 -44.15 97.24 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.459 HE22 HD21 ' A' ' 84' ' ' LEU . 56.6 tt0 -53.98 -49.76 68.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.057 1.343 . . . . 0.0 111.424 172.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -59.85 -36.14 76.23 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.126 -1.397 . . . . 0.0 114.054 175.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 19' ' ' ALA . 97.1 t -64.25 -46.73 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.114 0.566 . . . . 0.0 111.902 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.52 -49.86 63.97 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.668 0.787 . . . . 0.0 109.78 177.003 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -60.35 -47.29 86.69 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.54 1.536 . . . . 0.0 113.611 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.44 94.03 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 176.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -63.5 -30.84 71.9 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.003 0.921 . . . . 0.0 112.587 174.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.0 -21.79 61.78 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.916 1.722 . . . . 0.0 115.081 175.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -95.2 155.18 16.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.944 0.898 . . . . 0.0 112.734 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.6 p -78.8 -46.32 19.01 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 117.642 -1.17 . . . . 0.0 112.128 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -54.83 139.13 40.93 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.835 1.254 . . . . 0.0 110.449 175.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -78.94 110.11 13.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.963 175.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' SER . 2.9 mp -84.61 121.92 37.38 Favored 'Isoleucine or valine' 0 C--O 1.248 0.996 0 CA-C-N 110.751 -2.932 . . . . 0.0 112.149 175.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.3 m -116.54 132.67 56.62 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-N 111.43 -2.623 . . . . 0.0 109.017 174.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.558 HG13 HG21 ' A' ' 61' ' ' VAL . 6.0 t -113.41 93.32 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.821 -1.99 . . . . 0.0 107.727 -176.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -87.81 94.79 9.86 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.596 -178.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 t -92.98 95.65 9.61 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.956 -176.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . 0.566 HD21 ' HB ' ' A' ' 60' ' ' VAL . 12.7 m120 32.53 81.0 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.759 1.623 . . . . 0.0 114.811 -168.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.11 -49.29 4.2 Favored Glycine 0 N--CA 1.481 1.697 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.235 -174.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -67.27 102.12 1.02 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -177.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.0 m -91.61 100.36 13.1 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.377 -177.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.762 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -113.37 143.02 45.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.98 1.371 . . . . 0.0 111.81 174.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.4 t -61.58 121.23 12.24 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 112.802 -1.999 . . . . 0.0 111.374 175.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.83 -23.68 64.28 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.929 166.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -79.75 -17.68 52.91 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 176.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 t -107.95 120.54 42.58 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 177.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.2 mt -50.6 -62.84 1.36 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 112.872 -1.967 . . . . 0.0 113.875 -178.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -66.37 -13.0 59.97 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -177.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 68.7 mmtt -97.31 -37.25 10.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.367 178.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 50' ' ' LEU . 13.0 tp -75.37 -43.64 49.24 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 170.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -58.02 -23.75 55.46 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 176.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.8 p -95.06 -14.1 24.58 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 177.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.762 HD22 ' HB3' ' A' ' 42' ' ' ALA . 25.2 tp -77.51 134.65 38.26 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.189 0.995 . . . . 0.0 111.833 -176.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.39 82.26 0.02 OUTLIER Glycine 0 N--CA 1.481 1.652 0 CA-C-N 113.824 -1.534 . . . . 0.0 112.731 169.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.5 mt -102.1 78.71 1.8 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.686 -1.257 . . . . 0.0 109.811 171.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 t -125.74 169.53 12.47 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -174.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -47.26 118.03 1.99 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.56 1.544 . . . . 0.0 112.671 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.59 -29.87 11.45 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 112.625 -2.079 . . . . 0.0 113.923 175.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 m -66.4 118.49 10.12 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.981 0.896 . . . . 0.0 111.208 -173.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' HD21 ' A' ' 38' ' ' ASN . 61.5 t -77.06 107.51 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 112.419 -2.173 . . . . 0.0 109.261 -178.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.558 HG21 HG13 ' A' ' 35' ' ' VAL . 12.6 p -107.86 118.86 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 113.353 -1.748 . . . . 0.0 111.409 -178.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 m -84.3 100.67 11.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.918 174.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mt -78.16 110.8 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.23 172.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 13.7 t -119.71 139.49 52.17 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.378 1.049 . . . . 0.0 112.089 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.21 112.71 17.38 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 125.131 1.519 . . . . 0.0 110.93 175.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -109.01 101.24 10.34 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 112.574 -2.103 . . . . 0.0 110.26 -176.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.36 -159.03 24.67 Favored Glycine 0 N--CA 1.48 1.567 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.727 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -39.21 -84.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 -174.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -72.75 45.03 0.14 Allowed 'General case' 0 C--O 1.256 1.417 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -49.6 -61.17 2.26 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -177.015 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -65.78 -45.15 83.56 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -62.43 -40.49 96.72 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 113.897 -1.501 . . . . 0.0 113.166 178.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.23 -52.91 61.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.696 0.398 . . . . 0.0 111.964 -177.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 78' ' ' VAL . 61.3 t -56.43 -61.46 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.419 175.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -42.6 -56.88 2.92 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.895 1.278 . . . . 0.0 113.077 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -53.91 -47.34 71.27 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.44 1.496 . . . . 0.0 113.675 177.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.1 mt -73.45 -30.65 63.33 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 74' ' ' VAL . 12.3 t -64.2 -44.31 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -61.22 -42.9 99.4 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 176.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.28 -62.09 2.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.569 172.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 60.0 ttm -49.58 -46.9 49.58 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.96 1.304 . . . . 0.0 113.277 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.19 92.68 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -178.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.34 6.28 49.12 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 125.114 1.509 . . . . 0.0 114.711 -175.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.459 HD21 HE22 ' A' ' 21' ' ' GLN . 16.0 mt . . . . . 0 N--CA 1.479 1.01 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 172.301 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.518 ' HG2' ' HG2' ' A' ' 66' ' ' GLU . 10.0 tmm? . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -122.61 139.65 53.69 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.017 0.823 . . . . 0.0 111.491 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -123.95 147.22 47.91 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 113.942 -1.481 . . . . 0.0 111.377 178.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -137.55 134.22 35.39 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.539 1.15 . . . . 0.0 110.557 162.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -97.84 112.17 24.18 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.717 1.26 . . . . 0.0 108.813 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.36 151.83 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.169 -174.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.8 p -106.41 151.68 24.6 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 176.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.507 HD13 ' HB ' ' A' ' 59' ' ' THR . 4.5 mp -81.09 119.91 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -99.21 -38.65 8.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 112.593 -2.094 . . . . 0.0 114.629 -174.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.16 126.13 14.9 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.916 1.286 . . . . 0.0 113.062 176.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HA ' HE21 ' A' ' 57' ' ' GLN . 87.2 Cg_exo -49.69 -33.85 33.19 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 125.165 3.91 . . . . 0.0 115.035 -177.165 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -96.89 -70.63 0.71 Allowed 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.288 0.992 . . . . 0.0 111.539 171.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.42 -174.52 20.33 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 123.688 0.661 . . . . 0.0 113.397 173.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.68 73.53 1.51 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 122.79 1.281 . . . . 0.0 113.471 -179.02 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -73.99 -174.15 1.79 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.705 -1.588 . . . . 0.0 113.268 177.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -40.65 -48.37 2.91 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -171.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.265 48.0 mtm105 -82.97 -47.45 0.83 Allowed Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -175.346 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.23 -36.38 68.95 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 122.592 2.195 . . . . 0.0 113.795 168.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.61 91.85 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 171.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.5 -42.57 82.99 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 173.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -60.26 -49.72 76.5 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 172.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -57.01 -44.95 83.31 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.945 0.898 . . . . 0.0 112.068 177.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.417 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 92.4 t -56.41 -49.52 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.488 0.715 . . . . 0.0 111.67 174.123 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -51.16 -48.58 61.84 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.209 0.943 . . . . 0.0 112.493 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -64.58 -56.48 13.67 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.285 0.991 . . . . 0.0 112.078 175.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.74 -34.19 51.58 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -179.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 28.6 mtpp -55.18 -28.02 49.98 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 173.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.01 16.53 60.26 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 124.202 0.938 . . . . 0.0 115.405 -175.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -111.23 145.14 39.25 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.813 0.845 . . . . 0.0 109.318 169.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.4 p -63.81 -43.68 95.52 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.4 m -57.23 148.51 22.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.159 1.784 . . . . 0.0 112.588 176.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.73 104.35 14.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.837 1.304 . . . . 0.0 109.132 174.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.532 HD12 ' H ' ' A' ' 33' ' ' ILE . 2.6 mp -78.58 110.12 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 111.363 -2.653 . . . . 0.0 111.186 -175.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.4 m -90.18 95.45 10.21 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 112.879 -1.964 . . . . 0.0 108.137 176.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.6 t -84.4 99.35 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 112.418 -2.174 . . . . 0.0 107.348 178.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -96.35 104.4 16.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.346 -176.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -105.79 100.88 10.42 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.302 -175.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.5 m120 37.61 81.01 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.532 1.933 . . . . 0.0 115.404 -169.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.35 -39.13 1.43 Allowed Glycine 0 CA--C 1.544 1.887 0 CA-C-N 113.212 -1.813 . . . . 0.0 114.953 -178.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -89.15 125.59 35.11 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.649 0.78 . . . . 0.0 111.674 -174.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -111.92 142.5 44.23 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.568 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -140.56 142.61 35.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.207 -1.36 . . . . 0.0 114.247 173.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -61.85 117.77 6.33 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.573 171.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 50' ' ' LEU . . . -61.04 -16.44 43.56 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.621 174.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -91.77 5.17 50.86 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -176.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 38.3 t -127.72 128.39 45.31 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.95 0.9 . . . . 0.0 112.022 -178.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 67.7 mt -55.44 -59.85 4.24 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.276 -1.784 . . . . 0.0 111.989 175.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -53.16 -45.33 68.41 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.666 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.55 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 42.7 mmtt -62.9 -56.2 19.38 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.96 0.787 . . . . 0.0 112.989 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -70.65 -38.32 73.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -178.817 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -65.22 -11.73 43.89 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.4 p -119.44 9.78 11.68 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 173.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 42' ' ' ALA . 43.5 tp -84.83 149.5 25.66 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.749 0.82 . . . . 0.0 109.145 176.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.78 68.23 0.3 Allowed Glycine 0 CA--C 1.543 1.792 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.556 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.6 mt -102.75 82.96 2.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.123 0.969 . . . . 0.0 111.43 178.039 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.5 t -132.33 164.29 26.77 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.152 -1.84 . . . . 0.0 110.126 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.411 HE21 ' HA ' ' A' ' 11' ' ' PRO . 4.1 tp-100 -48.97 136.41 14.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.326 1.05 . . . . 0.0 113.004 177.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.24 -28.13 5.83 Favored Glycine 0 N--CA 1.483 1.823 0 CA-C-N 113.93 -1.487 . . . . 0.0 115.203 175.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.507 ' HB ' HD13 ' A' ' 8' ' ' ILE . 8.8 m -55.53 142.75 32.07 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.151 0.98 . . . . 0.0 112.298 -178.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.22 127.01 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.592 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -121.25 116.08 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-O 122.828 1.299 . . . . 0.0 114.034 -178.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.78 104.38 16.1 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.431 170.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.3 mt -87.11 95.23 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.9 t -107.11 122.16 45.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.018 -177.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.89 110.21 19.31 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 178.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.518 ' HG2' ' HG2' ' A' ' 1' ' ' MET . 36.5 mt-10 -91.37 122.02 33.61 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 113.038 -1.892 . . . . 0.0 110.573 169.123 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.42 -152.33 24.48 Favored Glycine 0 N--CA 1.475 1.269 0 O-C-N 124.737 1.273 . . . . 0.0 111.692 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -89.97 -60.78 1.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.186 1.394 . . . . 0.0 113.316 -174.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -77.58 38.06 0.24 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.663 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.8 pt-20 -48.06 -66.23 0.44 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.559 2.343 . . . . 0.0 114.918 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.663 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 57.3 mt-30 -56.25 -46.04 79.79 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.859 1.663 . . . . 0.0 113.374 177.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -61.74 -47.54 84.78 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.785 1.234 . . . . 0.0 111.776 -178.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.59 -50.82 71.88 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 124.23 0.956 . . . . 0.0 112.39 174.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.24 -51.02 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.632 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -48.25 -54.49 13.44 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.453 1.501 . . . . 0.0 112.466 178.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -65.28 -51.67 59.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.191 177.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.35 -26.4 68.01 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -176.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.0 t -57.02 -45.5 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.724 0.81 . . . . 0.0 111.569 169.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -59.09 -52.77 64.32 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.353 1.033 . . . . 0.0 110.978 176.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.03 -47.75 74.33 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.698 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 60.9 tpp -52.84 -36.81 59.34 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 174.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.11 -28.64 25.44 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -107.84 22.91 15.27 Favored 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -171.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 mt . . . . . 0 N--CA 1.488 1.469 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 179.69 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG2' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -136.74 141.9 43.03 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.882 1.364 . . . . 0.0 110.76 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -132.12 141.06 49.01 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.249 -179.271 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -133.89 125.0 27.39 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.159 0.912 . . . . 0.0 110.995 176.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HA ' HG22 ' A' ' 62' ' ' THR . 36.6 tt0 -74.09 111.6 9.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.654 172.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.459 HG21 HG22 ' A' ' 78' ' ' VAL . 95.9 t -128.98 140.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.818 -177.002 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 p -113.22 149.41 33.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.809 0.814 . . . . 0.0 111.313 171.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 mt -77.43 123.42 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.066 175.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -93.12 -36.0 12.89 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 177.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -77.12 133.94 68.26 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 176.15 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.737 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 85.8 Cg_exo -58.72 -49.54 11.44 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.859 3.04 . . . . 0.0 112.381 178.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -68.82 -44.73 72.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.123 1.769 . . . . 0.0 112.961 171.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 67.42 -141.51 39.09 Favored Glycine 0 N--CA 1.475 1.283 0 O-C-N 124.54 1.15 . . . . 0.0 113.153 172.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 81' ' ' MET . 3.6 tp -92.66 57.92 2.99 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.806 1.288 . . . . 0.0 110.145 -175.278 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -70.99 -162.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.088 176.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -47.34 -61.02 2.1 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -167.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.761 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.407 10.5 ptt180 -64.8 -49.37 69.46 Favored Pre-proline 0 N--CA 1.481 1.115 0 CA-C-O 115.375 -2.25 . . . . 0.0 116.297 -179.735 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.761 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 86.1 Cg_exo -59.33 -42.72 46.69 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.063 2.509 . . . . 0.0 113.03 172.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.13 -43.42 74.14 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.96 87.61 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -60.88 -45.86 92.9 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.759 1.224 . . . . 0.0 112.005 175.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -57.99 -45.28 87.06 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.233 1.413 . . . . 0.0 112.777 176.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.476 HG21 ' HA ' ' A' ' 47' ' ' LEU . 89.0 t -55.43 -47.8 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.355 0.662 . . . . 0.0 111.752 176.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -56.99 -46.44 82.27 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.948 0.78 . . . . 0.0 111.933 177.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -63.71 -47.26 81.84 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 123.796 0.685 . . . . 0.0 112.332 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.43 74.68 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.338 1.055 . . . . 0.0 113.791 172.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -54.35 -33.74 59.68 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 172.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.23 25.09 7.29 Favored Glycine 0 N--CA 1.479 1.511 0 C-N-CA 124.518 1.056 . . . . 0.0 114.264 -177.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -125.08 145.43 49.93 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.823 1.249 . . . . 0.0 110.469 169.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.7 p -66.06 -43.59 86.98 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.76 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.6 m -54.99 151.16 9.2 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.82 1.648 . . . . 0.0 113.462 174.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.29 124.76 43.09 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.663 1.221 . . . . 0.0 109.302 164.151 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.11 99.11 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 111.206 -2.725 . . . . 0.0 109.204 -176.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 13.0 m -83.59 115.46 22.14 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 112.422 -2.172 . . . . 0.0 108.678 175.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.37 103.83 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 114.031 -1.44 . . . . 0.0 108.746 -177.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 m -103.67 103.89 13.86 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.477 -175.018 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.1 t -96.96 97.46 9.28 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.708 176.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m120 38.06 79.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.059 -1.882 . . . . 0.0 115.444 -171.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.37 -48.69 4.09 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 113.605 -1.634 . . . . 0.0 114.247 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -77.47 119.43 21.05 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.785 0.834 . . . . 0.0 111.198 -176.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.7 p -110.1 139.57 45.09 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -173.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -133.35 138.93 46.55 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.348 176.388 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.5 t -69.42 118.16 11.95 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.249 170.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -23.79 66.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.129 174.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -77.86 6.15 8.19 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 175.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.8 t -130.36 125.26 34.17 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.782 1.233 . . . . 0.0 112.361 178.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.476 ' HA ' HG21 ' A' ' 23' ' ' VAL . 49.3 mt -53.59 -56.96 12.68 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.992 -1.458 . . . . 0.0 112.221 176.704 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.48 -34.73 77.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.89 -177.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 54.7 mmtt -67.72 -56.61 8.6 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 118.972 -0.537 . . . . 0.0 112.181 175.474 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.78 -47.18 84.61 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.99 -23.34 66.56 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -178.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 p -87.89 -25.1 23.43 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 175.668 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.5 tp -74.89 130.63 39.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.075 0.94 . . . . 0.0 111.818 178.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.06 95.84 0.18 Allowed Glycine 0 CA--C 1.537 1.451 0 CA-C-N 114.113 -1.403 . . . . 0.0 113.35 177.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 mt -105.77 74.7 1.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.322 1.058 . . . . 0.0 111.881 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 t -136.1 142.22 44.28 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.697 -2.047 . . . . 0.0 112.029 -171.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.737 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 6.6 tp-100 2.32 128.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 119.24 3.052 . . . . 0.0 119.24 171.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.91 -29.67 0.92 Allowed Glycine 0 N--CA 1.481 1.669 0 CA-C-N 114.003 -1.453 . . . . 0.0 115.981 168.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.7 m -61.4 136.53 58.07 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.73 1.212 . . . . 0.0 111.026 -178.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.56 110.0 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.521 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.9 p -108.16 92.32 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 112.488 -2.142 . . . . 0.0 109.395 178.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 5' ' ' GLU . 17.1 p -82.69 99.48 9.64 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.302 -177.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.8 mp -73.73 109.64 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 112.034 -2.348 . . . . 0.0 109.415 174.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.448 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 47.4 t -113.73 109.48 18.64 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.735 -2.03 . . . . 0.0 111.125 -177.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.64 123.24 47.82 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 122.408 1.099 . . . . 0.0 112.551 -178.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.428 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 39.6 tt0 -119.6 91.2 3.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.294 -177.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.08 -161.92 30.62 Favored Glycine 0 CA--C 1.548 2.116 0 CA-C-N 112.669 -2.059 . . . . 0.0 110.849 169.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.87 -51.18 58.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -79.63 36.81 0.33 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 176.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.627 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 5.2 pt-20 -39.95 -68.47 0.17 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 128.988 2.915 . . . . 0.0 115.475 -177.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.627 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 37.9 mt-30 -60.02 -41.43 92.15 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -71.34 -38.69 71.64 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.012 -176.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.57 74.9 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.105 0.878 . . . . 0.0 112.741 170.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -74.0 -66.03 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.318 176.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -42.37 -53.08 4.36 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 126.13 1.772 . . . . 0.0 112.633 -174.028 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -65.25 -45.88 82.82 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.473 -178.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.3 -30.45 67.45 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 6' ' ' VAL . 70.7 t -59.51 -41.62 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.32 0.648 . . . . 0.0 111.09 171.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.89 -53.31 59.42 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.788 0.68 . . . . 0.0 112.24 172.271 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mp -53.87 -44.61 70.56 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.449 ' HA ' HD13 ' A' ' 14' ' ' LEU . 52.0 tpp -55.9 -43.16 76.99 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.97 1.308 . . . . 0.0 113.669 173.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.41 -37.32 37.44 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 179.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -98.57 -27.08 14.18 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 119.084 2.994 . . . . 0.0 119.084 -169.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 17.1 mt . . . . . 0 N--CA 1.488 1.451 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.178 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 ttp . . . . . 0 C--O 1.237 0.444 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . 0.507 ' HD2' HG21 ' A' ' 74' ' ' VAL . 28.7 t80 -109.04 120.93 44.0 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.848 1.343 . . . . 0.0 109.074 177.016 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -111.84 120.65 42.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.842 -176.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -121.96 122.96 40.56 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.735 177.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.45 123.98 32.27 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.608 1.192 . . . . 0.0 112.55 177.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . 0.441 HG21 HG13 ' A' ' 78' ' ' VAL . 53.6 t -129.16 133.26 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.0 178.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.41 118.27 25.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.675 175.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.05 116.15 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 170.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p -124.24 16.67 9.1 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -178.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.68 134.34 39.98 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.255 175.4 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -49.27 -35.06 33.49 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.934 3.089 . . . . 0.0 115.996 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -92.63 -41.82 9.99 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 165.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.18 -133.83 48.66 Favored Glycine 0 N--CA 1.474 1.211 0 O-C-N 124.207 0.942 . . . . 0.0 111.564 -176.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.6 93.7 9.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.834 0.826 . . . . 0.0 111.132 -176.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -105.14 -147.79 0.4 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 113.693 -1.594 . . . . 0.0 113.059 174.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.2 p -57.24 -72.34 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.779 1.631 . . . . 0.0 114.785 -166.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.724 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.34 20.8 ptt180 -62.19 -33.83 13.47 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 176.397 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.724 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 45.5 Cg_exo -57.16 -47.35 23.02 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 122.356 2.037 . . . . 0.0 112.872 166.451 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.67 94.06 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 174.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.34 -46.99 69.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 173.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -62.7 -49.82 73.56 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.137 0.975 . . . . 0.0 112.174 174.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -54.57 -48.32 72.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.278 1.431 . . . . 0.0 111.987 178.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.5 t -59.39 -49.88 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 124.145 0.978 . . . . 0.0 112.249 176.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -53.23 -52.79 57.8 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 123.868 0.73 . . . . 0.0 110.829 178.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -72.33 -38.26 68.69 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 -178.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.85 82.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 173.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 36.9 mmtt -61.35 -21.17 63.77 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 173.33 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.63 4.16 81.92 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.665 1.126 . . . . 0.0 114.846 175.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -114.39 131.75 56.46 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.099 0.959 . . . . 0.0 108.478 171.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.4 p -64.48 -47.6 78.36 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.925 -175.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 m -46.2 130.34 10.34 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.422 2.289 . . . . 0.0 113.075 174.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.34 112.03 17.29 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.934 0.873 . . . . 0.0 109.385 176.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.52 HG21 HD12 ' A' ' 77' ' ' LEU . 2.1 mp -95.04 97.55 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 112.086 -2.324 . . . . 0.0 109.744 -171.155 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 5.1 m -84.4 104.99 14.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.437 178.768 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.479 HG13 HG21 ' A' ' 61' ' ' VAL . 5.2 t -87.38 92.81 3.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.0 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.8 m -97.55 92.12 5.77 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.578 -176.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.8 p -88.96 108.49 19.6 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.068 0.937 . . . . 0.0 111.24 178.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m120 36.33 70.77 0.15 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 112.514 -2.13 . . . . 0.0 114.545 -169.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.31 -28.24 3.85 Favored Glycine 0 N--CA 1.482 1.731 0 CA-C-N 113.884 -1.507 . . . . 0.0 116.161 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -88.57 111.26 21.66 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.1 p -96.92 124.18 40.82 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -170.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -132.58 140.52 48.29 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.199 -1.819 . . . . 0.0 111.152 171.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -72.4 127.73 33.46 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 120.897 0.379 . . . . 0.0 110.833 175.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.54 -20.75 22.1 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.733 -1.576 . . . . 0.0 115.07 176.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 79.6 mttt -85.01 -8.97 58.5 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.623 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 t -111.21 107.39 16.69 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.307 0.643 . . . . 0.0 112.29 -177.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.9 mt -38.7 -63.15 0.54 Allowed 'General case' 0 N--CA 1.483 1.181 0 O-C-N 125.697 1.873 . . . . 0.0 112.83 170.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -48.72 -55.03 12.57 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.746 1.218 . . . . 0.0 113.371 177.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.646 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 60.9 mttm -56.38 -53.61 55.32 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 178.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tp -62.33 -48.3 80.44 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.833 -178.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -61.89 -19.53 62.77 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 177.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.6 p -114.67 20.18 15.46 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' A' ' 42' ' ' ALA . 16.4 tp -115.76 135.09 54.36 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.05 0.94 . . . . 0.0 109.408 177.005 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.7 93.11 0.06 OUTLIER Glycine 0 N--CA 1.48 1.589 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.486 175.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.2 mt -121.7 49.3 1.56 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.717 -1.242 . . . . 0.0 113.18 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 t -118.71 -151.75 0.49 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.184 -170.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -46.14 135.19 7.87 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.057 2.143 . . . . 0.0 113.419 175.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.53 40.15 54.36 Favored Glycine 0 N--CA 1.483 1.784 0 CA-C-N 113.341 -1.754 . . . . 0.0 115.183 175.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.8 m -117.23 127.42 54.08 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.862 0.465 . . . . 0.0 109.973 -174.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.6 t -100.59 115.9 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.479 HG21 HG13 ' A' ' 35' ' ' VAL . 13.0 p -104.25 124.83 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.971 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -92.19 103.24 15.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.762 174.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mp -77.85 89.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.479 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 40.7 t -94.2 90.33 6.31 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.963 -177.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.03 114.58 26.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.481 -176.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.28 107.57 13.13 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.85 -158.61 31.18 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 114.337 -1.301 . . . . 0.0 113.092 173.35 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.63 -42.46 71.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -173.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 p30 -117.92 50.84 1.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -175.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.298 12.0 pt-20 -54.88 -50.16 69.41 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -172.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -67.99 -33.69 75.11 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.51 -45.83 92.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.927 1.291 . . . . 0.0 110.532 176.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.38 -47.81 84.04 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.507 HG21 ' HD2' ' A' ' 2' ' ' PHE . 38.4 t -58.88 -55.04 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 117.823 -1.084 . . . . 0.0 112.205 178.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -48.8 -51.77 27.57 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.575 1.172 . . . . 0.0 112.36 -177.131 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 34.4 t60 -72.45 -46.23 55.89 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -179.157 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.52 HD12 HG21 ' A' ' 33' ' ' ILE 0.258 76.4 mt -68.7 -26.63 65.38 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -176.878 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . 0.441 HG13 HG21 ' A' ' 6' ' ' VAL . 38.9 t -57.7 -52.71 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.132 0.973 . . . . 0.0 110.217 168.091 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 76' ' ' HIS . 56.5 mtmt -51.04 -56.13 14.05 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.827 1.33 . . . . 0.0 112.751 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.7 mt -54.04 -59.16 5.01 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 174.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.437 ' HG2' HG11 ' A' ' 61' ' ' VAL . 53.4 tpp -52.03 -49.71 62.87 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.98 -33.37 70.36 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -107.76 18.6 21.16 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -171.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 18' ' ' PRO . 16.4 mt . . . . . 0 N--CA 1.487 1.404 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 178.459 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -142.81 138.89 30.7 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 125.798 1.936 . . . . 0.0 111.243 -171.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -137.41 133.26 34.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 178.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -128.3 150.51 50.03 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.901 1.281 . . . . 0.0 111.378 177.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -111.25 126.35 54.78 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 t -116.94 139.21 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.321 -177.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.53 HG22 HG22 ' A' ' 60' ' ' VAL . 4.0 p -97.24 110.27 22.86 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.396 1.093 . . . . 0.0 111.032 174.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 mt -88.94 85.8 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.8 p -103.63 48.57 0.85 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.138 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.46 131.5 23.95 Favored Pre-proline 0 N--CA 1.48 1.046 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.556 -178.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.96 -54.88 3.46 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.927 3.751 . . . . 0.0 116.441 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -90.83 -36.04 14.45 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 169.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.96 -136.76 38.09 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.383 0.992 . . . . 0.0 112.771 174.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.715 HD23 HD13 ' A' ' 55' ' ' LEU . 5.8 tp -92.42 80.06 4.93 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.492 1.139 . . . . 0.0 109.038 -176.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -90.94 -166.14 1.51 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 113.038 -1.892 . . . . 0.0 112.738 177.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.6 p -33.17 -75.18 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.528 2.331 . . . . 0.0 117.155 -174.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.57 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.383 22.4 ptt85 -69.13 -31.69 2.88 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 179.322 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.57 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 47.7 Cg_exo -60.81 -40.72 51.58 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.94 1.76 . . . . 0.0 112.626 165.19 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -59.32 -42.42 91.36 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.566 0.746 . . . . 0.0 112.958 173.254 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.03 -42.45 65.7 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 172.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -69.7 -43.94 71.42 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 175.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.61 -42.6 83.6 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.184 0.927 . . . . 0.0 112.119 175.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 47' ' ' LEU . 60.6 t -59.73 -57.01 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 124.059 0.944 . . . . 0.0 110.395 173.05 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -48.27 -46.61 36.04 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 124.538 1.148 . . . . 0.0 112.4 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -68.85 -54.74 14.0 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 124.684 1.24 . . . . 0.0 112.754 179.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.53 66.61 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -53.87 -39.01 65.33 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 173.298 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.86 -37.01 93.64 Favored Glycine 0 N--CA 1.483 1.768 0 O-C-N 124.775 1.297 . . . . 0.0 113.632 -179.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . 0.602 ' HE1' ' HE2' ' A' ' 72' ' ' LYS . 72.1 m-85 -76.82 140.08 40.56 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.529 0.731 . . . . 0.0 111.746 178.247 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.0 p -65.47 -47.22 76.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.353 -174.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 m -49.37 132.0 20.39 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.665 1.586 . . . . 0.0 112.531 178.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -73.74 131.56 41.72 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 119.003 -1.079 . . . . 0.0 109.427 170.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.9 mt -119.37 115.28 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.872 -164.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -103.75 133.47 48.7 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.262 -2.245 . . . . 0.0 108.845 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.676 HG13 HG21 ' A' ' 61' ' ' VAL . 10.6 t -116.19 94.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 113.66 -1.609 . . . . 0.0 106.857 177.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.4 m -94.56 84.13 4.24 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 112.375 -2.193 . . . . 0.0 109.481 -176.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.3 p -85.19 97.91 10.17 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.152 -177.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.0 m120 45.52 68.61 0.55 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 113.071 -1.877 . . . . 0.0 113.778 -169.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.49 -35.19 2.24 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 113.672 -1.604 . . . . 0.0 114.915 178.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -73.02 98.06 2.45 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.06 0.944 . . . . 0.0 111.205 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.6 p -84.91 124.82 32.07 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.744 -1.571 . . . . 0.0 114.683 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.722 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -132.95 156.63 46.94 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 112.585 -2.098 . . . . 0.0 109.961 167.08 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -80.23 124.7 29.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.481 0.658 . . . . 0.0 110.422 174.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.465 ' HB2' HG23 ' A' ' 35' ' ' VAL . . . -58.31 -36.62 73.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.237 173.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -77.85 13.67 1.3 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.751 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.6 t -135.12 110.42 9.0 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.582 ' HA ' HG21 ' A' ' 23' ' ' VAL . 44.9 tp -45.04 -74.52 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -54.36 -34.6 61.5 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -66.94 -45.19 78.57 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 44' ' ' ALA . 14.6 tp -68.17 -42.03 80.6 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.432 1.082 . . . . 0.0 112.761 175.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -62.18 -36.33 81.54 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 175.152 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.9 p -88.89 15.79 7.92 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 175.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.722 HD22 ' HB3' ' A' ' 42' ' ' ALA . 18.0 tp -110.76 130.37 55.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.65 1.18 . . . . 0.0 108.065 177.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.34 86.54 0.33 Allowed Glycine 0 N--CA 1.485 1.916 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.061 -175.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.715 HD13 HD23 ' A' ' 14' ' ' LEU . 5.3 mt -106.92 62.2 0.63 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.938 1.351 . . . . 0.0 111.378 176.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 t -123.65 -164.71 1.25 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.006 -169.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -55.51 129.12 37.62 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.392 1.077 . . . . 0.0 112.56 179.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.3 38.66 93.9 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-N 113.215 -1.811 . . . . 0.0 115.084 -179.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 m -105.94 138.32 42.33 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.53 HG22 HG22 ' A' ' 7' ' ' THR . 12.1 t -114.43 122.39 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 172.686 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.676 HG21 HG13 ' A' ' 35' ' ' VAL . 14.9 p -116.71 117.59 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -174.53 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 m -80.38 100.8 8.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 113.309 -1.768 . . . . 0.0 109.015 170.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.467 HG12 HG22 ' A' ' 35' ' ' VAL . 64.2 mt -92.6 111.33 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.525 176.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 t -109.08 131.55 54.96 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.668 -177.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.14 125.99 48.61 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.15 1.532 . . . . 0.0 111.971 172.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -118.3 89.55 3.15 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 177.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.1 -156.12 21.84 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-N 113.193 -1.821 . . . . 0.0 112.611 169.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -57.52 -53.82 53.81 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.922 1.289 . . . . 0.0 114.19 -177.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -81.88 46.14 0.97 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 177.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . 0.441 ' CD ' HE22 ' A' ' 71' ' ' GLN . 4.4 pt-20 -55.25 -58.06 9.25 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -176.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . 0.441 HE22 ' CD ' ' A' ' 70' ' ' GLU . 10.9 mp0 -64.67 -48.81 73.36 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 171.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . 0.602 ' HE2' ' HE1' ' A' ' 29' ' ' PHE . 77.9 tttt -54.75 -49.3 71.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.48 1.512 . . . . 0.0 113.062 -173.03 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.46 -52.6 64.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.775 0.83 . . . . 0.0 112.88 177.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.4 t -68.97 -49.16 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.887 -175.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -53.06 -50.93 63.34 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.56 1.144 . . . . 0.0 112.65 179.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -61.6 -45.76 92.74 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.942 0.897 . . . . 0.0 112.052 177.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.08 -38.49 90.91 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 177.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.4 t -59.06 -48.45 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.053 0.941 . . . . 0.0 110.295 173.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -56.48 -56.88 15.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.183 0.993 . . . . 0.0 111.199 172.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.71 -43.66 62.91 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.533 1.533 . . . . 0.0 113.501 -177.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.3 tpp -49.53 -47.87 48.62 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.121 1.368 . . . . 0.0 112.654 176.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.08 -24.73 65.99 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -100.32 23.49 10.07 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 34.3 mt . . . . . 0 N--CA 1.482 1.167 0 C-N-CA 124.414 1.086 . . . . 0.0 113.834 178.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 ttp . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -116.52 130.15 56.59 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 125.004 1.44 . . . . 0.0 109.449 177.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -124.19 131.26 53.52 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 112.061 -2.336 . . . . 0.0 110.452 -177.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -128.08 98.55 5.16 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 112.986 -1.915 . . . . 0.0 111.779 168.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.22 102.29 1.34 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.878 168.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.38 142.67 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.776 -1.556 . . . . 0.0 113.235 -179.272 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -87.75 126.91 35.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.079 -1.418 . . . . 0.0 111.767 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . 0.483 HD12 ' HB ' ' A' ' 59' ' ' THR . 49.1 mt -75.55 108.59 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.581 169.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -92.38 -16.37 26.05 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.353 -1.749 . . . . 0.0 115.419 178.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.49 126.06 88.69 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.755 176.389 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 89.2 Cg_exo -49.74 -54.2 5.83 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 124.445 3.43 . . . . 0.0 113.139 -175.272 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -66.55 -59.05 3.99 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.211 1.805 . . . . 0.0 112.087 170.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.57 -151.59 20.41 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 124.538 1.149 . . . . 0.0 111.86 176.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.799 HD23 HD13 ' A' ' 55' ' ' LEU . 11.5 tp -92.55 70.01 4.94 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.151 -1.524 . . . . 0.0 108.407 -175.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -78.32 -155.58 0.08 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.633 -1.621 . . . . 0.0 114.488 -177.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.8 p -43.28 -70.41 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.654 1.982 . . . . 0.0 114.805 -170.813 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.327 12.8 ptt180 -73.21 -32.46 1.68 Allowed Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.565 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 47.6 Cg_exo -58.09 -47.15 21.42 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.732 2.288 . . . . 0.0 113.636 167.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -57.88 -47.16 83.56 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 175.479 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.66 -39.85 68.47 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 174.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -73.1 -42.14 63.29 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . 0.539 ' HE2' ' HB2' ' A' ' 81' ' ' MET . 12.1 t80 -54.76 -41.78 70.87 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 123.68 0.612 . . . . 0.0 111.512 174.079 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 47' ' ' LEU . 48.1 t -57.14 -49.71 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.881 0.872 . . . . 0.0 111.61 174.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -52.81 -52.56 56.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.611 0.764 . . . . 0.0 111.378 178.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -67.67 -44.55 77.57 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 124.757 1.286 . . . . 0.0 112.862 -178.503 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.85 -41.9 78.75 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -56.63 -32.48 65.35 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 174.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.88 -13.76 66.86 Favored Glycine 0 CA--C 1.544 1.891 0 O-C-N 125.201 1.563 . . . . 0.0 115.192 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -101.84 138.47 38.76 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.161 0.505 . . . . 0.0 110.478 176.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.3 p -64.3 -41.26 96.95 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.448 -175.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -54.19 141.44 29.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.103 1.761 . . . . 0.0 112.319 174.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -86.19 106.33 17.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.064 0.935 . . . . 0.0 109.377 174.25 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.521 HD12 ' HD2' ' A' ' 45' ' ' LYS . 3.7 mp -85.66 93.16 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.322 -175.089 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.18 129.95 38.81 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 113.732 -1.577 . . . . 0.0 107.753 169.223 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.445 HG13 ' CG2' ' A' ' 61' ' ' VAL . 10.6 t -114.35 92.96 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.8 m -93.1 93.22 8.18 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 111.184 -2.734 . . . . 0.0 109.731 -175.141 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB2' ' CG2' ' A' ' 59' ' ' THR . 99.4 p -101.29 100.26 10.75 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.32 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.3 m120 45.33 70.93 0.31 Allowed 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.005 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.25 -31.02 1.85 Allowed Glycine 0 CA--C 1.546 2.011 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.156 -177.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -80.99 93.71 6.41 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.186 0.993 . . . . 0.0 113.564 -177.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 p -88.68 104.41 16.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 112.726 -2.034 . . . . 0.0 113.907 -179.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -129.43 134.68 47.96 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.7 175.369 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.3 t -67.4 127.57 33.17 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 122.272 1.034 . . . . 0.0 113.273 175.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.22 -30.96 71.46 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.414 174.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HD2' HD12 ' A' ' 33' ' ' ILE . 59.2 mtpt -72.75 -0.64 13.81 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 178.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.8 t -121.69 129.07 52.49 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.349 0.595 . . . . 0.0 111.879 170.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HA ' HG21 ' A' ' 23' ' ' VAL . 1.6 tp -57.92 -70.48 0.13 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 112.825 -1.989 . . . . 0.0 112.651 -173.072 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.56 -39.17 70.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -56.23 -48.91 75.55 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 172.292 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.3 tp -75.19 -41.62 57.53 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 175.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -56.13 -45.49 79.54 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.644 1.178 . . . . 0.0 113.1 177.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.7 p -75.22 -7.82 54.91 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 175.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 42' ' ' ALA . 16.1 tp -86.37 118.72 25.99 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.175 0.988 . . . . 0.0 109.244 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.19 102.26 1.06 Allowed Glycine 0 N--CA 1.485 1.93 0 CA-C-N 113.237 -1.801 . . . . 0.0 113.081 -177.343 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . 0.799 HD13 HD23 ' A' ' 14' ' ' LEU . 5.9 mt -116.42 96.5 5.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.221 1.008 . . . . 0.0 110.604 -175.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -140.29 171.24 14.44 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.086 0.954 . . . . 0.0 113.175 -165.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 22.7 tt0 -52.77 110.89 0.57 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.834 0.826 . . . . 0.0 111.828 174.085 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.38 -7.89 30.52 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 112.709 -2.041 . . . . 0.0 115.275 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . 0.483 ' HB ' HD12 ' A' ' 8' ' ' ILE . 7.2 m -75.31 119.9 20.05 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.141 0.97 . . . . 0.0 111.665 -179.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.43 101.3 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 174.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG2' HG13 ' A' ' 35' ' ' VAL . 14.5 p -109.7 119.87 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.964 -174.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -89.63 103.04 15.72 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.535 175.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.0 mp -77.78 91.0 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 168.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -105.65 92.55 4.23 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 112.381 -2.191 . . . . 0.0 111.427 -171.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.41 111.04 23.28 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.188 -176.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.48 122.41 46.24 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.78 -154.91 22.89 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 113.025 -1.898 . . . . 0.0 111.126 -176.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -67.75 -63.92 0.96 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.356 1.463 . . . . 0.0 114.081 -171.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -80.22 40.04 0.47 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.079 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.39 -51.21 56.69 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.174 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -66.85 -54.33 23.5 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.053 0.941 . . . . 0.0 112.833 177.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -53.44 -42.57 67.25 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.386 1.475 . . . . 0.0 112.924 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.17 -54.96 40.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.6 0.76 . . . . 0.0 112.575 173.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.5 t -58.25 -51.2 74.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.348 178.089 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -48.2 -65.18 0.61 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.816 1.246 . . . . 0.0 113.173 -179.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -72.78 -27.87 62.26 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -176.444 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.4 mt -75.1 -41.78 57.92 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 174.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.05 -44.07 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 123.271 0.357 . . . . 0.0 110.477 174.68 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -49.01 -62.05 1.74 Allowed 'General case' 0 N--CA 1.479 1.021 0 O-C-N 125.159 1.537 . . . . 0.0 111.57 169.205 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.64 -46.66 73.97 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.733 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.539 ' HB2' ' HE2' ' A' ' 22' ' ' PHE . 24.4 ttp -50.9 -46.85 60.76 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.346 1.458 . . . . 0.0 113.045 178.525 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.65 76.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.461 1.1 . . . . 0.0 112.706 177.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.67 32.9 0.71 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.753 1.221 . . . . 0.0 114.088 -173.42 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 34.9 mt . . . . . 0 N--CA 1.479 1.003 0 CA-C-O 122.568 1.175 . . . . 0.0 112.4 -179.327 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 1' ' ' MET . . . . . 0.44 ' HG3' ' HB3' ' A' ' 66' ' ' GLU . 17.7 ttt . . . . . 0 C--O 1.239 0.535 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -137.63 141.18 41.22 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 126.021 2.075 . . . . 0.0 111.386 -173.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -125.14 131.16 53.3 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 125.42 1.7 . . . . 0.0 109.475 174.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -126.12 136.43 52.87 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 125.518 1.761 . . . . 0.0 109.872 172.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -115.28 94.2 4.62 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 122.509 1.147 . . . . 0.0 114.058 -169.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.0 m -120.95 159.95 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 113.521 -1.672 . . . . 0.0 114.328 -173.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 7' ' ' THR . . . . . 0.752 HG22 HG22 ' A' ' 60' ' ' VAL . 75.2 p -107.61 155.5 20.07 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -179.349 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.4 mt -103.23 113.76 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 111.211 -2.722 . . . . 0.0 108.401 168.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.7 p -94.84 -30.87 13.98 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 112.269 -2.241 . . . . 0.0 116.659 175.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 10' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -59.8 135.76 89.9 Favored Pre-proline 0 N--CA 1.484 1.269 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.406 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 76.9 Cg_exo -50.13 -48.68 18.81 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.816 3.677 . . . . 0.0 115.415 -178.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . 0.285 0.4 OUTLIER -95.48 -16.88 21.91 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 170.96 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 13' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 46.88 -128.81 11.71 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.163 1.84 . . . . 0.0 115.576 178.277 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 14' ' ' LEU . . . . . 0.549 HD11 ' HG2' ' A' ' 81' ' ' MET . 81.0 mt -98.47 54.93 1.07 Allowed 'General case' 0 C--O 1.2 -1.515 0 CA-C-N 111.933 -2.133 . . . . 0.0 112.4 -171.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -68.66 -166.43 0.08 Allowed 'General case' 0 C--N 1.364 1.233 0 CA-C-N 112.031 -2.349 . . . . 0.0 113.217 174.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -54.46 -51.58 64.55 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -164.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.254 43.5 ttt85 -69.61 -50.33 18.93 Favored Pre-proline 0 N--CA 1.479 0.976 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 174.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 47.1 Cg_exo -57.35 -38.6 94.16 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.958 2.439 . . . . 0.0 113.613 173.09 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 50' ' ' LEU . . . -68.14 -35.33 77.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 172.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.26 65.21 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 173.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 21' ' ' GLN . . . . . 0.547 ' NE2' HD11 ' A' ' 84' ' ' LEU . 42.0 tt0 -68.48 -39.79 81.23 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.149 0.98 . . . . 0.0 111.549 169.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.5 -47.45 83.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.853 0.861 . . . . 0.0 112.028 171.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 23' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 44' ' ' ALA . 75.5 t -53.47 -56.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.601 1.16 . . . . 0.0 112.023 175.336 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.91 -61.44 0.85 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.577 1.151 . . . . 0.0 112.389 170.043 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.99 -34.39 77.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -176.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.8 -44.38 96.97 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.867 0.867 . . . . 0.0 112.104 176.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -56.73 -22.68 37.2 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 176.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.97 65.47 Favored Glycine 0 CA--C 1.542 1.728 0 O-C-N 124.741 1.275 . . . . 0.0 111.468 178.701 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -81.79 148.35 28.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.355 1.074 . . . . 0.0 112.84 -174.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.1 p -70.44 -35.26 73.26 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.274 -176.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.1 m -49.34 148.73 2.48 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.971 1.308 . . . . 0.0 113.457 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -91.98 104.19 16.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 160.098 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 33' ' ' ILE . . . . . 0.66 HD12 ' H ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -91.1 113.15 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 112.052 -2.34 . . . . 0.0 106.851 176.115 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 34' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 95.9 m -90.98 142.66 27.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.407 173.144 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 35' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 44' ' ' ALA . 37.5 t -118.68 106.67 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 112.512 -2.131 . . . . 0.0 108.016 176.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 36' ' ' THR . . . . . 0.63 HG23 ' HB3' ' A' ' 41' ' ' SER . 3.9 m -114.06 92.27 3.91 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 112.787 -2.006 . . . . 0.0 109.577 -176.467 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 p -87.58 89.15 7.89 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 122.816 1.293 . . . . 0.0 110.68 179.701 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.6 m120 46.41 74.96 0.13 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.012 -1.904 . . . . 0.0 112.276 -172.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.75 -22.56 2.23 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 113.125 -1.852 . . . . 0.0 116.544 -179.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -85.86 91.87 8.47 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.854 -0.792 . . . . 0.0 110.0 -177.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 41' ' ' SER . . . . . 0.63 ' HB3' HG23 ' A' ' 36' ' ' THR . 28.1 p -101.78 127.99 48.32 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -169.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.82 144.81 31.33 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.065 -1.879 . . . . 0.0 110.94 177.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -55.33 130.44 42.43 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 168.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 44' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -53.77 -30.53 44.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.849 1.26 . . . . 0.0 111.581 172.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -74.0 -6.13 45.58 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 46' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -101.03 103.64 14.77 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -171.107 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild core ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 tp -49.06 -73.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -176.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -45.26 -48.6 12.81 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.16 1.384 . . . . 0.0 113.922 177.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 49' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 66.0 mmtt -52.33 -52.47 53.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 117.125 -1.417 . . . . 0.0 114.157 175.571 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 6.3 mp -71.98 -35.94 69.64 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -178.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.86 -31.08 72.04 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 175.014 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.9 p -84.78 -35.48 22.34 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 171.167 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 tp -67.61 122.92 19.07 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 111.174 -176.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.92 100.14 0.42 Allowed Glycine 0 CA--C 1.54 1.619 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.471 -177.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 mt -125.39 88.44 2.87 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.67 1.188 . . . . 0.0 110.293 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -143.49 -166.62 2.37 Favored 'General case' 0 C--O 1.199 -1.584 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.682 -175.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -56.28 118.31 4.62 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.774 1.23 . . . . 0.0 112.138 -178.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.58 -30.12 10.66 Favored Glycine 0 CA--C 1.544 1.863 0 CA-C-N 112.631 -2.077 . . . . 0.0 113.842 -178.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.04 137.68 55.24 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.874 1.27 . . . . 0.0 113.375 -174.335 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 60' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 7' ' ' THR . 11.5 t -116.77 114.38 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.333 -169.302 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 p -109.53 96.84 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 112.952 -1.931 . . . . 0.0 112.269 -166.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 62' ' ' THR . . . . . 0.515 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 30.6 m -72.07 101.75 2.82 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 111.614 -2.539 . . . . 0.0 108.6 173.425 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 63' ' ' ILE . . . . . 0.509 HG22 HG22 ' A' ' 74' ' ' VAL . 5.5 mt -94.23 112.57 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 123.772 1.748 . . . . 0.0 110.507 -178.336 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 64' ' ' SER . . . . . 0.649 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 13.3 t -123.79 96.03 4.8 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 109.973 -3.285 . . . . 0.0 113.215 -159.514 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.17 117.7 34.68 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.229 -170.046 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 66' ' ' GLU . . . . . 0.44 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 9.0 pt-20 -120.13 86.96 2.66 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -176.245 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.24 -164.48 30.46 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 112.34 -2.209 . . . . 0.0 110.048 171.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -34.82 73.59 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -179.658 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -104.55 43.39 1.1 Allowed 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 -176.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -63.12 1.28 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 -178.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -62.71 -44.97 94.86 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -49.08 -50.15 38.15 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.339 1.056 . . . . 0.0 113.124 173.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.42 -55.79 24.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.797 0.839 . . . . 0.0 112.394 -177.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 74' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 63' ' ' ILE . 31.4 t -62.44 -37.16 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-O 117.759 -1.115 . . . . 0.0 111.992 -177.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.67 -46.78 86.45 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.478 0.487 . . . . 0.0 111.548 178.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 76' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 67.3 t60 -74.27 -32.03 62.77 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.149 -178.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 77' ' ' LEU . . . . . 0.456 ' CD1' HG21 ' A' ' 33' ' ' ILE . 54.2 mt -74.85 -36.83 62.34 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 173.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.45 -38.7 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.525 173.347 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 76' ' ' HIS . 77.1 tttt -48.21 -58.69 4.19 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.628 1.205 . . . . 0.0 110.521 163.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -58.41 -48.04 81.96 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 176.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 81' ' ' MET . . . . . 0.549 ' HG2' HD11 ' A' ' 14' ' ' LEU . 13.5 tmm? -52.08 -44.67 64.47 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.513 1.525 . . . . 0.0 112.35 174.442 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild core ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.27 -25.34 54.84 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.767 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -83.89 -22.05 31.74 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 178.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild core ' A' A ' 84' ' ' LEU . . . . . 0.547 HD11 ' NE2' ' A' ' 21' ' ' GLN . 36.0 mt . . . . . 0 N--CA 1.478 0.966 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 -172.586 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.5 ttp . . . . . 0 CA--C 1.537 0.443 0 N-CA-C 106.741 -1.577 . . . . 0.0 106.741 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -120.7 134.07 55.31 Favored 'General case' 0 N--CA 1.475 0.823 0 O-C-N 125.639 1.837 . . . . 0.0 108.797 179.848 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 58.2 mt-30 -128.64 153.61 47.1 Favored 'General case' 0 N--CA 1.479 0.994 0 CA-C-N 113.915 -1.493 . . . . 0.0 112.634 -173.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 2.0 tp-100 -142.55 121.98 13.19 Favored 'General case' 0 N--CA 1.469 0.496 0 CA-C-N 113.609 -1.632 . . . . 0.0 110.113 168.39 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 65.2 mt-10 -87.72 97.37 10.85 Favored 'General case' 0 N--CA 1.468 0.443 0 CA-C-O 123.199 1.476 . . . . 0.0 111.275 175.683 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 18.5 t -107.57 155.48 8.31 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 CA-C-N 112.118 -2.31 . . . . 0.0 108.113 -171.145 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.8 p -120.09 154.76 34.21 Favored 'General case' 0 N--CA 1.48 1.047 0 CA-C-O 121.303 0.573 . . . . 0.0 112.215 174.423 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.479 HD12 ' HB ' ' A' ' 59' ' ' THR . 65.3 mt -103.5 115.16 44.95 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.403 0 CA-C-N 115.121 -0.945 . . . . 0.0 109.154 -177.784 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 28.3 p -99.24 -0.47 41.31 Favored 'General case' 0 N--CA 1.48 1.073 0 N-CA-C 115.249 1.574 . . . . 0.0 115.249 179.329 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.53 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -94.87 139.83 22.29 Favored Pre-proline 0 CA--C 1.546 0.789 0 C-N-CA 124.746 1.218 . . . . 0.0 110.638 -177.089 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 37.6 Cg_endo -55.5 -68.79 0.06 OUTLIER 'Trans proline' 0 CA--C 1.542 0.914 0 C-N-CA 123.655 2.903 . . . . 0.0 114.229 -174.003 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.855 HD21 ' HG2' ' A' ' 85' ' ' GLU . 0.8 OUTLIER -62.72 -35.77 80.84 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.245 1.018 . . . . 0.0 113.23 167.605 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.53 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 74.44 -135.62 19.87 Favored Glycine 0 N--CA 1.475 1.268 0 O-C-N 124.957 1.411 . . . . 0.0 111.299 -179.813 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 55' ' ' LEU . 1.8 tp -92.88 57.45 2.81 Favored 'General case' 0 CA--C 1.559 1.322 0 CA-C-N 113.013 -1.594 . . . . 0.0 109.417 -176.009 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.6 p80 -67.73 167.51 13.13 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 113.754 -1.566 . . . . 0.0 112.817 -179.444 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 55.4 p 1.26 -68.89 0.0 OUTLIER 'General case' 0 N--CA 1.496 1.855 0 N-CA-C 118.687 2.847 . . . . 0.0 118.687 171.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.416 7.7 ptt-85 -85.18 -38.82 0.62 Allowed Pre-proline 0 CA--C 1.545 0.784 0 N-CA-C 117.733 2.494 . . . . 0.0 117.733 -176.168 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.496 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 17.7 Cg_exo -54.91 -41.46 78.36 Favored 'Trans proline' 0 C--N 1.349 0.597 0 C-N-CA 123.214 2.61 . . . . 0.0 113.436 159.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.412 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -57.22 -47.27 81.73 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 113.031 0.752 . . . . 0.0 113.031 171.213 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.26 -44.38 79.64 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 172.539 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.428 ' O ' ' HB3' ' A' ' 24' ' ' LYS . 24.4 mt-30 -63.32 -42.05 98.97 Favored 'General case' 0 CA--C 1.552 1.034 0 C-N-CA 124.69 1.196 . . . . 0.0 113.728 174.246 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.7 t80 -62.62 -43.42 98.87 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.297 0.639 . . . . 0.0 112.119 173.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 19' ' ' ALA . 59.2 t -59.66 -48.16 88.48 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.385 0 C-N-CA 123.56 0.744 . . . . 0.0 111.936 173.258 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . 0.428 ' HB3' ' O ' ' A' ' 21' ' ' GLN . 17.2 tttm -43.74 -55.02 4.69 Favored 'General case' 0 N--CA 1.485 1.311 0 O-C-N 124.29 0.994 . . . . 0.0 111.781 172.337 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -66.03 -46.85 76.38 Favored 'General case' 0 N--CA 1.479 0.999 0 O-C-N 124.227 0.955 . . . . 0.0 112.674 -179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.81 -36.75 70.3 Favored 'General case' 0 CA--C 1.549 0.916 0 C-N-CA 124.814 1.245 . . . . 0.0 114.063 175.337 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 70.6 mmtt -61.17 -29.78 70.0 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.412 1.264 . . . . 0.0 114.412 172.616 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -85.33 19.29 23.95 Favored Glycine 0 N--CA 1.481 1.663 0 O-C-N 124.225 0.953 . . . . 0.0 114.787 177.075 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 73.0 m-85 -129.92 143.29 50.73 Favored 'General case' 0 CA--C 1.548 0.885 0 C-N-CA 124.323 1.049 . . . . 0.0 110.669 171.699 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 59.2 p -67.21 -41.46 85.74 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 115.184 -0.917 . . . . 0.0 111.987 -179.068 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 29.8 m -52.32 144.63 12.52 Favored 'General case' 0 N--CA 1.483 1.204 0 C-N-CA 125.591 1.556 . . . . 0.0 113.111 177.606 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.7 tp10 -86.82 92.38 8.96 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-O 122.137 0.97 . . . . 0.0 109.654 172.228 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.514 HG21 HD13 ' A' ' 77' ' ' LEU . 3.9 mp -76.96 107.39 8.21 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 112.66 -2.063 . . . . 0.0 109.478 179.389 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 97.7 m -106.86 137.67 44.47 Favored 'General case' 0 N--CA 1.47 0.541 0 CA-C-N 113.95 -1.477 . . . . 0.0 110.09 174.2 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 39.0 t -109.58 115.07 48.68 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.714 0 CA-C-N 112.48 -2.146 . . . . 0.0 107.398 -178.517 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 51.9 m -111.58 97.7 6.92 Favored 'General case' 0 N--CA 1.47 0.567 0 CA-C-N 114.397 -1.274 . . . . 0.0 111.451 -177.315 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 49.6 m -92.94 93.83 8.59 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 112.639 -2.073 . . . . 0.0 110.169 -177.528 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m120 48.52 76.97 0.11 Allowed 'General case' 0 N--CA 1.486 1.366 0 CA-C-N 113.443 -1.708 . . . . 0.0 113.443 -174.216 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 77.09 -46.34 2.42 Favored Glycine 0 N--CA 1.488 2.146 0 CA-C-N 113.704 -1.589 . . . . 0.0 114.83 -179.356 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 55.4 mtpt -76.3 126.94 31.91 Favored 'General case' 0 N--CA 1.475 0.814 0 C-N-CA 124.395 1.078 . . . . 0.0 113.156 -178.118 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 60.0 p -108.75 141.2 41.1 Favored 'General case' 0 N--CA 1.471 0.583 0 N-CA-C 115.341 1.608 . . . . 0.0 115.341 -171.397 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.587 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -145.51 135.97 24.14 Favored 'General case' 0 N--CA 1.475 0.805 0 CA-C-N 114.231 -1.35 . . . . 0.0 110.399 167.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 28.5 t -67.52 127.85 34.25 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 114.346 -1.297 . . . . 0.0 112.286 176.004 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.39 -9.47 48.49 Favored 'General case' 0 N--CA 1.481 1.078 0 CA-C-N 112.99 -1.914 . . . . 0.0 111.717 170.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 54.6 mtpt -95.24 35.61 1.29 Allowed 'General case' 0 CA--C 1.552 1.055 0 O-C-N 121.181 -0.949 . . . . 0.0 111.744 173.167 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.401 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 41.5 t -154.29 117.23 4.45 Favored 'General case' 0 N--CA 1.48 1.033 0 CA-C-N 113.911 -1.495 . . . . 0.0 111.334 174.774 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.401 ' HA ' HG21 ' A' ' 23' ' ' VAL . 44.9 mt -52.51 -61.58 2.19 Favored 'General case' 0 N--CA 1.485 1.279 0 CA-C-N 114.635 -1.166 . . . . 0.0 112.041 175.623 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 84.5 t80 -52.45 -45.97 66.27 Favored 'General case' 0 N--CA 1.476 0.857 0 C-N-CA 124.844 1.258 . . . . 0.0 113.751 178.317 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.587 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 63.3 mttt -66.39 -43.83 84.73 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.282 1.215 . . . . 0.0 114.282 179.786 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 3.7 tp -72.45 -23.95 61.14 Favored 'General case' 0 N--CA 1.471 0.588 0 N-CA-C 114.214 1.19 . . . . 0.0 114.214 176.82 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 42.4 mt-30 -78.73 -27.19 44.82 Favored 'General case' 0 N--CA 1.487 1.4 0 N-CA-C 114.87 1.433 . . . . 0.0 114.87 170.567 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 75.6 p -86.2 -33.27 20.82 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.1 1.148 . . . . 0.0 114.1 174.305 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.561 HD22 ' HB3' ' A' ' 42' ' ' ALA . 17.6 tp -64.86 131.51 46.92 Favored 'General case' 0 N--CA 1.475 0.821 0 C-N-CA 123.304 0.642 . . . . 0.0 111.732 174.726 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.83 90.39 0.21 Allowed Glycine 0 N--CA 1.476 1.319 0 CA-C-N 114.358 -1.292 . . . . 0.0 112.91 179.556 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.449 ' HB3' ' HB3' ' A' ' 14' ' ' LEU . 8.7 mt -107.93 76.78 1.07 Allowed 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 124.057 0.943 . . . . 0.0 111.985 176.371 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.1 t -137.73 172.87 12.31 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.444 -1.707 . . . . 0.0 112.331 -168.324 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.1 tp-100 -35.9 125.56 0.72 Allowed 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 126.763 2.025 . . . . 0.0 115.435 -179.655 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.02 -92.14 1.16 Allowed Glycine 0 CA--C 1.531 1.054 0 C-N-CA 125.372 1.463 . . . . 0.0 110.088 -178.78 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.479 ' HB ' HD12 ' A' ' 8' ' ' ILE . 11.3 m 24.55 123.63 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.563 0 C-N-CA 128.216 2.606 . . . . 0.0 117.895 174.446 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 41.2 t -92.8 102.3 13.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 CA-C-N 112.358 -2.201 . . . . 0.0 106.226 176.139 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.7 p -110.85 106.77 21.38 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.846 0 CA-C-N 113.294 -1.775 . . . . 0.0 112.173 -172.463 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 4.0 m -83.47 115.23 21.98 Favored 'General case' 0 N--CA 1.48 1.06 0 CA-C-N 114.198 -1.365 . . . . 0.0 109.945 175.015 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 65.4 mt -93.31 102.96 14.18 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.698 0 N-CA-C 107.459 -1.312 . . . . 0.0 107.459 174.903 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 26.6 t -116.62 117.72 30.61 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 114.486 -1.234 . . . . 0.0 112.091 -171.89 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -120.19 126.29 50.3 Favored 'General case' 0 N--CA 1.483 1.178 0 CA-C-N 115.105 -0.952 . . . . 0.0 112.927 178.738 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.2 pt-20 -127.93 122.75 33.21 Favored 'General case' 0 N--CA 1.483 1.18 0 O-C-N 125.003 1.44 . . . . 0.0 114.18 172.385 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.0 -168.01 31.79 Favored Glycine 0 N--CA 1.482 1.714 0 CA-C-N 113.033 -1.894 . . . . 0.0 110.575 -176.976 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 53.9 mt-10 -52.82 -40.65 63.49 Favored 'General case' 0 N--CA 1.491 1.589 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -175.225 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.9 p30 -111.09 37.66 2.76 Favored 'General case' 0 CA--C 1.552 1.025 0 N-CA-C 115.575 1.695 . . . . 0.0 115.575 -175.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -45.94 -58.5 3.5 Favored 'General case' 0 N--CA 1.503 2.185 0 N-CA-C 116.457 2.021 . . . . 0.0 116.457 -177.547 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 36.3 mt-30 -59.62 -51.22 70.75 Favored 'General case' 0 N--CA 1.476 0.827 0 C-N-CA 125.192 1.397 . . . . 0.0 113.859 176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 63.5 tttm -56.72 -41.12 76.91 Favored 'General case' 0 N--CA 1.477 0.889 0 C-N-CA 126.3 1.84 . . . . 0.0 112.387 -179.593 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.92 -59.84 4.74 Favored 'General case' 0 N--CA 1.477 0.879 0 N-CA-C 112.872 0.693 . . . . 0.0 112.872 172.376 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.412 ' O ' HG23 ' A' ' 78' ' ' VAL . 59.5 t -59.46 -44.94 93.94 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.393 0 CA-C-O 117.635 -1.174 . . . . 0.0 113.067 -175.753 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 8.6 tt0 -49.2 -62.54 1.48 Allowed 'General case' 0 N--CA 1.488 1.429 0 C-N-CA 124.086 0.954 . . . . 0.0 112.127 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 51.6 t60 -66.0 -35.48 80.68 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 125.063 1.345 . . . . 0.0 113.766 178.619 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.514 HD13 HG21 ' A' ' 33' ' ' ILE . 44.3 mt -69.94 -30.69 68.14 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 115.725 1.75 . . . . 0.0 115.725 177.534 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.412 HG23 ' O ' ' A' ' 74' ' ' VAL . 90.9 t -62.63 -39.9 86.38 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.386 0 C-N-CA 122.478 0.311 . . . . 0.0 110.322 171.332 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.8 mttt -57.4 -51.32 69.9 Favored 'General case' 0 N--CA 1.485 1.283 0 C-N-CA 123.236 0.614 . . . . 0.0 112.261 172.321 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.7 mp -54.5 -45.22 73.22 Favored 'General case' 0 N--CA 1.482 1.168 0 N-CA-C 113.614 0.968 . . . . 0.0 113.614 175.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.422 ' HE1' HD22 ' A' ' 55' ' ' LEU . 59.8 tpp -59.3 -48.74 80.49 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 113.235 0.828 . . . . 0.0 113.235 172.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.21 -31.9 73.0 Favored 'General case' 0 N--CA 1.488 1.429 0 N-CA-C 115.4 1.63 . . . . 0.0 115.4 -179.416 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.3 mt-10 -97.79 -27.64 14.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 117.101 2.26 . . . . 0.0 117.101 -176.001 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.496 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 17.1 mt -77.36 136.56 38.45 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 117.627 2.455 . . . . 0.0 117.627 -176.398 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.855 ' HG2' HD21 ' A' ' 12' ' ' ASN . 2.7 tt0 . . . . . 0 C--O 1.254 1.3 0 C-N-CA 126.917 2.087 . . . . 0.0 107.873 172.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.421 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 38.9 ttp . . . . . 0 N--CA 1.471 0.577 0 N-CA-C 108.774 -0.824 . . . . 0.0 108.774 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.485 ' HE1' ' HG3' ' A' ' 4' ' ' GLN . 0.3 OUTLIER -67.94 109.46 3.45 Favored 'General case' 0 N--CA 1.483 1.222 0 CA-C-N 113.756 -1.565 . . . . 0.0 109.86 175.264 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -119.03 125.25 48.91 Favored 'General case' 0 N--CA 1.479 1.006 0 O-C-N 124.338 1.024 . . . . 0.0 109.403 -178.713 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.485 ' HG3' ' HE1' ' A' ' 2' ' ' PHE . 5.9 mt-30 -129.9 130.86 45.69 Favored 'General case' 0 N--CA 1.485 1.295 0 CA-C-N 114.298 -1.319 . . . . 0.0 114.357 176.794 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.753 ' HG2' HG22 ' A' ' 62' ' ' THR . 58.9 mt-10 -98.16 90.45 4.86 Favored 'General case' 0 CA--C 1.541 0.618 0 CA-C-N 113.284 -1.78 . . . . 0.0 110.173 178.642 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 64.1 t -96.2 126.48 48.81 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.733 0 CA-C-N 113.984 -1.462 . . . . 0.0 108.158 173.755 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.407 ' HA ' ' HA ' ' A' ' 60' ' ' VAL . 13.7 m -102.32 120.31 40.27 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 177.905 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.579 HG12 HD12 ' A' ' 14' ' ' LEU . 76.3 mt -68.6 125.14 25.79 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.828 0 O-C-N 124.974 1.421 . . . . 0.0 108.051 178.193 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 6.0 t -119.25 -22.1 7.26 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 116.285 1.958 . . . . 0.0 116.285 -171.334 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -66.22 142.85 98.07 Favored Pre-proline 0 N--CA 1.48 1.036 0 N-CA-C 113.694 0.998 . . . . 0.0 113.694 176.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 46.8 Cg_endo -62.81 -30.95 78.24 Favored 'Trans proline' 0 N--CA 1.481 0.758 0 C-N-CA 123.436 2.757 . . . . 0.0 113.963 173.482 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.7 p-10 -72.97 -49.51 28.69 Favored 'General case' 0 N--CA 1.481 1.111 0 C-N-CA 123.831 0.852 . . . . 0.0 111.489 166.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 89.57 171.75 45.19 Favored Glycine 0 N--CA 1.471 0.995 0 C-N-CA 125.376 1.465 . . . . 0.0 112.129 177.052 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.579 HD12 HG12 ' A' ' 8' ' ' ILE . 37.1 mt -73.53 58.73 0.59 Allowed 'General case' 0 N--CA 1.485 1.315 0 CA-C-O 123.432 1.587 . . . . 0.0 110.49 164.6 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.5 p80 -70.19 -147.46 0.01 OUTLIER 'General case' 0 N--CA 1.479 0.977 0 CA-C-N 112.7 -2.045 . . . . 0.0 116.298 -166.896 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 81.6 p -60.49 -54.28 47.35 Favored 'General case' 0 N--CA 1.483 1.177 0 C-N-CA 125.069 1.347 . . . . 0.0 113.566 -168.594 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 26.9 mmm-85 -72.9 -36.77 3.6 Favored Pre-proline 0 N--CA 1.482 1.134 0 CA-C-O 116.57 -1.681 . . . . 0.0 113.517 -178.46 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 51.5 Cg_exo -57.78 -50.33 10.72 Favored 'Trans proline' 0 N--CA 1.486 1.059 0 C-N-CA 122.822 2.348 . . . . 0.0 112.017 165.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.443 ' HB2' HD13 ' A' ' 55' ' ' LEU . . . -54.11 -44.18 71.08 Favored 'General case' 0 CA--C 1.541 0.619 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 171.33 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.7 -47.01 77.53 Favored 'General case' 0 N--CA 1.479 1.015 0 C-N-CA 124.058 0.943 . . . . 0.0 113.369 174.418 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 14.5 mm100 -59.43 -46.09 89.71 Favored 'General case' 0 N--CA 1.482 1.173 0 N-CA-C 113.102 0.778 . . . . 0.0 113.102 170.559 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.485 ' HE2' HG21 ' A' ' 35' ' ' VAL . 17.0 t80 -63.78 -46.49 84.96 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 125.234 1.414 . . . . 0.0 113.293 -179.209 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.465 HG21 ' HA ' ' A' ' 47' ' ' LEU . 71.6 t -56.64 -51.18 69.39 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.647 0 C-N-CA 124.331 1.052 . . . . 0.0 110.461 173.083 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 48.9 tttm -52.5 -53.97 38.83 Favored 'General case' 0 CA--C 1.547 0.827 0 C-N-CA 125.355 1.462 . . . . 0.0 110.9 178.055 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.6 tp10 -62.17 -46.64 88.06 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 124.696 1.247 . . . . 0.0 114.024 178.96 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.91 -38.78 70.71 Favored 'General case' 0 N--CA 1.476 0.864 0 C-N-CA 123.984 0.914 . . . . 0.0 113.318 174.863 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.6 mttm -66.5 -12.18 56.18 Favored 'General case' 0 N--CA 1.479 0.999 0 N-CA-C 115.382 1.623 . . . . 0.0 115.382 174.204 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -100.97 21.21 44.51 Favored Glycine 0 CA--C 1.544 1.888 0 C-N-CA 124.309 0.957 . . . . 0.0 113.455 172.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 75.1 m-85 -122.59 125.15 45.08 Favored 'General case' 0 N--CA 1.473 0.693 0 C-N-CA 124.04 0.936 . . . . 0.0 108.49 167.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 28.2 p -57.95 -36.97 73.29 Favored 'General case' 0 N--CA 1.476 0.869 0 CA-C-O 118.538 -0.744 . . . . 0.0 111.825 177.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 70.2 p -59.23 157.97 9.8 Favored 'General case' 0 N--CA 1.481 1.084 0 C-N-CA 126.147 1.779 . . . . 0.0 112.624 168.772 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 tt0 -111.76 136.13 51.44 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.386 1.089 . . . . 0.0 112.841 175.665 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 0.0 OUTLIER -112.4 111.27 35.42 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.626 0 CA-C-N 111.893 -2.412 . . . . 0.0 112.205 177.405 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.2 m -93.21 98.82 11.52 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 112.551 -2.113 . . . . 0.0 107.122 -178.511 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.609 HG22 HG23 ' A' ' 63' ' ' ILE . 46.9 t -109.48 90.9 1.58 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.296 0 CA-C-N 114.228 -1.351 . . . . 0.0 107.737 -172.419 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.1 p -104.74 101.8 11.4 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-N 112.376 -2.193 . . . . 0.0 113.684 -172.712 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.522 ' HB3' HD12 ' A' ' 53' ' ' LEU . 29.0 t -60.27 103.86 0.27 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 115.208 -0.906 . . . . 0.0 110.521 166.702 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 22.4 p-10 -19.32 90.12 0.01 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 127.881 2.472 . . . . 0.0 116.885 -172.537 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 155.08 -72.38 0.26 Allowed Glycine 0 CA--C 1.538 1.53 0 CA-C-N 112.793 -2.003 . . . . 0.0 114.35 -176.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 28.7 mmtp -114.25 144.12 43.74 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 113.593 0.96 . . . . 0.0 113.593 -170.066 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 18.4 m -76.01 130.6 38.66 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.858 1.429 . . . . 0.0 114.858 -169.999 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -158.52 131.29 7.13 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.945 -1.48 . . . . 0.0 112.909 -174.22 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.2 t -89.06 140.85 29.03 Favored 'General case' 0 N--CA 1.475 0.817 0 CA-C-N 113.649 -1.614 . . . . 0.0 110.106 165.443 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -65.42 -23.2 66.89 Favored 'General case' 0 N--CA 1.475 0.803 0 CA-C-N 113.556 -1.656 . . . . 0.0 112.744 171.876 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 58.3 mtpt -82.14 31.17 0.38 Allowed 'General case' 0 N--CA 1.487 1.379 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 -177.464 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.6 t -160.23 113.32 2.1 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 112.959 -1.928 . . . . 0.0 109.182 -177.343 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.465 ' HA ' HG21 ' A' ' 23' ' ' VAL . 29.5 tp -52.98 -62.24 1.78 Allowed 'General case' 0 N--CA 1.475 0.783 0 CA-C-N 113.596 -1.638 . . . . 0.0 112.871 -174.191 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 17.5 m-30 -63.77 -32.72 74.32 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 115.2 1.555 . . . . 0.0 115.2 -179.377 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.429 ' O ' HD23 ' A' ' 53' ' ' LEU . 15.9 tttt -68.64 -39.64 80.63 Favored 'General case' 0 N--CA 1.479 0.998 0 O-C-N 123.731 0.644 . . . . 0.0 112.015 179.032 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 14.5 tp -70.85 -53.27 15.87 Favored 'General case' 0 N--CA 1.485 1.281 0 O-C-N 123.522 0.514 . . . . 0.0 111.464 173.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 82.1 mt-30 -63.9 -28.15 69.64 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 116.706 2.113 . . . . 0.0 116.706 -173.646 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.5 t -71.45 -16.82 62.39 Favored 'General case' 0 N--CA 1.486 1.33 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 174.446 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.522 HD12 ' HB3' ' A' ' 37' ' ' SER . 4.3 mm? -86.18 154.44 21.32 Favored 'General case' 0 N--CA 1.47 0.557 0 C-N-CA 123.621 0.768 . . . . 0.0 111.575 175.951 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -57.33 94.11 0.04 OUTLIER Glycine 0 N--CA 1.479 1.523 0 C-N-CA 124.695 1.141 . . . . 0.0 112.84 178.738 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.443 HD13 ' HB2' ' A' ' 19' ' ' ALA . 62.4 mt -100.38 48.45 0.92 Allowed 'General case' 0 CA--C 1.551 1.011 0 CA-C-O 122.887 1.327 . . . . 0.0 110.565 170.716 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.6 t -132.03 168.94 17.07 Favored 'General case' 0 N--CA 1.48 1.045 0 CA-C-N 113.061 -1.881 . . . . 0.0 111.573 -168.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 50.8 tt0 -55.0 121.73 9.36 Favored 'General case' 0 N--CA 1.477 0.925 0 C-N-CA 124.351 1.06 . . . . 0.0 111.902 -179.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.51 -29.06 12.08 Favored Glycine 0 N--CA 1.477 1.433 0 CA-C-N 114.481 -1.236 . . . . 0.0 115.275 174.66 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 82.2 p -73.67 136.93 43.84 Favored 'General case' 0 N--CA 1.486 1.348 0 N-CA-C 113.386 0.884 . . . . 0.0 113.386 -177.13 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.407 ' HA ' ' HA ' ' A' ' 7' ' ' THR . 9.3 t -96.72 111.89 27.67 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.123 0 CA-C-N 114.557 -1.201 . . . . 0.0 108.475 -178.524 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.4 m -92.95 101.59 12.77 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.548 0 CA-C-N 115.1 -0.954 . . . . 0.0 110.235 177.342 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.753 HG22 ' HG2' ' A' ' 5' ' ' GLU . 51.8 p -84.77 94.37 8.68 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 113.814 -1.539 . . . . 0.0 111.292 -176.233 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.609 HG23 HG22 ' A' ' 35' ' ' VAL . 2.7 mt -82.78 98.55 4.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.229 0 CA-C-N 112.899 -1.955 . . . . 0.0 109.013 -173.805 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 8.5 t -104.52 134.43 47.72 Favored 'General case' 0 N--CA 1.481 1.092 0 CA-C-N 113.906 -1.497 . . . . 0.0 110.895 -178.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.421 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -122.47 132.62 54.43 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 115.21 1.559 . . . . 0.0 115.21 -173.2 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -136.44 136.55 39.6 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 124.295 1.038 . . . . 0.0 113.162 174.295 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 125.8 -177.23 17.15 Favored Glycine 0 N--CA 1.486 1.982 0 N-CA-C 115.691 1.036 . . . . 0.0 115.691 173.854 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 7.2 tt0 -54.84 -33.0 61.19 Favored 'General case' 0 N--CA 1.485 1.31 0 N-CA-C 115.432 1.641 . . . . 0.0 115.432 -176.68 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.2 m-20 -110.32 28.27 8.81 Favored 'General case' 0 CA--C 1.556 1.186 0 N-CA-C 113.508 0.929 . . . . 0.0 113.508 178.145 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.451 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 2.3 pt-20 -53.63 -57.62 10.12 Favored 'General case' 0 N--CA 1.492 1.644 0 N-CA-C 115.419 1.637 . . . . 0.0 115.419 -172.223 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.451 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -54.3 -47.35 72.51 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 114.431 1.271 . . . . 0.0 114.431 174.909 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 59.9 mttp -57.73 -41.76 82.48 Favored 'General case' 0 CA--C 1.544 0.713 0 C-N-CA 125.222 1.409 . . . . 0.0 112.613 179.796 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -60.21 -57.51 12.48 Favored 'General case' 0 CA--C 1.546 0.809 0 C-N-CA 124.2 1.0 . . . . 0.0 112.599 178.766 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 40.2 t -67.96 -36.7 76.55 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.757 0 CA-C-O 118.72 -0.657 . . . . 0.0 112.166 -176.268 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 22.3 tt0 -52.85 -57.18 11.08 Favored 'General case' 0 N--CA 1.482 1.146 0 O-C-N 124.036 0.835 . . . . 0.0 111.173 174.704 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 84.5 t60 -65.66 -40.62 92.65 Favored 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 114.042 1.127 . . . . 0.0 114.042 177.834 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 96.1 mt -63.6 -43.16 97.74 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.773 1.397 . . . . 0.0 114.773 177.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 39.4 t -60.22 -43.67 93.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.308 0 C-N-CA 122.893 0.477 . . . . 0.0 111.496 172.3 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.5 ttpt -55.71 -43.66 76.71 Favored 'General case' 0 CA--C 1.552 1.056 0 C-N-CA 123.853 0.861 . . . . 0.0 111.517 174.855 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.6 mt -61.08 -56.89 15.66 Favored 'General case' 0 N--CA 1.483 1.209 0 C-N-CA 123.772 0.829 . . . . 0.0 112.888 172.0 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 20.3 mtp -47.75 -45.08 28.66 Favored 'General case' 0 N--CA 1.489 1.483 0 C-N-CA 124.613 1.165 . . . . 0.0 113.549 -179.253 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -51.83 -43.72 63.28 Favored 'General case' 0 N--CA 1.474 0.757 0 C-N-CA 125.769 1.627 . . . . 0.0 115.307 178.851 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.1 pt-20 -111.74 15.53 20.91 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.38 1.622 . . . . 0.0 115.38 -177.727 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 2.5 mp -116.66 20.71 13.89 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 172.085 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 20.0 tt0 . . . . . 0 N--CA 1.479 0.977 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 -179.674 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 43.1 ttp . . . . . 0 N--CA 1.464 0.265 0 N-CA-C 107.693 -1.225 . . . . 0.0 107.693 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 60.3 t80 -141.02 131.61 25.5 Favored 'General case' 0 N--CA 1.475 0.799 0 O-C-N 124.76 1.288 . . . . 0.0 109.095 172.751 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -122.7 127.35 49.15 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.41 -1.268 . . . . 0.0 110.799 -171.4 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.1 tt0 -126.56 122.5 35.28 Favored 'General case' 0 N--CA 1.478 0.939 0 CA-C-O 121.614 0.721 . . . . 0.0 112.664 171.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.632 ' HG2' HG22 ' A' ' 62' ' ' THR . 60.3 mt-10 -79.5 103.24 9.28 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 114.399 -1.273 . . . . 0.0 111.272 -179.394 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 17.7 t -112.25 135.58 51.16 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.926 0 CA-C-N 114.901 -1.045 . . . . 0.0 110.653 -177.592 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.586 HG23 HG22 ' A' ' 60' ' ' VAL . 0.6 OUTLIER -103.22 128.89 50.07 Favored 'General case' 0 N--CA 1.478 0.94 0 CA-C-N 114.447 -1.251 . . . . 0.0 108.154 -178.305 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 11.6 mt -97.95 92.4 2.86 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.611 0 N-CA-C 105.566 -2.013 . . . . 0.0 105.566 167.106 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.8 t -86.02 -24.72 26.3 Favored 'General case' 0 N--CA 1.476 0.851 0 N-CA-C 114.442 1.275 . . . . 0.0 114.442 -175.98 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -52.7 133.98 46.13 Favored Pre-proline 0 N--CA 1.482 1.145 0 N-CA-C 115.237 1.569 . . . . 0.0 115.237 179.272 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_exo -58.53 -47.35 19.44 Favored 'Trans proline' 0 N--CA 1.485 0.981 0 C-N-CA 123.83 3.02 . . . . 0.0 113.2 173.657 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -54.17 -36.37 63.31 Favored 'General case' 0 N--CA 1.478 0.948 0 N-CA-C 114.617 1.34 . . . . 0.0 114.617 166.784 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.92 -163.49 24.64 Favored Glycine 0 CA--C 1.532 1.094 0 O-C-N 125.118 1.511 . . . . 0.0 113.791 -178.417 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 55.4 mt -115.61 69.35 0.73 Allowed 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 112.481 -1.86 . . . . 0.0 110.271 178.559 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.1 p80 -73.71 -175.04 1.93 Allowed 'General case' 0 N--CA 1.481 1.089 0 CA-C-N 111.864 -2.426 . . . . 0.0 114.976 -166.699 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.4 p -40.3 -40.52 1.17 Allowed 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.552 1.686 . . . . 0.0 115.552 179.241 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.254 9.6 mmm180 -75.34 -48.43 4.16 Favored Pre-proline 0 N--CA 1.485 1.304 0 CA-C-O 116.139 -1.886 . . . . 0.0 113.48 -179.041 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_exo -54.64 -47.86 24.46 Favored 'Trans proline' 0 N--CA 1.482 0.826 0 C-N-CA 122.214 1.943 . . . . 0.0 113.877 162.718 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.29 -41.57 72.48 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 178.513 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.07 -31.59 72.76 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 114.751 1.389 . . . . 0.0 114.751 174.551 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 30.3 mm100 -80.75 -37.53 30.3 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 123.581 0.752 . . . . 0.0 112.282 173.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 11.3 t80 -57.19 -46.34 82.94 Favored 'General case' 0 CA--C 1.55 0.969 0 C-N-CA 124.255 1.022 . . . . 0.0 111.566 173.903 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 37.5 t -42.31 -61.04 0.31 Allowed 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 125.227 1.411 . . . . 0.0 113.14 170.006 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 52.4 tttm -42.71 -50.03 5.56 Favored 'General case' 0 N--CA 1.481 1.09 0 C-N-CA 124.986 1.315 . . . . 0.0 113.575 178.925 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.5 tp10 -66.16 -47.88 72.56 Favored 'General case' 0 N--CA 1.48 1.025 0 C-N-CA 123.907 0.883 . . . . 0.0 112.992 179.429 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.69 -31.62 71.77 Favored 'General case' 0 N--CA 1.484 1.228 0 N-CA-C 115.668 1.729 . . . . 0.0 115.668 -178.535 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 24.6 mmtt -50.62 -52.8 36.17 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.902 2.186 . . . . 0.0 116.902 -179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.09 -27.22 68.55 Favored Glycine 0 CA--C 1.541 1.661 0 O-C-N 125.843 1.964 . . . . 0.0 115.13 178.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 52.8 m-85 -70.15 110.61 5.26 Favored 'General case' 0 N--CA 1.478 0.957 0 N-CA-C 108.71 -0.848 . . . . 0.0 108.71 174.944 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -48.8 -38.45 22.06 Favored 'General case' 0 N--CA 1.488 1.469 0 C-N-CA 125.674 1.59 . . . . 0.0 111.617 177.627 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -61.02 140.31 57.86 Favored 'General case' 0 N--CA 1.482 1.135 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 169.814 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 20.1 tt0 -92.1 101.52 14.05 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 123.938 1.827 . . . . 0.0 111.55 174.523 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.428 HG21 HD13 ' A' ' 77' ' ' LEU . 6.9 mm -71.68 82.37 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 110.22 -3.173 . . . . 0.0 110.108 178.865 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.5 m -73.69 104.59 4.67 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 114.484 -1.234 . . . . 0.0 110.795 176.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.4 t -98.1 85.58 1.35 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 112.611 -2.086 . . . . 0.0 106.962 -175.666 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 89.2 m -86.79 97.69 10.77 Favored 'General case' 0 N--CA 1.478 0.974 0 CA-C-N 114.803 -1.09 . . . . 0.0 111.422 -175.663 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.499 ' HB3' HD12 ' A' ' 53' ' ' LEU . 5.6 t -70.44 92.15 0.8 Allowed 'General case' 0 N--CA 1.475 0.819 0 CA-C-N 115.228 -0.896 . . . . 0.0 110.379 172.616 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.289 37.7 p30 2.67 101.34 0.01 OUTLIER 'General case' 0 CA--C 1.558 1.266 0 CA-C-N 110.189 -3.187 . . . . 0.0 117.461 -174.142 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.37 -87.05 0.42 Allowed Glycine 0 CA--C 1.541 1.685 0 CA-C-N 112.721 -2.036 . . . . 0.0 110.122 -168.053 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.487 ' HB2' HD11 ' A' ' 53' ' ' LEU . 8.1 mptt -94.96 140.07 30.46 Favored 'General case' 0 N--CA 1.482 1.137 0 CA-C-O 121.202 0.525 . . . . 0.0 112.363 -173.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.1 m -78.61 128.56 33.67 Favored 'General case' 0 N--CA 1.475 0.808 0 N-CA-C 115.669 1.729 . . . . 0.0 115.669 178.095 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.444 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -117.65 169.54 9.48 Favored 'General case' 0 N--CA 1.478 0.96 0 CA-C-N 113.175 -1.83 . . . . 0.0 109.05 166.833 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 12.1 t -132.71 126.17 31.92 Favored 'General case' 0 N--CA 1.479 0.991 0 C-N-CA 122.596 0.358 . . . . 0.0 110.781 -176.337 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.551 ' HA ' HD22 ' A' ' 50' ' ' LEU . . . -60.05 -30.97 69.55 Favored 'General case' 0 N--CA 1.483 1.206 0 O-C-N 124.564 1.165 . . . . 0.0 112.925 178.073 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 30.3 mtpt -72.73 -36.13 67.7 Favored 'General case' 0 N--CA 1.484 1.251 0 C-N-CA 124.916 1.287 . . . . 0.0 113.403 175.616 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -96.73 102.84 14.69 Favored 'General case' 0 N--CA 1.482 1.148 0 CA-C-O 122.321 1.058 . . . . 0.0 110.794 -175.599 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 19.8 tp -44.3 -68.73 0.17 Allowed 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 111.959 -2.382 . . . . 0.0 114.503 -177.38 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 59.1 m-85 -63.17 -41.66 99.27 Favored 'General case' 0 N--CA 1.479 1.018 0 N-CA-C 114.88 1.437 . . . . 0.0 114.88 -177.353 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.437 ' HG2' ' HA ' ' A' ' 42' ' ' ALA . 83.2 tttt -55.91 -40.74 73.5 Favored 'General case' 0 N--CA 1.48 1.072 0 N-CA-C 113.328 0.862 . . . . 0.0 113.328 171.963 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.551 HD22 ' HA ' ' A' ' 44' ' ' ALA . 22.3 tp -68.03 -47.54 68.15 Favored 'General case' 0 N--CA 1.481 1.094 0 CA-C-O 118.927 -0.559 . . . . 0.0 111.677 172.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -63.66 -23.93 67.58 Favored 'General case' 0 N--CA 1.478 0.934 0 N-CA-C 117.294 2.331 . . . . 0.0 117.294 179.589 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.8 t -79.44 -27.98 41.67 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.276 1.213 . . . . 0.0 114.276 176.492 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.499 HD12 ' HB3' ' A' ' 37' ' ' SER . 2.7 mm? -84.33 168.82 15.27 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 124.044 0.938 . . . . 0.0 112.343 176.987 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -77.1 117.19 4.77 Favored Glycine 0 CA--C 1.546 2.002 0 C-N-CA 125.256 1.408 . . . . 0.0 113.428 -178.939 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.536 HD11 ' HG ' ' A' ' 50' ' ' LEU . 31.6 mt -123.7 60.53 1.09 Allowed 'General case' 0 N--CA 1.486 1.328 0 CA-C-O 122.405 1.098 . . . . 0.0 109.2 176.583 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.2 t -153.08 -169.59 3.37 Favored 'General case' 0 N--CA 1.486 1.37 0 CA-C-N 114.541 -1.209 . . . . 0.0 113.259 -160.928 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 61.7 tt0 -49.01 104.7 0.07 Allowed 'General case' 0 N--CA 1.475 0.82 0 C-N-CA 127.163 2.185 . . . . 0.0 113.128 -175.984 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 99.23 -18.65 56.27 Favored Glycine 0 CA--C 1.547 2.093 0 CA-C-N 112.919 -1.946 . . . . 0.0 114.556 172.503 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.4 p -69.61 125.16 25.88 Favored 'General case' 0 N--CA 1.487 1.378 0 C-N-CA 123.266 0.627 . . . . 0.0 111.838 -166.923 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.586 HG22 HG23 ' A' ' 7' ' ' THR . 45.9 t -97.83 122.56 49.57 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.306 0 CA-C-N 114.51 -1.223 . . . . 0.0 108.802 -178.712 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.5 m -105.04 103.45 15.35 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.748 0 CA-C-N 112.927 -1.942 . . . . 0.0 110.067 -177.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.632 HG22 ' HG2' ' A' ' 5' ' ' GLU . 75.0 p -83.22 88.15 6.93 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.965 -1.925 . . . . 0.0 109.502 179.122 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.8 mt -72.14 94.19 0.55 Allowed 'Isoleucine or valine' 0 N--CA 1.488 1.461 0 CA-C-N 111.622 -2.536 . . . . 0.0 108.625 -172.401 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 13.5 t -101.41 84.22 2.58 Favored 'General case' 0 N--CA 1.475 0.807 0 CA-C-N 113.377 -1.738 . . . . 0.0 109.726 -176.873 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -77.09 100.41 5.7 Favored 'General case' 0 N--CA 1.47 0.574 0 CA-C-N 114.846 -1.07 . . . . 0.0 109.624 179.195 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.0 pt-20 -94.42 136.34 34.83 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 114.285 -1.325 . . . . 0.0 113.784 -179.385 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 106.49 -147.9 16.32 Favored Glycine 0 CA--C 1.538 1.501 0 CA-C-N 112.735 -2.029 . . . . 0.0 114.172 175.31 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 75.4 mt-10 -67.32 -25.29 65.94 Favored 'General case' 0 N--CA 1.483 1.175 0 N-CA-C 118.271 2.693 . . . . 0.0 118.271 -163.723 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 22.1 m-20 -106.74 -1.69 22.37 Favored 'General case' 0 N--CA 1.485 1.281 0 N-CA-C 114.862 1.43 . . . . 0.0 114.862 -177.938 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.432 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 3.8 pt-20 -8.0 -70.9 0.0 OUTLIER 'General case' 0 N--CA 1.491 1.619 0 N-CA-C 120.323 3.453 . . . . 0.0 120.323 -177.41 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.432 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.5 OUTLIER -73.24 -48.08 37.89 Favored 'General case' 0 N--CA 1.489 1.509 0 N-CA-C 113.631 0.974 . . . . 0.0 113.631 -175.533 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 12.9 mtmm -55.66 -32.91 63.62 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.393 1.477 . . . . 0.0 112.233 174.344 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -69.16 -63.7 1.01 Allowed 'General case' 0 N--CA 1.469 0.49 0 CA-C-N 114.212 -1.358 . . . . 0.0 111.724 -178.223 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 12.5 t -55.03 -41.29 58.16 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.876 0 C-N-CA 123.709 0.804 . . . . 0.0 111.916 178.902 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 41.3 tt0 -45.43 -60.8 1.96 Allowed 'General case' 0 N--CA 1.485 1.31 0 C-N-CA 125.054 1.342 . . . . 0.0 112.203 179.259 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -69.28 -45.84 68.65 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 114.797 -1.092 . . . . 0.0 113.055 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.428 HD13 HG21 ' A' ' 33' ' ' ILE . 9.7 mt -61.35 -35.46 77.5 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 114.087 1.144 . . . . 0.0 114.087 -179.746 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.9 t -76.04 -43.54 38.38 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.038 0 C-N-CA 123.429 0.692 . . . . 0.0 110.655 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.6 ttpt -48.92 -48.28 42.83 Favored 'General case' 0 N--CA 1.475 0.824 0 C-N-CA 124.378 1.071 . . . . 0.0 111.988 172.325 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.4 mt -59.73 -59.1 5.98 Favored 'General case' 0 N--CA 1.486 1.361 0 O-C-N 123.914 0.759 . . . . 0.0 113.011 174.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 7.2 mtt -48.61 -27.2 2.65 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 116.03 1.863 . . . . 0.0 116.03 175.061 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.09 -23.88 67.49 Favored 'General case' 0 N--CA 1.476 0.846 0 N-CA-C 115.936 1.828 . . . . 0.0 115.936 178.377 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 11.7 pt-20 -123.34 44.99 2.54 Favored 'General case' 0 N--CA 1.49 1.574 0 CA-C-O 121.905 0.859 . . . . 0.0 112.626 174.443 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.1 mt -127.1 -28.72 2.84 Favored 'General case' 0 N--CA 1.482 1.174 0 N-CA-C 119.626 3.195 . . . . 0.0 119.626 -171.288 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 N--CA 1.484 1.23 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 174.978 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 18.6 ttp . . . . . 0 CA--C 1.536 0.434 0 N-CA-C 107.431 -1.322 . . . . 0.0 107.431 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 72.0 t80 -108.0 126.25 52.5 Favored 'General case' 0 N--CA 1.469 0.509 0 O-C-N 124.955 1.409 . . . . 0.0 109.523 179.668 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -117.61 116.02 26.25 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 113.544 -1.662 . . . . 0.0 108.815 -178.884 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -119.2 121.79 40.51 Favored 'General case' 0 N--CA 1.476 0.843 0 CA-C-N 114.58 -1.191 . . . . 0.0 111.694 177.301 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.1 tt0 -81.54 113.02 19.29 Favored 'General case' 0 CA--C 1.538 0.514 0 CA-C-N 112.743 -2.026 . . . . 0.0 108.72 173.81 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 92.6 t -124.84 141.05 46.18 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.994 0 CA-C-N 113.427 -1.715 . . . . 0.0 108.88 -178.345 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.474 HG22 HG22 ' A' ' 60' ' ' VAL . 40.4 p -113.9 121.01 42.67 Favored 'General case' 0 N--CA 1.484 1.273 0 CA-C-N 115.218 -0.901 . . . . 0.0 109.979 172.12 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 28.1 mt -101.09 126.34 54.87 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.992 0 N-CA-C 106.766 -1.568 . . . . 0.0 106.766 175.202 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.487 ' HA ' ' HA ' ' A' ' 57' ' ' GLN 0.315 5.1 t -126.14 55.52 1.48 Allowed 'General case' 0 N--CA 1.477 0.917 0 N-CA-C 115.732 1.753 . . . . 0.0 115.732 -177.453 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.735 ' HB2' ' HG3' ' A' ' 85' ' ' GLU . . . -101.74 114.87 65.5 Favored Pre-proline 0 N--CA 1.481 1.079 0 CA-C-N 112.205 -2.271 . . . . 0.0 113.602 -176.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.408 ' HD2' ' HA ' ' A' ' 10' ' ' ALA . 43.1 Cg_endo -63.72 -35.43 57.73 Favored 'Trans proline' 0 CA--C 1.539 0.763 0 C-N-CA 122.595 2.197 . . . . 0.0 112.126 171.367 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.13 -52.1 66.63 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 126.286 1.834 . . . . 0.0 113.128 168.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.97 146.05 1.25 Allowed Glycine 0 N--CA 1.483 1.806 0 O-C-N 124.706 1.254 . . . . 0.0 115.462 170.22 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 52.1 mt -84.25 79.06 9.66 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-O 123.169 1.461 . . . . 0.0 111.008 178.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 30.7 p80 -67.41 -167.03 0.06 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 112.501 -2.136 . . . . 0.0 114.795 179.0 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 39.7 p -51.86 -45.04 63.9 Favored 'General case' 0 N--CA 1.474 0.736 0 C-N-CA 126.191 1.796 . . . . 0.0 115.347 -175.103 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.251 13.9 mmm180 -73.04 -45.5 8.31 Favored Pre-proline 0 N--CA 1.481 1.096 0 CA-C-O 116.44 -1.743 . . . . 0.0 114.337 179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 45.2 Cg_exo -56.31 -45.8 35.14 Favored 'Trans proline' 0 C--N 1.355 0.881 0 C-N-CA 122.269 1.979 . . . . 0.0 112.647 165.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.453 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.27 -44.24 79.57 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 113.856 1.058 . . . . 0.0 113.856 175.007 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -63.25 -42.32 99.18 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 114.236 1.199 . . . . 0.0 114.236 174.874 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 51.4 tp60 -64.94 -43.07 93.93 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 124.078 0.951 . . . . 0.0 111.14 175.809 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 12.3 t80 -62.02 -41.4 98.05 Favored 'General case' 0 N--CA 1.478 0.933 0 C-N-CA 125.06 1.344 . . . . 0.0 111.994 174.218 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.537 HG21 ' HA ' ' A' ' 47' ' ' LEU . 81.6 t -53.36 -47.49 57.89 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.415 0 C-N-CA 123.063 0.545 . . . . 0.0 111.545 170.74 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 77.1 tttt -60.39 -47.22 87.04 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 119.08 -0.486 . . . . 0.0 112.135 177.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.6 tp10 -63.08 -42.07 99.56 Favored 'General case' 0 CA--C 1.554 1.1 0 N-CA-C 112.744 0.646 . . . . 0.0 112.744 178.014 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.06 -38.04 89.64 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 124.421 1.088 . . . . 0.0 113.715 172.533 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.419 ' HD3' ' HG2' ' A' ' 45' ' ' LYS . 52.9 mmtt -60.95 -28.4 68.94 Favored 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 113.54 0.941 . . . . 0.0 113.54 169.418 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.73 -43.77 98.47 Favored Glycine 0 CA--C 1.539 1.551 0 C-N-CA 125.095 1.331 . . . . 0.0 113.3 177.772 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.7 m-85 -78.38 147.0 34.28 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 113.546 0.943 . . . . 0.0 113.546 174.86 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 81.0 p -70.64 -38.53 73.87 Favored 'General case' 0 N--CA 1.487 1.421 0 CA-C-N 114.93 -1.032 . . . . 0.0 113.486 -172.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 27.0 p -64.36 152.5 41.14 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 172.001 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.51 ' HA ' ' HD2' ' A' ' 45' ' ' LYS . 2.9 tt0 -92.35 107.42 19.2 Favored 'General case' 0 N--CA 1.49 1.53 0 CA-C-O 122.891 1.329 . . . . 0.0 111.288 175.157 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.775 HD11 ' HB1' ' A' ' 73' ' ' ALA . 48.2 mm -75.28 104.94 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.719 0 CA-C-N 111.043 -2.798 . . . . 0.0 109.825 175.662 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 2.4 m -110.29 114.24 27.54 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.467 -1.242 . . . . 0.0 109.134 177.184 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 59.9 t -102.55 100.97 11.48 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.725 -1.579 . . . . 0.0 108.618 -174.203 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.41 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 72.5 m -86.34 97.05 10.2 Favored 'General case' 0 N--CA 1.479 0.982 0 CA-C-N 115.199 -0.909 . . . . 0.0 108.653 174.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.1 t -76.74 100.59 5.49 Favored 'General case' 0 N--CA 1.48 1.037 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.888 171.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.313 12.6 p-10 -0.55 87.51 0.0 OUTLIER 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 118.044 2.609 . . . . 0.0 118.044 -168.188 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 121.61 -60.73 0.55 Allowed Glycine 0 N--CA 1.483 1.815 0 CA-C-N 111.397 -2.638 . . . . 0.0 111.916 -175.654 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 96.8 mttt -102.61 116.07 31.85 Favored 'General case' 0 N--CA 1.476 0.861 0 N-CA-C 114.518 1.303 . . . . 0.0 114.518 -170.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.41 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 39.6 m -74.78 111.84 10.38 Favored 'General case' 0 N--CA 1.48 1.071 0 CA-C-N 113.472 -1.694 . . . . 0.0 114.912 176.787 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -116.12 112.54 21.87 Favored 'General case' 0 N--CA 1.477 0.914 0 CA-C-N 113.015 -1.902 . . . . 0.0 110.45 178.59 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.8 t -68.44 115.13 7.5 Favored 'General case' 0 N--CA 1.479 1.017 0 CA-C-N 114.634 -1.166 . . . . 0.0 110.752 176.826 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.23 -14.67 62.3 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.333 -1.758 . . . . 0.0 112.269 174.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.51 ' HD2' ' HA ' ' A' ' 32' ' ' GLU . 31.9 mttt -81.77 10.44 6.22 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 115.232 1.568 . . . . 0.0 115.232 167.714 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.545 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 34.9 t -133.91 127.41 32.43 Favored 'General case' 0 N--CA 1.473 0.698 0 C-N-CA 123.369 0.668 . . . . 0.0 111.933 169.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.537 ' HA ' HG21 ' A' ' 23' ' ' VAL . 10.1 tp -47.74 -69.14 0.13 Allowed 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 126.389 1.876 . . . . 0.0 110.972 175.805 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 89.7 m-85 -51.67 -45.16 63.31 Favored 'General case' 0 N--CA 1.483 1.218 0 C-N-CA 125.221 1.408 . . . . 0.0 113.418 178.335 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.545 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 40.6 mttt -64.94 -52.63 55.28 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.664 1.357 . . . . 0.0 114.664 -178.383 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.4 tp -63.0 -46.33 88.17 Favored 'General case' 0 CA--C 1.547 0.861 0 CA-C-O 118.78 -0.629 . . . . 0.0 112.319 177.846 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 92.8 mt-30 -56.72 -32.88 65.96 Favored 'General case' 0 N--CA 1.48 1.027 0 N-CA-C 115.635 1.717 . . . . 0.0 115.635 -179.112 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.3 t -78.87 -2.22 38.75 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -178.857 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.459 HD13 ' HA ' ' A' ' 53' ' ' LEU . 3.8 mm? -118.22 140.45 49.78 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 114.299 1.222 . . . . 0.0 114.299 176.089 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -73.27 118.27 6.21 Favored Glycine 0 CA--C 1.537 1.442 0 CA-C-N 113.52 -1.673 . . . . 0.0 113.307 -177.854 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.561 HD23 HG11 ' A' ' 61' ' ' VAL . 1.3 mp -116.35 87.35 2.67 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 168.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -135.3 -132.37 0.15 Allowed 'General case' 0 N--CA 1.486 1.34 0 CA-C-N 115.161 -0.927 . . . . 0.0 111.993 -162.093 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.487 ' HA ' ' HA ' ' A' ' 9' ' ' THR . 4.1 tt0 -86.57 134.75 33.62 Favored 'General case' 0 N--CA 1.473 0.688 0 C-N-CA 123.696 0.798 . . . . 0.0 111.636 176.232 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 80.28 -61.22 4.43 Favored Glycine 0 N--CA 1.484 1.876 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.763 -176.02 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.8 p -3.09 114.96 0.01 OUTLIER 'General case' 0 N--CA 1.491 1.621 0 N-CA-C 118.478 2.77 . . . . 0.0 118.478 -178.309 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.474 HG22 HG22 ' A' ' 7' ' ' THR . 57.3 t -100.26 108.03 22.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 112.45 -2.159 . . . . 0.0 107.325 -174.492 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.561 HG11 HD23 ' A' ' 55' ' ' LEU . 15.4 m -113.74 119.78 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.533 0 CA-C-N 113.402 -1.726 . . . . 0.0 111.885 -172.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 25.8 p -103.97 104.27 14.22 Favored 'General case' 0 N--CA 1.477 0.905 0 CA-C-N 114.026 -1.443 . . . . 0.0 111.945 177.278 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.448 HG23 HG23 ' A' ' 33' ' ' ILE . 4.9 mp -87.0 103.01 12.82 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.677 -2.056 . . . . 0.0 107.466 -179.575 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 4.3 t -101.24 108.86 20.62 Favored 'General case' 0 N--CA 1.465 0.288 0 CA-C-N 114.431 -1.259 . . . . 0.0 108.663 173.837 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.66 97.73 9.95 Favored 'General case' 0 N--CA 1.474 0.767 0 CA-C-N 112.928 -1.942 . . . . 0.0 111.825 -178.058 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -95.18 100.96 12.68 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 114.277 1.214 . . . . 0.0 114.277 179.477 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 154.77 -173.5 33.15 Favored Glycine 0 N--CA 1.48 1.592 0 CA-C-N 111.543 -2.572 . . . . 0.0 111.172 179.106 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.7 mp0 -59.98 -55.88 28.59 Favored 'General case' 0 N--CA 1.484 1.232 0 N-CA-C 117.34 2.348 . . . . 0.0 117.34 -175.991 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.8 p30 -81.3 33.73 0.35 Allowed 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.793 1.775 . . . . 0.0 115.793 -178.27 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -41.95 -50.1 4.55 Favored 'General case' 0 N--CA 1.486 1.364 0 C-N-CA 127.053 2.141 . . . . 0.0 115.878 -177.725 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.502 ' NE2' ' H ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -69.54 -55.45 10.15 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 125.378 1.471 . . . . 0.0 114.478 -178.454 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.8 mtmt -67.44 -33.77 75.82 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 113.817 1.043 . . . . 0.0 113.817 -178.21 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.775 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -54.82 -55.88 25.47 Favored 'General case' 0 N--CA 1.473 0.703 0 CA-C-N 115.063 -0.972 . . . . 0.0 112.012 173.35 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 23.0 t -64.1 -45.25 97.04 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.043 0 CA-C-O 118.486 -0.769 . . . . 0.0 110.98 177.611 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 36.5 tt0 -52.34 -54.3 33.43 Favored 'General case' 0 N--CA 1.485 1.322 0 C-N-CA 124.697 1.199 . . . . 0.0 113.847 -178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.434 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 85.6 t60 -63.01 -40.32 97.41 Favored 'General case' 0 CA--C 1.549 0.933 0 N-CA-C 113.163 0.801 . . . . 0.0 113.163 178.262 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 59.2 mt -67.34 -37.59 83.52 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 114.164 1.172 . . . . 0.0 114.164 174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 43.6 t -61.47 -46.05 97.37 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 C-N-CA 124.304 1.042 . . . . 0.0 111.094 173.587 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.434 ' HB3' ' O ' ' A' ' 76' ' ' HIS . 40.8 tttp -48.38 -53.44 17.62 Favored 'General case' 0 N--CA 1.483 1.196 0 O-C-N 124.441 1.088 . . . . 0.0 111.382 170.873 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.8 mt -61.91 -45.92 91.62 Favored 'General case' 0 N--CA 1.479 0.981 0 N-CA-C 114.65 1.352 . . . . 0.0 114.65 177.914 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 45.8 mtm -52.13 -50.94 60.72 Favored 'General case' 0 N--CA 1.484 1.241 0 O-C-N 124.092 0.87 . . . . 0.0 112.354 172.479 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.24 -35.59 79.88 Favored 'General case' 0 N--CA 1.475 0.78 0 N-CA-C 115.91 1.819 . . . . 0.0 115.91 -179.098 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.275 12.9 pt-20 -82.5 -18.45 41.53 Favored 'General case' 0 N--CA 1.485 1.288 0 N-CA-C 115.537 1.68 . . . . 0.0 115.537 176.579 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.4 mt -108.64 47.96 0.88 Allowed 'General case' 0 N--CA 1.481 1.081 0 N-CA-C 113.093 0.775 . . . . 0.0 113.093 176.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.735 ' HG3' ' HB2' ' A' ' 10' ' ' ALA . 28.9 tt0 . . . . . 0 C--O 1.252 1.204 0 N-CA-C 106.776 -1.565 . . . . 0.0 106.776 -179.476 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.3 mmm . . . . . 0 N--CA 1.475 0.796 0 N-CA-C 107.426 -1.324 . . . . 0.0 107.426 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 75.3 t80 -139.3 142.11 37.71 Favored 'General case' 0 N--CA 1.475 0.821 0 O-C-N 124.94 1.4 . . . . 0.0 110.976 -172.332 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -128.66 130.93 47.91 Favored 'General case' 0 N--CA 1.48 1.075 0 O-C-N 124.809 1.318 . . . . 0.0 110.315 177.703 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 40.3 mt-30 -112.66 113.06 25.0 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-N 114.271 -1.332 . . . . 0.0 111.212 163.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 7.7 tt0 -77.73 92.83 4.2 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 113.008 -1.905 . . . . 0.0 109.717 178.311 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 39.2 t -109.81 147.05 14.45 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.624 0 CA-C-N 112.249 -2.25 . . . . 0.0 108.762 -175.781 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.1 p -114.22 153.68 29.22 Favored 'General case' 0 N--CA 1.478 0.97 0 CA-C-N 115.16 -0.927 . . . . 0.0 111.031 172.096 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mt -115.24 104.81 17.43 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 N-CA-C 106.709 -1.589 . . . . 0.0 106.709 167.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 9.8 t -118.48 53.79 0.96 Allowed 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.116 172.432 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.483 ' HB2' ' HG3' ' A' ' 85' ' ' GLU . . . -119.72 121.64 29.71 Favored Pre-proline 0 C--N 1.325 -0.492 0 CA-C-N 111.765 -2.471 . . . . 0.0 110.86 -177.816 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 72.1 Cg_exo -55.55 -44.4 48.64 Favored 'Trans proline' 0 CA--C 1.544 0.997 0 C-N-CA 124.212 3.274 . . . . 0.0 111.473 179.126 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -60.19 -59.57 5.2 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 126.394 1.878 . . . . 0.0 112.768 168.095 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.22 -168.22 54.82 Favored Glycine 0 N--CA 1.478 1.485 0 C-N-CA 124.71 1.148 . . . . 0.0 113.955 178.1 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 14.1 tp -99.64 58.18 1.04 Allowed 'General case' 0 N--CA 1.475 0.817 0 CA-C-O 124.161 1.934 . . . . 0.0 108.837 -178.898 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 10.8 p80 -62.86 -169.6 0.02 OUTLIER 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 113.099 -1.864 . . . . 0.0 115.61 -174.676 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -46.36 -60.25 2.45 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 116.221 1.934 . . . . 0.0 116.221 -166.679 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HD2' ' HA ' ' A' ' 17' ' ' ARG 0.301 9.4 mmm180 -73.68 -37.84 3.69 Favored Pre-proline 0 N--CA 1.485 1.28 0 N-CA-C 117.151 2.278 . . . . 0.0 117.151 177.101 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.6 Cg_exo -54.57 -50.9 11.83 Favored 'Trans proline' 0 N--CA 1.478 0.61 0 C-N-CA 122.854 2.369 . . . . 0.0 113.082 167.052 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.481 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -57.73 -42.98 84.96 Favored 'General case' 0 N--CA 1.484 1.268 0 N-CA-C 113.401 0.889 . . . . 0.0 113.401 172.419 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.21 -41.5 88.72 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.616 1.339 . . . . 0.0 114.616 175.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 54.6 tp60 -66.7 -43.09 85.28 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 123.769 0.827 . . . . 0.0 111.79 176.176 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 47.0 t80 -59.66 -39.49 84.58 Favored 'General case' 0 CA--C 1.548 0.893 0 C-N-CA 126.064 1.745 . . . . 0.0 112.301 172.344 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.586 HG21 ' HA ' ' A' ' 47' ' ' LEU . 92.2 t -58.51 -51.43 71.72 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.249 0 C-N-CA 124.107 0.963 . . . . 0.0 111.585 172.045 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.3 tmtt? -49.08 -49.74 40.19 Favored 'General case' 0 N--CA 1.475 0.783 0 O-C-N 123.791 0.682 . . . . 0.0 111.71 174.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -63.59 -49.79 71.97 Favored 'General case' 0 N--CA 1.473 0.682 0 O-C-N 124.314 1.008 . . . . 0.0 113.624 178.58 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -57.45 -35.96 70.79 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.086 1.143 . . . . 0.0 114.086 176.934 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.511 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 61.1 mttt -65.33 -26.12 67.9 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 175.488 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.45 -35.82 90.64 Favored Glycine 0 CA--C 1.535 1.319 0 O-C-N 124.157 0.911 . . . . 0.0 113.71 175.675 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 47.2 m-85 -71.44 154.99 41.12 Favored 'General case' 0 N--CA 1.476 0.864 0 N-CA-C 115.413 1.635 . . . . 0.0 115.413 -177.643 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 76.0 p -73.88 -45.33 51.5 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-N 114.626 -1.17 . . . . 0.0 112.404 177.404 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 78.3 p -70.03 150.24 46.85 Favored 'General case' 0 N--CA 1.485 1.32 0 C-N-CA 124.175 0.99 . . . . 0.0 112.885 177.565 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.7 tt0 -94.22 101.37 13.35 Favored 'General case' 0 CA--C 1.542 0.654 0 CA-C-O 122.842 1.306 . . . . 0.0 110.541 175.207 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 24.0 mm -75.42 111.57 11.89 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.872 0 CA-C-N 110.883 -2.871 . . . . 0.0 110.021 178.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -112.02 120.26 41.26 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.072 -1.422 . . . . 0.0 111.176 173.186 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG22 HG12 ' A' ' 63' ' ' ILE . 96.9 t -108.78 84.2 0.71 Allowed 'Isoleucine or valine' 0 CA--C 1.547 0.827 0 CA-C-N 112.709 -2.041 . . . . 0.0 106.282 -174.574 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 92.0 m -81.86 110.95 17.63 Favored 'General case' 0 N--CA 1.484 1.236 0 CA-C-N 113.815 -1.539 . . . . 0.0 111.925 -175.32 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.428 ' HB3' HD12 ' A' ' 53' ' ' LEU . 39.0 t -85.48 99.82 11.47 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 113.084 -1.871 . . . . 0.0 110.104 179.053 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.445 ' HB3' ' HB ' ' A' ' 60' ' ' VAL . 14.7 p-10 2.56 89.7 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.152 0 C-N-CA 128.01 2.524 . . . . 0.0 117.462 179.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 117.17 -45.04 1.33 Allowed Glycine 0 CA--C 1.537 1.468 0 CA-C-N 112.836 -1.983 . . . . 0.0 113.005 -176.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.689 ' HB2' HD11 ' A' ' 53' ' ' LEU . 98.4 mttt -123.87 134.95 53.46 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 114.184 1.179 . . . . 0.0 114.184 -176.294 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 14.8 m -72.06 137.8 47.4 Favored 'General case' 0 N--CA 1.483 1.198 0 CA-C-N 113.954 -1.475 . . . . 0.0 112.943 176.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.597 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -138.07 137.16 37.5 Favored 'General case' 0 N--CA 1.474 0.752 0 CA-C-N 113.6 -1.636 . . . . 0.0 109.024 171.551 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.9 t -107.54 118.83 37.77 Favored 'General case' 0 N--CA 1.49 1.546 0 CA-C-O 121.51 0.671 . . . . 0.0 109.808 -177.283 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.61 -30.98 71.04 Favored 'General case' 0 N--CA 1.482 1.153 0 CA-C-N 113.725 -1.58 . . . . 0.0 112.143 179.862 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.511 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 48.2 tttt -77.28 16.01 0.66 Allowed 'General case' 0 CA--C 1.553 1.06 0 C-N-CA 123.827 0.851 . . . . 0.0 113.196 176.319 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 33.3 t -154.17 118.87 4.92 Favored 'General case' 0 N--CA 1.474 0.774 0 C-N-CA 125.56 1.544 . . . . 0.0 112.454 179.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.586 ' HA ' HG21 ' A' ' 23' ' ' VAL . 55.6 tp -53.37 -71.0 0.08 Allowed 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.503 -1.681 . . . . 0.0 114.611 -171.782 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 76.4 m-85 -63.13 -31.41 72.55 Favored 'General case' 0 N--CA 1.471 0.611 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 -177.67 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.4 tttt -66.28 -37.7 86.07 Favored 'General case' 0 CA--C 1.55 0.973 0 C-N-CA 123.113 0.565 . . . . 0.0 111.718 175.841 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.597 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 19.6 tp -72.88 -54.56 8.42 Favored 'General case' 0 N--CA 1.475 0.812 0 C-N-CA 123.023 0.529 . . . . 0.0 112.366 171.759 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 79.2 mt-30 -55.33 -38.29 68.54 Favored 'General case' 0 N--CA 1.487 1.422 0 N-CA-C 116.311 1.967 . . . . 0.0 116.311 -177.019 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 7.6 t -61.19 -18.58 58.93 Favored 'General case' 0 N--CA 1.481 1.092 0 N-CA-C 115.514 1.672 . . . . 0.0 115.514 177.568 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.689 HD11 ' HB2' ' A' ' 40' ' ' LYS . 1.0 OUTLIER -100.64 157.72 16.47 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.969 1.1 . . . . 0.0 113.969 -176.878 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.85 93.81 0.19 Allowed Glycine 0 N--CA 1.478 1.452 0 CA-C-N 113.457 -1.701 . . . . 0.0 113.362 -177.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.488 HD11 ' HG ' ' A' ' 50' ' ' LEU . 27.3 mt -103.82 56.75 0.73 Allowed 'General case' 0 N--CA 1.481 1.111 0 CA-C-N 113.647 -1.276 . . . . 0.0 111.134 173.845 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.5 t -143.03 178.63 7.56 Favored 'General case' 0 N--CA 1.482 1.125 0 CA-C-N 114.884 -1.053 . . . . 0.0 112.52 -168.909 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.6 tt0 -52.45 123.22 10.42 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.835 1.254 . . . . 0.0 113.586 179.002 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.99 34.18 10.16 Favored Glycine 0 CA--C 1.54 1.598 0 CA-C-N 112.784 -2.007 . . . . 0.0 113.347 176.756 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 50.0 p -119.3 140.2 50.68 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 122.658 0.383 . . . . 0.0 111.934 177.313 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.445 ' HB ' ' HB3' ' A' ' 38' ' ' ASN . 22.7 t -108.49 105.98 19.83 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.948 0 N-CA-C 107.215 -1.402 . . . . 0.0 107.215 -178.206 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 10.5 m -107.34 92.13 1.99 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.922 0 CA-C-N 113.206 -1.816 . . . . 0.0 111.394 -171.077 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 47.6 p -78.52 102.44 7.89 Favored 'General case' 0 N--CA 1.477 0.913 0 CA-C-N 113.579 -1.646 . . . . 0.0 110.2 179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.445 HG12 HG22 ' A' ' 35' ' ' VAL . 58.6 mt -87.14 95.93 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.902 0 CA-C-N 113.903 -1.499 . . . . 0.0 109.374 -174.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 38.5 t -104.21 122.22 44.92 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 112.827 -1.988 . . . . 0.0 110.913 -177.833 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -109.42 115.16 29.43 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.333 -1.303 . . . . 0.0 112.602 179.79 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -105.87 102.86 12.27 Favored 'General case' 0 N--CA 1.475 0.797 0 CA-C-N 112.858 -1.973 . . . . 0.0 112.434 172.855 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 148.82 -162.79 28.98 Favored Glycine 0 N--CA 1.477 1.402 0 CA-C-N 112.766 -2.015 . . . . 0.0 113.266 175.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -63.06 -61.04 2.65 Favored 'General case' 0 CA--C 1.549 0.934 0 N-CA-C 117.519 2.414 . . . . 0.0 117.519 -169.466 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.3 p30 -82.12 47.05 1.08 Allowed 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 177.358 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -48.62 -39.38 23.83 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 112.322 -2.217 . . . . 0.0 116.482 -175.942 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.444 ' HG2' ' HG3' ' A' ' 72' ' ' LYS . 0.0 OUTLIER -87.4 -53.16 4.97 Favored 'General case' 0 N--CA 1.472 0.667 0 N-CA-C 114.345 1.239 . . . . 0.0 114.345 -177.351 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.444 ' HG3' ' HG2' ' A' ' 71' ' ' GLN . 42.4 mttt -66.09 -44.66 83.76 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.302 1.441 . . . . 0.0 113.971 -173.117 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.88 -47.18 83.53 Favored 'General case' 0 N--CA 1.474 0.756 0 CA-C-N 114.877 -1.056 . . . . 0.0 112.878 179.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 41.0 t -65.36 -47.4 87.17 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.297 0 CA-C-N 115.333 -0.849 . . . . 0.0 110.438 178.183 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -47.52 -57.06 5.85 Favored 'General case' 0 N--CA 1.479 0.976 0 C-N-CA 125.253 1.421 . . . . 0.0 112.929 176.206 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 81.7 t60 -59.48 -46.25 89.32 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.492 0.923 . . . . 0.0 113.492 177.302 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.535 HD23 HD12 ' A' ' 80' ' ' LEU . 85.2 mt -67.01 -39.31 87.04 Favored 'General case' 0 CA--C 1.545 0.771 0 N-CA-C 114.947 1.462 . . . . 0.0 114.947 -179.997 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 81.2 t -61.76 -46.58 96.21 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.586 0 C-N-CA 123.588 0.755 . . . . 0.0 110.338 173.536 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 22.4 ttpp -50.83 -49.91 57.72 Favored 'General case' 0 N--CA 1.484 1.227 0 O-C-N 124.663 1.227 . . . . 0.0 111.993 172.651 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.535 HD12 HD23 ' A' ' 77' ' ' LEU . 95.9 mt -56.9 -54.15 49.84 Favored 'General case' 0 N--CA 1.477 0.923 0 C-N-CA 123.185 0.594 . . . . 0.0 112.514 177.713 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.419 ' HE3' HD11 ' A' ' 63' ' ' ILE . 49.6 ttm -54.28 -42.07 69.6 Favored 'General case' 0 CA--C 1.551 1.016 0 C-N-CA 124.227 1.011 . . . . 0.0 112.739 179.128 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -62.15 -39.44 92.6 Favored 'General case' 0 N--CA 1.478 0.946 0 N-CA-C 114.679 1.363 . . . . 0.0 114.679 179.477 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 13.5 pt-20 -95.85 22.97 6.72 Favored 'General case' 0 CA--C 1.555 1.159 0 N-CA-C 114.364 1.246 . . . . 0.0 114.364 174.498 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.1 mt -118.63 29.19 7.87 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.195 1.398 . . . . 0.0 113.073 171.441 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.483 ' HG3' ' HB2' ' A' ' 10' ' ' ALA . 26.1 tt0 . . . . . 0 N--CA 1.486 1.345 0 N-CA-C 105.982 -1.859 . . . . 0.0 105.982 -174.66 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.6 tmm? . . . . . 0 N--CA 1.473 0.708 0 N-CA-C 106.313 -1.736 . . . . 0.0 106.313 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -119.69 143.17 47.89 Favored 'General case' 0 N--CA 1.477 0.902 0 O-C-N 124.857 1.348 . . . . 0.0 111.111 -176.651 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.5 tm0? -127.06 136.06 51.64 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 114.995 -1.002 . . . . 0.0 109.48 175.317 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 11.8 tt0 -133.97 106.85 7.47 Favored 'General case' 0 N--CA 1.479 0.995 0 CA-C-N 115.192 -0.913 . . . . 0.0 111.188 167.748 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.622 ' HB3' HG22 ' A' ' 62' ' ' THR . 8.2 pt-20 -78.03 92.76 4.39 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-O 123.231 1.491 . . . . 0.0 115.002 176.055 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 19.4 t -109.35 137.89 39.32 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.35 0 CA-C-N 113.406 -1.725 . . . . 0.0 110.258 -175.454 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 12.2 p -93.58 147.18 23.23 Favored 'General case' 0 N--CA 1.481 1.106 0 N-CA-C 114.328 1.233 . . . . 0.0 114.328 -177.812 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 64.7 mt -112.85 122.62 67.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 115.147 -0.933 . . . . 0.0 109.779 168.322 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.4 t -115.75 -27.0 7.2 Favored 'General case' 0 N--CA 1.482 1.17 0 CA-C-N 113.609 -1.632 . . . . 0.0 114.84 -177.59 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.54 137.27 17.21 Favored Pre-proline 0 N--CA 1.493 1.701 0 C-N-CA 124.72 1.208 . . . . 0.0 112.996 172.531 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 43.2 Cg_endo -54.88 -54.07 5.04 Favored 'Trans proline' 0 CA--C 1.552 1.382 0 C-N-CA 124.468 3.446 . . . . 0.0 114.546 -171.585 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 23.3 p30 -63.95 -33.18 75.14 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 114.208 1.188 . . . . 0.0 114.208 174.114 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.606 ' HA3' ' HA ' ' A' ' 56' ' ' THR . . . 68.19 -170.2 38.3 Favored Glycine 0 N--CA 1.477 1.424 0 C-N-CA 124.993 1.282 . . . . 0.0 112.674 -163.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -82.03 81.89 7.82 Favored 'General case' 0 CA--C 1.549 0.919 0 CA-C-N 113.509 -1.345 . . . . 0.0 108.941 -179.688 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.6 p80 -62.75 175.59 0.8 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 112.577 -2.101 . . . . 0.0 115.351 -171.646 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 71.1 p -58.18 -37.98 75.79 Favored 'General case' 0 N--CA 1.486 1.358 0 N-CA-C 114.85 1.426 . . . . 0.0 114.85 -167.255 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 13.1 mmm180 -70.52 -46.74 18.64 Favored Pre-proline 0 N--CA 1.479 0.987 0 CA-C-O 116.608 -1.663 . . . . 0.0 113.414 179.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 46.5 Cg_exo -57.78 -45.86 30.29 Favored 'Trans proline' 0 C--N 1.355 0.873 0 C-N-CA 123.245 2.63 . . . . 0.0 113.457 164.191 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.27 -39.59 72.89 Favored 'General case' 0 N--CA 1.486 1.336 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 176.409 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -65.72 -44.14 86.94 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 113.998 1.11 . . . . 0.0 113.998 172.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 67.2 tp60 -58.63 -41.96 87.17 Favored 'General case' 0 N--CA 1.486 1.361 0 C-N-CA 123.784 0.833 . . . . 0.0 111.468 172.38 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.433 ' HE2' ' HG3' ' A' ' 81' ' ' MET . 29.5 t80 -58.78 -50.93 72.1 Favored 'General case' 0 CA--C 1.544 0.747 0 C-N-CA 124.987 1.315 . . . . 0.0 111.692 172.86 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 87.7 t -54.77 -42.65 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.593 0 C-N-CA 123.351 0.66 . . . . 0.0 112.575 172.854 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -52.53 -55.0 25.17 Favored 'General case' 0 N--CA 1.487 1.409 0 C-N-CA 122.779 0.432 . . . . 0.0 111.127 175.019 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.3 tp10 -62.57 -43.76 98.01 Favored 'General case' 0 CA--C 1.548 0.876 0 C-N-CA 123.202 0.601 . . . . 0.0 111.546 179.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.69 -42.31 78.87 Favored 'General case' 0 N--CA 1.485 1.311 0 N-CA-C 115.281 1.585 . . . . 0.0 115.281 176.708 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 57.8 mmtt -51.18 -36.17 39.84 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.954 1.094 . . . . 0.0 113.954 174.904 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.75 27.96 12.78 Favored Glycine 0 CA--C 1.539 1.541 0 C-N-CA 124.724 1.154 . . . . 0.0 115.489 -176.994 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.8 m-85 -117.86 149.93 40.04 Favored 'General case' 0 N--CA 1.478 0.946 0 C-N-CA 123.142 0.577 . . . . 0.0 110.768 165.421 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 82.3 p -69.23 -45.43 69.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-O 119.191 -0.433 . . . . 0.0 111.052 -179.604 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 28.5 p -55.23 136.06 49.09 Favored 'General case' 0 N--CA 1.486 1.368 0 C-N-CA 124.64 1.176 . . . . 0.0 113.498 172.731 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tt0 -91.51 83.76 5.44 Favored 'General case' 0 CA--C 1.537 0.47 0 CA-C-N 114.205 -1.362 . . . . 0.0 109.616 175.093 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.7 HD13 ' H ' ' A' ' 33' ' ' ILE . 0.2 OUTLIER -64.57 92.06 0.1 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.896 0 CA-C-N 110.509 -3.041 . . . . 0.0 113.42 176.509 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -85.51 113.37 21.71 Favored 'General case' 0 N--CA 1.476 0.871 0 CA-C-N 113.713 -1.585 . . . . 0.0 108.626 172.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 99.3 t -98.19 94.41 3.78 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.608 0 CA-C-O 122.559 1.171 . . . . 0.0 107.97 176.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.404 ' HB ' ' OG1' ' A' ' 62' ' ' THR . 54.3 m -88.81 118.42 28.5 Favored 'General case' 0 N--CA 1.477 0.889 0 CA-C-N 113.453 -1.703 . . . . 0.0 110.877 -173.803 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 31.3 t -90.15 90.95 8.33 Favored 'General case' 0 N--CA 1.482 1.162 0 CA-C-N 112.852 -1.976 . . . . 0.0 111.066 -175.595 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.26 26.4 p30 32.81 67.47 0.17 Allowed 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.958 1.703 . . . . 0.0 114.859 -176.188 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 101.13 -49.04 1.09 Allowed Glycine 0 N--CA 1.48 1.577 0 CA-C-N 113.043 -1.889 . . . . 0.0 112.93 -175.363 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 86.9 mttt -68.15 93.69 0.46 Allowed 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 115.037 1.495 . . . . 0.0 115.037 -177.75 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 m -58.44 106.41 0.38 Allowed 'General case' 0 N--CA 1.491 1.596 0 CA-C-N 113.489 -1.687 . . . . 0.0 115.431 176.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -122.79 97.24 5.35 Favored 'General case' 0 N--CA 1.474 0.73 0 CA-C-N 114.1 -1.409 . . . . 0.0 113.083 175.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.0 t -47.65 106.09 0.08 Allowed 'General case' 0 N--CA 1.489 1.506 0 CA-C-N 114.408 -1.269 . . . . 0.0 111.717 167.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -74.39 -4.64 37.67 Favored 'General case' 0 N--CA 1.481 1.084 0 CA-C-N 114.64 -1.164 . . . . 0.0 113.459 178.76 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 11.1 mttt -78.54 -15.98 57.97 Favored 'General case' 0 CA--C 1.543 0.695 0 C-N-CA 123.44 0.696 . . . . 0.0 112.592 163.564 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 39.8 t -103.49 106.23 16.69 Favored 'General case' 0 CA--C 1.541 0.617 0 CA-C-O 122.226 1.012 . . . . 0.0 110.656 174.733 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.51 ' HG ' HE21 ' A' ' 51' ' ' GLN . 4.7 tt -46.06 -40.23 10.42 Favored 'General case' 0 N--CA 1.483 1.205 0 CA-C-N 112.336 -2.211 . . . . 0.0 112.931 169.221 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 32.4 t80 -59.35 -62.97 1.48 Allowed 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 124.58 1.152 . . . . 0.0 109.846 174.535 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 74.9 mttt -57.39 -41.14 79.7 Favored 'General case' 0 N--CA 1.485 1.298 0 N-CA-C 114.917 1.451 . . . . 0.0 114.917 -176.488 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.42 ' HG ' HD11 ' A' ' 55' ' ' LEU . 5.8 tp -76.15 -37.59 57.77 Favored 'General case' 0 CA--C 1.54 0.574 0 N-CA-C 114.804 1.409 . . . . 0.0 114.804 178.548 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . 0.51 HE21 ' HG ' ' A' ' 47' ' ' LEU . 36.6 mt-30 -80.43 -15.91 55.66 Favored 'General case' 0 N--CA 1.486 1.365 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 175.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 5.4 t -87.13 -25.79 23.94 Favored 'General case' 0 N--CA 1.485 1.278 0 N-CA-C 114.069 1.137 . . . . 0.0 114.069 168.073 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -90.5 127.27 36.18 Favored 'General case' 0 N--CA 1.481 1.121 0 CA-C-O 122.278 1.037 . . . . 0.0 111.834 171.896 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -80.71 103.38 2.2 Favored Glycine 0 N--CA 1.479 1.561 0 CA-C-N 113.916 -1.493 . . . . 0.0 111.586 179.309 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.42 HD11 ' HG ' ' A' ' 50' ' ' LEU . 4.0 mp -80.8 67.07 6.56 Favored 'General case' 0 N--CA 1.484 1.262 0 CA-C-O 122.24 1.019 . . . . 0.0 109.389 174.775 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . 0.606 ' HA ' ' HA3' ' A' ' 13' ' ' GLY . 11.5 t -126.62 156.94 40.16 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.444 -1.253 . . . . 0.0 113.349 -164.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.8 tt0 -18.12 109.78 0.02 OUTLIER 'General case' 0 N--CA 1.487 1.387 0 C-N-CA 127.354 2.262 . . . . 0.0 115.83 178.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 98.19 14.1 40.11 Favored Glycine 0 CA--C 1.539 1.536 0 CA-C-N 113.169 -1.832 . . . . 0.0 114.766 178.305 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 80.7 p -103.4 124.87 49.52 Favored 'General case' 0 N--CA 1.483 1.186 0 CA-C-O 122.485 1.136 . . . . 0.0 113.609 173.722 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 44.5 t -84.7 110.77 19.48 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.911 0 CA-C-N 112.52 -2.127 . . . . 0.0 106.06 165.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.5 m -102.01 100.53 10.57 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.486 0 CA-C-N 114.727 -1.124 . . . . 0.0 112.125 -179.819 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.622 HG22 ' HB3' ' A' ' 5' ' ' GLU . 35.6 p -77.01 104.73 7.67 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 113.083 -1.871 . . . . 0.0 110.856 176.703 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.9 mt -85.17 94.21 3.87 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.771 0 CA-C-N 113.112 -1.858 . . . . 0.0 108.439 -179.205 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 28.3 t -94.27 102.22 14.22 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 112.816 -1.993 . . . . 0.0 110.716 -176.071 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -99.26 100.0 11.03 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 115.031 -0.986 . . . . 0.0 112.515 -177.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.1 pt-20 -97.05 101.33 12.88 Favored 'General case' 0 CA--C 1.543 0.676 0 CA-C-N 114.462 -1.245 . . . . 0.0 113.323 175.029 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 159.67 -164.76 34.27 Favored Glycine 0 N--CA 1.474 1.184 0 CA-C-N 112.195 -2.275 . . . . 0.0 110.501 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 27.2 mt-10 -82.1 -47.91 12.0 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 117.152 2.278 . . . . 0.0 117.152 -174.465 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.6 p30 -80.71 40.52 0.52 Allowed 'General case' 0 N--CA 1.484 1.238 0 N-CA-C 115.604 1.705 . . . . 0.0 115.604 173.602 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.581 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.8 pt-20 -47.78 -73.25 0.04 OUTLIER 'General case' 0 N--CA 1.473 0.711 0 C-N-CA 126.99 2.116 . . . . 0.0 116.243 -173.903 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.581 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -56.66 -36.09 69.16 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 114.439 1.274 . . . . 0.0 114.439 177.997 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 81.8 mttt -72.01 -46.25 57.89 Favored 'General case' 0 N--CA 1.482 1.131 0 CA-C-N 114.851 -1.068 . . . . 0.0 113.098 -171.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.64 -47.03 87.19 Favored 'General case' 0 CA--C 1.54 0.576 0 O-C-N 124.117 0.886 . . . . 0.0 111.462 173.304 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.426 ' O ' HG23 ' A' ' 78' ' ' VAL . 78.2 t -58.66 -54.37 34.38 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.738 0 C-N-CA 124.059 0.944 . . . . 0.0 111.114 177.816 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 57.3 tt0 -52.83 -51.39 61.07 Favored 'General case' 0 N--CA 1.484 1.258 0 C-N-CA 124.341 1.056 . . . . 0.0 112.978 179.025 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 86.4 t60 -63.61 -41.15 98.33 Favored 'General case' 0 N--CA 1.477 0.913 0 N-CA-C 113.226 0.824 . . . . 0.0 113.226 176.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.441 HD23 HD12 ' A' ' 80' ' ' LEU . 52.2 mt -69.68 -31.56 69.68 Favored 'General case' 0 N--CA 1.479 1.007 0 N-CA-C 115.125 1.528 . . . . 0.0 115.125 175.456 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.426 HG23 ' O ' ' A' ' 74' ' ' VAL . 49.4 t -68.08 -45.2 83.82 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.4 0 C-N-CA 123.921 0.889 . . . . 0.0 110.521 171.75 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 65.4 tttt -50.45 -46.15 56.48 Favored 'General case' 0 N--CA 1.486 1.326 0 C-N-CA 124.376 1.071 . . . . 0.0 111.59 167.791 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.441 HD12 HD23 ' A' ' 77' ' ' LEU . 22.6 mt -60.66 -50.35 73.84 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 114.084 1.142 . . . . 0.0 114.084 173.009 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.433 ' HG3' ' HE2' ' A' ' 22' ' ' PHE . 92.3 mtp -44.72 -48.7 10.75 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 124.379 1.072 . . . . 0.0 113.381 174.254 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -64.04 -32.64 74.27 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.217 1.932 . . . . 0.0 116.217 -177.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.27 13.7 pt-20 -100.47 25.57 7.56 Favored 'General case' 0 N--CA 1.481 1.107 0 CA-C-O 122.322 1.058 . . . . 0.0 113.779 175.813 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.5 mt -138.06 36.76 2.34 Favored 'General case' 0 CA--C 1.547 0.858 0 C-N-CA 127.724 2.41 . . . . 0.0 111.287 173.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 . . . . . 0 N--CA 1.488 1.436 0 C-N-CA 125.202 1.401 . . . . 0.0 107.821 -174.653 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.474 ' HA ' ' O ' ' A' ' 65' ' ' ALA . 9.0 tmm? . . . . . 0 N--CA 1.474 0.76 0 N-CA-C 108.073 -1.084 . . . . 0.0 108.073 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 67.6 t80 -125.54 134.3 52.04 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 125.336 1.647 . . . . 0.0 108.231 176.524 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -118.59 145.42 45.41 Favored 'General case' 0 CA--C 1.541 0.618 0 O-C-N 124.785 1.303 . . . . 0.0 113.764 -173.503 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 34.8 tt0 -157.14 117.73 3.57 Favored 'General case' 0 N--CA 1.478 0.942 0 O-C-N 125.481 1.738 . . . . 0.0 112.19 174.411 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.487 ' HB2' HG12 ' A' ' 60' ' ' VAL . 11.1 pt-20 -76.27 132.98 40.18 Favored 'General case' 0 CA--C 1.545 0.754 0 CA-C-N 114.717 -1.129 . . . . 0.0 112.562 169.426 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 47.0 t -127.17 129.84 71.0 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.014 0 CA-C-N 114.075 -1.42 . . . . 0.0 110.424 -175.066 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 6.4 p -81.67 143.41 31.91 Favored 'General case' 0 N--CA 1.487 1.379 0 CA-C-N 114.453 -1.248 . . . . 0.0 112.395 177.781 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.8 mt -120.44 113.53 40.58 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 113.191 -1.822 . . . . 0.0 106.57 167.684 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 12.9 t -100.75 -17.86 16.74 Favored 'General case' 0 N--CA 1.478 0.945 0 CA-C-N 113.25 -1.796 . . . . 0.0 114.371 177.699 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -62.04 143.7 94.67 Favored Pre-proline 0 N--CA 1.477 0.895 0 N-CA-C 114.52 1.304 . . . . 0.0 114.52 169.607 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_exo -42.08 -76.64 0.03 OUTLIER 'Trans proline' 0 C--N 1.356 0.968 1 C-N-CA 125.547 4.165 . . . . 0.0 116.095 -176.483 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.0 p30 -90.56 -22.5 21.25 Favored 'General case' 0 N--CA 1.48 1.048 0 N-CA-C 113.167 0.803 . . . . 0.0 113.167 171.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 60.85 -103.09 0.47 Allowed Glycine 0 N--CA 1.479 1.532 0 C-N-CA 125.533 1.54 . . . . 0.0 113.771 169.083 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 28.8 mt -97.35 66.21 2.02 Favored 'General case' 0 N--CA 1.474 0.731 0 CA-C-N 112.396 -1.902 . . . . 0.0 108.501 -176.603 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -66.49 -155.52 0.01 OUTLIER 'General case' 0 CA--C 1.553 1.094 0 CA-C-N 113.709 -1.587 . . . . 0.0 113.629 178.682 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 64.2 p -61.03 -49.73 76.2 Favored 'General case' 0 N--CA 1.472 0.63 0 C-N-CA 125.259 1.424 . . . . 0.0 113.61 -170.307 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 29.7 mmm180 -66.51 -43.74 53.14 Favored Pre-proline 0 N--CA 1.484 1.271 0 CA-C-O 116.041 -1.933 . . . . 0.0 115.126 -178.444 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.406 ' HB3' HD13 ' A' ' 84' ' ' LEU . 87.8 Cg_exo -60.59 -40.99 51.37 Favored 'Trans proline' 0 N--CA 1.48 0.735 0 C-N-CA 122.585 2.19 . . . . 0.0 111.977 168.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.452 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -59.83 -44.07 94.24 Favored 'General case' 0 N--CA 1.48 1.062 0 N-CA-C 113.489 0.922 . . . . 0.0 113.489 174.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.61 -49.78 71.88 Favored 'General case' 0 N--CA 1.485 1.284 0 N-CA-C 113.423 0.898 . . . . 0.0 113.423 171.568 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.6 mt-30 -56.37 -47.98 77.76 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 113.2 0.815 . . . . 0.0 113.2 174.254 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 15.3 m-30 -50.65 -43.66 57.32 Favored 'General case' 0 N--CA 1.482 1.147 0 O-C-N 124.984 1.428 . . . . 0.0 113.471 174.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.452 HG23 ' O ' ' A' ' 19' ' ' ALA . 23.3 t -59.93 -54.54 33.37 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.048 0 O-C-N 123.802 0.689 . . . . 0.0 111.175 178.08 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 31.7 tttm -54.24 -47.24 72.46 Favored 'General case' 0 N--CA 1.483 1.199 0 O-C-N 124.492 1.12 . . . . 0.0 112.456 177.721 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.6 tp10 -66.64 -53.76 30.6 Favored 'General case' 0 N--CA 1.474 0.752 0 O-C-N 124.776 1.298 . . . . 0.0 113.134 178.625 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.543 ' HA ' ' HD2' ' A' ' 29' ' ' PHE . . . -55.02 -37.88 67.2 Favored 'General case' 0 N--CA 1.48 1.033 0 C-N-CA 124.261 1.025 . . . . 0.0 113.42 179.031 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 49.9 mmtt -47.11 -34.0 5.58 Favored 'General case' 0 N--CA 1.473 0.695 0 N-CA-C 116.012 1.856 . . . . 0.0 116.012 174.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -103.87 28.93 13.28 Favored Glycine 0 CA--C 1.539 1.534 0 O-C-N 124.866 1.354 . . . . 0.0 114.263 -178.106 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.543 ' HD2' ' HA ' ' A' ' 26' ' ' ALA . 71.1 m-85 -113.82 145.54 41.28 Favored 'General case' 0 N--CA 1.478 0.927 0 C-N-CA 123.708 0.803 . . . . 0.0 110.971 168.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.8 p -78.77 -28.85 44.77 Favored 'General case' 0 N--CA 1.492 1.662 0 O-C-N 124.412 1.07 . . . . 0.0 112.552 -177.785 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 77.2 p -77.55 139.28 39.53 Favored 'General case' 0 N--CA 1.476 0.868 0 CA-C-N 114.76 -1.109 . . . . 0.0 112.044 164.925 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 31.9 tt0 -81.37 99.34 8.63 Favored 'General case' 0 N--CA 1.467 0.419 0 CA-C-O 121.882 0.849 . . . . 0.0 110.727 173.429 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.815 HD11 ' HB1' ' A' ' 73' ' ' ALA . 46.5 mm -61.72 101.7 0.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.06 0 CA-C-N 112.035 -2.348 . . . . 0.0 111.022 173.631 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.413 ' HA ' ' HA ' ' A' ' 43' ' ' SER . 1.2 m -100.49 131.84 46.19 Favored 'General case' 0 C--N 1.313 -0.986 0 CA-C-N 114.009 -1.451 . . . . 0.0 108.025 171.897 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG11 HD21 ' A' ' 55' ' ' LEU . 89.4 t -118.17 91.22 1.75 Allowed 'Isoleucine or valine' 0 N--CA 1.472 0.674 0 N-CA-C 107.596 -1.261 . . . . 0.0 107.596 175.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 9.5 m -83.63 137.99 33.55 Favored 'General case' 0 N--CA 1.481 1.122 0 CA-C-N 113.28 -1.782 . . . . 0.0 109.901 -179.753 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.41 ' HB2' HG12 ' A' ' 61' ' ' VAL . 37.8 t -127.41 92.43 3.5 Favored 'General case' 0 N--CA 1.479 0.986 0 N-CA-C 109.492 -0.558 . . . . 0.0 109.492 170.874 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.265 20.6 p30 47.47 88.47 0.02 OUTLIER 'General case' 0 N--CA 1.486 1.353 0 CA-C-N 112.786 -2.006 . . . . 0.0 115.726 -176.7 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.54 -49.26 2.69 Favored Glycine 0 N--CA 1.483 1.774 0 CA-C-N 113.383 -1.735 . . . . 0.0 114.025 -174.654 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.57 ' HB3' HD21 ' A' ' 53' ' ' LEU . 81.5 mttt -64.37 103.92 0.71 Allowed 'General case' 0 N--CA 1.472 0.645 0 N-CA-C 115.427 1.64 . . . . 0.0 115.427 -179.822 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.8 m -88.82 109.74 20.45 Favored 'General case' 0 N--CA 1.476 0.86 0 CA-C-N 114.109 -1.405 . . . . 0.0 114.531 -178.506 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.536 ' HB2' HD23 ' A' ' 53' ' ' LEU . . . -113.74 96.06 5.66 Favored 'General case' 0 N--CA 1.479 1.022 0 CA-C-N 113.716 -1.584 . . . . 0.0 112.703 177.61 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.413 ' HA ' ' HA ' ' A' ' 34' ' ' THR . 47.6 t -59.22 116.01 3.6 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.188 -1.369 . . . . 0.0 111.373 171.544 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.6 -22.74 65.48 Favored 'General case' 0 N--CA 1.474 0.758 0 CA-C-N 114.445 -1.252 . . . . 0.0 114.102 -175.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.519 ' HE2' ' O ' ' A' ' 26' ' ' ALA . 98.2 mttt -71.03 0.76 6.8 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 115.612 1.708 . . . . 0.0 115.612 179.523 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.473 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 40.6 t -131.73 118.77 20.4 Favored 'General case' 0 N--CA 1.474 0.765 0 C-N-CA 123.879 0.871 . . . . 0.0 110.538 174.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 27.3 tp -55.55 -42.82 75.18 Favored 'General case' 0 N--CA 1.481 1.086 0 CA-C-N 115.514 -0.766 . . . . 0.0 111.655 175.34 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.2 OUTLIER -54.08 -60.7 2.98 Favored 'General case' 0 N--CA 1.483 1.221 0 CA-C-N 114.479 -1.237 . . . . 0.0 113.366 171.358 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.473 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 18.5 mtpt -61.26 -30.97 70.79 Favored 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 115.363 1.616 . . . . 0.0 115.363 178.518 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.491 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 33.3 tp -86.3 -53.92 4.74 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 114.373 1.249 . . . . 0.0 114.373 -177.14 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 4.5 tt0 -67.93 -14.16 62.75 Favored 'General case' 0 N--CA 1.483 1.218 0 N-CA-C 114.573 1.323 . . . . 0.0 114.573 -173.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 12.3 t -68.25 -32.78 73.2 Favored 'General case' 0 N--CA 1.487 1.402 0 N-CA-C 113.89 1.07 . . . . 0.0 113.89 165.955 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.57 HD21 ' HB3' ' A' ' 40' ' ' LYS . 1.1 mm? -76.71 143.44 39.99 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-O 122.099 0.952 . . . . 0.0 111.578 172.16 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -91.82 108.02 3.57 Favored Glycine 0 CA--C 1.536 1.374 0 CA-C-N 113.162 -1.836 . . . . 0.0 110.355 176.321 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.422 HD21 HG11 ' A' ' 35' ' ' VAL . 6.2 mp -105.71 90.48 3.41 Favored 'General case' 0 N--CA 1.488 1.462 0 O-C-N 125.61 1.418 . . . . 0.0 107.301 175.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -149.57 -172.46 4.15 Favored 'General case' 0 N--CA 1.481 1.083 0 CA-C-N 114.297 -1.319 . . . . 0.0 112.553 -160.779 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 35.2 tt0 -57.13 113.34 1.67 Allowed 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 124.064 0.946 . . . . 0.0 111.908 -179.938 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 105.5 -35.68 4.9 Favored Glycine 0 N--CA 1.484 1.885 0 CA-C-N 112.301 -2.227 . . . . 0.0 113.595 176.551 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 66.7 p -64.37 101.87 0.48 Allowed 'General case' 0 N--CA 1.48 1.054 0 C-N-CA 123.779 0.832 . . . . 0.0 112.217 -176.143 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.487 HG12 ' HB2' ' A' ' 5' ' ' GLU . 11.8 t -76.72 101.72 3.04 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.831 0 CA-C-N 113.415 -1.72 . . . . 0.0 106.786 173.461 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.41 HG12 ' HB2' ' A' ' 37' ' ' SER . 9.9 m -94.77 128.2 46.17 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.016 0 CA-C-N 112.951 -1.931 . . . . 0.0 112.701 -174.212 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.0 m -98.35 109.26 22.05 Favored 'General case' 0 N--CA 1.475 0.778 0 CA-C-N 114.86 -1.064 . . . . 0.0 111.366 -171.802 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 10.1 mt -82.41 112.32 20.04 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 N-CA-C 107.176 -1.416 . . . . 0.0 107.176 173.096 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 46.1 t -120.46 110.56 16.64 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 111.718 -2.492 . . . . 0.0 108.842 -179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.474 ' O ' ' HA ' ' A' ' 1' ' ' MET . . . -102.47 97.16 7.43 Favored 'General case' 0 N--CA 1.473 0.696 0 N-CA-C 113.916 1.08 . . . . 0.0 113.916 -179.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -88.04 93.02 9.36 Favored 'General case' 0 N--CA 1.477 0.89 0 N-CA-C 115.158 1.54 . . . . 0.0 115.158 177.591 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.17 -163.03 29.4 Favored Glycine 0 CA--C 1.541 1.686 0 CA-C-N 112.645 -2.071 . . . . 0.0 113.83 175.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 16.8 mt-10 -54.76 -60.61 3.13 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 118.926 2.936 . . . . 0.0 118.926 -169.252 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.9 p30 -83.28 36.52 0.52 Allowed 'General case' 0 N--CA 1.484 1.274 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 179.016 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.543 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.3 pt-20 -40.82 -69.66 0.13 Allowed 'General case' 0 CA--C 1.548 0.881 0 N-CA-C 116.255 1.946 . . . . 0.0 116.255 -176.995 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.543 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.0 OUTLIER -61.19 -42.68 99.01 Favored 'General case' 0 CA--C 1.543 0.673 0 N-CA-C 114.254 1.205 . . . . 0.0 114.254 -178.617 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 41.9 mtmt -67.39 -44.44 78.87 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 113.714 1.005 . . . . 0.0 113.714 -178.97 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.815 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -62.11 -37.91 86.89 Favored 'General case' 0 N--CA 1.475 0.82 0 CA-C-N 115.606 -0.725 . . . . 0.0 112.533 173.816 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.463 ' O ' HG23 ' A' ' 78' ' ' VAL . 99.4 t -68.64 -47.66 75.64 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.858 0 CA-C-O 118.141 -0.933 . . . . 0.0 111.334 174.827 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 21.9 tt0 -49.39 -49.94 42.53 Favored 'General case' 0 N--CA 1.484 1.249 0 C-N-CA 124.695 1.198 . . . . 0.0 110.95 174.435 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.6 t60 -57.83 -57.13 14.13 Favored 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 126.28 1.832 . . . . 0.0 112.072 176.025 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -66.55 -26.31 67.07 Favored 'General case' 0 N--CA 1.476 0.829 0 N-CA-C 117.49 2.404 . . . . 0.0 117.49 -179.769 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.463 HG23 ' O ' ' A' ' 74' ' ' VAL . 23.2 t -66.74 -47.63 82.39 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.409 0 N-CA-C 108.831 -0.803 . . . . 0.0 108.831 167.559 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.9 tttt -54.37 -52.29 62.1 Favored 'General case' 0 N--CA 1.48 1.063 0 CA-C-O 118.331 -0.842 . . . . 0.0 111.598 -179.851 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 73.6 mt -52.52 -57.41 10.04 Favored 'General case' 0 CA--C 1.547 0.859 0 N-CA-C 114.401 1.259 . . . . 0.0 114.401 171.516 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 53.7 mtt -52.43 -39.79 61.43 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 114.809 1.411 . . . . 0.0 114.809 176.859 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.04 -44.07 73.4 Favored 'General case' 0 N--CA 1.473 0.679 0 O-C-N 124.543 1.152 . . . . 0.0 113.929 177.957 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . 0.314 10.3 pt-20 -72.4 -27.08 62.14 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 115.803 1.779 . . . . 0.0 115.803 177.688 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.406 HD13 ' HB3' ' A' ' 18' ' ' PRO . 40.4 mt -88.6 88.57 7.66 Favored 'General case' 0 N--CA 1.487 1.398 0 N-CA-C 115.369 1.618 . . . . 0.0 115.369 -178.479 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 25.4 mt-10 . . . . . 0 C--O 1.252 1.214 0 C-N-CA 124.652 1.181 . . . . 0.0 112.74 169.126 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 14.8 tmm? . . . . . 0 N--CA 1.465 0.318 0 N-CA-C 106.707 -1.59 . . . . 0.0 106.707 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 38.6 t80 -88.23 130.77 34.99 Favored 'General case' 0 N--CA 1.47 0.57 0 CA-C-O 121.755 0.788 . . . . 0.0 110.023 178.32 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . 0.472 ' HG2' HG22 ' A' ' 62' ' ' THR . 15.4 tt0 -134.05 142.32 47.53 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 113.073 -1.876 . . . . 0.0 111.72 -173.04 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.3 tt0 -147.71 139.72 24.19 Favored 'General case' 0 CA--C 1.546 0.801 0 O-C-N 124.94 1.4 . . . . 0.0 110.602 176.454 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 12.6 pt-20 -93.34 131.4 38.53 Favored 'General case' 0 N--CA 1.487 1.383 0 O-C-N 123.915 0.759 . . . . 0.0 112.535 177.369 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 69.8 t -122.84 136.14 60.61 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.812 0 CA-C-N 114.121 -1.399 . . . . 0.0 109.611 177.19 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.63 HG22 HG22 ' A' ' 60' ' ' VAL . 17.0 p -102.43 108.91 20.4 Favored 'General case' 0 N--CA 1.475 0.782 0 CA-C-N 112.588 -2.096 . . . . 0.0 110.631 -179.844 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 29.5 mt -71.19 96.43 0.54 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 CA-C-N 113.12 -1.854 . . . . 0.0 107.503 173.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 13.3 t -86.26 -26.91 24.73 Favored 'General case' 0 N--CA 1.485 1.32 0 CA-C-N 113.24 -1.8 . . . . 0.0 113.501 176.563 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -57.1 135.36 80.57 Favored Pre-proline 0 N--CA 1.483 1.21 0 C-N-CA 124.18 0.992 . . . . 0.0 111.219 171.037 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 59.1 Cg_exo -46.34 -37.65 19.36 Favored 'Trans proline' 0 N--CA 1.488 1.154 0 C-N-CA 124.638 3.559 . . . . 0.0 116.435 -175.045 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -127.29 -37.06 2.07 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 114.692 1.368 . . . . 0.0 114.692 172.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.97 -93.5 0.41 Allowed Glycine 0 N--CA 1.476 1.309 0 O-C-N 124.031 0.832 . . . . 0.0 112.903 163.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.567 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 6.4 mp -94.4 63.43 3.01 Favored 'General case' 0 N--CA 1.473 0.712 0 CA-C-O 122.615 1.198 . . . . 0.0 112.574 -178.252 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.9 p80 -72.34 -169.51 0.53 Allowed 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 114.147 -1.388 . . . . 0.0 111.291 173.007 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.6 p -47.47 -47.72 27.11 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 114.384 1.253 . . . . 0.0 114.384 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.417 ' HD3' ' HA ' ' A' ' 17' ' ' ARG 0.293 12.6 mmt180 -70.16 -51.7 13.57 Favored Pre-proline 0 N--CA 1.477 0.905 0 CA-C-O 115.398 -2.239 . . . . 0.0 114.932 -179.312 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.567 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 92.3 Cg_exo -60.8 -39.24 64.2 Favored 'Trans proline' 0 N--CA 1.478 0.616 0 C-N-CA 122.203 1.936 . . . . 0.0 113.816 172.613 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.54 -47.57 85.61 Favored 'General case' 0 CA--C 1.546 0.82 0 C-N-CA 123.25 0.62 . . . . 0.0 112.639 173.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.71 -38.52 85.32 Favored 'General case' 0 N--CA 1.482 1.152 0 N-CA-C 114.323 1.231 . . . . 0.0 114.323 174.312 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -66.4 -44.78 82.07 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 174.641 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.523 ' HE1' ' HG3' ' A' ' 81' ' ' MET . 0.9 OUTLIER -54.3 -51.63 64.04 Favored 'General case' 0 CA--C 1.549 0.927 0 C-N-CA 124.261 1.024 . . . . 0.0 111.162 171.328 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.581 HG21 ' HA ' ' A' ' 47' ' ' LEU . 71.6 t -51.62 -51.52 25.95 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.356 0 C-N-CA 124.465 1.106 . . . . 0.0 111.835 173.205 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.4 tmtt? -56.04 -53.97 50.6 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 124.717 1.207 . . . . 0.0 111.214 -179.46 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.403 ' HB3' HD21 ' A' ' 77' ' ' LEU . 7.9 tp10 -65.42 -43.94 88.94 Favored 'General case' 0 N--CA 1.479 1.014 0 O-C-N 124.361 1.038 . . . . 0.0 113.089 -178.415 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.95 -40.07 72.65 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 114.711 1.375 . . . . 0.0 114.711 174.341 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.5 mmtt -58.53 -14.33 7.76 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.149 1.907 . . . . 0.0 116.149 174.005 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -81.68 -35.49 22.22 Favored Glycine 0 N--CA 1.48 1.63 0 C-N-CA 124.41 1.005 . . . . 0.0 114.74 174.163 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 86.4 m-85 -80.8 154.33 27.23 Favored 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 123.849 0.86 . . . . 0.0 113.032 -174.282 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.2 p -69.77 -43.09 72.9 Favored 'General case' 0 N--CA 1.488 1.458 0 O-C-N 123.984 0.803 . . . . 0.0 111.787 179.597 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 24.6 p -61.23 145.54 50.88 Favored 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.597 1.332 . . . . 0.0 114.597 175.565 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.441 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 8.7 mt-10 -83.26 134.05 34.96 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 121.985 0.898 . . . . 0.0 111.189 167.436 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.6 mm -112.12 106.98 21.82 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.147 0 CA-C-N 113.895 -1.502 . . . . 0.0 109.074 -166.193 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -119.66 119.35 33.45 Favored 'General case' 0 N--CA 1.471 0.624 0 CA-C-N 113.248 -1.797 . . . . 0.0 109.438 -174.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.44 HG12 ' HB ' ' A' ' 61' ' ' VAL . 40.1 t -110.21 87.37 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.322 -0.604 0 N-CA-C 107.092 -1.447 . . . . 0.0 107.092 -175.394 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -77.88 100.65 6.45 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-N 113.332 -1.758 . . . . 0.0 111.845 -175.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 33.2 t -76.7 97.31 4.42 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-N 114.099 -1.409 . . . . 0.0 111.716 171.446 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.7 p30 35.12 61.97 0.59 Allowed 'General case' 0 N--CA 1.487 1.386 0 N-CA-C 117.263 2.32 . . . . 0.0 117.263 170.356 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.86 -76.26 0.3 Allowed Glycine 0 N--CA 1.485 1.919 0 CA-C-N 114.566 -1.197 . . . . 0.0 112.844 -178.537 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 98.9 mttt -75.63 138.84 41.66 Favored 'General case' 0 N--CA 1.48 1.051 0 CA-C-O 121.468 0.652 . . . . 0.0 112.513 177.487 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 63.5 m -99.35 140.13 33.98 Favored 'General case' 0 N--CA 1.475 0.784 0 N-CA-C 115.207 1.558 . . . . 0.0 115.207 -179.422 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.551 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -124.76 134.94 52.62 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 113.571 -1.649 . . . . 0.0 109.232 175.217 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.3 t -117.26 126.56 52.94 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 112.192 0.441 . . . . 0.0 112.192 -174.535 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.95 -15.46 43.61 Favored 'General case' 0 CA--C 1.551 0.997 0 O-C-N 125.488 1.743 . . . . 0.0 113.637 173.438 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.441 ' HE3' ' HA ' ' A' ' 32' ' ' GLU . 30.4 mmtt -71.87 -6.63 43.14 Favored 'General case' 0 N--CA 1.484 1.226 0 N-CA-C 113.936 1.087 . . . . 0.0 113.936 171.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 23.1 t -131.26 134.49 46.45 Favored 'General case' 0 N--CA 1.483 1.207 0 C-N-CA 125.63 1.572 . . . . 0.0 109.598 168.17 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.581 ' HA ' HG21 ' A' ' 23' ' ' VAL . 43.7 tp -59.67 -52.38 65.75 Favored 'General case' 0 CA--C 1.549 0.918 0 CA-C-N 114.85 -1.068 . . . . 0.0 110.498 169.633 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 6.6 t80 -62.92 -49.35 75.13 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-N 112.912 -1.949 . . . . 0.0 113.644 -175.478 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 82.6 tttt -65.22 -32.19 73.74 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 123.846 0.716 . . . . 0.0 112.909 178.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.551 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 12.2 tp -76.53 -44.93 32.87 Favored 'General case' 0 N--CA 1.474 0.773 0 CA-C-O 119.015 -0.517 . . . . 0.0 112.233 175.353 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.2 mt-30 -59.45 -39.54 83.93 Favored 'General case' 0 N--CA 1.483 1.187 0 N-CA-C 115.992 1.849 . . . . 0.0 115.992 -179.903 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 11.5 t -58.83 -39.46 81.31 Favored 'General case' 0 N--CA 1.486 1.356 0 N-CA-C 115.156 1.539 . . . . 0.0 115.156 -178.723 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -77.81 140.79 39.45 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-O 122.329 1.062 . . . . 0.0 113.159 -179.871 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.27 81.37 0.2 Allowed Glycine 0 CA--C 1.535 1.319 0 CA-C-N 113.671 -1.604 . . . . 0.0 112.274 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.436 HD23 HG11 ' A' ' 61' ' ' VAL . 61.8 mt -82.27 60.8 5.17 Favored 'General case' 0 N--CA 1.489 1.521 0 CA-C-O 123.626 1.679 . . . . 0.0 110.172 172.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 t -123.32 -178.68 4.06 Favored 'General case' 0 N--CA 1.479 0.976 0 CA-C-N 112.495 -2.139 . . . . 0.0 112.477 -166.698 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 42.4 tt0 -51.68 127.64 21.14 Favored 'General case' 0 N--CA 1.471 0.62 0 C-N-CA 124.774 1.229 . . . . 0.0 112.545 -179.757 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 97.71 -32.61 6.61 Favored Glycine 0 N--CA 1.475 1.248 0 CA-C-N 112.962 -1.926 . . . . 0.0 113.468 176.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 55.0 p -62.45 116.82 5.42 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 122.474 1.131 . . . . 0.0 113.858 -178.704 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.63 HG22 HG22 ' A' ' 7' ' ' THR . 4.2 t -86.75 95.13 4.69 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.083 0 CA-C-N 112.239 -2.255 . . . . 0.0 106.075 174.156 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.44 ' HB ' HG12 ' A' ' 35' ' ' VAL . 31.6 m -95.65 113.45 30.06 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.762 0 CA-C-N 112.608 -2.087 . . . . 0.0 110.365 -176.042 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.472 HG22 ' HG2' ' A' ' 3' ' ' GLN . 0.9 OUTLIER -91.43 108.74 20.1 Favored 'General case' 0 N--CA 1.474 0.769 0 CA-C-N 113.142 -1.845 . . . . 0.0 110.247 -173.42 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.6 mt -91.17 107.08 18.26 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.889 0 CA-C-N 113.039 -1.891 . . . . 0.0 109.724 -170.906 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 27.5 t -103.12 126.93 50.52 Favored 'General case' 0 C--O 1.238 0.495 0 CA-C-N 112.614 -2.085 . . . . 0.0 111.075 178.855 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.09 111.34 21.97 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 124.679 1.237 . . . . 0.0 110.533 168.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 12.2 pt-20 -103.05 99.17 9.03 Favored 'General case' 0 N--CA 1.478 0.972 0 N-CA-C 113.987 1.106 . . . . 0.0 113.987 -179.213 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.04 -159.74 28.68 Favored Glycine 0 CA--C 1.541 1.675 0 CA-C-N 114.159 -1.382 . . . . 0.0 112.576 178.494 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -62.6 -54.48 39.0 Favored 'General case' 0 N--CA 1.479 0.977 0 N-CA-C 116.454 2.02 . . . . 0.0 116.454 -173.729 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.3 p30 -83.05 33.49 0.44 Allowed 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 115.494 1.664 . . . . 0.0 115.494 179.299 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.416 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 2.2 pt-20 -45.04 -59.35 2.64 Favored 'General case' 0 N--CA 1.48 1.059 0 N-CA-C 116.016 1.858 . . . . 0.0 116.016 -175.582 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.43 ' H ' ' CD ' ' A' ' 71' ' ' GLN . 0.0 OUTLIER -65.87 -40.08 91.29 Favored 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 114.681 1.363 . . . . 0.0 114.681 -178.091 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 65.4 mttt -70.31 -43.14 70.94 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.763 -1.108 . . . . 0.0 112.228 -176.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -58.35 -52.82 64.01 Favored 'General case' 0 CA--C 1.543 0.7 0 CA-C-N 114.549 -1.205 . . . . 0.0 111.461 176.377 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 42.9 t -60.08 -47.05 93.42 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.034 0 CA-C-O 118.368 -0.825 . . . . 0.0 111.662 175.696 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 40.3 tt0 -52.78 -57.55 9.79 Favored 'General case' 0 N--CA 1.485 1.3 0 C-N-CA 124.16 0.984 . . . . 0.0 112.775 -178.265 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.9 t60 -60.79 -45.54 93.99 Favored 'General case' 0 N--CA 1.478 0.962 0 C-N-CA 124.215 1.006 . . . . 0.0 112.816 179.226 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.419 ' HB3' ' CZ ' ' A' ' 22' ' ' PHE . 88.1 mt -69.46 -33.44 72.92 Favored 'General case' 0 N--CA 1.486 1.364 0 N-CA-C 115.49 1.663 . . . . 0.0 115.49 178.929 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 55.1 t -69.01 -48.4 70.13 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.318 0 C-N-CA 123.787 0.835 . . . . 0.0 111.456 172.23 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 8.6 mtmt -52.0 -45.49 64.56 Favored 'General case' 0 N--CA 1.491 1.594 0 O-C-N 123.829 0.705 . . . . 0.0 112.046 172.342 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 31.9 tp -52.85 -59.25 4.74 Favored 'General case' 0 N--CA 1.484 1.27 0 C-N-CA 124.687 1.195 . . . . 0.0 112.475 174.089 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.523 ' HG3' ' HE1' ' A' ' 22' ' ' PHE . 38.7 mtt -47.95 -43.13 29.03 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.61 1.708 . . . . 0.0 115.61 173.008 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -63.89 -45.66 88.38 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-O 118.152 -0.928 . . . . 0.0 113.337 179.092 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -86.24 -3.18 58.92 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 116.235 1.939 . . . . 0.0 116.235 178.683 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 91.1 mt -97.66 96.66 8.42 Favored 'General case' 0 N--CA 1.484 1.231 0 C-N-CA 123.912 0.885 . . . . 0.0 111.141 170.747 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 27.5 tt0 . . . . . 0 C--O 1.254 1.314 0 CA-C-N 113.655 -1.611 . . . . 0.0 106.993 175.362 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.476 ' HG2' ' HA ' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.54 0.58 0 N-CA-C 106.438 -1.69 . . . . 0.0 106.438 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -133.13 127.51 34.07 Favored 'General case' 0 CA--C 1.543 0.679 0 O-C-N 124.385 1.053 . . . . 0.0 111.321 -178.385 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 65.5 mt-30 -110.28 146.03 36.37 Favored 'General case' 0 N--CA 1.483 1.203 0 CA-C-N 114.451 -1.25 . . . . 0.0 113.814 173.583 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 19.0 tt0 -155.07 125.82 7.0 Favored 'General case' 0 N--CA 1.475 0.813 0 C-N-CA 124.756 1.222 . . . . 0.0 108.072 174.026 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 15.5 pt-20 -105.86 96.16 6.3 Favored 'General case' 0 N--CA 1.475 0.823 0 CA-C-O 125.04 2.353 . . . . 0.0 113.622 -171.53 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.7 t -95.73 119.22 43.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.084 0 CA-C-N 111.222 -2.717 . . . . 0.0 110.841 -166.318 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 3.3 m -74.85 115.67 14.71 Favored 'General case' 0 N--CA 1.476 0.849 0 CA-C-N 113.745 -1.57 . . . . 0.0 109.571 175.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 8.3 mt -77.25 135.93 25.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.985 0 N-CA-C 108.339 -0.986 . . . . 0.0 108.339 177.358 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.34 -23.25 4.89 Favored 'General case' 0 N--CA 1.474 0.77 0 CA-C-N 113.37 -1.741 . . . . 0.0 113.856 -173.417 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -51.6 138.72 30.5 Favored Pre-proline 0 N--CA 1.477 0.922 0 C-N-CA 124.604 1.162 . . . . 0.0 111.386 169.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 17.3 Cg_exo -39.98 -50.71 3.3 Favored 'Trans proline' 0 N--CA 1.485 0.997 0 C-N-CA 124.66 3.573 . . . . 0.0 117.345 -175.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 14.0 p30 -116.88 21.95 12.96 Favored 'General case' 0 N--CA 1.489 1.508 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 174.835 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 46.01 -98.48 0.01 OUTLIER Glycine 0 CA--C 1.532 1.121 0 C-N-CA 125.352 1.453 . . . . 0.0 113.822 -174.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.549 HD21 ' HG3' ' A' ' 81' ' ' MET . 19.4 mt -119.1 110.93 17.65 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 113.766 -1.217 . . . . 0.0 111.604 175.496 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.2 p80 -91.15 -165.8 1.44 Allowed 'General case' 0 CA--C 1.546 0.824 0 CA-C-N 114.912 -1.04 . . . . 0.0 111.211 164.28 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -51.47 -43.93 62.28 Favored 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 116.529 2.048 . . . . 0.0 116.529 -174.623 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.253 11.4 ttm105 -68.98 -45.17 30.56 Favored Pre-proline 0 CA--C 1.545 0.769 0 CA-C-O 117.536 -1.221 . . . . 0.0 113.281 -178.626 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.555 ' HG3' HD22 ' A' ' 84' ' ' LEU . 65.9 Cg_exo -61.26 -30.21 87.68 Favored 'Trans proline' 0 C--N 1.355 0.889 0 C-N-CA 122.671 2.248 . . . . 0.0 115.169 167.674 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.55 -46.15 84.25 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-N 118.759 0.709 . . . . 0.0 112.207 168.143 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -66.68 -44.93 80.46 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.635 -1.166 . . . . 0.0 113.225 176.252 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.455 ' HB2' ' HA ' ' A' ' 18' ' ' PRO . 43.2 mt-30 -51.94 -53.25 43.39 Favored 'General case' 0 N--CA 1.488 1.456 0 C-N-CA 124.094 0.958 . . . . 0.0 112.971 172.061 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 8.3 m-85 -51.87 -60.52 3.08 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.106 1.15 . . . . 0.0 114.106 176.525 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 38.8 t -46.47 -55.88 1.46 Allowed 'Isoleucine or valine' 0 N--CA 1.483 1.207 0 C-N-CA 124.908 1.283 . . . . 0.0 112.707 175.575 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.9 tttm -51.97 -47.42 64.84 Favored 'General case' 0 CA--C 1.545 0.77 0 O-C-N 124.563 1.164 . . . . 0.0 112.279 -179.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.5 tp10 -69.01 -56.06 8.92 Favored 'General case' 0 N--CA 1.479 1.019 0 O-C-N 124.713 1.258 . . . . 0.0 112.688 178.465 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.22 -44.46 75.44 Favored 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 126.248 1.819 . . . . 0.0 115.049 -178.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 25.6 mttm -51.56 -31.98 26.59 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 114.441 1.275 . . . . 0.0 114.441 175.311 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -60.14 -49.42 78.8 Favored Glycine 0 CA--C 1.538 1.493 0 O-C-N 125.449 1.718 . . . . 0.0 114.394 173.527 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 80.2 m-85 -60.45 154.74 19.88 Favored 'General case' 0 N--CA 1.486 1.354 0 N-CA-C 117.23 2.307 . . . . 0.0 117.23 -177.474 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 67.3 p -86.72 -15.88 38.13 Favored 'General case' 0 N--CA 1.496 1.843 0 CA-C-N 114.554 -1.203 . . . . 0.0 113.838 -177.444 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 32.4 p -82.94 153.02 25.25 Favored 'General case' 0 N--CA 1.474 0.728 0 CA-C-N 115.345 -0.843 . . . . 0.0 112.718 164.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.421 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 0.0 OUTLIER -94.3 131.89 39.45 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.388 0.675 . . . . 0.0 109.191 173.56 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 8.4 mm -112.97 100.47 10.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.006 0 CA-C-N 115.106 -0.952 . . . . 0.0 110.998 -159.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 3.9 m -104.28 126.34 51.3 Favored 'General case' 0 N--CA 1.481 1.104 0 N-CA-C 106.898 -1.519 . . . . 0.0 106.898 174.743 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 42.4 t -110.18 85.82 0.82 Allowed 'Isoleucine or valine' 0 N--CA 1.468 0.47 0 CA-C-N 113.348 -1.751 . . . . 0.0 107.599 175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.572 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 50.3 m -64.45 120.68 12.74 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 113.956 -1.474 . . . . 0.0 108.348 170.847 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.567 ' HA ' HG12 ' A' ' 61' ' ' VAL . 40.8 t -94.0 95.43 9.04 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 107.57 -1.27 . . . . 0.0 107.57 174.686 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 51.9 p-10 24.98 63.98 0.05 Allowed 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 118.172 2.656 . . . . 0.0 118.172 -177.34 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 118.63 -24.6 8.43 Favored Glycine 0 N--CA 1.486 1.984 0 N-CA-C 117.3 1.68 . . . . 0.0 117.3 178.371 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 80.9 mttt -130.51 140.93 50.5 Favored 'General case' 0 N--CA 1.488 1.454 0 CA-C-N 118.656 1.228 . . . . 0.0 109.641 177.821 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.572 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 77.6 p -101.28 129.44 47.25 Favored 'General case' 0 C--N 1.317 -0.837 0 N-CA-C 117.414 2.376 . . . . 0.0 117.414 -162.737 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.684 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -114.99 104.05 11.52 Favored 'General case' 0 N--CA 1.474 0.744 0 CA-C-N 113.43 -1.714 . . . . 0.0 109.103 179.278 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 44.4 t -59.34 113.84 2.37 Favored 'General case' 0 N--CA 1.475 0.8 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 169.977 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -82.48 0.15 43.72 Favored 'General case' 0 N--CA 1.472 0.667 0 CA-C-N 114.83 -1.077 . . . . 0.0 113.59 -178.218 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.421 ' HE3' ' HA ' ' A' ' 32' ' ' GLU . 44.8 mttt -89.99 -44.43 9.87 Favored 'General case' 0 N--CA 1.472 0.668 0 CA-C-N 115.5 -0.773 . . . . 0.0 110.533 164.835 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.0 t -70.62 116.96 11.54 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 121.362 0.601 . . . . 0.0 112.016 169.165 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 59.7 tp -64.37 -44.76 90.36 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-N 114.461 -1.245 . . . . 0.0 113.241 175.035 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 61.1 t80 -66.25 -34.79 78.81 Favored 'General case' 0 CA--C 1.55 0.963 0 C-N-CA 124.416 1.086 . . . . 0.0 111.693 -176.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.479 ' O ' HG22 ' A' ' 52' ' ' THR . 28.7 tttt -76.96 -47.73 20.05 Favored 'General case' 0 N--CA 1.474 0.753 0 N-CA-C 114.186 1.18 . . . . 0.0 114.186 173.652 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.684 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 26.9 tp -51.81 -49.37 62.89 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.146 0.795 . . . . 0.0 113.146 175.68 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 11.2 mt-30 -63.85 -27.37 69.12 Favored 'General case' 0 N--CA 1.473 0.683 0 N-CA-C 115.597 1.702 . . . . 0.0 115.597 178.364 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.479 HG22 ' O ' ' A' ' 49' ' ' LYS 0.266 3.6 t -74.09 -20.61 60.21 Favored 'General case' 0 N--CA 1.477 0.924 0 N-CA-C 114.02 1.119 . . . . 0.0 114.02 179.502 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 4.5 mm? -87.14 135.8 33.16 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 122.419 1.104 . . . . 0.0 113.001 170.659 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.02 90.75 1.1 Allowed Glycine 0 CA--C 1.537 1.466 0 CA-C-N 113.182 -1.826 . . . . 0.0 109.561 175.313 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 4.1 mt -93.65 64.64 3.57 Favored 'General case' 0 N--CA 1.484 1.274 0 CA-C-O 122.558 1.17 . . . . 0.0 110.288 -172.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.7 t -108.13 174.73 5.75 Favored 'General case' 0 N--CA 1.492 1.668 0 CA-C-N 114.711 -1.131 . . . . 0.0 113.045 -170.708 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 31.6 tt0 -50.63 137.45 19.71 Favored 'General case' 0 N--CA 1.481 1.123 0 C-N-CA 124.305 1.042 . . . . 0.0 110.667 174.228 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 96.24 -47.19 1.79 Allowed Glycine 0 N--CA 1.481 1.699 0 CA-C-N 114.551 -1.204 . . . . 0.0 112.597 -177.237 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 43.8 p -56.92 120.75 8.47 Favored 'General case' 0 N--CA 1.49 1.532 0 O-C-N 123.875 0.397 . . . . 0.0 111.275 179.992 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.1 t -86.65 109.63 19.21 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 111.837 -2.438 . . . . 0.0 107.917 178.815 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.567 HG12 ' HA ' ' A' ' 37' ' ' SER . 30.5 m -104.95 116.41 48.7 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.671 0 N-CA-C 114.378 1.251 . . . . 0.0 114.378 -170.883 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 m -82.8 97.47 8.63 Favored 'General case' 0 N--CA 1.473 0.7 0 C-N-CA 124.149 0.98 . . . . 0.0 109.006 -179.102 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.456 HD12 HG22 ' A' ' 78' ' ' VAL . 16.2 mt -74.05 92.16 0.66 Allowed 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 N-CA-C 107.557 -1.275 . . . . 0.0 107.557 166.858 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 32.7 t -100.13 108.75 20.97 Favored 'General case' 0 C--N 1.323 -0.573 0 CA-C-N 110.129 -3.214 . . . . 0.0 109.578 -179.298 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -108.42 100.49 9.77 Favored 'General case' 0 N--CA 1.483 1.182 0 CA-C-N 112.701 -2.045 . . . . 0.0 112.747 -175.479 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.476 ' HA ' ' HG2' ' A' ' 1' ' ' MET . 7.6 pt-20 -96.72 89.82 5.07 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.924 1.453 . . . . 0.0 114.924 -178.936 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 150.05 -162.7 29.27 Favored Glycine 0 CA--C 1.536 1.368 0 CA-C-N 113.826 -1.534 . . . . 0.0 112.637 176.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 42.3 mt-10 -56.39 -59.35 5.09 Favored 'General case' 0 N--CA 1.488 1.462 0 N-CA-C 118.721 2.86 . . . . 0.0 118.721 -162.334 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 14.0 p30 -85.41 50.16 1.9 Allowed 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 114.944 1.461 . . . . 0.0 114.944 179.339 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.3 pt-20 -51.72 -53.15 42.58 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 112.193 -2.276 . . . . 0.0 116.079 -174.923 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -74.51 -43.17 57.16 Favored 'General case' 0 N--CA 1.479 0.994 0 N-CA-C 114.354 1.242 . . . . 0.0 114.354 179.692 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.2 mtmt -60.69 -49.78 76.14 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 113.959 1.096 . . . . 0.0 113.959 177.79 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -50.6 -52.07 42.69 Favored 'General case' 0 N--CA 1.474 0.733 0 O-C-N 124.918 1.387 . . . . 0.0 112.614 172.206 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.567 ' O ' HG23 ' A' ' 78' ' ' VAL . 86.5 t -53.68 -56.08 10.51 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.507 0 O-C-N 123.975 0.797 . . . . 0.0 111.795 176.22 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.3 mt-10 -59.13 -53.09 62.25 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 114.591 1.33 . . . . 0.0 114.591 -177.226 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 43.5 t60 -52.91 -47.6 67.86 Favored 'General case' 0 CA--C 1.542 0.638 0 C-N-CA 124.952 1.301 . . . . 0.0 113.969 175.846 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 76.0 mt -66.22 -36.71 83.74 Favored 'General case' 0 N--CA 1.47 0.537 0 N-CA-C 115.991 1.849 . . . . 0.0 115.991 177.333 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.567 HG23 ' O ' ' A' ' 74' ' ' VAL . 9.0 t -64.94 -47.21 89.12 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.913 0 O-C-N 122.336 -0.227 . . . . 0.0 110.698 175.53 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 mtmt -54.05 -37.74 64.48 Favored 'General case' 0 N--CA 1.471 0.624 0 N-CA-C 115.243 1.571 . . . . 0.0 115.243 169.059 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.9 tt -60.99 -51.84 67.53 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.043 0.937 . . . . 0.0 110.014 176.494 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.549 ' HG3' HD21 ' A' ' 14' ' ' LEU . 10.6 ttm -60.57 -46.98 88.2 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.393 1.077 . . . . 0.0 113.005 176.879 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -53.12 -14.79 0.69 Allowed 'General case' 0 N--CA 1.482 1.143 0 N-CA-C 117.763 2.505 . . . . 0.0 117.763 175.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 9.9 pt-20 -125.49 45.19 2.64 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 114.062 1.134 . . . . 0.0 114.062 170.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.555 HD22 ' HG3' ' A' ' 18' ' ' PRO . 44.8 mt -123.38 121.97 37.12 Favored 'General case' 0 N--CA 1.476 0.85 0 CA-C-N 114.553 -1.203 . . . . 0.0 112.258 169.705 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.5 mt-10 . . . . . 0 C--O 1.249 1.076 0 O-C-N 125.626 1.829 . . . . 0.0 110.64 171.489 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 32.5 ttm . . . . . 0 N--CA 1.466 0.347 0 N-CA-C 107.706 -1.22 . . . . 0.0 107.706 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 34.2 t80 -120.8 140.62 51.47 Favored 'General case' 0 N--CA 1.474 0.75 0 O-C-N 124.964 1.415 . . . . 0.0 109.576 173.683 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 72.6 mt-30 -128.65 142.67 50.96 Favored 'General case' 0 N--CA 1.481 1.11 0 O-C-N 124.518 1.136 . . . . 0.0 112.032 -178.671 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 36.3 tt0 -150.49 119.62 6.75 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 125.025 1.453 . . . . 0.0 110.799 169.294 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.401 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 11.7 pt-20 -72.88 126.65 30.44 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.888 -1.506 . . . . 0.0 113.223 173.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 97.2 t -124.12 131.75 72.41 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.877 0 CA-C-N 113.343 -1.753 . . . . 0.0 109.098 179.501 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 13.9 m -111.34 110.48 20.97 Favored 'General case' 0 N--CA 1.477 0.915 0 CA-C-N 115.637 -0.71 . . . . 0.0 109.73 -177.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.1 mt -72.62 113.9 10.83 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.184 0 CA-C-N 114.849 -1.069 . . . . 0.0 110.445 -179.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.1 t -85.74 -19.08 31.34 Favored 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.388 -1.733 . . . . 0.0 114.844 176.511 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.468 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -54.87 127.64 62.03 Favored Pre-proline 0 N--CA 1.477 0.893 0 C-N-CA 124.554 1.142 . . . . 0.0 113.009 178.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.468 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 52.3 Cg_exo -54.11 -62.3 0.32 Allowed 'Trans proline' 0 N--CA 1.485 0.999 0 C-N-CA 124.602 3.535 . . . . 0.0 113.314 -169.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -94.29 29.62 2.16 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 112.638 0.607 . . . . 0.0 112.638 174.44 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.414 ' HA3' ' O ' ' A' ' 55' ' ' LEU . . . 33.74 -134.06 0.31 Allowed Glycine 0 N--CA 1.479 1.546 0 C-N-CA 127.345 2.402 . . . . 0.0 116.345 -175.613 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 41.8 mt -102.8 122.43 44.5 Favored 'General case' 0 C--N 1.32 -0.713 0 CA-C-N 112.117 -2.042 . . . . 0.0 109.966 -176.794 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . 0.425 ' HB2' ' H ' ' A' ' 16' ' ' THR . 2.2 p80 -109.2 -154.93 0.54 Allowed 'General case' 0 N--CA 1.486 1.364 0 CA-C-N 113.195 -1.82 . . . . 0.0 113.579 -179.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . 0.425 ' H ' ' HB2' ' A' ' 15' ' ' HIS . 15.3 m -61.01 -48.36 82.15 Favored 'General case' 0 N--CA 1.472 0.664 0 N-CA-C 114.925 1.454 . . . . 0.0 114.925 -166.682 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 22.2 ttt-85 -63.27 -47.61 84.4 Favored Pre-proline 0 N--CA 1.489 1.502 0 CA-C-O 116.599 -1.667 . . . . 0.0 112.233 176.39 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 32.3 Cg_exo -54.79 -47.14 28.29 Favored 'Trans proline' 0 CA--C 1.54 0.816 0 C-N-CA 122.823 2.349 . . . . 0.0 113.48 170.26 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.92 -48.26 73.32 Favored 'General case' 0 N--CA 1.477 0.902 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.288 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.9 -46.91 84.21 Favored 'General case' 0 CA--C 1.549 0.917 0 C-N-CA 124.118 0.967 . . . . 0.0 113.381 174.654 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -57.89 -42.78 85.37 Favored 'General case' 0 N--CA 1.483 1.217 0 C-N-CA 124.112 0.965 . . . . 0.0 113.203 177.826 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.576 ' HE1' ' HB3' ' A' ' 80' ' ' LEU . 21.7 m-85 -66.28 -49.24 67.78 Favored 'General case' 0 N--CA 1.483 1.214 0 N-CA-C 112.616 0.599 . . . . 0.0 112.616 178.55 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.62 HG21 ' HA ' ' A' ' 47' ' ' LEU . 40.6 t -58.07 -35.84 54.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.815 0 C-N-CA 123.448 0.699 . . . . 0.0 112.521 176.166 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 34.8 tttm -62.81 -65.07 0.74 Allowed 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 124.029 0.932 . . . . 0.0 111.014 171.796 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.3 tp10 -62.52 -52.76 62.18 Favored 'General case' 0 CA--C 1.554 1.127 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 -174.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.439 ' HB3' ' O ' ' A' ' 44' ' ' ALA . . . -64.91 -27.27 68.74 Favored 'General case' 0 N--CA 1.49 1.545 0 N-CA-C 114.485 1.291 . . . . 0.0 114.485 -176.665 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.473 ' HA ' ' HE3' ' A' ' 45' ' ' LYS . 38.0 mttm -58.5 -35.52 72.38 Favored 'General case' 0 CA--C 1.543 0.679 0 N-CA-C 114.041 1.126 . . . . 0.0 114.041 169.393 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.66 -31.83 79.31 Favored Glycine 0 N--CA 1.482 1.731 0 O-C-N 125.78 1.925 . . . . 0.0 113.579 177.441 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 90.3 m-85 -79.01 142.17 36.83 Favored 'General case' 0 N--CA 1.475 0.822 0 C-N-CA 123.294 0.638 . . . . 0.0 110.695 174.967 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.1 p -64.5 -43.75 93.12 Favored 'General case' 0 N--CA 1.493 1.718 0 CA-C-N 114.655 -1.157 . . . . 0.0 111.64 -177.694 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 22.2 p -59.68 143.8 49.68 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 125.432 1.493 . . . . 0.0 114.419 176.802 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -90.78 126.3 35.97 Favored 'General case' 0 N--CA 1.472 0.636 0 CA-C-O 122.744 1.259 . . . . 0.0 109.999 174.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.549 HG21 HD13 ' A' ' 77' ' ' LEU . 15.4 mm -98.4 98.56 7.37 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.754 0 CA-C-N 112.765 -2.016 . . . . 0.0 109.71 -169.418 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.404 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 0.2 OUTLIER -83.86 101.28 11.54 Favored 'General case' 0 N--CA 1.478 0.965 0 CA-C-N 113.705 -1.588 . . . . 0.0 107.554 175.756 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 52.5 t -87.43 77.6 1.47 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.92 0 N-CA-C 106.088 -1.819 . . . . 0.0 106.088 178.084 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 22.9 m -75.45 88.28 2.63 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-N 113.439 -1.71 . . . . 0.0 108.339 179.567 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 47.7 t -79.8 86.68 5.34 Favored 'General case' 0 N--CA 1.473 0.723 0 CA-C-N 113.74 -1.573 . . . . 0.0 108.819 178.653 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 13.5 p-10 21.12 81.4 0.01 OUTLIER 'General case' 0 N--CA 1.476 0.835 0 CA-C-N 111.295 -2.684 . . . . 0.0 115.484 -177.601 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 112.37 -63.37 0.28 Allowed Glycine 0 CA--C 1.543 1.81 0 CA-C-N 112.173 -2.285 . . . . 0.0 112.79 -171.248 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 33.6 mttp -104.9 133.02 50.4 Favored 'General case' 0 N--CA 1.477 0.923 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 -169.479 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 12.6 p -88.71 116.23 26.82 Favored 'General case' 0 N--CA 1.482 1.139 0 CA-C-N 113.557 -1.656 . . . . 0.0 115.444 -175.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.463 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -102.29 164.96 11.39 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 112.532 -2.122 . . . . 0.0 109.546 168.847 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.6 t -125.69 119.38 27.85 Favored 'General case' 0 N--CA 1.482 1.15 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.305 178.221 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.439 ' O ' ' HB3' ' A' ' 26' ' ' ALA . . . -72.57 5.97 2.72 Favored 'General case' 0 N--CA 1.483 1.222 0 O-C-N 124.42 1.075 . . . . 0.0 113.059 170.885 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.473 ' HE3' ' HA ' ' A' ' 27' ' ' LYS . 50.9 mtpt -113.89 -15.21 12.4 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.964 1.098 . . . . 0.0 113.964 172.923 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 45.0 t -119.02 120.9 38.58 Favored 'General case' 0 N--CA 1.478 0.958 0 C-N-CA 123.824 0.849 . . . . 0.0 111.685 172.448 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.62 ' HA ' HG21 ' A' ' 23' ' ' VAL . 20.0 tp -57.44 -61.83 2.21 Favored 'General case' 0 N--CA 1.476 0.851 0 CA-C-N 114.018 -1.447 . . . . 0.0 113.386 -172.391 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 23.4 t80 -45.37 -50.78 11.96 Favored 'General case' 0 N--CA 1.474 0.743 0 C-N-CA 125.29 1.436 . . . . 0.0 113.238 173.299 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 71.7 tttt -67.67 -30.93 70.59 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.422 0.897 . . . . 0.0 113.422 -174.809 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.463 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 18.6 tp -72.98 -47.06 48.59 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 123.513 0.508 . . . . 0.0 111.752 174.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 73.0 mt-30 -65.99 -31.53 72.48 Favored 'General case' 0 N--CA 1.481 1.086 0 N-CA-C 114.721 1.378 . . . . 0.0 114.721 178.669 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 8.5 t -85.03 33.71 0.54 Allowed 'General case' 0 N--CA 1.484 1.269 0 CA-C-O 122.856 1.313 . . . . 0.0 114.351 175.121 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -136.05 140.72 44.03 Favored 'General case' 0 N--CA 1.473 0.677 0 CA-C-N 114.926 -1.034 . . . . 0.0 110.907 171.555 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -65.7 93.23 0.17 Allowed Glycine 0 N--CA 1.479 1.525 0 CA-C-N 113.833 -1.53 . . . . 0.0 112.256 176.14 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.414 ' O ' ' HA3' ' A' ' 13' ' ' GLY . 17.0 mt -94.96 57.86 2.14 Favored 'General case' 0 N--CA 1.48 1.054 0 CA-C-O 122.293 1.044 . . . . 0.0 110.721 173.884 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 6.4 t -109.39 176.88 4.92 Favored 'General case' 0 N--CA 1.483 1.209 0 CA-C-N 114.213 -1.358 . . . . 0.0 112.866 -172.507 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 46.0 tt0 -58.58 126.15 26.38 Favored 'General case' 0 N--CA 1.475 0.794 0 CA-C-O 121.758 0.79 . . . . 0.0 111.888 -179.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.66 16.23 64.23 Favored Glycine 0 CA--C 1.537 1.44 0 CA-C-N 113.385 -1.734 . . . . 0.0 114.925 179.463 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 36.0 p -88.23 120.44 29.59 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-O 121.543 0.687 . . . . 0.0 111.313 175.961 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 8.3 t -93.54 85.92 2.02 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.044 0 CA-C-N 112.4 -2.182 . . . . 0.0 107.642 -173.819 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.8 m -80.5 94.46 2.24 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.574 0 CA-C-N 112.129 -2.305 . . . . 0.0 112.382 -179.66 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.401 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 17.0 m -76.12 100.66 5.06 Favored 'General case' 0 N--CA 1.476 0.867 0 CA-C-N 114.946 -1.024 . . . . 0.0 108.761 172.267 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.507 HG22 HG22 ' A' ' 74' ' ' VAL . 67.3 mt -79.23 102.12 5.05 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.651 0 CA-C-N 113.189 -1.823 . . . . 0.0 107.975 177.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.404 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 47.8 t -106.56 104.86 14.65 Favored 'General case' 0 N--CA 1.481 1.113 0 CA-C-N 111.82 -2.445 . . . . 0.0 110.408 -177.616 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -95.59 101.49 13.2 Favored 'General case' 0 C--N 1.322 -0.63 0 CA-C-N 115.553 -0.749 . . . . 0.0 111.763 -179.198 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 10.6 pt-20 -91.89 99.56 12.39 Favored 'General case' 0 N--CA 1.481 1.101 0 CA-C-N 113.717 -1.583 . . . . 0.0 111.982 176.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 153.09 -169.15 31.99 Favored Glycine 0 N--CA 1.482 1.758 0 CA-C-N 112.39 -2.187 . . . . 0.0 111.38 177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 52.7 mt-10 -63.42 -48.9 75.91 Favored 'General case' 0 N--CA 1.481 1.111 0 N-CA-C 116.979 2.214 . . . . 0.0 116.979 -169.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.6 p30 -85.62 42.71 0.98 Allowed 'General case' 0 CA--C 1.548 0.866 0 N-CA-C 114.287 1.217 . . . . 0.0 114.287 177.169 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -51.77 -48.65 63.65 Favored 'General case' 0 N--CA 1.48 1.052 0 N-CA-C 116.466 2.025 . . . . 0.0 116.466 -175.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.44 -42.88 28.72 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.521 0.934 . . . . 0.0 113.521 177.947 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 39.5 mtmt -59.11 -44.19 91.95 Favored 'General case' 0 N--CA 1.486 1.335 0 C-N-CA 124.545 1.138 . . . . 0.0 112.719 179.597 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -64.34 -49.68 70.72 Favored 'General case' 0 CA--C 1.54 0.57 0 C-N-CA 124.192 0.997 . . . . 0.0 113.308 175.005 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.507 HG22 HG22 ' A' ' 63' ' ' ILE . 76.3 t -59.84 -55.11 26.17 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.433 0 CA-C-O 117.925 -1.036 . . . . 0.0 111.47 -179.733 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.0 mt-10 -47.97 -45.04 30.94 Favored 'General case' 0 N--CA 1.486 1.352 0 N-CA-C 114.749 1.389 . . . . 0.0 114.749 177.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 55.9 t60 -70.13 -51.22 33.22 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.0 0.741 . . . . 0.0 113.0 -179.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.549 HD13 HG21 ' A' ' 33' ' ' ILE . 5.7 mt -60.56 -33.86 73.31 Favored 'General case' 0 N--CA 1.476 0.836 0 N-CA-C 115.014 1.487 . . . . 0.0 115.014 176.445 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 75.3 t -58.65 -54.69 29.9 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 O-C-N 124.039 0.837 . . . . 0.0 109.966 170.535 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 17.1 mtpt -50.99 -49.98 59.33 Favored 'General case' 0 N--CA 1.485 1.299 0 O-C-N 124.17 0.919 . . . . 0.0 112.988 176.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.576 ' HB3' ' HE1' ' A' ' 22' ' ' PHE . 9.4 mp -61.48 -46.25 90.84 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.676 1.361 . . . . 0.0 114.676 179.683 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 44.5 mtt -66.41 -21.67 66.22 Favored 'General case' 0 N--CA 1.493 1.678 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 174.381 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.3 -32.46 16.51 Favored 'General case' 0 CA--C 1.55 0.944 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 174.231 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -74.25 -39.72 62.85 Favored 'General case' 0 N--CA 1.487 1.412 0 N-CA-C 114.606 1.336 . . . . 0.0 114.606 173.929 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 24.5 mt -81.35 104.97 12.17 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.414 0.894 . . . . 0.0 113.414 178.545 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 31.1 tt0 . . . . . 0 C--O 1.251 1.167 0 N-CA-C 105.414 -2.069 . . . . 0.0 105.414 173.857 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 36.8 ttp . . . . . 0 N--CA 1.473 0.715 0 N-CA-C 108.453 -0.943 . . . . 0.0 108.453 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 12.4 t80 -124.88 135.64 53.06 Favored 'General case' 0 N--CA 1.478 0.932 0 O-C-N 125.277 1.611 . . . . 0.0 108.246 173.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 1.3 tm0? -133.97 135.19 43.32 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.059 -172.41 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 31.8 mt-30 -142.76 144.49 32.65 Favored 'General case' 0 N--CA 1.483 1.219 0 C-N-CA 125.047 1.339 . . . . 0.0 112.185 171.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 10.3 pt-20 -91.16 141.91 28.31 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 114.699 -1.137 . . . . 0.0 112.507 169.244 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.609 HG11 ' HB3' ' A' ' 81' ' ' MET . 44.5 t -123.73 135.18 64.28 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.918 0 CA-C-N 113.577 -1.647 . . . . 0.0 106.722 160.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 57.9 m -102.75 113.7 27.32 Favored 'General case' 0 N--CA 1.478 0.939 0 N-CA-C 108.004 -1.11 . . . . 0.0 108.004 177.324 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.4 mt -72.63 124.69 29.96 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.53 0 CA-C-O 122.317 1.056 . . . . 0.0 108.735 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.7 t -127.11 -30.12 2.71 Favored 'General case' 0 N--CA 1.487 1.398 0 CA-C-N 112.05 -2.341 . . . . 0.0 112.868 -171.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.516 ' HB2' ' HG2' ' A' ' 85' ' ' GLU . . . -45.62 121.86 5.48 Favored Pre-proline 0 N--CA 1.477 0.886 0 C-N-CA 124.258 1.023 . . . . 0.0 111.367 161.483 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.433 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 34.1 Cg_endo -53.67 -69.35 0.06 OUTLIER 'Trans proline' 0 CA--C 1.537 0.662 0 C-N-CA 123.454 2.769 . . . . 0.0 114.048 -169.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.425 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 0.0 OUTLIER -74.55 -24.0 58.87 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 114.135 1.161 . . . . 0.0 114.135 173.918 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 69.25 -125.2 17.83 Favored Glycine 0 CA--C 1.531 1.078 0 C-N-CA 124.999 1.285 . . . . 0.0 113.599 167.238 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.674 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 5.1 mp -96.45 110.43 22.8 Favored 'General case' 0 C--O 1.241 0.609 0 CA-C-O 122.896 1.331 . . . . 0.0 112.984 -175.656 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 21.3 p80 -109.6 -169.81 1.54 Allowed 'General case' 0 CA--C 1.553 1.08 0 CA-C-N 111.95 -2.386 . . . . 0.0 111.203 173.436 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 1.2 m -27.53 -76.1 0.02 OUTLIER 'General case' 0 N--CA 1.482 1.13 0 C-N-CA 127.394 2.278 . . . . 0.0 115.933 -173.963 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 56.4 ttt-85 -62.63 -49.35 83.33 Favored Pre-proline 0 N--CA 1.488 1.458 0 CA-C-O 116.237 -1.84 . . . . 0.0 113.696 -178.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 40.1 Cg_exo -51.51 -45.95 34.6 Favored 'Trans proline' 0 C--N 1.357 0.979 0 C-N-CA 123.448 2.765 . . . . 0.0 114.044 171.163 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.7 -51.14 68.35 Favored 'General case' 0 N--CA 1.487 1.401 0 C-N-CA 123.289 0.636 . . . . 0.0 112.403 176.775 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -58.23 -40.28 81.31 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 176.927 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 39.1 mt-30 -54.62 -58.08 8.91 Favored 'General case' 0 N--CA 1.485 1.294 0 C-N-CA 124.44 1.096 . . . . 0.0 111.986 171.565 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 9.2 t80 -57.79 -41.69 82.62 Favored 'General case' 0 CA--C 1.542 0.649 0 C-N-CA 124.206 1.003 . . . . 0.0 112.719 178.328 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.608 HG21 ' HA ' ' A' ' 47' ' ' LEU . 58.9 t -64.58 -51.06 72.5 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.01 0 C-N-CA 123.122 0.569 . . . . 0.0 111.642 177.365 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.6 tmtt? -53.15 -47.94 68.35 Favored 'General case' 0 N--CA 1.485 1.311 0 C-N-CA 123.354 0.662 . . . . 0.0 109.827 176.069 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -66.06 -49.72 66.64 Favored 'General case' 0 N--CA 1.467 0.411 0 N-CA-C 114.75 1.389 . . . . 0.0 114.75 -179.588 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.01 -45.85 75.13 Favored 'General case' 0 N--CA 1.482 1.151 0 C-N-CA 123.525 0.73 . . . . 0.0 112.081 174.133 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 62.4 mttm -59.59 -36.08 75.55 Favored 'General case' 0 N--CA 1.483 1.213 0 N-CA-C 114.992 1.479 . . . . 0.0 114.992 173.1 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.22 -43.07 93.79 Favored Glycine 0 CA--C 1.537 1.46 0 O-C-N 124.875 1.359 . . . . 0.0 112.199 179.526 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 28.8 m-85 -62.02 145.99 51.48 Favored 'General case' 0 N--CA 1.481 1.116 0 C-N-CA 123.99 0.916 . . . . 0.0 112.554 172.69 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 64.7 p -79.44 -31.36 42.53 Favored 'General case' 0 N--CA 1.484 1.275 0 CA-C-N 114.792 -1.094 . . . . 0.0 113.232 -178.232 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 12.7 p -71.95 141.82 49.43 Favored 'General case' 0 N--CA 1.484 1.248 0 C-N-CA 123.76 0.824 . . . . 0.0 112.398 178.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.484 ' HB3' ' HG3' ' A' ' 66' ' ' GLU . 16.4 tp10 -72.35 130.62 41.17 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.479 0.656 . . . . 0.0 110.462 178.009 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 37.7 mm -113.43 86.32 0.88 Allowed 'Isoleucine or valine' 0 N--CA 1.475 0.789 0 CA-C-N 113.369 -1.742 . . . . 0.0 109.303 -164.417 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 41.1 m -92.54 111.9 23.65 Favored 'General case' 0 N--CA 1.476 0.832 0 CA-C-N 112.26 -2.245 . . . . 0.0 108.707 179.6 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 44.3 t -105.51 103.46 15.4 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.731 0 CA-C-N 113.45 -1.705 . . . . 0.0 108.873 179.964 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.417 ' HA ' ' HA ' ' A' ' 41' ' ' SER . 42.0 m -81.57 98.35 8.28 Favored 'General case' 0 N--CA 1.478 0.961 0 CA-C-N 114.041 -1.436 . . . . 0.0 109.219 176.499 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.41 ' HB3' HD12 ' A' ' 53' ' ' LEU . 10.6 t -95.39 94.16 7.67 Favored 'General case' 0 N--CA 1.475 0.777 0 CA-C-N 114.752 -1.113 . . . . 0.0 109.16 -179.142 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.288 30.7 p-10 43.51 77.32 0.07 Allowed 'General case' 0 N--CA 1.48 1.05 0 CA-C-N 111.053 -2.794 . . . . 0.0 115.628 -176.643 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.06 -52.59 3.21 Favored Glycine 0 CA--C 1.534 1.254 0 CA-C-N 112.276 -2.238 . . . . 0.0 113.742 -177.854 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 42.7 mttp -93.46 134.48 35.67 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 112.956 0.724 . . . . 0.0 112.956 -173.484 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.417 ' HA ' ' HA ' ' A' ' 36' ' ' THR . 39.5 p -89.8 148.9 22.94 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 122.526 1.155 . . . . 0.0 113.561 -179.623 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.473 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -143.66 122.59 12.76 Favored 'General case' 0 N--CA 1.47 0.56 0 CA-C-N 112.791 -2.004 . . . . 0.0 109.586 171.185 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 47.5 t -57.73 107.45 0.45 Allowed 'General case' 0 N--CA 1.472 0.633 0 CA-C-O 121.315 0.578 . . . . 0.0 110.059 166.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.78 -23.4 60.15 Favored 'General case' 0 N--CA 1.478 0.934 0 CA-C-N 113.705 -1.589 . . . . 0.0 112.378 176.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 78.9 mttt -65.11 3.46 0.6 Allowed 'General case' 0 CA--C 1.545 0.782 0 CA-C-N 113.789 -1.551 . . . . 0.0 114.994 168.215 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.493 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 31.1 t -125.94 118.04 24.57 Favored 'General case' 0 N--CA 1.471 0.624 0 C-N-CA 123.885 0.874 . . . . 0.0 110.427 175.24 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.608 ' HA ' HG21 ' A' ' 23' ' ' VAL . 31.1 tp -53.41 -47.75 69.29 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-N 113.209 -1.814 . . . . 0.0 110.793 174.841 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -58.22 -51.05 71.35 Favored 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.544 176.08 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.493 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 63.9 mttt -68.19 -43.69 77.56 Favored 'General case' 0 N--CA 1.478 0.931 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 -177.805 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 12.4 tp -62.41 -45.53 92.72 Favored 'General case' 0 N--CA 1.476 0.861 0 CA-C-O 118.275 -0.869 . . . . 0.0 111.057 175.223 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.0 mt-30 -64.49 -36.45 84.22 Favored 'General case' 0 N--CA 1.484 1.235 0 N-CA-C 115.877 1.806 . . . . 0.0 115.877 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.446 HG22 ' HA ' ' A' ' 49' ' ' LYS . 5.2 t -74.62 -30.44 61.66 Favored 'General case' 0 N--CA 1.484 1.267 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 177.283 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.41 HD12 ' HB3' ' A' ' 37' ' ' SER . 3.2 mm? -83.07 155.6 23.78 Favored 'General case' 0 N--CA 1.484 1.228 0 CA-C-O 122.067 0.937 . . . . 0.0 113.475 173.093 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -56.63 121.05 23.17 Favored Glycine 0 N--CA 1.487 2.087 0 CA-C-N 113.776 -1.556 . . . . 0.0 113.433 178.25 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.674 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 76.1 mt -124.31 36.66 4.57 Favored 'General case' 0 CA--C 1.545 0.784 0 C-N-CA 125.061 1.344 . . . . 0.0 113.355 177.875 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.4 t -139.36 160.32 40.1 Favored 'General case' 0 N--CA 1.487 1.401 0 N-CA-C 112.525 0.565 . . . . 0.0 112.525 -163.036 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.433 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 51.1 tt0 -34.52 109.51 0.08 Allowed 'General case' 0 CA--C 1.551 1.004 0 C-N-CA 125.618 1.567 . . . . 0.0 113.429 173.663 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.75 -40.8 1.93 Allowed Glycine 0 CA--C 1.534 1.276 0 CA-C-N 113.097 -1.865 . . . . 0.0 113.817 -178.522 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.7 p -74.89 133.35 41.83 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -172.673 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.5 t -102.57 110.06 28.23 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.128 0 CA-C-N 113.279 -1.782 . . . . 0.0 106.785 -176.38 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 6.2 m -98.7 89.67 1.91 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 O-C-N 125.065 1.478 . . . . 0.0 111.968 -176.922 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -75.15 90.16 2.52 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.717 -2.038 . . . . 0.0 110.096 177.003 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.3 mt -76.65 111.87 13.83 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 CA-C-N 113.25 -1.796 . . . . 0.0 108.275 179.494 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 9.2 t -117.2 124.75 49.87 Favored 'General case' 0 N--CA 1.479 0.989 0 CA-C-N 113.821 -1.536 . . . . 0.0 109.631 176.12 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -110.28 110.66 21.55 Favored 'General case' 0 N--CA 1.471 0.584 0 CA-C-N 114.104 -1.407 . . . . 0.0 111.365 178.939 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.484 ' HG3' ' HB3' ' A' ' 32' ' ' GLU . 3.3 pt-20 -108.95 110.34 21.62 Favored 'General case' 0 N--CA 1.473 0.708 0 CA-C-N 114.651 -1.158 . . . . 0.0 113.674 177.579 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 146.82 -158.57 27.77 Favored Glycine 0 N--CA 1.483 1.831 0 CA-C-N 113.399 -1.728 . . . . 0.0 112.002 -177.286 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 15.2 mt-10 -59.88 -65.76 0.63 Allowed 'General case' 0 N--CA 1.479 1.015 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -173.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 9.1 p30 -81.34 45.38 0.85 Allowed 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.816 1.043 . . . . 0.0 113.816 -178.682 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.406 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 10.1 pt-20 -51.33 -62.27 1.72 Allowed 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 125.683 1.593 . . . . 0.0 114.533 -177.424 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.406 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 0.6 OUTLIER -65.28 -41.98 93.62 Favored 'General case' 0 N--CA 1.481 1.119 0 N-CA-C 114.445 1.276 . . . . 0.0 114.445 176.242 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 87.8 mttt -56.96 -49.01 77.01 Favored 'General case' 0 N--CA 1.478 0.968 0 C-N-CA 124.457 1.103 . . . . 0.0 113.52 179.209 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.9 -51.64 68.8 Favored 'General case' 0 N--CA 1.475 0.797 0 C-N-CA 123.451 0.701 . . . . 0.0 111.838 175.103 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 47.4 t -61.68 -46.32 96.79 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.981 0 CA-C-O 118.281 -0.866 . . . . 0.0 112.449 -178.178 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 34.0 tt0 -49.21 -54.73 15.22 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 125.21 1.404 . . . . 0.0 112.096 175.287 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 9.2 t60 -69.09 -34.75 75.6 Favored 'General case' 0 CA--C 1.542 0.643 0 N-CA-C 113.459 0.911 . . . . 0.0 113.459 -177.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 41.5 mt -73.24 -39.9 65.1 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.288 1.218 . . . . 0.0 114.288 178.408 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 90.8 t -58.91 -43.6 88.89 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.625 0 C-N-CA 123.289 0.636 . . . . 0.0 110.217 170.492 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.466 ' HB3' ' HE2' ' A' ' 79' ' ' LYS . 34.0 mtpt -56.63 -53.66 55.12 Favored 'General case' 0 N--CA 1.478 0.95 0 N-CA-C 113.392 0.886 . . . . 0.0 113.392 171.537 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 4.3 mt -49.76 -48.77 50.1 Favored 'General case' 0 N--CA 1.477 0.92 0 C-N-CA 124.06 0.944 . . . . 0.0 113.464 175.33 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.609 ' HB3' HG11 ' A' ' 6' ' ' VAL . 11.9 mmt -59.16 -43.73 92.1 Favored 'General case' 0 N--CA 1.476 0.845 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 176.102 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.36 -40.66 89.91 Favored 'General case' 0 N--CA 1.482 1.175 0 N-CA-C 113.162 0.801 . . . . 0.0 113.162 -179.813 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 40.5 mt-10 -74.18 -19.09 60.66 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 117.203 2.298 . . . . 0.0 117.203 -178.301 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 46.3 mt -101.1 88.84 3.62 Favored 'General case' 0 CA--C 1.554 1.117 0 N-CA-C 115.092 1.516 . . . . 0.0 115.092 -172.53 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.516 ' HG2' ' HB2' ' A' ' 10' ' ' ALA . 23.9 mt-10 . . . . . 0 C--O 1.258 1.519 0 C-N-CA 125.162 1.385 . . . . 0.0 109.37 171.388 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.2 tmt? . . . . . 0 N--CA 1.466 0.339 0 N-CA-C 107.373 -1.343 . . . . 0.0 107.373 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 23.8 t80 -141.29 134.07 28.8 Favored 'General case' 0 N--CA 1.48 1.065 0 O-C-N 124.969 1.418 . . . . 0.0 111.318 -178.736 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 20.4 pt20 -122.98 139.94 53.55 Favored 'General case' 0 N--CA 1.474 0.729 0 CA-C-N 113.423 -1.717 . . . . 0.0 111.156 173.454 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.491 ' HB2' HG11 ' A' ' 74' ' ' VAL . 0.0 OUTLIER -138.73 140.31 38.66 Favored 'General case' 0 N--CA 1.474 0.732 0 CA-C-N 115.417 -0.81 . . . . 0.0 111.171 175.06 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 26.2 mt-10 -100.63 116.14 31.85 Favored 'General case' 0 N--CA 1.481 1.102 0 CA-C-O 122.74 1.257 . . . . 0.0 111.443 -179.583 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 13.5 p -122.62 135.72 61.8 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 112.88 -1.963 . . . . 0.0 111.286 -175.501 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.7 p -87.91 162.54 16.85 Favored 'General case' 0 N--CA 1.481 1.09 0 CA-C-N 113.629 -1.623 . . . . 0.0 112.494 176.461 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.6 mm -115.85 132.38 65.49 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.108 0 O-C-N 125.234 1.584 . . . . 0.0 106.885 174.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -102.77 -29.92 11.19 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 114.57 1.322 . . . . 0.0 114.57 178.248 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.904 ' HB2' ' HB3' ' A' ' 85' ' ' GLU . . . -40.54 132.83 1.69 Allowed Pre-proline 0 N--CA 1.474 0.747 0 N-CA-C 116.596 2.073 . . . . 0.0 116.596 177.422 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 79.4 Cg_exo -54.69 -45.94 37.15 Favored 'Trans proline' 0 CA--C 1.54 0.795 0 C-N-CA 123.915 3.077 . . . . 0.0 112.411 170.468 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.2 p-10 -73.03 -64.37 0.98 Allowed 'General case' 0 N--CA 1.481 1.099 0 O-C-N 124.531 1.144 . . . . 0.0 112.967 171.344 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 105.61 100.31 2.64 Favored Glycine 0 N--CA 1.475 1.286 0 N-CA-C 110.386 -1.085 . . . . 0.0 110.386 179.28 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER 32.21 84.57 0.01 OUTLIER 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 127.134 2.173 . . . . 0.0 114.722 179.201 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 9.7 p80 -64.23 169.81 4.25 Favored 'General case' 0 N--CA 1.476 0.836 0 CA-C-O 123.111 1.434 . . . . 0.0 114.213 -177.44 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 11.1 p -59.71 -17.28 33.36 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 116.437 2.014 . . . . 0.0 116.437 -175.077 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.261 96.8 mtt180 -80.32 -47.38 1.32 Allowed Pre-proline 0 N--CA 1.478 0.929 0 CA-C-O 116.75 -1.595 . . . . 0.0 114.473 176.465 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 6.8 Cg_endo -59.66 -37.22 89.16 Favored 'Trans proline' 0 N--CA 1.478 0.568 0 C-N-CA 122.097 1.865 . . . . 0.0 113.976 162.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.38 -44.99 89.16 Favored 'General case' 0 N--CA 1.48 1.034 0 N-CA-C 113.913 1.079 . . . . 0.0 113.913 170.877 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.31 -40.08 92.89 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 114.092 1.145 . . . . 0.0 114.092 172.224 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.4 mt-30 -63.54 -48.1 78.88 Favored 'General case' 0 N--CA 1.489 1.482 0 CA-C-O 118.543 -0.741 . . . . 0.0 112.864 173.301 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.8 OUTLIER -45.92 -56.27 5.68 Favored 'General case' 0 N--CA 1.485 1.29 0 C-N-CA 125.54 1.536 . . . . 0.0 113.519 176.727 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 42.8 t -57.01 -43.66 81.37 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.491 0 C-N-CA 124.185 0.994 . . . . 0.0 112.496 179.82 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 54.7 mtmt -64.35 -50.13 68.96 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 112.942 0.719 . . . . 0.0 112.942 -178.126 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.4 tp10 -59.58 -48.92 79.78 Favored 'General case' 0 CA--C 1.548 0.876 0 O-C-N 124.778 1.299 . . . . 0.0 111.257 176.756 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.67 -39.36 80.44 Favored 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 115.001 1.482 . . . . 0.0 115.001 175.641 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.6 mttm -65.65 -38.02 88.19 Favored 'General case' 0 N--CA 1.477 0.916 0 N-CA-C 114.038 1.125 . . . . 0.0 114.038 173.491 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.18 -53.6 35.55 Favored Glycine 0 N--CA 1.482 1.726 0 O-C-N 125.614 1.821 . . . . 0.0 111.794 177.361 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 23.9 m-85 -52.34 137.03 30.01 Favored 'General case' 0 N--CA 1.487 1.403 0 O-C-N 125.322 1.248 . . . . 0.0 110.378 171.652 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 2.9 p -74.11 -36.36 64.21 Favored 'General case' 0 N--CA 1.479 1.008 0 N-CA-C 112.763 0.653 . . . . 0.0 112.763 179.145 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 16.4 m -46.28 146.85 1.25 Allowed 'General case' 0 N--CA 1.487 1.398 0 C-N-CA 126.135 1.774 . . . . 0.0 114.877 170.735 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 22.8 tp10 -86.05 133.72 33.88 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-O 121.792 0.806 . . . . 0.0 109.878 171.435 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.0 mm -117.04 97.44 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.98 0 CA-C-N 114.823 -1.08 . . . . 0.0 110.165 -164.243 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.487 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 57.0 m -94.77 117.91 30.9 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 112.62 -2.082 . . . . 0.0 109.4 -176.391 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.0 t -116.88 100.92 11.32 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.894 0 CA-C-N 112.796 -2.002 . . . . 0.0 107.17 -175.392 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.7 m -111.26 102.46 10.87 Favored 'General case' 0 N--CA 1.474 0.747 0 CA-C-N 114.135 -1.393 . . . . 0.0 112.673 -167.352 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.5 m -76.52 91.8 3.39 Favored 'General case' 0 N--CA 1.483 1.188 0 CA-C-N 114.783 -1.099 . . . . 0.0 108.751 170.254 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.263 6.8 p-10 32.24 105.24 0.0 OUTLIER 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 118.706 2.854 . . . . 0.0 118.706 -172.424 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 73.38 -37.37 0.82 Allowed Glycine 0 CA--C 1.54 1.627 0 N-CA-C 116.525 1.37 . . . . 0.0 116.525 175.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.634 ' HD3' HD21 ' A' ' 53' ' ' LEU . 78.1 tttt -94.58 120.05 34.2 Favored 'General case' 0 N--CA 1.474 0.775 0 C-N-CA 123.938 0.895 . . . . 0.0 110.161 -179.294 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 54.0 m -98.31 124.21 42.83 Favored 'General case' 0 N--CA 1.491 1.608 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -169.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.493 ' HB1' ' O ' ' A' ' 49' ' ' LYS . . . -117.28 166.6 12.09 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.74 -2.027 . . . . 0.0 109.723 175.659 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.645 ' HB3' ' HD3' ' A' ' 49' ' ' LYS . 18.2 t -126.01 132.34 52.03 Favored 'General case' 0 N--CA 1.48 1.04 0 N-CA-C 113.035 0.754 . . . . 0.0 113.035 178.232 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.91 -20.43 64.23 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.327 -1.761 . . . . 0.0 113.907 178.12 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 15.7 mtpt -66.29 -12.3 55.64 Favored 'General case' 0 N--CA 1.486 1.328 0 N-CA-C 115.406 1.632 . . . . 0.0 115.406 -174.988 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 84.4 p -136.44 137.26 40.25 Favored 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 109.146 -0.687 . . . . 0.0 109.146 160.19 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 24.6 tp -55.11 -39.23 69.13 Favored 'General case' 0 N--CA 1.486 1.352 0 O-C-N 124.121 0.888 . . . . 0.0 111.908 174.806 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 78.8 t80 -46.4 -56.35 6.02 Favored 'General case' 0 N--CA 1.473 0.722 0 C-N-CA 126.04 1.736 . . . . 0.0 113.272 168.822 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.645 ' HD3' ' HB3' ' A' ' 43' ' ' SER . 56.1 tttt -76.49 -30.47 57.25 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 112.664 0.616 . . . . 0.0 112.664 -179.316 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 50.3 tp -59.9 -65.56 0.66 Allowed 'General case' 0 CA--C 1.545 0.783 0 N-CA-C 113.641 0.978 . . . . 0.0 113.641 173.038 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 46.1 mt-30 -59.99 -23.62 63.78 Favored 'General case' 0 N--CA 1.487 1.385 0 N-CA-C 117.974 2.583 . . . . 0.0 117.974 -169.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 14.9 t -60.88 -26.5 67.46 Favored 'General case' 0 N--CA 1.484 1.263 0 N-CA-C 114.05 1.13 . . . . 0.0 114.05 174.407 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.634 HD21 ' HD3' ' A' ' 40' ' ' LYS . 5.4 mt -123.27 85.15 2.37 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 124.542 1.137 . . . . 0.0 109.459 169.173 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -76.88 135.86 17.72 Favored Glycine 0 CA--C 1.533 1.181 0 CA-C-N 112.949 -1.932 . . . . 0.0 113.135 -173.209 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.46 HD23 HG11 ' A' ' 61' ' ' VAL . 5.0 mp -79.22 101.32 7.93 Favored 'General case' 0 N--CA 1.485 1.282 0 CA-C-N 113.47 -1.365 . . . . 0.0 109.715 -179.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 15.0 t -129.71 162.23 28.86 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 113.804 -1.543 . . . . 0.0 111.979 -174.251 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.4 pt20 -58.02 145.74 35.19 Favored 'General case' 0 N--CA 1.476 0.827 0 N-CA-C 113.055 0.761 . . . . 0.0 113.055 179.529 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 84.44 -51.16 4.52 Favored Glycine 0 CA--C 1.535 1.307 0 CA-C-N 114.474 -1.239 . . . . 0.0 112.95 -175.263 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.2 m -71.38 113.33 8.31 Favored 'General case' 0 N--CA 1.485 1.296 0 CA-C-O 121.907 0.86 . . . . 0.0 111.245 179.87 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 15.0 p -71.43 132.37 33.4 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 CA-C-N 113.699 -1.591 . . . . 0.0 110.709 171.119 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.46 HG11 HD23 ' A' ' 55' ' ' LEU . 14.8 p -116.59 123.92 72.15 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.692 0 CA-C-N 113.652 -1.613 . . . . 0.0 112.08 -177.825 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 m -79.95 120.53 24.28 Favored 'General case' 0 N--CA 1.476 0.847 0 CA-C-N 113.948 -1.478 . . . . 0.0 108.968 174.484 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 45.2 mm -102.01 100.33 10.18 Favored 'Isoleucine or valine' 0 N--CA 1.471 0.579 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 172.912 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.487 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 44.6 t -110.18 125.39 52.99 Favored 'General case' 0 N--CA 1.473 0.696 0 CA-C-N 112.909 -1.95 . . . . 0.0 112.104 -176.568 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -119.15 111.89 18.83 Favored 'General case' 0 N--CA 1.482 1.174 0 CA-C-N 114.03 -1.441 . . . . 0.0 111.547 178.481 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 11.2 pt-20 -111.53 103.8 12.15 Favored 'General case' 0 CA--C 1.546 0.812 0 CA-C-N 113.778 -1.555 . . . . 0.0 112.91 176.098 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 151.57 -156.4 26.66 Favored Glycine 0 N--CA 1.479 1.533 0 CA-C-N 111.798 -2.455 . . . . 0.0 109.8 -176.174 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 3.2 mp0 -67.3 -49.53 63.84 Favored 'General case' 0 N--CA 1.483 1.177 0 N-CA-C 114.318 1.229 . . . . 0.0 114.318 -174.353 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 4.3 m-20 -68.93 20.44 0.03 OUTLIER 'General case' 0 N--CA 1.476 0.862 0 N-CA-C 115.847 1.795 . . . . 0.0 115.847 -178.106 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -41.43 -55.71 2.72 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 117.119 2.266 . . . . 0.0 117.119 -171.957 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 41.2 mt-30 -75.75 -52.26 10.84 Favored 'General case' 0 N--CA 1.487 1.383 0 C-N-CA 123.939 0.896 . . . . 0.0 112.157 177.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 20.9 ttmm -48.33 -54.31 14.28 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 126.421 1.888 . . . . 0.0 113.069 -179.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.92 -51.99 66.95 Favored 'General case' 0 N--CA 1.478 0.928 0 C-N-CA 124.452 1.101 . . . . 0.0 112.732 -179.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.491 HG11 ' HB2' ' A' ' 4' ' ' GLN . 60.7 t -64.8 -49.24 80.99 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.832 0 CA-C-N 115.746 -0.661 . . . . 0.0 110.734 -178.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 27.7 tt0 -53.79 -51.79 62.33 Favored 'General case' 0 N--CA 1.49 1.53 0 O-C-N 124.31 1.006 . . . . 0.0 111.025 178.171 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 22.7 t60 -65.17 -43.65 91.04 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.49 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 68.7 mt -64.51 -35.61 81.53 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 113.931 1.085 . . . . 0.0 113.931 176.665 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 92.4 t -74.08 -35.18 40.63 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.756 0 C-N-CA 123.126 0.57 . . . . 0.0 111.451 172.919 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 47.2 mtpt -66.66 -36.01 81.51 Favored 'General case' 0 N--CA 1.475 0.787 0 N-CA-C 114.232 1.197 . . . . 0.0 114.232 171.259 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.3 tt -55.32 -50.27 70.04 Favored 'General case' 0 N--CA 1.484 1.226 0 O-C-N 124.515 1.135 . . . . 0.0 109.335 168.221 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 66.0 mtt -58.12 -44.14 87.6 Favored 'General case' 0 N--CA 1.486 1.349 0 N-CA-C 114.108 1.151 . . . . 0.0 114.108 172.276 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -57.16 -20.62 27.41 Favored 'General case' 0 N--CA 1.482 1.16 0 N-CA-C 115.92 1.822 . . . . 0.0 115.92 176.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 47.5 mt-10 -110.81 -31.73 7.08 Favored 'General case' 0 CA--C 1.551 1.007 0 N-CA-C 114.629 1.344 . . . . 0.0 114.629 173.991 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 22.2 mt -124.41 115.29 20.71 Favored 'General case' 0 N--CA 1.481 1.113 0 C-N-CA 124.858 1.263 . . . . 0.0 114.079 -173.777 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . 0.904 ' HB3' ' HB2' ' A' ' 10' ' ' ALA . 16.9 mt-10 . . . . . 0 C--O 1.258 1.517 0 C-N-CA 125.482 1.513 . . . . 0.0 108.92 169.397 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 3.2 tmm? . . . . . 0 C--O 1.239 0.531 0 N-CA-C 104.547 -2.39 . . . . 0.0 104.547 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 5.2 t80 -124.7 128.3 48.59 Favored 'General case' 0 N--CA 1.478 0.97 0 O-C-N 124.669 1.23 . . . . 0.0 109.397 -179.911 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.1 pt20 -124.74 138.84 54.26 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-N 114.517 -1.22 . . . . 0.0 112.512 173.028 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 15.3 mm100 -129.68 140.79 51.04 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 114.509 -1.223 . . . . 0.0 111.203 172.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.1 tt0 -98.78 120.77 39.78 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.773 -1.558 . . . . 0.0 109.683 178.814 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.437 HG11 HG13 ' A' ' 78' ' ' VAL . 2.4 m -123.22 144.83 31.42 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.811 0 CA-C-N 113.875 -1.512 . . . . 0.0 113.131 176.166 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 17.8 p -105.26 143.81 32.92 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.896 -1.047 . . . . 0.0 112.618 -177.324 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 38.4 mm -114.49 133.16 61.46 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.909 0 CA-C-N 113.523 -1.671 . . . . 0.0 109.67 -176.007 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.3 p -116.95 -41.05 3.06 Favored 'General case' 0 N--CA 1.487 1.378 0 N-CA-C 115.336 1.606 . . . . 0.0 115.336 -173.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -43.6 132.49 3.79 Favored Pre-proline 0 N--CA 1.475 0.789 0 N-CA-C 114.028 1.121 . . . . 0.0 114.028 170.262 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 36.4 Cg_endo -58.23 -42.67 54.25 Favored 'Trans proline' 0 CA--C 1.539 0.739 0 C-N-CA 122.979 2.453 . . . . 0.0 113.752 178.331 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.5 p-10 -69.22 -35.18 75.91 Favored 'General case' 0 N--CA 1.482 1.152 0 O-C-N 124.692 1.245 . . . . 0.0 114.051 172.902 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 63.51 80.66 0.12 Allowed Glycine 0 N--CA 1.473 1.158 0 O-C-N 125.154 1.533 . . . . 0.0 112.431 -176.894 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.485 HD22 ' HZ ' ' A' ' 22' ' ' PHE . 8.1 mt 61.16 92.34 0.05 Allowed 'General case' 0 N--CA 1.481 1.089 0 C-N-CA 126.211 1.804 . . . . 0.0 112.849 176.748 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 6.7 p80 -71.71 -165.66 0.17 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 116.238 1.94 . . . . 0.0 116.238 -173.634 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -44.46 -46.17 9.5 Favored 'General case' 0 CA--C 1.542 0.656 0 C-N-CA 128.477 2.711 . . . . 0.0 113.692 -176.229 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.267 68.1 mtt180 -80.52 -42.64 1.31 Allowed Pre-proline 0 N--CA 1.486 1.349 0 N-CA-C 116.003 1.853 . . . . 0.0 116.003 -177.751 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 36.1 Cg_exo -53.02 -48.39 22.4 Favored 'Trans proline' 0 CA--C 1.536 0.609 0 C-N-CA 122.903 2.402 . . . . 0.0 113.295 168.697 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.81 -47.39 77.24 Favored 'General case' 0 N--CA 1.484 1.236 0 N-CA-C 113.9 1.074 . . . . 0.0 113.9 175.907 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.54 -39.34 76.42 Favored 'General case' 0 N--CA 1.483 1.204 0 N-CA-C 114.226 1.195 . . . . 0.0 114.226 176.336 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.9 mt-30 -62.01 -50.7 71.01 Favored 'General case' 0 N--CA 1.48 1.073 0 C-N-CA 123.856 0.863 . . . . 0.0 112.931 174.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.485 ' HZ ' HD22 ' A' ' 14' ' ' LEU . 11.8 m-30 -53.66 -41.03 66.4 Favored 'General case' 0 N--CA 1.488 1.434 0 C-N-CA 123.936 0.894 . . . . 0.0 111.759 179.342 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.415 HG21 HD12 ' A' ' 47' ' ' LEU . 45.3 t -60.3 -59.9 3.4 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 C-N-CA 124.605 1.162 . . . . 0.0 111.804 176.266 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -53.31 -48.08 68.72 Favored 'General case' 0 N--CA 1.476 0.849 0 O-C-N 123.666 0.604 . . . . 0.0 111.699 178.367 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -66.36 -45.89 78.59 Favored 'General case' 0 N--CA 1.472 0.654 0 N-CA-C 114.24 1.2 . . . . 0.0 114.24 -177.88 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -63.75 -32.95 74.61 Favored 'General case' 0 N--CA 1.473 0.692 0 N-CA-C 113.505 0.928 . . . . 0.0 113.505 173.678 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 60.8 mttm -66.16 -45.55 80.55 Favored 'General case' 0 N--CA 1.476 0.828 0 N-CA-C 114.013 1.116 . . . . 0.0 114.013 169.43 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.31 -45.65 96.02 Favored Glycine 0 CA--C 1.54 1.6 0 C-N-CA 125.693 1.616 . . . . 0.0 113.319 177.075 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -65.65 147.58 53.16 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 123.83 0.852 . . . . 0.0 111.122 167.5 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 40.5 p -66.79 -56.6 9.72 Favored 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 124.777 1.231 . . . . 0.0 113.664 -178.551 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 48.8 m -46.6 144.96 2.02 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 116.035 1.865 . . . . 0.0 116.035 176.415 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 25.6 tp10 -82.35 117.24 22.27 Favored 'General case' 0 N--CA 1.476 0.872 0 CA-C-N 113.413 -1.721 . . . . 0.0 107.582 165.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.487 HG21 HD13 ' A' ' 77' ' ' LEU . 26.0 mm -94.5 114.61 31.45 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.21 0 CA-C-N 114.222 -1.354 . . . . 0.0 111.22 -174.604 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -84.08 120.9 26.71 Favored 'General case' 0 N--CA 1.47 0.527 0 O-C-N 125.419 1.699 . . . . 0.0 110.596 173.492 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 88.8 t -108.8 86.55 0.89 Allowed 'Isoleucine or valine' 0 CA--C 1.542 0.637 0 N-CA-C 105.728 -1.953 . . . . 0.0 105.728 174.561 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 62.9 m -94.0 90.61 6.51 Favored 'General case' 0 N--CA 1.476 0.857 0 CA-C-N 114.145 -1.388 . . . . 0.0 111.225 -175.02 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 13.7 p -76.2 98.59 4.46 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.203 -1.817 . . . . 0.0 111.253 177.091 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.255 52.0 p-10 24.09 60.12 0.04 OUTLIER 'General case' 0 N--CA 1.484 1.272 0 C-N-CA 127.051 2.14 . . . . 0.0 116.533 -167.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 113.69 -34.93 4.76 Favored Glycine 0 CA--C 1.542 1.747 0 CA-C-N 113.72 -1.582 . . . . 0.0 115.449 -178.078 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . 0.597 ' HB3' HD23 ' A' ' 53' ' ' LEU . 97.8 mttt -81.26 96.92 7.42 Favored 'General case' 0 N--CA 1.482 1.163 0 N-CA-C 114.018 1.118 . . . . 0.0 114.018 -175.334 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 58.4 m -73.3 89.62 1.59 Allowed 'General case' 0 N--CA 1.477 0.88 0 N-CA-C 116.655 2.094 . . . . 0.0 116.655 178.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -86.15 158.43 19.77 Favored 'General case' 0 N--CA 1.479 0.99 0 CA-C-N 112.902 -1.954 . . . . 0.0 110.792 170.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 8.8 t -110.62 120.84 43.73 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.848 -1.069 . . . . 0.0 109.432 174.635 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -63.93 -32.21 73.66 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.302 1.626 . . . . 0.0 112.637 176.253 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 17.8 tttp -67.89 -9.95 49.12 Favored 'General case' 0 N--CA 1.483 1.2 0 C-N-CA 125.552 1.541 . . . . 0.0 114.201 -179.181 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 46.0 t -121.85 118.22 28.43 Favored 'General case' 0 N--CA 1.47 0.535 0 C-N-CA 124.743 1.217 . . . . 0.0 111.326 178.951 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.415 HD12 HG21 ' A' ' 23' ' ' VAL . 30.7 tp -55.38 -47.21 76.17 Favored 'General case' 0 N--CA 1.484 1.261 0 CA-C-N 113.55 -1.659 . . . . 0.0 112.621 -179.11 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 66.2 t80 -60.57 -57.77 11.33 Favored 'General case' 0 N--CA 1.478 0.944 0 CA-C-N 114.817 -1.083 . . . . 0.0 111.973 174.038 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 65.8 tttt -61.47 -43.97 97.93 Favored 'General case' 0 N--CA 1.481 1.108 0 N-CA-C 113.156 0.798 . . . . 0.0 113.156 -172.768 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 42.5 tp -57.88 -57.32 13.31 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.514 1.134 . . . . 0.0 112.612 173.684 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 34.0 mt-30 -71.38 -27.67 63.49 Favored 'General case' 0 N--CA 1.477 0.881 0 N-CA-C 116.737 2.125 . . . . 0.0 116.737 -177.748 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.593 HG23 HD12 ' A' ' 53' ' ' LEU . 10.5 t -72.77 -24.8 60.99 Favored 'General case' 0 N--CA 1.49 1.565 0 N-CA-C 113.934 1.087 . . . . 0.0 113.934 171.098 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.597 HD23 ' HB3' ' A' ' 40' ' ' LYS . 6.8 mp -104.76 74.46 1.14 Allowed 'General case' 0 N--CA 1.474 0.736 0 CA-C-O 122.968 1.366 . . . . 0.0 110.505 172.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.49 152.54 49.83 Favored Glycine 0 N--CA 1.482 1.705 0 CA-C-N 112.428 -2.169 . . . . 0.0 114.611 -174.976 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.9 mp -100.39 158.71 15.7 Favored 'General case' 0 N--CA 1.476 0.856 0 CA-C-N 112.588 -1.806 . . . . 0.0 109.787 173.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.8 t -161.54 165.87 27.88 Favored 'General case' 0 N--CA 1.48 1.061 0 C-N-CA 125.081 1.352 . . . . 0.0 110.588 -178.784 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 28.1 pt20 -63.65 125.65 24.98 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 113.552 0.945 . . . . 0.0 113.552 -176.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 94.08 -19.29 54.03 Favored Glycine 0 CA--C 1.54 1.609 0 CA-C-N 113.616 -1.629 . . . . 0.0 114.527 178.726 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 74.6 m -75.98 104.12 6.36 Favored 'General case' 0 N--CA 1.476 0.872 0 C-N-CA 123.234 0.613 . . . . 0.0 109.393 175.633 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.0 p -66.51 137.37 24.99 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 CA-C-N 113.875 -1.512 . . . . 0.0 110.724 176.284 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.4 p -127.36 123.69 62.34 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.775 0 CA-C-O 122.245 1.022 . . . . 0.0 113.557 -175.479 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -89.85 116.86 28.25 Favored 'General case' 0 CA--C 1.539 0.52 0 CA-C-N 113.963 -1.471 . . . . 0.0 110.111 175.429 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 44.7 mm -92.66 103.93 15.15 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.002 0 N-CA-C 106.978 -1.49 . . . . 0.0 106.978 171.8 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.4 t -115.92 129.52 56.43 Favored 'General case' 0 N--CA 1.477 0.908 0 CA-C-N 113.721 -1.581 . . . . 0.0 111.068 -177.735 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.88 122.84 40.35 Favored 'General case' 0 N--CA 1.474 0.739 0 CA-C-O 122.547 1.165 . . . . 0.0 111.665 177.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 7.5 pt-20 -96.88 116.67 29.57 Favored 'General case' 0 N--CA 1.477 0.884 0 CA-C-N 112.382 -2.19 . . . . 0.0 114.059 -178.714 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 67.38 177.6 10.36 Favored Glycine 0 CA--C 1.541 1.697 0 CA-C-N 111.824 -2.444 . . . . 0.0 113.237 175.674 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . 0.257 50.3 mt-10 41.6 -93.24 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 116.864 2.172 . . . . 0.0 116.864 172.045 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 84.9 m-20 -77.15 -0.64 25.72 Favored 'General case' 0 N--CA 1.488 1.456 0 N-CA-C 116.491 2.034 . . . . 0.0 116.491 -178.704 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.4 pt-20 -18.51 -62.91 0.02 OUTLIER 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 118.787 2.884 . . . . 0.0 118.787 -179.685 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 64.7 mt-30 -64.93 -57.59 8.37 Favored 'General case' 0 N--CA 1.487 1.388 0 C-N-CA 123.882 0.873 . . . . 0.0 112.882 -175.864 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.6 tttt -62.6 -38.15 89.06 Favored 'General case' 0 N--CA 1.476 0.846 0 C-N-CA 123.583 0.753 . . . . 0.0 112.214 -179.651 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.87 -57.42 12.12 Favored 'General case' 0 N--CA 1.475 0.785 0 C-N-CA 123.781 0.832 . . . . 0.0 112.269 175.28 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 39.8 t -62.89 -49.15 84.78 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.816 0 CA-C-O 118.51 -0.757 . . . . 0.0 111.771 -177.648 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 28.8 tt0 -49.7 -55.82 12.47 Favored 'General case' 0 N--CA 1.479 1.013 0 C-N-CA 123.86 0.864 . . . . 0.0 113.255 179.618 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 8.0 t60 -63.67 -48.68 76.18 Favored 'General case' 0 N--CA 1.479 1.0 0 CA-C-N 115.065 -0.97 . . . . 0.0 112.816 179.376 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.487 HD13 HG21 ' A' ' 33' ' ' ILE . 23.4 mt -61.56 -38.3 86.97 Favored 'General case' 0 N--CA 1.486 1.333 0 N-CA-C 115.133 1.531 . . . . 0.0 115.133 178.208 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.437 HG13 HG11 ' A' ' 6' ' ' VAL . 10.4 t -65.14 -42.1 93.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 C-N-CA 123.537 0.735 . . . . 0.0 111.167 174.109 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 33.6 mttm -60.78 -45.69 93.36 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-O 118.283 -0.865 . . . . 0.0 112.968 173.093 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 87.2 mt -52.34 -52.59 52.41 Favored 'General case' 0 N--CA 1.484 1.26 0 C-N-CA 123.574 0.75 . . . . 0.0 112.79 170.779 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 28.0 mtt -60.09 -33.6 72.32 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 115.595 1.702 . . . . 0.0 115.595 177.0 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -75.42 -36.1 60.87 Favored 'General case' 0 N--CA 1.481 1.112 0 N-CA-C 114.561 1.319 . . . . 0.0 114.561 175.668 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.1 mt-10 -85.59 -21.08 28.66 Favored 'General case' 0 N--CA 1.484 1.234 0 N-CA-C 115.829 1.788 . . . . 0.0 115.829 -178.863 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 35.3 mt -107.04 145.64 32.11 Favored 'General case' 0 N--CA 1.471 0.616 0 N-CA-C 114.59 1.329 . . . . 0.0 114.59 -174.931 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.4 mt-10 . . . . . 0 C--O 1.251 1.182 0 C-N-CA 126.599 1.96 . . . . 0.0 107.97 169.713 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.785 ' HG2' ' HB3' ' A' ' 66' ' ' GLU . 2.1 tmm? . . . . . 0 N--CA 1.47 0.534 0 N-CA-C 105.433 -2.062 . . . . 0.0 105.433 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.9 t80 -125.12 131.18 53.31 Favored 'General case' 0 N--CA 1.477 0.915 0 O-C-N 125.093 1.495 . . . . 0.0 110.345 -177.016 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 16.2 pt20 -135.11 128.27 31.85 Favored 'General case' 0 N--CA 1.478 0.953 0 O-C-N 124.61 1.194 . . . . 0.0 113.527 179.437 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 24.4 mm100 -125.71 127.77 46.74 Favored 'General case' 0 N--CA 1.487 1.389 0 O-C-N 124.823 1.327 . . . . 0.0 112.126 170.484 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HA ' ' HA ' ' A' ' 62' ' ' THR . 8.2 tt0 -84.57 135.89 34.02 Favored 'General case' 0 N--CA 1.476 0.829 0 CA-C-N 113.563 -1.653 . . . . 0.0 112.385 176.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 21.3 t -126.93 142.42 43.47 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.792 0 CA-C-N 113.355 -1.748 . . . . 0.0 109.173 -176.022 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -106.01 136.7 45.22 Favored 'General case' 0 N--CA 1.481 1.097 0 CA-C-N 115.027 -0.988 . . . . 0.0 110.235 173.092 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.748 HD11 ' HG3' ' A' ' 81' ' ' MET . 38.0 mm -105.93 139.09 28.27 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.972 0 CA-C-N 115.302 -0.863 . . . . 0.0 111.059 -177.006 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 30.5 p -103.27 -37.51 7.64 Favored 'General case' 0 N--CA 1.485 1.276 0 CA-C-N 113.992 -1.458 . . . . 0.0 114.777 -179.783 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.467 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -48.88 124.49 12.78 Favored Pre-proline 0 N--CA 1.475 0.811 0 C-N-CA 124.206 1.002 . . . . 0.0 112.629 -179.725 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.467 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 72.7 Cg_exo -56.27 -52.03 8.08 Favored 'Trans proline' 0 C--N 1.352 0.747 0 C-N-CA 123.942 3.095 . . . . 0.0 112.936 -175.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.9 p-10 -63.53 -42.61 98.43 Favored 'General case' 0 N--CA 1.484 1.246 0 C-N-CA 124.846 1.258 . . . . 0.0 113.241 168.53 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 74.98 -158.57 51.27 Favored Glycine 0 N--CA 1.475 1.261 0 CA-C-N 114.867 -1.06 . . . . 0.0 112.013 -173.342 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 5.5 mp -84.09 80.36 9.2 Favored 'General case' 0 C--O 1.241 0.627 0 CA-C-N 113.404 -1.398 . . . . 0.0 111.465 -175.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 29.0 p80 -75.92 -169.05 1.0 Allowed 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 112.609 -2.087 . . . . 0.0 111.721 177.473 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 8.9 m -37.44 -52.42 1.14 Allowed 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 127.472 2.309 . . . . 0.0 113.24 179.591 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.252 44.5 ttt180 -69.95 -50.84 15.96 Favored Pre-proline 0 N--CA 1.48 1.055 0 CA-C-O 115.881 -2.009 . . . . 0.0 114.537 -174.645 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.498 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 80.1 Cg_exo -63.88 -42.72 18.49 Favored 'Trans proline' 0 CA--C 1.539 0.773 0 C-N-CA 122.64 2.227 . . . . 0.0 113.188 170.13 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.49 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -56.31 -45.29 80.34 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 113.237 0.829 . . . . 0.0 113.237 177.624 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.96 -41.65 68.05 Favored 'General case' 0 CA--C 1.541 0.632 0 N-CA-C 114.374 1.249 . . . . 0.0 114.374 174.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 42.0 tt0 -70.73 -47.98 56.89 Favored 'General case' 0 N--CA 1.481 1.099 0 C-N-CA 123.246 0.618 . . . . 0.0 111.12 176.842 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 4.7 t80 -57.52 -40.09 77.99 Favored 'General case' 0 N--CA 1.48 1.067 0 C-N-CA 124.131 0.972 . . . . 0.0 113.342 176.84 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.49 HG23 ' O ' ' A' ' 19' ' ' ALA . 98.1 t -56.56 -53.86 35.82 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.534 0 C-N-CA 124.059 0.944 . . . . 0.0 110.71 171.703 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 56.1 mtpt -56.73 -46.35 81.37 Favored 'General case' 0 N--CA 1.479 1.012 0 N-CA-C 113.402 0.889 . . . . 0.0 113.402 179.239 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 1.8 tp10 -61.23 -48.95 79.14 Favored 'General case' 0 N--CA 1.478 0.927 0 O-C-N 124.18 0.925 . . . . 0.0 112.345 175.617 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.459 ' O ' ' HE2' ' A' ' 45' ' ' LYS . . . -56.28 -40.52 74.4 Favored 'General case' 0 N--CA 1.487 1.396 0 C-N-CA 124.183 0.993 . . . . 0.0 113.477 173.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 58.9 mttm -58.23 -36.34 73.02 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.065 1.135 . . . . 0.0 114.065 173.507 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -71.92 -41.05 56.3 Favored Glycine 0 N--CA 1.483 1.773 0 O-C-N 124.87 1.356 . . . . 0.0 112.522 176.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 34.8 m-85 -69.94 117.56 11.68 Favored 'General case' 0 N--CA 1.472 0.648 0 CA-C-O 122.609 1.195 . . . . 0.0 112.41 175.049 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.5 p -49.11 -49.52 41.53 Favored 'General case' 0 N--CA 1.485 1.29 0 CA-C-N 113.306 -1.77 . . . . 0.0 113.093 -179.874 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.5 p -62.8 140.66 58.78 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 124.704 1.202 . . . . 0.0 113.817 177.399 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.7 tp10 -77.09 93.17 3.83 Favored 'General case' 0 N--CA 1.471 0.611 0 CA-C-N 114.675 -1.148 . . . . 0.0 112.619 -175.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.531 HD11 ' HB1' ' A' ' 73' ' ' ALA . 35.5 mm -68.73 84.6 0.14 Allowed 'Isoleucine or valine' 0 N--CA 1.474 0.765 0 CA-C-N 112.788 -2.005 . . . . 0.0 111.276 179.313 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.8 m -82.9 115.93 21.98 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 113.004 -1.907 . . . . 0.0 107.797 169.797 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 74.1 t -101.22 99.84 9.2 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.033 0 N-CA-C 106.185 -1.783 . . . . 0.0 106.185 178.688 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 18.1 m -88.33 99.04 11.95 Favored 'General case' 0 N--CA 1.477 0.894 0 CA-C-N 112.387 -2.188 . . . . 0.0 109.696 -176.626 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 23.0 t -101.45 109.91 21.82 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 115.398 -0.819 . . . . 0.0 111.605 -179.383 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.296 37.6 p30 25.26 75.63 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.484 0 C-N-CA 126.687 1.995 . . . . 0.0 115.953 -164.402 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 82.58 -26.5 4.06 Favored Glycine 0 CA--C 1.544 1.869 0 CA-C-N 112.055 -2.339 . . . . 0.0 115.182 -177.31 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 63.2 mttm -84.69 87.98 7.33 Favored 'General case' 0 N--CA 1.481 1.11 0 CA-C-O 122.713 1.244 . . . . 0.0 112.87 -175.373 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 1.7 m -71.0 104.64 3.04 Favored 'General case' 0 N--CA 1.478 0.932 0 CA-C-N 112.742 -2.026 . . . . 0.0 113.573 178.266 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.469 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -131.41 120.51 23.15 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 177.876 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 14.8 t -56.76 123.8 16.22 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.771 -1.104 . . . . 0.0 113.588 170.272 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -60.93 -30.56 70.29 Favored 'General case' 0 CA--C 1.541 0.607 0 CA-C-N 112.594 -2.094 . . . . 0.0 113.805 177.749 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.459 ' HE2' ' O ' ' A' ' 26' ' ' ALA . 82.2 mttt -62.82 -22.21 66.47 Favored 'General case' 0 N--CA 1.48 1.036 0 N-CA-C 114.396 1.258 . . . . 0.0 114.396 -175.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 47.6 t -94.35 112.94 24.75 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-O 121.878 0.847 . . . . 0.0 108.93 172.093 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 15.4 tp -46.22 -52.05 13.2 Favored 'General case' 0 N--CA 1.48 1.04 0 CA-C-N 113.254 -1.794 . . . . 0.0 112.981 -178.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -54.34 -46.2 72.85 Favored 'General case' 0 CA--C 1.547 0.859 0 CA-C-N 114.018 -1.447 . . . . 0.0 113.637 175.556 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.445 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 74.0 mttt -63.41 -53.42 52.56 Favored 'General case' 0 N--CA 1.48 1.055 0 O-C-N 124.241 0.963 . . . . 0.0 113.209 -176.434 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.2 tp -64.71 -33.42 75.92 Favored 'General case' 0 N--CA 1.475 0.794 0 O-C-N 124.135 0.897 . . . . 0.0 113.187 179.137 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 25.0 mt-30 -63.99 -47.37 80.61 Favored 'General case' 0 N--CA 1.489 1.496 0 N-CA-C 115.102 1.519 . . . . 0.0 115.102 172.391 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 9.4 t -74.35 -19.13 60.56 Favored 'General case' 0 N--CA 1.48 1.057 0 N-CA-C 114.078 1.14 . . . . 0.0 114.078 179.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.469 HD22 ' HB3' ' A' ' 42' ' ' ALA . 17.1 tp -73.95 130.64 40.27 Favored 'General case' 0 CA--C 1.544 0.732 0 C-N-CA 125.086 1.355 . . . . 0.0 111.346 177.28 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -74.39 102.06 1.33 Allowed Glycine 0 N--CA 1.482 1.762 0 CA-C-N 114.39 -1.277 . . . . 0.0 111.823 179.583 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 26.0 mt -113.06 69.3 0.69 Allowed 'General case' 0 N--CA 1.478 0.926 0 CA-C-O 121.628 0.728 . . . . 0.0 112.818 -176.318 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.6 t -145.79 179.88 7.15 Favored 'General case' 0 N--CA 1.484 1.264 0 N-CA-C 113.257 0.836 . . . . 0.0 113.257 -171.213 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 pt20 -61.08 138.7 58.19 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 124.343 1.057 . . . . 0.0 112.665 176.335 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 90.08 -52.7 3.55 Favored Glycine 0 N--CA 1.481 1.674 0 CA-C-N 113.936 -1.484 . . . . 0.0 111.123 -172.637 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.4 m -72.53 97.38 2.1 Favored 'General case' 0 N--CA 1.482 1.169 0 C-N-CA 125.08 1.352 . . . . 0.0 110.522 176.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 10.5 p -75.24 142.16 14.92 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-N 114.487 -1.233 . . . . 0.0 112.151 -175.051 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.584 HG21 ' HE2' ' A' ' 81' ' ' MET . 9.0 p -127.29 125.39 65.91 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 N-CA-C 114.59 1.33 . . . . 0.0 114.59 -170.77 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.433 ' HA ' ' HA ' ' A' ' 5' ' ' GLU . 0.3 OUTLIER -105.64 118.17 35.91 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.059 -0.973 . . . . 0.0 110.602 177.027 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 42.7 mm -87.25 96.4 5.63 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.39 0 N-CA-C 107.457 -1.312 . . . . 0.0 107.457 178.578 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 37.4 t -108.81 128.58 55.02 Favored 'General case' 0 N--CA 1.477 0.921 0 O-C-N 124.721 1.263 . . . . 0.0 111.65 -176.167 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -132.25 127.35 35.52 Favored 'General case' 0 N--CA 1.472 0.656 0 N-CA-C 114.381 1.252 . . . . 0.0 114.381 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.785 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 9.0 pt-20 -118.44 130.9 56.23 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 113.607 0.966 . . . . 0.0 113.607 168.049 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.88 -155.08 22.15 Favored Glycine 0 N--CA 1.483 1.782 0 O-C-N 124.29 0.994 . . . . 0.0 111.472 179.229 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -64.73 -65.9 0.61 Allowed 'General case' 0 N--CA 1.486 1.341 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 -175.917 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 36.0 m-20 -66.16 14.91 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 116.924 2.194 . . . . 0.0 116.924 176.955 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.448 ' HG3' ' HG3' ' A' ' 71' ' ' GLN . 7.0 pt-20 -42.34 -58.83 2.04 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 116.261 1.948 . . . . 0.0 116.261 -168.04 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.448 ' HG3' ' HG3' ' A' ' 70' ' ' GLU . 36.3 mt-30 -71.25 -47.22 58.4 Favored 'General case' 0 CA--C 1.545 0.77 0 CA-C-N 114.712 -1.131 . . . . 0.0 114.044 -177.226 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 28.6 ttpt -63.79 -45.54 89.24 Favored 'General case' 0 N--CA 1.485 1.293 0 CA-C-N 115.636 -0.711 . . . . 0.0 111.469 179.068 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -60.26 -43.99 95.68 Favored 'General case' 0 N--CA 1.48 1.045 0 C-N-CA 123.946 0.899 . . . . 0.0 112.086 177.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 76.8 t -58.34 -57.14 12.13 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 CA-C-O 116.951 -1.5 . . . . 0.0 110.129 171.897 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 29.7 tt0 -50.71 -49.6 57.19 Favored 'General case' 0 N--CA 1.48 1.042 0 C-N-CA 123.479 0.712 . . . . 0.0 112.91 -179.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 20.2 t60 -61.54 -52.21 65.39 Favored 'General case' 0 N--CA 1.478 0.96 0 C-N-CA 124.364 1.066 . . . . 0.0 112.693 178.768 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.1 mt -74.03 -27.29 60.87 Favored 'General case' 0 N--CA 1.477 0.894 0 N-CA-C 116.485 2.032 . . . . 0.0 116.485 -178.627 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 41.7 t -54.94 -44.48 73.49 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.499 0 C-N-CA 124.07 0.948 . . . . 0.0 110.388 170.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 99.4 mttt -62.81 -61.27 2.52 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.693 1.246 . . . . 0.0 111.12 176.549 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 65.1 mt -51.13 -37.16 44.43 Favored 'General case' 0 N--CA 1.488 1.466 0 N-CA-C 116.552 2.056 . . . . 0.0 116.552 178.062 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.748 ' HG3' HD11 ' A' ' 8' ' ' ILE . 11.0 tpt -53.68 -38.58 64.33 Favored 'General case' 0 CA--C 1.543 0.686 0 C-N-CA 124.054 0.942 . . . . 0.0 113.429 178.461 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -90.55 -16.53 28.64 Favored 'General case' 0 N--CA 1.483 1.183 0 N-CA-C 115.073 1.509 . . . . 0.0 115.073 176.658 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.4 mt-10 -94.73 -25.4 16.71 Favored 'General case' 0 N--CA 1.487 1.39 0 N-CA-C 116.289 1.959 . . . . 0.0 116.289 -174.795 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.498 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 44.2 mt -74.31 125.61 28.84 Favored 'General case' 0 N--CA 1.482 1.132 0 N-CA-C 117.025 2.231 . . . . 0.0 117.025 179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 47.0 mt-10 . . . . . 0 N--CA 1.491 1.615 0 C-N-CA 125.303 1.441 . . . . 0.0 111.466 178.12 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.5 tmm? . . . . . 0 N--CA 1.465 0.322 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 58.7 t80 -127.06 130.3 49.67 Favored 'General case' 0 N--CA 1.47 0.555 0 O-C-N 125.15 1.531 . . . . 0.0 108.145 176.265 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 24.2 pt20 -134.74 153.54 51.97 Favored 'General case' 0 CA--C 1.538 0.51 0 CA-C-N 113.392 -1.731 . . . . 0.0 113.227 174.38 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.493 ' CB ' HG21 ' A' ' 78' ' ' VAL . 19.2 mm-40 -141.76 144.16 33.85 Favored 'General case' 0 N--CA 1.471 0.601 0 O-C-N 126.353 2.283 . . . . 0.0 110.318 173.718 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 21.8 tt0 -113.12 134.39 54.57 Favored 'General case' 0 N--CA 1.474 0.758 0 O-C-N 124.915 1.385 . . . . 0.0 111.316 -173.322 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.546 HG23 HG13 ' A' ' 61' ' ' VAL . 0.1 OUTLIER -125.17 124.8 68.17 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.747 0 CA-C-N 111.724 -2.489 . . . . 0.0 113.237 -177.481 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 2.2 m -94.21 123.71 37.77 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 112.65 -2.068 . . . . 0.0 107.732 177.263 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 21.1 mm -95.64 106.22 18.0 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 CA-C-N 115.146 -0.933 . . . . 0.0 110.17 -173.06 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 69.9 p -92.34 -20.87 20.64 Favored 'General case' 0 N--CA 1.491 1.585 0 CA-C-N 113.101 -1.863 . . . . 0.0 113.218 178.43 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.409 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -62.65 130.82 93.93 Favored Pre-proline 0 N--CA 1.477 0.91 0 C-N-CA 124.995 1.318 . . . . 0.0 111.51 179.035 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 57.8 Cg_endo -56.57 -34.12 94.54 Favored 'Trans proline' 0 CA--C 1.541 0.833 0 C-N-CA 123.945 3.097 . . . . 0.0 114.733 -172.797 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -113.82 4.46 15.91 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 115.269 1.581 . . . . 0.0 115.269 175.541 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.409 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 38.65 -117.06 0.6 Allowed Glycine 0 CA--C 1.537 1.453 0 C-N-CA 126.874 2.178 . . . . 0.0 115.2 178.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.51 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 4.8 mp -109.53 74.01 0.87 Allowed 'General case' 0 N--CA 1.476 0.87 0 CA-C-O 123.643 1.687 . . . . 0.0 111.507 -177.736 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 17.7 p80 -75.37 -162.06 0.18 Allowed 'General case' 0 N--CA 1.484 1.227 0 CA-C-N 111.885 -2.416 . . . . 0.0 112.718 177.323 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 21.2 p -55.9 -44.49 78.28 Favored 'General case' 0 N--CA 1.486 1.361 0 N-CA-C 114.538 1.31 . . . . 0.0 114.538 -175.069 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.403 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 52.2 ttt180 -66.93 -47.81 52.48 Favored Pre-proline 0 CA--C 1.555 1.172 0 CA-C-O 116.702 -1.618 . . . . 0.0 114.377 178.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.403 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 75.5 Cg_exo -68.16 -40.47 8.7 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.104 2.536 . . . . 0.0 113.571 173.324 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.28 -44.7 72.13 Favored 'General case' 0 N--CA 1.485 1.302 0 N-CA-C 113.281 0.845 . . . . 0.0 113.281 175.673 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -52.11 -41.04 62.15 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 170.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 48.8 tt0 -69.3 -45.89 68.49 Favored 'General case' 0 N--CA 1.49 1.532 0 C-N-CA 123.258 0.623 . . . . 0.0 111.647 172.64 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -60.95 -49.87 75.7 Favored 'General case' 0 N--CA 1.475 0.796 0 C-N-CA 125.07 1.348 . . . . 0.0 113.381 -171.374 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.509 HG11 HD13 ' A' ' 47' ' ' LEU . 8.0 p -53.76 -42.57 52.6 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.097 0 C-N-CA 124.32 1.048 . . . . 0.0 113.492 173.678 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.1 ttpt -62.72 -51.77 65.85 Favored 'General case' 0 N--CA 1.479 0.993 0 CA-C-O 118.761 -0.638 . . . . 0.0 110.997 -179.21 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.515 ' HG3' ' HE2' ' A' ' 29' ' ' PHE . 6.6 tp10 -57.69 -49.68 75.72 Favored 'General case' 0 N--CA 1.475 0.777 0 O-C-N 124.412 1.07 . . . . 0.0 111.915 175.88 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.3 -40.17 70.77 Favored 'General case' 0 CA--C 1.549 0.906 0 N-CA-C 115.06 1.504 . . . . 0.0 115.06 176.163 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 52.0 mttm -55.46 -38.56 69.22 Favored 'General case' 0 N--CA 1.481 1.101 0 N-CA-C 114.772 1.397 . . . . 0.0 114.772 173.011 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -67.27 -28.83 73.77 Favored Glycine 0 N--CA 1.483 1.816 0 O-C-N 125.812 1.945 . . . . 0.0 114.786 -178.099 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.566 ' HE1' ' HE2' ' A' ' 72' ' ' LYS . 77.1 m-85 -92.45 134.63 34.77 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 108.756 -0.831 . . . . 0.0 108.756 177.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 61.3 p -71.28 -42.97 68.07 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 115.804 -0.635 . . . . 0.0 112.503 -175.341 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 23.6 m -44.15 136.4 3.9 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 126.243 1.817 . . . . 0.0 114.728 168.07 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 11.9 tp10 -82.81 134.03 35.12 Favored 'General case' 0 C--O 1.243 0.716 0 CA-C-N 115.008 -0.996 . . . . 0.0 112.213 -179.259 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 11.6 mm -111.18 101.14 12.13 Favored 'Isoleucine or valine' 0 CA--C 1.539 0.538 0 CA-C-N 114.858 -1.064 . . . . 0.0 109.076 -171.748 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.405 ' HB ' ' HB2' ' A' ' 41' ' ' SER . 7.7 p -94.72 120.92 35.73 Favored 'General case' 0 N--CA 1.475 0.788 0 CA-C-O 122.654 1.216 . . . . 0.0 111.927 170.722 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 43.6 t -97.83 91.7 2.62 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.779 0 CA-C-N 110.901 -2.863 . . . . 0.0 105.846 -174.932 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -83.59 84.07 7.67 Favored 'General case' 0 N--CA 1.479 1.005 0 CA-C-N 111.987 -2.37 . . . . 0.0 111.057 -169.158 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 38.1 t -74.83 90.95 2.39 Favored 'General case' 0 N--CA 1.482 1.141 0 CA-C-N 113.95 -1.477 . . . . 0.0 109.418 -178.907 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.322 6.7 p30 37.08 69.38 0.22 Allowed 'General case' 0 N--CA 1.48 1.029 0 CA-C-N 113.157 -1.838 . . . . 0.0 114.767 -169.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 93.72 -46.55 2.31 Favored Glycine 0 CA--C 1.541 1.683 0 CA-C-N 112.175 -2.284 . . . . 0.0 114.147 -174.96 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 50.4 mttm -76.43 96.75 4.11 Favored 'General case' 0 N--CA 1.48 1.064 0 N-CA-C 114.508 1.299 . . . . 0.0 114.508 -173.921 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.405 ' HB2' ' HB ' ' A' ' 34' ' ' THR . 13.3 p -83.8 119.31 24.68 Favored 'General case' 0 C--O 1.247 0.938 0 CA-C-N 112.659 -2.064 . . . . 0.0 115.44 -177.983 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.74 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -137.42 146.36 44.3 Favored 'General case' 0 N--CA 1.482 1.158 0 CA-C-N 114.065 -1.425 . . . . 0.0 112.256 176.944 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 32.1 t -62.3 134.57 56.68 Favored 'General case' 0 N--CA 1.481 1.079 0 N-CA-C 115.0 1.481 . . . . 0.0 115.0 -178.775 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.494 ' HA ' HD13 ' A' ' 50' ' ' LEU . . . -70.9 -41.31 71.45 Favored 'General case' 0 N--CA 1.477 0.894 0 O-C-N 125.686 1.866 . . . . 0.0 113.114 170.385 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 83.7 mttt -60.18 -38.35 82.96 Favored 'General case' 0 N--CA 1.484 1.271 0 C-N-CA 125.097 1.359 . . . . 0.0 111.624 -178.639 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.3 t -76.23 94.5 3.55 Favored 'General case' 0 N--CA 1.469 0.477 0 CA-C-N 113.396 -1.729 . . . . 0.0 107.896 170.298 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.509 HD13 HG11 ' A' ' 23' ' ' VAL . 30.9 tp -51.93 -32.14 31.76 Favored 'General case' 0 N--CA 1.486 1.335 0 CA-C-N 114.916 -1.038 . . . . 0.0 111.726 170.275 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . 0.477 ' O ' HG22 ' A' ' 52' ' ' THR . 64.9 t80 -52.66 -64.23 0.89 Allowed 'General case' 0 CA--C 1.548 0.873 0 C-N-CA 124.755 1.222 . . . . 0.0 110.653 170.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.74 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 94.6 mttt -63.8 -47.36 81.17 Favored 'General case' 0 N--CA 1.48 1.031 0 N-CA-C 115.316 1.598 . . . . 0.0 115.316 178.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.494 HD13 ' HA ' ' A' ' 44' ' ' ALA . 23.2 tp -51.15 -46.34 61.98 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.573 1.324 . . . . 0.0 114.573 174.743 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 2.5 mm100 -74.27 -41.15 61.73 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 113.976 1.102 . . . . 0.0 113.976 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.477 HG22 ' O ' ' A' ' 48' ' ' PHE . 10.6 t -84.63 53.16 2.59 Favored 'General case' 0 N--CA 1.482 1.167 0 CA-C-O 122.237 1.017 . . . . 0.0 112.102 174.304 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.437 ' HB2' ' O ' ' A' ' 49' ' ' LYS . 17.5 tp -154.67 136.13 14.19 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.125 -1.852 . . . . 0.0 110.409 -172.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.59 108.37 2.46 Favored Glycine 0 N--CA 1.48 1.623 0 C-N-CA 125.275 1.417 . . . . 0.0 113.076 -177.252 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.51 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 11.7 mt -127.68 35.09 4.55 Favored 'General case' 0 N--CA 1.477 0.925 0 N-CA-C 115.926 1.824 . . . . 0.0 115.926 -177.924 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.2 t -119.31 178.37 4.56 Favored 'General case' 0 N--CA 1.481 1.102 0 N-CA-C 112.534 0.568 . . . . 0.0 112.534 -175.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.7 pt20 -57.13 139.56 52.1 Favored 'General case' 0 N--CA 1.479 0.983 0 N-CA-C 113.47 0.915 . . . . 0.0 113.47 -176.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 93.42 -9.91 73.69 Favored Glycine 0 CA--C 1.542 1.765 0 CA-C-N 113.886 -1.506 . . . . 0.0 114.254 -179.442 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 99.6 m -102.65 127.5 49.73 Favored 'General case' 0 C--O 1.246 0.89 0 N-CA-C 109.173 -0.677 . . . . 0.0 109.173 169.453 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.5 p -91.92 132.74 35.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.942 0 CA-C-N 114.164 -1.38 . . . . 0.0 109.279 167.502 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.546 HG13 HG23 ' A' ' 6' ' ' VAL . 11.5 p -125.2 137.92 56.02 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.718 0 CA-C-N 113.948 -1.478 . . . . 0.0 111.523 -175.212 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -110.57 126.5 54.5 Favored 'General case' 0 N--CA 1.476 0.825 0 CA-C-N 114.365 -1.288 . . . . 0.0 109.291 177.322 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.541 HG22 HG22 ' A' ' 74' ' ' VAL . 51.0 mm -99.08 108.01 21.57 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.1 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 177.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 17.4 t -113.45 135.21 54.13 Favored 'General case' 0 N--CA 1.482 1.125 0 O-C-N 124.56 1.162 . . . . 0.0 112.137 -177.473 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -139.11 146.72 41.02 Favored 'General case' 0 N--CA 1.475 0.786 0 CA-C-N 114.264 -1.335 . . . . 0.0 112.751 -177.544 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -131.1 138.62 49.62 Favored 'General case' 0 CA--C 1.546 0.81 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.818 -173.032 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 95.11 -146.82 18.36 Favored Glycine 0 CA--C 1.537 1.464 0 N-CA-C 114.577 0.591 . . . . 0.0 114.577 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 4.5 mt-10 -50.14 -48.7 53.53 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 116.459 2.022 . . . . 0.0 116.459 -169.429 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 17.1 m-20 -107.43 31.63 5.27 Favored 'General case' 0 N--CA 1.482 1.165 0 CA-C-N 115.569 -0.741 . . . . 0.0 112.214 -174.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.5 pt-20 -60.32 -48.23 82.64 Favored 'General case' 0 N--CA 1.49 1.554 0 N-CA-C 115.997 1.851 . . . . 0.0 115.997 -171.692 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.1 mt-30 -70.2 -61.46 1.76 Allowed 'General case' 0 N--CA 1.482 1.158 0 O-C-N 124.023 0.827 . . . . 0.0 112.232 176.082 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.566 ' HE2' ' HE1' ' A' ' 29' ' ' PHE . 64.5 tttt -49.07 -50.62 35.85 Favored 'General case' 0 N--CA 1.479 0.983 0 C-N-CA 125.641 1.576 . . . . 0.0 114.256 -177.105 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.5 -55.09 38.11 Favored 'General case' 0 N--CA 1.489 1.475 0 N-CA-C 114.14 1.163 . . . . 0.0 114.14 179.081 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.541 HG22 HG22 ' A' ' 63' ' ' ILE . 85.4 t -67.9 -47.98 77.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.924 0 CA-C-O 118.896 -0.573 . . . . 0.0 110.942 -174.593 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -45.08 -49.15 11.82 Favored 'General case' 0 N--CA 1.485 1.297 0 C-N-CA 125.175 1.39 . . . . 0.0 112.747 175.976 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 52.9 t60 -66.91 -55.8 13.03 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.973 0.909 . . . . 0.0 113.168 173.462 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.519 HD23 HD12 ' A' ' 80' ' ' LEU . 97.7 mt -59.72 -28.91 67.74 Favored 'General case' 0 N--CA 1.478 0.963 0 N-CA-C 115.016 1.487 . . . . 0.0 115.016 -177.296 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.493 HG21 ' CB ' ' A' ' 4' ' ' GLN . 32.5 t -74.09 -45.74 47.28 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.056 0 C-N-CA 123.288 0.635 . . . . 0.0 112.346 173.703 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 21.0 mttm -52.61 -37.67 58.72 Favored 'General case' 0 N--CA 1.478 0.955 0 N-CA-C 113.21 0.819 . . . . 0.0 113.21 170.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.519 HD12 HD23 ' A' ' 77' ' ' LEU . 46.3 mt -56.83 -33.44 66.76 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 117.447 2.388 . . . . 0.0 117.447 176.738 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 1.6 mpt? -62.7 -24.48 67.68 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.583 1.327 . . . . 0.0 114.583 173.285 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -84.32 -31.59 24.76 Favored 'General case' 0 N--CA 1.482 1.168 0 C-N-CA 124.192 0.997 . . . . 0.0 113.115 176.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.3 mt-10 -91.42 -33.3 15.3 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 118.37 2.729 . . . . 0.0 118.37 177.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 19.9 mt -84.5 142.19 30.22 Favored 'General case' 0 N--CA 1.484 1.242 0 N-CA-C 115.808 1.781 . . . . 0.0 115.808 178.418 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 5.5 tt0 . . . . . 0 C--O 1.263 1.779 0 C-N-CA 127.631 2.372 . . . . 0.0 107.537 172.439 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.894 ' HG2' ' HB3' ' A' ' 66' ' ' GLU . 7.9 tmm? . . . . . 0 N--CA 1.468 0.472 0 N-CA-C 105.509 -2.034 . . . . 0.0 105.509 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -122.47 135.82 54.75 Favored 'General case' 0 N--CA 1.484 1.234 0 O-C-N 124.287 0.992 . . . . 0.0 112.749 -167.038 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 75.0 mt-30 -121.34 137.19 54.81 Favored 'General case' 0 N--CA 1.479 0.991 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.859 173.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 47.7 mm-40 -128.13 123.59 34.81 Favored 'General case' 0 N--CA 1.481 1.121 0 N-CA-C 113.112 0.782 . . . . 0.0 113.112 171.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 23.1 tt0 -96.3 99.0 10.73 Favored 'General case' 0 N--CA 1.482 1.16 0 O-C-N 124.991 1.432 . . . . 0.0 112.144 -174.048 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.7 t -100.7 126.17 54.42 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 113.539 -1.664 . . . . 0.0 110.408 -175.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 9.6 m -83.92 116.83 22.98 Favored 'General case' 0 N--CA 1.477 0.893 0 CA-C-N 114.613 -1.176 . . . . 0.0 108.053 165.03 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 32.4 mm -84.81 125.79 40.31 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.875 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 171.874 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 19.7 p -117.1 -36.48 3.78 Favored 'General case' 0 N--CA 1.48 1.029 0 N-CA-C 116.171 1.915 . . . . 0.0 116.171 -172.173 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -40.56 113.05 0.94 Allowed Pre-proline 0 N--CA 1.481 1.098 0 C-N-CA 125.947 1.699 . . . . 0.0 115.072 179.883 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 80.6 Cg_exo -53.59 -33.03 66.9 Favored 'Trans proline' 0 N--CA 1.483 0.894 0 C-N-CA 124.481 3.454 . . . . 0.0 114.35 -176.449 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.4 p30 -62.86 -27.24 69.2 Favored 'General case' 0 N--CA 1.485 1.299 0 N-CA-C 116.914 2.19 . . . . 0.0 116.914 173.195 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 75.82 161.96 11.31 Favored Glycine 0 CA--C 1.543 1.821 0 C-N-CA 123.988 0.804 . . . . 0.0 113.244 -168.823 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 55' ' ' LEU . 82.3 mt -79.89 78.04 6.52 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 122.871 1.319 . . . . 0.0 109.245 177.556 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.3 p80 -72.94 -153.65 0.03 OUTLIER 'General case' 0 N--CA 1.481 1.107 0 CA-C-N 113.999 -1.455 . . . . 0.0 113.218 -175.223 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 13.3 p -51.75 -59.54 4.19 Favored 'General case' 0 N--CA 1.487 1.424 0 C-N-CA 124.205 1.002 . . . . 0.0 113.685 -175.558 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 44.6 ttt180 -55.39 -49.16 94.1 Favored Pre-proline 0 CA--C 1.554 1.097 0 CA-C-O 115.978 -1.963 . . . . 0.0 114.84 -179.894 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.614 ' HG3' ' HB3' ' A' ' 84' ' ' LEU . 78.3 Cg_exo -58.25 -52.05 6.42 Favored 'Trans proline' 0 N--CA 1.478 0.571 0 C-N-CA 122.33 2.02 . . . . 0.0 112.473 173.028 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.55 -41.22 89.58 Favored 'General case' 0 CA--C 1.544 0.733 0 N-CA-C 114.896 1.443 . . . . 0.0 114.896 179.456 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.74 -47.73 84.96 Favored 'General case' 0 N--CA 1.485 1.325 0 C-N-CA 124.059 0.944 . . . . 0.0 113.494 175.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.5 mt-30 -68.54 -36.82 79.35 Favored 'General case' 0 N--CA 1.481 1.077 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.777 179.111 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.407 ' HB3' HD21 ' A' ' 50' ' ' LEU . 11.8 t80 -64.42 -48.67 74.47 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 124.549 1.14 . . . . 0.0 112.568 178.561 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 9.0 p -61.72 -48.0 90.72 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.124 0 N-CA-C 113.089 0.774 . . . . 0.0 113.089 176.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.2 tmtt? -51.85 -45.0 63.87 Favored 'General case' 0 N--CA 1.479 1.003 0 C-N-CA 124.81 1.244 . . . . 0.0 112.635 174.415 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.687 ' HB3' HD21 ' A' ' 77' ' ' LEU . 4.4 tp10 -75.61 -46.59 30.79 Favored 'General case' 0 CA--C 1.541 0.598 0 O-C-N 123.658 0.599 . . . . 0.0 112.172 179.772 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.05 -39.87 63.56 Favored 'General case' 0 N--CA 1.484 1.242 0 C-N-CA 124.777 1.231 . . . . 0.0 114.262 173.624 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 54.1 mttm -63.18 -37.27 86.56 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.218 1.192 . . . . 0.0 114.218 175.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -59.24 -33.08 73.64 Favored Glycine 0 CA--C 1.537 1.468 0 C-N-CA 125.053 1.311 . . . . 0.0 114.629 175.561 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.4 m-85 -86.65 121.75 29.6 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 121.788 0.804 . . . . 0.0 110.809 -179.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.8 p -58.18 -39.78 79.8 Favored 'General case' 0 N--CA 1.487 1.405 0 CA-C-N 114.434 -1.257 . . . . 0.0 111.897 176.867 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -47.44 144.25 3.11 Favored 'General case' 0 N--CA 1.487 1.386 0 C-N-CA 126.86 2.064 . . . . 0.0 113.496 166.73 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 28.0 tp10 -94.68 122.06 36.9 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-O 122.529 1.157 . . . . 0.0 111.529 179.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 10.2 mm -108.63 106.2 20.24 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.684 0 CA-C-N 112.324 -2.216 . . . . 0.0 106.949 -173.681 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.509 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 98.1 m -103.2 122.72 45.32 Favored 'General case' 0 N--CA 1.475 0.816 0 CA-C-N 112.131 -2.304 . . . . 0.0 108.113 -176.202 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 15.3 t -101.67 103.84 15.5 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.835 0 CA-C-N 113.534 -1.666 . . . . 0.0 107.01 -174.097 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 1.9 m -104.34 97.79 7.68 Favored 'General case' 0 N--CA 1.474 0.742 0 CA-C-N 114.589 -1.187 . . . . 0.0 111.035 -174.416 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 42.8 t -88.36 92.39 9.15 Favored 'General case' 0 N--CA 1.472 0.631 0 CA-C-N 113.808 -1.542 . . . . 0.0 109.548 173.811 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.7 p30 44.08 61.03 2.49 Favored 'General case' 0 N--CA 1.488 1.449 0 CA-C-N 113.753 -1.567 . . . . 0.0 114.184 174.538 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 103.28 -63.37 0.41 Allowed Glycine 0 CA--C 1.543 1.801 0 CA-C-N 113.65 -1.614 . . . . 0.0 113.222 -168.59 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 20.9 mttm -68.62 111.02 4.53 Favored 'General case' 0 N--CA 1.489 1.484 0 CA-C-O 122.394 1.093 . . . . 0.0 112.847 -170.6 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.1 p -106.62 117.82 35.06 Favored 'General case' 0 C--O 1.241 0.613 0 CA-C-N 113.289 -1.778 . . . . 0.0 112.413 -176.244 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.724 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -117.74 143.58 46.09 Favored 'General case' 0 C--N 1.316 -0.888 0 CA-C-N 112.197 -2.274 . . . . 0.0 110.275 173.133 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 27.8 t -73.96 134.21 43.11 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-O 121.12 0.486 . . . . 0.0 109.816 173.501 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -66.65 -28.02 68.14 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 113.66 0.985 . . . . 0.0 113.66 179.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 95.6 mttt -68.06 -0.53 4.59 Favored 'General case' 0 N--CA 1.483 1.199 0 N-CA-C 115.096 1.517 . . . . 0.0 115.096 179.605 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 48.2 t -127.17 111.58 14.15 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.92 1.288 . . . . 0.0 111.067 178.404 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 32.9 tp -59.07 -39.99 83.84 Favored 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 124.233 1.013 . . . . 0.0 111.552 -178.856 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.1 t80 -55.53 -50.15 70.76 Favored 'General case' 0 N--CA 1.472 0.662 0 CA-C-N 115.068 -0.969 . . . . 0.0 112.623 173.186 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.724 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 83.9 mttt -65.19 -45.29 85.43 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.649 0.779 . . . . 0.0 112.943 179.56 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.407 HD21 ' HB3' ' A' ' 22' ' ' PHE . 20.3 tp -63.82 -47.25 81.58 Favored 'General case' 0 CA--C 1.54 0.559 0 O-C-N 124.568 1.168 . . . . 0.0 113.486 178.571 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 21.3 mt-30 -70.56 -37.24 73.97 Favored 'General case' 0 N--CA 1.475 0.799 0 N-CA-C 115.585 1.698 . . . . 0.0 115.585 -179.493 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 6.6 t -74.62 -11.62 60.24 Favored 'General case' 0 N--CA 1.489 1.497 0 N-CA-C 113.869 1.062 . . . . 0.0 113.869 177.653 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.403 HD22 ' HB3' ' A' ' 42' ' ' ALA . 15.1 tp -88.43 143.81 26.76 Favored 'General case' 0 N--CA 1.48 1.064 0 C-N-CA 124.353 1.061 . . . . 0.0 109.335 -179.721 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -66.37 88.78 0.13 Allowed Glycine 0 N--CA 1.484 1.859 0 CA-C-N 114.201 -1.363 . . . . 0.0 113.092 179.392 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.424 ' HB3' HD12 ' A' ' 14' ' ' LEU . 93.4 mt -122.35 74.33 1.17 Allowed 'General case' 0 N--CA 1.485 1.278 0 CA-C-O 123.813 1.768 . . . . 0.0 110.353 176.488 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.9 t -137.25 175.0 10.0 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-N 113.371 -1.741 . . . . 0.0 109.716 -179.645 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -45.58 150.06 0.53 Allowed 'General case' 0 N--CA 1.479 0.991 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 177.744 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 54.76 34.33 56.55 Favored Glycine 0 N--CA 1.481 1.671 0 C-N-CA 125.155 1.36 . . . . 0.0 115.261 -179.971 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 20.3 m -120.99 141.3 50.85 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 107.945 -1.131 . . . . 0.0 107.945 -179.006 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . 0.276 11.8 p -111.22 116.4 52.41 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.714 0 CA-C-O 121.731 0.776 . . . . 0.0 112.524 176.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 8.7 p -123.54 129.55 74.58 Favored 'Isoleucine or valine' 0 CA--C 1.548 0.87 0 CA-C-N 112.286 -2.233 . . . . 0.0 112.989 -169.719 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -103.12 123.12 46.08 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 114.105 -1.407 . . . . 0.0 111.537 -178.475 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 15.0 mm -97.17 94.05 3.77 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.227 0 CA-C-N 113.402 -1.727 . . . . 0.0 108.037 -177.622 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.509 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 12.5 t -88.62 132.52 34.52 Favored 'General case' 0 N--CA 1.48 1.058 0 CA-C-N 113.418 -1.719 . . . . 0.0 112.097 -177.589 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -146.71 138.58 24.62 Favored 'General case' 0 N--CA 1.474 0.756 0 N-CA-C 116.619 2.081 . . . . 0.0 116.619 176.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.894 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 16.6 pt-20 -134.0 149.54 51.21 Favored 'General case' 0 N--CA 1.473 0.689 0 CA-C-N 113.612 -1.631 . . . . 0.0 109.612 162.618 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 135.38 -165.09 24.81 Favored Glycine 0 CA--C 1.54 1.614 0 O-C-N 124.753 1.283 . . . . 0.0 111.429 177.115 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 63.5 tt0 -50.81 -75.12 0.03 OUTLIER 'General case' 0 N--CA 1.487 1.397 0 C-N-CA 125.22 1.408 . . . . 0.0 113.184 -175.352 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -73.69 74.78 1.54 Allowed 'General case' 0 N--CA 1.483 1.203 0 C-N-CA 124.052 0.941 . . . . 0.0 108.621 168.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 6.4 pt-20 -69.22 -64.73 0.82 Allowed 'General case' 0 N--CA 1.482 1.144 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 179.839 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 20.5 mt-30 -80.82 -55.41 4.83 Favored 'General case' 0 N--CA 1.476 0.832 0 N-CA-C 113.867 1.062 . . . . 0.0 113.867 -171.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -42.33 -53.19 4.27 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 113.371 -1.741 . . . . 0.0 113.717 172.281 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -37.94 78.85 Favored 'General case' 0 N--CA 1.469 0.506 0 N-CA-C 115.391 1.626 . . . . 0.0 115.391 -177.711 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 4.9 t -65.78 -60.42 2.69 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.344 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 175.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 56.6 tt0 -46.28 -47.55 18.23 Favored 'General case' 0 CA--C 1.551 1.01 0 C-N-CA 125.513 1.525 . . . . 0.0 114.62 173.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.3 t60 -61.18 -51.15 70.22 Favored 'General case' 0 N--CA 1.488 1.426 0 C-N-CA 124.322 1.049 . . . . 0.0 113.155 178.443 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.687 HD21 ' HB3' ' A' ' 25' ' ' GLU . 64.0 mt -69.15 -27.87 65.93 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 115.01 1.485 . . . . 0.0 115.01 174.455 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 34.9 t -63.86 -34.63 69.42 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.398 0 CA-C-O 118.957 -0.544 . . . . 0.0 110.738 170.492 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 9.4 mtpm? -62.18 -42.2 99.05 Favored 'General case' 0 N--CA 1.473 0.688 0 N-CA-C 113.324 0.861 . . . . 0.0 113.324 170.947 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.9 mp -57.55 -44.07 84.91 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 175.306 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 12.4 mtt -62.42 -18.9 62.79 Favored 'General case' 0 N--CA 1.483 1.217 0 N-CA-C 115.09 1.515 . . . . 0.0 115.09 175.995 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -97.6 -43.25 7.3 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -179.684 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 55.0 mt-10 -74.03 -39.36 63.6 Favored 'General case' 0 N--CA 1.488 1.428 0 N-CA-C 115.858 1.799 . . . . 0.0 115.858 -173.189 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.614 ' HB3' ' HG3' ' A' ' 18' ' ' PRO . 15.3 mt -82.86 132.88 35.15 Favored 'General case' 0 N--CA 1.47 0.546 0 N-CA-C 115.197 1.555 . . . . 0.0 115.197 -171.379 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 40.0 mt-10 . . . . . 0 N--CA 1.487 1.388 0 CA-C-N 112.103 -2.317 . . . . 0.0 108.203 169.661 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.566 ' HG2' ' HB3' ' A' ' 66' ' ' GLU . 7.3 mtm . . . . . 0 C--O 1.223 -0.342 0 N-CA-C 109.089 -0.708 . . . . 0.0 109.089 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 28.3 t80 -107.6 109.18 20.75 Favored 'General case' 0 C--N 1.325 -0.496 0 O-C-N 125.395 1.685 . . . . 0.0 108.254 171.796 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 76.3 mt-30 -117.8 125.18 50.1 Favored 'General case' 0 N--CA 1.471 0.595 0 CA-C-N 112.367 -2.197 . . . . 0.0 109.576 -170.273 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.46 ' HB3' HG11 ' A' ' 74' ' ' VAL . 33.1 tt0 -138.73 129.93 26.97 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 114.479 -1.237 . . . . 0.0 112.189 -175.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.486 ' HB3' HG22 ' A' ' 60' ' ' VAL . 46.5 mt-10 -89.42 116.88 27.93 Favored 'General case' 0 N--CA 1.48 1.066 0 CA-C-N 113.272 -1.785 . . . . 0.0 112.061 -175.698 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.0 t -115.07 119.86 62.97 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.232 0 CA-C-N 114.408 -1.269 . . . . 0.0 109.749 -174.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 29.2 m -86.17 112.45 21.34 Favored 'General case' 0 N--CA 1.487 1.377 0 CA-C-N 114.955 -1.02 . . . . 0.0 109.732 -177.949 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.1 mm -108.05 122.05 61.89 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.64 0 CA-C-N 114.684 -1.143 . . . . 0.0 110.083 -177.147 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 27.4 p -107.23 -0.4 22.66 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 116.358 1.985 . . . . 0.0 116.358 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -65.22 117.76 43.08 Favored Pre-proline 0 CA--C 1.55 0.946 0 C-N-CA 124.133 0.973 . . . . 0.0 111.723 -178.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.455 ' HA ' ' HB3' ' A' ' 57' ' ' GLN . 85.0 Cg_exo -49.67 -41.94 44.36 Favored 'Trans proline' 0 N--CA 1.479 0.667 0 C-N-CA 124.75 3.634 . . . . 0.0 114.49 -174.305 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.6 p30 -57.77 -40.82 80.7 Favored 'General case' 0 N--CA 1.477 0.878 0 N-CA-C 117.362 2.356 . . . . 0.0 117.362 -177.368 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 78.17 50.83 6.05 Favored Glycine 0 CA--C 1.55 2.252 0 O-C-N 123.757 0.661 . . . . 0.0 113.788 -169.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 75.8 mt 58.81 59.76 2.74 Favored 'General case' 0 N--CA 1.487 1.382 0 C-N-CA 126.241 1.816 . . . . 0.0 115.03 175.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . 0.254 28.1 p80 -41.27 -97.82 0.0 OUTLIER 'General case' 0 N--CA 1.49 1.569 0 N-CA-C 119.091 2.997 . . . . 0.0 119.091 -163.844 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 29.5 p -108.49 -64.9 1.18 Allowed 'General case' 0 N--CA 1.484 1.238 0 C-N-CA 123.842 0.857 . . . . 0.0 111.214 -178.189 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.431 ' HB3' ' HD3' ' A' ' 18' ' ' PRO . 22.0 ttt180 -51.71 -51.97 65.09 Favored Pre-proline 0 CA--C 1.557 1.232 0 C-N-CA 125.988 1.715 . . . . 0.0 113.67 175.686 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.431 ' HD3' ' HB3' ' A' ' 17' ' ' ARG . 52.9 Cg_exo -64.96 -44.32 10.15 Favored 'Trans proline' 0 CA--C 1.542 0.91 0 C-N-CA 122.431 2.087 . . . . 0.0 113.407 179.485 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -51.65 -52.03 51.19 Favored 'General case' 0 N--CA 1.487 1.377 0 N-CA-C 113.181 0.808 . . . . 0.0 113.181 174.645 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -60.73 -45.96 92.25 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.454 0.909 . . . . 0.0 113.454 175.655 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.411 ' OE1' ' HG2' ' A' ' 17' ' ' ARG . 55.1 mt-30 -61.59 -41.73 97.85 Favored 'General case' 0 N--CA 1.48 1.067 0 N-CA-C 114.451 1.278 . . . . 0.0 114.451 178.476 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -58.4 -53.23 60.6 Favored 'General case' 0 N--CA 1.482 1.149 0 O-C-N 124.09 0.869 . . . . 0.0 111.226 174.793 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 45.0 t -59.22 -43.42 89.64 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.426 0 C-N-CA 123.663 0.785 . . . . 0.0 111.782 178.446 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 35.7 tttm -48.39 -56.24 8.68 Favored 'General case' 0 N--CA 1.486 1.346 0 C-N-CA 123.57 0.748 . . . . 0.0 111.723 173.716 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -70.73 -40.83 72.54 Favored 'General case' 0 N--CA 1.47 0.562 0 N-CA-C 113.733 1.012 . . . . 0.0 113.733 -177.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.88 -41.61 67.73 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.828 0.851 . . . . 0.0 113.281 172.521 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.412 ' HE2' ' O ' ' A' ' 45' ' ' LYS . 69.8 mttt -70.04 -30.61 67.92 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 174.226 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -66.3 -29.44 74.9 Favored Glycine 0 CA--C 1.54 1.612 0 C-N-CA 124.911 1.243 . . . . 0.0 113.069 174.797 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.2 m-85 -86.01 124.33 32.33 Favored 'General case' 0 N--CA 1.472 0.646 0 CA-C-O 122.189 0.995 . . . . 0.0 112.557 172.602 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.0 p -65.65 -42.88 90.88 Favored 'General case' 0 N--CA 1.479 1.021 0 CA-C-N 113.905 -1.498 . . . . 0.0 111.086 170.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.1 t -44.1 143.15 1.23 Allowed 'General case' 0 N--CA 1.476 0.863 0 C-N-CA 126.168 1.787 . . . . 0.0 112.228 162.753 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 19.7 tp10 -95.27 136.26 35.83 Favored 'General case' 0 N--CA 1.48 1.049 0 CA-C-O 122.056 0.932 . . . . 0.0 112.757 -173.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 29.6 mm -115.28 101.63 12.61 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.641 0 CA-C-N 113.11 -1.859 . . . . 0.0 110.213 -169.292 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 62.0 m -99.82 130.1 45.99 Favored 'General case' 0 N--CA 1.482 1.132 0 CA-C-N 114.018 -1.446 . . . . 0.0 108.887 173.199 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 7.5 t -110.06 107.72 23.6 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.755 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 176.466 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 2.8 m -105.62 122.68 46.54 Favored 'General case' 0 N--CA 1.48 1.041 0 CA-C-N 114.49 -1.232 . . . . 0.0 110.079 -176.817 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 36.3 t -125.3 98.75 5.76 Favored 'General case' 0 N--CA 1.472 0.645 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.437 177.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 3.3 p30 32.47 85.97 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.19 0 CA-C-N 112.007 -2.36 . . . . 0.0 116.251 178.305 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 87.56 -41.99 3.11 Favored Glycine 0 N--CA 1.478 1.484 0 CA-C-N 112.77 -2.013 . . . . 0.0 114.355 -176.594 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.2 mmtt -92.46 138.59 31.39 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-O 121.532 0.682 . . . . 0.0 112.248 -174.698 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 55.0 p -116.9 135.62 53.58 Favored 'General case' 0 N--CA 1.474 0.734 0 C-N-CA 124.549 1.14 . . . . 0.0 113.513 -177.348 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.459 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -131.24 131.04 43.63 Favored 'General case' 0 N--CA 1.478 0.927 0 CA-C-N 114.837 -1.074 . . . . 0.0 113.237 173.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 13.3 t -81.0 111.24 17.29 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-N 114.497 -1.229 . . . . 0.0 109.022 170.3 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -59.28 -26.21 64.75 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.324 -1.762 . . . . 0.0 114.631 -178.353 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.412 ' O ' ' HE2' ' A' ' 27' ' ' LYS . 91.9 mttt -61.69 -21.01 64.09 Favored 'General case' 0 N--CA 1.485 1.315 0 N-CA-C 114.473 1.286 . . . . 0.0 114.473 175.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 t -105.52 116.23 31.6 Favored 'General case' 0 N--CA 1.47 0.545 0 CA-C-O 121.543 0.687 . . . . 0.0 110.809 167.533 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 60.8 tp -52.23 -46.31 65.65 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 113.579 -1.646 . . . . 0.0 112.386 174.307 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 9.6 t80 -50.95 -51.3 53.78 Favored 'General case' 0 N--CA 1.487 1.423 0 C-N-CA 124.185 0.994 . . . . 0.0 112.359 171.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 40.8 mttm -63.31 -49.0 75.71 Favored 'General case' 0 N--CA 1.477 0.918 0 N-CA-C 113.605 0.965 . . . . 0.0 113.605 -179.739 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 13.6 tp -54.08 -43.76 70.6 Favored 'General case' 0 N--CA 1.479 0.986 0 O-C-N 124.606 1.191 . . . . 0.0 112.468 176.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 38.0 mt-30 -65.16 -31.56 72.8 Favored 'General case' 0 N--CA 1.477 0.895 0 N-CA-C 115.704 1.742 . . . . 0.0 115.704 178.328 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.9 t -93.12 55.78 2.4 Favored 'General case' 0 N--CA 1.485 1.304 0 CA-C-O 123.999 1.857 . . . . 0.0 112.142 -179.892 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.459 HD22 ' HB3' ' A' ' 42' ' ' ALA . 8.5 tp -152.27 150.63 29.99 Favored 'General case' 0 N--CA 1.474 0.759 0 CA-C-N 113.441 -1.709 . . . . 0.0 111.722 -175.361 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -81.14 76.62 2.13 Favored Glycine 0 N--CA 1.482 1.729 0 C-N-CA 124.231 0.92 . . . . 0.0 113.467 -178.443 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 65.7 mt -93.65 42.23 1.09 Allowed 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 113.225 0.824 . . . . 0.0 113.225 178.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 13.5 t -102.53 170.75 7.85 Favored 'General case' 0 N--CA 1.482 1.126 0 CA-C-N 113.704 -1.589 . . . . 0.0 115.22 -158.674 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.455 ' HB3' ' HA ' ' A' ' 11' ' ' PRO . 11.9 pt20 -52.17 114.99 1.5 Allowed 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 125.342 1.457 . . . . 0.0 113.831 176.77 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.93 -21.39 38.3 Favored Glycine 0 CA--C 1.543 1.802 0 CA-C-N 113.043 -1.89 . . . . 0.0 113.535 175.724 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 63.7 m -72.67 132.16 43.34 Favored 'General case' 0 N--CA 1.481 1.098 0 CA-C-O 122.304 1.05 . . . . 0.0 112.86 -171.758 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.486 HG22 ' HB3' ' A' ' 5' ' ' GLU . 8.7 p -86.0 110.81 20.28 Favored 'Isoleucine or valine' 0 CA--C 1.551 0.998 0 CA-C-N 113.156 -1.838 . . . . 0.0 108.326 164.066 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.6 p -106.07 129.04 59.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.556 0 CA-C-N 113.709 -1.587 . . . . 0.0 110.896 -177.63 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.3 m -91.56 107.66 19.36 Favored 'General case' 0 N--CA 1.472 0.663 0 CA-C-N 114.731 -1.122 . . . . 0.0 110.24 -174.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 39.5 mm -81.18 100.7 5.44 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.013 0 N-CA-C 106.711 -1.588 . . . . 0.0 106.711 172.28 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 47.6 t -99.55 100.56 11.59 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 112.163 -2.289 . . . . 0.0 109.323 -177.658 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -107.06 126.69 52.68 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 114.494 -1.23 . . . . 0.0 111.332 179.434 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.566 ' HB3' ' HG2' ' A' ' 1' ' ' MET . 7.4 pt-20 -127.22 138.91 53.21 Favored 'General case' 0 N--CA 1.477 0.88 0 CA-C-N 113.385 -1.734 . . . . 0.0 113.125 176.441 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 113.02 -141.58 16.97 Favored Glycine 0 N--CA 1.48 1.608 0 CA-C-N 114.439 -1.255 . . . . 0.0 112.659 173.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -46.13 -86.92 0.0 OUTLIER 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 114.907 1.447 . . . . 0.0 114.907 -174.744 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.41 ' HB3' ' HB3' ' A' ' 72' ' ' LYS . 2.3 m-20 -82.25 48.46 1.27 Allowed 'General case' 0 N--CA 1.488 1.443 0 N-CA-C 113.531 0.938 . . . . 0.0 113.531 174.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.275 10.8 pt-20 -58.34 -37.27 74.82 Favored 'General case' 0 N--CA 1.489 1.479 0 N-CA-C 115.663 1.727 . . . . 0.0 115.663 -177.946 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 89.0 mt-30 -69.66 -59.59 2.86 Favored 'General case' 0 N--CA 1.481 1.095 0 C-N-CA 123.645 0.778 . . . . 0.0 112.813 174.705 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.41 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 56.3 tttt -56.66 -47.9 78.75 Favored 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.915 1.686 . . . . 0.0 114.168 -176.479 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -51.99 -41.76 62.41 Favored 'General case' 0 CA--C 1.548 0.872 0 N-CA-C 114.338 1.236 . . . . 0.0 114.338 -177.458 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.46 HG11 ' HB3' ' A' ' 4' ' ' GLN . 16.9 t -66.28 -55.52 18.47 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.007 0 O-C-N 123.753 0.658 . . . . 0.0 110.893 -179.325 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.5 tt0 -46.5 -49.63 18.18 Favored 'General case' 0 N--CA 1.482 1.133 0 C-N-CA 125.319 1.448 . . . . 0.0 112.794 176.447 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 79.1 t60 -63.0 -50.63 69.97 Favored 'General case' 0 CA--C 1.548 0.866 0 CA-C-N 114.513 -1.221 . . . . 0.0 113.619 176.746 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 57.6 mt -59.39 -37.96 79.3 Favored 'General case' 0 N--CA 1.478 0.96 0 N-CA-C 114.463 1.283 . . . . 0.0 114.463 177.295 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 51.6 t -55.09 -53.64 32.37 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.148 0 C-N-CA 123.819 0.847 . . . . 0.0 111.173 174.56 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 38.5 tttm -61.13 -46.15 91.75 Favored 'General case' 0 N--CA 1.479 1.011 0 O-C-N 124.311 1.007 . . . . 0.0 111.733 177.6 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.4 tt -53.66 -50.24 66.22 Favored 'General case' 0 N--CA 1.476 0.84 0 C-N-CA 124.011 0.924 . . . . 0.0 111.73 178.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 32.5 mtp -58.17 -46.39 85.81 Favored 'General case' 0 CA--C 1.551 1.001 0 C-N-CA 124.806 1.242 . . . . 0.0 112.903 176.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.28 -21.76 66.28 Favored 'General case' 0 CA--C 1.55 0.966 0 N-CA-C 115.837 1.791 . . . . 0.0 115.837 178.362 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.6 mt-10 -80.42 1.79 27.68 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.973 1.472 . . . . 0.0 114.973 174.863 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 39.3 mt -116.17 150.87 36.76 Favored 'General case' 0 N--CA 1.48 1.065 0 N-CA-C 115.56 1.689 . . . . 0.0 115.56 -169.459 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 34.0 mt-10 . . . . . 0 CA--C 1.545 0.784 0 CA-C-N 111.357 -2.656 . . . . 0.0 105.786 175.985 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 76.8 mtm . . . . . 0 N--CA 1.467 0.411 0 N-CA-C 106.326 -1.731 . . . . 0.0 106.326 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.1 t80 -127.14 114.54 17.84 Favored 'General case' 0 N--CA 1.47 0.558 0 O-C-N 124.252 0.97 . . . . 0.0 111.76 -173.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 8.2 pt20 -123.53 121.57 35.99 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-N 114.489 -1.232 . . . . 0.0 113.59 177.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 70.4 mt-30 -124.01 158.8 31.26 Favored 'General case' 0 N--CA 1.481 1.124 0 CA-C-N 113.787 -1.551 . . . . 0.0 112.053 177.552 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 46.5 mt-10 -104.25 122.22 44.94 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 114.818 -1.083 . . . . 0.0 111.563 -178.608 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 44.6 t -119.43 129.44 75.29 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.862 -1.517 . . . . 0.0 108.749 178.79 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 64.2 m -96.38 126.61 41.7 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 113.977 -1.465 . . . . 0.0 109.105 176.143 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 19.3 mm -76.26 108.46 8.84 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.753 0 N-CA-C 107.738 -1.208 . . . . 0.0 107.738 175.681 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 20.6 p -99.94 -16.61 17.91 Favored 'General case' 0 N--CA 1.488 1.439 0 N-CA-C 115.545 1.683 . . . . 0.0 115.545 179.222 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -56.06 120.0 30.96 Favored Pre-proline 0 N--CA 1.479 1.022 0 C-N-CA 124.457 1.103 . . . . 0.0 112.891 -177.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 50.2 Cg_endo -63.5 -45.63 11.15 Favored 'Trans proline' 0 CA--C 1.537 0.644 0 C-N-CA 123.696 2.931 . . . . 0.0 113.914 -177.051 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 p30 -71.53 -36.0 70.88 Favored 'General case' 0 N--CA 1.483 1.191 0 O-C-N 123.379 0.424 . . . . 0.0 112.14 175.018 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 116.05 179.98 18.02 Favored Glycine 0 N--CA 1.477 1.428 0 O-C-N 124.506 1.129 . . . . 0.0 110.706 171.869 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.611 ' HB2' ' HB3' ' A' ' 55' ' ' LEU . 85.5 mt -99.84 85.11 3.02 Favored 'General case' 0 N--CA 1.473 0.702 0 CA-C-O 122.593 1.187 . . . . 0.0 110.88 175.659 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -91.74 -148.41 0.23 Allowed 'General case' 0 CA--C 1.547 0.849 0 CA-C-N 113.352 -1.749 . . . . 0.0 114.693 -176.426 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 26.0 p -57.57 -55.92 28.64 Favored 'General case' 0 N--CA 1.49 1.537 0 N-CA-C 115.018 1.488 . . . . 0.0 115.018 -168.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 20.5 ttt-85 -57.14 -49.13 95.72 Favored Pre-proline 0 CA--C 1.557 1.235 0 CA-C-O 116.927 -1.511 . . . . 0.0 112.568 176.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 61.0 Cg_exo -57.92 -50.3 10.64 Favored 'Trans proline' 0 N--CA 1.482 0.818 0 C-N-CA 122.909 2.406 . . . . 0.0 113.903 172.311 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.61 -49.33 75.27 Favored 'General case' 0 N--CA 1.48 1.025 0 CA-C-O 118.046 -0.978 . . . . 0.0 112.616 178.325 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -55.51 -44.78 76.94 Favored 'General case' 0 N--CA 1.482 1.154 0 C-N-CA 124.117 0.967 . . . . 0.0 113.274 176.331 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 35.0 mt-30 -61.71 -51.31 68.89 Favored 'General case' 0 N--CA 1.475 0.794 0 C-N-CA 123.972 0.909 . . . . 0.0 113.305 175.088 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 0.5 OUTLIER -57.62 -50.89 71.66 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 125.362 1.465 . . . . 0.0 111.832 178.481 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 62.6 t -59.71 -45.81 94.07 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.365 0 C-N-CA 124.449 1.099 . . . . 0.0 111.616 178.706 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -55.73 -47.29 77.16 Favored 'General case' 0 N--CA 1.485 1.323 0 O-C-N 123.881 0.738 . . . . 0.0 111.408 179.434 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . 0.453 ' HG2' ' CD2' ' A' ' 76' ' ' HIS . 1.7 tp10 -69.25 -44.57 71.67 Favored 'General case' 0 N--CA 1.474 0.761 0 N-CA-C 113.884 1.068 . . . . 0.0 113.884 178.359 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.44 -39.79 73.71 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 113.64 0.978 . . . . 0.0 113.64 173.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.529 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 48.7 mmtt -71.23 -38.79 71.96 Favored 'General case' 0 N--CA 1.477 0.893 0 N-CA-C 114.819 1.414 . . . . 0.0 114.819 172.752 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -58.99 -42.95 97.15 Favored Glycine 0 N--CA 1.479 1.512 0 O-C-N 125.294 1.621 . . . . 0.0 112.823 173.501 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 25.1 m-85 -73.02 135.54 44.93 Favored 'General case' 0 N--CA 1.477 0.901 0 C-N-CA 123.864 0.866 . . . . 0.0 110.124 168.99 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.8 p -67.61 -41.55 83.83 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 112.892 0.701 . . . . 0.0 112.892 171.084 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -41.87 123.36 2.3 Favored 'General case' 0 N--CA 1.477 0.907 0 C-N-CA 126.074 1.749 . . . . 0.0 115.099 172.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . 0.42 ' OE2' ' HG3' ' A' ' 45' ' ' LYS . 22.9 tp10 -81.74 132.0 35.28 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-O 121.908 0.861 . . . . 0.0 111.316 -177.495 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.6 mm -121.51 110.31 27.35 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.042 0 CA-C-N 113.917 -1.492 . . . . 0.0 111.529 -168.128 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.2 m -102.07 117.6 35.14 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-N 113.113 -1.858 . . . . 0.0 109.156 178.005 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 76.5 t -108.72 96.17 4.43 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.424 0 CA-C-N 113.372 -1.74 . . . . 0.0 106.395 -174.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.0 m -106.99 109.27 21.13 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 113.926 -1.488 . . . . 0.0 112.054 -168.818 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 14.0 t -106.5 109.2 21.06 Favored 'General case' 0 N--CA 1.484 1.266 0 CA-C-N 115.841 -0.618 . . . . 0.0 109.766 174.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.0 p30 45.88 60.67 3.03 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.376 -1.738 . . . . 0.0 114.688 -176.622 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.99 -28.87 2.16 Favored Glycine 0 N--CA 1.485 1.919 0 CA-C-N 114.29 -1.323 . . . . 0.0 114.877 -178.525 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -75.21 105.55 6.28 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-O 122.101 0.953 . . . . 0.0 111.1 179.007 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 31.6 p -93.31 114.14 26.51 Favored 'General case' 0 C--O 1.238 0.486 0 N-CA-C 115.931 1.826 . . . . 0.0 115.931 -172.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -103.84 148.41 26.15 Favored 'General case' 0 N--CA 1.479 0.988 0 CA-C-N 112.625 -2.079 . . . . 0.0 109.879 171.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 23.5 t -103.36 118.46 36.82 Favored 'General case' 0 N--CA 1.481 1.077 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 175.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -55.02 -29.14 56.75 Favored 'General case' 0 N--CA 1.476 0.858 0 O-C-N 125.241 1.588 . . . . 0.0 113.222 177.254 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.529 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 43.7 mmtt -63.03 -24.34 67.87 Favored 'General case' 0 N--CA 1.479 0.999 0 C-N-CA 125.145 1.378 . . . . 0.0 114.251 179.071 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.7 t -115.49 117.05 29.29 Favored 'General case' 0 N--CA 1.477 0.918 0 C-N-CA 122.815 0.446 . . . . 0.0 110.866 -178.284 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 35.9 tp -49.98 -52.7 31.65 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 125.116 1.367 . . . . 0.0 112.719 176.017 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 2.0 t80 -60.08 -36.48 77.46 Favored 'General case' 0 CA--C 1.552 1.044 0 C-N-CA 124.402 1.081 . . . . 0.0 112.745 179.135 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 69.8 tttt -77.59 -44.12 29.44 Favored 'General case' 0 CA--C 1.545 0.771 0 O-C-N 123.549 0.531 . . . . 0.0 112.047 -179.189 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.2 tp -62.33 -39.61 93.65 Favored 'General case' 0 CA--C 1.549 0.921 0 C-N-CA 123.636 0.774 . . . . 0.0 112.594 174.64 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 78.8 mt-30 -60.21 -37.0 78.95 Favored 'General case' 0 N--CA 1.481 1.113 0 N-CA-C 115.451 1.648 . . . . 0.0 115.451 177.873 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 13.4 t -90.38 59.68 4.43 Favored 'General case' 0 N--CA 1.485 1.307 0 CA-C-O 123.538 1.637 . . . . 0.0 112.025 175.716 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -144.14 153.01 41.69 Favored 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 112.757 -2.02 . . . . 0.0 109.579 176.361 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.12 79.68 0.05 OUTLIER Glycine 0 N--CA 1.485 1.916 0 C-N-CA 124.604 1.097 . . . . 0.0 112.844 175.06 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.611 ' HB3' ' HB2' ' A' ' 14' ' ' LEU . 73.5 mt -100.13 42.56 1.1 Allowed 'General case' 0 CA--C 1.55 0.979 0 CA-C-O 122.222 1.01 . . . . 0.0 111.98 173.842 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.8 t -113.26 156.89 22.52 Favored 'General case' 0 N--CA 1.482 1.128 0 CA-C-N 113.352 -1.749 . . . . 0.0 112.179 -176.101 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 9.9 pt20 -48.98 108.09 0.17 Allowed 'General case' 0 CA--C 1.544 0.742 0 C-N-CA 125.558 1.543 . . . . 0.0 114.2 179.535 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 115.02 -23.19 11.71 Favored Glycine 0 CA--C 1.548 2.125 0 CA-C-N 113.277 -1.783 . . . . 0.0 115.495 178.208 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 3.5 m -73.42 127.03 31.56 Favored 'General case' 0 N--CA 1.494 1.736 0 CA-C-N 117.638 0.719 . . . . 0.0 112.358 -172.021 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 7.3 p -91.65 140.46 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 121.837 0.827 . . . . 0.0 111.803 172.667 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 11.2 p -137.74 131.38 43.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.93 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.985 -178.708 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -81.71 109.18 15.88 Favored 'General case' 0 N--CA 1.482 1.151 0 CA-C-N 114.542 -1.208 . . . . 0.0 109.489 174.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 35.7 mm -91.43 96.69 6.5 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.095 0 N-CA-C 106.989 -1.485 . . . . 0.0 106.989 178.334 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.9 t -104.58 113.73 27.5 Favored 'General case' 0 N--CA 1.481 1.124 0 O-C-N 124.74 1.275 . . . . 0.0 112.054 -175.598 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -113.12 131.29 55.89 Favored 'General case' 0 N--CA 1.477 0.917 0 CA-C-N 114.141 -1.391 . . . . 0.0 112.372 179.169 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -122.15 152.59 39.76 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-N 114.126 -1.397 . . . . 0.0 112.5 173.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 100.33 -152.35 19.21 Favored Glycine 0 N--CA 1.48 1.605 0 CA-C-N 115.537 -0.756 . . . . 0.0 113.532 173.784 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 36.3 mt-10 -42.75 -61.88 1.14 Allowed 'General case' 0 N--CA 1.487 1.38 0 N-CA-C 117.052 2.242 . . . . 0.0 117.052 -173.668 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 10.1 m-20 -104.79 40.56 1.47 Allowed 'General case' 0 N--CA 1.48 1.062 0 C-N-CA 123.353 0.661 . . . . 0.0 112.315 -174.371 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -47.77 -48.48 30.08 Favored 'General case' 0 N--CA 1.482 1.129 0 N-CA-C 116.721 2.119 . . . . 0.0 116.721 -173.743 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 87.4 mt-30 -75.05 -48.73 22.52 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.446 1.276 . . . . 0.0 114.446 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 73.3 tttt -57.81 -39.35 77.4 Favored 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 125.117 1.367 . . . . 0.0 112.85 179.821 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.95 -61.22 2.43 Favored 'General case' 0 N--CA 1.473 0.683 0 CA-C-N 115.27 -0.877 . . . . 0.0 111.918 173.687 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.402 ' O ' HG23 ' A' ' 78' ' ' VAL . 29.2 t -64.53 -41.69 93.02 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.913 0 CA-C-O 118.384 -0.817 . . . . 0.0 111.216 -176.738 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 37.6 tt0 -51.2 -61.15 2.41 Favored 'General case' 0 N--CA 1.493 1.689 0 C-N-CA 124.133 0.973 . . . . 0.0 112.375 175.528 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.453 ' CD2' ' HG2' ' A' ' 25' ' ' GLU . 67.1 t60 -69.44 -30.52 68.46 Favored 'General case' 0 N--CA 1.476 0.873 0 N-CA-C 114.823 1.416 . . . . 0.0 114.823 179.758 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 86.1 mt -66.2 -34.95 79.19 Favored 'General case' 0 N--CA 1.475 0.821 0 N-CA-C 114.06 1.134 . . . . 0.0 114.06 173.515 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.402 HG23 ' O ' ' A' ' 74' ' ' VAL . 63.0 t -65.82 -46.66 88.14 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.546 0 CA-C-O 119.002 -0.523 . . . . 0.0 109.717 169.815 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 50.2 tttm -51.34 -49.59 61.1 Favored 'General case' 0 N--CA 1.486 1.375 0 C-N-CA 124.042 0.937 . . . . 0.0 111.574 176.337 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 10.2 mt -50.42 -62.11 1.78 Allowed 'General case' 0 N--CA 1.484 1.227 0 C-N-CA 124.631 1.173 . . . . 0.0 113.533 171.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 69.0 mtm -57.03 -36.04 70.01 Favored 'General case' 0 N--CA 1.479 0.993 0 N-CA-C 114.778 1.399 . . . . 0.0 114.778 179.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.97 -32.38 67.2 Favored 'General case' 0 N--CA 1.481 1.08 0 N-CA-C 115.0 1.482 . . . . 0.0 115.0 177.567 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 28.9 mt-10 -79.59 -17.96 52.7 Favored 'General case' 0 N--CA 1.486 1.345 0 N-CA-C 115.173 1.545 . . . . 0.0 115.173 173.417 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 18.2 mt -85.67 126.38 33.89 Favored 'General case' 0 N--CA 1.475 0.798 0 C-N-CA 123.713 0.805 . . . . 0.0 111.175 174.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 . . . . . 0 C--O 1.249 1.026 0 C-N-CA 125.296 1.438 . . . . 0.0 108.173 178.715 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 2.2 mpt? . . . . . 0 N--CA 1.475 0.816 0 N-CA-C 106.865 -1.532 . . . . 0.0 106.865 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 88.1 t80 -130.39 116.76 18.72 Favored 'General case' 0 N--CA 1.479 1.024 0 O-C-N 124.849 1.343 . . . . 0.0 111.391 -176.597 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 15.5 pt20 -123.72 140.93 52.5 Favored 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 112.783 0.66 . . . . 0.0 112.783 175.385 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 35.1 mt-30 -135.71 139.84 43.97 Favored 'General case' 0 N--CA 1.478 0.974 0 O-C-N 125.089 1.493 . . . . 0.0 113.303 173.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 25.2 tt0 -84.98 120.01 26.03 Favored 'General case' 0 N--CA 1.47 0.528 0 CA-C-N 114.06 -1.427 . . . . 0.0 110.633 -179.266 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.417 HG21 HG22 ' A' ' 78' ' ' VAL . 66.2 t -126.21 121.5 59.34 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.065 0 CA-C-N 115.254 -0.885 . . . . 0.0 110.43 -177.291 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -83.51 129.71 34.98 Favored 'General case' 0 N--CA 1.484 1.254 0 CA-C-O 122.108 0.956 . . . . 0.0 110.619 170.747 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 46.8 mm -107.79 117.89 54.37 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.176 0 N-CA-C 107.27 -1.381 . . . . 0.0 107.27 169.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . 0.408 ' HA ' ' H ' ' A' ' 58' ' ' GLY . 21.9 p -111.45 -2.14 15.65 Favored 'General case' 0 N--CA 1.477 0.882 0 N-CA-C 116.018 1.859 . . . . 0.0 116.018 179.78 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -64.08 121.1 69.67 Favored Pre-proline 0 N--CA 1.475 0.801 0 C-N-CA 124.071 0.948 . . . . 0.0 111.947 -179.174 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 38.1 Cg_endo -57.78 -44.56 39.78 Favored 'Trans proline' 0 N--CA 1.487 1.122 0 C-N-CA 123.403 2.735 . . . . 0.0 114.018 -177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 15.5 p30 -68.88 -34.73 75.91 Favored 'General case' 0 CA--C 1.548 0.89 0 N-CA-C 113.594 0.961 . . . . 0.0 113.594 176.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.87 -170.18 54.87 Favored Glycine 0 CA--C 1.542 1.746 0 C-N-CA 125.535 1.54 . . . . 0.0 114.56 178.134 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.2 mp -79.58 74.35 6.24 Favored 'General case' 0 N--CA 1.479 1.024 0 CA-C-O 123.24 1.495 . . . . 0.0 113.474 177.026 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 35.1 p80 -102.08 169.98 8.4 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 113.568 -1.651 . . . . 0.0 110.329 173.288 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 72.9 p 38.9 -104.48 0.04 OUTLIER 'General case' 0 N--CA 1.481 1.121 0 C-N-CA 126.507 1.923 . . . . 0.0 115.658 170.096 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 41.3 ttt-85 -78.0 -44.26 2.29 Favored Pre-proline 0 CA--C 1.555 1.165 0 CA-C-O 115.553 -2.165 . . . . 0.0 112.948 -177.841 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.528 ' HA ' HD22 ' A' ' 84' ' ' LEU . 15.8 Cg_exo -48.95 -46.88 23.44 Favored 'Trans proline' 0 N--CA 1.484 0.931 0 C-N-CA 122.621 2.214 . . . . 0.0 113.908 168.212 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.83 -54.8 40.71 Favored 'General case' 0 CA--C 1.546 0.818 0 C-N-CA 123.251 0.621 . . . . 0.0 112.531 174.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.78 -40.85 69.86 Favored 'General case' 0 N--CA 1.479 1.02 0 N-CA-C 114.82 1.415 . . . . 0.0 114.82 177.263 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 31.4 mt-30 -57.07 -53.63 55.94 Favored 'General case' 0 N--CA 1.48 1.071 0 C-N-CA 123.861 0.865 . . . . 0.0 113.126 175.466 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 28.2 t80 -61.18 -47.76 84.68 Favored 'General case' 0 N--CA 1.485 1.285 0 CA-C-N 115.561 -0.745 . . . . 0.0 111.733 178.187 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.453 HG21 ' HA ' ' A' ' 47' ' ' LEU . 83.0 t -57.49 -52.04 62.09 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.189 0 C-N-CA 124.504 1.122 . . . . 0.0 112.048 176.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.0 tmtt? -60.44 -47.57 85.52 Favored 'General case' 0 N--CA 1.481 1.12 0 C-N-CA 123.222 0.609 . . . . 0.0 111.742 179.899 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -62.62 -43.02 99.86 Favored 'General case' 0 CA--C 1.546 0.816 0 O-C-N 124.097 0.873 . . . . 0.0 112.55 179.521 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.411 ' O ' ' HE2' ' A' ' 45' ' ' LYS . . . -60.78 -43.01 98.6 Favored 'General case' 0 N--CA 1.482 1.162 0 N-CA-C 112.982 0.734 . . . . 0.0 112.982 171.604 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 35.6 mmtt -61.16 -23.67 65.73 Favored 'General case' 0 N--CA 1.481 1.114 0 N-CA-C 115.08 1.511 . . . . 0.0 115.08 172.339 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -78.38 -30.66 49.02 Favored Glycine 0 CA--C 1.548 2.107 0 C-N-CA 124.535 1.064 . . . . 0.0 114.041 173.194 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 27.0 m-85 -87.79 124.7 33.88 Favored 'General case' 0 N--CA 1.485 1.291 0 CA-C-O 122.109 0.957 . . . . 0.0 112.578 -179.804 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 22.6 p -71.36 -4.31 25.46 Favored 'General case' 0 N--CA 1.482 1.159 0 N-CA-C 114.975 1.472 . . . . 0.0 114.975 179.292 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 17.4 m -93.19 145.39 24.46 Favored 'General case' 0 N--CA 1.476 0.836 0 C-N-CA 124.603 1.161 . . . . 0.0 108.6 179.151 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -86.55 131.16 34.24 Favored 'General case' 0 N--CA 1.474 0.751 0 CA-C-O 121.5 0.667 . . . . 0.0 112.492 -175.43 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 22.5 mm -120.89 118.48 56.45 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.252 0 CA-C-N 112.976 -1.92 . . . . 0.0 108.834 -168.736 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.559 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 20.2 m -113.53 123.25 49.56 Favored 'General case' 0 N--CA 1.481 1.087 0 CA-C-N 112.148 -2.297 . . . . 0.0 110.689 -173.472 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 79.9 t -99.0 90.45 2.05 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.104 0 CA-C-N 113.52 -1.673 . . . . 0.0 106.49 -179.692 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 3.8 m -97.52 112.89 24.55 Favored 'General case' 0 N--CA 1.477 0.903 0 CA-C-N 114.066 -1.424 . . . . 0.0 112.516 -171.238 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 45.3 t -111.49 98.0 7.14 Favored 'General case' 0 N--CA 1.488 1.474 0 CA-C-N 113.359 -1.746 . . . . 0.0 109.184 178.81 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 6.3 p30 39.35 64.84 0.77 Allowed 'General case' 0 N--CA 1.491 1.581 0 CA-C-N 114.043 -1.435 . . . . 0.0 114.822 -176.108 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 91.51 -49.9 2.93 Favored Glycine 0 N--CA 1.482 1.746 0 CA-C-N 113.455 -1.702 . . . . 0.0 113.432 -175.301 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 70.1 mmtt -63.02 112.89 2.79 Favored 'General case' 0 N--CA 1.485 1.287 0 C-N-CA 124.295 1.038 . . . . 0.0 111.711 -177.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 25.2 p -106.99 104.76 14.51 Favored 'General case' 0 N--CA 1.485 1.308 0 CA-C-N 113.903 -1.499 . . . . 0.0 114.214 -171.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -94.2 144.02 25.88 Favored 'General case' 0 N--CA 1.477 0.891 0 CA-C-N 114.067 -1.424 . . . . 0.0 111.414 176.21 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.9 t -80.04 124.93 29.16 Favored 'General case' 0 N--CA 1.486 1.342 0 CA-C-N 115.267 -0.879 . . . . 0.0 109.647 173.119 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -58.5 -26.42 63.44 Favored 'General case' 0 CA--C 1.543 0.709 0 O-C-N 125.009 1.443 . . . . 0.0 114.515 178.185 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.411 ' HE2' ' O ' ' A' ' 26' ' ' ALA . 92.2 mttt -83.04 27.47 0.55 Allowed 'General case' 0 N--CA 1.484 1.261 0 N-CA-C 114.948 1.462 . . . . 0.0 114.948 -169.734 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 27.5 t -145.2 118.27 8.85 Favored 'General case' 0 N--CA 1.473 0.703 0 C-N-CA 124.777 1.231 . . . . 0.0 113.004 179.512 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.453 ' HA ' HG21 ' A' ' 23' ' ' VAL . 44.7 tp -56.74 -47.01 81.0 Favored 'General case' 0 N--CA 1.476 0.846 0 CA-C-N 113.736 -1.574 . . . . 0.0 112.062 177.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 74.3 t80 -54.56 -51.54 64.93 Favored 'General case' 0 N--CA 1.481 1.082 0 CA-C-O 117.961 -1.019 . . . . 0.0 112.07 171.392 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 63.1 mttm -58.34 -43.05 88.13 Favored 'General case' 0 N--CA 1.487 1.389 0 N-CA-C 113.977 1.103 . . . . 0.0 113.977 -179.685 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.42 HD22 HG23 ' A' ' 23' ' ' VAL . 4.7 mp -63.89 -52.5 59.61 Favored 'General case' 0 N--CA 1.476 0.869 0 N-CA-C 113.862 1.06 . . . . 0.0 113.862 174.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 57.9 mt-30 -66.46 -27.81 68.1 Favored 'General case' 0 N--CA 1.48 1.058 0 N-CA-C 115.744 1.757 . . . . 0.0 115.744 179.706 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 2.3 t -79.26 -15.02 58.64 Favored 'General case' 0 N--CA 1.48 1.061 0 N-CA-C 114.673 1.36 . . . . 0.0 114.673 173.717 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 13.4 tp -107.12 137.38 45.29 Favored 'General case' 0 N--CA 1.477 0.876 0 CA-C-O 121.844 0.831 . . . . 0.0 109.415 -177.461 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.43 71.11 0.65 Allowed Glycine 0 CA--C 1.541 1.681 0 CA-C-N 114.605 -1.179 . . . . 0.0 114.659 -178.113 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 1.6 mp -85.05 71.91 10.87 Favored 'General case' 0 N--CA 1.48 1.056 0 CA-C-O 121.751 0.786 . . . . 0.0 110.181 170.526 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.8 t -128.93 -157.56 0.83 Allowed 'General case' 0 N--CA 1.488 1.465 0 N-CA-C 113.806 1.039 . . . . 0.0 113.806 -162.056 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.5 pt20 -66.5 102.43 0.89 Allowed 'General case' 0 N--CA 1.474 0.746 0 C-N-CA 125.74 1.616 . . . . 0.0 114.806 179.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . 0.408 ' H ' ' HA ' ' A' ' 9' ' ' THR . . . 86.64 39.85 7.49 Favored Glycine 0 CA--C 1.543 1.782 0 CA-C-N 112.84 -1.982 . . . . 0.0 112.328 176.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 6.8 m -105.72 114.73 29.06 Favored 'General case' 0 N--CA 1.473 0.687 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 178.3 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -95.19 112.03 26.86 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-N 114.567 -1.197 . . . . 0.0 109.397 175.817 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.1 p -122.6 112.91 36.17 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.212 -2.267 . . . . 0.0 111.838 -172.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 3.3 m -78.29 98.85 6.07 Favored 'General case' 0 N--CA 1.476 0.864 0 CA-C-N 114.301 -1.318 . . . . 0.0 109.812 176.772 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.4 HG22 HG22 ' A' ' 74' ' ' VAL . 27.0 mm -76.35 107.89 8.13 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.149 0 CA-C-N 113.747 -1.57 . . . . 0.0 108.126 176.348 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.559 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 23.1 t -101.35 138.47 38.33 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 112.851 -1.977 . . . . 0.0 111.671 -179.453 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.612 ' HB2' HG23 ' A' ' 74' ' ' VAL . . . -131.35 144.48 51.27 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.518 1.127 . . . . 0.0 112.832 174.748 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.5 pt-20 -143.38 140.18 30.35 Favored 'General case' 0 N--CA 1.478 0.955 0 CA-C-N 113.779 -1.555 . . . . 0.0 112.148 167.774 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.98 -145.16 15.99 Favored Glycine 0 N--CA 1.48 1.618 0 N-CA-C 115.138 0.815 . . . . 0.0 115.138 173.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 18.2 tt0 -55.44 -66.22 0.45 Allowed 'General case' 0 CA--C 1.555 1.156 0 N-CA-C 114.865 1.432 . . . . 0.0 114.865 -169.352 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 7.8 m-20 -100.25 23.07 10.57 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 124.777 1.231 . . . . 0.0 112.756 176.666 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 7.7 pt-20 -32.35 -59.46 0.3 Allowed 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 119.027 2.973 . . . . 0.0 119.027 -168.791 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 29.4 tt0 -60.12 -54.67 43.17 Favored 'General case' 0 N--CA 1.494 1.751 0 N-CA-C 113.12 0.785 . . . . 0.0 113.12 178.877 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 66.3 tttt -58.77 -43.06 90.31 Favored 'General case' 0 N--CA 1.483 1.208 0 C-N-CA 125.356 1.463 . . . . 0.0 111.953 178.231 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -52.01 -52.42 50.8 Favored 'General case' 0 N--CA 1.48 1.037 0 C-N-CA 123.944 0.898 . . . . 0.0 112.658 178.488 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.612 HG23 ' HB2' ' A' ' 65' ' ' ALA 0.263 17.5 t -71.61 -39.09 69.37 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-O 117.925 -1.036 . . . . 0.0 113.588 176.385 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 25.9 tt0 -50.31 -50.96 49.13 Favored 'General case' 0 N--CA 1.481 1.114 0 C-N-CA 124.396 1.078 . . . . 0.0 111.923 175.428 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.3 t60 -59.18 -53.38 58.92 Favored 'General case' 0 N--CA 1.482 1.162 0 C-N-CA 124.751 1.221 . . . . 0.0 111.63 174.28 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 79.3 mt -57.69 -35.43 70.59 Favored 'General case' 0 N--CA 1.495 1.798 0 N-CA-C 115.089 1.514 . . . . 0.0 115.089 178.627 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.417 HG22 HG21 ' A' ' 6' ' ' VAL . 74.2 t -67.03 -46.35 84.89 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.998 0 C-N-CA 123.987 0.915 . . . . 0.0 110.831 176.858 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 31.9 tttt -58.53 -48.41 80.95 Favored 'General case' 0 N--CA 1.477 0.879 0 O-C-N 123.463 0.477 . . . . 0.0 111.006 172.421 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.432 ' O ' ' HG ' ' A' ' 84' ' ' LEU . 6.9 tp -51.94 -51.08 59.49 Favored 'General case' 0 N--CA 1.479 0.98 0 C-N-CA 124.979 1.312 . . . . 0.0 112.387 175.097 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.0 mtt -53.12 -27.57 21.45 Favored 'General case' 0 N--CA 1.48 1.069 0 N-CA-C 116.363 1.986 . . . . 0.0 116.363 174.825 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -92.77 -28.24 16.71 Favored 'General case' 0 CA--C 1.545 0.784 0 N-CA-C 114.574 1.324 . . . . 0.0 114.574 176.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -69.57 -23.17 63.51 Favored 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.393 1.627 . . . . 0.0 115.393 175.422 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.528 HD22 ' HA ' ' A' ' 18' ' ' PRO . 52.6 mt -62.99 143.76 57.47 Favored 'General case' 0 N--CA 1.492 1.628 0 C-N-CA 124.163 0.985 . . . . 0.0 113.649 -177.055 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.9 mt-10 . . . . . 0 CA--C 1.557 1.228 0 C-N-CA 126.296 1.838 . . . . 0.0 108.734 -171.762 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 1.7 mpt? . . . . . 0 N--CA 1.47 0.56 0 N-CA-C 106.307 -1.738 . . . . 0.0 106.307 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 46.7 t80 -123.73 137.17 54.74 Favored 'General case' 0 N--CA 1.482 1.15 0 O-C-N 124.895 1.372 . . . . 0.0 111.352 -171.731 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.3 pt20 -128.45 141.52 51.37 Favored 'General case' 0 N--CA 1.482 1.126 0 O-C-N 125.376 1.673 . . . . 0.0 112.115 179.912 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 44.0 mt-30 -132.26 123.32 26.7 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-N 114.757 -1.111 . . . . 0.0 111.821 167.367 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.45 ' HG2' HG22 ' A' ' 60' ' ' VAL . 11.9 tt0 -96.64 118.13 32.46 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 124.073 0.858 . . . . 0.0 110.817 174.34 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.5 m -118.13 134.0 63.13 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.394 0 CA-C-N 112.81 -1.995 . . . . 0.0 113.246 -175.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.4 m -89.64 86.75 6.79 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 114.01 -1.45 . . . . 0.0 109.404 -179.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 37.6 mm -77.16 112.32 14.95 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.952 0 CA-C-N 113.756 -1.566 . . . . 0.0 111.19 -176.837 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 10.0 p -114.5 39.62 2.76 Favored 'General case' 0 N--CA 1.476 0.831 0 CA-C-N 112.686 -2.052 . . . . 0.0 113.019 -178.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.448 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -76.54 123.0 87.63 Favored Pre-proline 0 N--CA 1.477 0.903 0 CA-C-N 115.094 -0.957 . . . . 0.0 112.188 -172.648 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.448 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 98.9 Cg_exo -47.54 -47.14 18.71 Favored 'Trans proline' 0 CA--C 1.541 0.855 0 C-N-CA 124.89 3.727 . . . . 0.0 115.55 -173.295 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.1 m120 -102.56 -50.56 3.54 Favored 'General case' 0 N--CA 1.477 0.884 0 N-CA-C 112.399 0.518 . . . . 0.0 112.399 169.334 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 109.55 -157.1 15.28 Favored Glycine 0 CA--C 1.535 1.286 0 O-C-N 124.575 1.172 . . . . 0.0 112.568 171.868 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.474 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 5.7 mp -93.13 75.72 4.66 Favored 'General case' 0 N--CA 1.473 0.715 0 CA-C-O 122.83 1.3 . . . . 0.0 112.424 -178.839 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 32.8 p80 -97.21 -152.23 0.38 Allowed 'General case' 0 N--CA 1.478 0.952 0 CA-C-N 111.804 -2.453 . . . . 0.0 110.232 172.881 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 34.6 p -42.96 -71.58 0.08 Allowed 'General case' 0 N--CA 1.484 1.257 0 N-CA-C 115.556 1.687 . . . . 0.0 115.556 -163.663 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . . 24.1 ttt-85 -74.16 -44.04 6.11 Favored Pre-proline 0 CA--C 1.553 1.086 0 CA-C-O 116.152 -1.88 . . . . 0.0 114.766 179.909 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.474 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 73.2 Cg_exo -56.51 -43.58 53.98 Favored 'Trans proline' 0 C--N 1.357 1.02 0 C-N-CA 122.579 2.186 . . . . 0.0 113.911 173.929 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -64.69 -44.94 88.7 Favored 'General case' 0 N--CA 1.484 1.228 0 C-N-CA 122.982 0.513 . . . . 0.0 112.308 174.477 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -56.94 -41.97 79.21 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 172.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.7 mt-30 -58.91 -45.88 89.25 Favored 'General case' 0 N--CA 1.48 1.038 0 C-N-CA 124.188 0.995 . . . . 0.0 113.071 173.379 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 16.1 t80 -62.35 -48.67 78.75 Favored 'General case' 0 N--CA 1.475 0.783 0 C-N-CA 124.39 1.076 . . . . 0.0 112.121 175.386 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.415 HG22 ' O ' ' A' ' 44' ' ' ALA . 91.2 t -57.63 -44.73 85.94 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 C-N-CA 124.137 0.975 . . . . 0.0 111.962 175.889 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 11.9 tmtt? -54.17 -51.81 63.16 Favored 'General case' 0 N--CA 1.481 1.08 0 C-N-CA 123.797 0.839 . . . . 0.0 111.125 177.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 17.8 tp10 -69.67 -39.26 77.1 Favored 'General case' 0 N--CA 1.476 0.825 0 N-CA-C 113.572 0.952 . . . . 0.0 113.572 179.617 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.86 -44.98 78.6 Favored 'General case' 0 N--CA 1.483 1.22 0 C-N-CA 123.371 0.668 . . . . 0.0 112.117 170.6 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.2 mmtt -61.46 -29.39 69.93 Favored 'General case' 0 N--CA 1.486 1.335 0 N-CA-C 114.995 1.479 . . . . 0.0 114.995 173.164 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -64.6 -33.65 87.81 Favored Glycine 0 CA--C 1.544 1.882 0 C-N-CA 124.879 1.228 . . . . 0.0 113.126 174.025 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 32.0 m-85 -85.67 139.39 31.42 Favored 'General case' 0 N--CA 1.473 0.72 0 C-N-CA 124.027 0.931 . . . . 0.0 111.958 177.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 32.4 p -74.4 -45.99 43.21 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 115.359 -0.837 . . . . 0.0 112.052 172.105 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 41.3 m -53.43 144.14 17.54 Favored 'General case' 0 N--CA 1.48 1.068 0 C-N-CA 125.127 1.371 . . . . 0.0 113.143 174.605 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 6.0 tp10 -92.77 127.09 38.15 Favored 'General case' 0 N--CA 1.475 0.808 0 CA-C-O 122.119 0.961 . . . . 0.0 112.999 -175.31 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.531 HD11 ' HB1' ' A' ' 73' ' ' ALA . 37.2 mm -101.27 117.42 46.51 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.97 0 CA-C-N 112.972 -1.922 . . . . 0.0 110.705 -178.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 7.4 m -102.22 119.21 38.44 Favored 'General case' 0 N--CA 1.477 0.901 0 CA-C-N 112.049 -2.342 . . . . 0.0 108.632 175.817 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 70.7 t -103.16 99.47 8.46 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.09 0 CA-C-N 113.792 -1.549 . . . . 0.0 107.036 179.468 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 8.7 m -113.85 113.76 25.34 Favored 'General case' 0 N--CA 1.475 0.804 0 CA-C-N 115.811 -0.631 . . . . 0.0 111.606 -171.517 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 8.2 t -119.87 115.06 23.07 Favored 'General case' 0 N--CA 1.48 1.065 0 CA-C-N 115.954 -0.566 . . . . 0.0 110.697 173.509 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . 0.282 24.1 p30 35.57 69.92 0.16 Allowed 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 112.697 -2.047 . . . . 0.0 115.935 -174.842 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 86.77 -36.62 3.24 Favored Glycine 0 CA--C 1.545 1.959 0 CA-C-N 112.594 -2.094 . . . . 0.0 114.784 -178.67 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.6 mmtt -78.89 102.3 8.16 Favored 'General case' 0 N--CA 1.484 1.25 0 N-CA-C 113.528 0.936 . . . . 0.0 113.528 -173.682 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.9 p -84.85 115.29 22.67 Favored 'General case' 0 N--CA 1.484 1.272 0 CA-C-N 113.39 -1.732 . . . . 0.0 114.16 178.782 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -109.83 138.61 45.95 Favored 'General case' 0 C--N 1.325 -0.465 0 CA-C-N 114.308 -1.314 . . . . 0.0 112.171 178.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 29.1 t -90.22 102.14 14.86 Favored 'General case' 0 N--CA 1.478 0.931 0 CA-C-N 114.34 -1.3 . . . . 0.0 110.788 176.733 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.415 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -51.13 -40.2 57.96 Favored 'General case' 0 N--CA 1.476 0.871 0 N-CA-C 115.495 1.665 . . . . 0.0 115.495 -176.675 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 75.9 mttt -63.54 -12.27 31.13 Favored 'General case' 0 N--CA 1.488 1.449 0 N-CA-C 116.472 2.027 . . . . 0.0 116.472 178.939 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.533 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 22.7 t -109.13 121.19 44.61 Favored 'General case' 0 N--CA 1.476 0.87 0 N-CA-C 109.076 -0.712 . . . . 0.0 109.076 173.704 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 34.3 tp -53.47 -46.0 69.77 Favored 'General case' 0 N--CA 1.484 1.229 0 O-C-N 125.042 1.463 . . . . 0.0 112.285 176.484 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 48.0 t80 -57.63 -53.55 56.92 Favored 'General case' 0 CA--C 1.546 0.797 0 CA-C-N 115.315 -0.857 . . . . 0.0 111.809 172.228 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.533 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 96.6 mttt -67.28 -31.37 71.64 Favored 'General case' 0 N--CA 1.483 1.207 0 N-CA-C 115.348 1.61 . . . . 0.0 115.348 -176.292 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 21.1 tp -67.55 -55.38 13.66 Favored 'General case' 0 CA--C 1.548 0.875 0 C-N-CA 123.126 0.57 . . . . 0.0 111.732 168.689 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 39.3 mt-30 -63.15 -30.32 71.49 Favored 'General case' 0 N--CA 1.484 1.272 0 N-CA-C 116.357 1.984 . . . . 0.0 116.357 -178.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.42 HG22 ' HA ' ' A' ' 49' ' ' LYS . 14.7 t -63.52 -16.58 61.15 Favored 'General case' 0 N--CA 1.489 1.514 0 N-CA-C 114.093 1.145 . . . . 0.0 114.093 173.028 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 14.8 tp -96.52 129.21 43.93 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 170.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.51 88.1 0.43 Allowed Glycine 0 N--CA 1.478 1.436 0 CA-C-N 114.551 -1.204 . . . . 0.0 113.297 -176.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 74.6 mt -98.24 90.73 4.94 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-O 121.188 0.518 . . . . 0.0 111.196 178.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.9 t -136.1 -145.99 0.23 Allowed 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.307 -1.315 . . . . 0.0 110.772 -178.759 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -88.35 115.12 25.63 Favored 'General case' 0 N--CA 1.476 0.868 0 N-CA-C 114.651 1.352 . . . . 0.0 114.651 175.4 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 103.18 40.67 2.39 Favored Glycine 0 N--CA 1.484 1.842 0 CA-C-N 112.614 -2.085 . . . . 0.0 113.617 177.08 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 5.6 m -115.58 104.95 12.23 Favored 'General case' 0 N--CA 1.484 1.237 0 N-CA-C 109.498 -0.556 . . . . 0.0 109.498 -175.726 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.45 HG22 ' HG2' ' A' ' 5' ' ' GLU . 4.8 p -85.46 105.12 13.98 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.035 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 172.771 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.6 p -122.46 123.89 69.6 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.906 0 CA-C-N 111.582 -2.553 . . . . 0.0 113.077 -171.21 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -85.67 115.28 23.25 Favored 'General case' 0 N--CA 1.468 0.437 0 CA-C-N 113.396 -1.729 . . . . 0.0 110.009 176.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 20.6 mm -98.39 103.93 15.32 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.003 0 N-CA-C 106.601 -1.629 . . . . 0.0 106.601 176.408 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.3 t -116.31 130.56 56.84 Favored 'General case' 0 N--CA 1.482 1.134 0 CA-C-N 114.28 -1.327 . . . . 0.0 113.097 -175.151 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . 0.437 ' HB2' HD13 ' A' ' 33' ' ' ILE . . . -119.24 141.15 49.18 Favored 'General case' 0 N--CA 1.483 1.221 0 N-CA-C 114.885 1.439 . . . . 0.0 114.885 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -128.87 130.01 46.31 Favored 'General case' 0 N--CA 1.472 0.628 0 CA-C-N 113.181 -1.827 . . . . 0.0 113.218 169.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 128.27 -154.09 19.78 Favored Glycine 0 CA--C 1.541 1.691 0 CA-C-N 113.105 -1.861 . . . . 0.0 112.235 174.498 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 21.0 mt-10 -45.13 -71.25 0.08 Allowed 'General case' 0 N--CA 1.489 1.489 0 C-N-CA 126.253 1.821 . . . . 0.0 115.348 -177.198 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 24.2 m-20 -93.68 46.95 1.21 Allowed 'General case' 0 N--CA 1.479 0.994 0 C-N-CA 123.82 0.848 . . . . 0.0 112.414 -173.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -48.98 -60.6 2.63 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 116.481 2.03 . . . . 0.0 116.481 -172.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 35.3 mt-30 -62.55 -43.82 97.87 Favored 'General case' 0 N--CA 1.481 1.12 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 178.286 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 72.1 tttt -63.61 -52.46 60.78 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.126 0.97 . . . . 0.0 112.868 -178.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . 0.531 ' HB1' HD11 ' A' ' 33' ' ' ILE . . . -54.43 -40.5 68.39 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.288 0.847 . . . . 0.0 113.288 -179.221 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 59.2 t -66.43 -62.23 1.34 Allowed 'Isoleucine or valine' 0 N--CA 1.485 1.287 0 CA-C-N 115.508 -0.769 . . . . 0.0 110.067 172.552 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 31.8 tt0 -47.99 -53.07 17.34 Favored 'General case' 0 CA--C 1.552 1.048 0 C-N-CA 126.106 1.763 . . . . 0.0 113.297 -177.529 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 15.7 t60 -66.68 -41.16 88.56 Favored 'General case' 0 N--CA 1.483 1.19 0 N-CA-C 113.648 0.981 . . . . 0.0 113.648 -178.857 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 36.1 mt -68.28 -36.17 78.98 Favored 'General case' 0 N--CA 1.48 1.044 0 N-CA-C 114.178 1.177 . . . . 0.0 114.178 172.665 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 49.8 t -63.39 -45.23 98.6 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.285 0 C-N-CA 123.911 0.884 . . . . 0.0 110.204 172.026 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 37.1 tttm -52.34 -53.62 42.26 Favored 'General case' 0 CA--C 1.548 0.874 0 C-N-CA 125.553 1.541 . . . . 0.0 111.018 173.12 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.5 tt -53.33 -55.84 21.52 Favored 'General case' 0 N--CA 1.482 1.137 0 C-N-CA 124.204 1.002 . . . . 0.0 111.866 173.805 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 6.3 ttt -56.3 -48.64 76.25 Favored 'General case' 0 N--CA 1.484 1.234 0 C-N-CA 125.013 1.325 . . . . 0.0 113.767 -177.659 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.53 -29.12 68.43 Favored 'General case' 0 N--CA 1.476 0.839 0 N-CA-C 114.993 1.479 . . . . 0.0 114.993 -177.957 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.3 mt-10 -99.18 14.65 28.68 Favored 'General case' 0 CA--C 1.555 1.137 0 N-CA-C 114.807 1.41 . . . . 0.0 114.807 -178.387 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 17.7 mt -80.85 144.25 32.16 Favored 'General case' 0 N--CA 1.486 1.338 0 N-CA-C 115.756 1.761 . . . . 0.0 115.756 -178.212 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 16.4 tt0 . . . . . 0 C--O 1.248 0.997 0 C-N-CA 127.378 2.271 . . . . 0.0 105.045 179.587 . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.4 mtt . . . . . 0 N--CA 1.476 0.839 0 N-CA-C 106.317 -1.734 . . . . 0.0 106.317 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 33.2 t80 -124.48 142.5 51.28 Favored 'General case' 0 N--CA 1.47 0.568 0 O-C-N 124.623 1.202 . . . . 0.0 111.236 -179.361 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 19.8 pt20 -139.46 142.92 37.35 Favored 'General case' 0 CA--C 1.545 0.757 0 CA-C-N 113.666 -1.606 . . . . 0.0 114.527 -174.27 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 29.9 mt-30 -131.23 124.16 29.99 Favored 'General case' 0 N--CA 1.477 0.918 0 O-C-N 125.621 1.826 . . . . 0.0 110.888 168.277 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 24.6 tt0 -98.05 128.21 44.44 Favored 'General case' 0 N--CA 1.472 0.643 0 CA-C-N 113.537 -1.665 . . . . 0.0 111.155 179.529 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 5.9 m -128.29 138.97 53.18 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.027 0 CA-C-N 113.682 -1.599 . . . . 0.0 113.128 -178.625 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.8 m -88.29 103.2 15.58 Favored 'General case' 0 N--CA 1.477 0.9 0 CA-C-N 113.508 -1.678 . . . . 0.0 108.523 174.221 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 47.4 mm -84.73 102.73 11.1 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.829 0 CA-C-N 114.234 -1.348 . . . . 0.0 108.03 176.904 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 4.3 p -116.02 13.64 15.92 Favored 'General case' 0 CA--C 1.544 0.747 0 CA-C-N 112.259 -2.246 . . . . 0.0 116.063 178.534 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -72.74 134.12 81.84 Favored Pre-proline 0 N--CA 1.484 1.233 0 N-CA-C 108.697 -0.853 . . . . 0.0 108.697 168.721 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 83.0 Cg_exo -42.57 -53.54 3.73 Favored 'Trans proline' 0 C--N 1.354 0.851 0 C-N-CA 125.135 3.89 . . . . 0.0 115.293 -169.098 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 11.2 m120 -95.27 -39.36 10.1 Favored 'General case' 0 N--CA 1.482 1.156 0 N-CA-C 113.554 0.946 . . . . 0.0 113.554 172.629 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 77.02 -88.17 0.98 Allowed Glycine 0 N--CA 1.483 1.781 0 O-C-N 124.495 1.122 . . . . 0.0 112.385 171.664 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.456 ' HA ' ' HB2' ' A' ' 18' ' ' PRO . 6.8 mp -112.43 73.46 0.82 Allowed 'General case' 0 CA--C 1.546 0.805 0 CA-C-O 122.867 1.318 . . . . 0.0 113.343 177.917 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.5 p80 -81.38 -165.04 0.86 Allowed 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 113.091 -1.868 . . . . 0.0 109.928 169.075 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 28.8 p -53.31 -46.09 69.26 Favored 'General case' 0 N--CA 1.48 1.05 0 N-CA-C 114.706 1.373 . . . . 0.0 114.706 -171.041 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.25 32.8 ttt180 -70.25 -54.8 8.74 Favored Pre-proline 0 CA--C 1.555 1.156 0 CA-C-O 116.689 -1.624 . . . . 0.0 114.274 178.839 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.456 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 98.0 Cg_exo -56.58 -38.22 95.94 Favored 'Trans proline' 0 N--CA 1.485 0.987 0 C-N-CA 122.343 2.029 . . . . 0.0 112.881 173.685 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.66 -56.05 25.89 Favored 'General case' 0 N--CA 1.472 0.662 0 N-CA-C 113.306 0.854 . . . . 0.0 113.306 172.78 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.65 -40.8 66.16 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.982 1.105 . . . . 0.0 113.982 175.308 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.497 ' HB3' HD11 ' A' ' 80' ' ' LEU . 33.7 mt-30 -55.55 -58.47 7.64 Favored 'General case' 0 CA--C 1.545 0.774 0 C-N-CA 124.516 1.127 . . . . 0.0 112.477 170.859 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -54.39 -49.4 69.98 Favored 'General case' 0 N--CA 1.481 1.116 0 O-C-N 124.73 1.269 . . . . 0.0 111.853 179.644 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 84.7 t -57.8 -53.39 45.63 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.265 0 C-N-CA 125.084 1.353 . . . . 0.0 111.789 177.431 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 55.3 tttm -58.92 -48.84 80.05 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 124.033 0.833 . . . . 0.0 112.131 -177.994 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.61 -40.97 80.18 Favored 'General case' 0 N--CA 1.477 0.908 0 O-C-N 124.677 1.236 . . . . 0.0 112.696 -178.675 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . 0.526 ' O ' ' HE2' ' A' ' 45' ' ' LYS . . . -58.34 -39.61 79.93 Favored 'General case' 0 N--CA 1.473 0.685 0 N-CA-C 112.839 0.681 . . . . 0.0 112.839 170.41 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.532 ' HE3' ' O ' ' A' ' 45' ' ' LYS . 71.4 mttt -64.87 -32.01 73.51 Favored 'General case' 0 N--CA 1.479 1.002 0 N-CA-C 115.774 1.768 . . . . 0.0 115.774 175.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.46 -41.04 99.8 Favored Glycine 0 N--CA 1.487 2.092 0 O-C-N 124.587 1.179 . . . . 0.0 112.034 169.064 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 33.7 m-85 -70.7 120.63 16.59 Favored 'General case' 0 N--CA 1.473 0.678 0 CA-C-O 121.705 0.764 . . . . 0.0 112.799 174.543 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 26.8 p -62.26 -38.05 87.79 Favored 'General case' 0 N--CA 1.479 0.992 0 CA-C-N 114.359 -1.292 . . . . 0.0 112.216 174.741 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 59.1 m -61.35 153.58 26.37 Favored 'General case' 0 N--CA 1.49 1.553 0 C-N-CA 126.634 1.973 . . . . 0.0 111.352 175.168 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 7.4 tp10 -96.52 137.08 36.13 Favored 'General case' 0 N--CA 1.484 1.264 0 CA-C-O 122.086 0.946 . . . . 0.0 111.885 -175.352 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.451 HG21 HD13 ' A' ' 77' ' ' LEU . 13.7 mm -118.29 106.32 19.48 Favored 'Isoleucine or valine' 0 CA--C 1.551 1.0 0 CA-C-N 113.524 -1.671 . . . . 0.0 109.179 -166.224 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 85.2 m -99.25 134.48 42.05 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 113.175 -1.83 . . . . 0.0 110.436 179.532 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.401 ' HB ' ' HB3' ' A' ' 42' ' ' ALA . 47.3 t -119.66 110.57 29.74 Favored 'Isoleucine or valine' 0 CA--C 1.543 0.678 0 CA-C-N 113.582 -1.644 . . . . 0.0 107.338 177.879 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 44.7 m -115.53 119.87 37.61 Favored 'General case' 0 N--CA 1.486 1.37 0 N-CA-C 113.762 1.023 . . . . 0.0 113.762 -178.718 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 48.3 t -111.92 99.8 8.39 Favored 'General case' 0 N--CA 1.479 1.015 0 CA-C-N 114.103 -1.408 . . . . 0.0 109.428 171.923 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 9.4 p30 36.38 85.44 0.01 OUTLIER 'General case' 0 N--CA 1.487 1.417 0 N-CA-C 116.673 2.101 . . . . 0.0 116.673 -178.979 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.94 -41.41 2.19 Favored Glycine 0 N--CA 1.484 1.887 0 CA-C-N 114.265 -1.334 . . . . 0.0 115.097 177.174 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 14.0 mptt -93.09 123.08 36.1 Favored 'General case' 0 N--CA 1.47 0.569 0 CA-C-O 121.758 0.79 . . . . 0.0 111.619 177.419 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 79.0 p -113.08 153.44 28.16 Favored 'General case' 0 N--CA 1.48 1.041 0 N-CA-C 116.069 1.877 . . . . 0.0 116.069 -173.973 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.49 ' HB1' ' HA ' ' A' ' 50' ' ' LEU . . . -114.99 152.93 31.56 Favored 'General case' 0 CA--C 1.547 0.832 0 CA-C-N 111.987 -2.37 . . . . 0.0 112.55 -176.408 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . 0.487 ' HB3' ' HB3' ' A' ' 49' ' ' LYS . 26.5 t -105.86 105.85 16.08 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-N 112.606 -2.088 . . . . 0.0 108.054 175.801 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.58 -32.87 72.99 Favored 'General case' 0 N--CA 1.489 1.516 0 O-C-N 125.245 1.59 . . . . 0.0 115.139 -170.414 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.532 ' O ' ' HE3' ' A' ' 27' ' ' LYS . 91.3 mttt -71.32 19.09 0.06 Allowed 'General case' 0 CA--C 1.55 0.949 0 N-CA-C 115.325 1.602 . . . . 0.0 115.325 176.054 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 29.1 t -145.16 126.15 14.53 Favored 'General case' 0 N--CA 1.482 1.143 0 C-N-CA 123.958 0.903 . . . . 0.0 111.077 176.614 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 16.1 mt -53.99 -53.18 56.53 Favored 'General case' 0 N--CA 1.474 0.757 0 O-C-N 124.238 0.961 . . . . 0.0 113.041 173.781 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 30.7 t80 -54.42 -60.27 3.56 Favored 'General case' 0 N--CA 1.478 0.965 0 C-N-CA 123.625 0.77 . . . . 0.0 112.061 172.011 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 43' ' ' SER . 7.0 mttm -68.34 -17.88 64.36 Favored 'General case' 0 N--CA 1.48 1.06 0 N-CA-C 116.21 1.93 . . . . 0.0 116.21 -173.11 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.49 ' HA ' ' HB1' ' A' ' 42' ' ' ALA . 27.8 tp -81.3 -65.8 0.97 Allowed 'General case' 0 N--CA 1.479 0.984 0 O-C-N 124.396 1.06 . . . . 0.0 111.667 164.888 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 41.1 mt-30 -63.45 -19.45 64.73 Favored 'General case' 0 N--CA 1.482 1.145 0 N-CA-C 117.167 2.284 . . . . 0.0 117.167 -171.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . 0.458 HG23 HD12 ' A' ' 53' ' ' LEU . 9.2 t -51.25 -29.27 13.96 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 113.245 0.831 . . . . 0.0 113.245 168.48 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.462 HD13 ' HB2' ' A' ' 42' ' ' ALA . 9.4 mp -84.71 139.34 32.07 Favored 'General case' 0 N--CA 1.469 0.491 0 C-N-CA 124.784 1.234 . . . . 0.0 110.499 171.378 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -78.48 75.23 1.99 Allowed Glycine 0 CA--C 1.541 1.667 0 CA-C-N 114.284 -1.325 . . . . 0.0 111.419 177.757 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.421 ' HA ' HG21 ' A' ' 59' ' ' THR . 7.3 mt -81.05 79.13 7.78 Favored 'General case' 0 N--CA 1.48 1.031 0 CA-C-O 122.475 1.131 . . . . 0.0 109.459 176.142 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 14.5 t -129.83 -155.37 0.69 Allowed 'General case' 0 N--CA 1.479 1.011 0 CA-C-N 113.272 -1.785 . . . . 0.0 110.942 -165.552 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 22.0 pt20 -77.87 120.5 22.84 Favored 'General case' 0 N--CA 1.475 0.813 0 O-C-N 121.672 -0.643 . . . . 0.0 111.705 172.957 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 88.72 35.52 8.39 Favored Glycine 0 N--CA 1.487 2.073 0 CA-C-N 112.95 -1.932 . . . . 0.0 112.419 -178.376 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.421 HG21 ' HA ' ' A' ' 55' ' ' LEU . 22.9 m -109.53 91.89 3.83 Favored 'General case' 0 N--CA 1.474 0.77 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 178.579 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 11.0 p -74.43 103.49 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.046 0 CA-C-N 115.344 -0.844 . . . . 0.0 109.223 167.641 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.5 p -122.67 137.43 56.2 Favored 'Isoleucine or valine' 0 CA--C 1.552 1.032 0 CA-C-N 111.502 -2.59 . . . . 0.0 112.168 -173.16 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.4 OUTLIER -99.57 128.68 45.68 Favored 'General case' 0 N--CA 1.485 1.313 0 CA-C-N 114.073 -1.422 . . . . 0.0 110.262 179.763 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 16.2 mm -101.6 108.36 23.43 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.964 0 N-CA-C 106.847 -1.538 . . . . 0.0 106.847 174.655 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 67.3 m -113.54 128.39 56.42 Favored 'General case' 0 N--CA 1.482 1.173 0 O-C-N 125.845 1.966 . . . . 0.0 111.809 -176.765 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -117.06 122.68 44.84 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.32 -0.855 . . . . 0.0 111.641 177.044 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -114.85 136.82 52.67 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 113.297 -1.774 . . . . 0.0 112.24 175.233 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 122.05 -131.03 8.26 Favored Glycine 0 CA--C 1.532 1.104 0 CA-C-N 114.161 -1.382 . . . . 0.0 111.546 175.859 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -71.4 -66.77 0.58 Allowed 'General case' 0 CA--C 1.548 0.9 0 C-N-CA 125.064 1.346 . . . . 0.0 113.574 -172.047 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . 0.487 ' HB3' ' HB3' ' A' ' 72' ' ' LYS . 73.9 m-20 -92.88 49.69 1.47 Allowed 'General case' 0 N--CA 1.477 0.895 0 C-N-CA 123.975 0.91 . . . . 0.0 111.763 -172.583 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 11.0 pt-20 -54.0 -45.24 71.42 Favored 'General case' 0 N--CA 1.488 1.473 0 N-CA-C 115.101 1.519 . . . . 0.0 115.101 -175.173 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 3.1 tp60 -68.78 -62.03 1.56 Allowed 'General case' 0 N--CA 1.479 0.996 0 C-N-CA 123.698 0.799 . . . . 0.0 111.359 173.742 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.487 ' HB3' ' HB3' ' A' ' 69' ' ' ASP . 62.6 tttm -48.15 -51.69 23.84 Favored 'General case' 0 CA--C 1.55 0.943 0 C-N-CA 126.804 2.042 . . . . 0.0 113.656 -176.452 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.26 -48.23 82.4 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 114.098 1.148 . . . . 0.0 114.098 -179.918 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 3.2 t -62.94 -53.72 42.94 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.842 0 CA-C-O 118.412 -0.804 . . . . 0.0 111.17 178.835 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 38.7 tt0 -48.48 -50.36 31.94 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 124.985 1.314 . . . . 0.0 112.508 176.343 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 7.6 t60 -65.15 -41.43 94.75 Favored 'General case' 0 N--CA 1.486 1.342 0 C-N-CA 125.189 1.395 . . . . 0.0 113.279 -179.101 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.451 HD13 HG21 ' A' ' 33' ' ' ILE . 11.3 mt -80.28 -24.47 40.01 Favored 'General case' 0 CA--C 1.55 0.952 0 N-CA-C 116.229 1.937 . . . . 0.0 116.229 177.684 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 94.7 t -70.91 -41.72 77.14 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.343 0 N-CA-C 109.744 -0.465 . . . . 0.0 109.744 168.188 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 30.8 tttm -52.57 -50.64 62.58 Favored 'General case' 0 CA--C 1.546 0.806 0 C-N-CA 124.64 1.176 . . . . 0.0 110.889 169.577 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.497 HD11 ' HB3' ' A' ' 21' ' ' GLN . 6.0 tt -53.6 -49.97 66.64 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.412 1.085 . . . . 0.0 113.01 171.974 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 18.4 mtt -64.05 -29.55 70.68 Favored 'General case' 0 N--CA 1.487 1.407 0 N-CA-C 117.152 2.279 . . . . 0.0 117.152 176.48 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -71.57 -51.3 24.13 Favored 'General case' 0 N--CA 1.474 0.773 0 N-CA-C 113.015 0.746 . . . . 0.0 113.015 174.001 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 45.2 mt-10 -82.1 60.37 4.86 Favored 'General case' 0 N--CA 1.485 1.281 0 C-N-CA 124.462 1.105 . . . . 0.0 112.371 -174.469 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 92.3 mt -116.96 138.8 51.31 Favored 'General case' 0 N--CA 1.479 1.005 0 C-N-CA 124.272 1.029 . . . . 0.0 113.75 -179.481 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 42.6 mt-10 . . . . . 0 C--O 1.245 0.832 0 C-N-CA 127.009 2.124 . . . . 0.0 106.803 -178.98 . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.672 ' HG3' ' HG2' ' A' ' 66' ' ' GLU . 18.5 ttt . . . . . 0 N--CA 1.472 0.643 0 N-CA-C 106.1 -1.815 . . . . 0.0 106.1 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 13.4 t80 -131.18 142.13 50.16 Favored 'General case' 0 N--CA 1.478 0.925 0 O-C-N 125.829 1.956 . . . . 0.0 111.678 -177.625 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -136.97 151.53 49.11 Favored 'General case' 0 N--CA 1.471 0.592 0 O-C-N 124.77 1.293 . . . . 0.0 113.371 176.333 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 8.5 tp-100 -142.61 128.28 19.22 Favored 'General case' 0 N--CA 1.483 1.187 0 CA-C-N 114.063 -1.426 . . . . 0.0 111.135 167.314 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.552 ' HB3' HG12 ' A' ' 60' ' ' VAL . 50.0 mt-10 -91.06 109.95 21.21 Favored 'General case' 0 N--CA 1.475 0.809 0 CA-C-N 114.417 -1.265 . . . . 0.0 109.006 174.631 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 9.5 p -118.74 115.75 49.01 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 CA-C-N 114.329 -1.305 . . . . 0.0 113.719 -174.176 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.3 m -68.53 114.66 7.13 Favored 'General case' 0 N--CA 1.479 1.004 0 CA-C-N 114.008 -1.451 . . . . 0.0 111.481 177.525 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 85.8 mt -68.73 100.05 0.53 Allowed 'Isoleucine or valine' 0 N--CA 1.486 1.332 0 CA-C-O 122.285 1.041 . . . . 0.0 110.289 174.287 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.1 p -76.84 -22.44 53.54 Favored 'General case' 0 N--CA 1.474 0.761 0 CA-C-N 112.144 -2.298 . . . . 0.0 115.191 172.07 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.418 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -57.84 118.25 24.93 Favored Pre-proline 0 C--O 1.245 0.839 0 C-N-CA 124.518 1.127 . . . . 0.0 110.924 177.986 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.418 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 68.8 Cg_exo -55.59 -53.31 5.86 Favored 'Trans proline' 0 N--CA 1.491 1.336 0 C-N-CA 124.194 3.263 . . . . 0.0 111.872 -172.282 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 27.8 p-10 -62.8 -52.52 62.85 Favored 'General case' 0 N--CA 1.478 0.97 0 C-N-CA 125.764 1.626 . . . . 0.0 112.531 170.82 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 104.91 -156.18 16.97 Favored Glycine 0 CA--C 1.539 1.584 0 C-N-CA 124.57 1.081 . . . . 0.0 111.558 179.905 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.596 ' HG ' ' HB2' ' A' ' 18' ' ' PRO . 0.7 OUTLIER -113.89 84.95 2.12 Favored 'General case' 0 CA--C 1.543 0.684 0 CA-C-O 122.962 1.363 . . . . 0.0 110.086 -173.732 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 16.5 p80 -81.94 -165.8 1.08 Allowed 'General case' 0 N--CA 1.473 0.711 0 CA-C-N 113.996 -1.457 . . . . 0.0 113.991 178.508 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 33.0 p -53.38 -49.28 67.54 Favored 'General case' 0 N--CA 1.482 1.167 0 N-CA-C 116.177 1.917 . . . . 0.0 116.177 -166.888 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.776 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.439 15.8 ptt-85 -65.36 -47.3 70.26 Favored Pre-proline 0 N--CA 1.481 1.105 0 CA-C-O 115.795 -2.05 . . . . 0.0 116.471 178.155 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.776 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 73.8 Cg_exo -65.84 -39.36 20.14 Favored 'Trans proline' 0 CA--C 1.539 0.767 0 C-N-CA 121.832 1.688 . . . . 0.0 113.209 169.824 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.96 -42.22 79.76 Favored 'General case' 0 N--CA 1.484 1.249 0 N-CA-C 113.692 0.997 . . . . 0.0 113.692 172.783 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -61.41 -47.39 86.01 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 113.333 0.864 . . . . 0.0 113.333 172.901 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 32.9 mt-30 -56.68 -45.14 81.9 Favored 'General case' 0 N--CA 1.478 0.937 0 C-N-CA 124.153 0.981 . . . . 0.0 112.558 174.121 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 5.7 t80 -56.99 -47.61 80.41 Favored 'General case' 0 N--CA 1.477 0.875 0 C-N-CA 125.744 1.618 . . . . 0.0 111.897 175.836 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.448 HG13 ' O ' ' A' ' 44' ' ' ALA . 97.0 t -65.33 -43.2 95.04 Favored 'Isoleucine or valine' 0 N--CA 1.492 1.667 0 C-N-CA 123.786 0.835 . . . . 0.0 112.522 175.544 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 10.7 tmtt? -58.37 -41.95 85.93 Favored 'General case' 0 N--CA 1.487 1.405 0 C-N-CA 123.197 0.599 . . . . 0.0 111.34 178.607 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 3.8 tp10 -65.55 -52.96 48.55 Favored 'General case' 0 N--CA 1.481 1.093 0 O-C-N 125.054 1.471 . . . . 0.0 111.868 169.668 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -53.81 -38.49 64.63 Favored 'General case' 0 N--CA 1.488 1.457 0 N-CA-C 115.891 1.811 . . . . 0.0 115.891 -178.799 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 23.3 mtpt -75.76 10.95 1.52 Allowed 'General case' 0 N--CA 1.484 1.273 0 N-CA-C 116.589 2.07 . . . . 0.0 116.589 174.268 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -94.04 -17.57 40.09 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 124.572 1.17 . . . . 0.0 112.389 163.441 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 35.6 m-85 -96.24 125.56 40.84 Favored 'General case' 0 N--CA 1.478 0.948 0 CA-C-O 122.152 0.977 . . . . 0.0 108.973 179.325 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 75.4 p -62.4 -35.73 80.11 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.354 -1.293 . . . . 0.0 111.987 -177.133 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 19.8 m -53.84 150.73 7.19 Favored 'General case' 0 N--CA 1.48 1.075 0 C-N-CA 126.597 1.959 . . . . 0.0 114.973 176.834 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.8 tp10 -80.83 89.77 5.84 Favored 'General case' 0 N--CA 1.469 0.482 0 CA-C-N 115.144 -0.934 . . . . 0.0 110.719 173.675 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.496 HD13 ' HB3' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -73.94 98.3 1.09 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.887 0 CA-C-N 109.822 -3.354 . . . . 0.0 114.288 175.903 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 23.8 m -104.01 128.58 51.59 Favored 'General case' 0 N--CA 1.485 1.324 0 CA-C-N 112.261 -2.245 . . . . 0.0 109.512 -178.96 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 86.5 t -114.52 107.54 23.14 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 114.035 -1.439 . . . . 0.0 108.455 179.623 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.405 ' HB ' ' HB ' ' A' ' 62' ' ' THR . 60.4 m -108.69 104.29 13.55 Favored 'General case' 0 N--CA 1.479 1.012 0 CA-C-N 114.818 -1.083 . . . . 0.0 112.88 -176.908 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 79.6 p -90.37 54.64 2.81 Favored 'General case' 0 CA--C 1.547 0.846 0 CA-C-N 113.797 -1.547 . . . . 0.0 113.548 -177.252 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.6 m120 48.89 94.04 0.01 OUTLIER 'General case' 0 N--CA 1.483 1.207 0 CA-C-O 123.672 1.701 . . . . 0.0 114.758 -174.854 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 96.91 -32.62 6.43 Favored Glycine 0 N--CA 1.479 1.534 0 CA-C-N 112.481 -2.145 . . . . 0.0 114.055 -178.998 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -111.58 132.93 54.2 Favored 'General case' 0 N--CA 1.478 0.963 0 C-N-CA 123.373 0.669 . . . . 0.0 109.287 -177.301 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 69.8 m -123.13 134.84 54.18 Favored 'General case' 0 N--CA 1.481 1.123 0 CA-C-O 122.183 0.992 . . . . 0.0 111.808 178.589 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.497 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -134.74 125.69 27.48 Favored 'General case' 0 N--CA 1.472 0.637 0 CA-C-N 113.692 -1.595 . . . . 0.0 111.992 174.149 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 26.0 t -68.58 122.26 18.11 Favored 'General case' 0 N--CA 1.481 1.114 0 CA-C-N 113.898 -1.501 . . . . 0.0 111.725 171.366 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.496 ' HB3' HD13 ' A' ' 33' ' ' ILE . . . -74.76 13.2 0.67 Allowed 'General case' 0 N--CA 1.482 1.163 0 CA-C-N 114.344 -1.298 . . . . 0.0 114.126 176.832 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 19.6 mmtt -77.57 -7.72 56.75 Favored 'General case' 0 N--CA 1.478 0.926 0 N-CA-C 113.527 0.936 . . . . 0.0 113.527 169.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.4 t -133.46 133.66 42.57 Favored 'General case' 0 N--CA 1.474 0.772 0 C-N-CA 124.377 1.071 . . . . 0.0 112.381 174.076 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 3.6 tp -57.44 -53.25 60.3 Favored 'General case' 0 N--CA 1.48 1.029 0 C-N-CA 125.116 1.366 . . . . 0.0 111.131 177.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 63.0 t80 -56.55 -34.41 67.04 Favored 'General case' 0 N--CA 1.478 0.972 0 CA-C-N 114.107 -1.406 . . . . 0.0 114.559 176.118 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 42.6 mmtt -58.57 -53.32 59.71 Favored 'General case' 0 N--CA 1.484 1.254 0 N-CA-C 112.615 0.598 . . . . 0.0 112.615 175.745 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 4.7 mp -75.04 -32.88 61.66 Favored 'General case' 0 N--CA 1.468 0.443 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 176.941 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.8 mt-30 -68.94 -14.88 63.3 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 114.494 1.294 . . . . 0.0 114.494 173.213 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 36.3 p -106.13 18.59 21.81 Favored 'General case' 0 N--CA 1.484 1.241 0 N-CA-C 113.768 1.025 . . . . 0.0 113.768 167.407 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.497 HD22 ' HB3' ' A' ' 42' ' ' ALA . 14.2 tp -114.81 120.89 41.55 Favored 'General case' 0 N--CA 1.473 0.723 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 176.366 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -75.53 70.51 1.93 Allowed Glycine 0 N--CA 1.482 1.755 0 CA-C-N 114.008 -1.451 . . . . 0.0 114.393 -175.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 22.7 mt -75.9 94.55 3.38 Favored 'General case' 0 N--CA 1.473 0.706 0 CA-C-N 114.499 -0.85 . . . . 0.0 110.898 176.327 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -142.33 -174.65 4.18 Favored 'General case' 0 N--CA 1.479 1.019 0 N-CA-C 113.182 0.808 . . . . 0.0 113.182 -179.626 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 10.1 tp-100 -43.05 136.07 2.93 Favored 'General case' 0 N--CA 1.478 0.935 0 C-N-CA 127.884 2.474 . . . . 0.0 113.83 -176.693 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 85.05 -32.16 3.57 Favored Glycine 0 N--CA 1.476 1.346 0 CA-C-N 113.481 -1.69 . . . . 0.0 115.71 175.555 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 73.2 p -59.37 120.2 8.86 Favored 'General case' 0 N--CA 1.483 1.198 0 N-CA-C 113.179 0.807 . . . . 0.0 113.179 -177.981 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.552 HG12 ' HB3' ' A' ' 5' ' ' GLU . 4.9 t -90.34 77.4 1.37 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.052 0 N-CA-C 105.162 -2.162 . . . . 0.0 105.162 178.599 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 9.4 p -75.87 113.37 14.7 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.708 0 CA-C-N 112.518 -2.128 . . . . 0.0 112.692 -169.59 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.405 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 0.7 OUTLIER -71.51 94.77 1.31 Allowed 'General case' 0 N--CA 1.473 0.679 0 CA-C-N 113.993 -1.458 . . . . 0.0 110.716 176.381 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 2.1 mp -81.48 103.97 9.35 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.912 0 N-CA-C 106.905 -1.517 . . . . 0.0 106.905 167.224 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 22.8 t -115.67 133.7 55.77 Favored 'General case' 0 N--CA 1.475 0.818 0 CA-C-N 112.342 -2.208 . . . . 0.0 110.922 -176.558 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -128.65 120.06 25.85 Favored 'General case' 0 N--CA 1.473 0.707 0 O-C-N 124.27 0.981 . . . . 0.0 112.721 -179.781 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.672 ' HG2' ' HG3' ' A' ' 1' ' ' MET . 38.6 mt-10 -115.25 118.05 32.2 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-N 113.336 -1.756 . . . . 0.0 111.697 -178.568 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 139.25 -151.63 21.94 Favored Glycine 0 N--CA 1.482 1.755 0 CA-C-N 115.536 -0.756 . . . . 0.0 111.314 -178.932 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 1.6 mp0 -68.52 -67.91 0.43 Allowed 'General case' 0 N--CA 1.479 1.014 0 N-CA-C 115.565 1.691 . . . . 0.0 115.565 -176.699 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 2.5 p30 -80.95 40.51 0.54 Allowed 'General case' 0 CA--C 1.557 1.224 0 N-CA-C 115.062 1.504 . . . . 0.0 115.062 -178.92 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.569 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 7.5 pt-20 -46.7 -62.82 1.21 Allowed 'General case' 0 N--CA 1.481 1.101 0 C-N-CA 126.462 1.905 . . . . 0.0 115.569 -176.936 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.569 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 97.0 mt-30 -64.83 -40.63 95.49 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 124.676 1.19 . . . . 0.0 113.309 -178.984 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 23.8 ttmm -59.71 -48.5 81.41 Favored 'General case' 0 CA--C 1.547 0.863 0 C-N-CA 124.177 0.991 . . . . 0.0 111.158 179.417 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -56.68 -51.68 67.84 Favored 'General case' 0 N--CA 1.477 0.89 0 O-C-N 124.212 0.945 . . . . 0.0 112.918 175.734 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 88.0 t -61.9 -53.86 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 C-N-CA 123.289 0.636 . . . . 0.0 111.302 178.431 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 26.8 tt0 -50.92 -50.8 56.81 Favored 'General case' 0 N--CA 1.487 1.376 0 C-N-CA 125.01 1.324 . . . . 0.0 111.507 -178.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.3 t60 -60.95 -61.05 2.86 Favored 'General case' 0 N--CA 1.476 0.845 0 C-N-CA 124.972 1.309 . . . . 0.0 111.61 177.933 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.8 mt -61.63 -36.66 81.38 Favored 'General case' 0 N--CA 1.478 0.942 0 N-CA-C 115.044 1.498 . . . . 0.0 115.044 -175.733 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 54.4 t -65.06 -47.72 86.78 Favored 'Isoleucine or valine' 0 N--CA 1.487 1.383 0 C-N-CA 123.342 0.657 . . . . 0.0 111.67 176.4 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 63.7 mttm -59.2 -50.08 75.41 Favored 'General case' 0 N--CA 1.481 1.117 0 O-C-N 123.709 0.631 . . . . 0.0 111.655 175.701 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 21.0 tp -52.27 -51.61 57.47 Favored 'General case' 0 CA--C 1.543 0.703 0 C-N-CA 125.428 1.491 . . . . 0.0 112.426 175.578 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 51.4 tpp -52.2 -52.41 52.34 Favored 'General case' 0 N--CA 1.481 1.079 0 C-N-CA 125.634 1.574 . . . . 0.0 113.002 173.968 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -69.16 -28.33 66.33 Favored 'General case' 0 N--CA 1.479 0.984 0 N-CA-C 114.74 1.385 . . . . 0.0 114.74 -177.915 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 51.0 mt-10 -88.96 -20.13 24.86 Favored 'General case' 0 CA--C 1.554 1.11 0 N-CA-C 116.425 2.009 . . . . 0.0 116.425 178.645 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 70.6 mt -87.21 125.25 34.07 Favored 'General case' 0 N--CA 1.48 1.038 0 N-CA-C 113.943 1.09 . . . . 0.0 113.943 176.512 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 8.4 tt0 . . . . . 0 C--O 1.254 1.322 0 CA-C-N 113.13 -1.85 . . . . 0.0 106.25 179.352 . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.494 ' HG2' ' HG2' ' A' ' 66' ' ' GLU . 4.2 tmm? . . . . . 0 N--CA 1.469 0.511 0 N-CA-C 106.459 -1.682 . . . . 0.0 106.459 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 32.0 t80 -141.07 140.05 34.15 Favored 'General case' 0 N--CA 1.478 0.935 0 O-C-N 124.539 1.149 . . . . 0.0 111.652 173.724 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 18.4 pt20 -132.27 155.82 47.64 Favored 'General case' 0 N--CA 1.477 0.906 0 O-C-N 124.722 1.264 . . . . 0.0 113.775 176.405 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . 0.643 ' HB3' HG21 ' A' ' 78' ' ' VAL . 7.3 tp-100 -141.65 125.46 17.02 Favored 'General case' 0 N--CA 1.479 1.016 0 O-C-N 124.563 1.165 . . . . 0.0 113.811 165.489 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.3 mt-10 -81.43 106.19 13.19 Favored 'General case' 0 N--CA 1.471 0.576 0 CA-C-N 114.014 -1.448 . . . . 0.0 108.871 174.258 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 12.7 p -124.33 140.12 48.61 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.716 0 CA-C-N 114.732 -1.122 . . . . 0.0 111.913 -177.416 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 7.9 p -99.94 129.01 45.97 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 115.173 -0.921 . . . . 0.0 112.129 178.072 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.4 mt -65.86 122.38 16.72 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-N 112.196 -2.275 . . . . 0.0 110.429 -179.781 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 1.6 p -77.96 -35.17 50.57 Favored 'General case' 0 N--CA 1.471 0.608 0 O-C-N 125.655 1.847 . . . . 0.0 114.472 176.94 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.79 123.4 81.47 Favored Pre-proline 0 N--CA 1.473 0.724 0 C-N-CA 124.472 1.109 . . . . 0.0 113.208 -174.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_exo -52.86 -50.47 13.97 Favored 'Trans proline' 0 CA--C 1.544 0.978 0 C-N-CA 123.86 3.04 . . . . 0.0 112.022 174.169 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.8 p30 -62.29 -39.23 92.29 Favored 'General case' 0 N--CA 1.481 1.109 0 N-CA-C 114.729 1.381 . . . . 0.0 114.729 169.151 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 95.97 -136.04 12.64 Favored Glycine 0 N--CA 1.481 1.672 0 C-N-CA 124.342 0.973 . . . . 0.0 111.9 179.854 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.404 ' HG ' ' HB2' ' A' ' 18' ' ' PRO . 2.5 mp -115.53 75.14 0.92 Allowed 'General case' 0 N--CA 1.474 0.74 0 CA-C-O 122.16 0.981 . . . . 0.0 112.521 174.511 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 14.5 p80 -75.55 -153.29 0.04 OUTLIER 'General case' 0 N--CA 1.487 1.41 0 CA-C-N 113.388 -1.733 . . . . 0.0 111.773 174.793 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 48.1 p -57.75 -61.1 2.76 Favored 'General case' 0 N--CA 1.472 0.673 0 N-CA-C 114.257 1.206 . . . . 0.0 114.257 -167.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.357 20.7 ptt-85 -68.9 -38.38 11.3 Favored Pre-proline 0 N--CA 1.48 1.062 0 N-CA-C 119.017 2.969 . . . . 0.0 119.017 179.99 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.404 ' HB2' ' HG ' ' A' ' 14' ' ' LEU . 59.5 Cg_endo -75.75 -37.08 1.81 Allowed 'Trans proline' 0 CA--C 1.539 0.741 0 CA-C-N 122.816 2.041 . . . . 0.0 113.747 173.225 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -62.61 -43.41 98.87 Favored 'General case' 0 N--CA 1.481 1.1 0 N-CA-C 112.602 0.593 . . . . 0.0 112.602 169.61 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.81 -44.04 73.48 Favored 'General case' 0 N--CA 1.478 0.936 0 N-CA-C 113.391 0.886 . . . . 0.0 113.391 172.688 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 37.9 tt0 -63.18 -47.14 83.86 Favored 'General case' 0 N--CA 1.473 0.68 0 O-C-N 123.569 0.543 . . . . 0.0 112.442 174.256 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.482 ' CE2' ' HG3' ' A' ' 81' ' ' MET . 38.3 t80 -60.74 -47.74 84.93 Favored 'General case' 0 N--CA 1.485 1.305 0 N-CA-C 112.648 0.61 . . . . 0.0 112.648 177.894 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 86.7 t -51.83 -48.95 38.23 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.291 0 C-N-CA 124.405 1.082 . . . . 0.0 111.765 175.626 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 12.9 tmtt? -54.48 -49.16 70.78 Favored 'General case' 0 N--CA 1.48 1.067 0 O-C-N 123.831 0.707 . . . . 0.0 111.414 179.328 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 5.3 tp10 -66.07 -49.59 67.08 Favored 'General case' 0 N--CA 1.477 0.876 0 O-C-N 124.591 1.182 . . . . 0.0 110.959 -178.665 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.35 -42.05 77.13 Favored 'General case' 0 N--CA 1.489 1.52 0 N-CA-C 114.668 1.359 . . . . 0.0 114.668 175.003 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 42.3 tptt -58.44 -31.7 68.0 Favored 'General case' 0 N--CA 1.481 1.11 0 C-N-CA 123.822 0.849 . . . . 0.0 112.615 176.365 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -82.74 5.55 74.27 Favored Glycine 0 CA--C 1.544 1.901 0 O-C-N 124.919 1.387 . . . . 0.0 115.369 -176.873 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 72.0 m-85 -104.83 141.78 35.9 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 117.517 0.658 . . . . 0.0 110.212 169.318 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -56.57 -45.19 81.43 Favored 'General case' 0 N--CA 1.49 1.537 0 CA-C-O 119.002 -0.523 . . . . 0.0 111.588 176.596 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 38.5 m -52.88 136.61 34.0 Favored 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 126.129 1.772 . . . . 0.0 113.512 179.205 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -73.78 112.77 10.21 Favored 'General case' 0 N--CA 1.476 0.853 0 N-CA-C 108.129 -1.063 . . . . 0.0 108.129 167.553 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 33.9 mt -104.02 120.37 54.14 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.671 0 CA-C-N 112.838 -1.983 . . . . 0.0 108.88 -174.804 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 27.7 m -123.32 133.37 54.15 Favored 'General case' 0 N--CA 1.472 0.65 0 CA-C-N 112.235 -2.257 . . . . 0.0 110.713 -176.672 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.425 HG13 ' CG2' ' A' ' 61' ' ' VAL . 21.9 t -118.11 108.15 23.69 Favored 'Isoleucine or valine' 0 CA--C 1.542 0.661 0 CA-C-N 110.929 -2.85 . . . . 0.0 107.15 -169.206 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 78.7 m -112.54 103.23 11.29 Favored 'General case' 0 N--CA 1.48 1.043 0 CA-C-N 112.876 -1.966 . . . . 0.0 113.035 -175.23 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 69.2 p -90.6 89.47 7.55 Favored 'General case' 0 N--CA 1.475 0.785 0 CA-C-N 112.991 -1.913 . . . . 0.0 111.53 -179.992 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 25.6 m120 50.93 63.26 2.31 Favored 'General case' 0 CA--C 1.546 0.794 0 CA-C-O 123.406 1.574 . . . . 0.0 114.047 -178.7 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 85.69 -25.66 6.43 Favored Glycine 0 CA--C 1.548 2.13 0 CA-C-N 113.724 -1.58 . . . . 0.0 115.698 -176.551 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 12.9 mptt -84.5 121.02 27.0 Favored 'General case' 0 N--CA 1.484 1.248 0 N-CA-C 112.957 0.725 . . . . 0.0 112.957 177.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 50.6 m -111.19 139.32 46.67 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 114.584 1.327 . . . . 0.0 114.584 -172.35 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -146.99 145.31 29.69 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.27 -1.332 . . . . 0.0 111.634 166.844 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 42.0 t -71.26 119.43 15.39 Favored 'General case' 0 N--CA 1.477 0.895 0 CA-C-N 114.477 -1.238 . . . . 0.0 112.999 171.535 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.554 ' HA ' HD13 ' A' ' 50' ' ' LEU . . . -58.78 -30.69 67.76 Favored 'General case' 0 N--CA 1.471 0.6 0 CA-C-N 113.083 -1.872 . . . . 0.0 112.908 174.069 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.5 mtpt -74.44 15.06 0.38 Allowed 'General case' 0 CA--C 1.549 0.924 0 N-CA-C 115.414 1.635 . . . . 0.0 115.414 176.813 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 37.4 t -133.36 138.94 46.54 Favored 'General case' 0 N--CA 1.47 0.572 0 C-N-CA 124.166 0.986 . . . . 0.0 111.572 170.909 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 20.8 tp -66.72 -62.36 1.49 Allowed 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 111.713 -2.494 . . . . 0.0 110.188 -178.84 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 53.4 t80 -50.27 -55.62 14.62 Favored 'General case' 0 N--CA 1.472 0.644 0 C-N-CA 125.524 1.529 . . . . 0.0 111.224 176.609 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 44.9 mmtt -58.56 -53.86 53.59 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 -177.255 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.554 HD13 ' HA ' ' A' ' 44' ' ' ALA . 11.4 tp -64.79 -46.97 79.81 Favored 'General case' 0 N--CA 1.475 0.803 0 N-CA-C 113.82 1.044 . . . . 0.0 113.82 -179.111 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 98.5 mt-30 -57.07 -37.79 72.36 Favored 'General case' 0 N--CA 1.483 1.191 0 N-CA-C 114.387 1.255 . . . . 0.0 114.387 174.772 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 45.7 p -86.19 -10.1 55.33 Favored 'General case' 0 N--CA 1.485 1.276 0 N-CA-C 115.265 1.579 . . . . 0.0 115.265 179.266 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 15.6 tp -77.47 120.81 22.98 Favored 'General case' 0 N--CA 1.47 0.556 0 CA-C-O 121.911 0.863 . . . . 0.0 108.869 164.401 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -68.94 89.3 0.24 Allowed Glycine 0 CA--C 1.538 1.508 0 C-N-CA 125.054 1.311 . . . . 0.0 113.558 -176.211 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.59 HD13 ' HE1' ' A' ' 81' ' ' MET . 58.2 mt -106.0 103.88 13.47 Favored 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 114.384 -0.908 . . . . 0.0 110.571 -179.773 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.4 t -130.75 177.22 7.57 Favored 'General case' 0 N--CA 1.478 0.951 0 CA-C-N 114.67 -1.15 . . . . 0.0 113.046 -177.606 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.2 tp-100 -43.18 120.9 1.98 Allowed 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.483 1.913 . . . . 0.0 114.03 177.567 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 78.64 -14.1 14.47 Favored Glycine 0 CA--C 1.543 1.825 0 N-CA-C 117.796 1.878 . . . . 0.0 117.796 177.575 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 8.6 m -58.9 129.17 40.86 Favored 'General case' 0 N--CA 1.476 0.827 0 CA-C-N 119.107 1.454 . . . . 0.0 111.278 -179.145 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 21.2 t -83.22 93.56 3.0 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.067 0 CA-C-N 113.221 -1.809 . . . . 0.0 107.843 -174.725 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.425 ' CG2' HG13 ' A' ' 35' ' ' VAL . 8.7 p -100.1 111.85 30.95 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.726 0 CA-C-N 113.028 -1.896 . . . . 0.0 112.794 -176.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.4 m -81.68 102.27 10.6 Favored 'General case' 0 N--CA 1.472 0.674 0 CA-C-N 113.48 -1.691 . . . . 0.0 109.737 175.758 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 79.2 mt -87.36 103.3 13.22 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.752 0 N-CA-C 107.1 -1.445 . . . . 0.0 107.1 172.127 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 19.2 t -115.58 146.24 41.94 Favored 'General case' 0 N--CA 1.478 0.938 0 CA-C-N 113.427 -1.715 . . . . 0.0 111.813 -179.461 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -131.43 132.79 44.6 Favored 'General case' 0 N--CA 1.472 0.644 0 O-C-N 124.685 1.24 . . . . 0.0 113.734 178.335 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.494 ' HG2' ' HG2' ' A' ' 1' ' ' MET . 46.3 mt-10 -121.3 110.44 16.13 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-N 112.871 -1.968 . . . . 0.0 112.54 177.939 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 165.58 -124.84 1.28 Allowed Glycine 0 CA--C 1.536 1.403 0 CA-C-N 115.135 -0.939 . . . . 0.0 112.85 171.936 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 8.4 mp0 -103.17 -53.38 2.83 Favored 'General case' 0 N--CA 1.48 1.03 0 CA-C-N 113.599 -1.3 . . . . 0.0 113.631 179.423 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 46.3 p30 -88.92 46.74 1.42 Allowed 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 114.456 1.28 . . . . 0.0 114.456 175.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.414 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 8.2 pt-20 -55.38 -63.64 1.1 Allowed 'General case' 0 N--CA 1.483 1.214 0 CA-C-N 113.352 -1.749 . . . . 0.0 115.485 -178.79 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.414 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 35.3 mt-30 -67.78 -43.32 80.03 Favored 'General case' 0 N--CA 1.478 0.975 0 N-CA-C 113.09 0.774 . . . . 0.0 113.09 -175.41 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 48.7 tttm -52.43 -47.7 66.22 Favored 'General case' 0 N--CA 1.48 1.061 0 O-C-N 124.781 1.301 . . . . 0.0 112.157 173.457 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -63.97 -50.63 67.82 Favored 'General case' 0 N--CA 1.481 1.109 0 C-N-CA 123.65 0.78 . . . . 0.0 112.931 177.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 94.3 t -56.46 -52.57 51.14 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.154 0 CA-C-O 118.324 -0.846 . . . . 0.0 110.985 178.964 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 68.9 tt0 -48.97 -54.52 15.24 Favored 'General case' 0 N--CA 1.484 1.266 0 C-N-CA 125.329 1.452 . . . . 0.0 111.518 177.507 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 2.0 t-160 -56.66 -46.39 81.12 Favored 'General case' 0 N--CA 1.48 1.055 0 C-N-CA 125.347 1.459 . . . . 0.0 113.121 -178.914 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 95.3 mt -82.53 -36.03 26.72 Favored 'General case' 0 N--CA 1.481 1.105 0 N-CA-C 115.379 1.622 . . . . 0.0 115.379 -176.271 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.643 HG21 ' HB3' ' A' ' 4' ' ' GLN . 13.3 t -61.39 -41.33 89.44 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.113 0 C-N-CA 123.438 0.695 . . . . 0.0 110.745 172.24 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 12.9 mtpt -63.27 -50.04 71.69 Favored 'General case' 0 N--CA 1.477 0.897 0 N-CA-C 113.822 1.045 . . . . 0.0 113.822 172.869 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 53.6 tp -54.43 -51.9 63.47 Favored 'General case' 0 N--CA 1.477 0.883 0 O-C-N 123.738 0.649 . . . . 0.0 112.667 175.008 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.59 ' HE1' HD13 ' A' ' 55' ' ' LEU . 0.0 OUTLIER -59.82 -36.69 77.31 Favored 'General case' 0 N--CA 1.481 1.098 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 176.648 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -65.4 -38.43 89.93 Favored 'General case' 0 CA--C 1.548 0.885 0 N-CA-C 115.181 1.548 . . . . 0.0 115.181 174.148 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -79.04 -30.74 44.29 Favored 'General case' 0 N--CA 1.48 1.056 0 N-CA-C 116.991 2.219 . . . . 0.0 116.991 179.818 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 38.7 mt -64.61 124.43 21.86 Favored 'General case' 0 N--CA 1.486 1.367 0 C-N-CA 123.504 0.722 . . . . 0.0 112.396 178.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 23.9 tt0 . . . . . 0 C--O 1.261 1.668 0 C-N-CA 125.468 1.507 . . . . 0.0 109.531 176.96 . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 15.1 tmm? . . . . . 0 N--CA 1.467 0.395 0 N-CA-C 107.197 -1.408 . . . . 0.0 107.197 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 37.8 t80 -121.08 133.69 55.24 Favored 'General case' 0 N--CA 1.469 0.503 0 O-C-N 125.335 1.647 . . . . 0.0 107.677 175.13 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 14.8 pt20 -134.9 136.96 42.75 Favored 'General case' 0 N--CA 1.484 1.255 0 CA-C-N 113.803 -1.544 . . . . 0.0 112.667 178.635 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -125.85 116.11 21.04 Favored 'General case' 0 N--CA 1.481 1.112 0 CA-C-N 114.757 -1.11 . . . . 0.0 112.844 175.919 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 36.1 tt0 -81.14 100.39 9.04 Favored 'General case' 0 N--CA 1.473 0.676 0 CA-C-N 112.122 -2.308 . . . . 0.0 108.499 175.099 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 14.5 p -133.6 140.18 47.24 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.776 0 CA-C-N 114.279 -1.328 . . . . 0.0 112.486 -172.807 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.2 p -73.34 152.08 41.02 Favored 'General case' 0 N--CA 1.483 1.211 0 CA-C-O 123.039 1.4 . . . . 0.0 113.242 173.279 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.6 mt -85.58 110.39 19.53 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.103 0 N-CA-C 105.786 -1.931 . . . . 0.0 105.786 164.512 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.8 p -88.09 -21.61 24.61 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 112.823 -1.99 . . . . 0.0 115.376 -175.51 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -60.12 121.14 56.92 Favored Pre-proline 0 N--CA 1.479 0.988 0 C-N-CA 125.091 1.356 . . . . 0.0 112.598 174.524 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 82.4 Cg_exo -60.34 -52.45 4.01 Favored 'Trans proline' 0 C--N 1.353 0.774 0 C-N-CA 123.277 2.651 . . . . 0.0 115.509 179.417 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.7 p30 -67.61 -31.8 72.09 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 113.796 1.035 . . . . 0.0 113.796 176.499 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 94.95 158.35 32.98 Favored Glycine 0 N--CA 1.481 1.674 0 O-C-N 124.525 1.141 . . . . 0.0 112.564 168.399 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 4.9 mp -78.73 72.44 5.25 Favored 'General case' 0 CA--C 1.546 0.814 0 CA-C-O 122.622 1.201 . . . . 0.0 112.92 -175.551 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 34.3 p80 -67.19 -167.8 0.06 Allowed 'General case' 0 CA--C 1.549 0.924 0 CA-C-N 113.351 -1.75 . . . . 0.0 113.97 179.107 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 7.1 p -46.24 -48.86 17.78 Favored 'General case' 0 N--CA 1.478 0.944 0 N-CA-C 117.033 2.235 . . . . 0.0 117.033 -174.655 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.51 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.475 35.9 ptt180 -78.22 -39.44 1.74 Allowed Pre-proline 0 N--CA 1.479 1.019 0 N-CA-C 118.689 2.848 . . . . 0.0 118.689 177.618 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.51 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 79.8 Cg_exo -59.51 -39.2 77.66 Favored 'Trans proline' 0 N--CA 1.483 0.89 0 C-N-CA 121.836 1.69 . . . . 0.0 112.055 169.803 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.499 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -61.46 -42.02 98.13 Favored 'General case' 0 N--CA 1.481 1.116 0 N-CA-C 113.373 0.879 . . . . 0.0 113.373 173.202 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -62.19 -44.15 97.24 Favored 'General case' 0 N--CA 1.484 1.265 0 N-CA-C 113.983 1.105 . . . . 0.0 113.983 175.194 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.459 HE22 HD21 ' A' ' 84' ' ' LEU . 56.6 tt0 -53.98 -49.76 68.09 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.057 1.343 . . . . 0.0 111.424 172.679 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 7.4 t80 -59.85 -36.14 76.23 Favored 'General case' 0 N--CA 1.48 1.073 0 CA-C-N 114.126 -1.397 . . . . 0.0 114.054 175.501 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.499 HG23 ' O ' ' A' ' 19' ' ' ALA . 97.1 t -64.25 -46.73 92.49 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.144 0 C-N-CA 123.114 0.566 . . . . 0.0 111.902 179.256 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.52 -49.86 63.97 Favored 'General case' 0 N--CA 1.482 1.171 0 C-N-CA 123.668 0.787 . . . . 0.0 109.78 177.003 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.0 tp10 -60.35 -47.29 86.69 Favored 'General case' 0 N--CA 1.476 0.871 0 C-N-CA 125.54 1.536 . . . . 0.0 113.611 177.904 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -64.15 -39.44 94.03 Favored 'General case' 0 N--CA 1.48 1.051 0 N-CA-C 114.026 1.121 . . . . 0.0 114.026 176.225 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -63.5 -30.84 71.9 Favored 'General case' 0 N--CA 1.478 0.966 0 C-N-CA 124.003 0.921 . . . . 0.0 112.587 174.4 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -62.0 -21.79 61.78 Favored Glycine 0 CA--C 1.542 1.757 0 C-N-CA 125.916 1.722 . . . . 0.0 115.081 175.764 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 78.4 m-85 -95.2 155.18 16.84 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 123.944 0.898 . . . . 0.0 112.734 175.844 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 41.6 p -78.8 -46.32 19.01 Favored 'General case' 0 N--CA 1.487 1.41 0 CA-C-O 117.642 -1.17 . . . . 0.0 112.128 179.885 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.6 m -54.83 139.13 40.93 Favored 'General case' 0 N--CA 1.492 1.646 0 C-N-CA 124.835 1.254 . . . . 0.0 110.449 175.97 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 14.4 tt0 -78.94 110.11 13.86 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 119.525 -0.87 . . . . 0.0 109.963 175.076 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.406 ' HA ' ' O ' ' A' ' 64' ' ' SER . 2.9 mp -84.61 121.92 37.38 Favored 'Isoleucine or valine' 0 C--O 1.248 0.996 0 CA-C-N 110.751 -2.932 . . . . 0.0 112.149 175.504 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 98.3 m -116.54 132.67 56.62 Favored 'General case' 0 C--O 1.247 0.927 0 CA-C-N 111.43 -2.623 . . . . 0.0 109.017 174.803 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.558 HG13 HG21 ' A' ' 61' ' ' VAL . 6.0 t -113.41 93.32 2.46 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.869 0 CA-C-N 112.821 -1.99 . . . . 0.0 107.727 -176.945 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 6.3 m -87.81 94.79 9.86 Favored 'General case' 0 N--CA 1.474 0.757 0 CA-C-N 113.418 -1.719 . . . . 0.0 111.596 -178.436 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 26.4 t -92.98 95.65 9.61 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-N 114.582 -1.19 . . . . 0.0 110.956 -176.299 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . 0.566 HD21 ' HB ' ' A' ' 60' ' ' VAL . 12.7 m120 32.53 81.0 0.02 OUTLIER 'General case' 0 N--CA 1.485 1.307 0 C-N-CA 125.759 1.623 . . . . 0.0 114.811 -168.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.11 -49.29 4.2 Favored Glycine 0 N--CA 1.481 1.697 0 CA-C-N 113.265 -1.789 . . . . 0.0 113.235 -174.673 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 51.0 mttp -67.27 102.12 1.02 Allowed 'General case' 0 N--CA 1.481 1.082 0 N-CA-C 115.252 1.575 . . . . 0.0 115.252 -177.445 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 29.0 m -91.61 100.36 13.1 Favored 'General case' 0 N--CA 1.478 0.971 0 CA-C-N 113.984 -1.462 . . . . 0.0 112.377 -177.201 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.762 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -113.37 143.02 45.17 Favored 'General case' 0 N--CA 1.468 0.429 0 CA-C-O 122.98 1.371 . . . . 0.0 111.81 174.677 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 35.4 t -61.58 121.23 12.24 Favored 'General case' 0 N--CA 1.481 1.099 0 CA-C-N 112.802 -1.999 . . . . 0.0 111.374 175.049 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -68.83 -23.68 64.28 Favored 'General case' 0 CA--C 1.543 0.704 0 CA-C-N 114.471 -1.24 . . . . 0.0 111.929 166.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 91.7 mttt -79.75 -17.68 52.91 Favored 'General case' 0 CA--C 1.552 1.034 0 N-CA-C 116.024 1.861 . . . . 0.0 116.024 176.538 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 10.3 t -107.95 120.54 42.58 Favored 'General case' 0 N--CA 1.479 1.013 0 N-CA-C 113.805 1.039 . . . . 0.0 113.805 177.768 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 22.2 mt -50.6 -62.84 1.36 Allowed 'General case' 0 N--CA 1.482 1.16 0 CA-C-N 112.872 -1.967 . . . . 0.0 113.875 -178.657 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 55.5 t80 -66.37 -13.0 59.97 Favored 'General case' 0 N--CA 1.478 0.969 0 N-CA-C 114.358 1.244 . . . . 0.0 114.358 -177.087 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.4 ' HD3' ' HA ' ' A' ' 49' ' ' LYS . 68.7 mmtt -97.31 -37.25 10.12 Favored 'General case' 0 N--CA 1.476 0.826 0 CA-C-O 118.682 -0.675 . . . . 0.0 112.367 178.992 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.41 HD12 ' HA ' ' A' ' 50' ' ' LEU . 13.0 tp -75.37 -43.64 49.24 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.064 0.765 . . . . 0.0 113.064 170.713 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 27.4 mt-30 -58.02 -23.75 55.46 Favored 'General case' 0 N--CA 1.481 1.084 0 N-CA-C 114.888 1.44 . . . . 0.0 114.888 176.312 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 24.8 p -95.06 -14.1 24.58 Favored 'General case' 0 N--CA 1.484 1.243 0 N-CA-C 115.077 1.51 . . . . 0.0 115.077 177.634 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.762 HD22 ' HB3' ' A' ' 42' ' ' ALA . 25.2 tp -77.51 134.65 38.26 Favored 'General case' 0 N--CA 1.482 1.172 0 CA-C-O 122.189 0.995 . . . . 0.0 111.833 -176.789 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.39 82.26 0.02 OUTLIER Glycine 0 N--CA 1.481 1.652 0 CA-C-N 113.824 -1.534 . . . . 0.0 112.731 169.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 32.5 mt -102.1 78.71 1.8 Allowed 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.686 -1.257 . . . . 0.0 109.811 171.008 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 2.4 t -125.74 169.53 12.47 Favored 'General case' 0 C--O 1.246 0.876 0 N-CA-C 114.644 1.35 . . . . 0.0 114.644 -174.529 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 6.0 tp-100 -47.26 118.03 1.99 Allowed 'General case' 0 N--CA 1.489 1.517 0 C-N-CA 125.56 1.544 . . . . 0.0 112.671 178.881 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.59 -29.87 11.45 Favored Glycine 0 N--CA 1.48 1.589 0 CA-C-N 112.625 -2.079 . . . . 0.0 113.923 175.579 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.0 m -66.4 118.49 10.12 Favored 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 121.981 0.896 . . . . 0.0 111.208 -173.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.566 ' HB ' HD21 ' A' ' 38' ' ' ASN . 61.5 t -77.06 107.51 8.55 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.878 0 CA-C-N 112.419 -2.173 . . . . 0.0 109.261 -178.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.558 HG21 HG13 ' A' ' 35' ' ' VAL . 12.6 p -107.86 118.86 56.41 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.683 0 CA-C-N 113.353 -1.748 . . . . 0.0 111.409 -178.814 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 11.4 m -84.3 100.67 11.39 Favored 'General case' 0 N--CA 1.478 0.962 0 CA-C-N 114.191 -1.368 . . . . 0.0 108.918 174.285 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 48.3 mt -78.16 110.8 14.27 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.079 0 CA-C-N 113.941 -1.481 . . . . 0.0 107.23 172.15 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.406 ' O ' ' HA ' ' A' ' 33' ' ' ILE . 13.7 t -119.71 139.49 52.17 Favored 'General case' 0 N--CA 1.468 0.462 0 O-C-N 124.378 1.049 . . . . 0.0 112.089 -179.495 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -124.21 112.71 17.38 Favored 'General case' 0 N--CA 1.469 0.493 0 O-C-N 125.131 1.519 . . . . 0.0 110.93 175.917 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 42.7 mt-10 -109.01 101.24 10.34 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 112.574 -2.103 . . . . 0.0 110.26 -176.117 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.36 -159.03 24.67 Favored Glycine 0 N--CA 1.48 1.567 0 CA-C-N 113.962 -1.472 . . . . 0.0 112.727 179.549 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -39.21 -84.28 0.0 OUTLIER 'General case' 0 N--CA 1.485 1.301 0 N-CA-C 118.136 2.643 . . . . 0.0 118.136 -174.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 5.1 p30 -72.75 45.03 0.14 Allowed 'General case' 0 C--O 1.256 1.417 0 N-CA-C 115.575 1.694 . . . . 0.0 115.575 179.441 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -49.6 -61.17 2.26 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 116.089 1.885 . . . . 0.0 116.089 -177.015 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 67.4 mt-30 -65.78 -45.15 83.56 Favored 'General case' 0 N--CA 1.485 1.28 0 N-CA-C 113.4 0.889 . . . . 0.0 113.4 -175.753 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 53.2 tttm -62.43 -40.49 96.72 Favored 'General case' 0 CA--C 1.539 0.551 0 CA-C-N 113.897 -1.501 . . . . 0.0 113.166 178.386 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.23 -52.91 61.87 Favored 'General case' 0 N--CA 1.482 1.164 0 C-N-CA 122.696 0.398 . . . . 0.0 111.964 -177.228 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.482 ' O ' HG23 ' A' ' 78' ' ' VAL . 61.3 t -56.43 -61.46 1.18 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.031 0 CA-C-N 114.963 -1.017 . . . . 0.0 111.419 175.663 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 23.0 tt0 -42.6 -56.88 2.92 Favored 'General case' 0 N--CA 1.489 1.522 0 C-N-CA 124.895 1.278 . . . . 0.0 113.077 -179.032 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 40.0 t60 -53.91 -47.34 71.27 Favored 'General case' 0 CA--C 1.551 1.007 0 C-N-CA 125.44 1.496 . . . . 0.0 113.675 177.827 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 37.1 mt -73.45 -30.65 63.33 Favored 'General case' 0 N--CA 1.488 1.461 0 N-CA-C 114.701 1.371 . . . . 0.0 114.701 -178.075 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.482 HG23 ' O ' ' A' ' 74' ' ' VAL . 12.3 t -64.2 -44.31 97.45 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.116 0 N-CA-C 109.228 -0.656 . . . . 0.0 109.228 171.778 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 11.7 mmtt -61.22 -42.9 99.4 Favored 'General case' 0 CA--C 1.548 0.869 0 N-CA-C 114.079 1.14 . . . . 0.0 114.079 176.144 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -57.28 -62.09 2.02 Favored 'General case' 0 N--CA 1.478 0.943 0 CA-C-N 115.798 -0.637 . . . . 0.0 112.569 172.786 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 60.0 ttm -49.58 -46.9 49.58 Favored 'General case' 0 N--CA 1.484 1.262 0 C-N-CA 124.96 1.304 . . . . 0.0 113.277 179.509 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -59.75 -42.19 92.68 Favored 'General case' 0 CA--C 1.546 0.809 0 N-CA-C 114.382 1.252 . . . . 0.0 114.382 -178.461 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 44.6 mt-10 -96.34 6.28 49.12 Favored 'General case' 0 N--CA 1.483 1.192 0 O-C-N 125.114 1.509 . . . . 0.0 114.711 -175.206 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.459 HD21 HE22 ' A' ' 21' ' ' GLN . 16.0 mt -98.86 137.93 36.72 Favored 'General case' 0 N--CA 1.479 1.01 0 N-CA-C 114.53 1.307 . . . . 0.0 114.53 172.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.0 mt-10 . . . . . 0 C--O 1.255 1.349 0 C-N-CA 127.329 2.252 . . . . 0.0 107.63 173.915 . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.518 ' HG2' ' HG2' ' A' ' 66' ' ' GLU . 10.0 tmm? . . . . . 0 N--CA 1.475 0.813 0 N-CA-C 106.594 -1.632 . . . . 0.0 106.594 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -122.61 139.65 53.69 Favored 'General case' 0 N--CA 1.473 0.703 0 O-C-N 124.017 0.823 . . . . 0.0 111.491 179.815 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 39.7 mt-30 -123.95 147.22 47.91 Favored 'General case' 0 N--CA 1.478 0.966 0 CA-C-N 113.942 -1.481 . . . . 0.0 111.377 178.877 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 5.8 tp-100 -137.55 134.22 35.39 Favored 'General case' 0 N--CA 1.474 0.762 0 O-C-N 124.539 1.15 . . . . 0.0 110.557 162.645 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 27.9 tt0 -97.84 112.17 24.18 Favored 'General case' 0 N--CA 1.476 0.827 0 O-C-N 124.717 1.26 . . . . 0.0 108.813 179.249 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 98.1 t -128.36 151.83 35.69 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.132 0 CA-C-N 113.736 -1.575 . . . . 0.0 109.169 -174.921 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 21.8 p -106.41 151.68 24.6 Favored 'General case' 0 N--CA 1.483 1.22 0 N-CA-C 113.063 0.764 . . . . 0.0 113.063 176.723 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.507 HD13 ' HB ' ' A' ' 59' ' ' THR . 4.5 mp -81.09 119.91 31.68 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.84 0 N-CA-C 108.095 -1.076 . . . . 0.0 108.095 170.76 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 17.4 p -99.21 -38.65 8.81 Favored 'General case' 0 N--CA 1.482 1.168 0 CA-C-N 112.593 -2.094 . . . . 0.0 114.629 -174.796 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -49.16 126.13 14.9 Favored Pre-proline 0 N--CA 1.481 1.08 0 C-N-CA 124.916 1.286 . . . . 0.0 113.062 176.931 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.411 ' HA ' HE21 ' A' ' 57' ' ' GLN . 87.2 Cg_exo -49.69 -33.85 33.19 Favored 'Trans proline' 0 CA--C 1.543 0.948 0 C-N-CA 125.165 3.91 . . . . 0.0 115.035 -177.165 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.5 p30 -96.89 -70.63 0.71 Allowed 'General case' 0 N--CA 1.475 0.776 0 O-C-N 124.288 0.992 . . . . 0.0 111.539 171.733 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 132.42 -174.52 20.33 Favored Glycine 0 CA--C 1.536 1.375 0 C-N-CA 123.688 0.661 . . . . 0.0 113.397 173.367 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 6.8 mp -73.68 73.53 1.51 Allowed 'General case' 0 N--CA 1.48 1.052 0 CA-C-O 122.79 1.281 . . . . 0.0 113.471 -179.02 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 24.3 p80 -73.99 -174.15 1.79 Allowed 'General case' 0 N--CA 1.479 0.98 0 CA-C-N 113.705 -1.588 . . . . 0.0 113.268 177.259 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 41.0 p -40.65 -48.37 2.91 Favored 'General case' 0 N--CA 1.491 1.614 0 N-CA-C 116.42 2.007 . . . . 0.0 116.42 -171.844 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.265 48.0 mtm105 -82.97 -47.45 0.83 Allowed Pre-proline 0 CA--C 1.55 0.968 0 N-CA-C 115.758 1.762 . . . . 0.0 115.758 -175.346 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -62.23 -36.38 68.95 Favored 'Trans proline' 0 N--CA 1.487 1.106 0 C-N-CA 122.592 2.195 . . . . 0.0 113.795 168.746 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -59.83 -45.61 91.85 Favored 'General case' 0 CA--C 1.546 0.814 0 N-CA-C 112.574 0.583 . . . . 0.0 112.574 171.211 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -57.5 -42.57 82.99 Favored 'General case' 0 N--CA 1.48 1.03 0 N-CA-C 113.613 0.968 . . . . 0.0 113.613 173.686 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 45.1 mt-30 -60.26 -49.72 76.5 Favored 'General case' 0 N--CA 1.486 1.339 0 N-CA-C 113.445 0.905 . . . . 0.0 113.445 172.99 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 30.6 t80 -57.01 -44.95 83.31 Favored 'General case' 0 N--CA 1.48 1.039 0 C-N-CA 123.945 0.898 . . . . 0.0 112.068 177.588 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.417 ' O ' ' HG3' ' A' ' 27' ' ' LYS . 92.4 t -56.41 -49.52 76.65 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.901 0 C-N-CA 123.488 0.715 . . . . 0.0 111.67 174.123 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 13.9 tmtt? -51.16 -48.58 61.84 Favored 'General case' 0 N--CA 1.476 0.862 0 O-C-N 124.209 0.943 . . . . 0.0 112.493 -179.775 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 16.3 tp10 -64.58 -56.48 13.67 Favored 'General case' 0 N--CA 1.48 1.034 0 O-C-N 124.285 0.991 . . . . 0.0 112.078 175.938 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -52.74 -34.19 51.58 Favored 'General case' 0 N--CA 1.481 1.125 0 N-CA-C 115.167 1.543 . . . . 0.0 115.167 -179.109 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.417 ' HG3' ' O ' ' A' ' 23' ' ' VAL . 28.6 mtpp -55.18 -28.02 49.98 Favored 'General case' 0 N--CA 1.478 0.951 0 N-CA-C 115.377 1.621 . . . . 0.0 115.377 173.879 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -93.01 16.53 60.26 Favored Glycine 0 N--CA 1.49 2.254 0 O-C-N 124.202 0.938 . . . . 0.0 115.405 -175.845 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 68.8 m-85 -111.23 145.14 39.25 Favored 'General case' 0 N--CA 1.475 0.819 0 C-N-CA 123.813 0.845 . . . . 0.0 109.318 169.58 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 65.4 p -63.81 -43.68 95.52 Favored 'General case' 0 N--CA 1.487 1.413 0 N-CA-C 111.809 0.3 . . . . 0.0 111.809 -179.133 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 14.4 m -57.23 148.51 22.26 Favored 'General case' 0 N--CA 1.477 0.913 0 C-N-CA 126.159 1.784 . . . . 0.0 112.588 176.483 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -105.73 104.35 14.05 Favored 'General case' 0 N--CA 1.471 0.617 0 CA-C-O 122.837 1.304 . . . . 0.0 109.132 174.726 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.532 HD12 ' H ' ' A' ' 33' ' ' ILE . 2.6 mp -78.58 110.12 13.97 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.682 0 CA-C-N 111.363 -2.653 . . . . 0.0 111.186 -175.468 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 57.4 m -90.18 95.45 10.21 Favored 'General case' 0 CA--C 1.542 0.651 0 CA-C-N 112.879 -1.964 . . . . 0.0 108.137 176.186 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 63.6 t -84.4 99.35 6.63 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.973 0 CA-C-N 112.418 -2.174 . . . . 0.0 107.348 178.166 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 86.0 m -96.35 104.4 16.37 Favored 'General case' 0 N--CA 1.479 0.998 0 CA-C-N 113.644 -1.616 . . . . 0.0 111.346 -176.509 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 1.7 t -105.79 100.88 10.42 Favored 'General case' 0 N--CA 1.485 1.322 0 CA-C-N 114.025 -1.443 . . . . 0.0 109.302 -175.607 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 11.5 m120 37.61 81.01 0.03 OUTLIER 'General case' 0 N--CA 1.486 1.374 0 C-N-CA 126.532 1.933 . . . . 0.0 115.404 -169.648 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.35 -39.13 1.43 Allowed Glycine 0 CA--C 1.544 1.887 0 CA-C-N 113.212 -1.813 . . . . 0.0 114.953 -178.791 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 60.9 mttp -89.15 125.59 35.11 Favored 'General case' 0 N--CA 1.482 1.148 0 C-N-CA 123.649 0.78 . . . . 0.0 111.674 -174.255 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 20.0 m -111.92 142.5 44.23 Favored 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 115.474 1.657 . . . . 0.0 115.474 -173.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.568 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -140.56 142.61 35.12 Favored 'General case' 0 N--CA 1.48 1.038 0 CA-C-N 114.207 -1.36 . . . . 0.0 114.247 173.011 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 41.1 t -61.85 117.77 6.33 Favored 'General case' 0 N--CA 1.484 1.232 0 CA-C-N 114.36 -1.291 . . . . 0.0 111.573 171.786 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.515 ' HA ' HD13 ' A' ' 50' ' ' LEU . . . -61.04 -16.44 43.56 Favored 'General case' 0 N--CA 1.478 0.975 0 CA-C-N 113.761 -1.563 . . . . 0.0 113.621 174.651 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 51.8 mtpt -91.77 5.17 50.86 Favored 'General case' 0 N--CA 1.475 0.777 0 N-CA-C 114.0 1.111 . . . . 0.0 114.0 -176.317 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.434 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 38.3 t -127.72 128.39 45.31 Favored 'General case' 0 N--CA 1.489 1.485 0 C-N-CA 123.95 0.9 . . . . 0.0 112.022 -178.966 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 67.7 mt -55.44 -59.85 4.24 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-N 113.276 -1.784 . . . . 0.0 111.989 175.858 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 7.3 t80 -53.16 -45.33 68.41 Favored 'General case' 0 N--CA 1.482 1.146 0 CA-C-N 114.153 -1.385 . . . . 0.0 112.666 -179.855 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.55 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 42.7 mmtt -62.9 -56.2 19.38 Favored 'General case' 0 N--CA 1.48 1.047 0 O-C-N 123.96 0.787 . . . . 0.0 112.989 179.189 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.515 HD13 ' HA ' ' A' ' 44' ' ' ALA . 0.8 OUTLIER -70.65 -38.32 73.81 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.779 1.77 . . . . 0.0 115.779 -178.817 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 94.9 mt-30 -65.22 -11.73 43.89 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 114.662 1.356 . . . . 0.0 114.662 175.583 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 59.4 p -119.44 9.78 11.68 Favored 'General case' 0 N--CA 1.491 1.585 0 N-CA-C 114.466 1.284 . . . . 0.0 114.466 173.893 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.568 HD22 ' HB3' ' A' ' 42' ' ' ALA . 43.5 tp -84.83 149.5 25.66 Favored 'General case' 0 N--CA 1.478 0.925 0 C-N-CA 123.749 0.82 . . . . 0.0 109.145 176.538 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -67.78 68.23 0.3 Allowed Glycine 0 CA--C 1.543 1.792 0 CA-C-N 115.396 -0.82 . . . . 0.0 113.556 179.507 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 54.6 mt -102.75 82.96 2.19 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 124.123 0.969 . . . . 0.0 111.43 178.039 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 10.5 t -132.33 164.29 26.77 Favored 'General case' 0 N--CA 1.479 1.018 0 CA-C-N 113.152 -1.84 . . . . 0.0 110.126 -179.13 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.411 HE21 ' HA ' ' A' ' 11' ' ' PRO . 4.1 tp-100 -48.97 136.41 14.35 Favored 'General case' 0 N--CA 1.485 1.293 0 C-N-CA 124.326 1.05 . . . . 0.0 113.004 177.373 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 87.24 -28.13 5.83 Favored Glycine 0 N--CA 1.483 1.823 0 CA-C-N 113.93 -1.487 . . . . 0.0 115.203 175.604 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.507 ' HB ' HD13 ' A' ' 8' ' ' ILE . 8.8 m -55.53 142.75 32.07 Favored 'General case' 0 N--CA 1.478 0.95 0 C-N-CA 124.151 0.98 . . . . 0.0 112.298 -178.714 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 57.9 t -99.22 127.01 52.36 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.908 0 CA-C-N 114.43 -1.259 . . . . 0.0 108.592 179.497 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 12.9 p -121.25 116.08 48.6 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.859 0 CA-C-O 122.828 1.299 . . . . 0.0 114.034 -178.411 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -86.78 104.38 16.1 Favored 'General case' 0 C--O 1.24 0.568 0 CA-C-N 113.751 -1.568 . . . . 0.0 109.431 170.591 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 69.3 mt -87.11 95.23 4.86 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.032 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 178.694 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 35.9 t -107.11 122.16 45.93 Favored 'General case' 0 N--CA 1.475 0.791 0 CA-C-N 113.545 -1.661 . . . . 0.0 112.018 -177.218 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -114.89 110.21 19.31 Favored 'General case' 0 N--CA 1.473 0.699 0 N-CA-C 112.923 0.712 . . . . 0.0 112.923 178.042 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.518 ' HG2' ' HG2' ' A' ' 1' ' ' MET . 36.5 mt-10 -91.37 122.02 33.61 Favored 'General case' 0 N--CA 1.48 1.072 0 CA-C-N 113.038 -1.892 . . . . 0.0 110.573 169.123 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 147.42 -152.33 24.48 Favored Glycine 0 N--CA 1.475 1.269 0 O-C-N 124.737 1.273 . . . . 0.0 111.692 179.189 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 30.1 mt-10 -89.97 -60.78 1.84 Allowed 'General case' 0 N--CA 1.479 1.017 0 C-N-CA 125.186 1.394 . . . . 0.0 113.316 -174.927 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 6.4 p30 -77.58 38.06 0.24 Allowed 'General case' 0 N--CA 1.486 1.362 0 N-CA-C 114.723 1.379 . . . . 0.0 114.723 173.837 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.663 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 6.8 pt-20 -48.06 -66.23 0.44 Allowed 'General case' 0 CA--C 1.542 0.657 0 C-N-CA 127.559 2.343 . . . . 0.0 114.918 -179.904 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.663 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 57.3 mt-30 -56.25 -46.04 79.79 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 125.859 1.663 . . . . 0.0 113.374 177.898 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 60.8 tttm -61.74 -47.54 84.78 Favored 'General case' 0 N--CA 1.478 0.967 0 C-N-CA 124.785 1.234 . . . . 0.0 111.776 -178.435 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.59 -50.82 71.88 Favored 'General case' 0 N--CA 1.484 1.249 0 O-C-N 124.23 0.956 . . . . 0.0 112.39 174.857 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.5 t -62.24 -51.02 77.51 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.199 0 CA-C-O 118.307 -0.854 . . . . 0.0 111.632 -179.512 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 30.2 tt0 -48.25 -54.49 13.44 Favored 'General case' 0 N--CA 1.486 1.349 0 C-N-CA 125.453 1.501 . . . . 0.0 112.466 178.785 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 82.5 t60 -65.28 -51.67 59.23 Favored 'General case' 0 N--CA 1.475 0.8 0 CA-C-N 114.95 -1.023 . . . . 0.0 113.191 177.798 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 81.0 mt -65.35 -26.4 68.01 Favored 'General case' 0 N--CA 1.481 1.099 0 N-CA-C 116.014 1.857 . . . . 0.0 116.014 -176.527 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 40.0 t -57.02 -45.5 83.92 Favored 'Isoleucine or valine' 0 N--CA 1.49 1.538 0 C-N-CA 123.724 0.81 . . . . 0.0 111.569 169.87 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 36.6 mttm -59.09 -52.77 64.32 Favored 'General case' 0 N--CA 1.484 1.264 0 O-C-N 124.353 1.033 . . . . 0.0 110.978 176.47 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 9.3 mp -55.03 -47.75 74.33 Favored 'General case' 0 N--CA 1.475 0.78 0 CA-C-N 114.686 -1.143 . . . . 0.0 113.698 177.916 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 60.9 tpp -52.84 -36.81 59.34 Favored 'General case' 0 N--CA 1.479 0.979 0 N-CA-C 114.222 1.193 . . . . 0.0 114.222 174.829 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -85.11 -28.64 25.44 Favored 'General case' 0 N--CA 1.485 1.283 0 N-CA-C 114.558 1.318 . . . . 0.0 114.558 179.886 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 41.8 mt-10 -107.84 22.91 15.27 Favored 'General case' 0 CA--C 1.56 1.365 0 N-CA-C 115.492 1.664 . . . . 0.0 115.492 -171.262 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . . . . . . . . . 41.9 mt -116.79 141.89 47.62 Favored 'General case' 0 N--CA 1.488 1.469 0 N-CA-C 115.039 1.496 . . . . 0.0 115.039 179.69 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 . . . . . 0 C--O 1.258 1.53 0 C-N-CA 128.103 2.561 . . . . 0.0 107.73 176.587 . . . . . . . . 0 0 . 1 . 026 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.428 ' HG2' ' HG3' ' A' ' 66' ' ' GLU . 0.0 OUTLIER . . . . . 0 CA--C 1.545 0.753 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 . . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 70.1 t80 -136.74 141.9 43.03 Favored 'General case' 0 N--CA 1.48 1.037 0 O-C-N 124.882 1.364 . . . . 0.0 110.76 -179.906 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 45.9 mt-30 -132.12 141.06 49.01 Favored 'General case' 0 N--CA 1.474 0.741 0 CA-C-N 114.808 -1.087 . . . . 0.0 110.249 -179.271 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 3.7 tp60 -133.89 125.0 27.39 Favored 'General case' 0 N--CA 1.469 0.501 0 O-C-N 124.159 0.912 . . . . 0.0 110.995 176.702 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . 0.433 ' HA ' HG22 ' A' ' 62' ' ' THR . 36.6 tt0 -74.09 111.6 9.41 Favored 'General case' 0 N--CA 1.474 0.737 0 CA-C-N 113.725 -1.58 . . . . 0.0 109.654 172.502 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.459 HG21 HG22 ' A' ' 78' ' ' VAL . 95.9 t -128.98 140.32 49.56 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.844 0 CA-C-N 113.458 -1.701 . . . . 0.0 108.818 -177.002 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 66.5 p -113.22 149.41 33.79 Favored 'General case' 0 N--CA 1.471 0.614 0 CA-C-O 121.809 0.814 . . . . 0.0 111.313 171.438 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 6.3 mt -77.43 123.42 34.04 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.457 0 CA-C-N 114.707 -1.133 . . . . 0.0 109.066 175.765 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 5.4 p -93.12 -36.0 12.89 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.974 1.472 . . . . 0.0 114.974 177.871 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.521 ' HB3' ' HA2' ' A' ' 13' ' ' GLY . . . -77.12 133.94 68.26 Favored Pre-proline 0 N--CA 1.477 0.881 0 N-CA-C 112.679 0.622 . . . . 0.0 112.679 176.15 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.737 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 85.8 Cg_exo -58.72 -49.54 11.44 Favored 'Trans proline' 0 N--CA 1.481 0.745 0 C-N-CA 123.859 3.04 . . . . 0.0 112.381 178.397 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.8 p-10 -68.82 -44.73 72.87 Favored 'General case' 0 N--CA 1.474 0.74 0 C-N-CA 126.123 1.769 . . . . 0.0 112.961 171.236 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.521 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 67.42 -141.51 39.09 Favored Glycine 0 N--CA 1.475 1.283 0 O-C-N 124.54 1.15 . . . . 0.0 113.153 172.086 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.449 HD13 ' HA ' ' A' ' 81' ' ' MET . 3.6 tp -92.66 57.92 2.99 Favored 'General case' 0 N--CA 1.475 0.781 0 CA-C-O 122.806 1.288 . . . . 0.0 110.145 -175.278 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 18.5 p80 -70.99 -162.18 0.06 Allowed 'General case' 0 N--CA 1.484 1.252 0 CA-C-N 114.257 -1.338 . . . . 0.0 112.088 176.595 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.6 p -47.34 -61.02 2.1 Favored 'General case' 0 N--CA 1.479 0.992 0 N-CA-C 115.603 1.705 . . . . 0.0 115.603 -167.288 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.761 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.407 10.5 ptt180 -64.8 -49.37 69.46 Favored Pre-proline 0 N--CA 1.481 1.115 0 CA-C-O 115.375 -2.25 . . . . 0.0 116.297 -179.735 . . . . . . . . 3 3 . 1 . 026 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.761 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 86.1 Cg_exo -59.33 -42.72 46.69 Favored 'Trans proline' 0 CA--C 1.539 0.768 0 C-N-CA 123.063 2.509 . . . . 0.0 113.03 172.047 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.429 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -55.13 -43.42 74.14 Favored 'General case' 0 N--CA 1.481 1.076 0 N-CA-C 114.626 1.343 . . . . 0.0 114.626 178.746 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -59.83 -46.96 87.61 Favored 'General case' 0 N--CA 1.483 1.208 0 N-CA-C 113.109 0.781 . . . . 0.0 113.109 176.779 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 20.6 mt-30 -60.88 -45.86 92.9 Favored 'General case' 0 N--CA 1.483 1.181 0 C-N-CA 124.759 1.224 . . . . 0.0 112.005 175.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 33.8 t80 -57.99 -45.28 87.06 Favored 'General case' 0 N--CA 1.479 1.01 0 C-N-CA 125.233 1.413 . . . . 0.0 112.777 176.153 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.476 HG21 ' HA ' ' A' ' 47' ' ' LEU . 89.0 t -55.43 -47.8 77.83 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.088 0 C-N-CA 123.355 0.662 . . . . 0.0 111.752 176.407 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 9.5 tmtt? -56.99 -46.44 82.27 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 123.948 0.78 . . . . 0.0 111.933 177.715 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.8 tp10 -63.71 -47.26 81.84 Favored 'General case' 0 CA--C 1.549 0.906 0 O-C-N 123.796 0.685 . . . . 0.0 112.332 178.102 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.41 -40.43 74.68 Favored 'General case' 0 N--CA 1.492 1.672 0 C-N-CA 124.338 1.055 . . . . 0.0 113.791 172.876 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 32.8 mmtt -54.35 -33.74 59.68 Favored 'General case' 0 N--CA 1.48 1.074 0 N-CA-C 113.919 1.081 . . . . 0.0 113.919 172.33 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -86.23 25.09 7.29 Favored Glycine 0 N--CA 1.479 1.511 0 C-N-CA 124.518 1.056 . . . . 0.0 114.264 -177.257 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -125.08 145.43 49.93 Favored 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 124.823 1.249 . . . . 0.0 110.469 169.453 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 56.7 p -66.06 -43.59 86.98 Favored 'General case' 0 N--CA 1.48 1.068 0 CA-C-O 118.569 -0.729 . . . . 0.0 111.76 178.474 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 21.6 m -54.99 151.16 9.2 Favored 'General case' 0 N--CA 1.492 1.635 0 C-N-CA 125.82 1.648 . . . . 0.0 113.462 174.902 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -98.29 124.76 43.09 Favored 'General case' 0 N--CA 1.479 0.986 0 CA-C-O 122.663 1.221 . . . . 0.0 109.302 164.151 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 5.3 mp -96.11 99.11 8.58 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.493 0 CA-C-N 111.206 -2.725 . . . . 0.0 109.204 -176.796 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.448 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 13.0 m -83.59 115.46 22.14 Favored 'General case' 0 N--CA 1.478 0.937 0 CA-C-N 112.422 -2.172 . . . . 0.0 108.678 175.792 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . . . . . . . . . 53.9 t -106.37 103.83 16.06 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.879 0 CA-C-N 114.031 -1.44 . . . . 0.0 108.746 -177.072 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 12.8 m -103.67 103.89 13.86 Favored 'General case' 0 N--CA 1.478 0.958 0 CA-C-N 114.357 -1.292 . . . . 0.0 111.477 -175.018 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 44.1 t -96.96 97.46 9.28 Favored 'General case' 0 N--CA 1.482 1.143 0 CA-C-N 114.913 -1.039 . . . . 0.0 109.708 176.801 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 4.1 m120 38.06 79.53 0.03 OUTLIER 'General case' 0 N--CA 1.489 1.489 0 CA-C-N 113.059 -1.882 . . . . 0.0 115.444 -171.541 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.37 -48.69 4.09 Favored Glycine 0 CA--C 1.54 1.627 0 CA-C-N 113.605 -1.634 . . . . 0.0 114.247 179.543 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 77.4 mttt -77.47 119.43 21.05 Favored 'General case' 0 N--CA 1.48 1.034 0 C-N-CA 123.785 0.834 . . . . 0.0 111.198 -176.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 13.7 p -110.1 139.57 45.09 Favored 'General case' 0 N--CA 1.482 1.161 0 N-CA-C 115.159 1.54 . . . . 0.0 115.159 -173.1 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.499 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -133.35 138.93 46.55 Favored 'General case' 0 N--CA 1.482 1.166 0 CA-C-N 112.638 -2.074 . . . . 0.0 112.348 176.388 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 46.5 t -69.42 118.16 11.95 Favored 'General case' 0 N--CA 1.483 1.185 0 CA-C-N 114.698 -1.137 . . . . 0.0 111.249 170.041 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -61.67 -23.79 66.32 Favored 'General case' 0 N--CA 1.478 0.941 0 CA-C-N 114.302 -1.317 . . . . 0.0 113.129 174.721 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 34.0 mttt -77.86 6.15 8.19 Favored 'General case' 0 N--CA 1.48 1.045 0 N-CA-C 114.657 1.354 . . . . 0.0 114.657 175.648 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 30.8 t -130.36 125.26 34.17 Favored 'General case' 0 N--CA 1.479 1.019 0 C-N-CA 124.782 1.233 . . . . 0.0 112.361 178.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.476 ' HA ' HG21 ' A' ' 23' ' ' VAL . 49.3 mt -53.59 -56.96 12.68 Favored 'General case' 0 N--CA 1.478 0.933 0 CA-C-N 113.992 -1.458 . . . . 0.0 112.221 176.704 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 12.6 t80 -62.48 -34.73 77.43 Favored 'General case' 0 N--CA 1.474 0.735 0 CA-C-N 114.295 -1.32 . . . . 0.0 112.89 -177.511 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.499 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 54.7 mmtt -67.72 -56.61 8.6 Favored 'General case' 0 N--CA 1.481 1.095 0 CA-C-O 118.972 -0.537 . . . . 0.0 112.181 175.474 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 11.9 tp -62.78 -47.18 84.61 Favored 'General case' 0 N--CA 1.481 1.123 0 N-CA-C 113.311 0.856 . . . . 0.0 113.311 -178.744 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 49.7 mt-30 -65.99 -23.34 66.56 Favored 'General case' 0 N--CA 1.474 0.747 0 N-CA-C 116.645 2.091 . . . . 0.0 116.645 -178.79 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 31.8 p -87.89 -25.1 23.43 Favored 'General case' 0 N--CA 1.492 1.645 0 N-CA-C 113.922 1.082 . . . . 0.0 113.922 175.668 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 28.5 tp -74.89 130.63 39.74 Favored 'General case' 0 N--CA 1.48 1.029 0 CA-C-O 122.075 0.94 . . . . 0.0 111.818 178.518 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.06 95.84 0.18 Allowed Glycine 0 CA--C 1.537 1.451 0 CA-C-N 114.113 -1.403 . . . . 0.0 113.35 177.495 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 36.1 mt -105.77 74.7 1.08 Allowed 'General case' 0 N--CA 1.486 1.354 0 CA-C-O 122.322 1.058 . . . . 0.0 111.881 178.578 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 7.6 t -136.1 142.22 44.28 Favored 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 112.697 -2.047 . . . . 0.0 112.029 -171.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.737 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 6.6 tp-100 2.32 128.42 0.0 OUTLIER 'General case' 0 N--CA 1.482 1.153 0 N-CA-C 119.24 3.052 . . . . 0.0 119.24 171.533 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 73.91 -29.67 0.92 Allowed Glycine 0 N--CA 1.481 1.669 0 CA-C-N 114.003 -1.453 . . . . 0.0 115.981 168.895 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 87.7 m -61.4 136.53 58.07 Favored 'General case' 0 N--CA 1.477 0.908 0 C-N-CA 124.73 1.212 . . . . 0.0 111.026 -178.318 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 24.6 t -81.56 110.0 16.41 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.481 0 CA-C-N 113.557 -1.656 . . . . 0.0 107.521 -179.008 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 14.9 p -108.16 92.32 2.04 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.474 0 CA-C-N 112.488 -2.142 . . . . 0.0 109.395 178.799 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.433 HG22 ' HA ' ' A' ' 5' ' ' GLU . 17.1 p -82.69 99.48 9.64 Favored 'General case' 0 N--CA 1.476 0.866 0 CA-C-N 114.061 -1.427 . . . . 0.0 112.302 -177.844 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 3.8 mp -73.73 109.64 6.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.0 0 CA-C-N 112.034 -2.348 . . . . 0.0 109.415 174.794 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.448 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 47.4 t -113.73 109.48 18.64 Favored 'General case' 0 N--CA 1.479 1.007 0 CA-C-N 112.735 -2.03 . . . . 0.0 111.125 -177.479 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -106.64 123.24 47.82 Favored 'General case' 0 N--CA 1.484 1.241 0 CA-C-O 122.408 1.099 . . . . 0.0 112.551 -178.901 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.428 ' HG3' ' HG2' ' A' ' 1' ' ' MET . 39.6 tt0 -119.6 91.2 3.49 Favored 'General case' 0 N--CA 1.468 0.46 0 CA-C-N 112.865 -1.97 . . . . 0.0 113.294 -177.873 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 176.08 -161.92 30.62 Favored Glycine 0 CA--C 1.548 2.116 0 CA-C-N 112.669 -2.059 . . . . 0.0 110.849 169.807 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 2.6 mt-10 -66.87 -51.18 58.6 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 114.918 1.451 . . . . 0.0 114.918 -179.384 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 11.8 p30 -79.63 36.81 0.33 Allowed 'General case' 0 N--CA 1.488 1.438 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 176.621 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.627 ' HG3' ' H ' ' A' ' 71' ' ' GLN . 5.2 pt-20 -39.95 -68.47 0.17 Allowed 'General case' 0 N--CA 1.488 1.442 0 C-N-CA 128.988 2.915 . . . . 0.0 115.475 -177.879 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.627 ' H ' ' HG3' ' A' ' 70' ' ' GLU . 37.9 mt-30 -60.02 -41.43 92.15 Favored 'General case' 0 N--CA 1.476 0.856 0 N-CA-C 114.215 1.191 . . . . 0.0 114.215 178.968 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 49.9 tttm -71.34 -38.69 71.64 Favored 'General case' 0 N--CA 1.472 0.671 0 CA-C-N 115.878 -0.601 . . . . 0.0 112.012 -176.354 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -55.95 -41.57 74.9 Favored 'General case' 0 CA--C 1.545 0.786 0 O-C-N 124.105 0.878 . . . . 0.0 112.741 170.189 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 58.0 t -74.0 -66.03 0.62 Allowed 'Isoleucine or valine' 0 N--CA 1.477 0.89 0 CA-C-O 118.989 -0.529 . . . . 0.0 112.318 176.343 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.3 tt0 -42.37 -53.08 4.36 Favored 'General case' 0 N--CA 1.494 1.751 0 C-N-CA 126.13 1.772 . . . . 0.0 112.633 -174.028 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 28.4 t60 -65.25 -45.88 82.82 Favored 'General case' 0 CA--C 1.539 0.524 0 CA-C-N 114.218 -1.355 . . . . 0.0 113.473 -178.503 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 82.2 mt -70.3 -30.45 67.45 Favored 'General case' 0 N--CA 1.474 0.75 0 N-CA-C 115.201 1.556 . . . . 0.0 115.201 177.399 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.459 HG22 HG21 ' A' ' 6' ' ' VAL . 70.7 t -59.51 -41.62 85.32 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.112 0 C-N-CA 123.32 0.648 . . . . 0.0 111.09 171.635 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 97.1 mttt -56.89 -53.31 59.42 Favored 'General case' 0 N--CA 1.485 1.317 0 O-C-N 123.788 0.68 . . . . 0.0 112.24 172.271 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 mp -53.87 -44.61 70.56 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.93 1.085 . . . . 0.0 113.93 174.674 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.449 ' HA ' HD13 ' A' ' 14' ' ' LEU . 52.0 tpp -55.9 -43.16 76.99 Favored 'General case' 0 N--CA 1.482 1.157 0 C-N-CA 124.97 1.308 . . . . 0.0 113.669 173.712 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -79.41 -37.32 37.44 Favored 'General case' 0 N--CA 1.479 1.024 0 N-CA-C 115.45 1.648 . . . . 0.0 115.45 179.009 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 39.9 mt-10 -98.57 -27.08 14.18 Favored 'General case' 0 N--CA 1.479 0.99 0 N-CA-C 119.084 2.994 . . . . 0.0 119.084 -169.945 . . . . . . . . 1 1 . 1 . 026 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.452 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 17.1 mt -76.25 129.8 37.23 Favored 'General case' 0 N--CA 1.488 1.451 0 N-CA-C 117.445 2.387 . . . . 0.0 117.445 -176.178 . . . . . . . . 2 2 . 1 . 026 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 11.4 mt-10 . . . . . 0 N--CA 1.485 1.298 0 CA-C-O 117.002 -1.475 . . . . 0.0 114.805 166.279 . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 62.0 ttp . . . . . 0 C--O 1.237 0.444 0 N-CA-C 107.722 -1.214 . . . . 0.0 107.722 . . . . . . . . . 0 0 . 1 . 027 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . 0.507 ' HD2' HG21 ' A' ' 74' ' ' VAL . 28.7 t80 -109.04 120.93 44.0 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 124.848 1.343 . . . . 0.0 109.074 177.016 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 55.3 mt-30 -111.84 120.65 42.68 Favored 'General case' 0 N--CA 1.479 0.999 0 CA-C-N 113.582 -1.645 . . . . 0.0 110.842 -176.954 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 4.0 tp-100 -121.96 122.96 40.56 Favored 'General case' 0 N--CA 1.476 0.833 0 CA-C-N 114.697 -1.138 . . . . 0.0 111.735 177.727 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 50.0 mt-10 -86.45 123.98 32.27 Favored 'General case' 0 N--CA 1.483 1.204 0 O-C-N 124.608 1.192 . . . . 0.0 112.55 177.534 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . 0.441 HG21 HG13 ' A' ' 78' ' ' VAL . 53.6 t -129.16 133.26 66.1 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.326 0 CA-C-N 114.466 -1.243 . . . . 0.0 111.0 178.911 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -86.41 118.27 25.74 Favored 'General case' 0 N--CA 1.473 0.714 0 CA-C-N 113.935 -1.484 . . . . 0.0 113.675 175.423 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 2.7 mt -100.05 116.15 42.74 Favored 'Isoleucine or valine' 0 N--CA 1.478 0.968 0 N-CA-C 106.532 -1.655 . . . . 0.0 106.532 170.842 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 82.4 p -124.24 16.67 9.1 Favored 'General case' 0 N--CA 1.49 1.539 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -178.863 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -85.68 134.34 39.98 Favored Pre-proline 0 N--CA 1.484 1.266 0 CA-C-O 119.168 -0.444 . . . . 0.0 110.255 175.4 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 41.2 Cg_exo -49.27 -35.06 33.49 Favored 'Trans proline' 0 CA--C 1.539 0.769 0 C-N-CA 123.934 3.089 . . . . 0.0 115.996 179.343 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -92.63 -41.82 9.99 Favored 'General case' 0 N--CA 1.474 0.729 0 N-CA-C 115.238 1.57 . . . . 0.0 115.238 165.7 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 61.18 -133.83 48.66 Favored Glycine 0 N--CA 1.474 1.211 0 O-C-N 124.207 0.942 . . . . 0.0 111.564 -176.332 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -88.6 93.7 9.64 Favored 'General case' 0 CA--C 1.543 0.69 0 CA-C-O 121.834 0.826 . . . . 0.0 111.132 -176.79 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 25.8 p80 -105.14 -147.79 0.4 Allowed 'General case' 0 N--CA 1.48 1.047 0 CA-C-N 113.693 -1.594 . . . . 0.0 113.059 174.025 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 40.2 p -57.24 -72.34 0.08 Allowed 'General case' 0 N--CA 1.489 1.481 0 C-N-CA 125.779 1.631 . . . . 0.0 114.785 -166.818 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.724 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.34 20.8 ptt180 -62.19 -33.83 13.47 Favored Pre-proline 0 CA--C 1.553 1.087 0 N-CA-C 116.141 1.904 . . . . 0.0 116.141 176.397 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.724 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 45.5 Cg_exo -57.16 -47.35 23.02 Favored 'Trans proline' 0 N--CA 1.48 0.703 0 C-N-CA 122.356 2.037 . . . . 0.0 112.872 166.451 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -60.33 -41.67 94.06 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 113.354 0.872 . . . . 0.0 113.354 174.823 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.34 -46.99 69.74 Favored 'General case' 0 N--CA 1.487 1.394 0 N-CA-C 113.824 1.046 . . . . 0.0 113.824 173.742 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 34.6 mt-30 -62.7 -49.82 73.56 Favored 'General case' 0 N--CA 1.487 1.392 0 C-N-CA 124.137 0.975 . . . . 0.0 112.174 174.165 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -54.57 -48.32 72.21 Favored 'General case' 0 N--CA 1.48 1.047 0 C-N-CA 125.278 1.431 . . . . 0.0 111.987 178.953 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . . . . . . . . . 49.5 t -59.39 -49.88 81.92 Favored 'Isoleucine or valine' 0 N--CA 1.483 1.208 0 C-N-CA 124.145 0.978 . . . . 0.0 112.249 176.492 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -53.23 -52.79 57.8 Favored 'General case' 0 N--CA 1.483 1.217 0 O-C-N 123.868 0.73 . . . . 0.0 110.829 178.826 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.5 tp10 -72.33 -38.26 68.69 Favored 'General case' 0 N--CA 1.482 1.157 0 N-CA-C 114.158 1.169 . . . . 0.0 114.158 -178.441 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -58.93 -39.85 82.82 Favored 'General case' 0 N--CA 1.485 1.292 0 N-CA-C 113.403 0.89 . . . . 0.0 113.403 173.254 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . 0.523 ' HE2' ' HB3' ' A' ' 45' ' ' LYS . 36.9 mmtt -61.35 -21.17 63.77 Favored 'General case' 0 N--CA 1.477 0.883 0 N-CA-C 114.421 1.267 . . . . 0.0 114.421 173.33 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -90.63 4.16 81.92 Favored Glycine 0 CA--C 1.537 1.454 0 C-N-CA 124.665 1.126 . . . . 0.0 114.846 175.988 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 57.0 m-85 -114.39 131.75 56.46 Favored 'General case' 0 N--CA 1.478 0.94 0 C-N-CA 124.099 0.959 . . . . 0.0 108.478 171.822 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 46.4 p -64.48 -47.6 78.36 Favored 'General case' 0 N--CA 1.488 1.446 0 CA-C-N 114.847 -1.07 . . . . 0.0 110.925 -175.523 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 15.7 m -46.2 130.34 10.34 Favored 'General case' 0 N--CA 1.47 0.551 0 C-N-CA 127.422 2.289 . . . . 0.0 113.075 174.511 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 9.6 tp10 -80.34 112.03 17.29 Favored 'General case' 0 N--CA 1.472 0.661 0 CA-C-O 121.934 0.873 . . . . 0.0 109.385 176.597 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.52 HG21 HD12 ' A' ' 77' ' ' LEU . 2.1 mp -95.04 97.55 6.95 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.787 0 CA-C-N 112.086 -2.324 . . . . 0.0 109.744 -171.155 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.479 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 5.1 m -84.4 104.99 14.89 Favored 'General case' 0 C--N 1.32 -0.702 0 CA-C-N 112.58 -2.1 . . . . 0.0 109.437 178.768 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.479 HG13 HG21 ' A' ' 61' ' ' VAL . 5.2 t -87.38 92.81 3.9 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.916 0 N-CA-C 107.454 -1.313 . . . . 0.0 107.454 178.0 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 32.8 m -97.55 92.12 5.77 Favored 'General case' 0 N--CA 1.477 0.902 0 CA-C-N 111.443 -2.617 . . . . 0.0 110.578 -176.287 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.8 p -88.96 108.49 19.6 Favored 'General case' 0 N--CA 1.483 1.213 0 CA-C-O 122.068 0.937 . . . . 0.0 111.24 178.411 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 15.3 m120 36.33 70.77 0.15 Allowed 'General case' 0 N--CA 1.482 1.144 0 CA-C-N 112.514 -2.13 . . . . 0.0 114.545 -169.083 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 83.31 -28.24 3.85 Favored Glycine 0 N--CA 1.482 1.731 0 CA-C-N 113.884 -1.507 . . . . 0.0 116.161 -179.173 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 mtmt -88.57 111.26 21.66 Favored 'General case' 0 N--CA 1.478 0.933 0 N-CA-C 114.854 1.427 . . . . 0.0 114.854 -174.731 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 57.1 p -96.92 124.18 40.82 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 -170.979 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.646 ' HB1' ' HB3' ' A' ' 49' ' ' LYS . . . -132.58 140.52 48.29 Favored 'General case' 0 N--CA 1.474 0.755 0 CA-C-N 113.199 -1.819 . . . . 0.0 111.152 171.188 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 7.9 t -72.4 127.73 33.46 Favored 'General case' 0 N--CA 1.481 1.115 0 CA-C-O 120.897 0.379 . . . . 0.0 110.833 175.327 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -56.54 -20.75 22.1 Favored 'General case' 0 N--CA 1.475 0.802 0 CA-C-N 113.733 -1.576 . . . . 0.0 115.07 176.789 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.523 ' HB3' ' HE2' ' A' ' 27' ' ' LYS . 79.6 mttt -85.01 -8.97 58.5 Favored 'General case' 0 N--CA 1.481 1.093 0 N-CA-C 114.34 1.237 . . . . 0.0 114.34 -178.623 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 40.5 t -111.21 107.39 16.69 Favored 'General case' 0 N--CA 1.479 1.021 0 C-N-CA 123.307 0.643 . . . . 0.0 112.29 -177.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 40.9 mt -38.7 -63.15 0.54 Allowed 'General case' 0 N--CA 1.483 1.181 0 O-C-N 125.697 1.873 . . . . 0.0 112.83 170.375 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 81.1 t80 -48.72 -55.03 12.57 Favored 'General case' 0 N--CA 1.487 1.39 0 C-N-CA 124.746 1.218 . . . . 0.0 113.371 177.706 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.646 ' HB3' ' HB1' ' A' ' 42' ' ' ALA . 60.9 mttm -56.38 -53.61 55.32 Favored 'General case' 0 N--CA 1.478 0.967 0 N-CA-C 112.888 0.699 . . . . 0.0 112.888 178.919 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 2.3 tp -62.33 -48.3 80.44 Favored 'General case' 0 N--CA 1.479 0.985 0 CA-C-N 114.874 -1.057 . . . . 0.0 113.833 -178.439 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -61.89 -19.53 62.77 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 115.456 1.65 . . . . 0.0 115.456 177.348 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 43.6 p -114.67 20.18 15.46 Favored 'General case' 0 N--CA 1.486 1.366 0 N-CA-C 113.71 1.004 . . . . 0.0 113.71 179.776 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.418 HD22 ' HB3' ' A' ' 42' ' ' ALA . 16.4 tp -115.76 135.09 54.36 Favored 'General case' 0 N--CA 1.475 0.803 0 C-N-CA 124.05 0.94 . . . . 0.0 109.408 177.005 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -60.7 93.11 0.06 OUTLIER Glycine 0 N--CA 1.48 1.589 0 CA-C-N 114.845 -1.071 . . . . 0.0 112.486 175.364 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 27.2 mt -121.7 49.3 1.56 Allowed 'General case' 0 N--CA 1.482 1.135 0 CA-C-N 113.717 -1.242 . . . . 0.0 113.18 178.044 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 12.0 t -118.71 -151.75 0.49 Allowed 'General case' 0 N--CA 1.486 1.345 0 CA-C-N 115.003 -0.999 . . . . 0.0 112.184 -170.734 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 7.5 tp-100 -46.14 135.19 7.87 Favored 'General case' 0 N--CA 1.479 1.023 0 C-N-CA 127.057 2.143 . . . . 0.0 113.419 175.634 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 52.53 40.15 54.36 Favored Glycine 0 N--CA 1.483 1.784 0 CA-C-N 113.341 -1.754 . . . . 0.0 115.183 175.942 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 39.8 m -117.23 127.42 54.08 Favored 'General case' 0 N--CA 1.474 0.756 0 C-N-CA 122.862 0.465 . . . . 0.0 109.973 -174.928 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 19.6 t -100.59 115.9 42.95 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.02 0 N-CA-C 107.299 -1.371 . . . . 0.0 107.299 177.335 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.479 HG21 HG13 ' A' ' 35' ' ' VAL . 13.0 p -104.25 124.83 58.97 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.763 0 CA-C-N 113.158 -1.837 . . . . 0.0 111.971 179.724 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 2.0 m -92.19 103.24 15.74 Favored 'General case' 0 N--CA 1.474 0.764 0 CA-C-N 114.116 -1.402 . . . . 0.0 108.762 174.39 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 5.2 mp -77.85 89.91 1.11 Allowed 'Isoleucine or valine' 0 N--CA 1.476 0.848 0 N-CA-C 107.338 -1.356 . . . . 0.0 107.338 175.345 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.479 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 40.7 t -94.2 90.33 6.31 Favored 'General case' 0 N--CA 1.474 0.748 0 CA-C-N 113.194 -1.821 . . . . 0.0 111.963 -177.057 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.03 114.58 26.31 Favored 'General case' 0 N--CA 1.474 0.774 0 CA-C-N 114.946 -1.025 . . . . 0.0 111.481 -176.599 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 8.0 pt-20 -120.28 107.57 13.13 Favored 'General case' 0 N--CA 1.482 1.128 0 N-CA-C 115.147 1.536 . . . . 0.0 115.147 179.033 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 163.85 -158.61 31.18 Favored Glycine 0 CA--C 1.537 1.447 0 CA-C-N 114.337 -1.301 . . . . 0.0 113.092 173.35 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 44.2 mt-10 -54.63 -42.46 71.24 Favored 'General case' 0 N--CA 1.493 1.68 0 N-CA-C 114.053 1.131 . . . . 0.0 114.053 -173.074 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 16.8 p30 -117.92 50.84 1.1 Allowed 'General case' 0 CA--C 1.548 0.884 0 N-CA-C 114.682 1.364 . . . . 0.0 114.682 -175.743 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . 0.298 12.0 pt-20 -54.88 -50.16 69.41 Favored 'General case' 0 N--CA 1.486 1.355 0 N-CA-C 117.323 2.342 . . . . 0.0 117.323 -172.44 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 37.9 mt-30 -67.99 -33.69 75.11 Favored 'General case' 0 N--CA 1.482 1.131 0 N-CA-C 115.501 1.667 . . . . 0.0 115.501 175.922 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 86.0 tttt -61.51 -45.83 92.56 Favored 'General case' 0 N--CA 1.48 1.04 0 C-N-CA 124.927 1.291 . . . . 0.0 110.532 176.768 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.38 -47.81 84.04 Favored 'General case' 0 N--CA 1.473 0.712 0 N-CA-C 114.202 1.186 . . . . 0.0 114.202 171.251 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.507 HG21 ' HD2' ' A' ' 2' ' ' PHE . 38.4 t -58.88 -55.04 25.84 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.073 0 CA-C-O 117.823 -1.084 . . . . 0.0 112.205 178.672 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 13.6 tt0 -48.8 -51.77 27.57 Favored 'General case' 0 N--CA 1.478 0.941 0 O-C-N 124.575 1.172 . . . . 0.0 112.36 -177.131 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.47 ' HA ' ' HE2' ' A' ' 79' ' ' LYS . 34.4 t60 -72.45 -46.23 55.89 Favored 'General case' 0 CA--C 1.544 0.731 0 N-CA-C 115.184 1.55 . . . . 0.0 115.184 -179.157 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.52 HD12 HG21 ' A' ' 33' ' ' ILE 0.258 76.4 mt -68.7 -26.63 65.38 Favored 'General case' 0 N--CA 1.475 0.822 0 N-CA-C 115.617 1.71 . . . . 0.0 115.617 -176.878 . . . . . . . . 3 3 . 1 . 027 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . 0.441 HG13 HG21 ' A' ' 6' ' ' VAL . 38.9 t -57.7 -52.71 54.18 Favored 'Isoleucine or valine' 0 N--CA 1.486 1.333 0 C-N-CA 124.132 0.973 . . . . 0.0 110.217 168.091 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.47 ' HE2' ' HA ' ' A' ' 76' ' ' HIS . 56.5 mtmt -51.04 -56.13 14.05 Favored 'General case' 0 N--CA 1.476 0.859 0 O-C-N 124.827 1.33 . . . . 0.0 112.751 178.734 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 16.7 mt -54.04 -59.16 5.01 Favored 'General case' 0 N--CA 1.475 0.812 0 N-CA-C 112.983 0.735 . . . . 0.0 112.983 174.957 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.437 ' HG2' HG11 ' A' ' 61' ' ' VAL . 53.4 tpp -52.03 -49.71 62.87 Favored 'General case' 0 N--CA 1.476 0.859 0 N-CA-C 114.615 1.339 . . . . 0.0 114.615 -177.263 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -70.98 -33.37 70.36 Favored 'General case' 0 N--CA 1.481 1.078 0 N-CA-C 114.556 1.317 . . . . 0.0 114.556 -177.356 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 49.0 mt-10 -107.76 18.6 21.16 Favored 'General case' 0 N--CA 1.485 1.296 0 N-CA-C 115.358 1.614 . . . . 0.0 115.358 -171.601 . . . . . . . . 1 1 . 1 . 027 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.593 HD13 ' HB3' ' A' ' 18' ' ' PRO . 16.4 mt -102.1 138.19 39.38 Favored 'General case' 0 N--CA 1.487 1.404 0 N-CA-C 116.323 1.972 . . . . 0.0 116.323 178.459 . . . . . . . . 2 2 . 1 . 027 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 18.7 mt-10 . . . . . 0 C--O 1.254 1.298 0 C-N-CA 127.995 2.518 . . . . 0.0 109.37 169.685 . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 17.3 ttt . . . . . 0 CA--C 1.543 0.705 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 . . . . . . . . . 0 0 . 1 . 028 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 70.9 t80 -142.81 138.89 30.7 Favored 'General case' 0 N--CA 1.481 1.092 0 O-C-N 125.798 1.936 . . . . 0.0 111.243 -171.024 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 6.0 pt20 -137.41 133.26 34.57 Favored 'General case' 0 N--CA 1.478 0.965 0 N-CA-C 114.264 1.209 . . . . 0.0 114.264 178.004 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 96.9 mt-30 -128.3 150.51 50.03 Favored 'General case' 0 N--CA 1.483 1.176 0 C-N-CA 124.901 1.281 . . . . 0.0 111.378 177.825 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 34.2 mt-10 -111.25 126.35 54.78 Favored 'General case' 0 N--CA 1.478 0.928 0 N-CA-C 113.398 0.888 . . . . 0.0 113.398 -176.743 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 6.7 t -116.94 139.21 44.85 Favored 'Isoleucine or valine' 0 N--CA 1.489 1.501 0 CA-C-N 114.197 -1.365 . . . . 0.0 109.321 -177.502 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.53 HG22 HG22 ' A' ' 60' ' ' VAL . 4.0 p -97.24 110.27 22.86 Favored 'General case' 0 N--CA 1.477 0.899 0 CA-C-O 122.396 1.093 . . . . 0.0 111.032 174.996 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 17.3 mt -88.94 85.8 2.54 Favored 'Isoleucine or valine' 0 N--CA 1.479 1.009 0 N-CA-C 106.497 -1.668 . . . . 0.0 106.497 175.542 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 15.8 p -103.63 48.57 0.85 Allowed 'General case' 0 N--CA 1.477 0.883 0 CA-C-N 112.416 -2.175 . . . . 0.0 113.138 -179.895 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -126.46 131.5 23.95 Favored Pre-proline 0 N--CA 1.48 1.046 0 CA-C-N 114.361 -1.291 . . . . 0.0 110.556 -178.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . . . . . . . . . 51.1 Cg_exo -43.96 -54.88 3.46 Favored 'Trans proline' 0 CA--C 1.535 0.558 0 C-N-CA 124.927 3.751 . . . . 0.0 116.441 -174.473 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 4.0 p-10 -90.83 -36.04 14.45 Favored 'General case' 0 N--CA 1.481 1.083 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 169.587 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 64.96 -136.76 38.09 Favored Glycine 0 CA--C 1.537 1.41 0 C-N-CA 124.383 0.992 . . . . 0.0 112.771 174.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.715 HD23 HD13 ' A' ' 55' ' ' LEU . 5.8 tp -92.42 80.06 4.93 Favored 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 122.492 1.139 . . . . 0.0 109.038 -176.722 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 20.1 p80 -90.94 -166.14 1.51 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 113.038 -1.892 . . . . 0.0 112.738 177.446 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 52.6 p -33.17 -75.18 0.03 OUTLIER 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 127.528 2.331 . . . . 0.0 117.155 -174.786 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.57 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.383 22.4 ptt85 -69.13 -31.69 2.88 Favored Pre-proline 0 CA--C 1.548 0.891 0 N-CA-C 117.896 2.554 . . . . 0.0 117.896 179.322 . . . . . . . . 3 3 . 1 . 028 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.57 ' HD3' ' HG3' ' A' ' 17' ' ' ARG . 47.7 Cg_exo -60.81 -40.72 51.58 Favored 'Trans proline' 0 CA--C 1.54 0.821 0 C-N-CA 121.94 1.76 . . . . 0.0 112.626 165.19 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.486 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -59.32 -42.42 91.36 Favored 'General case' 0 N--CA 1.476 0.862 0 C-N-CA 123.566 0.746 . . . . 0.0 112.958 173.254 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -53.03 -42.45 65.7 Favored 'General case' 0 N--CA 1.485 1.304 0 N-CA-C 114.177 1.177 . . . . 0.0 114.177 172.485 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 33.9 mt-30 -69.7 -43.94 71.42 Favored 'General case' 0 N--CA 1.478 0.97 0 N-CA-C 113.349 0.87 . . . . 0.0 113.349 175.165 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 10.5 t80 -57.61 -42.6 83.6 Favored 'General case' 0 N--CA 1.478 0.938 0 O-C-N 124.184 0.927 . . . . 0.0 112.119 175.238 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.582 HG21 ' HA ' ' A' ' 47' ' ' LEU . 60.6 t -59.73 -57.01 13.56 Favored 'Isoleucine or valine' 0 N--CA 1.488 1.438 0 C-N-CA 124.059 0.944 . . . . 0.0 110.395 173.05 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 14.7 tmtt? -48.27 -46.61 36.04 Favored 'General case' 0 N--CA 1.486 1.33 0 O-C-N 124.538 1.148 . . . . 0.0 112.4 179.247 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 8.0 tp10 -68.85 -54.74 14.0 Favored 'General case' 0 N--CA 1.477 0.886 0 O-C-N 124.684 1.24 . . . . 0.0 112.754 179.059 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -55.88 -35.53 66.61 Favored 'General case' 0 N--CA 1.489 1.495 0 N-CA-C 114.216 1.191 . . . . 0.0 114.216 177.577 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 38.8 mmtt -53.87 -39.01 65.33 Favored 'General case' 0 N--CA 1.484 1.262 0 N-CA-C 115.214 1.561 . . . . 0.0 115.214 173.298 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -61.86 -37.01 93.64 Favored Glycine 0 N--CA 1.483 1.768 0 O-C-N 124.775 1.297 . . . . 0.0 113.632 -179.412 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . 0.602 ' HE1' ' HE2' ' A' ' 72' ' ' LYS . 72.1 m-85 -76.82 140.08 40.56 Favored 'General case' 0 C--O 1.24 0.587 0 C-N-CA 123.529 0.731 . . . . 0.0 111.746 178.247 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 48.0 p -65.47 -47.22 76.82 Favored 'General case' 0 N--CA 1.489 1.519 0 CA-C-N 114.658 -1.155 . . . . 0.0 112.353 -174.294 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 33.8 m -49.37 132.0 20.39 Favored 'General case' 0 N--CA 1.477 0.883 0 C-N-CA 125.665 1.586 . . . . 0.0 112.531 178.239 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 16.7 tp10 -73.74 131.56 41.72 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 119.003 -1.079 . . . . 0.0 109.427 170.759 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . . . . . . . . . 34.9 mt -119.37 115.28 47.22 Favored 'Isoleucine or valine' 0 N--CA 1.476 0.838 0 CA-C-N 113.136 -1.847 . . . . 0.0 110.872 -164.275 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 1.2 m -103.75 133.47 48.7 Favored 'General case' 0 N--CA 1.474 0.726 0 CA-C-N 112.262 -2.245 . . . . 0.0 108.845 179.695 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.676 HG13 HG21 ' A' ' 61' ' ' VAL . 10.6 t -116.19 94.77 3.3 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.895 0 CA-C-N 113.66 -1.609 . . . . 0.0 106.857 177.699 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 7.4 m -94.56 84.13 4.24 Favored 'General case' 0 N--CA 1.475 0.812 0 CA-C-N 112.375 -2.193 . . . . 0.0 109.481 -176.923 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 91.3 p -85.19 97.91 10.17 Favored 'General case' 0 N--CA 1.484 1.233 0 CA-C-N 114.432 -1.258 . . . . 0.0 111.152 -177.976 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 31.0 m120 45.52 68.61 0.55 Allowed 'General case' 0 N--CA 1.484 1.246 0 CA-C-N 113.071 -1.877 . . . . 0.0 113.778 -169.651 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 80.49 -35.19 2.24 Favored Glycine 0 N--CA 1.48 1.569 0 CA-C-N 113.672 -1.604 . . . . 0.0 114.915 178.101 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 88.4 mttt -73.02 98.06 2.45 Favored 'General case' 0 N--CA 1.474 0.747 0 C-N-CA 124.06 0.944 . . . . 0.0 111.205 -179.439 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 67.6 p -84.91 124.82 32.07 Favored 'General case' 0 N--CA 1.469 0.489 0 CA-C-N 113.744 -1.571 . . . . 0.0 114.683 -179.735 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.722 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -132.95 156.63 46.94 Favored 'General case' 0 N--CA 1.48 1.059 0 CA-C-N 112.585 -2.098 . . . . 0.0 109.961 167.08 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 22.8 t -80.23 124.7 29.04 Favored 'General case' 0 N--CA 1.473 0.717 0 CA-C-O 121.481 0.658 . . . . 0.0 110.422 174.187 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.465 ' HB2' HG23 ' A' ' 35' ' ' VAL . . . -58.31 -36.62 73.62 Favored 'General case' 0 N--CA 1.484 1.238 0 CA-C-N 113.725 -1.58 . . . . 0.0 111.237 173.75 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 49.3 mtpt -77.85 13.67 1.3 Allowed 'General case' 0 CA--C 1.553 1.085 0 CA-C-N 114.267 -1.333 . . . . 0.0 113.751 -179.741 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 26.6 t -135.12 110.42 9.0 Favored 'General case' 0 N--CA 1.476 0.849 0 N-CA-C 113.277 0.843 . . . . 0.0 113.277 179.429 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.582 ' HA ' HG21 ' A' ' 23' ' ' VAL . 44.9 tp -45.04 -74.52 0.03 OUTLIER 'General case' 0 N--CA 1.485 1.295 0 N-CA-C 116.173 1.916 . . . . 0.0 116.173 -174.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 73.4 t80 -54.36 -34.6 61.5 Favored 'General case' 0 N--CA 1.482 1.155 0 N-CA-C 114.528 1.307 . . . . 0.0 114.528 179.541 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 51.8 mttm -66.94 -45.19 78.57 Favored 'General case' 0 N--CA 1.474 0.759 0 N-CA-C 112.895 0.702 . . . . 0.0 112.895 178.308 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.454 HD13 ' HA ' ' A' ' 44' ' ' ALA . 14.6 tp -68.17 -42.03 80.6 Favored 'General case' 0 N--CA 1.479 0.993 0 O-C-N 124.432 1.082 . . . . 0.0 112.761 175.885 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 36.4 mt-30 -62.18 -36.33 81.54 Favored 'General case' 0 N--CA 1.484 1.275 0 N-CA-C 114.76 1.393 . . . . 0.0 114.76 175.152 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 33.9 p -88.89 15.79 7.92 Favored 'General case' 0 N--CA 1.489 1.506 0 N-CA-C 114.302 1.223 . . . . 0.0 114.302 175.898 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.722 HD22 ' HB3' ' A' ' 42' ' ' ALA . 18.0 tp -110.76 130.37 55.59 Favored 'General case' 0 CA--C 1.542 0.67 0 C-N-CA 124.65 1.18 . . . . 0.0 108.065 177.005 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -70.34 86.54 0.33 Allowed Glycine 0 N--CA 1.485 1.916 0 CA-C-N 114.831 -1.077 . . . . 0.0 113.061 -175.594 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.715 HD13 HD23 ' A' ' 14' ' ' LEU . 5.3 mt -106.92 62.2 0.63 Allowed 'General case' 0 N--CA 1.479 0.977 0 CA-C-O 122.938 1.351 . . . . 0.0 111.378 176.981 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 11.8 t -123.65 -164.71 1.25 Allowed 'General case' 0 N--CA 1.487 1.411 0 CA-C-N 114.593 -1.185 . . . . 0.0 112.006 -169.18 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 5.4 tp-100 -55.51 129.12 37.62 Favored 'General case' 0 N--CA 1.481 1.117 0 C-N-CA 124.392 1.077 . . . . 0.0 112.56 179.343 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 66.3 38.66 93.9 Favored Glycine 0 CA--C 1.545 1.91 0 CA-C-N 113.215 -1.811 . . . . 0.0 115.084 -179.34 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 7.3 m -105.94 138.32 42.33 Favored 'General case' 0 N--CA 1.479 1.003 0 N-CA-C 109.432 -0.581 . . . . 0.0 109.432 176.534 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.53 HG22 HG22 ' A' ' 7' ' ' THR . 12.1 t -114.43 122.39 68.45 Favored 'Isoleucine or valine' 0 N--CA 1.479 0.993 0 N-CA-C 107.891 -1.152 . . . . 0.0 107.891 172.686 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.676 HG21 HG13 ' A' ' 35' ' ' VAL . 14.9 p -116.71 117.59 55.97 Favored 'Isoleucine or valine' 0 CA--C 1.545 0.765 0 N-CA-C 114.915 1.45 . . . . 0.0 114.915 -174.53 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.5 m -80.38 100.8 8.63 Favored 'General case' 0 CA--C 1.543 0.682 0 CA-C-N 113.309 -1.768 . . . . 0.0 109.015 170.022 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.467 HG12 HG22 ' A' ' 35' ' ' VAL . 64.2 mt -92.6 111.33 24.26 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.852 0 CA-C-N 114.932 -1.031 . . . . 0.0 108.525 176.848 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 43.5 t -109.08 131.55 54.96 Favored 'General case' 0 N--CA 1.476 0.875 0 CA-C-N 113.507 -1.679 . . . . 0.0 111.668 -177.533 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -121.14 125.99 48.61 Favored 'General case' 0 N--CA 1.481 1.113 0 O-C-N 125.15 1.532 . . . . 0.0 111.971 172.921 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 14.4 pt-20 -118.3 89.55 3.15 Favored 'General case' 0 CA--C 1.55 0.957 0 N-CA-C 115.534 1.679 . . . . 0.0 115.534 177.224 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 175.1 -156.12 21.84 Favored Glycine 0 CA--C 1.539 1.542 0 CA-C-N 113.193 -1.821 . . . . 0.0 112.611 169.194 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 35.7 mt-10 -57.52 -53.82 53.81 Favored 'General case' 0 N--CA 1.484 1.259 0 C-N-CA 124.922 1.289 . . . . 0.0 114.19 -177.552 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 3.3 p30 -81.88 46.14 0.97 Allowed 'General case' 0 N--CA 1.48 1.066 0 N-CA-C 114.039 1.126 . . . . 0.0 114.039 177.543 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . 0.441 ' CD ' HE22 ' A' ' 71' ' ' GLN . 4.4 pt-20 -55.25 -58.06 9.25 Favored 'General case' 0 CA--C 1.545 0.762 0 N-CA-C 116.038 1.866 . . . . 0.0 116.038 -176.396 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . 0.441 HE22 ' CD ' ' A' ' 70' ' ' GLU . 10.9 mp0 -64.67 -48.81 73.36 Favored 'General case' 0 N--CA 1.488 1.431 0 N-CA-C 113.106 0.78 . . . . 0.0 113.106 171.649 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . 0.602 ' HE2' ' HE1' ' A' ' 29' ' ' PHE . 77.9 tttt -54.75 -49.3 71.19 Favored 'General case' 0 N--CA 1.481 1.092 0 C-N-CA 125.48 1.512 . . . . 0.0 113.062 -173.03 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -57.46 -52.6 64.73 Favored 'General case' 0 CA--C 1.54 0.583 0 C-N-CA 123.775 0.83 . . . . 0.0 112.88 177.17 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 5.4 t -68.97 -49.16 65.65 Favored 'Isoleucine or valine' 0 N--CA 1.482 1.139 0 CA-C-O 118.146 -0.931 . . . . 0.0 110.887 -175.403 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 16.0 tt0 -53.06 -50.93 63.34 Favored 'General case' 0 N--CA 1.48 1.056 0 C-N-CA 124.56 1.144 . . . . 0.0 112.65 179.296 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 16.9 t60 -61.6 -45.76 92.74 Favored 'General case' 0 CA--C 1.549 0.922 0 C-N-CA 123.942 0.897 . . . . 0.0 112.052 177.19 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 63.0 mt -65.08 -38.49 90.91 Favored 'General case' 0 N--CA 1.481 1.089 0 N-CA-C 114.742 1.386 . . . . 0.0 114.742 177.026 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 79.4 t -59.06 -48.45 86.68 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.261 0 C-N-CA 124.053 0.941 . . . . 0.0 110.295 173.845 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 74.3 tttt -56.48 -56.88 15.66 Favored 'General case' 0 N--CA 1.479 0.978 0 C-N-CA 124.183 0.993 . . . . 0.0 111.199 172.794 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 6.5 tp -51.71 -43.66 62.91 Favored 'General case' 0 N--CA 1.476 0.858 0 C-N-CA 125.533 1.533 . . . . 0.0 113.501 -177.783 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . . . . . . . . . 57.3 tpp -49.53 -47.87 48.62 Favored 'General case' 0 N--CA 1.479 1.025 0 C-N-CA 125.121 1.368 . . . . 0.0 112.654 176.613 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -67.08 -24.73 65.99 Favored 'General case' 0 CA--C 1.547 0.844 0 N-CA-C 114.962 1.467 . . . . 0.0 114.962 -178.39 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 50.2 mt-10 -100.32 23.49 10.07 Favored 'General case' 0 CA--C 1.556 1.192 0 N-CA-C 113.487 0.921 . . . . 0.0 113.487 -177.511 . . . . . . . . 1 1 . 1 . 028 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.423 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 34.3 mt -132.26 130.26 40.68 Favored 'General case' 0 N--CA 1.482 1.167 0 C-N-CA 124.414 1.086 . . . . 0.0 113.834 178.31 . . . . . . . . 2 2 . 1 . 028 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 15.3 tt0 . . . . . 0 C--O 1.254 1.292 0 C-N-CA 125.84 1.656 . . . . 0.0 107.121 176.114 . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . . . . . . . . . 65.7 ttp . . . . . 0 N--CA 1.468 0.433 0 N-CA-C 106.83 -1.544 . . . . 0.0 106.83 . . . . . . . . . 0 0 . 1 . 029 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -116.52 130.15 56.59 Favored 'General case' 0 C--O 1.217 -0.634 0 O-C-N 125.004 1.44 . . . . 0.0 109.449 177.038 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 86.0 mt-30 -124.19 131.26 53.52 Favored 'General case' 0 N--CA 1.477 0.909 0 CA-C-N 112.061 -2.336 . . . . 0.0 110.452 -177.546 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 13.3 mt-30 -128.08 98.55 5.16 Favored 'General case' 0 N--CA 1.473 0.684 0 CA-C-N 112.986 -1.915 . . . . 0.0 111.779 168.095 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 44.8 mt-10 -68.22 102.29 1.34 Allowed 'General case' 0 N--CA 1.478 0.949 0 CA-C-N 113.437 -1.71 . . . . 0.0 109.878 168.905 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 3.0 m -126.38 142.67 42.31 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.666 0 CA-C-N 113.776 -1.556 . . . . 0.0 113.235 -179.272 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . . . . . . . . . 18.4 p -87.75 126.91 35.26 Favored 'General case' 0 N--CA 1.476 0.838 0 CA-C-N 114.079 -1.418 . . . . 0.0 111.767 179.098 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . 0.483 HD12 ' HB ' ' A' ' 59' ' ' THR . 49.1 mt -75.55 108.59 7.78 Favored 'Isoleucine or valine' 0 N--CA 1.477 0.914 0 CA-C-N 114.278 -1.328 . . . . 0.0 107.581 169.829 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 37.6 p -92.38 -16.37 26.05 Favored 'General case' 0 N--CA 1.483 1.219 0 CA-C-N 113.353 -1.749 . . . . 0.0 115.419 178.056 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . . . . . . . . . . . -63.49 126.06 88.69 Favored Pre-proline 0 N--CA 1.481 1.095 0 CA-C-O 117.918 -1.039 . . . . 0.0 110.755 176.389 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.425 ' HA ' ' HB2' ' A' ' 57' ' ' GLN . 89.2 Cg_exo -49.74 -54.2 5.83 Favored 'Trans proline' 0 N--CA 1.49 1.274 0 C-N-CA 124.445 3.43 . . . . 0.0 113.139 -175.272 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 8.1 p-10 -66.55 -59.05 3.99 Favored 'General case' 0 N--CA 1.478 0.941 0 C-N-CA 126.211 1.805 . . . . 0.0 112.087 170.184 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . . . . . . . . . . . 93.57 -151.59 20.41 Favored Glycine 0 CA--C 1.534 1.273 0 O-C-N 124.538 1.149 . . . . 0.0 111.86 176.907 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.799 HD23 HD13 ' A' ' 55' ' ' LEU . 11.5 tp -92.55 70.01 4.94 Favored 'General case' 0 N--CA 1.48 1.053 0 CA-C-N 113.151 -1.524 . . . . 0.0 108.407 -175.482 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 28.7 p80 -78.32 -155.58 0.08 Allowed 'General case' 0 N--CA 1.473 0.702 0 CA-C-N 113.633 -1.621 . . . . 0.0 114.488 -177.115 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 57.8 p -43.28 -70.41 0.11 Allowed 'General case' 0 N--CA 1.491 1.603 0 C-N-CA 126.654 1.982 . . . . 0.0 114.805 -170.813 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . 0.479 ' HG3' ' HD3' ' A' ' 18' ' ' PRO 0.327 12.8 ptt180 -73.21 -32.46 1.68 Allowed Pre-proline 0 N--CA 1.48 1.069 0 N-CA-C 116.231 1.937 . . . . 0.0 116.231 179.708 . . . . . . . . 3 3 . 1 . 029 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.565 ' HB3' ' HB3' ' A' ' 84' ' ' LEU . 47.6 Cg_exo -58.09 -47.15 21.42 Favored 'Trans proline' 0 C--N 1.35 0.637 0 C-N-CA 122.732 2.288 . . . . 0.0 113.636 167.698 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.48 ' O ' HG23 ' A' ' 23' ' ' VAL . . . -57.88 -47.16 83.56 Favored 'General case' 0 N--CA 1.484 1.256 0 N-CA-C 113.36 0.874 . . . . 0.0 113.36 175.479 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -54.66 -39.85 68.47 Favored 'General case' 0 CA--C 1.547 0.846 0 N-CA-C 114.887 1.44 . . . . 0.0 114.887 174.641 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . . . . . . . . . 36.6 tt0 -73.1 -42.14 63.29 Favored 'General case' 0 N--CA 1.483 1.216 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 176.819 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . 0.539 ' HE2' ' HB2' ' A' ' 81' ' ' MET . 12.1 t80 -54.76 -41.78 70.87 Favored 'General case' 0 N--CA 1.48 1.072 0 O-C-N 123.68 0.612 . . . . 0.0 111.512 174.079 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.574 HG21 ' HA ' ' A' ' 47' ' ' LEU . 48.1 t -57.14 -49.71 78.8 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 C-N-CA 123.881 0.872 . . . . 0.0 111.61 174.771 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 18.0 tttt -52.81 -52.56 56.39 Favored 'General case' 0 N--CA 1.481 1.119 0 C-N-CA 123.611 0.764 . . . . 0.0 111.378 178.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -67.67 -44.55 77.57 Favored 'General case' 0 N--CA 1.479 1.02 0 O-C-N 124.757 1.286 . . . . 0.0 112.862 -178.503 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -56.85 -41.9 78.75 Favored 'General case' 0 N--CA 1.479 0.982 0 N-CA-C 114.245 1.202 . . . . 0.0 114.245 175.766 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 63.6 mttm -56.63 -32.48 65.35 Favored 'General case' 0 N--CA 1.479 0.985 0 N-CA-C 114.954 1.464 . . . . 0.0 114.954 174.371 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -68.88 -13.76 66.86 Favored Glycine 0 CA--C 1.544 1.891 0 O-C-N 125.201 1.563 . . . . 0.0 115.192 178.3 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 83.3 m-85 -101.84 138.47 38.76 Favored 'General case' 0 N--CA 1.485 1.286 0 CA-C-O 121.161 0.505 . . . . 0.0 110.478 176.673 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 63.3 p -64.3 -41.26 96.95 Favored 'General case' 0 N--CA 1.483 1.21 0 CA-C-N 114.563 -1.199 . . . . 0.0 112.448 -175.557 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 20.3 m -54.19 141.44 29.23 Favored 'General case' 0 N--CA 1.472 0.654 0 C-N-CA 126.103 1.761 . . . . 0.0 112.319 174.781 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 27.3 tp10 -86.19 106.33 17.22 Favored 'General case' 0 N--CA 1.48 1.026 0 CA-C-O 122.064 0.935 . . . . 0.0 109.377 174.25 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.521 HD12 ' HD2' ' A' ' 45' ' ' LYS . 3.7 mp -85.66 93.16 3.64 Favored 'Isoleucine or valine' 0 N--CA 1.481 1.087 0 CA-C-N 112.96 -1.927 . . . . 0.0 110.322 -175.089 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -74.18 129.95 38.81 Favored 'General case' 0 N--CA 1.476 0.858 0 CA-C-N 113.732 -1.577 . . . . 0.0 107.753 169.223 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.445 HG13 ' CG2' ' A' ' 61' ' ' VAL . 10.6 t -114.35 92.96 2.27 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.697 0 N-CA-C 107.029 -1.471 . . . . 0.0 107.029 176.59 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . . . . . . . . . 23.8 m -93.1 93.22 8.18 Favored 'General case' 0 N--CA 1.478 0.953 0 CA-C-N 111.184 -2.734 . . . . 0.0 109.731 -175.141 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . 0.417 ' HB2' ' CG2' ' A' ' 59' ' ' THR . 99.4 p -101.29 100.26 10.75 Favored 'General case' 0 CA--C 1.544 0.731 0 CA-C-N 113.865 -1.516 . . . . 0.0 111.32 -176.834 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 17.3 m120 45.33 70.93 0.31 Allowed 'General case' 0 N--CA 1.485 1.321 0 N-CA-C 114.295 1.22 . . . . 0.0 114.295 -176.005 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 78.25 -31.02 1.85 Allowed Glycine 0 CA--C 1.546 2.011 0 CA-C-N 114.489 -1.232 . . . . 0.0 115.156 -177.108 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 73.9 mttt -80.99 93.71 6.41 Favored 'General case' 0 N--CA 1.477 0.916 0 CA-C-O 122.186 0.993 . . . . 0.0 113.564 -177.198 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . . . . . . . . . 4.0 p -88.68 104.41 16.84 Favored 'General case' 0 N--CA 1.479 1.008 0 CA-C-N 112.726 -2.034 . . . . 0.0 113.907 -179.474 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . 0.409 ' HB3' HD22 ' A' ' 53' ' ' LEU . . . -129.43 134.68 47.96 Favored 'General case' 0 N--CA 1.48 1.036 0 CA-C-N 113.474 -1.694 . . . . 0.0 110.7 175.369 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 30.3 t -67.4 127.57 33.17 Favored 'General case' 0 N--CA 1.48 1.042 0 CA-C-O 122.272 1.034 . . . . 0.0 113.273 175.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . . . . . . . . . . . -62.22 -30.96 71.46 Favored 'General case' 0 CA--C 1.542 0.67 0 CA-C-N 112.146 -2.297 . . . . 0.0 112.414 174.01 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . 0.521 ' HD2' HD12 ' A' ' 33' ' ' ILE . 59.2 mtpt -72.75 -0.64 13.81 Favored 'General case' 0 N--CA 1.479 0.976 0 N-CA-C 114.251 1.204 . . . . 0.0 114.251 178.883 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . . . . . . . . . 36.8 t -121.69 129.07 52.49 Favored 'General case' 0 N--CA 1.483 1.176 0 CA-C-O 121.349 0.595 . . . . 0.0 111.879 170.31 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . 0.574 ' HA ' HG21 ' A' ' 23' ' ' VAL . 1.6 tp -57.92 -70.48 0.13 Allowed 'General case' 0 N--CA 1.484 1.244 0 CA-C-N 112.825 -1.989 . . . . 0.0 112.651 -173.072 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 0.9 OUTLIER -55.56 -39.17 70.3 Favored 'General case' 0 N--CA 1.475 0.806 0 N-CA-C 115.626 1.713 . . . . 0.0 115.626 -179.402 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . . . . . . . . . 50.1 mmtt -56.23 -48.91 75.55 Favored 'General case' 0 N--CA 1.481 1.11 0 N-CA-C 113.57 0.952 . . . . 0.0 113.57 172.292 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . . . . . . . . . 24.3 tp -75.19 -41.62 57.53 Favored 'General case' 0 CA--C 1.55 0.972 0 N-CA-C 114.294 1.22 . . . . 0.0 114.294 175.644 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 32.7 tt0 -56.13 -45.49 79.54 Favored 'General case' 0 N--CA 1.479 0.993 0 C-N-CA 124.644 1.178 . . . . 0.0 113.1 177.815 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 63.7 p -75.22 -7.82 54.91 Favored 'General case' 0 N--CA 1.484 1.271 0 N-CA-C 115.392 1.627 . . . . 0.0 115.392 175.296 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . 0.409 HD22 ' HB3' ' A' ' 42' ' ' ALA . 16.1 tp -86.37 118.72 25.99 Favored 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 122.175 0.988 . . . . 0.0 109.244 179.174 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -71.19 102.26 1.06 Allowed Glycine 0 N--CA 1.485 1.93 0 CA-C-N 113.237 -1.801 . . . . 0.0 113.081 -177.343 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . 0.799 HD13 HD23 ' A' ' 14' ' ' LEU . 5.9 mt -116.42 96.5 5.56 Favored 'General case' 0 CA--C 1.545 0.765 0 C-N-CA 124.221 1.008 . . . . 0.0 110.604 -175.484 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 9.0 t -140.29 171.24 14.44 Favored 'General case' 0 N--CA 1.492 1.645 0 C-N-CA 124.086 0.954 . . . . 0.0 113.175 -165.155 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . 0.425 ' HB2' ' HA ' ' A' ' 11' ' ' PRO . 22.7 tt0 -52.77 110.89 0.57 Allowed 'General case' 0 N--CA 1.485 1.276 0 CA-C-O 121.834 0.826 . . . . 0.0 111.828 174.085 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 110.38 -7.89 30.52 Favored Glycine 0 CA--C 1.537 1.428 0 CA-C-N 112.709 -2.041 . . . . 0.0 115.275 -179.58 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . 0.483 ' HB ' HD12 ' A' ' 8' ' ' ILE . 7.2 m -75.31 119.9 20.05 Favored 'General case' 0 N--CA 1.473 0.688 0 CA-C-N 118.141 0.97 . . . . 0.0 111.665 -179.284 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . . . . . . . . . 13.5 t -88.43 101.3 11.6 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.778 0 N-CA-C 106.06 -1.829 . . . . 0.0 106.06 174.859 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . 0.445 ' CG2' HG13 ' A' ' 35' ' ' VAL . 14.5 p -109.7 119.87 59.75 Favored 'Isoleucine or valine' 0 CA--C 1.547 0.843 0 CA-C-N 112.891 -1.959 . . . . 0.0 111.964 -174.557 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . . . . . . . . . 1.2 m -89.63 103.04 15.72 Favored 'General case' 0 N--CA 1.476 0.842 0 CA-C-N 113.071 -1.877 . . . . 0.0 109.535 175.261 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . . . . . . . . . 4.0 mp -77.78 91.0 1.15 Allowed 'Isoleucine or valine' 0 N--CA 1.481 1.078 0 N-CA-C 106.067 -1.827 . . . . 0.0 106.067 168.073 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . . . . . . . . . 30.4 t -105.65 92.55 4.23 Favored 'General case' 0 N--CA 1.47 0.546 0 CA-C-N 112.381 -2.191 . . . . 0.0 111.427 -171.33 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -96.41 111.04 23.28 Favored 'General case' 0 N--CA 1.475 0.815 0 CA-C-N 113.887 -1.506 . . . . 0.0 111.188 -176.999 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . . . . . . . . . 9.7 pt-20 -106.48 122.41 46.24 Favored 'General case' 0 N--CA 1.479 0.98 0 N-CA-C 115.192 1.553 . . . . 0.0 115.192 177.32 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . 137.78 -154.91 22.89 Favored Glycine 0 N--CA 1.481 1.648 0 CA-C-N 113.025 -1.898 . . . . 0.0 111.126 -176.243 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 17.5 mt-10 -67.75 -63.92 0.96 Allowed 'General case' 0 N--CA 1.478 0.939 0 C-N-CA 125.356 1.463 . . . . 0.0 114.081 -171.547 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 12.3 p30 -80.22 40.04 0.47 Allowed 'General case' 0 N--CA 1.476 0.852 0 N-CA-C 114.736 1.384 . . . . 0.0 114.736 179.079 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 10.1 pt-20 -51.39 -51.21 56.69 Favored 'General case' 0 N--CA 1.481 1.091 0 N-CA-C 114.821 1.415 . . . . 0.0 114.821 -177.174 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 90.5 mt-30 -66.85 -54.33 23.5 Favored 'General case' 0 N--CA 1.485 1.304 0 C-N-CA 124.053 0.941 . . . . 0.0 112.833 177.824 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 79.4 tttt -53.44 -42.57 67.25 Favored 'General case' 0 N--CA 1.48 1.05 0 C-N-CA 125.386 1.475 . . . . 0.0 112.924 179.244 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -59.17 -54.96 40.96 Favored 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.6 0.76 . . . . 0.0 112.575 173.721 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . . . . . . . . . 98.5 t -58.25 -51.2 74.09 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.931 0 CA-C-O 118.255 -0.879 . . . . 0.0 111.348 178.089 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 51.5 tt0 -48.2 -65.18 0.61 Allowed 'General case' 0 N--CA 1.478 0.969 0 C-N-CA 124.816 1.246 . . . . 0.0 113.173 -179.409 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . . . . . . . . . 85.8 t60 -72.78 -27.87 62.26 Favored 'General case' 0 N--CA 1.476 0.833 0 N-CA-C 114.417 1.265 . . . . 0.0 114.417 -176.444 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . . . . . . . . . 58.4 mt -75.1 -41.78 57.92 Favored 'General case' 0 N--CA 1.476 0.844 0 N-CA-C 115.897 1.814 . . . . 0.0 115.897 174.486 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 71.8 t -61.05 -44.07 97.49 Favored 'Isoleucine or valine' 0 N--CA 1.484 1.264 0 O-C-N 123.271 0.357 . . . . 0.0 110.477 174.68 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . . . . . . . . . 70.4 tttt -49.01 -62.05 1.74 Allowed 'General case' 0 N--CA 1.479 1.021 0 O-C-N 125.159 1.537 . . . . 0.0 111.57 169.205 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -54.64 -46.66 73.97 Favored 'General case' 0 N--CA 1.485 1.316 0 CA-C-N 114.918 -1.037 . . . . 0.0 113.733 179.373 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.539 ' HB2' ' HE2' ' A' ' 22' ' ' PHE . 24.4 ttp -50.9 -46.85 60.76 Favored 'General case' 0 N--CA 1.48 1.035 0 C-N-CA 125.346 1.458 . . . . 0.0 113.045 178.525 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -66.07 -46.65 76.99 Favored 'General case' 0 N--CA 1.482 1.153 0 O-C-N 124.461 1.1 . . . . 0.0 112.706 177.779 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -87.67 32.9 0.71 Allowed 'General case' 0 N--CA 1.48 1.072 0 C-N-CA 124.753 1.221 . . . . 0.0 114.088 -173.42 . . . . . . . . 1 1 . 1 . 029 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.565 ' HB3' ' HB3' ' A' ' 18' ' ' PRO . 34.9 mt -132.36 99.28 4.63 Favored 'General case' 0 N--CA 1.479 1.003 0 CA-C-O 122.568 1.175 . . . . 0.0 112.4 -179.327 . . . . . . . . 2 2 . 1 . 029 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 30.3 mt-10 . . . . . 0 C--O 1.255 1.352 0 CA-C-N 113.091 -1.868 . . . . 0.0 111.631 -169.976 . . . . . . . . 0 0 . 1 . 030 nuclear nobuild full ' A' A ' 1' ' ' MET . . . . . 0.44 ' HG3' ' HB3' ' A' ' 66' ' ' GLU . 17.7 ttt . . . . . 0 C--O 1.239 0.535 0 N-CA-C 106.73 -1.582 . . . . 0.0 106.73 . . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 2' ' ' PHE . . . . . . . . . . . . . 73.6 t80 -137.63 141.18 41.22 Favored 'General case' 0 C--N 1.321 -0.663 0 O-C-N 126.021 2.075 . . . . 0.0 111.386 -173.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 3' ' ' GLN . . . . . . . . . . . . . 66.6 mt-30 -125.14 131.16 53.3 Favored 'General case' 0 N--CA 1.478 0.946 0 O-C-N 125.42 1.7 . . . . 0.0 109.475 174.753 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 4' ' ' GLN . . . . . . . . . . . . . 43.2 tt0 -126.12 136.43 52.87 Favored 'General case' 0 N--CA 1.473 0.704 0 O-C-N 125.518 1.761 . . . . 0.0 109.872 172.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 5' ' ' GLU . . . . . . . . . . . . . 5.3 tt0 -115.28 94.2 4.62 Favored 'General case' 0 CA--C 1.545 0.777 0 CA-C-O 122.509 1.147 . . . . 0.0 114.058 -169.928 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 6' ' ' VAL . . . . . . . . . . . . . 23.0 m -120.95 159.95 22.28 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.289 0 CA-C-N 113.521 -1.672 . . . . 0.0 114.328 -173.126 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 7' ' ' THR . . . . . 0.752 HG22 HG22 ' A' ' 60' ' ' VAL . 75.2 p -107.61 155.5 20.07 Favored 'General case' 0 N--CA 1.489 1.51 0 N-CA-C 115.54 1.681 . . . . 0.0 115.54 -179.349 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 16.4 mt -103.23 113.76 40.93 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.807 0 CA-C-N 111.211 -2.722 . . . . 0.0 108.401 168.606 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 9' ' ' THR . . . . . . . . . . . . . 24.7 p -94.84 -30.87 13.98 Favored 'General case' 0 N--CA 1.477 0.907 0 CA-C-N 112.269 -2.241 . . . . 0.0 116.659 175.214 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 10' ' ' ALA . . . . . 0.429 ' HA ' ' HD3' ' A' ' 11' ' ' PRO . . . -59.8 135.76 89.9 Favored Pre-proline 0 N--CA 1.484 1.269 0 N-CA-C 114.634 1.346 . . . . 0.0 114.634 -177.406 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 11' ' ' PRO . . . . . 0.429 ' HD3' ' HA ' ' A' ' 10' ' ' ALA . 76.9 Cg_exo -50.13 -48.68 18.81 Favored 'Trans proline' 0 CA--C 1.54 0.805 0 C-N-CA 124.816 3.677 . . . . 0.0 115.415 -178.646 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . 0.285 0.4 OUTLIER -95.48 -16.88 21.91 Favored 'General case' 0 N--CA 1.483 1.2 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 170.96 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 13' ' ' GLY . . . . . 0.404 ' HA2' ' HB3' ' A' ' 10' ' ' ALA . . . 46.88 -128.81 11.71 Favored Glycine 0 CA--C 1.527 0.838 0 C-N-CA 126.163 1.84 . . . . 0.0 115.576 178.277 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 14' ' ' LEU . . . . . 0.549 HD11 ' HG2' ' A' ' 81' ' ' MET . 81.0 mt -98.47 54.93 1.07 Allowed 'General case' 0 C--O 1.2 -1.515 0 CA-C-N 111.933 -2.133 . . . . 0.0 112.4 -171.926 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 15' ' ' HIS . . . . . . . . . . . . . 26.5 p80 -68.66 -166.43 0.08 Allowed 'General case' 0 C--N 1.364 1.233 0 CA-C-N 112.031 -2.349 . . . . 0.0 113.217 174.914 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 16' ' ' THR . . . . . . . . . . . . . 30.9 p -54.46 -51.58 64.55 Favored 'General case' 0 N--CA 1.484 1.233 0 N-CA-C 114.922 1.453 . . . . 0.0 114.922 -164.993 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 17' ' ' ARG . . . . . . . . . . . . 0.254 43.5 ttt85 -69.61 -50.33 18.93 Favored Pre-proline 0 N--CA 1.479 0.976 0 N-CA-C 115.465 1.654 . . . . 0.0 115.465 174.814 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 18' ' ' PRO . . . . . 0.436 ' HB2' ' HA ' ' A' ' 14' ' ' LEU . 47.1 Cg_exo -57.35 -38.6 94.16 Favored 'Trans proline' 0 CA--C 1.545 1.044 0 C-N-CA 122.958 2.439 . . . . 0.0 113.613 173.09 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.405 ' HB1' ' HB3' ' A' ' 50' ' ' LEU . . . -68.14 -35.33 77.92 Favored 'General case' 0 N--CA 1.479 0.989 0 N-CA-C 114.756 1.391 . . . . 0.0 114.756 172.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 20' ' ' ALA . . . . . . . . . . . . . . . -68.68 -26.26 65.21 Favored 'General case' 0 N--CA 1.484 1.246 0 N-CA-C 114.484 1.29 . . . . 0.0 114.484 173.354 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 21' ' ' GLN . . . . . 0.547 ' NE2' HD11 ' A' ' 84' ' ' LEU . 42.0 tt0 -68.48 -39.79 81.23 Favored 'General case' 0 N--CA 1.479 1.002 0 C-N-CA 124.149 0.98 . . . . 0.0 111.549 169.582 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 22' ' ' PHE . . . . . . . . . . . . . 2.2 t80 -62.5 -47.45 83.9 Favored 'General case' 0 N--CA 1.473 0.718 0 C-N-CA 123.853 0.861 . . . . 0.0 112.028 171.267 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 23' ' ' VAL . . . . . 0.424 HG22 ' O ' ' A' ' 44' ' ' ALA . 75.5 t -53.47 -56.91 6.36 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.588 0 C-N-CA 124.601 1.16 . . . . 0.0 112.023 175.336 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 24' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -39.91 -61.44 0.85 Allowed 'General case' 0 N--CA 1.481 1.076 0 C-N-CA 124.577 1.151 . . . . 0.0 112.389 170.043 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 25' ' ' GLU . . . . . . . . . . . . . 4.6 tp10 -65.99 -34.39 77.99 Favored 'General case' 0 CA--C 1.542 0.647 0 N-CA-C 114.753 1.39 . . . . 0.0 114.753 -176.156 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 26' ' ' ALA . . . . . . . . . . . . . . . -61.8 -44.38 96.97 Favored 'General case' 0 N--CA 1.482 1.172 0 C-N-CA 123.867 0.867 . . . . 0.0 112.104 176.476 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 27' ' ' LYS . . . . . . . . . . . . . 55.8 mttm -56.73 -22.68 37.2 Favored 'General case' 0 N--CA 1.478 0.938 0 N-CA-C 115.279 1.585 . . . . 0.0 115.279 176.69 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . -69.65 -43.97 65.47 Favored Glycine 0 CA--C 1.542 1.728 0 O-C-N 124.741 1.275 . . . . 0.0 111.468 178.701 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 29' ' ' PHE . . . . . . . . . . . . . 55.3 m-85 -81.79 148.35 28.92 Favored 'General case' 0 N--CA 1.469 0.51 0 CA-C-O 122.355 1.074 . . . . 0.0 112.84 -174.933 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 73.1 p -70.44 -35.26 73.26 Favored 'General case' 0 N--CA 1.488 1.468 0 CA-C-N 113.179 -1.828 . . . . 0.0 112.274 -176.048 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 31' ' ' SER . . . . . . . . . . . . . 61.1 m -49.34 148.73 2.48 Favored 'General case' 0 N--CA 1.484 1.235 0 C-N-CA 124.971 1.308 . . . . 0.0 113.457 170.021 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 32' ' ' GLU . . . . . . . . . . . . . 3.9 tp10 -91.98 104.19 16.63 Favored 'General case' 0 N--CA 1.47 0.57 0 N-CA-C 105.973 -1.862 . . . . 0.0 105.973 160.098 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 33' ' ' ILE . . . . . 0.66 HD12 ' H ' ' A' ' 33' ' ' ILE . 0.5 OUTLIER -91.1 113.15 26.32 Favored 'Isoleucine or valine' 0 N--CA 1.474 0.77 0 CA-C-N 112.052 -2.34 . . . . 0.0 106.851 176.115 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 34' ' ' THR . . . . . 0.649 ' HB ' ' HB3' ' A' ' 64' ' ' SER . 95.9 m -90.98 142.66 27.54 Favored 'General case' 0 C--N 1.316 -0.872 0 CA-C-N 113.633 -1.621 . . . . 0.0 110.407 173.144 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 35' ' ' VAL . . . . . 0.422 HG23 ' HB2' ' A' ' 44' ' ' ALA . 37.5 t -118.68 106.67 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.48 1.053 0 CA-C-N 112.512 -2.131 . . . . 0.0 108.016 176.542 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 36' ' ' THR . . . . . 0.63 HG23 ' HB3' ' A' ' 41' ' ' SER . 3.9 m -114.06 92.27 3.91 Favored 'General case' 0 N--CA 1.476 0.865 0 CA-C-N 112.787 -2.006 . . . . 0.0 109.577 -176.467 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 37' ' ' SER . . . . . . . . . . . . . 19.8 p -87.58 89.15 7.89 Favored 'General case' 0 C--O 1.244 0.767 0 CA-C-O 122.816 1.293 . . . . 0.0 110.68 179.701 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 38' ' ' ASN . . . . . . . . . . . . . 26.6 m120 46.41 74.96 0.13 Allowed 'General case' 0 N--CA 1.487 1.4 0 CA-C-N 113.012 -1.904 . . . . 0.0 112.276 -172.536 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 39' ' ' GLY . . . . . . . . . . . . . . . 76.75 -22.56 2.23 Favored Glycine 0 CA--C 1.542 1.742 0 CA-C-N 113.125 -1.852 . . . . 0.0 116.544 -179.727 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 40' ' ' LYS . . . . . . . . . . . . . 27.1 mttp -85.86 91.87 8.47 Favored 'General case' 0 N--CA 1.484 1.232 0 O-C-N 121.854 -0.792 . . . . 0.0 110.0 -177.709 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 41' ' ' SER . . . . . 0.63 ' HB3' HG23 ' A' ' 36' ' ' THR . 28.1 p -101.78 127.99 48.32 Favored 'General case' 0 CA--C 1.542 0.652 0 N-CA-C 116.502 2.038 . . . . 0.0 116.502 -169.109 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 42' ' ' ALA . . . . . . . . . . . . . . . -144.82 144.81 31.33 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-N 113.065 -1.879 . . . . 0.0 110.94 177.604 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 43' ' ' SER . . . . . . . . . . . . . 31.4 t -55.33 130.44 42.43 Favored 'General case' 0 C--O 1.247 0.951 0 N-CA-C 111.995 0.368 . . . . 0.0 111.995 168.486 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 44' ' ' ALA . . . . . 0.424 ' O ' HG22 ' A' ' 23' ' ' VAL . . . -53.77 -30.53 44.98 Favored 'General case' 0 N--CA 1.477 0.877 0 C-N-CA 124.849 1.26 . . . . 0.0 111.581 172.371 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 45' ' ' LYS . . . . . . . . . . . . . 90.0 mttt -74.0 -6.13 45.58 Favored 'General case' 0 N--CA 1.483 1.18 0 N-CA-C 114.784 1.401 . . . . 0.0 114.784 179.814 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 46' ' ' SER . . . . . 0.508 ' HB3' ' HB2' ' A' ' 49' ' ' LYS . 0.3 OUTLIER -101.03 103.64 14.77 Favored 'General case' 0 N--CA 1.482 1.14 0 N-CA-C 114.472 1.286 . . . . 0.0 114.472 -171.107 . . . . . . . . 3 3 . 1 . 030 nuclear nobuild full ' A' A ' 47' ' ' LEU . . . . . . . . . . . . . 17.2 tp -49.06 -73.06 0.04 OUTLIER 'General case' 0 N--CA 1.492 1.641 0 N-CA-C 115.208 1.558 . . . . 0.0 115.208 -176.807 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 48' ' ' PHE . . . . . . . . . . . . . 51.5 t80 -45.26 -48.6 12.81 Favored 'General case' 0 N--CA 1.479 1.02 0 C-N-CA 125.16 1.384 . . . . 0.0 113.922 177.657 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 49' ' ' LYS . . . . . 0.508 ' HB2' ' HB3' ' A' ' 46' ' ' SER . 66.0 mmtt -52.33 -52.47 53.0 Favored 'General case' 0 N--CA 1.469 0.522 0 CA-C-O 117.125 -1.417 . . . . 0.0 114.157 175.571 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 50' ' ' LEU . . . . . 0.405 ' HB3' ' HB1' ' A' ' 19' ' ' ALA . 6.3 mp -71.98 -35.94 69.64 Favored 'General case' 0 N--CA 1.478 0.956 0 N-CA-C 115.505 1.669 . . . . 0.0 115.505 -178.556 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 51' ' ' GLN . . . . . . . . . . . . . 37.5 mt-30 -62.86 -31.08 72.04 Favored 'General case' 0 N--CA 1.473 0.705 0 N-CA-C 113.241 0.83 . . . . 0.0 113.241 175.014 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 52' ' ' THR . . . . . . . . . . . . . 40.9 p -84.78 -35.48 22.34 Favored 'General case' 0 N--CA 1.484 1.266 0 N-CA-C 115.831 1.789 . . . . 0.0 115.831 171.167 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 53' ' ' LEU . . . . . . . . . . . . . 7.8 tp -67.61 122.92 19.07 Favored 'General case' 0 N--CA 1.474 0.733 0 C-N-CA 124.033 0.933 . . . . 0.0 111.174 -176.823 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 54' ' ' GLY . . . . . . . . . . . . . . . -64.92 100.14 0.42 Allowed Glycine 0 CA--C 1.54 1.619 0 CA-C-N 113.512 -1.676 . . . . 0.0 113.471 -177.446 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 55' ' ' LEU . . . . . . . . . . . . . 6.2 mt -125.39 88.44 2.87 Favored 'General case' 0 CA--C 1.544 0.73 0 C-N-CA 124.67 1.188 . . . . 0.0 110.293 -179.681 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 56' ' ' THR . . . . . . . . . . . . . 8.9 t -143.49 -166.62 2.37 Favored 'General case' 0 C--O 1.199 -1.584 0 CA-C-N 115.679 -0.692 . . . . 0.0 112.682 -175.396 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 57' ' ' GLN . . . . . . . . . . . . . 34.7 tt0 -56.28 118.31 4.62 Favored 'General case' 0 C--N 1.355 0.828 0 C-N-CA 124.774 1.23 . . . . 0.0 112.138 -178.399 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 104.58 -30.12 10.66 Favored Glycine 0 CA--C 1.544 1.863 0 CA-C-N 112.631 -2.077 . . . . 0.0 113.842 -178.697 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 59' ' ' THR . . . . . . . . . . . . . 2.2 m -68.04 137.68 55.24 Favored 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 124.874 1.27 . . . . 0.0 113.375 -174.335 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 60' ' ' VAL . . . . . 0.752 HG22 HG22 ' A' ' 7' ' ' THR . 11.5 t -116.77 114.38 45.73 Favored 'Isoleucine or valine' 0 N--CA 1.475 0.821 0 CA-C-N 113.328 -1.76 . . . . 0.0 109.333 -169.302 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 61' ' ' VAL . . . . . . . . . . . . . 13.9 p -109.53 96.84 5.02 Favored 'Isoleucine or valine' 0 CA--C 1.549 0.925 0 CA-C-N 112.952 -1.931 . . . . 0.0 112.269 -166.704 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 62' ' ' THR . . . . . 0.515 ' HB ' ' HB ' ' A' ' 36' ' ' THR . 30.6 m -72.07 101.75 2.82 Favored 'General case' 0 N--CA 1.48 1.048 0 CA-C-N 111.614 -2.539 . . . . 0.0 108.6 173.425 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 63' ' ' ILE . . . . . 0.509 HG22 HG22 ' A' ' 74' ' ' VAL . 5.5 mt -94.23 112.57 27.21 Favored 'Isoleucine or valine' 0 N--CA 1.473 0.688 0 CA-C-O 123.772 1.748 . . . . 0.0 110.507 -178.336 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 64' ' ' SER . . . . . 0.649 ' HB3' ' HB ' ' A' ' 34' ' ' THR . 13.3 t -123.79 96.03 4.8 Favored 'General case' 0 N--CA 1.476 0.844 0 CA-C-N 109.973 -3.285 . . . . 0.0 113.215 -159.514 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 65' ' ' ALA . . . . . . . . . . . . . . . -105.17 117.7 34.68 Favored 'General case' 0 N--CA 1.471 0.622 0 CA-C-N 113.523 -1.671 . . . . 0.0 113.229 -170.046 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 66' ' ' GLU . . . . . 0.44 ' HB3' ' HG3' ' A' ' 1' ' ' MET . 9.0 pt-20 -120.13 86.96 2.66 Favored 'General case' 0 N--CA 1.481 1.097 0 N-CA-C 115.719 1.748 . . . . 0.0 115.719 -176.245 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 67' ' ' GLY . . . . . . . . . . . . . . . -176.24 -164.48 30.46 Favored Glycine 0 N--CA 1.477 1.398 0 CA-C-N 112.34 -2.209 . . . . 0.0 110.048 171.114 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 68' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -59.83 -34.82 73.59 Favored 'General case' 0 CA--C 1.541 0.598 0 N-CA-C 114.757 1.391 . . . . 0.0 114.757 -179.658 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 69' ' ' ASP . . . . . . . . . . . . . 13.9 p30 -104.55 43.39 1.1 Allowed 'General case' 0 C--O 1.206 -1.2 0 N-CA-C 116.223 1.935 . . . . 0.0 116.223 -176.187 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 70' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -55.77 -63.12 1.28 Allowed 'General case' 0 CA--C 1.552 1.02 0 N-CA-C 117.15 2.278 . . . . 0.0 117.15 -178.892 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 71' ' ' GLN . . . . . . . . . . . . . 23.1 mt-30 -62.71 -44.97 94.86 Favored 'General case' 0 N--CA 1.483 1.205 0 N-CA-C 115.723 1.749 . . . . 0.0 115.723 173.419 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 72' ' ' LYS . . . . . . . . . . . . . 83.3 tttt -49.08 -50.15 38.15 Favored 'General case' 0 N--CA 1.475 0.805 0 C-N-CA 124.339 1.056 . . . . 0.0 113.124 173.63 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -62.42 -55.79 24.47 Favored 'General case' 0 N--CA 1.473 0.706 0 C-N-CA 123.797 0.839 . . . . 0.0 112.394 -177.483 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 74' ' ' VAL . . . . . 0.509 HG22 HG22 ' A' ' 63' ' ' ILE . 31.4 t -62.44 -37.16 78.07 Favored 'Isoleucine or valine' 0 CA--C 1.544 0.749 0 CA-C-O 117.759 -1.115 . . . . 0.0 111.992 -177.962 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 75' ' ' GLU . . . . . . . . . . . . . 2.7 tt0 -58.67 -46.78 86.45 Favored 'General case' 0 N--CA 1.484 1.225 0 O-C-N 123.478 0.487 . . . . 0.0 111.548 178.659 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 76' ' ' HIS . . . . . 0.46 ' O ' ' HB3' ' A' ' 79' ' ' LYS . 67.3 t60 -74.27 -32.03 62.77 Favored 'General case' 0 N--CA 1.477 0.882 0 CA-C-N 114.466 -1.243 . . . . 0.0 113.149 -178.852 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 77' ' ' LEU . . . . . 0.456 ' CD1' HG21 ' A' ' 33' ' ' ILE . 54.2 mt -74.85 -36.83 62.34 Favored 'General case' 0 N--CA 1.481 1.122 0 N-CA-C 113.199 0.814 . . . . 0.0 113.199 173.688 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 78' ' ' VAL . . . . . . . . . . . . . 53.2 t -65.45 -38.7 83.1 Favored 'Isoleucine or valine' 0 N--CA 1.485 1.3 0 CA-C-O 118.577 -0.725 . . . . 0.0 110.525 173.347 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 79' ' ' LYS . . . . . 0.46 ' HB3' ' O ' ' A' ' 76' ' ' HIS . 77.1 tttt -48.21 -58.69 4.19 Favored 'General case' 0 N--CA 1.479 0.979 0 O-C-N 124.628 1.205 . . . . 0.0 110.521 163.597 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 7.8 mp -58.41 -48.04 81.96 Favored 'General case' 0 N--CA 1.482 1.169 0 N-CA-C 117.162 2.282 . . . . 0.0 117.162 176.375 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 81' ' ' MET . . . . . 0.549 ' HG2' HD11 ' A' ' 14' ' ' LEU . 13.5 tmm? -52.08 -44.67 64.47 Favored 'General case' 0 N--CA 1.48 1.027 0 C-N-CA 125.513 1.525 . . . . 0.0 112.35 174.442 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 82' ' ' ALA . . . . . . . . . . . . . . . -76.27 -25.34 54.84 Favored 'General case' 0 N--CA 1.484 1.23 0 N-CA-C 112.978 0.733 . . . . 0.0 112.978 -179.767 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 83' ' ' GLU . . . . . . . . . . . . . 24.3 mt-10 -83.89 -22.05 31.74 Favored 'General case' 0 CA--C 1.554 1.104 0 N-CA-C 116.713 2.116 . . . . 0.0 116.713 178.977 . . . . . . . . 1 1 . 1 . 030 nuclear nobuild full ' A' A ' 84' ' ' LEU . . . . . 0.547 HD11 ' NE2' ' A' ' 21' ' ' GLN . 36.0 mt -93.75 142.43 27.37 Favored 'General case' 0 N--CA 1.478 0.966 0 N-CA-C 119.021 2.971 . . . . 0.0 119.021 -172.586 . . . . . . . . 2 2 . 1 . 030 nuclear nobuild full ' A' A ' 85' ' ' GLU . . . . . . . . . . . . . 28.8 mt-10 . . . . . 0 CA--C 1.556 1.196 0 CA-C-N 111.514 -2.584 . . . . 0.0 109.513 -167.766 . . . . . . . . 0 0 . 1 stop_ save_